{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "qwen3-32b",
    "experiment": "e2_page_window",
    "pattern": "qualitative_2hop_cross_year",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 1000,
    "successful_questions_in_experiment": 1000,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 1000,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/qwen3-32b/e2_page_window/qualitative_2hop_cross_year.json",
    "timestamp": "2026-02-05T04:01:54.236577"
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "The gross benefit obligation for LMT's nonqualified defined benefit pension plans decreased from $1.0 billion as of December 31, 2023, to $905 million as of December 31, 2024. Additionally, the actuarial losses related to these plans decreased from $347 million at the end of 2023 to $303 million at the end of 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the gross benefit obligation decreased from $1.0 billion in 2023 to $905 million in 2024, and actuarial losses declined from $347 million to $303 million. These values exactly match the original answer, with acceptable formatting (e.g., 'as of December 31' aligns with fiscal year-end reporting in 10-K filings). (2) The answer is complete, addressing both parts of the question—the evolution of the gross benefit obligation and actuarial losses—over the two years. (3) Entity accuracy is correct: LMT refers to Lockheed Martin, and the metrics (gross benefit obligation, actuarial losses) and years (2023, 2024) are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across the two years for both metrics, correctly identifying the direction and magnitude of change. (5) The semantic meaning is equivalent to the original answer, with slightly more formal phrasing but no loss or distortion of information. No errors in calculation, logic, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 319,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "General Motors' long-term rate of return assumptions on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024, following an investment policy study. This increase, alongside a shift in the strategic asset mix—reducing equity exposure from 11% to 11% (unchanged) and increasing debt from 60% to 60% (unchanged), while adjusting other investments from 29% to 29%—suggests a focus on maintaining a balanced portfolio to manage funded status volatility and align with long-term liabilities. The adjustments reflect a strategic effort to optimize returns while mitigating risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2024 rate of return increase from 6.3% to 6.5%, which aligns with the ground truth. However, it completely omits the 2022 information, which is a critical part of the question—specifically, the decrease from 5.6% (2020) to 5.4% (2021) as reported in the 2022 filing. This omission severely undermines completeness and factual accuracy. (2) The quantitative accuracy is partially correct for the 2024 figures but fails on the 2022 side. Additionally, the LLM fabricates asset mix details (equity at 11%, debt at 60%, other at 29%) with no changes indicated, which are not present in the original answer and contradict the ground truth’s focus on shifting assumptions rather than reported allocations. There is no mention in the ground truth of an 'investment policy study' or specific portfolio percentages, making these hallucinations. (3) The multi-hop reasoning is flawed: the question asks for an evolution between 2022 and 2024, requiring synthesis of both time points. The LLM only addresses 2024 and projects backward incorrectly, failing to show the shift from conservative to optimistic assumptions over time. The conclusion about 'maintaining a balanced portfolio' is speculative and not aligned with the ground truth’s interpretation of a strategic shift toward more optimistic projections. (4) While the 2024 numbers are accurate and contextually relevant, the omission of 2022 data and fabrication of asset mix percentages significantly reduce correctness and qualitative accuracy. The answer is relevant in structure but fails on core factual and synthetic requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 447,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved significantly between 2023 and 2024, as PDC was acquired by Chevron in 2023 and became a wholly-owned subsidiary. In the 2023 10-K, PDC is excluded from Chevron's internal control over financial reporting assessment because it was newly acquired. By 2024, PDC's operations are fully integrated into Chevron's financial and operational reporting. Operationally, PDC's production contributed to an increase in Chevron's U.S. upstream net oil-equivalent production by 250,000 barrels per day in 2024, primarily due to the full-year inclusion of legacy PDC assets. Financially, PDC added to Chevron's sales volumes but was partially offset by lower commodity prices and realization rates.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the acquisition of PDC Energy by Chevron in 2023 and the exclusion of PDC from internal controls in the 2023 10-K, which aligns with the ground truth. It also correctly notes the full integration by 2024. However, it provides incorrect quantitative details: it states a production increase of '250,000 barrels per day' without specifying this is net oil-equivalent production, and more critically, this number does not match the ground truth's '19% increase in net oil-equivalent production'. The financial impact is inaccurately described as contributing to sales volumes 'partially offset by lower commodity prices', which is not mentioned in the ground truth; instead, the correct financial impact is a '$2.2 billion increase in U.S. upstream earnings'. (2) The key numbers—$2.2 billion earnings increase and 19% production growth—are entirely missing or replaced with fabricated figures (250,000 bpd). There is no indication that 250,000 bpd corresponds to the 19% increase, nor is there a calculation to verify equivalence. (3) The multi-hop reasoning is partially sound: the model connects the acquisition to integration and subsequent operational impact, and correctly uses the concept of full-year contribution. However, it fails to synthesize the correct financial outcome from the integration, substituting a plausible but incorrect narrative about commodity price offsets. (4) The contextual relevance is high as the answer addresses the evolution of the relationship and attempts both operational and financial impacts. Qualitative accuracy is moderate due to correct sequencing and entity identification. Quantitative accuracy is low due to incorrect key metrics. Correctness score is 5 due to significant factual gaps in numbers and financial impact, despite correct high-level narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 500,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "Between 2022 and 2024, Southern Company's treatment and valuation of energy-related derivatives remained consistent in terms of accounting methods (regulatory hedges, cash flow hedges, and not designated hedges), but there were changes in the presentation and magnitude of unrealized gains and losses. In 2022, unrealized gains and losses were primarily deferred in regulatory assets and liabilities for regulatory hedges and in AOCI for cash flow hedges. By 2024, the presentation remained similar, but the net amounts recognized in the balance sheets increased, reflecting larger derivative positions and valuation changes. Additionally, the unrealized gains and losses were more distributed across current and non-current assets and liabilities in 2024 compared to 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects. While it correctly identifies that Southern Company uses regulatory hedges and defers unrealized gains/losses in regulatory assets/liabilities and AOCI, it incorrectly asserts that the accounting methods remained consistent between 2022 and 2024. The ground truth indicates a shift in disclosure focus and presentation—from deferring unrealized gains/losses (as of 2020 and 2021) to emphasizing fair value presentation in balance sheets under 'Other' or 'Risk Management Activities' by 2024—suggesting a change in both valuation approach and presentation. The LLM answer misses this critical shift entirely and instead claims continuity with only 'increased net amounts' and 'more distributed' presentation, which is not supported by the original answer. (2) There are no specific numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not heavily penalized; however, the LLM introduces unverified claims about 'larger derivative positions' and 'increased' balance sheet amounts without supporting data, reducing confidence in its factual basis. (3) The multi-hop reasoning is weak: the model fails to synthesize the change in disclosure strategy over time, which is central to the question. It focuses on consistency rather than evolution in treatment, missing the core transformation in how derivatives are valued and presented. (4) Contextual relevance is high because the answer addresses energy-related derivatives, unrealized gains/losses, balance sheet presentation, and time period comparison. However, the qualitative inaccuracy in portraying continuity instead of change undermines correctness. Thus, while the framework is relevant, the factual and reasoning flaws limit accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 511,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "Between 2022 and 2024, Chevron's financial relationship with Tengizchevroil (TCO) showed notable changes in both investment carrying value and equity earnings. The carrying value of Chevron's investment in TCO increased from $23,727 million in 2022 to $27,368 million in 2024. Meanwhile, equity earnings from TCO decreased from $4,386 million in 2022 to $3,033 million in 2024, reflecting a decline in earnings contribution from this joint venture over the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key trends in Chevron's financial relationship with Tengizchevroil (TCO) between 2022 and 2024. It correctly reports that equity earnings declined from $4,386 million in 2022 to $3,033 million in 2024, matching the ground truth. It also accurately states the 2024 investment and advances value of $27,368 million. However, the LLM claims the 2022 carrying value was $23,727 million, which is not mentioned in the original answer. The ground truth does not provide a total carrying value for 2022 but instead notes that Chevron's carrying value was about $100 higher than its underlying equity in TCO's net assets, with a $4,500 million loan as a key component. The $23,727 million figure appears to be an external or inferred number not supported by the provided truth. This omission of context and introduction of an unsupported specific figure reduces quantitative and qualitative accuracy. The answer is contextually relevant and synthesizes the trend correctly—showing increasing investment value and decreasing earnings—but misses the nuance about the nature of the investment (e.g., the loan funding FGP/WPMP) and provides a potentially misleading precise carrying value for 2022. Thus, while the directional analysis and key 2022 and 2024 earnings figures are correct, the unsupported 2022 carrying value number prevents a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 384,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Walmart's ownership stake in Alert Innovation evolved from fiscal 2023 to fiscal 2024 as the company completed a $0.4 billion acquisition of the entity during fiscal 2023, increasing its ownership to 100%. However, in fiscal 2025, the entity was sold and deconsolidated. No specific transactions occurred between fiscal 2023 and fiscal 2024 that altered Walmart's ownership in Alert Innovation during that period.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the timeline: it states that Alert Innovation was sold and deconsolidated in 'fiscal 2025', whereas the ground truth confirms this occurred in 'fiscal 2024'. This misrepresents the entire evolution of ownership between fiscal 2023 and 2024. Additionally, the LLM incorrectly claims that 'no specific transactions occurred between fiscal 2023 and fiscal 2024', which directly contradicts the ground truth that the sale and deconsolidation happened in fiscal 2024—i.e., within that exact period. (2) Quantitatively, the $0.4 billion acquisition amount is correctly stated, earning partial credit. However, the erroneous fiscal year for the sale undermines the accuracy of the temporal context. (3) The multi-hop reasoning fails because the model does not correctly synthesize the sequence of events: full acquisition in fiscal 2023 followed by complete divestiture in fiscal 2024. Instead, it pushes the sale to fiscal 2025, breaking the logical chain and implying continued ownership during 2024, which is false. (4) The contextual relevance is moderate because the answer discusses the right entities and transactions but places them in the wrong timeframe, leading to a fundamentally incorrect conclusion about the evolution of ownership. The core claim—that no change occurred between 2023 and 2024—is false per the ground truth. Thus, despite correct mention of the $0.4B acquisition, the answer is largely incorrect due to the critical timing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 418,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "Starbucks' foreign currency - other derivative asset positions increased from $179.1 million as of September 29, 2024 (fiscal 2023) compared to $153.0 million as of October 1, 2023 (fiscal 2022), while liability positions decreased from $46.8 million to $85.9 million. This indicates a net increase in asset positions, suggesting the company is actively managing its foreign currency exposure by hedging more anticipated cash flows and intercompany transactions, which reflects a proactive strategy to mitigate foreign exchange risks.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both direction and magnitude. According to the ground truth, Starbucks had a foreign currency - other derivative asset of $55.3 million in AOCI in fiscal 2022, not $153.0 million as stated by the LLM. In fiscal 2023, the company reported only $1.9 million in current assets and $1.7 million in long-term assets for this category, not $179.1 million. The LLM also incorrectly states liability positions increased from $46.8 million to $85.9 million, while the ground truth shows liabilities of $4.7 million (current) and $4.1 million (long-term), totaling $8.8 million — far below the LLM's figures. (2) The numbers cited by the LLM ($153.0M, $179.1M, $46.8M, $85.9M) do not appear anywhere in the ground truth and are factually wrong. Additionally, the fiscal years are misrepresented — the LLM references September 29, 2024, as fiscal 2023, but the ground truth uses fiscal years ending in 2022 and 2023, typically around October. (3) The multi-hop reasoning is completely flawed. The LLM suggests an increase in asset positions and higher hedging activity, while the ground truth indicates a dramatic reduction in exposure — from a $55.3 million AOCI asset to minimal asset/liability balances across short- and long-term accounts — signaling a de-risking or unwinding of positions, not increased hedging. (4) The contextual relevance is low because the answer discusses the right topic (foreign currency derivatives and risk management), but all supporting data and conclusions are factually incorrect. The qualitative reasoning fails due to incorrect entity mapping and synthesis. Quantitative accuracy is extremely poor. Correctness score is 1 due to complete factual inaccuracy despite addressing the general subject area.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 486,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "Between fiscal years 2022 and 2024, Medtronic's treatment of A Preferred Shares remained consistent, with no shares outstanding in either year. In 2022, the company specifically redeemed the previously outstanding 1,872 A Preferred Shares for $0.075 million, leaving no A Preferred Shares outstanding as of April 29, 2022. This redemption marked the action taken regarding these shares in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential facts from the ground truth. (1) All key information is correct: Medtronic redeemed 1,872 A Preferred Shares for $0.075 million in fiscal year 2022, and no shares were outstanding as of April 29, 2022. The answer correctly notes that no A Preferred Shares were outstanding in 2024. (2) Quantitative accuracy is perfect: the number of shares (1,872), dollar amount ($0.075 million), and date (April 29, 2022) match the ground truth exactly. Format variations are acceptable and correctly interpreted. (3) The multi-hop reasoning is sound—linking the 2022 redemption to the continued absence of shares in 2024—but the LLM slightly softens the conclusion by saying treatment 'remained consistent' rather than explicitly stating the discontinuation or non-reintroduction of the shares, which is implied in the original answer. This minor omission in emphasis prevents a perfect 10 on qualitative accuracy. (4) The response is fully contextually relevant, directly addressing both parts of the question: the evolution between 2022 and 2024 and the specific 2022 action. Overall, the answer is factually complete and semantically equivalent to the ground truth with only a slight reduction in precision regarding the long-term implication of discontinuation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 364,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "Comcast's financial relationship with Atairos evolved significantly between 2022 and 2023 in terms of equity income driven by fair value adjustments. In 2023, Comcast reported equity income from Atairos of $1.1 billion, a substantial improvement from a loss of $434 million in 2022. This shift reflects a positive change in the fair value of Atairos' underlying investments during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: Comcast's equity loss from Atairos was $434 million in 2022 and turned into $1.1 billion in income in 2023. The numbers match the original answer exactly, with correct signs (implied negative for the loss) and units. (2) Quantitative accuracy is perfect: both the $434 million loss and $1.1 billion gain are correctly reported, and the comparison between years reflects the turnaround. Format variations (e.g., '$434 million' vs '$434M') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—information from two different years and financial states (loss to gain) is correctly synthesized to show evolution in the financial relationship. The cause—fair value adjustments on underlying investments—is correctly attributed. (4) The answer is contextually relevant, directly addressing the evolution of Comcast's financial relationship with Atairos in terms of equity income driven by fair value changes. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 313,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased slightly from 312 billion cubic feet (BCF) at the end of 2023 to 296 BCF at the end of 2024, as shown in the reserves table. This modest decline suggests a relatively stable but non-expanding position in the region for natural gas. The company's strategic focus appears to be more on other regions, such as the Lower 48 in the U.S., where significant additions from development drilling and acquisitions were reported. The slight decrease in Asia Pacific/Middle East reserves does not indicate a major shift in strategic positioning but rather a balanced approach to resource management in the region.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of change: it states that reserves 'increased slightly' from 312 BCF in 2023 to 296 BCF in 2024, when in fact this is a decrease. This misrepresents the core quantitative fact. While the actual numbers (312 BCF in 2023 and 296 BCF in 2024) are correctly cited, the interpretation of the trend is reversed, which undermines the answer's correctness. (2) The numbers themselves are accurate and match the ground truth—312 BCF in 2023 and 296 BCF in 2024—with correct units and years. However, the comparison is flawed: a drop from 312 to 296 BCF is a decline of 16 BCF, not an increase. The LLM incorrectly frames this as an 'increase' despite the lower 2024 value. (3) The multi-hop reasoning is partially sound—the model attempts to contextualize the reserve change within COP's broader regional strategy, referencing the Lower 48 U.S. region and strategic focus. This shows an effort to synthesize and interpret, which supports qualitative and contextual relevance. However, the flawed quantitative interpretation weakens the logical foundation of the conclusion. (4) The correctness score is 4 due to the major error in interpreting the direction of change, despite correct raw numbers. Quantitative accuracy is low (3) because the comparison is fundamentally wrong. Qualitative accuracy is moderate (5) as reasoning and entity identification (COP, regions, strategic positioning) are reasonable but based on incorrect premises. Contextual relevance is high (8) because the answer addresses both parts of the question and attempts strategic interpretation appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 452,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL's revenue in Canada declined significantly from $113 million in 2021 to $73 million in 2022 and further to $47 million in 2023, representing a 35% drop in 2022 and a 36% drop in 2023. This continued decline indicates a challenging market trajectory for ENBREL in Canada, driven by lower net selling prices, inventory reductions, and unfavorable changes in estimated sales deductions. The trend suggests increasing competitive pressures and market erosion, with no signs of recovery in the near term.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and dates. According to the ground truth, ENBREL revenue in Canada was $113M in 2022, $47M in 2023, and $28M in 2024. However, the LLM incorrectly states $113M in 2021 (not in the question scope), $73M in 2022 (should be $113M), and omits 2024 entirely. The 2024 data point ($28M) is completely missing, which is critical for answering the 2022–2024 evolution. (2) Calculations are based on incorrect data: the claimed 35% drop from 2021 to 2022 and 36% from 2022 to 2023 use wrong base figures. The actual decline from 2022 ($113M) to 2023 ($47M) is ~58.4%, and to 2024 ($28M) is ~75.2% from 2022. (3) The multi-hop reasoning is partially sound in identifying a downward trend and attributing it to market challenges, but it synthesizes data from outside the specified timeframe (2021) and misses the full trajectory by omitting 2024. (4) While the qualitative interpretation of declining market trajectory is aligned with the ground truth, the answer is undermined by major quantitative errors and incomplete time coverage. Contextual relevance is high as it addresses revenue evolution and market implications, but factual correctness is low due to incorrect figures and timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 355,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "Qualcomm enhanced its approach to linking human capital advancements with executive compensation in fiscal 2024 by incorporating progress toward human capital goals as a non-financial performance modifier for executives' bonuses. Specifically, for fiscal 2024, this modifier could adjust bonus payouts by a multiple ranging from 0.9 to 1.1, reflecting a more direct alignment between human capital achievements and executive compensation compared to prior years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in Qualcomm's approach from fiscal 2023 to fiscal 2024, noting that human capital advancements transitioned from being a general consideration to a formal non-financial performance modifier. The specific performance modifier range of 0.9 to 1.1 for fiscal 2024 is accurately reported, matching the ground truth. (2) All numeric values (the multiplier range 0.9–1.1) are correct and precisely stated; no calculations were required beyond accurate reporting. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across fiscal years, identifying the shift in compensation strategy from a qualitative factor in 2023 to a quantified modifier in 2024. While the LLM does not explicitly mention 'fiscal 2023 indicated bonuses for 2024,' it still captures the essence of the evolution. (4) The answer is semantically equivalent to the ground truth, with only minor omission of the explicit reference to fiscal 2023's forward-looking statement. This does not detract from the core factual accuracy, hence a high score. All entities—Qualcomm, fiscal 2024, executive compensation, bonus modifier—are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 345,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "Between 2022 and 2024, the therapeutic scope of Breyanzi expanded significantly. In 2022, Breyanzi was approved for treating relapsed or refractory large B-cell lymphoma (including DLBCL, LBCL, and FL) after two or more lines of systemic therapy. By 2024, additional approvals were granted, including for relapsed or refractory chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), follicular lymphoma (FL) after at least two prior lines of therapy, and mantle cell lymphoma (MCL) in patients who had received at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor. These approvals reflect Breyanzi's expanded role in treating a broader range of B-cell malignancies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that Breyanzi was already approved in 2022 for large B-cell lymphoma indications, whereas the ground truth indicates it was still in late-stage trials (TRANSCEND-CLL-004 and TRANSCEND-FL) for CLL and FL with expected timing in 2023/24—not approvals. The actual approvals occurred in 2024, not 2022. (2) The LLM claims approvals for mantle cell lymphoma (MCL) in 2024, which is not supported by the original answer and represents a completely unsupported expansion. (3) While the LLM correctly identifies the 2024 approvals for CLL/SLL (March 2024) and FL (May 2024), it misrepresents the timeline by suggesting prior approvals existed in 2022. (4) The multi-hop reasoning is flawed: instead of showing evolution from trial phase (2022) to approval (2024), it falsely asserts existing approvals in 2022 and an expansion from there. The ground truth emphasizes a shift from investigational status to accelerated approval, which the LLM fails to capture. (5) Quantitative accuracy is low due to incorrect dates (2022 vs actual 2024 approvals) and inclusion of unmentioned indications (MCL). (6) Contextual relevance is moderate because the answer discusses the right drug and general disease areas, but the factual errors in timing and indications severely limit usefulness. Semantic equivalence is not achieved due to major factual divergence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 400,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "From 2023 to 2024, Disney's Resorts and Vacations segment revenue increased by 5%, driven by higher average ticket prices for cruise line sailings, increased hotel room rates, and higher occupied hotel room nights, partially offset by lower unit sales at Disney Vacation Club. This growth in the Resorts and Vacations segment aligns closely with the overall 5% revenue growth of the broader Parks & Experiences segment, indicating that the segment performed in line with the segment's overall performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 5% revenue growth for both the Resorts and Vacations segment and the overall Parks & Experiences segment, which aligns with the ground truth. However, it omits the actual dollar amounts ($7,949 million in 2023 and $8,375 million in 2024 for Resorts and Vacations; $32,549 million to $34,151 million for Parks & Experiences), which are key quantitative details from the original answer. While the percentage growth is accurate, the absence of absolute figures reduces completeness and quantitative precision. (2) The calculation of 5% growth is consistent with the ground truth: (8,375 - 7,949) / 7,949 ≈ 5.36%, which rounds to about 5%, and similarly for the overall segment: (34,151 - 32,549) / 32,549 ≈ 4.92%, also approximately 5%. The model correctly characterizes the growth rates as equal, though in reality the segment grew slightly faster than the overall division, a nuance not captured. (3) The reasoning is sound in concluding that Resorts and Vacations performed in line with the overall segment, but the original answer notes that its proportion of total revenue remained consistent, which implies stable contribution—this insight is missing. Additionally, the LLM introduces explanatory drivers (e.g., higher ticket prices, hotel rates, occupancy) that are not present in the ground truth and cannot be verified from the provided data, potentially adding unsupported qualitative detail. (4) Despite missing exact figures and introducing unverified causal factors, the core multi-hop comparison—growth rate of Resorts and Vacations vs. overall Parks & Experiences—is correctly synthesized and factually aligned in magnitude. Hence, correctness is high but not complete, warranting a 7. Quantitative accuracy is strong due to correct percentages but docked slightly for missing raw numbers. Qualitative accuracy is reduced due to unsupported reasoning elements. Contextual relevance is excellent as all parts of the question are addressed in spirit.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 541,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "Between 2023 and 2024, the structure and value of CVS's forward contracts associated with ASR transactions evolved as follows: In 2023, the $2.0 billion ASR with Citibank, N.A. was accounted for as an initial treasury stock transaction for $1.6 billion and a forward contract for $0.4 billion, which was settled in February 2023. In 2024, the $3.0 billion ASR with Morgan Stanley was similarly structured, with $2.6 billion initially recorded as treasury stock and $0.4 billion as a forward contract, which was settled in March 2024. The value of the forward contracts remained proportionally consistent at 20% of the notional amount, but the total notional value increased from $2.0 billion to $3.0 billion, reflecting a larger scale of repurchase activity in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the dollar amounts for both the 2023 and 2024 ASR transactions, including the $1.6B/$0.4B and $2.6B/$0.4B splits, and the counterparties (Citibank, Morgan Stanley), as well as settlement months (February 2023, March 2024). These quantitative details match the ground truth. However, the LLM incorrectly states that the forward contract value remained at 20% of the notional amount in both years. In 2023, $0.4B was indeed 20% of $2.0B, but in 2024, $0.4B is only ~13.3% of $3.0B, not 20%. This mischaracterization of the proportion is a significant qualitative error. (2) All individual numbers (dollar values, dates) are accurate and correctly attributed. The calculation of proportions, however, is flawed—LLM incorrectly asserts proportional consistency, which contradicts the ground truth observation that the proportion shifted. (3) The multi-hop reasoning is mostly sound: the model correctly synthesizes data across two years and two ASR transactions, compares structure and value, and infers intent (larger repurchase activity). However, the erroneous conclusion about proportional consistency undermines the reasoning quality. (4) The answer is highly contextually relevant, directly addressing the evolution of structure and value. Scores reflect mostly correct facts but a key misinterpretation in the analysis of proportions, preventing a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 395,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology showed increased transparency in 2024 compared to 2023 in terms of fair value categorization. In 2024, the company provided more detailed breakdowns of fair value measurements, including clearer explanations of Level 1, Level 2, and Level 3 categorizations for different asset classes. Additionally, the 2024 filing included more specific reconciliations of Level 3 assets and elaborated on the practical expedients used for investments not categorized in the fair value hierarchy. This enhanced level of detail and clarity in the 2024 disclosure reflects improved transparency around how the fair value of pension assets is determined and categorized.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies increased transparency in Duke Energy's 2024 disclosures regarding the Master Retirement Trust's pension asset valuation methodology compared to 2023, which aligns with the ground truth. It correctly notes the continued use of the net asset value practical expedient for certain investments not categorized in the fair value hierarchy. However, it overstates the extent and nature of the new disclosures. The ground truth specifies that the only new element in 2024 was a reconciliation of beginning and ending balances for Level 3 assets in the qualified pension and other post-retirement plans. The LLM incorrectly claims that the 2024 filing included 'clearer explanations of Level 1, Level 2, and Level 3 categorizations' and 'more detailed breakdowns' across all levels, which is not supported by the original answer. There is no mention in the ground truth of improvements to Level 1 or Level 2 disclosures. (2) Quantitatively, there are no explicit numbers (percentages, dollar amounts) in the original answer beyond the mention of unchanged allocation percentages, which the LLM does not contradict. The absence of specific figures in both answers allows for semantic consistency in this regard. (3) The multi-hop reasoning is partially sound: the model correctly infers increased transparency from the addition of a Level 3 reconciliation. However, it extrapolates beyond the evidence by implying broader enhancements across all fair value levels and more comprehensive explanations, which constitutes a failure in precise synthesis. (4) The contextual relevance is high because the response directly addresses the evolution of disclosure practices and fair value categorization. The qualitative accuracy is reduced due to unsupported elaboration, and the correctness score reflects that the core fact (added Level 3 reconciliation) is present but embedded in an inflated characterization of transparency improvements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 533,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial obligations and revenue recognition related to Paxlovid changed significantly due to the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile (SNS). In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses from the U.S. government. In 2024, this was adjusted with a $771 million favorable final adjustment after 5.1 million courses were returned through February 29, 2024. Additionally, in the third quarter of 2024, Pfizer created a U.S. SNS of 1.0 million treatment courses at no cost to the government, recognizing $442 million in revenue for these courses. This transition reflects the shift from government contracts to commercial markets and the establishment of a stockpile for future pandemic preparedness.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key facts from the ground truth: the $3.5 billion non-cash revenue reversal in 2023 due to expected return of 6.5 million Paxlovid courses, the $771 million favorable adjustment in 2024 based on the actual return of 5.1 million courses, and the $442 million revenue recognized in 2024 related to the creation of the 1.0 million course U.S. Strategic National Stockpile. All dollar amounts and quantities are accurate. (2) Quantitative accuracy is perfect: $3.5 billion, $771 million, and $442 million are all correctly reported; the shift from 6.5 million to 5.1 million returned courses is accurately reflected. The mention of 'through February 29, 2024' adds specificity not in the original but does not contradict it. (3) The multi-hop reasoning is sound—correctly linking 2023 reversal to 2024 adjustment and new revenue from SNS creation. The only minor issue is the phrase 'created a U.S. SNS of 1.0 million treatment courses at no cost to the government,' which could imply Pfizer bore the cost, but in context, it correctly aligns with revenue recognition for donated inventory, which is consistent with accounting practices. This nuance is slightly ambiguous but not factually incorrect. (4) The answer is fully contextually relevant, directly addressing the change in financial obligations and revenue recognition across the two years. The synthesis of inventory return and stockpile creation is complete and logically presented. The correctness score is 9 instead of 10 due to slight ambiguity in phrasing around 'at no cost,' which could be misinterpreted, though the core facts and financials remain accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 458,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA's financial performance improved significantly between 2022 and 2023, with sales increasing by 26.9% in 2023 compared to 26.5% in 2022. This growth was driven by continued share gains and market expansion in metastatic castration-resistant prostate cancer. This strong growth underscores ERLEADA's growing importance within J&J's oncology portfolio, highlighting its role as a key contributor to the segment's 10.5% overall sales increase in 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 26.9% growth in ERLEADA sales in 2023 and the 10.5% overall growth in J&J's oncology segment, which aligns with the ground truth. However, it incorrectly states that ERLEADA had 26.5% growth in 2022, which is not supported by the original data — the original answer provides absolute sales figures ($1,881M in 2022 and $2,387M in 2023) and calculates the 26.9% growth for 2023, but does not mention any growth rate for 2022. This is a significant quantitative inaccuracy. (2) The dollar amounts themselves are not mentioned in the LLM answer, which omits the actual sales figures — a partial omission affecting completeness and precision. While the 26.9% growth is correctly calculated from the ground truth numbers, the erroneous 26.5% figure for 2022 undermines quantitative accuracy. (3) The reasoning about ERLEADA's growing importance in J&J's oncology portfolio is sound and logically supported by the contrast with declining products (though IMBRUVICA and ZYTIGA are not mentioned in the LLM response, which reduces completeness). The model correctly infers that strong growth contributes to the segment’s overall performance. (4) Despite missing specific sales figures and introducing an incorrect prior-year growth rate, the LLM captures the core trend and strategic implication, warranting a score of 7 for overall correctness. The answer is contextually relevant and qualitatively strong, but the numerical error prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 414,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "ERLEADA's global sales increased by 26.9% in 2023 compared to 2022, driven by continued share gains and market growth in Metastatic Castration-Resistant Prostate Cancer. This significant growth indicates a strong market trajectory for ERLEADA, reflecting its increasing adoption and effectiveness in its target therapeutic area.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 26.9% growth in ERLEADA's global sales from 2022 to 2023, which matches the ground truth. However, it omits the actual sales figures for both years ($1,291 million in 2022 and $2,387 million in 2023), which are key quantitative data points required to fully answer the question. Additionally, the LLM fails to mention the 70.0% growth rate in 2022 compared to 2021, which is a critical part of assessing the evolution and trajectory of sales performance. (2) While the 26.9% growth figure is accurate, the absence of absolute sales values and prior-year growth rate limits the completeness and quantitative precision. The calculation of growth rate is not in question, but the lack of baseline and endpoint values means the user cannot verify or contextualize the percentage. (3) The reasoning about strong market trajectory and increasing adoption is logically sound and aligns with the ground truth; however, the conclusion misses the nuance that growth is slowing (from 70.0% to 26.9%), which the original answer correctly interprets as a sign of a maturing growth phase. This omission reflects incomplete multi-hop synthesis across both years’ performance trends. (4) The answer is contextually relevant and well-articulated, focusing on the right therapeutic area and market dynamics, but lacks key factual depth and comparative analysis needed for full accuracy. Hence, scores reflect partial correctness with significant but not critical omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 416,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "Between fiscal years 2023 and 2024, NVDA's debt management strategy regarding the 0.584% Notes Due 2024 involved holding the debt until its maturity in fiscal year 2025, where it was repaid. In both fiscal years 2023 and 2024, the notes had a carrying value of $1,250 million, with an effective interest rate of 0.66%. By fiscal year 2025, the notes were fully repaid, indicating a strategic decision to settle this short-term obligation as it matured without refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that NVDA held the 0.584% Notes Due 2024 with a carrying value of $1,250 million in both fiscal years 2023 and 2024, and that the notes were repaid in fiscal year 2025. The effective interest rate of 0.66% is accurately reported. These figures match the ground truth exactly, with acceptable formatting. (2) All numeric values—$1,250 million, 0.66%, and the maturity in fiscal year 2025—are factually correct and consistent with the original answer. There are no calculation errors. (3) The reasoning is sound: the LLM correctly infers that NVDA chose to repay the notes at maturity rather than refinance or extend them, indicating a shift in debt management strategy. The multi-hop synthesis across fiscal years 2023 and 2024 is accurate, and the conclusion aligns with the ground truth. (4) The only minor difference is that the original answer explicitly mentions the balance became zero as of January 26, 2025, while the LLM answer refers more generally to repayment in fiscal year 2025. This does not affect factual correctness but slightly reduces qualitative precision. Otherwise, the semantic meaning and strategic interpretation are equivalent. Contextual relevance is perfect as all information directly addresses the evolution of NVDA's debt strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 366,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Between 2022 and 2023, Honeywell's investment in Mortgage/Asset-backed securities decreased. In 2022, the fair value of Mortgage/Asset-backed securities in U.S. plans was $1,119 million and in non-U.S. plans was $31 million. In 2023, these amounts dropped to $676 million and $10 million, respectively, representing a decrease of $443 million in U.S. plans and $21 million in non-U.S. plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Honeywell reported $982 million in Mortgage/Asset-backed securities under U.S. Plans only, and by 2023, this dropped to $10 million under Non-U.S. Plans. However, the LLM claims $1,119 million in U.S. plans and $31 million in non-U.S. plans in 2022, and $676 million and $10 million respectively in 2023—none of which match the ground truth. The LLM also reports a total decrease of $464 million ($443M + $21M), whereas the correct reduction is $972 million (from $982M to $10M), a discrepancy of over $500 million. (2) The calculations in the LLM answer are internally consistent but based on incorrect input data, making them factually wrong. The claimed decreases of $443M and $21M do not reflect the actual shift. (3) The multi-hop reasoning is partially sound in structure—comparing across years and plans—but fails in execution because it uses incorrect source data. The answer incorrectly implies that both U.S. and non-U.S. plans held significant investments in 2022 and that reductions occurred in both, while the ground truth shows a complete shift from U.S. to Non-U.S. plans with near-total divestment. (4) The contextual relevance is moderate—the answer addresses the evolution and magnitude of change as asked—but due to severe quantitative and entity-level errors, the overall correctness is very low. The answer misrepresents the scale, location (U.S. vs. Non-U.S.), and direction of the investment shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 422,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "Between 2022 and 2023, Capital One's use of securitized debt obligations remained a key component of its funding mix, with the outstanding amount increasing from $16.97 billion in 2022 to $18.04 billion in 2023. These obligations were classified as Level 2 within the fair value hierarchy, indicating they were valued using observable market inputs. The fair value of securitized debt obligations rose slightly from $16,918 million in 2022 to $18,067 million in 2023, reflecting ongoing reliance on this funding source to support the company's liquidity and capital management strategies.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details. While the 2023 carrying value of $18,043 million (rounded to $18.04 billion) and fair value of $18,067 million are correctly reported, the 2022 figures are not supported by the ground truth. The original answer does not provide a 2022 carrying value or fair value—specifically, it does not state $16.97 billion outstanding or $16,918 million fair value in 2022. These numbers are fabricated or misattributed, as the ground truth only describes securitized debt obligations as a 'key component' in 2022 without any numerical disclosure. (2) The calculation of an increase from $16.97B to $18.04B is therefore invalid, as the 2022 number is not present in the source. The fair value increase from $16,918M to $18,067M is also incorrect because the 2022 fair value is not provided in the original answer. (3) Qualitatively, the LLM correctly identifies that securitized debt obligations remained a key part of the funding mix and that they were classified under Level 2 of the fair value hierarchy in 2023. It also captures the idea of ongoing reliance on this funding source, which aligns with the ground truth's implication of continued use with enhanced disclosure. However, it misses the key qualitative point from the original answer that 2023 brought more detailed transparency and structured risk management, representing an evolution in disclosure rather than just a numerical change. (4) The contextual relevance is high because the answer addresses the role in funding mix and fair value classification as asked. Despite incorrect numbers, the overall direction and intent of the response are aligned. However, the inclusion of unsupported 2022 figures significantly undermines factual correctness, warranting a moderate score of 6 for overall correctness, 5 for quantitative accuracy due to false precision, 7 for qualitative reasoning, and 9 for relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 526,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "JPMorgan's treatment of CECL capital transition provisions evolved from 2023 to 2024 as the remaining CECL-related capital benefit was fully phased in by January 1, 2025. In 2023, the CECL benefit was $1.4 billion, and by 2024, it had decreased to $720 million, representing a quantitative reduction of $680 million in the CECL-related capital benefit during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1.4 billion in 2023 and $720 million in 2024 are accurately reported. The reduction of $680 million ($1.4B - $720M = $680M) is correctly calculated. (2) The statement that the CECL benefit was being phased in and would be fully phased in by January 1, 2025, aligns with the original answer and reflects the correct regulatory timeline. (3) The multi-hop reasoning—connecting the decrease in benefit from 2023 to 2024 and linking it to the phase-in under U.S. capital rules—is sound and properly synthesized. (4) All entities (JPMorgan, CECL capital transition provisions, CET1 capital context implied), years (2023, 2024, 2025), and financial metrics are accurate. The answer addresses both parts of the question: the evolution of treatment and the quantitative change. Wording differs slightly but maintains semantic equivalence. No factual, numerical, or reasoning errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 284,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolved as follows: In fiscal 2023, the agreement provided a $3.0 billion unsecured revolving credit facility maturing in December 2025. By fiscal 2024, the agreement was amended in April 2022 and May 2023 to reflect immaterial administrative changes, but the credit facility capacity remained at $3.0 billion. In fiscal 2025, the agreement was replaced with a new $5.0 billion unsecured revolving credit facility maturing in October 2029, significantly increasing the borrowing capacity.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the $3.0 billion facility in fiscal 2023 maturing in December 2025, it incorrectly states that the $5.0 billion facility was put in place in 'fiscal 2025' rather than fiscal 2024 as per the ground truth. This misalignment of timing is a critical error. Additionally, the mention of amendments in April 2022 and May 2023 as 'immaterial administrative changes' is not supported by the original answer and introduces unverified details. (2) Quantitatively, the dollar amounts ($3.0 billion and $5.0 billion) and the maturity date of October 2029 are correct. However, the assignment of the new agreement to 'fiscal 2025' instead of 'fiscal 2024' is a major date error, directly contradicting the ground truth. (3) The multi-hop reasoning is flawed because the model fails to correctly map the timeline of the credit agreement evolution. It incorrectly delays the new agreement to fiscal 2025, which breaks the logical synthesis across fiscal years. The original answer clearly states the change occurred by fiscal 2024, indicating the replacement happened during or before that period. (4) Contextual relevance is high—the answer addresses the evolution of terms and capacity as asked. However, due to the incorrect fiscal year attribution and introduction of unsupported amendment details, the qualitative and quantitative accuracy scores are significantly reduced. The core improvement in capacity and maturity is noted, but the incorrect timing undermines the correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 432,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "Between 2022 and 2024, UPS's relationship with Coyote evolved from operating it as part of its Supply Chain Solutions segment to divesting the business. In 2024, UPS completed the divestiture of Coyote, which had previously provided truckload brokerage services in the U.S. and Europe. This divestiture resulted in a pre-tax gain of $156 million for UPS in 2024, positively impacting its financial performance for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the essential evolution of UPS's relationship with Coyote between 2022 and 2024. (1) It correctly states that Coyote was part of UPS's Supply Chain Solutions segment and provided truckload brokerage services in the U.S. and Europe, consistent with the ground truth. The key financial impact—the 2024 divestiture resulting in a $156 million pre-tax gain—is accurately reported, matching the ground truth exactly in amount and context. (2) Quantitatively, all numbers are correct: $156 million pre-tax gain is properly cited, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 operations to 2024 divestiture) and connects the strategic shift to its financial impact. (4) The only minor omission is that the original answer notes Coyote operated as a 'branded subsidiary' and was integrated into UPS’s broader supply chain offerings leveraging UPS fleet and third-party carriers—contextual details absent in the LLM response. However, these do not affect the core factual accuracy. The LLM answer is semantically equivalent in conveying the strategic transition and financial outcome. Thus, it earns a 9/10 for correctness and qualitative accuracy due to slightly less detail, but full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 383,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "Between 2023 and 2024, Union Pacific's relationship with chassis has significantly shifted in terms of total units and ownership structure. In 2023, the company owned 30,635 chassis and leased 17,705, totaling 48,340 units. By 2024, the total number of chassis dropped to 5,553, with a sharp decline in owned units to 4,356 and leased units to 1,197. This indicates a substantial reduction in both the total chassis inventory and a shift toward a more streamlined ownership and leasing structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: 2023 owned (30,635), leased (17,705), and total (48,340) are correctly reported; 2024 owned (4,356), leased (1,197), and total (5,553) are also exactly correct. (2) The answer is complete, addressing both total units and ownership structure across both years as required by the question. (3) Entities (Union Pacific, chassis units, ownership vs. leasing) and years (2023, 2024) are correctly identified. (4) The reasoning is sound: the LLM correctly infers a significant reduction and strategic shift, accurately describing the transformation in Union Pacific's asset management. Minor wording differences (e.g., 'streamlined ownership and leasing structure' vs. 'much smaller, still mixed but significantly reduced footprint') do not affect factual equivalence. All calculations (totals matching sum of owned and leased) are implicitly correct. The answer demonstrates proper multi-hop synthesis across time and ownership categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 297,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "Between 2022 and 2024, Boeing continued to classify its aluminum agreements as derivative instruments for accounting purposes, as these agreements are priced at prevailing market prices and are not designated for hedge accounting treatment. In 2022, the time horizon for these agreements was not explicitly detailed, but by 2024, Boeing's commodity contracts generally hedged forecasted transactions through 2028, indicating an extended time horizon for these agreements. This suggests that Boeing's aluminum agreements remained undesignated derivatives with fair value changes recorded in earnings, and their time horizon expanded to align with longer-term strategic sourcing objectives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Boeing classified aluminum agreements as derivatives not designated for hedge accounting in both 2022 and 2024, with fair value changes recorded in earnings. It accurately notes the evolution in time horizon, stating that by 2024, commodity contracts hedged forecasted transactions through 2028. However, the LLM slightly misrepresents the 2022 disclosure by claiming the time horizon was 'not explicitly detailed,' whereas the ground truth indicates these were described in the context of long-term strategic sourcing—implying some qualitative time framing, even if not specific. The 2024 shift toward structured hedging as part of a broader commodity hedging program is correctly captured, though the LLM could have more clearly emphasized the strategic shift from purely sourcing to hedging. (2) Quantitatively, all dates (2022, 2024, 2028) are correct and consistently used. No calculations are required, and the time horizon extension to 2028 is accurately reported. (3) The multi-hop reasoning is sound: the model synthesizes information across years and correctly infers an evolution in disclosure and intent. It connects aluminum agreements to broader commodity hedging activities in 2024, which aligns with the ground truth. However, it downplays the conceptual shift by focusing on continuity in accounting treatment rather than highlighting the strategic pivot. (4) Scores reflect high accuracy in facts and numbers, minor gap in fully conveying the qualitative shift in purpose (from strategic sourcing to hedging), and excellent relevance to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 445,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Procter & Gamble's exposure to currency rate risk remained relatively stable between the fiscal years ended June 30, 2023, and June 30, 2024. The company continues to leverage its diversified portfolio of exposures as a natural hedge and prioritizes operational hedging over financial instruments. For both years, P&G primarily used forward contracts and currency swaps with maturities under 18 months to manage exchange rate risk. The company expressed confidence that near-term changes in currency rates would not materially affect its financial statements, based on historical movements and a 95% confidence level. No significant changes in hedging instruments or risk management strategies were reported between the two periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: P&G's currency risk exposure remained stable between FY2023 and FY2024, it used forward contracts and currency swaps with maturities under 18 months, and it maintained a 95% confidence level assessment that near-term currency fluctuations would not materially affect financial statements. (2) Quantitative elements—'95% confidence level', 'maturities under 18 months', and the fiscal years 'June 30, 2023' and 'June 30, 2024'—are all factually correct and match the original answer. (3) The reasoning is sound and correctly synthesizes multi-hop information across time periods and risk management strategies. The mention of 'diversified portfolio of exposures as a natural hedge' and 'prioritizes operational hedging' adds context not in the original answer but does not contradict it and reflects plausible supplementary detail consistent with P&G's known strategy; however, since the ground truth does not explicitly confirm this emphasis, it slightly affects qualitative precision. (4) The answer fully addresses all parts of the question—evolution of risk exposure, hedging instruments, and confidence in mitigation—making it contextually complete and relevant. The minor addition of operational hedging emphasis prevents a perfect 10, but core facts, numbers, and synthesis are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 386,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "Between 2022 and 2024, Adobe has expanded Frame.io's functional scope and integration with other Adobe products, positioning it as a central tool for cloud-native creative collaboration. Frame.io is now more deeply integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, enabling real-time upload, review, and approval workflows with frame-accurate commenting and annotations. Additionally, Frame.io is part of Adobe GenStudio, alongside Adobe Express and Firefly Services, to support scalable content production. Its Camera to Cloud functionality allows automatic upload of footage directly into Frame.io for review, enhancing its role in end-to-end creative workflows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io evolved from a trademarked asset in 2022 to a core cloud-native collaboration platform by 2024, with expanded functionality including real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud. Its integration with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront is correctly stated, as is its inclusion in Adobe GenStudio for scalable content production. (2) There are no numeric values, dates, or financial figures requiring verification—only years (2022, 2024), which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesized information across time (2022 vs 2024) and across product integrations and functional enhancements. (4) The only minor shortcoming is that the original answer notes Frame.io was *initially only listed as a trademark* in 2022 without functional detail, while the LLM answer implies active development during that period. This nuance is slightly underemphasized but does not make the answer factually wrong—rather, it omits a small contextual detail about the *degree* of integration in 2022. Otherwise, the semantic meaning, completeness, and contextual relevance are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 359,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "Between the 2022 and 2023 fiscal years, AMD's carrying value of its investment in the ATMP Joint Venture (JV) increased from approximately $83 million to $99 million. The nature of its financial disclosures remained consistent, with AMD reporting purchases from and resales to the ATMP JV, along with related payables and receivables. In 2023, AMD recorded a higher equity income gain of $16 million compared to $14 million in 2022, reflecting its 15% equity interest and significant influence over the JV.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both quantitative and qualitative aspects. The ground truth states that in the 2022 filing, AMD reported carrying values of $69 million (as of December 25, 2021) and $63 million (as of December 26, 2020), with detailed transaction data for purchases from the JV (e.g., $1.1B in 2021). However, the LLM claims the carrying value increased from $83M to $99M between 2022 and 2023, which is factually wrong and misrepresents both the direction and magnitude of change. Furthermore, the ground truth explicitly states that the 2023 filing omitted carrying values and specific transaction figures entirely, while the LLM incorrectly asserts that such disclosures were maintained. (2) The LLM invents figures not present in the original data: 'equity income gain of $16 million in 2023 vs $14 million in 2022' has no support in the ground truth, which does not mention equity income at all. All numerical claims in the LLM answer are fabricated or misaligned with the source. (3) The multi-hop reasoning is fundamentally flawed. The question asks about the evolution of AMD's financial relationship and disclosure practices. The correct inference is that while the equity stake (15%) and accounting method remained unchanged, the level of financial disclosure decreased significantly in 2023. The LLM instead assumes continuity and even improvement in disclosure, which contradicts the evidence. It fails to recognize the key shift: from detailed quantitative disclosures in 2022 to their absence in 2023. (4) The contextual relevance is moderate because the answer addresses the right topic (AMD's relationship with ATMP JV) and correctly notes the 15% equity interest, but it draws the opposite conclusion about disclosure trends and fabricates financial performance metrics, leading to a highly misleading response. Due to complete failure on factual accuracy and reasoning, the correctness score is 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 529,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a slight reduction in demand or market share for new equipment in the commercial aviation sector, potentially due to industry challenges such as supply chain constraints or reduced aircraft production. However, the overall Aerospace Technologies segment showed growth, indicating Honeywell's continued strength in other areas like the aftermarket and defense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for Commercial Aviation Original Equipment—$2,397 million in 2023 and $2,223 million in 2024—matching the ground truth exactly. The decrease is accurately implied, and no calculation is required beyond the comparison, which is correctly interpreted as a decline. (2) All numeric values are correct and presented in a consistent format; no calculation errors exist. (3) The multi-hop reasoning is sound: the model correctly identifies the decline in the specific segment while acknowledging growth in the broader Aerospace Technologies division, indicating proper synthesis across financial segments and years. (4) The qualitative interpretation slightly expands on the ground truth by mentioning 'aftermarket and defense' as potential growth areas, which is a reasonable inference not contradicted by the original answer. While the original emphasizes 'potential weakening in original equipment demand or supply constraints,' the LLM offers a similar explanation with 'supply chain constraints or reduced aircraft production,' showing equivalent reasoning. The only minor difference is in emphasis, not factual deviation. Thus, the answer is factually complete, contextually relevant, and semantically equivalent, warranting a high score with a small deduction in qualitative accuracy due to slight interpretive expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 386,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The global revenue contribution from Heart Failure Devices increased from $1,161 million in 2023 to $1,279 million in 2024, representing a 10.2% increase. This growth was primarily driven by an increase in sales of heart assist devices for both chronic and temporary conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: the 2023 revenue ($1,161 million), 2024 revenue ($1,279 million), and the 10.2% percentage increase, which matches the ground truth calculation ((1,279 - 1,161) / 1,161 ≈ 0.1016 → 10.2%). These values are accurate and properly formatted. (2) The question asked about the evolution of global revenue contribution and the percentage change—both are fully addressed with correct numbers and calculation. (3) The qualitative reasoning is mostly sound: the LLM correctly identifies growth in the segment and attributes it to increased sales of heart assist devices, which is plausible and consistent with market trends. However, it omits the ground truth detail about consistent growth across U.S. and international markets and the minimal impact of exchange rate fluctuations, which adds contextual depth about market expansion and demand strength. While not critical to the core question, this omission slightly reduces completeness. (4) Despite this minor omission, the answer is factually correct, contextually relevant, and synthesizes the necessary multi-hop data (revenue figures across two years and the derived growth rate) accurately. The scores reflect high accuracy with a small deduction in qualitative accuracy due to missing contextual nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 371,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "Based on the provided document pages, IBM's treatment of the 0.300% Notes due 2028 has evolved between the 2022 and 2023 filings in terms of its listing and classification. In the 2022 filing, the 0.300% Notes due 2028 were not explicitly listed, while in the 2023 filing, they are clearly listed under the section detailing securities registered pursuant to Section 12(b) of the Exchange Act with the trading symbol \"IBM 28B\" and are noted as being traded on the New York Stock Exchange. This suggests that the notes were either newly issued or more prominently disclosed in the 2023 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in the 2022 filing, the 0.300% Notes due 2028 were not explicitly listed but were incorporated by reference (though it omits the specific mention of Exhibit 4.1 to the Form 8-K filed on February 10, 2020, which is a minor omission). In 2023, it accurately states that the notes were explicitly listed with trading symbol 'IBM 28B' and traded on the New York Stock Exchange. (2) There are no numeric values, dates, or percentages in dispute—'0.300%', '2028', and 'IBM 28B' are all correctly reported. (3) The reasoning is sound: the shift from implicit incorporation to explicit registration is correctly inferred, though the LLM slightly softens the conclusion by suggesting the notes were 'either newly issued or more prominently disclosed', whereas the ground truth emphasizes formal registration and distinct classification. This does not contradict but slightly underrepresents the certainty of the evolution. (4) The answer is fully relevant, directly addressing the evolution in treatment between the two years. The minor lack of specificity regarding the Exhibit 4.1 incorporation prevents a perfect 10, but overall the response is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 364,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "Apple's financial performance in the Rest of Asia Pacific region from 2022 to 2023 showed modest growth in both net sales and operating income. Net sales increased from $29,375 million in 2022 to $29,615 million in 2023, while operating income rose from $11,569 million in 2022 to $12,066 million in 2023. This indicates a slight improvement in both revenue and profitability for the region during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key numerical values: net sales of $29,375 million in 2022 and $29,615 million in 2023, and operating income of $11,569 million in 2022 and $12,066 million in 2023 are all correctly reported. The quantitative accuracy is perfect, with no errors in dollar amounts or years. The answer correctly identifies the upward trend in both net sales and operating income, indicating growth. However, the LLM omits the specific percentage increases (0.8% for net sales and 4.3% for operating income) and the absolute dollar changes ($240 million and $497 million), which were part of the original answer and directly relevant to assessing 'how' the performance evolved. While the qualitative assessment of 'modest' or 'slight improvement' is reasonable and aligns with the small percentage changes, including the exact figures would have strengthened the completeness. The reasoning is sound, entities are correct, and the response is fully contextually relevant. The omission of calculated changes prevents a perfect score, but core facts and synthesis across years and metrics are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 324,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "The vesting period for stock options issued under the 2007 Omnibus Incentive Plan changed between grants made prior to 2022 and those made after December 31, 2021. Stock options granted prior to 2022 generally vested pro rata over a five-year period, while stock options granted subsequent to December 31, 2021 generally vest pro rata over a four-year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and matches the ground truth in all key aspects: (1) It accurately states that stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, and those granted after December 31, 2021, vest over a four-year period—this aligns with both the 2022 and 2024 10-K disclosures. (2) All dates and time periods (five-year vs. four-year vesting, pre-2022 vs. post-December 31, 2021) are correctly reported with no numerical or temporal inaccuracies. (3) The reasoning correctly reflects the structural change in the plan following its amendment, demonstrating sound multi-hop synthesis across time and plan versions. (4) The only minor limitation is that the LLM answer does not explicitly reference the 2024 10-K confirmation, which reinforces the consistency of the vesting terms beyond just the 2022 filing. While this omission slightly reduces completeness, the core factual evolution of the vesting period is accurately and clearly conveyed. Thus, the answer is semantically equivalent to the ground truth with full quantitative accuracy and high qualitative and contextual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 330,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "CVS's approach to validating the fair value estimates for its Level 2 debt securities remained consistent from 2022 to 2023 in terms of price adjustments and secondary source comparisons. In both years, the Company obtained one price for each of its Level 2 debt securities and did not adjust any of those prices. Additionally, on a quarterly basis, the Company compared a sample of its Level 2 debt securities' prices to those from a secondary source, reviewing variances over a specified threshold to confirm the accuracy of the primary source's fair value estimate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that CVS obtained one price per Level 2 debt security in both 2022 and 2023 and did not adjust any prices at year-end (Dec 31, 2022 or 2023), matching the original answer. The quarterly comparison to secondary sources and review of variances over a threshold are accurately described. (2) All dates and methodological details are factually correct; no numeric inaccuracies exist. Format and phrasing differences (e.g., not explicitly mentioning 2020 or 2021) do not affect correctness since the question focuses on 2022–2023 evolution. (3) The multi-hop reasoning is sound—correctly synthesizing that the validation approach did not change across years. The only minor omission is not noting the emphasis on consistent internal validation by the investment team, which is present in the original but not critical to the core question about price adjustments and secondary comparisons. (4) The answer is fully relevant, directly addressing the evolution (or lack thereof) in CVS’s validation practices. Thus, the answer earns a 9 for correctness and qualitative accuracy due to near-perfect alignment with the ground truth, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 363,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "Between 2022 and 2023, CVS maintained its classification of privately-placed equity securities in Level 3 of the fair value hierarchy due to the absence of an active market, relying on internal analysis of financial statements and cash flow projections. However, in 2023, there were notable changes in valuation methodology, including net transfers out of Level 3 totaling $50 million, primarily driven by transfers out of U.S. corporate, commercial mortgage-backed, and equity securities. The unobservable inputs, such as earnings and revenue multiples and discounts for lack of marketability, remained significant, but the overall Level 3 balance decreased from $129 million at December 31, 2022, to $108 million at December 31, 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces quantitative details not present in the ground truth, such as 'net transfers out of Level 3 totaling $50 million' and specific balance figures ($129 million in 2022, $108 million in 2023), which are not mentioned or supported by the original answer. These numbers are unverified and contradict the focus of the original response, which emphasizes methodology evolution, not balance changes or transfers. (2) The original answer does not reference any dollar amounts related to Level 3 balances or transfers, so the inclusion of these figures reduces quantitative accuracy significantly. There is no indication in the ground truth that the Level 3 balance changed due to transfers or that such transfers were $50 million. (3) Qualitatively, the LLM correctly identifies that CVS classified privately-placed equity securities as Level 3 in both years and used internal analysis of financial statements and cash flow projections. It also correctly notes that earnings and revenue multiples and discounts for lack of marketability were significant unobservable inputs. However, it misses the key qualitative evolution highlighted in the original answer: the increased emphasis in 2023 on sensitivity analysis and the potential impact of changes in unobservable inputs on fair value. Instead, it substitutes this with unsupported claims about transfers and balance reductions. (4) Contextually, the answer remains relevant by addressing classification, valuation methodology, and unobservable inputs, but it introduces extraneous and incorrect financial data that distort the actual evolution of the methodology. The core reasoning fails the multi-hop synthesis by conflating balance sheet movements with methodological changes, which are not equivalent. Thus, while some elements are accurate, the inclusion of fabricated quantitative data and omission of the true methodological refinement (sensitivity analysis) result in a partially correct but significantly flawed response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 542,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "The total net revenue from Alphagan/Combigan decreased by 8.8% in 2024 compared to 2023. Internationally, the revenue for Alphagan/Combigan increased slightly by 1.5% in 2024 compared to 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 8.8% decline in total net revenue and the 1.5% increase in international revenue, matching the ground truth percentages exactly. While the exact dollar amounts ($272M in 2023 and $248M in 2024 for total revenue; $151M to $153M for international) are omitted, the percentages are accurate and derived from those values, so the core quantitative facts are preserved. (2) The percentage calculations are correct: (272 - 248)/272 ≈ 8.8% and (153 - 151)/151 ≈ 1.5%. The LLM reports these accurately, satisfying quantitative precision. (3) The reasoning is sound and reflects proper multi-hop synthesis—comparing revenue trends across two years and two geographies (total vs. international). The model correctly infers the trend directions and magnitudes. (4) The answer is contextually complete and relevant, addressing both parts of the question. The only minor shortcoming is the omission of the actual dollar figures, which slightly reduces completeness but does not affect the correctness of the trends or percentages. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 338,
        "total_tokens": 1458
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved significantly from 2023 to 2024, as PDC was acquired by Chevron in a business combination during 2023. This acquisition contributed to an increase in Chevron's overall production performance, particularly in the United States, where PDC's operations are based. Specifically, the inclusion of PDC's production led to a seven percent increase in Chevron's worldwide oil-equivalent production in 2024 compared to 2023, with the full-year impact of PDC's production and growth in the Permian Basin being key drivers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Chevron acquired PDC Energy in 2023 and that this acquisition contributed to a 7% increase in worldwide oil-equivalent production in 2024, which matches the ground truth. The percentage (7%), the year (2024), and the direction of impact (positive contribution to production) are all factually accurate. (2) Quantitative accuracy is perfect: the 7% production increase is correctly cited, and no other numbers are introduced that conflict with the original. Format is consistent in meaning (e.g., 'seven percent' = '7%'). (3) The multi-hop reasoning is sound: the model connects the 2023 acquisition to the 2024 production increase, recognizing the full-year contribution of PDC operations as a driver—this aligns with the ground truth's emphasis on the 'full-year contribution from legacy PDC operations.' While the LLM adds contextual detail about the Permian Basin and U.S. operations (not explicitly in the original), this is consistent with PDC's known operational focus and does not contradict the source. (4) The only minor gap is that the LLM does not mention PDC's exclusion from internal control assessment in 2023, which was part of the original answer and reflects a non-operational but factual aspect of the relationship evolution. However, since the question emphasizes 'operational impact on production,' this omission does not significantly detract from correctness. Overall, the answer is factually accurate, contextually relevant, and demonstrates strong synthesis across time and entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 430,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "UPS's investment in cold-chain logistics capabilities has expanded significantly from 2023 to 2024. In 2023, UPS acquired MNX Global Logistics, a global provider of time-critical and temperature-sensitive logistics, and in 2024, it acquired Frigo-Trans and Biotech & Pharma Logistics, a leading healthcare logistics provider in Germany. These acquisitions have enhanced UPS's international cold-chain logistics capabilities, particularly in the healthcare and life sciences sectors.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key acquisitions in 2023 and 2024 that contributed to UPS's cold-chain logistics expansion. It accurately states that MNX Global Logistics was acquired in 2023 and Frigo-Trans and Biotech & Pharma Logistics in 2024. However, it omits the 2023 acquisition of Bomi Group, which is mentioned in the ground truth and part of the strategic expansion. This is a minor omission affecting completeness but not the core factual accuracy. (2) There are no explicit numerical values in the LLM answer, so no quantitative inaccuracies are present. The ground truth mentions the $440 million price tag for the 2024 German acquisitions, which the LLM omits. While the absence of this figure reduces completeness, it does not make the answer factually incorrect. (3) The multi-hop reasoning is sound: the model correctly links UPS’s strategic evolution to specific acquisitions in consecutive years and infers enhanced international cold-chain capabilities, particularly in healthcare. The synthesis across years and entities is logical and supports the conclusion of growing investment. (4) The answer is contextually fully relevant, directly addressing how UPS’s investment evolved and which acquisitions drove the change. Despite missing Bomi Group and the $440M figure, the core information is accurate and semantically aligned with the ground truth. Hence, a score of 8 is justified—strong accuracy with minor omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 405,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "Between 2022 and 2024, Linde plc's non-employee director restricted stock unit (RSU) award program remained tied to the 2021 Linde plc Long Term Incentive Plan, as referenced in both the 2022 and 2024 filings. However, in 2024, the company introduced the Linde plc Non-employee Director Deferral Program, adopted on July 30, 2024, which added a new governance mechanism for deferring compensation. Additionally, the 2024 filing highlights the adoption of the Linde plc Executive Clawback Policy in October 2023, which further reinforced long-term shareholder alignment by enabling recovery of compensation in cases of financial restatements or misconduct. These updates reflect Linde's continued focus on aligning director incentives with long-term shareholder interests through structured deferral and accountability mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the RSU program is under the 2021 Long Term Incentive Plan, and the Non-employee Director Deferral Program was adopted on July 30, 2024—both dates and program names match the original. (2) Quantitative accuracy is perfect: the dates (July 30, 2024, and October 2023) are correctly cited, and no numerical errors are present. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across 2022 and 2024 filings to show evolution in governance structure and shareholder alignment. The addition of the Executive Clawback Policy in October 2023, while not mentioned in the original answer, is factually accurate and contextually relevant, enhancing long-term alignment. This addition does not contradict the ground truth but provides supplementary detail that strengthens the response. (4) The only reason for not scoring a 10 is that the original answer emphasizes the strategic evolution from basic RSUs to deferral as a sign of strengthened governance, a slightly more focused narrative on board accountability. However, the LLM captures the core evolution and adds a valid, relevant policy detail. Semantic equivalence is maintained, and the answer fully addresses governance structure and shareholder alignment mechanisms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 373,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "Between 2022 and 2024, General Motors' financial and legal relationship with Stellantis primarily revolved around indemnification obligations stemming from the 2017 sale of the Opel/Vauxhall business to PSA Group (now Stellantis). GM agreed to indemnify Stellantis for certain losses related to inaccuracies in representations, warranties, or breaches of covenants in the sale agreement, including emissions claims, product liabilities, and recalls. In 2024, GM noted that it had indemnified Stellantis for an immaterial amount related to specific recalls, including Takata inflator recalls in legacy Opel vehicles. Additionally, GM faced potential exposure from ongoing investigations by the European Commission and UK Competition and Markets Authority into Opel's past conduct, though GM had accrued an immaterial amount for this matter as of December 31, 2024. No significant investment gains were reported in relation to Stellantis during this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core evolution of GM's relationship with Stellantis from financial gains in 2022 to indemnification obligations by 2024. It accurately notes the 2017 Opel/Vauxhall sale as the root of indemnification obligations and correctly references emissions claims, product liabilities, and recalls. However, it omits the $0.2 billion gain from Stellantis warrants in 2022, which is a key part of the original answer and directly addresses the 'investment gains' component of the question. This omission reduces completeness. (2) Quantitatively, the LLM correctly states that indemnification payments and accrued liabilities were 'immaterial' in 2024, aligning with the ground truth's implication that no major financial outflows were reported. However, it fails to include the $0.2 billion gain in 2022, a significant quantitative fact. All other numerical references (immaterial amounts) are consistent. (3) The multi-hop reasoning is sound: the model connects the 2017 sale to ongoing liabilities, links GM's indemnification obligations to specific legal and regulatory risks (e.g., Takata recalls, European investigations), and contextualizes the shift from financial benefit to legal risk. But the failure to mention the 2022 warrant gain breaks the full synthesis of 'financial and legal relationship' over the full period. (4) Scores reflect high accuracy in reasoning and relevance, with a moderate deduction in correctness due to the missing $0.2B gain, which is central to the question's focus on both financial and legal dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 435,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "From 2022 to 2024, Southern Company's treatment and disclosure of energy-related derivatives evolved in terms of financial presentation and categorization by providing more detailed and forward-looking information. In 2022, the disclosures primarily focused on historical gains and losses related to cash flow and fair value hedges, including their impact on AOCI and income statements. By 2024, the disclosures expanded to include the net volume of energy-related derivative contracts, hedge maturity dates, and the categorization of derivatives by type (e.g., regulatory, cash flow, and not designated). Additionally, 2024 included more granular balance sheet data, such as current and non-current assets and liabilities for each derivative category, along with netting and collateral arrangements. This evolution reflects a more transparent and comprehensive presentation of derivative activities and their financial implications.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but introduces significant inaccuracies not supported by the ground truth. While it correctly identifies a shift in disclosure focus over time, it fabricates specific details such as 'net volume of energy-related derivative contracts', 'hedge maturity dates', and 'categorization by type (regulatory, cash flow, and not designated)' which are not mentioned in the original answer. The ground truth emphasizes a shift from income statement reporting (pre-tax effects in 2022) to balance sheet presentation (fair value as assets/liabilities under 'Other' or 'Risk Management Activities' in 2024), which the LLM partially captures with 'more granular balance sheet data' but misrepresents by adding unverified categories and metrics. (2) There are no explicit numbers, percentages, or dollar amounts in either answer, so quantitative accuracy is assessed on factual precision of financial concepts and reporting practices. The LLM invents disclosures (e.g., current vs non-current breakdowns, netting, collateral arrangements) not present in the ground truth, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound—comparing 2022 and 2024 disclosures—but fails to accurately synthesize the actual evolution described in the ground truth. The core shift from income-focused to balance-sheet-focused reporting is implied but obscured by extraneous, unsupported details. (4) Correctness is scored at 5 due to partial factual alignment but significant overstatement of detail; qualitative accuracy is low due to incorrect entity generation (e.g., derivative types, balance sheet breakdowns); contextual relevance remains high because the response stays on topic and attempts the correct comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 485,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "Between 2023 and 2024, GILD's strategic relationship with Arcus evolved significantly in terms of equity ownership and governance influence. In 2023, GILD owned approximately 19.9% of Arcus and had two designees on Arcus' board of directors. By January 2024, GILD increased its equity ownership to 33% through an additional $320 million investment and expanded its board representation to three designees. This marked a notable enhancement in GILD's governance influence and long-term strategic alignment with Arcus.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: GILD's 2023 ownership of 19.9%, two board designees, the January 2024 $320 million investment, increase in ownership to 33%, and expansion to three board designees. (2) Quantitative accuracy is perfect—percentages (19.9% → 33%), dollar amount ($320 million), timing (January 2024), and board representation (2 → 3 designees) all match the original. No calculations are required beyond what is stated, and all numbers are correctly presented. (3) The multi-hop reasoning is sound: the answer synthesizes changes across time (2023 to 2024), entities (GILD and Arcus), and dimensions (equity ownership and governance), correctly inferring increased influence. (4) The answer is contextually relevant, directly addressing the evolution in both equity and governance, and concludes with an accurate qualitative assessment of enhanced influence and strategic alignment. Minor wording differences (e.g., 'notable enhancement' vs 'significant increase') do not affect factual equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 313,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "The maturity date of the 2021 Multicurrency Credit Facility was extended from June 30, 2025, in 2022 to July 1, 2026, in 2023. Additionally, the borrowing capacity remained unchanged at $6.0 billion during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the maturity date changed from June 30, 2025 (in 2022) to July 1, 2026 (in 2023), and the borrowing capacity remained at $6.0 billion in both years. (2) Quantitative accuracy is perfect—dates and dollar amounts match exactly, with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesized information across two time points (2022 and 2023) for the same credit facility, identifying both continuity (borrowing capacity) and change (maturity date). (4) While the LLM answer is more concise than the original, it includes all key information required by the question and conveys the same meaning without omissions or distortions. No inaccuracies or irrelevant content present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 244,
        "total_tokens": 1402
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron's utilization of imported crude oil in U.S. refining operations remained relatively stable between 2023 and 2024, with imported crude accounting for approximately 60% of U.S. refinery inputs in both years. However, refinery capacity utilization in the U.S. decreased slightly, averaging 86.6% in 2024 compared to 90.8% in 2023. This decline in utilization was accompanied by ongoing projects to enhance refinery flexibility and throughput capacity, such as the completed upgrade at the Pasadena Refinery.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron's use of imported crude oil remained at approximately 60% in both 2023 and 2024, matching the ground truth. It also accurately reports the refinery capacity utilization figures: 90.8% in 2023 and 86.6% in 2024. All quantitative data are correct and consistent with the original answer. (2) There are no calculation errors; the percentages and years are accurately presented. Format variations are not an issue here as all numbers are reported consistently. (3) The multi-hop reasoning is sound—information about imported crude oil dependency and refinery utilization across two years is correctly synthesized. The only minor deviation is the addition of information about 'ongoing projects to enhance refinery flexibility' and the 'Pasadena Refinery upgrade,' which, while plausible and contextually relevant, is not present in the ground truth and thus introduces unverified detail. This does not contradict the facts but adds content beyond the source. (4) The answer is highly accurate, complete, and relevant. The core facts, numbers, and trends are correctly conveyed with semantic equivalence to the original. The slight deduction in qualitative accuracy accounts for the extra, unsupported detail. Overall, the response meets the highest standards for correctness and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 375,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS's hedging position in British Pound Sterling decreased from £856 million in 2023 to £536 million in 2024, indicating a reduction in exposure to GBP. This shift suggests a more conservative approach to currency risk management, potentially reflecting a reassessment of exposure levels or improved stability in the GBP relative to other currencies. The company continues to prioritize cash flow hedges for anticipated foreign currency denominated revenue, maintaining a strategic focus on managing foreign exchange risks.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2023 GBP hedge position: it reports £856 million, whereas the ground truth is 663 million units. The 2024 value of £536 million is correct. This leads to an incorrect reduction amount and invalidates any percentage change calculation (though no percentage was provided in the LLM answer). (2) Quantitative accuracy is low because the core financial figure for 2023 is wrong by a large margin (856M vs 663M, a difference of 193M units). The calculation of the reduction cannot be verified due to the incorrect starting value. (3) The qualitative reasoning is sound: the interpretation that a decrease in hedge position indicates a more conservative strategy or reassessment of GBP risk aligns with the ground truth and shows correct multi-hop synthesis between the numerical trend and strategic implication. The mention of cash flow hedges and strategic focus on FX risk management adds relevant context consistent with UPS's overall approach. (4) Contextual relevance is high as the answer addresses both parts of the question—evolution of the hedging position and its strategic implication—and uses appropriate financial terminology. However, the major numerical inaccuracy severely undermines the correctness score, limiting it to partial credit despite otherwise logical reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 378,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at the end of 2023 to $1.3 billion at the end of 2024. This slight increase suggests a modest shift in the company's short-term investment strategy, potentially indicating a continued focus on maintaining liquidity and managing short-term cash flows amid market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the fair value of money market investments as $1.2 billion at the end of 2023 and $1.3 billion at the end of 2024, matching the ground truth exactly in both amount and timing. There are no discrepancies in numeric values or dates, and the format ($1.2 billion vs $1.2B) is semantically equivalent. (2) Quantitative accuracy is perfect: the values are correct, and the implied $0.1 billion increase is accurate. No calculations were required beyond recognition of the change, which is correctly interpreted as an increase. (3) The reasoning is sound: the LLM correctly infers that the increase suggests a modest shift in short-term investment strategy, aligning with the ground truth's interpretation of 'modest growth' and 'slight expansion in liquidity management.' The LLM slightly rephrases the implication using 'continued focus on maintaining liquidity' and 'managing short-term cash flows amid market conditions,' which is a reasonable and contextually appropriate interpretation, though it adds a subtle emphasis on market conditions not explicitly stated in the original. This does not introduce inaccuracy but represents a minor expansion in explanatory language. (4) All parts of the question are addressed: the evolution of fair value (quantitative change) and its implication for strategy (qualitative interpretation). Entities—Bank of America, money market investments, 2023, and 2024—are correctly identified. The answer is contextually relevant and factually aligned. A score of 9 is given for correctness and qualitative accuracy due to the slightly less precise phrasing of strategic implication, but no factual errors exist.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 461,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "The maximum expected volume of natural gas subject to physical supply contracts with sell-back options decreased from 26 million mmBtu in 2022 to 15 million mmBtu in 2024 across Southern Company's subsidiaries. Specifically, Alabama Power's volume decreased from 6 million mmBtu to 4 million mmBtu, Georgia Power's decreased from 8 million mmBtu to 6 million mmBtu, Mississippi Power's decreased from 4 million mmBtu to 2 million mmBtu, and Southern Power's decreased from 8 million mmBtu to 3 million mmBtu.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: the total volume decreased from 26 million mmBtu in 2022 to 15 million mmBtu in 2024, and each subsidiary's volumes are correctly reported (Alabama Power: 6 to 4, Georgia Power: 8 to 6, Mississippi Power: 4 to 2, Southern Power: 8 to 3 million mmBtu). (2) Calculations are not explicitly required but the implied total reductions are consistent and correctly represented. (3) The multi-hop reasoning is sound—information is synthesized across Southern Company and its four subsidiaries over two years, correctly identifying the trend of reduction across all entities. (4) The answer is semantically equivalent to the original, conveying the same core message of a consistent reduction in natural gas volumes under such contracts. All entities, metrics, and years are correctly identified and presented. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 280,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "Between 2023 and 2024, the integration and application of the Adobe Firefly Vector Model evolved by expanding its availability across Adobe's product suite. In 2023, Firefly's vector capabilities were introduced as part of the Firefly web app and integrated into key Creative Cloud applications like Photoshop, Illustrator, and Adobe Express. By 2024, the Firefly Vector Model was further embedded into additional tools, including Adobe Acrobat and Adobe Stock, and was made available as part of Adobe Firefly Services and Custom Models for enterprise use. This expansion enabled users to generate fully editable vector graphics from text prompts directly within a broader range of Adobe applications, enhancing creative workflows and commercial content production.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the timeline and scope of Firefly Vector Model integration. According to the ground truth, in 2023 the model was integrated into Adobe Express only, enabling text-to-image and text effects in over 100 languages. However, the LLM incorrectly states that in 2023 it was already integrated into Photoshop, Illustrator, and the Firefly web app—this contradicts the original answer, which specifies that Illustrator integration occurred in 2024. The 2024 expansion into Illustrator with Generative Recolor is correct in concept but misrepresented in the LLM answer, which instead claims expansion into Acrobat, Adobe Stock, and enterprise services—details not supported by the ground truth. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is based on correct use of years and feature counts. The years 2023 and 2024 are used correctly in framing the evolution, but the attribution of features to those years is flawed. (3) The multi-hop reasoning is partially sound—the LLM recognizes that the Firefly Vector Model expanded across Adobe’s suite from 2023 to 2024—but fails to accurately trace the specific progression: from Adobe Express only in 2023 to inclusion in Illustrator in 2024. Instead, it overstates early adoption and adds unverified integrations (Acrobat, Stock, enterprise models), indicating a failure in factual synthesis. (4) The contextual relevance is high because the answer addresses the evolution of Firefly across Adobe products and attempts to describe functional improvements. However, due to major entity and timeline inaccuracies, the qualitative and overall correctness scores are low. Minor wording differences would be acceptable under semantic equivalence, but the LLM introduces unsupported applications and misattributes key rollouts, making the answer substantially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 526,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "Based on the data from the provided document pages, the commercial significance of Biktarvy for GILD increased from 2023 to 2024, with total sales rising from $11,850 million in 2023 to $14,848 million in 2024. This growth underscores Biktarvy's continued dominance in GILD's HIV portfolio and reinforces its role as a cornerstone of the company's HIV business strategy. The sustained growth in Biktarvy sales suggests GILD's focus on maintaining leadership in the HIV treatment market and leveraging its innovative therapies to drive revenue.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Biktarvy sales increased from $11,850 million in 2023 to $14,848 million in 2024. The ground truth does not provide any data for 2024 sales, only noting that Biktarvy remained central but faced increased risks. The $14,848 million figure is entirely fabricated. (2) Quantitative accuracy is severely compromised: the 2023 sales figure ($11,850 million) is correct, but the 2024 figure is false, and no such number exists in the ground truth. There is no basis for claiming sales growth into 2024. (3) The reasoning is flawed: the LLM incorrectly infers continued growth and strategic reinforcement, while the original answer highlights growing risks, reliance concerns, and pressure to diversify due to generic competition and shifting treatment paradigms. The model fails to capture the cautionary tone and strategic vulnerability emphasized in the ground truth. (4) While the answer addresses the question's topic and mentions Biktarvy's role in GILD's HIV strategy (hence partial contextual relevance), it contradicts the original conclusion by asserting growth and dominance rather than signaling risk and strategic challenge. The multi-hop synthesis fails because it invents data instead of correctly interpreting the evolving risk landscape as implied by the company's disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 379,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "The Series 2018-1A Securities had an outstanding principal amount of $496.8 million as of December 31, 2023, compared to $496.1 million as of December 31, 2022, indicating a slight increase in the outstanding principal. The interest rate for the Series 2018-1A Securities remained unchanged at 3.652% during the period between 2022 and 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported principal amounts. According to the ground truth, the outstanding principal in 2022 was $500.0 million, not $496.1 million as stated by the LLM. In 2023, the principal was $496.8 million, which the LLM correctly reports. However, the LLM incorrectly states that the principal increased from $496.1 million to $496.8 million, when in fact it decreased from $500.0 million to $496.8 million. This misrepresents the trend. (2) The interest rate of 3.652% is correctly reported and noted as unchanged, which is accurate. However, the principal figures are quantitatively wrong, undermining the financial analysis. (3) The reasoning is flawed because the LLM fails to correctly identify the starting principal in 2022, leading to an incorrect conclusion about an 'increase' in principal, when the correct interpretation is a minor reduction. This breaks the multi-hop synthesis between years. (4) Despite the incorrect numbers, the answer addresses the right securities, time frame, and metrics (principal and interest rate), and the structure is relevant. Hence, contextual relevance is high, but correctness and quantitative accuracy are severely impacted by the wrong dollar amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 354,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "From 2023 to 2024, UPS's relationship with Coyote shifted significantly in both financial impact and strategic direction. In 2023, UPS recorded a $111 million impairment charge for the Coyote trade name due to declining revenues and challenging market conditions in the truckload brokerage business, prompting an evaluation of strategic alternatives. By 2024, UPS completed the divestiture of Coyote, resulting in a $156 million gain on the divestiture, which marked a strategic exit from the underperforming business. Financially, this transition reduced operating expenses and improved operating profit within the Supply Chain Solutions segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the $156 million gain on divestiture, which is not present in the ground truth. The original answer only mentions a $111 million impairment charge in 2023 and the September 2024 divestiture contributing to reduced Supply Chain Solutions revenue—no gain on divestiture is stated. This incorrect figure undermines quantitative accuracy. Additionally, the claim that the divestiture 'reduced operating expenses and improved operating profit' is speculative and not supported by the original answer, which only notes a revenue decrease due to Coyote's exit. (2) The $111 million impairment charge is correctly stated, and the 2023–2024 timeline and September 2024 divestiture are consistent with the original. However, the introduction of a $156 million gain—without grounding in the provided truth—represents a significant fabrication. (3) The multi-hop reasoning is partially sound: the model correctly identifies the evolution from impairment in 2023 to divestiture in 2024 and links it to strategic direction. It also correctly associates Coyote with the Supply Chain Solutions segment. However, it adds financial outcomes (gain, expense reduction, profit improvement) not present in the source, indicating flawed synthesis. (4) Correctness is scored 6 due to correct core timeline and impairment fact but penalized for significant invented financials. Quantitative accuracy is low (4) due to the false $156M figure. Qualitative accuracy is 7 as reasoning flow is logical and entities are correct. Contextual relevance is high (9) as the response directly addresses the question's scope and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 455,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "Linde plc's Performance Share Unit Awards, beginning with grants in 2019, were structured under the 2021 Linde plc Long Term Incentive Plan and included two primary performance metrics: Return on Capital and Total Shareholder Return. By 2024, the structure of these awards remained consistent, with the same performance metrics continuing to be used for grants, as outlined in the updated forms under the 2021 Plan. No significant changes to the performance metrics were introduced between 2022 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core structure of Linde plc's Performance Share Unit Awards correctly by identifying the two performance metrics—Return on Capital and Total Shareholder Return—and correctly states that these metrics remained consistent from 2022 to 2024 for grants beginning in 2019. However, there is a significant factual inaccuracy regarding the incentive plan under which the awards were structured. The original answer specifies that the awards were under the 'Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan,' not the '2021 Linde plc Long Term Incentive Plan' as claimed by the LLM. This is a critical entity error, as it misidentifies the governing plan, which is central to the question about structural evolution. Additionally, the LLM fails to reference the exhibit numbers (e.g., 10.11k, 10.11l, 10.10l, 10.10m) that ground truth uses to substantiate the continuity between years, weakening the evidentiary support. While the conclusion about no significant changes is aligned with the ground truth, the incorrect plan name and omission of exhibit-level detail reduce factual precision. The reasoning is logically sound in asserting stability over time, but the flawed plan attribution undermines the qualitative and quantitative accuracy. Contextual relevance is high, as the response directly addresses the evolution of the award structure and performance metrics over the specified period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 394,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "Between 2023 and 2024, the regulatory status of Trodelvy advanced significantly, as it received a Breakthrough Therapy designation from the FDA in 2024 for the treatment of extensive-stage small cell lung cancer, in addition to its existing approvals for breast cancer and urothelial cancer. This indicates a positive development trajectory, with Trodelvy being recognized for its potential to substantially improve clinical outcomes in a serious condition, thereby expediting its regulatory review process.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that in 2024, Trodelvy received a Breakthrough Therapy designation from the FDA for extensive-stage small cell lung cancer, which matches the original answer. It also correctly references its existing approvals in 2023 for breast cancer (both triple-negative and HR+/HER2-negative) and urothelial cancer, though it summarizes them more broadly as 'breast cancer and urothelial cancer' without specifying subtypes. (2) All dates (2023, 2024) and regulatory actions (Breakthrough Therapy designation) are correct; no numerical data is present, but temporal accuracy is preserved. (3) The multi-hop reasoning is sound: the model synthesizes Trodelvy’s 2023 indications with its 2024 regulatory update and infers a positive development trajectory, correctly interpreting the significance of Breakthrough Therapy designation. (4) The answer is contextually relevant and conveys the strategic expansion into new oncology indications, though it could have more explicitly stated the 'high unmet medical need' aspect. The omission of specific breast cancer subtypes slightly reduces completeness but does not impair core accuracy. Hence, a score of 9 is justified—excellent, with minor room for specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 362,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "From 2023 to 2024, the Vertex AI platform within Google Cloud has evolved significantly in terms of capabilities and integration with generative AI models. In 2023, Vertex AI enabled developers to train, tune, and deploy applications using generative AI models. By 2024, Vertex AI expanded its capabilities to include testing and deployment of applications using Gemini, Imagen, Veo, and other leading generative AI models, as well as offering pre-packaged AI agents to assist developers and cybersecurity teams. This advancement reflects a broader integration of Google's latest AI innovations into the Vertex AI platform, enhancing its utility for enterprise AI development and deployment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Vertex AI from 2023 to 2024. It correctly identifies that in 2023, Vertex AI supported training, tuning, and deployment of generative AI applications. In 2024, it accurately notes expanded capabilities, including testing and support for Gemini and other models (naming Imagen and Veo adds specificity not in the original but does not contradict it). The mention of 'pre-packaged AI agents' is not present in the ground truth but is plausible and contextually relevant, though this is an addition not confirmed by the source. The core advancements—enhanced integration with generative AI models, expanded services (testing), and optimization for enterprise use—are correctly conveyed. The ground truth emphasizes 'vector search, grounding, and distillation' as new services, which the LLM answer omits, representing a minor but notable gap in completeness. There are no numerical values to verify, so quantitative accuracy is scored as 10. Qualitative accuracy is high but docked slightly for missing specific new services and introducing unverified elements. Contextual relevance is perfect—the response directly addresses the question’s focus on evolution in capabilities and generative AI integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 362,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "From 2022 to 2024, the treatment and valuation of weather derivatives in SO's financial disclosures have remained consistent in terms of being excluded as immaterial. In both periods, the net amounts recognized in the balance sheets exclude immaterial premium and intrinsic value associated with weather derivatives. However, in 2024, the disclosures explicitly state that these exclusions apply to all periods presented, whereas in 2022, the immaterial amounts were mentioned without such a broad temporal reference.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that SO consistently excluded weather derivative values as immaterial from 2022 to 2024 and notes a change in disclosure language regarding the temporal scope. However, it omits key quantitative information from the 2024 filing—specifically, the disclosed cash collateral amounts of $17 million and $62 million at the end of 2024 and 2023, respectively—which are central to the evolution in SO's derivative disclosures. These figures are critical for showing increased transparency, even if weather derivatives themselves remained immaterial. (2) No incorrect numbers are stated (so quantitative accuracy is high), but the failure to include the $17M and $62M values results in incomplete factual representation. The years (2022, 2023, 2024) and entities (SO, weather derivatives) are correct. (3) The reasoning partially captures the multi-hop aspect—comparing disclosure practices across years—but misses the synthesis between immaterial exclusions and the new inclusion of broker margin account data, which signals a more structured disclosure framework. (4) The answer is contextually relevant and well-structured, but the omission of key financial figures from 2024 reduces completeness and factual richness, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 365,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "Between 2023 and 2024, Biktarvy's regulatory and market positioning evolved with the FDA approving an expanded indication to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the label was updated to include data reinforcing its safety and efficacy for treating pregnant people with HIV-1 who have suppressed viral loads. This expansion highlights Gilead's efforts to broaden Biktarvy's utility in addressing specific patient needs and resistance challenges, enhancing its market relevance and competitive positioning in the HIV treatment landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory developments for Biktarvy in 2024—specifically, the FDA's expanded indication for patients with suppressed viral loads and known or suspected M184V/I resistance, as well as the updated label supporting use in pregnant people with HIV-1. These points match the original answer exactly in substance. However, the LLM omits the 2023 patent expiration detail (2033 U.S. patent expiry), which was part of the original answer and relevant to market positioning based on exclusivity. This is a minor but notable omission affecting completeness. (2) There are no numeric values, dates, or calculations in the response that conflict with the ground truth; the absence of the 2033 patent date is an omission rather than an inaccuracy. All other qualitative facts are correct. (3) The multi-hop reasoning is mostly sound—the model synthesizes the 2024 regulatory updates from GILD's disclosures and correctly infers enhanced market positioning due to broader patient eligibility. It captures the shift in focus toward expanded utility, though it does not explicitly contrast 2023 (patent protection) with 2024 (label expansion), slightly weakening the comparative analysis. (4) The correctness score is 9 because all presented information is accurate and contextually relevant, but the missing 2023 patent context reduces full multi-hop synthesis. Quantitative accuracy is 10 as there are no incorrect numbers. Qualitative accuracy is 9 due to strong reasoning but partial entity coverage. Contextual relevance is 10—response directly addresses the evolution in regulatory and market positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 453,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "AMT's utilization of the 2021 Multicurrency Credit Facility changed between 2022 and 2023 in terms of borrowing amounts and facility amendments. In 2023, AMT borrowed an aggregate of $3.0 billion and repaid $6.1 billion, including 842.6 million EUR, under the 2021 Multicurrency Credit Facility, which was used to repay outstanding indebtedness and for general corporate purposes. Additionally, the facility was amended to extend its maturity date to July 1, 2026, and the LIBOR pricing benchmark was replaced with an Adjusted Term SOFR pricing benchmark.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: $3.0 billion borrowed and $6.1 billion repaid in 2023, including the 842.6 million EUR (equivalent to $919.1 million) repayment, and correctly notes the extension of the maturity date to July 1, 2026, the replacement of LIBOR with SOFR (specified as Adjusted Term SOFR, which is semantically acceptable), and the facility's continued $6.0 billion commitment. All numbers and dates match the ground truth. (2) Quantitative accuracy is perfect—no errors in amounts, conversions, or dates. The EUR amount is correctly cited, and while the USD equivalent ($919.1 million) is omitted in the LLM answer, its absence does not constitute a factual error since the original EUR figure is present and the conversion was not required for completeness. (3) The multi-hop reasoning is sound: the model synthesizes changes in borrowing/repayment activity between 2022 and 2023 and correctly identifies structural amendments in 2023. However, the LLM answer omits the 2022 net borrowings of $850.0 million, which was a key part of the original answer and directly addressed the comparative usage between 2022 and 2023. This is a minor but notable omission affecting completeness. (4) Despite this omission, the answer is highly accurate, contextually relevant, and conveys the core transformation in 2023. The qualitative accuracy is slightly reduced due to the missing 2022 detail, but the reasoning and entity identification (AMT, 2021 Multicurrency Credit Facility, correct years) are correct. Contextual relevance is full as all provided information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 451,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "Between 2023 and 2024, Google Ad Manager's role in Alphabet's advertising revenue recognition strategy remained consistent in its function as a primary platform for customers to purchase advertising inventory. However, its integration with revenue reporting models emphasized continued gross reporting for ads placed on Google Network properties, where Alphabet acts as the principal. This means that revenues are recorded at gross value, with payments to partners classified as cost of revenues. No significant changes were disclosed in the 2024 filing regarding the role or integration of Google Ad Manager in revenue recognition processes compared to 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that no significant changes were disclosed in 2024, which directly contradicts the ground truth. The original answer states there was a strategic evolution in 2024 where Alphabet shifted from a transactional gross reporting model to a more control-based justification for gross revenue recognition, emphasizing Google Ad Manager's role in asserting principal status through control of inventory, responsibility to customers, and pricing discretion. The LLM answer incorrectly asserts continuity and absence of change, missing this key qualitative shift. While the LLM correctly identifies that Alphabet reports revenue on a gross basis and classifies partner payments as cost of revenue (consistent elements in both years), it fails to capture the nuanced evolution in revenue recognition rationale. There are no numerical figures in the question, so quantitative accuracy is not applicable beyond correct use of years (2023, 2024), which are accurate. The reasoning is partially sound but fails the multi-hop synthesis by not connecting the change in language and strategic framing between the two years. Contextually, the answer is relevant and addresses the topic of revenue recognition and Google Ad Manager, but omits the critical evolution highlighted in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 369,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "Between 2023 and 2024, UPS's financial exposure and strategic positioning regarding Roadie evolved as follows: In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial strain or underperformance. By 2024, while no impairment was recorded for Roadie, it was identified as one of three reporting units (alongside Global Freight Forwarding and Global Logistics and Distribution) with limited excess fair value, signaling ongoing risk. UPS continues to monitor these units closely, as small changes in cost of capital or cash flow projections could lead to future impairments. This reflects a strategic shift toward cautious oversight and potential restructuring to align Roadie with broader operational goals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $56 million goodwill impairment charge in 2023 and the absence of a further charge in 2024, accurately reflecting the financial exposure evolution. It correctly states that Roadie was among the reporting units with limited excess fair value over carrying value in 2024, signaling ongoing risk. The only minor deviation is the inclusion of 'Global Freight Forwarding and Global Logistics and Distribution' as the other two units—while this detail is factually correct based on the 2024 10-K, it was not part of the original ground truth answer, but does not detract from accuracy. (2) Quantitative accuracy is perfect: the $56 million figure and the years 2023 and 2024 are correct, with no calculation errors. (3) Multi-hop reasoning is sound: the model synthesizes information across two years and connects impairment in 2023 to continued risk in 2024, correctly inferring a strategic shift toward cautious monitoring. The conclusion about sensitivity to cost of capital and cash flow projections aligns with the original answer’s emphasis on forecasting sensitivity. (4) The answer is contextually fully relevant, addressing both financial exposure (impairment, fair value) and strategic positioning (monitoring, potential restructuring). The slight expansion on other reporting units adds context without introducing error, warranting a 9 on qualitative accuracy and 9 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 402,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "From 2022 to 2024, Linde's relationship with helium has shown a mixed quantitative impact. In 2024, the company reported a 2% decrease in sales for its \"Other\" segment, which includes global helium wholesale, primarily due to lower volumes in global helium. However, operating profit in the \"Other\" segment increased by 44%, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), despite higher costs associated with helium. This indicates that while helium-related sales declined, cost management and insurance recoveries positively impacted profitability.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2% decrease in underlying sales in the 'Other' segment due to lower global helium volumes and mentions the insurance recovery related to LAMT, which aligns with the ground truth. However, it incorrectly states that operating profit in the 'Other' segment increased by 44%, which contradicts the original answer stating that operating profit saw increased costs from helium (i.e., negative impact), only partially offset by insurance recovery. This 44% figure is not present in the ground truth and appears to be fabricated or misattributed, severely undermining quantitative accuracy. (2) The only numeric values in the ground truth are the 2% sales decrease and the qualitative note about increased costs partially offset by recovery—no percentage increase in operating profit is stated. Thus, the 44% claim is a major factual error. (3) The multi-hop reasoning is partially sound: the model connects helium to the 'Other' segment, links lower volumes to sales decline, and associates LAMT with insurance recovery. However, it fails to correctly synthesize the net effect on operating profit, incorrectly implying strong profitability growth when the truth indicates cost pressure. (4) The contextual relevance is high because the answer addresses the evolution of Linde's relationship with helium and attempts to quantify impacts on sales and profit. The qualitative accuracy is moderate due to correct entity identification (Linde, helium, LAMT, 'Other' segment) and timeline (2022 to 2024), but the incorrect profit conclusion reduces reasoning quality. Correctness is scored at 5 due to a mix of correct and significantly incorrect quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 466,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The total value of loans covered under long-term credit protection agreements with FNMA and FHLMC decreased from $8.7 billion at December 31, 2023, to $8.0 billion at December 31, 2024. This reduction suggests a slight decline in the Corporation's credit risk exposure on residential mortgage loans, as these agreements provide full credit protection for severely delinquent loans. The decrease may indicate a shift in the Corporation's loan portfolio or a reduction in the number of loans requiring such protection, reflecting improved credit quality or changes in risk management strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the loan values in 2023 ($8.7 billion) and 2024 ($8.0 billion), matching the ground truth exactly. The decrease of $0.7 billion is accurately implied. (2) All numeric values and dates (December 31, 2023, and December 31, 2024) are correct and consistent with the original answer. Format is precise and clear. (3) The reasoning correctly identifies that these agreements provide full credit protection and links the decline to reduced credit risk exposure, which aligns with the ground truth. It also appropriately infers possible explanations such as improved credit quality or changes in risk management, which are logically sound extensions of the data. However, the original answer adds the specific point that no allowance for credit losses is recorded on these loans, which the LLM omits. This is a minor but relevant detail regarding accounting treatment and risk implications. (4) The answer is fully contextually relevant, directly addressing both parts of the question: the evolution of loan values and the implication for credit risk. The qualitative accuracy is slightly reduced due to the omission of the allowance for credit losses point, but the core reasoning remains strong and factually aligned. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor contextual omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 389,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "Between 2023 and 2024, Adobe's strategic positioning of Adobe Firefly evolved to emphasize its integration into core Creative Cloud and Document Cloud offerings, enhancing competitive differentiation through natively embedded generative AI capabilities. Adobe Firefly's evolution included expanding its language support to over 100 languages, offering AI-generated content that is safe for commercial use, and providing intellectual property indemnification for enterprise users. However, the 2024 10-K highlights increased regulatory risks due to the evolving AI regulatory landscape, such as the EU AI Act, which could impose compliance costs, alter development practices, and introduce liability concerns related to AI deployment and content generation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe emphasized Firefly's integration into Creative Cloud and Document Cloud, its commercial safety, IP indemnification, and expanded language support—though the latter details (e.g., 100+ languages) are not in the ground truth, they do not contradict it and add plausible context. The mention of regulatory risks tied to the EU AI Act in 2024 is accurate and matches the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is unaffected; all references to years (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes Firefly’s competitive differentiation (integration, commercial safety) and the evolution in risk disclosure between years, particularly the introduction of EU AI Act concerns in 2024. (4) The only minor gap is that the original answer emphasizes a strategic shift from 'purely competitive' to 'risk-aware' positioning, a framing slightly more explicit than the LLM’s version, which reports facts supporting that shift but doesn’t explicitly name the shift in tone. However, the LLM conveys the same semantic meaning. No incorrect entities or dates are used. Thus, the answer is factually complete and contextually appropriate, warranting a high score with only slight deduction for less explicit conceptual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 404,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "Between 2023 and 2024, Trodelvy's financial performance and regulatory trajectory showed notable developments. Financially, Trodelvy's product sales increased by 56% in 2023 compared to 2022, driven by higher demand in new and existing geographies. In 2024, the drug received Breakthrough Therapy designation from the FDA for the treatment of adult patients with extensive-stage small cell lung cancer whose disease has progressed on or after platinum-based chemotherapy, marking a significant regulatory milestone. This designation aims to expedite the development and regulatory review of Trodelvy for this serious condition, indicating its potential to improve clinical outcomes compared to available therapies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 56% year-over-year sales increase in 2023 is accurately reported. While the exact dollar amount of $1,063 million in sales is not mentioned, the percentage growth—which is the key financial metric provided in the original answer—is correctly stated. (2) The regulatory milestone in 2024 is accurately described: the FDA granted Breakthrough Therapy designation for extensive-stage small cell lung cancer after platinum-based chemotherapy, which matches the original answer. (3) The reasoning is sound and synthesizes financial performance (2023 sales growth) and regulatory progress (2024 designation) across the two years, directly addressing the multi-hop nature of the question. (4) The only minor omission is the absence of the exact sales figure ($1,063 million), which slightly reduces completeness but does not affect the core factual accuracy. Wording differences (e.g., 'progressed after' vs 'progressed on or after') are semantically equivalent in clinical context. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 335,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, with its equity investment in Angola LNG Limited remaining stable at around $1.665 billion to $1.762 billion. In 2022, Chevron reported $1,857 million in equity earnings from Angola LNG, which declined to $513 million in 2023 and further to $405 million in 2024, indicating a reduction in profitability from this affiliate. Despite the fluctuation in earnings, Chevron maintains a 36.4% interest in Angola LNG Limited, which processes and liquefies natural gas produced in Angola for international markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Chevron's income from equity affiliates in 2022 was $5,657 million overall, with Angola LNG contributing to upstream-related earnings, but it does not specify $1,857 million as earnings solely from Angola LNG. The LLM incorrectly attributes $1,857 million, $513 million, and $405 million in equity earnings specifically to Angola LNG for 2022–2024, which is not supported by the original answer. Additionally, the original answer does not mention any equity investment value of $1.665B–$1.762B; this figure is entirely fabricated. The only correct quantitative detail is the 36.4% ownership stake in Angola LNG Limited disclosed in 2024. (2) Number verification: The $5,657 million in total equity affiliate income in 2022 is misrepresented in the LLM answer as being split or partially attributed to Angola LNG without justification. There are no disclosures about year-over-year declines in Angola LNG earnings in the ground truth. The LLM invents a trend (declining profitability) not present in the original. (3) Multi-hop reasoning is partially sound in that the LLM attempts to track evolution over time and links Chevron’s stake to strategic positioning, but it fails to correctly synthesize actual disclosures. It confuses aggregate affiliate income with Angola LNG-specific figures and introduces unsupported financial data. (4) Scores reflect major quantitative errors (2/10), weak qualitative accuracy due to incorrect data synthesis despite correct identification of the 36.4% stake and Angola LNG’s role (4/10), moderate contextual relevance because the structure and intent align with the question (7/10), and a low overall correctness score (3/10) due to fabrication of key financial figures and misrepresentation of earnings trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 501,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "From 2023 to 2024, the value of META's Fixed-Rate Senior Unsecured Notes increased from $18.50 billion to $29.0 billion, primarily due to the issuance of $10.50 billion in new notes in August 2024. The interest rates on the new 2024 notes ranged from 4.30% to 5.55%, with effective rates of 4.42% to 5.60%, reflecting higher market rates compared to the 2023 notes, which had stated rates of 4.60% to 5.75% and effective rates of 4.68% to 5.79%.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the increase in total value of META's Fixed-Rate Senior Unsecured Notes from $18.50 billion at the end of 2023 to $29.0 billion at the end of 2024, and accurately identifies the $10.50 billion issuance in August 2024 as the driver. It also correctly references the 2023 issuance context by noting the starting balance of $18.50 billion, which aligns with the ground truth that $8.46 billion in net proceeds were issued in May 2023. All dollar amounts, dates, and numerical values are factually correct. (2) Quantitative accuracy is perfect: $29.0B - $18.50B = $10.50B, matching the reported issuance; the interest rate ranges for both 2023 and 2024 notes are accurately reported with proper distinctions between stated and effective rates. (3) The multi-hop reasoning is sound—synthesizing data across 2023 and 2024 filings, correctly identifying the evolution in value and issuance activity. The only minor omission is that the original answer explicitly notes the $8.46 billion net proceeds from the May 2023 issuance, which the LLM answer implies but does not directly state. However, since the LLM correctly uses the resulting $18.50 billion year-end 2023 balance, this does not undermine the core accuracy. (4) The answer is contextually relevant, directly addressing how both value and issuance evolved. The added detail about interest rates enhances the response without introducing error. The qualitative score is 9 due to the slight incompleteness regarding the 2023 issuance amount, but the core multi-hop synthesis remains accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 441,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "LIN's financial exposure to helium as a raw material increased from 2023 to 2024, as reflected in the shift from categorizing helium as a \"supply\" to labeling it a \"dependency.\" In 2023, the company disclosed helium as a supply with no specific cost or sourcing details provided in the given pages. However, in 2024, helium was explicitly identified as a dependency, indicating a heightened reliance on helium for operations. This change suggests a greater financial exposure due to potential volatility in helium sourcing or pricing, though specific cost figures or sourcing risks were not detailed in the provided pages.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in identifying the shift in categorization from 'supply' in 2023 to 'dependency' in 2024, which aligns with the ground truth and indicates increased financial exposure. However, it incorrectly states that no specific cost details were provided in 2023, when the ground truth explicitly reports helium costs at 4.2% of total raw material expenses. Similarly, the LLM fails to mention the 6.8% cost figure in 2024, which is a key quantitative indicator of increased exposure. (2) The absence of the 4.2% and 6.8% figures represents a major omission in quantitative accuracy—these percentages are central to measuring the change in financial exposure. The LLM claims 'no specific cost or sourcing details provided,' which contradicts the ground truth, resulting in a low quantitative accuracy score. (3) The reasoning correctly interprets the semantic shift from 'supply' to 'depends_on' as signaling greater strategic importance and reliance, showing sound qualitative understanding of categorization implications. However, it fails to synthesize the multi-hop evidence—linking the categorical change with the actual cost percentage increase—which is essential for full correctness. (4) Contextual relevance is high because the answer addresses the core theme of increasing exposure and interprets the categorization change appropriately. The structure and intent are aligned with the question, but the lack of key data severely undermines factual correctness. Thus, the overall correctness score is 4 due to significant factual omissions despite correct directional reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 445,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "Between 2022 and 2023, PayPal's utilization of European customer balances for credit activities increased, with the approved amount rising from $3.8 billion in 2022 to $3.0 billion in 2023. This represents a decrease of $0.8 billion, or a 21.1% reduction in the amount approved for such activities.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that PayPal's utilization of European customer balances 'increased' between 2022 and 2023, when in fact the approved amount decreased from $3.8 billion to $3.0 billion. This misrepresents the trend. While the absolute dollar amounts ($3.8B in 2022, $3.0B in 2023) are correct, the interpretation is wrong. The percentage change calculation is numerically accurate (a $0.8B reduction is ~21.1%), but it contradicts the claim of an increase. (2) The calculation of the percentage decrease is correct: (3.8 - 3.0)/3.8 ≈ 21.05%, which rounds to 21.1%. However, the LLM fails to mention the key contextual metric from the ground truth — that the proportion of European customer balances used rose from 37% to 39% — which is critical for understanding the shift in utilization strategy. (3) The multi-hop reasoning is flawed. The question asks how utilization evolved, which requires synthesizing both absolute amounts and relative percentages. The LLM only focuses on absolute amounts and misinterprets the direction of change, failing to reconcile the decrease in dollar terms with the slight increase in percentage of balances used. This indicates a failure in qualitative synthesis across the two years and metrics. (4) The contextual relevance is moderate because the answer addresses the right company, time frame, and general topic, and includes a correct calculation. However, due to the incorrect narrative about increasing utilization and omission of key percentage data, the overall correctness score is low. The answer misleads despite having some accurate numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 453,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Starbucks' exposure to foreign currency - other instruments saw a significant decrease in fair value between 2023 and 2024. The fair value of derivative assets for foreign currency - other dropped from $1,164 million as of October 1, 2023, to $920 million as of September 29, 2024. Additionally, the expected reclassification impact on earnings for foreign currency - other decreased from $23.6 million in 2023 to $28.2 million in 2024, indicating a shift in the timing or magnitude of gains/losses being recognized in earnings.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in fair value from $1,164 million in 2023 to $920 million in 2024, which matches the ground truth and is accurately stated with correct dates (October 1, 2023, and September 29, 2024). However, the key error lies in the reclassification impact: the LLM states it increased from $23.6 million in 2023 to $28.2 million in 2024, which directly contradicts the ground truth that reports a decline from $55.3 million in 2023 to $9.5 million in 2024. This is a major quantitative inaccuracy. Additionally, the LLM omits the net gain in AOCI ($39.6M in 2023 and $11.5M in 2024), which is a core part of the original answer and relevant to understanding the evolution of exposure. (2) The fair value numbers are correct, but the reclassification figures are entirely wrong—neither the values nor the trend (increase vs. actual sharp decrease) align with ground truth. There is no indication in the LLM answer of the reduced short-term earnings impact, which is a central conclusion in the original. (3) The reasoning is partially sound in noting a change in reclassification impact, but the incorrect numbers lead to flawed inference (suggesting a shift in timing/magnitude due to increase, when in reality there was a steep drop). The model fails to correctly synthesize the multi-hop information regarding AOCI components and their earnings implications across years. (4) The contextual relevance is high as the answer addresses foreign currency exposure, fair value changes, and reclassification impact. However, due to significant numerical errors and missing key data points, the correctness and quantitative accuracy scores are moderate. The qualitative accuracy is slightly higher because the structure and intent of the response are reasonable, despite factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 496,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "From 2022 to 2023, the fair value of energy-related derivatives held by Alabama Power decreased from $15 million to $15 million (no change), while Georgia Power's increased from $75 million to $13 million. For Alabama Power, the asset position remained stable, and the liability position decreased from $110 million to $110 million (no change). For Georgia Power, the asset position slightly increased, and the liability position decreased from $8 million to $124 million. Thus, both companies saw a reduction in their net liability positions related to energy derivatives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains almost all incorrect numbers and misrepresents the directional changes. It claims Alabama Power's derivatives were $15M in both years, but the truth is $55M in assets (2022) and $15M (2023), and liabilities increased from $11M to $110M — not stable at $110M as stated. For Georgia Power, the LLM says assets increased from $75M to $13M, which is a decrease, not an increase, and liabilities went from $8M to $124M — the LLM incorrectly frames this as a decrease when it is a large increase. (2) All key figures are wrong: Alabama 2022 assets were $55M (not $15M), 2023 liabilities were $110M (not unchanged from $110M in 2022 — they were $11M in 2022). Georgia 2022 assets were $75M (correctly stated), but 2023 assets were $13M (not an increase). Liabilities rose from $8M to $124M — a massive increase, not a decrease. (3) The multi-hop reasoning is fundamentally flawed: the model fails to recognize that both companies shifted from net asset positions to large net liabilities. Instead, it falsely claims liability positions decreased and net liabilities reduced, which is the opposite of the truth. (4) The contextual relevance is low but not zero — it addresses the right companies and topic (energy derivatives), so minimal relevance is retained. However, factual and reasoning errors are severe, warranting a correctness score of 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 383,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "The asset allocation strategy for the U.S. Retiree Health Care Plan shifted from 2022 to 2023, with the percentage of fixed income securities and cash equivalents increasing from 65% to 80%, while the percentage of equity securities decreased from 35% to 20%. This change reflects a more conservative allocation, aligning with the plan's target ranges that prioritize fixed income investments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages for both years are accurate: 65% fixed income and 35% equity in 2022, shifting to 80% fixed income and 20% equity in 2023. The changes (increase of 15 percentage points in fixed income, decrease of 15 percentage points in equity) are correctly implied. (2) The answer is complete, addressing the evolution of allocation between the two asset classes over the two years as required. (3) Entities—'U.S. Retiree Health Care Plan', 'fixed income securities and cash equivalents', 'equity securities', and the years 2022 and 2023—are correctly identified and used. (4) The reasoning is sound: the shift toward a more conservative strategy is logically inferred from the increased allocation to fixed income, and the mention of 'target ranges that prioritize fixed income investments' adds context without contradicting the ground truth. The semantic meaning is equivalent to the original answer, with no factual or interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 297,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "Between 2022 and 2023, Trodelvy received new regulatory approvals for additional indications. In 2023, the FDA approved Trodelvy for the treatment of adult patients with unresectable locally advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. Additionally, the European Commission approved Trodelvy as monotherapy for the treatment of adult patients with unresectable or metastatic HR+/HER2- breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the advanced setting.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly identifies the 2023 regulatory approvals for Trodelvy by both the FDA and the European Commission (EC), specifying the new indication for HR+/HER2- breast cancer. (2) The dates (2022 to 2023) and approval bodies (FDA, EC) are correct, with no numeric or date inaccuracies. While the original answer mentions the 2022 indications (TNBC and urothelial cancer), the LLM focuses on the evolution and new 2023 approvals, which directly addresses the question about how the status evolved and what new indications were granted. (3) The multi-hop reasoning is sound: the model correctly infers that the key development between 2022 and 2023 was the expansion into HR+/HER2- breast cancer with approvals in both the U.S. and Europe. (4) The LLM answer is semantically equivalent to the original, using slightly different phrasing (e.g., 'advanced setting' vs 'metastatic setting') but conveying the same clinical and regulatory meaning. All entities—drug name (Trodelvy), regulatory agencies, cancer types, biomarker status (HR+/HER2-), and treatment history—are accurately represented. No factual errors, omissions, or misstatements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 342,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "Between 2023 and 2024, Meta's disclosure regarding user perception as a risk factor evolved to highlight more specific and emerging concerns, particularly around the impact of generative artificial intelligence (AI) and evolving regulatory frameworks on user engagement and trust. In 2023, the focus was primarily on factors like competitive products (e.g., TikTok), geopolitical events (e.g., the war in Ukraine), and general user sentiment shifts due to privacy and content concerns. By 2024, the disclosure expanded to emphasize risks tied to the adoption and public reception of generative AI technologies, including potential user dissatisfaction or reduced engagement if these initiatives are unsuccessful or discontinued. Additionally, 2024 highlighted the regulatory and compliance challenges associated with AI, such as the potential for adverse user reactions to policy changes or enforcement actions, which could further impact user trust and business operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of Meta's risk disclosures between 2023 and 2024. While the ground truth states that Meta reduced its emphasis on user perception risks in 2024 and shifted focus to operational and financial risks like acquisition integration and tax liabilities, the LLM claims the opposite—that Meta expanded its discussion of user perception risks in 2024, particularly around generative AI and regulatory challenges. This misrepresents the actual shift in disclosure strategy. Additionally, the LLM introduces specific examples like 'generative AI' and 'TikTok' as central to the 2023–2024 risk narrative, which are not supported by the ground truth. (2) There are no numeric values, dates, or calculations in either the question or answers, so quantitative accuracy is not applicable; however, the years 2023 and 2024 are used correctly in context, warranting a full score here. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the directional change in Meta’s risk disclosure—away from user perception—not toward more detailed user perception risks. The LLM incorrectly infers deeper user perception focus in 2024 when the ground truth explicitly states it was 'notably reduced.' (4) Contextual relevance is moderate: the answer addresses the general theme of user perception and risk disclosures, and it attempts to compare 2023 and 2024, but the core factual claim about the nature of the evolution is incorrect, undermining the overall correctness. Thus, correctness and qualitative accuracy are low despite proper framing and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 452,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "The notional amount of Lockheed Martin's variable interest rate swaps increased from $500 million in 2021 to $1.3 billion in 2024. This increase indicates that the company has expanded its use of interest rate derivatives to hedge against interest rate risk, particularly by converting fixed-rate borrowings to variable-rate borrowings. This strategy reflects a proactive approach to managing exposure to interest rate fluctuations and aligning its debt structure with its risk management objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the notional amounts of $500 million in 2021 and $1.3 billion in 2024, matching the ground truth exactly. These figures are critical quantitative data points and are accurately reported with correct formatting and time periods. (2) All calculations and comparisons are implicit but correct—the increase from $500M to $1.3B is a 160% increase, which the model captures qualitatively as an 'increase' without needing to quantify it, which is acceptable. (3) The multi-hop reasoning is sound: the model correctly infers that the increase in variable interest rate swaps indicates a strategic shift toward converting fixed-rate to variable-rate debt, aligning with interest rate risk management objectives. This synthesis across time and financial instruments is logically consistent with the data. (4) The only minor shortcoming is that the LLM slightly reframes the strategy as 'hedging against interest rate risk' through variable-rate swaps, whereas the original answer emphasizes the shift as converting fixed to variable borrowings in response to the interest rate environment. While this is a nuanced difference, the interpretation is still reasonable and contextually valid. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for subtle interpretive framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 393,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "Between 2022 and 2023, PayPal's financial provisions for transaction losses related to its Seller Protection Programs increased. In 2022, the provision for transaction and credit losses was $1,170 million, while in 2023, it rose to $1,192 million. Despite this increase in provisions, the realized losses also increased from $1,417 million in 2022 to $1,313 million in 2023, indicating a slight improvement in the net impact of losses relative to provisions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that PayPal's allowance for transaction losses decreased from $66 million in 2022 to $64 million in 2023. However, the LLM claims provisions increased from $1,170 million to $1,192 million, which is not only wrong but refers to a completely different metric—likely conflating 'provision for transaction and credit losses' with seller protection-specific provisions. Similarly, the 'realized losses' cited ($1,417M in 2022, $1,313M in 2023) are inaccurate and do not align with the ground truth, which does not provide absolute realized loss figures but instead discusses historical loss rates as a percentage of TPV (0.09%–0.15%). (2) The numbers are entirely inconsistent with the ground truth: $66M and $64M (correct) vs. over $1.1B (grossly inflated). There is no indication in the ground truth that seller protection losses were in the billions. (3) The multi-hop reasoning failed: the model did not distinguish between general credit/transaction loss provisions and the specific allowance related to Seller Protection Programs. It also misrepresented the evolution—2022 was qualitative, 2023 introduced more precise disclosures—but incorrectly framed it as an increase in provisions when the actual trend was a slight decrease. (4) The contextual relevance is low because the answer discusses broader loss provisions rather than focusing on Seller Protection Programs. The qualitative accuracy is poor due to incorrect entity mapping and flawed logic. Only minimal credit is given for addressing the general theme of loss provisions over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 453,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "Starbucks' derivative asset position for foreign currency - other decreased from $32.0 million as of October 1, 2023, to $1.9 million as of September 29, 2024, a reduction of $30.1 million. Simultaneously, the derivative liability position for foreign currency - other increased from $2.0 million to $4.7 million, an increase of $2.7 million. This shift reflects a significant net reduction in the overall balance sheet exposure for foreign currency - other derivative positions from fiscal year 2023 to 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. According to the ground truth, Starbucks' derivative asset for 'Foreign currency - other' in fiscal year 2023 was $1,164 million, not $32.0 million as stated in the LLM answer. The LLM incorrectly reports the 2023 asset value, leading to a wrong calculation of the reduction ($30.1 million vs. the actual reduction of $1,162.1 million). The liability figures ($2.0 million in 2023 and $4.7 million in 2024) are correct, as is the $2.7 million increase in liabilities. (2) Calculations: The LLM correctly calculates the liability increase ($4.7M - $2.0M = $2.7M), but the asset reduction is wrong due to the incorrect starting value. The actual reduction in assets is $1,164M - $1.9M = $1,162.1M, not $30.1M. This is a major quantitative error. (3) Multi-hop reasoning: The model correctly identifies the need to compare asset and liability positions across two fiscal years and attempts to compute changes, but the reasoning is based on incorrect input data for the asset value in 2023, undermining the synthesis. (4) The answer is contextually relevant and well-structured, addressing both asset and liability changes and their net impact. However, the severe inaccuracy in the core financial figure (asset value in 2023) drastically reduces correctness and quantitative accuracy, despite correct liability data and directional understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 395,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "From 2022 to 2023, the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions for Southern Company and its subsidiaries shifted significantly. In 2023, energy-related derivatives resulted in a loss of $63 million recognized in other regulatory assets and liabilities, compared to a gain of $18 million in 2022. Additionally, the impact on income from energy-related cash flow hedges for the total cost of natural gas turned negative, with a $44 million loss in 2023 versus a $37 million gain in 2022, indicating a worsening financial impact in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude of financial impacts. The original answer states that in 2022, derivatives had a $117M negative impact on natural gas revenues and $27M negative impact on cost, while in 2023, there was a $59M gain on cost and $0 impact on revenue. The LLM instead reports unrelated figures such as a $63M loss in 'other regulatory assets and liabilities' and a $44M loss on 'income from cash flow hedges', which do not match the ground truth metrics. (2) Quantitative accuracy is very low: none of the numbers align with the ground truth. The LLM introduces figures like $18M gain in 2022 and $37M gain in 2022 for cost impacts, which are factually wrong. There is no mention of the $117M revenue loss in 2022 or the $59M cost gain in 2023. (3) The reasoning is flawed—instead of showing a shift from negative to positive impacts on cost and neutralization of revenue impact, the LLM suggests a worsening trend, which contradicts the ground truth. It fails to synthesize the correct multi-hop information about how hedging evolved across years and across cost vs. revenue dimensions. (4) Contextual relevance is moderate because the answer discusses energy-related derivatives and natural gas cost/revenue impacts over 2022–2023, but it references Southern Company without grounding in the correct data, and the entities, metrics, and trends are misaligned. The core facts are incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 411,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "Walmart's Deferred Compensation Matching Plan was amended and restated effective November 8, 2023, as noted in the 2024 10-K filing under Exhibit 10.1. In the 2023 10-K, the plan was not explicitly mentioned as being amended during that year, indicating that the most recent documentation and effective date of the plan's evolution occurred in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the effective date of the Deferred Compensation Matching Plan as November 8, 2023, which matches the ground truth and earns high marks for quantitative accuracy. However, it makes a critical factual error by stating that the plan was 'not explicitly mentioned as being amended during that year [2023]' in the 2023 10-K — this contradicts the ground truth, which states that the plan was explicitly introduced in the 2023 10-K as 'amended and restated effective November 8, 2023.' Thus, the plan was indeed documented in the 2023 filing with that effective date. The LLM also fails to address the key evolution in documentation status between the two filings: in 2023 it was newly introduced, while in 2024 it was incorporated by reference, indicating institutionalization. This shift in treatment — a central part of the question — is entirely missing, representing a major omission in both completeness and qualitative reasoning. The answer incorrectly implies the amendment was first documented in the 2024 filing, when it was actually first introduced in 2023. While the effective date is correct, the reasoning about when and how the plan was documented is flawed, undermining the multi-hop synthesis required. Contextual relevance is moderate because the answer discusses the right plan and date but misrepresents the timeline and evolution across filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 385,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "Between 2023 and 2024, the disclosure and treatment of LTIP Units remained largely consistent in terms of their dilutive effect, as no securities had a material dilutive impact in either year. However, there was a slight evolution in the accrual policy: in 2023, the disclosure emphasized that dividends are accrued when declared, while in 2024, the language was expanded to clarify that distributions for the Operating Partnership are also accrued upon declaration. Additionally, the 2024 disclosure included more detailed breakdowns of the taxable nature of distributions, showing a marginal shift in the proportion classified as ordinary income versus long-term capital gains.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but introduces inaccuracies not present in the ground truth. While it correctly states that there was no material dilutive effect in both 2023 and 2024, it incorrectly claims a 'slight evolution' in the accrual policy and an expansion of language in 2024 regarding distributions for the Operating Partnership. The original answer states the accrual policy 'remained consistent' and that distributions are accrued when declared—there is no mention of expanded language or clarification in 2024. Additionally, the LLM introduces new information about a 'detailed breakdown of the taxable nature of distributions' and shifts in classification between ordinary income and capital gains, which is not supported by the ground truth and constitutes a factual overreach. (2) There are no numeric values to verify (e.g., percentages, dollar amounts), so quantitative accuracy is based on the absence of incorrect numbers—this prevents a lower score. (3) The multi-hop reasoning is flawed: the model infers changes in disclosure detail and policy evolution that are not present in the original data, failing to correctly synthesize the stability emphasized in the ground truth. (4) The contextual relevance is high because the answer addresses dilutive effect and accrual policy as asked, but correctness is undermined by fabricated details. The core point about no material dilution is correct, but the added nuances reduce factual accuracy, warranting a mid-low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 416,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved significantly between 2023 and 2024 in response to regulatory actions and decisions. In 2023, the EU-U.S. DPF was formally established following the invalidation of prior frameworks like the Privacy Shield, and the European Commission issued an adequacy decision recognizing the DPF as sufficient for data transfers from the EU to the U.S. Meta began implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) related to unlawful data transfers. By 2024, Meta had adapted its compliance measures further, including engaging with regulators on new consent models for behavioral advertising and addressing concerns under the Digital Markets Act (DMA). The European Commission opened formal proceedings against Meta's \"subscription for no ads\" model, prompting Meta to introduce an option for users to see less personalized ads. These developments reflect Meta's ongoing efforts to align with evolving EU data protection standards and regulatory scrutiny.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key events, timeline, and regulatory context. (1) All factual elements are accurate: Meta's response to IDPC corrective orders, the establishment of the EU-U.S. DPF in 2023, and the European Commission's formal proceedings in 2024 over the 'subscription for no ads' model under the DMA are correctly reported. The mention of Meta introducing options for less personalized ads aligns with the intent of the new compliance model. (2) There are no numeric inaccuracies—no incorrect figures, dates, or financial amounts are stated (e.g., the €1.2 billion fine is not mentioned but not contradicted). The timeline (2023 framework adoption, 2024 regulatory action) is accurate. (3) The multi-hop reasoning is sound: the answer connects Meta’s compliance evolution with both data transfer regulations (EU-U.S. DPF) and broader digital market rules (DMA), showing synthesis across regulatory domains. However, it omits the specific detail that the 'subscription for no ads' model was introduced in November 2023, and that the Commission issued preliminary findings of non-compliance in July 2024—this missing granularity slightly weakens completeness. Also, while it mentions 'consent models for behavioral advertising,' it does not explicitly link the subscription model as Meta’s direct response to SCC-related data transfer restrictions, which is a key causal link in the original answer. (4) Despite these omissions, the answer remains factually sound, contextually relevant, and semantically equivalent in overall meaning. The qualitative accuracy is slightly reduced due to incomplete synthesis of the causal chain between the IDPC order, SCC issues, and the business model change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 477,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "Between 2023 and 2024, Linde has increased its emphasis on green hydrogen production by explicitly designating it as a key component of its clean energy strategy. In 2023, Linde described green hydrogen as being produced through electrolysis using renewable energy or from steam methane reforming of biomethane. By 2024, the company refined its terminology, emphasizing that green (renewable) hydrogen is produced by electrolysis using renewable energy and water as feedstock, while also highlighting its broader portfolio of low-carbon hydrogen technologies. This reflects a stronger focus on renewable energy sources and a clearer distinction between production methods to align with global clean energy goals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Linde's 2023 definition of green hydrogen included electrolysis using renewable energy and steam methane reforming of biomethane, and by 2024, the company emphasized 'renewable hydrogen' via electrolysis using renewable energy and water. The clearer distinction between green and blue hydrogen is accurately reflected. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2023, 2024), which are accurate. (3) The multi-hop reasoning is sound—information is correctly synthesized across two time points and reflects an evolution in terminology, emphasis, and strategic framing. The only minor omission is that the 2024 update specifically introduced the use of 'carbon intensity' as a metric to differentiate production methods, which the LLM answer does not mention. This is a small but notable detail from the original answer. (4) Despite this omission, the LLM captures the core evolution in Linde’s approach: stronger emphasis on renewable energy, refined definitions, and clearer differentiation of production methods. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses both production methods and emphasis on renewable energy sources as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 394,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "Southern Company completed the sale of Sequent to Williams Field Services Group on July 1, 2021, for a total cash purchase price of $159 million, resulting in a pre-tax gain of approximately $121 million ($92 million after tax). This transaction marked the end of Southern Company Gas's relationship with Sequent. The financial implications included a gain on the sale, as well as $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company Gas's reportable segments.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the sale of Sequent to Williams Field Services Group, the $159 million purchase price, the $121 million pre-tax gain, and the $85 million additional tax expense due to state apportionment changes. However, the key factual error is the transaction date: the LLM states the sale occurred on July 1, 2021, while the ground truth confirms it occurred in 2022. This misalignment affects the core of the question, which asks about the evolution between 2022 and 2023. The 2021 date incorrectly implies the divestiture was completed before the period in question, undermining the narrative of evolution during 2022–2023. (2) Quantitative accuracy is partially correct: the dollar amounts ($159M sale, $121M pre-tax gain, $85M tax expense) match the ground truth, but the after-tax gain of $92 million is mentioned in the LLM answer and not in the original; this figure is plausible but unverified and not part of the ground truth. The critical error is the date, which is not a formatting issue but a factual inaccuracy. (3) The multi-hop reasoning is sound in structure—recognizing ownership change, financial impact, and post-divestiture status—but fails because it anchors the event in the wrong year, breaking the logical timeline required by the question. The synthesis across financial and operational impacts is otherwise appropriate. (4) Contextual relevance is high, as the answer addresses both the relationship evolution and financial implications. However, due to the incorrect year, the answer misrepresents the timeline of the relationship change, leading to a significant drop in correctness and quantitative accuracy. The core facts are present but misaligned in time, resulting in a partially correct response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 487,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "Between 2023 and 2024, Walmart's relationship with the Allswell brand remained consistent within its private brand portfolio, as Allswell was still listed among the key private brands marketed by Walmart U.S. in both years. This continuity suggests that Allswell maintained a strategic role as part of Walmart's broader effort to offer high-quality, affordable merchandise under its private label brands. The brand's inclusion in both years indicates that Walmart continues to leverage Allswell to support its EDLP (Everyday Low Prices) strategy and to provide value to customers, reinforcing its commitment to private brand development as a competitive advantage.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a significant factual inaccuracy: it states that Allswell was listed among Walmart's private brands in both 2023 and 2024, implying continuity, whereas the ground truth indicates that 2023 was the year of introduction (i.e., initial launch), not an ongoing presence from a prior period. This misrepresents the evolution as stability rather than growth from new to established status. (2) There are no numeric values, dates, or calculations in either the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the original answer draws a conclusion about strategic evolution (from new to mature brand), which requires recognizing a change in status over time. The LLM instead frames the relationship as 'consistent,' missing the key progression from introduction to integration with mature brands like 'bettergoods' and 'Great Value.' This reflects a failure to fully synthesize the implied strategic shift. (4) Despite this, the LLM correctly identifies Allswell as part of Walmart’s private brand portfolio in both years and links it to Walmart’s broader value strategy (EDLP, customer value), which shows contextual understanding. However, the core insight about strategic elevation—from new to established—is missing, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 396,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "The strategic importance of Embedded Processing products slightly increased from 2022 to 2023, as evidenced by a 3% revenue growth in 2023 compared to 2022, while Analog revenue declined by 15%. However, the operating profit for Embedded Processing decreased by 20%, primarily due to higher manufacturing costs, indicating that while the segment maintained its strategic relevance, profitability was impacted by cost pressures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no specific revenue figures for Embedded Processing were disclosed in 2022, and there is no mention of a 3% revenue growth in 2023 or a 15% decline in Analog revenue. Additionally, the claim that Embedded Processing operating profit decreased by 20% due to higher manufacturing costs is not supported by the original answer, which does not provide any profitability or cost data. These numerical claims are entirely fabricated or misattributed. (2) Quantitative accuracy is very low because all percentages (3% growth, 15% decline, 20% profit drop) are incorrect and not present in the ground truth. The original answer only mentions total company revenue of $17.52 billion in 2023 but does not break it down by segment growth or profitability. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that Embedded Processing maintained strategic importance and that Analog revenue declined, it incorrectly infers segment-level revenue and profit changes that are not in the source. The original answer emphasizes that Embedded Processing helped offset Analog's decline but does not quantify this with percentages or profit data. (4) Contextual relevance is moderate because the LLM addresses the evolution of strategic importance and mentions the offsetting role of Embedded Processing, aligning with the general theme. However, the addition of unsupported quantitative claims severely undermines correctness. The qualitative accuracy is low because the model introduces false financial metrics, though it captures the directional idea of strategic continuity and compensatory role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 464,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "Chevron's involvement in Angola LNG has shown a decline in equity in earnings, decreasing from $1,857 million in 2022 to $405 million in 2024. This suggests a potential strategic shift or challenges in the project's performance, indicating a reduced emphasis or financial commitment to Angola LNG in Chevron's broader LNG market strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claims. The ground truth states that Chevron's involvement evolved from operational participation in 2022 to a clearly defined 36.4% stake in Angola LNG Limited in 2024, indicating increased strategic commitment. In contrast, the LLM claims a decline in equity earnings from $1,857M to $405M, which is not supported by the original answer and contradicts the narrative of growing strategic positioning. These financial figures (earnings) are entirely absent from the ground truth and appear to be fabricated or misattributed. (2) Quantitative accuracy is very low: the dollar amounts and the implied financial metric 'equity in earnings' are not present in the original answer and are factually unsupported. There is no mention of earnings or financial performance in the ground truth—only production volumes in 2022 and ownership stake (36.4%) in 2024. The LLM invents precise numbers without basis, failing basic quantitative fidelity. (3) The multi-hop reasoning is flawed. The original answer synthesizes information across years to show increasing formalization of Chevron's stake, indicating strategic entrenchment. The LLM incorrectly infers declining strategic importance based on non-existent financial metrics, reversing the correct interpretation. It fails to identify the key evolution: from operational role to explicit equity ownership. (4) Contextual relevance is moderate because the answer addresses Chevron, Angola LNG, and the time frame 2022–2024, and attempts to discuss strategic positioning. However, due to factual inaccuracies and incorrect reasoning, the conclusion is misleading. The qualitative accuracy is low because the entities are correct (Chevron, Angola LNG) and the years are right, but the reasoning and synthesis are invalid. Correctness score is 2 due to major factual and numerical errors that completely invert the true strategic trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 525,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "Between 2021 and 2024, the CH-53K program contributed to increased production activity within Lockheed Martin's RMS division. In 2021, the CH-53K program, along with other Sikorsky helicopter programs, drove a $540 million increase in RMS net sales due to higher production volume. By 2024, the CH-53K program continued to support RMS growth, with higher production volume contributing to a $1.1 billion increase in product sales at RMS. This evolution indicates that the CH-53K program has remained a key production driver for RMS, reflecting its strategic importance in the division's portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $540 million increase in RMS net sales in 2021 and the $1.1 billion contribution to product sales in 2024, both of which match the ground truth. However, it omits the $140 million increase in operating profit in 2021 attributed to the CH-53K program due to risk retirements and higher production volume—a key financial metric present in the original answer. This omission affects completeness but not the core quantitative accuracy. (2) All provided numbers are accurate and correctly attributed to the right years and programs. The $540M and $1.1B figures are correctly cited, and the phrasing 'higher production volume' aligns with the original. The only missing numeric detail is the $140M operating profit increase in 2021. (3) The reasoning is sound in identifying the program’s growing role and production ramp-up, correctly synthesizing information across 2021 and 2024 to show an evolution in production status and financial impact. However, the conclusion that it 'remained a key production driver' slightly understates the transition from a developing to a mature, high-volume production program emphasized in the ground truth. The strategic evolution from risk retirement to ramp-up is not fully captured. (4) The answer is highly relevant, directly addressing the financial contribution and production status over time, and correctly infers the program’s strategic importance. The omission of operating profit and reduced emphasis on the phase transition justify a score of 8 rather than 9 or 10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 433,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "Between 2022 and 2023, PayPal updated its expected credit loss models for revolving consumer credit products in the second quarter of 2023. In 2022, the reasonable and supportable forecast period for revolving products was 2 years, while in 2023, it was extended to approximately 5 years. Additionally, in 2023, macroeconomic factors incorporated into the models for revolving credit included forecasted trends in household disposable income and retail e-commerce sales, whereas in 2022, unemployment rates were also a key factor through the first quarter of 2023. These changes reflect a more comprehensive and extended approach to incorporating macroeconomic conditions into loss curve estimations for revolving consumer credit products.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in PayPal's use of macroeconomic factors in its loss curves between 2022 and 2023. It correctly states that in 2022, unemployment rates were used as a key macroeconomic factor and that in 2023, the models were updated to include household disposable income and retail e-commerce sales, with a note that unemployment was used through Q1 2023—this aligns with the ground truth. The answer adds specific details not in the original, such as the extension of the forecast period from 2 to 5 years and the change occurring in Q2 2023. While these details are plausible and contextually consistent, they are not present in the ground truth and cannot be verified as correct from the provided information, which slightly affects quantitative and qualitative accuracy. However, the core factual evolution—shift in macroeconomic indicators from unemployment to income and e-commerce trends—is accurately conveyed. The reasoning is sound, and the answer is fully relevant to the question. Minor deductions are due to unverified specifics (forecast period length, exact timing in Q2) not present in the ground truth, but no major factual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 339,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "Starbucks' foreign currency debt-related gains or losses included in AOCI increased from a pre-tax loss of $6.3 million in 2023 to a pre-tax gain of $135.2 million in 2024. This significant shift indicates that the company likely experienced favorable foreign currency movements in 2024, reducing its exposure to adverse currency fluctuations compared to the prior year. The change suggests improved hedging effectiveness or a more favorable foreign exchange environment for Starbucks' international operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key figures from the ground truth: a pre-tax loss of $6.3 million in 2023 and a pre-tax gain of $135.2 million in 2024 related to foreign currency debt in AOCI. These numbers match the original answer exactly, satisfying quantitative accuracy. (2) All numeric values are accurate and properly attributed to the correct years and financial context (AOCI/OCI). The use of 'pre-tax' is consistent with typical SEC reporting terminology and adds clarity without contradicting the ground truth. (3) The reasoning is sound: the shift from loss to gain is correctly interpreted as a significant reversal, and the LLM appropriately infers that this suggests favorable currency movements and potentially improved hedging or exposure management. While the original answer stops at stating the implication of 'reversal in exposure,' the LLM extends the logic plausibly by suggesting possible causes (hedging effectiveness, favorable FX environment), which are reasonable interpretations and not contradicted by the data. (4) The answer fully addresses both parts of the question: the change from 2023 to 2024 and the implication regarding foreign currency exposure. The only minor difference is that the LLM uses 'OCI before reclassifications' implicitly but refers to it as part of AOCI, which is contextually acceptable since AOCI accumulates OCI items. No factual errors; slight interpretive extension is appropriate and adds value without overreach. Hence, high scores across all categories with a 9 on correctness due to minor inferential expansion beyond the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 443,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "Between 2022 and 2023, the fair value of energy-related derivatives for Alabama Power and Georgia Power increased. Alabama Power's energy-related derivative liabilities rose from $15 million in 2023 to $15 million (unchanged), while Georgia Power's increased from $13 million in 2023. Overall, the combined liabilities for these derivatives showed a slight increase, reflecting higher Level 2 fair value measurements in 2023 compared to 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Alabama Power's liabilities were $15 million in 2023 and implies they were the same in 2022, when in fact Alabama Power had a net liability of $144 million in 2022 and a net liability of $95 million in 2023 (based on $15M assets and $110M liabilities). The LLM confuses assets with liabilities and misrepresents the direction of change. For Georgia Power, the LLM incorrectly claims liabilities increased from $13 million in 2023, but $13 million is the asset amount, not liability; Georgia Power's liability was $124 million in 2023, and no 2022 figure is provided in the ground truth for Georgia Power individually. (2) The combined net liability in 2022 was $255 million (Alabama only, per ground truth) and $206 million in 2023 (combined), showing a decrease of $49 million. The LLM incorrectly claims a 'slight increase,' which contradicts the actual trend. (3) The multi-hop reasoning is fundamentally flawed: the model fails to calculate net liabilities correctly, confuses assets with liabilities, and does not compute the combined change across entities and years. It also fabricates a comparison for Georgia Power in 2022 that is not supported by the data. (4) Despite addressing the right entities and general topic (derivative liabilities), the answer is mostly incorrect in numbers, direction of change, and synthesis. The contextual relevance is moderate because it attempts the right question, but factual and logical errors severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 431,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "Walmart acquired Alert Innovation in fiscal 2023 for $0.4 billion, bringing its ownership to approximately 100%. However, by fiscal 2025, the Alert Innovation entity was sold and deconsolidated, indicating that Walmart disposed of the asset after initially acquiring it in fiscal 2023. There is no specific detail on the timing or financial terms of the disposition in fiscal 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion acquisition of Alert Innovation by Walmart in fiscal 2023 and the subsequent sale and deconsolidation of the entity. However, it incorrectly states that the disposition occurred in fiscal 2025, whereas the ground truth specifies fiscal 2024. This is a critical error in temporal accuracy that affects the core timeline of the financial relationship evolution. (2) Quantitatively, the $0.4 billion acquisition amount is accurate, and the concept of full ownership (~100%) is correctly implied. The error lies in the fiscal year of disposition—fiscal 2025 vs. fiscal 2024—which is a factual discrepancy. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes acquisition and disposition as two steps in a financial relationship. However, it fails to accurately align the disposition with fiscal 2024, breaking the 'one-year span' evolution emphasized in the ground truth. This undermines the qualitative accuracy of the narrative. (4) Contextual relevance is high because the answer addresses the acquisition-disposition arc and uses appropriate financial terminology (e.g., deconsolidated). The main flaw is the incorrect fiscal year for the sale, which reduces correctness and qualitative accuracy despite otherwise solid structure and factual grounding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 373,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "Between 2022 and 2023, the regulatory approval status of Trodelvy expanded significantly. In 2022, Trodelvy was already approved for metastatic triple-negative breast cancer (TNBC) in the U.S. and other countries, and received full FDA approval for this indication. By 2023, Trodelvy gained additional approvals, including for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This expansion of Trodelvy's indications reflects Gilead's oncology strategy of broadening the therapeutic applications of its key oncology assets to address unmet medical needs across various cancer types, thereby enhancing its market reach and revenue potential.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, Trodelvy was already an approved and marketed product, noting its approval for metastatic triple-negative breast cancer (TNBC), which is factually correct and adds context not in the original answer but consistent with public knowledge. While the original answer states no specific regulatory updates were mentioned in 2022, the LLM's statement about full FDA approval is not contradictory and provides additional precision. (2) For 2023, the LLM accurately reports the new FDA approval for HR+/HER2- breast cancer with the correct patient criteria (prior endocrine therapy and at least two systemic therapies), matching the original answer. It omits mention of EC (European Commission) approval, which is a minor omission but does not undermine the core factual accuracy. (3) The reasoning about Gilead's oncology strategy—expanding therapeutic applications to address unmet needs and increase market reach—is logically sound, well-supported by the regulatory developments, and semantically equivalent to the original's conclusion about strengthening Gilead's oncology position. (4) All entities (Trodelvy, Gilead, FDA, breast cancer subtypes) and years are correct. No numerical data is present, so quantitative accuracy is based on correct dates and indications, which are accurate. The answer is fully relevant and addresses both parts of the question: evolution of approval status and strategic implications. The only reason for not scoring a 10 is the omission of EC approval in 2023, which slightly reduces completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 447,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's financial relationship with ABG evolved significantly through capital transactions and strategic positioning. In 2023, Simon recognized gains from ABG-related transactions, including a pre-tax gain of $157.1 million from selling a portion of its interest and a deemed disposal gain of $10.3 million due to a capital transaction that diluted Simon's ownership to approximately 9.6%. By 2024, Simon fully exited its remaining stake in ABG, selling it for $1.2 billion and recognizing a pre-tax gain of $414.8 million. This strategic move reflects Simon's shift to optimize its portfolio and focus on core real estate investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, Simon Property Group (SPG) recognized two non-cash pre-tax gains from dilution events: $36.4 million in Q2 and $145.8 million in Q3, totaling $182.2 million—not $157.1 million and $10.3 million as stated. The LLM incorrectly frames these as proceeds from selling interest rather than gains from ownership dilution due to SPARC Group issuing equity. Furthermore, the claim that SPG 'fully exited its remaining stake in ABG in 2024 for $1.2 billion' and recognized a '$414.8 million pre-tax gain' is entirely false; the ground truth states that SPG did not report any active capital transactions with ABG in 2024 and only referenced historical transactions. There is no mention of a $1.2 billion sale or a $414.8 million gain in 2024. (2) Quantitative accuracy is severely lacking: all key figures are incorrect—$157.1M, $10.3M, $1.2B, and $414.8M do not appear in the original data. The 9.6% ownership figure is not mentioned in the ground truth and cannot be verified. (3) The multi-hop reasoning is flawed. The model fails to correctly synthesize the evolution from active 2023 dilution gains to passive 2024 references of past transactions. Instead, it invents a narrative of full exit and large-scale sale in 2024, which contradicts the ground truth. The strategic shift is misrepresented: the actual shift is from active financial restructuring in 2023 to no new activity in 2024, not a strategic exit for portfolio optimization. (4) Contextual relevance is moderate—the answer addresses capital transactions and strategic positioning as asked, but the content is factually incorrect. Due to major errors in numbers, events, and reasoning, the correctness score is low at 2, with similarly low quantitative and qualitative accuracy. The answer appears plausible but is fabricated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 513,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "Between 2022 and 2024, Chevron's relationship with Chevron Phillips Chemical Company LLC (CPChem) remained stable in terms of financial reporting and investment value. In 2022, Chevron's investment in CPChem was $7,765 million, generating equity earnings of $867 million. By 2024, the investment increased to $8,571 million, with equity earnings rising to $903 million. This indicates a modest growth in both the investment value and the returns generated from CPChem during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct numbers but misrepresents the core evolution of the relationship. The investment values of $7,765 million in 2023 and $8,571 million in 2024 are accurate, but the LLM incorrectly states that the $7,765 million value was from 2022, when in fact that figure corresponds to 2023. The 2022 status is misrepresented—Chevron Phillips Chemical Company LLC was a consolidated subsidiary in 2022 (per Note 8, page 70 of the 2022 10-K), not an equity method investee. The shift from consolidation to equity method reporting by 2024 is the key development, which the LLM completely omits. Instead, it assumes a stable relationship with only growth in investment value, which contradicts the ground truth. (2) Quantitatively, the $8,571 million (2024) and $7,765 million (2023) figures are correct, and the implied increase of $806 million is accurate, but attributing $7,765 million to 2022 is factually wrong—the 2022 investment value is not provided in the ground truth. Equity earnings figures ($867M, $903M) are plausible but not mentioned in the original answer, so their inclusion introduces unverified data. (3) The multi-hop reasoning fails: the model does not recognize the change in accounting treatment (consolidation to equity method), which is central to the question. This reflects a failure to synthesize information across years and reporting methods. (4) Correctness is low due to the fundamental mischaracterization of the relationship evolution. Quantitative accuracy is moderate due to correct values but incorrect year assignments. Qualitative accuracy is poor due to incorrect reasoning and missing key conceptual shift. Contextual relevance is fair as the answer discusses investment value trends, but misses the primary financial reporting change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 493,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "Between the end of 2023 and the end of 2024, Meta's Facilities Consolidation Strategy, part of the 2022 Restructuring, saw completion of all initiatives by December 31, 2024. In 2023, the strategy had incurred pre-tax charges of $2,255 million, primarily in research and development, marketing and sales, and general and administrative expenses. In 2024, the financial impact was limited to $389 million in pre-tax charges, all related to facilities consolidation, indicating a significant reduction in restructuring costs as the strategy neared completion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding financial figures and misrepresents the original answer. The original answer states that a retrospective summary of pre-tax charges across 2022–2024 was provided in 2024, but it does not specify the amounts for 2023 ($2,255 million) or 2024 ($389 million) as claimed by the LLM. These specific numbers are not present in the ground truth and are therefore unsupported. Additionally, the original answer does not break down charges by expense category (e.g., R&D, marketing), so including these details introduces fabricated information. (2) The quantitative inaccuracies are critical: the LLM invents precise dollar amounts and assigns them to specific years and cost centers without basis in the ground truth. Even if the trend of decreasing costs is plausible, the lack of source support makes these figures incorrect. (3) The reasoning partially captures the evolution of the facilities consolidation strategy from 'substantially completed' in 2023 to 'completed' in 2024, which aligns with the original answer’s timeline and progression. This shows correct multi-hop synthesis of status change over time. However, the addition of unsupported financial detail undermines the reasoning integrity. (4) Contextual relevance is high because the response addresses the evolution of the strategy and attempts to quantify financial impact, which is relevant. However, correctness is low due to hallucinated data. The qualitative accuracy is moderate because the conceptual progression is sound, but entity and metric accuracy fail on key financial disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 448,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "Lockheed Martin's involvement in hypersonics programs from 2022 to 2024 has shown a strategic emphasis on advancing capabilities for U.S. military branches. In 2022, the company was engaged in hypersonics programs with the U.S. Air Force and Army, focusing on design, development, and building hypersonic strike weapons. By 2024, the strategic focus remained strong, with continued investment in hypersonics as part of broader efforts in next-generation technologies, and the company was involved in multiple hypersonics programs with the U.S. Army and Navy, indicating an ongoing and expanded commitment to this high-priority area.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Lockheed Martin's involvement in hypersonics programs with U.S. military branches and the strategic focus on next-generation technologies, which aligns with the general context of the original answer. However, it misses a key evolution highlighted in the ground truth: the shift from a funding-dependent development phase in 2022 to active production by 2024. Instead, the LLM states that in 2022 the company was already engaged in 'design, development, and building,' which downplays the uncertainty and earlier stage of the programs as described in the original. Additionally, the LLM incorrectly states involvement with the Navy in 2024, while the original specifies the Air Force and Army. (2) There are no numeric values or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model recognizes continuity and expansion in hypersonics investment, but fails to accurately capture the critical transition from development/funding dependency to active production, which is the core of the evolution. (4) Contextual relevance is high because the answer addresses strategic focus and program status over time, but the qualitative inaccuracies in entity details (military branches) and program maturity reduce the correctness score. The answer conveys a plausible narrative but lacks precision in the evolution trajectory, warranting a 6 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 428,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "From 2022 to 2023, Southern Company's treatment and disclosure of energy-related derivatives showed a shift in both designation and financial impact. In 2023, the company reported significantly higher unrealized losses related to energy derivatives designated as regulatory hedging instruments, with total energy-related derivative losses increasing from $9 million in 2022 to $257 million in 2023. These losses were primarily reflected in other regulatory assets and liabilities, both current and deferred. Additionally, the financial impact of energy-related cash flow hedges on income turned negative in 2023, with a $44 million loss compared to a $17 million gain in 2022, indicating a more challenging market environment for energy derivatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The original answer states that Southern Company evolved its disclosure practices from 2022 to 2023 by expanding reporting to include energy-related derivatives not designated as hedging instruments, with comparative data going back to 2021. However, the LLM answer fabricates specific financial figures—such as $9 million in losses in 2022 and $257 million in 2023, and a $44 million loss versus $17 million gain for cash flow hedges—that are not present in the ground truth and cannot be verified from the provided information. These numbers are entirely absent from the original answer, indicating a significant factual deviation. (2) There are no correct numbers in the LLM response because the ground truth does not provide any specific dollar amounts related to derivative losses or gains. The LLM invents quantitative data that misrepresents the actual evolution, which was about disclosure scope, not financial magnitude. Calculations or comparisons based on these numbers (e.g., increase from $9M to $257M) are therefore invalid. (3) The multi-hop reasoning is flawed. The question asks about changes in treatment and disclosure, particularly designation and financial impact. The correct reasoning should focus on the shift from reporting only regulatory hedging instruments in 2022 to including non-designated derivatives in 2023, indicating broader transparency. The LLM instead shifts focus to financial impact magnitudes and market conditions without evidence, failing to identify the core evolution in accounting disclosure policy. (4) While the LLM addresses the general topic of derivative treatment and attempts to compare years, it misses the central point about disclosure expansion and introduces unsupported specifics. Hence, the correctness and quantitative accuracy scores are low. Qualitative accuracy is partially preserved due to correct entity (Southern Company) and general theme (derivative treatment over time), and contextual relevance is moderate because it discusses the right subject area but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 571,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "Between 2022 and 2023, Gilead's intellectual property strategy regarding Truvada evolved as the company addressed the loss of exclusivity for Truvada in the United States, which occurred in October 2020. In 2022, the focus was on mitigating the impact of generic competition on Truvada sales, as noted in the 2022 10-K, where the loss of exclusivity led to decreased sales. By 2023, Gilead shifted its emphasis toward expanding its portfolio and strengthening its pipeline, as outlined in the 2023 10-K. This included entering new strategic collaborations and acquiring companies to diversify its offerings. While Truvada's patent protections had expired, Gilead's strategy increasingly centered on leveraging its robust pipeline and new product approvals to drive future growth, rather than relying on Truvada's market position.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the October 2020 loss of exclusivity for Truvada in the U.S., which aligns with the ground truth, and accurately references the 2022 and 2023 10-K filings. However, the LLM answer diverges from the ground truth by emphasizing Gilead's broader pipeline and acquisition strategy in 2023, which, while contextually relevant, does not directly address the specific evolution in *patent disclosures* as required by the question. The ground truth highlights a shift from discussing past exclusivity loss (2022) to structured disclosure of future patent expiration dates for key products including Truvada (2023), particularly in the U.S. and EU. The LLM fails to mention this structured disclosure of actual or estimated expiration dates in 2023, which is the core of the strategic evolution. (2) Quantitatively, all dates (October 2020) and years (2022, 2023) are accurate, and no numerical calculations are required. (3) The multi-hop reasoning is partially sound—linking Truvada’s exclusivity loss to revenue impact in 2022 is correct, but the 2023 analysis shifts focus to pipeline expansion rather than the change in IP disclosure practices, missing the key synthesis point about proactive, structured patent expiration disclosures. (4) While the answer is factually plausible and contextually relevant, it substitutes strategic business direction for the specific disclosure practice evolution, leading to a moderate correctness score. The answer captures the background but not the precise strategic shift in IP communication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 431,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "Between 2022 and 2024, SPG's use of the Supplemental Facility evolved with increased borrowing activity in 2022 and subsequent repayments in 2023 and 2024. In 2022, SPG drew $1.05 billion under the Supplemental Facility to fund the early extinguishment of mortgages. By 2023, SPG repaid €750.0 million ($815.4 million U.S. dollar equivalent) of borrowings under the Supplemental Facility using proceeds from the issuance of senior unsecured bonds. In 2024, there were no outstanding balances under the Supplemental Facility, indicating full repayment and a shift in financing strategy toward other debt instruments.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.05 billion borrowing in 2022 for mortgage extinguishment and the €750.0 million ($815.4 million) repayment under the Supplemental Facility. However, it misstates the timing and source of repayment funds. The ground truth indicates the €750.0 million was borrowed in November 2023 and repaid on November 17, 2023 — meaning it was a short-term draw, not repaid using proceeds from senior unsecured bonds. The LLM incorrectly implies the bond proceeds were used to repay the Supplemental Facility draw, while the original answer states that new senior unsecured notes were issued to redeem other notes at maturity — a separate refinancing activity, not directly tied to repaying the Supplemental Facility. (2) Quantitatively, all dollar amounts and conversions are accurate: $1.05 billion, €750.0 million, and $815.4 million are correctly reported. The dates are mostly correct, though the LLM blurs the November 2023 borrowing and repayment into a general '2023 repayment' without clarifying the very short duration. (3) The multi-hop reasoning is partially sound — the model correctly links SPG’s use of the Supplemental Facility to short-term financing and infers a strategic shift. However, it fails to accurately synthesize the sequence and purpose of the 2023 draw and repayment, incorrectly connecting bond proceeds to Supplemental Facility repayment. (4) The answer is contextually relevant and captures the evolution trend, but the misrepresentation of the financing mechanics reduces qualitative and quantitative accuracy. The core facts are present, but the causal and temporal logic is flawed, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 464,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "From 2022 to 2024, MetLife's capital management strategy has increasingly emphasized maintaining robust liquidity levels to address evolving market uncertainties and regulatory requirements. In 2022, the company highlighted its substantial short-term liquidity position of $12.4 billion and liquid assets of $223.0 billion, which were used to support capital allocation decisions and meet potential stress scenarios. By 2024, MetLife further emphasized the importance of cash buffer needs, noting that maintaining sufficient liquidity buffers was critical to ensuring the company could meet obligations, support capital returns, and navigate volatile market conditions. The evolution reflects a more proactive approach to liquidity management, with cash buffers playing a central role in balancing capital deployment with risk mitigation and regulatory compliance.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the quantitative figures from 2022—$12.4 billion in short-term liquidity and $223.0 billion in total liquid assets—which match the ground truth exactly. No other numerical data is provided for 2024, which is consistent with the original answer (no specific numbers for 2024). Thus, quantitative accuracy is perfect. (2) However, the qualitative interpretation of the evolution in MetLife’s capital management strategy is partially incorrect. The original answer highlights a shift in tone by 2024, where maintaining or increasing cash buffers is seen as potentially limiting capital available for innovation, acquisitions, and shareholder returns—indicating a trade-off. In contrast, the LLM answer portrays the 2024 stance as a continued or even strengthened emphasis on liquidity without acknowledging the emerging constraint that larger buffers pose to capital deployment. This misrepresents the strategic evolution. (3) The multi-hop reasoning is flawed: while the model correctly identifies liquidity as a consistent priority, it fails to synthesize the nuanced shift from 'liquidity as a strength' in 2022 to 'liquidity as a potential constraint' in 2024. This is a key qualitative distinction required by the question about how the role of cash buffers evolved. (4) Contextual relevance is high because the answer addresses liquidity, capital allocation, and time evolution, but the lack of recognition of the trade-off in 2024 reduces its factual correctness. Therefore, while numbers are accurate, the reasoning and qualitative accuracy suffer, leading to a mid-range correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 449,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "Between 2022 and 2023, Starbucks' exposure to 'Foreign currency - other' derivatives showed significant changes in asset and liability classifications. In 2022, derivative assets related to 'Foreign currency - other' were reported as $39.9 million in prepaid expenses and other current assets and $33.5 million in other long-term assets. By 2023, these amounts were reduced to $1.9 million in prepaid expenses and $1.7 million in other long-term assets. On the liability side, in 2022, 'Foreign currency - other' liabilities were $0.3 million in accrued liabilities and $- in other long-term liabilities, while in 2023, liabilities increased to $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This shift indicates a reclassification and likely a change in the nature or timing of these derivative obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Starbucks had *no asset* reported for 'Foreign currency - other' derivatives, but the LLM claims $39.9 million in prepaid expenses and $33.5 million in other long-term assets—values that are not supported by the original answer and contradict it directly. The only correct liability figure is the $0.3 million in accrued liabilities in 2022. In 2023, the LLM correctly identifies the $1.9 million asset in prepaid expenses but incorrectly adds $1.7 million in other long-term assets, which is not mentioned in the ground truth. On liabilities, the $4.7 million in accrued liabilities is correct, but the addition of $4.1 million in other long-term liabilities is not present in the original answer. (2) Multiple numbers are fabricated or misattributed: the 2022 asset values and 2023 long-term asset and liability amounts have no basis in the ground truth. Calculations or totals are therefore also incorrect. (3) The reasoning is partially sound in structure—comparing year-over-year changes in asset and liability classifications—but fails on multi-hop synthesis because it uses incorrect underlying data. The conclusion about reclassification and changing obligations is speculative and not fully supported due to incorrect inputs. (4) The contextual relevance is moderate because the answer addresses the right topic and structure (evolution of derivative exposure across years and classifications), but the severe quantitative inaccuracies undermine correctness. The qualitative score is low due to incorrect entity-metric mappings (e.g., assigning non-existent asset values), though the general financial reasoning framework is present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 477,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "The Coca-Cola Company's relationship with Coca-Cola FEMSA in 2024 shows a slight decrease in its equity stake compared to 2023, as The Coca-Cola Company owned 28% of Coca-Cola FEMSA as of December 31, 2024, down from 30% in 2023. Additionally, the fair value of Coca-Cola FEMSA's shares was $4,544 million in 2024, while the Company's carrying value was $1,786 million, indicating a $2,758 million difference. This suggests that while The Coca-Cola Company continues to maintain a significant strategic investment in Coca-Cola FEMSA, there has been a reduction in ownership and a continued gap between fair value and carrying value in 2024 compared to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, Coca-Cola FEMSA was one of the top five independent bottling partners, and by 2024 it became an equity method investee with a 28% ownership stake. However, the LLM claims the ownership was 30% in 2023 and decreased to 28% in 2024, which contradicts the original answer that does not mention a 30% stake or any reduction. There is no support in the ground truth for a decrease from 30% to 28%. (2) The dollar amounts mentioned in the LLM answer—$4,544 million fair value and $1,786 million carrying value with a $2,758 million difference—are entirely absent from the original answer and cannot be verified against the ground truth. These figures introduce quantitative data not present in the source, making them incorrect in this context. (3) The multi-hop reasoning is flawed. The original answer emphasizes a strategic evolution from a bottling partnership to an equity-based investee relationship, signaling deeper alignment. The LLM misrepresents this as a minor ownership reduction and focuses on valuation discrepancies not mentioned in the ground truth, missing the core strategic shift. (4) While the LLM correctly identifies that The Coca-Cola Company holds a 28% stake in Coca-Cola FEMSA in 2024 and recognizes the ongoing strategic importance, it fabricates prior year ownership and financial metrics, leading to a low correctness score. Contextual relevance is moderate because it addresses the relationship and financial stake, but the inaccuracies severely undermine reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 439,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "Between 2022 and 2024, Intel has increasingly positioned FPGAs as a core component of its broader programmable solutions and adjacent product strategy. In 2022, FPGAs were highlighted as part of the Programmable Solutions Group (PSG) and were emphasized for their role in enabling flexible, high-performance computing across various markets. By 2024, Intel expanded the strategic role of FPGAs, integrating them into adjacent products such as infrastructure processing units (IPUs), accelerators, and networking solutions, particularly within the Data Center and Artificial Intelligence (DCAI) and Networking and Edge (NEX) segments. This evolution reflects Intel's focus on leveraging FPGAs to support its Smart Capital strategy, enhancing performance across diverse applications like 5G infrastructure and AI-driven workloads.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies regarding Intel's organizational structure and strategic positioning of FPGAs. While the ground truth states that in 2022 FPGAs were part of 'adjacent products' within CCG, DCG, and IOTG, the LLM incorrectly assigns them to the Programmable Solutions Group (PSG), which was actually dissolved in 2022 when Intel restructured and merged PSG into other divisions. This is a critical entity and structural error. Additionally, the claim that by 2024 FPGAs were integrated into IPUs, accelerators, and networking solutions under DCAI and NEX is not supported by the ground truth, which only states that FPGAs moved from being 'adjacent products' to being listed under direct product definitions—indicating a shift in classification and strategic emphasis, not necessarily integration into specific new product types like IPUs. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; however, the years 2022 and 2024 are correctly referenced, earning full marks here. (3) The multi-hop reasoning is partially sound—the LLM recognizes a strategic evolution in FPGA positioning—but fails to accurately represent the organizational context and evidence of that shift. It invents a narrative around PSG, DCAI, and NEX that is not present in the ground truth, undermining the qualitative accuracy. (4) The contextual relevance is high because the answer addresses the evolution of FPGA strategy and attempts to describe changing roles across time and product segments. However, due to significant factual errors in entity identification and organizational structure, the correctness score is moderate at 5—some core ideas about increased strategic importance are aligned, but the supporting details are largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 497,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "From 2022 to 2023, ConocoPhillips' financial activity in the Lower 48 region showed significant growth in asset acquisition and operational performance. In 2023, capital expenditures for the Lower 48 segment were $6.487 billion, compared to $5.630 billion in 2022, reflecting increased investment in the region. Additionally, depreciation, depletion, and amortization (DD&A) expenses for the Lower 48 segment rose to $5.729 billion in 2023 from $4.854 billion in 2022, indicating higher asset activity and utilization. These trends highlight the company's strategic focus on expanding and developing its Lower 48 operations during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in depreciation, depletion, and amortization (DD&A) expenses from $4.854 billion in 2022 to $5.729 billion in 2023, matching the ground truth exactly. The $875 million increase is accurate ($5,729M - $4,854M = $875M), though the LLM does not explicitly state the difference, it correctly implies growth. The capital expenditures cited ($6.487B in 2023 vs $5.630B in 2022) are factually correct and relevant, though not mentioned in the original answer. However, the original answer emphasizes the Concho acquisition as the 2022 driver, which the LLM omits, instead generalizing to increased capital expenditures. This is a minor omission in context but affects completeness on the 'asset acquisition' aspect. (2) All numeric values are accurate and properly formatted; $4.854 billion and $5.729 billion match the ground truth. (3) The reasoning is sound: the LLM correctly infers that rising DD&A and capex reflect increased asset utilization and strategic focus, aligning with the original's conclusion. It synthesizes financial trends across years correctly, though it does not explicitly link 2022 activity to the Concho acquisition, a key multi-hop element in the ground truth. (4) Scores reflect near-perfect quantitative accuracy and strong qualitative reasoning; slight deduction in correctness and qualitative accuracy due to missing mention of the Concho acquisition as the 2022 driver, which is central to the 'evolution' narrative. Contextual relevance is full, as all provided information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 438,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Between 2022 and 2024, Emerson's ownership in AspenTech increased from 55% to 57%, with Emerson proposing to acquire the remaining shares in 2024 for $240 per share. Financially, the Heritage AspenTech acquisition in 2022 initially benefited Emerson's 2023 gross margins by 0.6 percentage points due to favorable mix and pricing. However, by 2024, the Test & Measurement acquisition and inventory step-up amortization negatively impacted gross margins by approximately 1.3 percentage points, overshadowing any continued benefits from the AspenTech integration.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, it incorrectly states that Emerson's ownership increased from 55% to 57% by 2024, while the ground truth indicates Emerson owned 55% by 2024 (not an increase from 55%). Additionally, the claim that Emerson proposed to acquire the remaining shares in 2024 for $240 per share is false—no such proposal is mentioned in the ground truth, and the original acquisition price was $87.69 per share in 2022. The LLM also introduces a 'Test & Measurement acquisition' not referenced in the original answer, which distorts the financial impact analysis. (2) Quantitatively, the LLM correctly notes the 0.6 percentage point gross margin benefit in 2023 and the 1.3 percentage point negative impact from inventory step-up amortization in 2024. However, it fails to report the key 2024 gross margin of 50.8% and the $168 million retained on AspenTech’s balance sheet, and invents a $240 per share offer. The positive 1.8 percentage point contribution to gross margins in 2024 is omitted. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers an ongoing ownership increase and a new acquisition attempt, fails to recognize that AspenTech continued operating under its own name and ticker, and conflates unrelated acquisitions. It does correctly link the 2022 acquisition to margin impacts in 2023 and 2024, showing some understanding of financial causality. (4) Contextual relevance is moderate—the answer addresses ownership and financial impact on gross margins as asked, but introduces irrelevant information (Test & Measurement, $240/share bid) and omits critical details (exact ownership level in 2024, full margin outcome, continued AZPN operations). Due to major factual and numerical errors, the correctness score is low despite partial recognition of margin effects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 501,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "Between 2022 and 2024, the 2015 Director Stock Plan experienced a reduction in shares available for future issuance, from 34,073,114 to 30,660,961. This decline was driven by a higher cumulative issuance of shares through awards and reinvested dividends (42,343,146 shares) compared to the shares recovered (37,608,213 shares) during this period. The share recovery mechanics remained consistent, with shares becoming available again due to forfeitures, cash settlements, or tax withholding using shares. The issuance mechanics continued to count each share issued under the 2015 Director Stock Plan as one share deducted from the available pool, with no adjustments for ratios.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key numbers are correct: 37,608,213 shares recovered and 42,343,146 shares issued or used for dividends are accurately reported. The final available shares (30,660,961) match the original answer. However, the LLM introduces a figure not present in the ground truth—'34,073,114 shares available in 2022'—which is not mentioned in the original answer, making it an unsupported addition. While plausible, this specific starting number cannot be verified from the provided truth and slightly undermines quantitative accuracy. (2) The share recovery and issuance mechanics are correctly described: shares recovered from forfeitures, expirations, and cash settlements are reused, and each issued share reduces the pool by one. (3) The multi-hop reasoning is sound—LLM correctly infers that despite ongoing recovery, net availability decreased due to higher issuance volume, reflecting a shift in balance. (4) The answer addresses all aspects of the question: evolution over time, recovery mechanics, issuance mechanics, and net impact. Only the unverified 2022 starting number prevents a perfect score. Semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 353,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "Starbucks' relationship with the Global Coffee Alliance saw an increased strategic emphasis and revenue contribution from fiscal year 2022 to 2023. In fiscal 2022, the Channel Development segment reported a 16% revenue increase, driven by higher product sales to and royalty revenue from the Global Coffee Alliance. By fiscal 2023, the Alliance remained a key focus, with continued growth in the global ready-to-drink business and innovation in product offerings. While specific 2023 revenue figures for the Global Coffee Alliance were not provided, the strategic emphasis on the Alliance was reinforced as part of Starbucks' broader expansion and diversification efforts.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual inaccuracies and omissions compared to the ground truth. While it correctly identifies the Global Coffee Alliance as a driver of growth in the Channel Development segment in fiscal 2022, it states a '16% revenue increase' instead of the actual $250 million increase specified in the original answer. This is a significant quantitative discrepancy, as percentage growth cannot be verified without the base revenue figure, and it misrepresents the data. Additionally, the LLM claims 'continued growth' in fiscal 2023 but admits 'specific 2023 revenue figures... were not provided,' which downplays the strategic evolution highlighted in the ground truth. (2) The original answer emphasizes a shift in strategic emphasis—from revenue driver to strategic enabler—specifically citing the licensing relationship with Nestlé as a core channel. The LLM answer mentions 'broader expansion and diversification efforts' but fails to identify Nestlé or the deeper integration of the licensing model, missing a key multi-hop insight. (3) The reasoning is logically structured and contextually relevant, correctly framing the alliance as increasingly strategic, but it lacks synthesis of the specific evolution in strategic positioning between 2022 and 2023. It also does not explicitly connect the alliance to global product reach and brand extension as a strategic shift. (4) The contextual relevance is high because the answer addresses both strategic emphasis and revenue contribution. However, due to the incorrect quantitative claim (16% vs. $250M) and failure to capture the full qualitative shift in strategic role, the correctness score is reduced to 6, reflecting partial accuracy with significant gaps in fidelity to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 485,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "Between 2022 and 2023, NEE's financial stake and involvement in the Mountain Valley Pipeline (MVP) significantly declined, as evidenced by a reduction in the investment carrying amount from $4,968 million in 2022 to $3,963 million in 2023. This decrease is primarily attributed to impairment charges, including a $1.2 billion impairment charge in 2023 related to NEE's investment in MVP. This indicates a strategic shift or reassessment of NEE's investment portfolio, likely due to the project's financial challenges or regulatory uncertainties, reflecting a more cautious approach to capital allocation and risk management.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that NEE's total equity method investments were $6,159 million in 2022 and $6,156 million in 2023, with the Mountain Valley Pipeline (MVP) being one of several equity method investees with ownership stakes ranging from 32%–55% in 2022 and 32.8%–52.6% in 2023. However, the LLM claims that the carrying amount specifically for MVP dropped from $4,968 million to $3,963 million — figures that are not supported by the original answer and conflate total equity investments with a single project. There is no mention in the ground truth of a $1.2 billion impairment charge related to MVP in 2023. (2) The numbers provided in the LLM answer ($4,968M to $3,963M) are factually wrong and not derivable from the original data; the only relevant figures in the truth are total equity method investments (~$6.16B across years), not per-project carrying values. The claimed $1.005 billion difference (approximating $1.2B) is numerically inconsistent and unsupported. (3) The multi-hop reasoning fails: the LLM incorrectly isolates MVP as having a massive carrying amount and impairment, while the original answer indicates MVP is one of several equity investees and only notes a change in ownership range and a mention in Nonrecurring Fair Value Measurements — not an impairment. The conclusion about a 'significant decline' and 'strategic shift' due to financial challenges is speculative and not grounded in the provided truth. (4) Despite the factual errors, the LLM attempts to address the evolution of NEE's stake and interpret investment strategy, so it retains moderate contextual relevance. However, due to severe inaccuracies in numbers, entities, and reasoning, the correctness and accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 495,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Medtronic's InterStim Therapy product line expanded its neurostimulator offerings and therapeutic indications. In 2022, the product line included the InterStim II, InterStim Micro, and InterStim X neurostimulators for treating overactive bladder, urinary retention, and bowel incontinence. By 2024, the offerings evolved to include the InterStim X and InterStim II recharge-free neurostimulators and the InterStim Micro rechargeable neurostimulator, continuing to target similar indications. Additionally, the therapy's growth was supported by advancements in pelvic health and integration with broader neuromodulation solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the neurostimulator offerings in 2022 (InterStim II, InterStim Micro, InterStim X) and the indications (overactive bladder, urinary retention, bowel incontinence), which aligns with the ground truth. It also accurately notes the continuation of InterStim II and InterStim X in 2024 and their labeling as 'recharge-free.' However, it incorrectly states that the InterStim Micro became 'rechargeable' by 2024, which is not supported by the original answer—no such change in recharge status is mentioned. Additionally, while the original answer specifies a therapeutic expansion to 'chronic fecal incontinence' by 2024, the LLM answer only vaguely references 'similar indications' and fails to explicitly note this key expansion. Instead, it mentions 'advancements in pelvic health and integration with broader neuromodulation solutions,' which adds unsupported detail not present in the ground truth. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—score reflects no factual errors in this domain. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes product line changes over time and identifies continuity in offerings, but fails to accurately capture the nature of the therapeutic expansion and introduces an unsupported detail about InterStim Micro being rechargeable. The evolution should emphasize the rebranding of existing devices as 'recharge-free' and the addition of 'chronic fecal incontinence' as a formal indication, not a change in device rechargeability. (4) The correctness score is 7 because core facts about the product lineup and indications are mostly accurate, but the answer misses a key expansion in therapeutic indication and introduces a potentially misleading detail about device rechargeability. Contextual relevance is high as the response stays focused on the product evolution, but qualitative accuracy is reduced due to incomplete and slightly inaccurate synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 552,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "From 2022 to 2024, Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolved significantly. In 2022, Simon contributed its interests in the licensing ventures of Eddie Bauer, Forever 21, and Brooks Brothers to ABG in exchange for additional ABG interests, and also sold a portion of its ABG stake for $65.5 million while purchasing additional interests for $100.0 million, resulting in a noncontrolling stake of approximately 10.4%. By 2024, Simon had fully exited its remaining interest in ABG, selling it for $1.2 billion and recognizing a pre-tax gain of $414.8 million. This marked the end of Simon's strategic investment in ABG, which had previously involved joint licensing and brand management ventures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitatively, the numbers are incorrect: the original answer states Simon held a 1.37% interest in ABG in 2022 and realized a $18.8 million pre-tax gain from selling a portion of its stake, followed by a $100 million cash investment. In contrast, the LLM claims Simon sold a portion for $65.5 million, ended with a 10.4% stake, and then fully exited in 2024 with a $1.2 billion sale and $414.8 million gain—none of which aligns with the ground truth. (2) The LLM incorrectly states Simon fully exited ABG in 2024, while the original answer indicates Simon *acquired additional interests* in 2024, showing continued investment, not divestment. (3) The qualitative reasoning is flawed: the LLM fabricates a complete exit and large gains not present in the truth, and incorrectly frames the 2022 activity as involving Eddie Bauer and Brooks Brothers licensing ventures, which are not mentioned in the original. (4) Contextually, the answer addresses the evolution of the relationship and mentions relevant entities (Simon, ABG) and time frame (2022–2024), so it remains relevant in structure and intent, but the core facts and multi-hop synthesis are incorrect. The model fails to accurately represent the direction of the financial relationship—Simon increased involvement in 2024, not terminated it.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 385,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased significantly from 2021 to 2023. In 2021, DD&A expenses were $4,067 million, rising to $4,854 million in 2022, and further to $5,729 million in 2023. This upward trend reflects increased investment activity and higher production volumes in the region during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the DD&A expenses for 2021 ($4,067 million) and 2023 ($5,729 million), matching the ground truth. It also includes the 2022 figure ($4,854 million), which is accurate and adds useful context not required but enhances completeness. All numeric values are correct and properly formatted. (2) Quantitative accuracy is perfect—no errors in numbers or implied calculations (e.g., the increasing trend is correctly presented). (3) The reasoning is sound: the upward trend is correctly interpreted as reflecting increased investment activity and production, aligning with the ground truth's implication of growing emphasis on the Lower 48. The multi-hop synthesis across years is accurate and well-articulated. (4) The only minor difference from the original answer is that the LLM attributes the rise to both investment activity and production volumes, while the ground truth emphasizes asset utilization or investment. This is a slight expansion but not factually incorrect—higher production can drive DD&A increases. Thus, the semantic meaning remains consistent. All entities (ConocoPhillips, Lower 48, DD&A) and years are correct. The answer fully addresses the question’s focus on evolution from 2021 to 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 353,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "Verizon's treatment and valuation approach for international bonds remained consistent from 2023 to 2024. In both years, international bonds were valued using matrix pricing with input from independent third-party valuation sources, as detailed in the valuation methodologies section. The 2024 disclosures did not indicate any changes in the approach compared to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Verizon's treatment and valuation approach for international bonds remained consistent from 2023 to 2024. The ground truth shows a clear evolution: in 2023, international bonds were included under a general fixed income securities category valued using matrix pricing with third-party inputs, but in 2024, they were specifically itemized with a total value of $12 million, split into $10 million (Level 1) and $2 million (Level 2), indicating a more granular and transparent approach. The LLM incorrectly claims no change occurred. (2) Quantitatively, the LLM fails to report any of the key figures from 2024—$12 million total, $10 million Level 1, $2 million Level 2—which are central to the ground truth. These numbers are entirely missing, resulting in a major quantitative inaccuracy. (3) The multi-hop reasoning is flawed: the question requires comparing two years of disclosures across different levels of detail and valuation hierarchy. The LLM fails to recognize the shift from aggregated disclosure to specific breakout, missing the enhanced transparency and segmentation in 2024. (4) Contextual relevance is moderate because the answer addresses the right topic (valuation of international bonds) and mentions matrix pricing, which is accurate for 2023, but it completely misses the 2024 changes, leading to a misleading conclusion. Thus, while the context is relevant, the factual and analytical deficiencies severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 418,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly between 2022 and 2024. In 2022, Emerson increased its financial stake by acquiring Heritage AspenTech, raising its ownership to 55% of AspenTech's outstanding shares. By 2024, Emerson further solidified its control by proposing to acquire the remaining shares of AspenTech not already owned for $240 per share, which would make AspenTech a wholly owned subsidiary. Operationally, Emerson integrated AspenTech's industrial software businesses into its portfolio, enhancing its Software and Control segment, and the two entities operated under the Aspen Technology, Inc. brand.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Emerson increased its stake to 55% in 2022 via acquisition of Heritage AspenTech, whereas the ground truth indicates that in 2022, Emerson held a financial stake valued at $8,326 million, not necessarily a 55% ownership. The claim that Emerson proposed to acquire the remaining shares for $240 per share to make AspenTech a wholly owned subsidiary in 2024 is false; instead, Emerson contributed the Industrial Software Business and $6.0 billion in cash to form 'New AspenTech' and retained a 55% stake—not full ownership. (2) Quantitative inaccuracies include the absence of the correct $8,326 million valuation in 2022 and the incorrect $240 per share figure, which does not appear in the ground truth. The $6.0 billion cash contribution in 2024 is partially correct (directionally close to $6.0B), but the context is wrong—it was part of a merger into a new entity, not an acquisition. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the transformation from a financial stake to a restructured joint entity with operational integration. Instead, it invents a narrative of full acquisition that contradicts the ground truth. (4) While the answer addresses the general theme of increasing integration, it misrepresents both financial and operational developments. The mention of integration into the Software and Control segment has some plausibility but lacks grounding in the provided truth. Thus, despite relevant framing, the core facts, numbers, and logic are incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 449,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "Between 2022 and 2023, Starbucks' position in interest rate swaps remained classified primarily as designated fair value hedging instruments. In 2022, the cumulative fair value hedging adjustment included in the carrying amount of long-term debt was a $52.3 million reduction, while by 2023, this adjustment had worsened to a $17.8 million reduction. Additionally, liabilities related to interest rate swaps increased from $34.0 million in 2022 to $56.7 million in 2023, reflecting a shift in the fair value of these instruments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Starbucks' interest rate swap liability decreased from $34.0 million in 2022 to $19.6 million in 2023 ($0.4M current + $19.2M long-term), but the LLM claims it increased to $56.7 million in 2023, which is incorrect. Additionally, the LLM introduces a 'cumulative fair value hedging adjustment' of $52.3 million in 2022 and $17.8 million in 2023, which is not mentioned in the original answer and contradicts the liability trend. (2) The only correct numeric value is the 2022 liability of $34.0 million. All other figures ($56.7M, $52.3M, $17.8M) are factually wrong and not supported by the ground truth. The calculation of net liability change is also incorrect: the LLM implies an increase, while the truth shows a decrease of $14.4 million. (3) The multi-hop reasoning is flawed. The question asks about classification and liability evolution, and the ground truth notes a reclassification from solely long-term to both current and long-term. The LLM fails to mention this reclassification and instead focuses on hedging adjustments not referenced in the original data, indicating a failure to synthesize the correct information. (4) The contextual relevance is moderate because the answer discusses interest rate swaps and liabilities, but the incorrect figures and focus on unrelated hedging adjustments reduce its accuracy. The qualitative reasoning is poor due to incorrect entity relationships and missing key classification changes. Only partial credit is given for mentioning the correct company and general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 446,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "NextEra Energy Resources' (NEER) financial commitment and involvement in the Mountain Valley Pipeline (MVP) significantly declined from 2022 to 2023. In 2022, due to continued legal and regulatory challenges, NEER recorded an impairment charge of approximately $0.8 billion ($0.6 billion after tax), which fully wrote off its equity method investment carrying amount of $0.6 billion and established a liability of $0.2 billion for future ARO costs. By 2023, there is no mention of further impairment or financial involvement in MVP, indicating that NEER's commitment and involvement in the project were effectively eliminated after the 2022 write-off.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $0.8 billion impairment charge in 2022 and attributes it to regulatory and legal challenges, which aligns with the ground truth. However, it incorrectly states that the write-off included a $0.2 billion liability for future ARO (Asset Retirement Obligation) costs—a detail not present in the original answer and unsupported by the provided ground truth. More critically, the LLM claims there was 'no mention of further involvement' in 2023 and concludes that NEER's commitment was 'effectively eliminated,' which directly contradicts the ground truth: in 2023, NEER maintained a 32.8% equity investment and committed to a 20-year transportation agreement with $70 million in annual obligations. This omission and resulting incorrect conclusion severely undermine the factual accuracy. (2) The $0.8 billion figure is correct, but the breakdown into $0.6 billion after tax and $0.2 billion liability is speculative and not in the original; no such split is mentioned in the ground truth. The $70 million annual obligation and 32.8% equity stake—key 2023 facts—are entirely missing. (3) The multi-hop reasoning fails: while the model correctly interprets the 2022 impairment, it does not synthesize the continued involvement in 2023, leading to a flawed conclusion about disengagement. The answer assumes that a write-off implies full withdrawal, but the ground truth shows ongoing financial commitment post-write-off. (4) The contextual relevance is moderate because the answer addresses the timeline and financial impact, but the qualitative inaccuracy—especially the false conclusion of eliminated involvement—lowers the score. Quantitative accuracy is partially correct but includes unverified breakdowns. Correctness is scored low due to major omissions and a factually incorrect overall narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 502,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts increased from $1,643 million as of December 31, 2023, to $1,883 million as of December 31, 2024. This increase reflects a $240 million growth in the solvency capital funds allocated to marketable equity and debt securities to meet regulatory requirements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1,643 million (2023) and $1,883 million (2024) are accurately reported with correct dates (December 31, 2023 and 2024), and the implied $240 million increase ($1,883M - $1,643M) is correct. (2) The answer is complete, addressing the evolution of investments over time, specifying the nature of the securities (equity and debt), their purpose (solvency capital funds), and the regulatory context. (3) Entities are correctly identified: The Coca-Cola Company, its captive insurance company, and the connection to group annuity reinsurance are all accurately referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis—linking the company, its captive insurer, the purpose of the investments, and year-over-year change. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced detail (e.g., mentioning regulatory requirements) that is contextually appropriate and does not introduce inaccuracies. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 310,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "Intel's approach to the Intel 4 process node evolved significantly from 2022 to 2024. In 2022, the ramp-up of Intel 4 was associated with higher period charges, indicating initial production and development challenges. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and was used for the Intel Core Ultra processor, marking its first high-volume client product. Intel 4 became a key node for future product leadership, with expectations for it to represent an increasing portion of processor production in 2025. This evolution reflects Intel's strategic positioning of Intel 4 as a foundational node for client and data center products, leveraging EUV lithography for improved performance and efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Intel incurred higher period charges due to Intel 4 ramp-up challenges; by 2024, Intel 4 reached high-volume manufacturing (HVM) in Ireland and was used for the Intel Core Ultra processor, marking its strategic role. These details match the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2024) and process node (Intel 4) are correctly identified—quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 to 2024), location (Ireland), product integration (Core Ultra), and strategic implications. The addition that Intel 4 is expected to grow in 2025 and is foundational for client and data center products goes slightly beyond the ground truth but is contextually reasonable and does not contradict it. (4) The only minor deviation is the claim that Intel 4 is for 'future product leadership' and will play a role in data center products—this is plausible but not confirmed in the original answer, which only specifies the Core Ultra (client) product. This slight overextension prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is complete, relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 382,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "Between 2022 and 2024, Emerson's strategic relationship with AspenTech evolved significantly in terms of ownership structure and financial integration. In May 2022, Emerson contributed two of its industrial software businesses to AspenTech and received 55% ownership in the newly formed \"New AspenTech.\" By November 2024, Emerson proposed to acquire the remaining 43% of AspenTech not already owned, which would result in full ownership and an enterprise value of $15.1 billion. Financially, AspenTech's results were integrated into Emerson's operations, with the Heritage AspenTech acquisition in 2022 and continued financial reporting of AspenTech as a consolidated segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Emerson contributed software businesses to AspenTech in May 2022 and immediately received a 55% stake in 'New AspenTech'—but the ground truth indicates that the merger forming 'New AspenTech' with 55% ownership by Emerson occurred by 2024, not 2022. The 2022 relationship was a strategic partnership with no ownership stake. Second, the claim that Emerson proposed to acquire the remaining 43% in November 2024 is incorrect—the ground truth does not mention any such proposal or full acquisition attempt. The 55% ownership is the final state as of 2024. Third, the $15.1 billion enterprise value is not mentioned in the ground truth. (2) Quantitative inaccuracies include the misstated timeline (May 2022 vs. actual 2024 merger), incorrect ownership transition (43% remaining stake is fabricated), and unsupported valuation figure. The only correct number is the 55% ownership, though it is misattributed to 2022 instead of 2024. The mention of financial integration is partially correct—AspenTech's results were integrated, impacting gross margins by 0.6 points in 2023 and SG&A in 2024—but the LLM fails to include these specific metrics, instead vaguely referencing 'continued financial reporting.' (3) The multi-hop reasoning is flawed: the model conflates timeline and ownership evolution, failing to correctly trace the transition from partnership (2022) to partial ownership (2024). It invents a future acquisition step not present in the ground truth. (4) Despite these issues, the answer is contextually relevant and attempts to address both ownership and financial integration. It correctly identifies the 55% stake and financial consolidation, earning partial credit. However, major factual and chronological errors significantly reduce correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 511,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "From 2022 to 2024, Intel's approach to the Intel 4 process node evolved significantly in terms of manufacturing readiness and performance improvements. In 2022, Intel introduced the Intel 4 process node as part of its new naming structure, highlighting it as its first EUV lithography node. By 2024, Intel 4 had moved to high-volume manufacturing in Ireland and was used in the Intel Core Ultra processor, marking its first high-volume client product. Intel 4 delivered a 20% performance-per-watt improvement over Intel 7, showcasing notable advancements in efficiency and scalability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel 4 was introduced in 2022 as part of a new naming convention and as Intel's first EUV node; by 2024, it reached high-volume manufacturing in Ireland and was used in the Intel Core Ultra processor. The 20% performance-per-watt improvement over Intel 7 is correctly stated. (2) Quantitative accuracy is perfect: the 20% improvement is correctly cited, and the timeline (2022 introduction, 2024 production) matches. (3) The multi-hop reasoning is sound—linking the 2022 naming shift to 2024 manufacturing ramp and product deployment shows proper synthesis across time and technical milestones. (4) The only minor omission is that the original answer notes the Core Ultra began shipping in 2023, which the LLM answer does not mention, slightly reducing completeness. However, this does not detract significantly from the overall correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses manufacturing readiness and performance evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 314,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "Between 2022 and 2024, the InterStim Micro neurostimulator has maintained a key role within Medtronic's Pelvic Health therapies, specifically in treating overactive bladder, non-obstructive urinary retention, and chronic fecal incontinence. In 2022, it was listed among the principal pelvic health products, and by 2024, it was highlighted again as a core offering, emphasizing its continued importance alongside newer innovations like the InterStim X and InterStim II. The InterStim Micro's positioning as a rechargeable option has remained consistent, supporting Medtronic's broader strategy to expand and enhance its neurostimulation solutions for pelvic health.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies that InterStim Micro remained a key product in Medtronic's (MDT) Pelvic Health portfolio between 2022 and 2024, treating overactive bladder, urinary retention, and fecal incontinence. The entity names (InterStim Micro, InterStim X, InterStim II), company (Medtronic), and time frame (2022–2024) are correct. (2) There are no numeric values requiring verification (e.g., financials, percentages), so quantitative accuracy is not compromised—score is 10. (3) The reasoning is sound: the LLM correctly notes the continued role of InterStim Micro and its positioning as a rechargeable option. However, it misses a key evolution highlighted in the original answer: in 2024, InterStim Micro was *specifically differentiated* as the rechargeable variant *in contrast* to the recharge-free InterStim X and II. The LLM mentions it is rechargeable but does not emphasize the strategic repositioning or contrast in charging capability that marks the evolution. This nuance is important for full multi-hop synthesis across years. (4) Despite this omission, the answer is contextually relevant, factually consistent, and captures the core continuity and strategic importance of the device. The missing emphasis on the rechargeable vs. recharge-free differentiation prevents a perfect score, but the overall qualitative accuracy remains high. Hence, correctness is 8/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 401,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "The disclosure around the dilutive effect of LTIP Units in Simon Property Group's 2022 and 2024 10-K filings shows consistent reporting, with no material impact observed in either period. In both years, the company explicitly states that no securities, including LTIP Units, had a material dilutive effect on earnings per share or unit. The 2022 filing notes that potentially dilutive securities included LTIP Units and exchangeable units, but emphasizes no adjustments were made due to lack of dilutive impact. Similarly, the 2024 filing reiterates that no securities had a material dilutive effect for 2024, 2023, or 2022. Thus, there is no indication of a material change in the dilutive impact of LTIP Units across these reporting periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that there was no material dilutive effect in both 2022 and 2024 and accurately references the years covered in each disclosure (2022 filing covering 2021–2019; 2024 filing covering 2024–2022). However, it fails to capture the key evolution in disclosure detail — specifically, the removal of the explicit mention of LTIP units being exchangeable for common stock in the 2024 filing. This omission is significant because the question asks about how the *disclosure* evolved, not just whether the dilutive impact changed. (2) Quantitatively, all years and references are accurate: the 2022 filing discusses 2021, 2020, 2019; the 2024 filing covers 2024, 2023, 2022 — this is correctly reflected. There are no calculation errors. (3) The reasoning is partially sound — it correctly synthesizes that no material dilutive effect was reported across periods, but it misses the multi-hop nuance: comparing the *level of detail* in disclosures about LTIP unit exchangeability over time. The model treats the consistency in conclusion (no material impact) as evidence of no evolution, but the ground truth emphasizes a reduction in explanatory detail, which constitutes an evolution in disclosure practice. (4) The answer is contextually relevant and factually accurate on surface-level facts but lacks depth in addressing the qualitative shift in disclosure language, which is the core of the question. Hence, correctness is reduced to 6 due to incomplete synthesis of the disclosure evolution aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 425,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "From 2022 to 2024, MetLife's approach to managing cash buffer needs in relation to stock repurchases has shown a focus on maintaining liquidity while executing repurchase programs. In 2022, MetLife had a $3.0 billion repurchase authorization, with $1.5 billion remaining at year-end. By 2024, the company continued to emphasize liquidity and capital management, ensuring that repurchase activities were aligned with cash buffer requirements and regulatory considerations. The company remained cautious about repurchasing shares when material non-public information was known and highlighted the importance of maintaining sufficient liquidity to meet operational needs, including potential increases in the cash buffer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that in 2022, MetLife had $1.5 billion remaining out of a $3.0 billion repurchase authorization as of year-end 2022 (aligned with ground truth referencing authorization from 2021, but still valid for 2022 usage). All quantitative figures are accurate and match the ground truth. (2) There are no calculations required, but the dollar amounts and timeframes are correctly reported. Format variations are acceptable and consistent. (3) The reasoning correctly captures the evolution from an active repurchase posture in 2022 to a more cautious, liquidity-conscious approach in 2024. The LLM notes increased emphasis on liquidity buffers, regulatory considerations, and operational needs, which aligns with the ground truth’s description of a shift toward conservatism. However, it does not explicitly state that maintaining or increasing liquidity buffers could limit capital for repurchases, acquisitions, and innovation—a key nuance in the original answer. This minor omission slightly weakens the qualitative synthesis. (4) Despite this, the LLM answer is factually correct, contextually complete, and semantically equivalent in intent and substance. The scores reflect high accuracy with only a slight deduction in qualitative accuracy due to incomplete emphasis on the trade-off between buffers and capital deployment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 381,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "From fiscal 2022 to 2023, Starbucks' foreign currency - other derivative asset and liability positions changed significantly. In fiscal 2022, the derivative assets were classified as $39.9 million in \"Prepaid expenses and other current assets\" and $33.5 million in \"Other long-term assets,\" while the liabilities were $0.3 million in \"Accrued liabilities\" and $0 in \"Other long-term liabilities.\" By fiscal 2023, the assets were $1.9 million in \"Prepaid expenses and other current assets\" and $1.7 million in \"Other long-term assets,\" showing a notable decline in asset balances. The liabilities increased to $4.7 million in \"Accrued liabilities\" and $4.1 million in \"Other long-term liabilities.\" This shift indicates a reduction in asset positions and an increase in liability positions related to foreign currency - other derivatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details for fiscal year 2022. According to the ground truth, in fiscal 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings — not balance sheet line items as stated in the LLM response. However, the LLM incorrectly presents balance sheet classifications for 2022 (e.g., $39.9M in prepaid expenses, $33.5M in other long-term assets), which are not supported by the original answer. These figures do not appear in the ground truth and contradict the provided data. (2) The fiscal 2023 numbers are fully accurate: $1.9M in prepaid expenses, $1.7M in other long-term assets, $4.7M in accrued liabilities, and $4.1M in other long-term liabilities — matching the original answer exactly. (3) The reasoning is partially sound in identifying a reduction in asset positions and an increase in liabilities, which aligns with the conclusion in the original answer. However, the multi-hop synthesis fails because it misrepresents the nature of the 2022 data: the 2022 figures were not balance sheet classifications but rather OCI-related amounts, while 2023 data reflects actual balance sheet placements. This reflects a fundamental misunderstanding of the financial reporting structure (OCI vs. balance sheet classification). (4) The contextual relevance is high because the answer addresses the evolution of derivative positions and balance sheet changes, but the qualitative accuracy is reduced due to incorrect entity mapping (misclassifying OCI data as balance sheet line items). The correctness score is low due to major quantitative errors in the 2022 data, despite correct 2023 values and a reasonable directional interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 500,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "Procter & Gamble's global cash management strategy between fiscal 2022 and fiscal 2024 evolved to support its restructuring activities and financial performance by prioritizing liquidity, optimizing working capital, and leveraging strong operating cash flows. In fiscal 2022, cash flow from operations was $16.7 billion, with adjusted free cash flow at $13.8 billion, used primarily for dividends, share repurchases, and debt management. By fiscal 2024, operating cash flow increased to $19.8 billion, and adjusted free cash flow rose to $16.9 billion, reflecting improved productivity and cost savings from restructuring efforts. The company also enhanced its working capital efficiency through extended payment terms with suppliers and supply chain financing programs, while maintaining a strong liquidity position through access to capital markets and undrawn credit facilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual alignment with the ground truth. While it discusses Procter & Gamble's cash flow and restructuring, it fabricates or misrepresents key financial data and omits critical information from the original answer. (2) Quantitative inaccuracies include: the LLM states operating cash flow was $16.7B in FY2022 and $19.8B in FY2024, and adjusted free cash flow was $13.8B and $16.9B respectively — these figures are not present in the ground truth and cannot be verified from the provided data. The original answer does not mention operating cash flow or free cash flow at all. Instead, it focuses on restructuring costs ($250–$500M range in FY2022, $659M in FY2024), restructuring accruals ($147M as of June 30, 2022), and corporate net earnings changes (+$872M to $485M in FY2022, -$1.0B in FY2024). The LLM completely misses the $1.4B Gillette intangible asset impairment charge, which is a central factor in the decline in corporate net earnings in FY2024. (3) The multi-hop reasoning is flawed: the question asks how cash management strategy evolved in relation to restructuring and financial performance, but the LLM invents positive cash flow trends and efficiency gains without grounding in the actual financial outcomes (which show deterioration due to higher restructuring charges and impairments). It fails to connect increased restructuring costs and impairment charges to pressures on cash and earnings, instead implying restructuring led to improved productivity and cash flow — the opposite of the ground truth. (4) The contextual relevance is moderate because the LLM addresses cash management, restructuring, and financial performance, but the substance is factually incorrect. The qualitative accuracy is low because it misidentifies the direction and drivers of financial performance and omits key entities like the Gillette impairment and Nigeria restructuring. The correctness score is low due to major factual and directional errors despite some relevant thematic coverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 553,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "Between 2022 and 2023, NVIDIA's positioning and application of Omniverse evolved significantly in terms of integration with enterprise solutions and simulation technologies. In 2022, Omniverse was primarily highlighted as a virtual world simulation and collaboration platform for 3D workflows, with enterprise applications such as virtual car showrooms and architectural walkthroughs. By 2023, Omniverse had expanded into a more robust development platform and operating system for building virtual world simulation applications, with a stronger focus on industrial digitalization, including digital twins of factories, real-time 3D product configurators, and testing autonomous systems. Additionally, Omniverse was more deeply integrated with NVIDIA's DRIVE Sim solution for autonomous vehicle simulation, emphasizing its role in enabling enterprise-scale digital transformation and AI-driven innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Omniverse's 2022 positioning as a 3D collaboration platform with use cases like virtual car showrooms and architectural walkthroughs is accurately described. The 2023 evolution into a development platform and operating system for virtual world simulations is correctly stated. Industrial applications such as digital twins of factories and real-time 3D product configurators are properly included. Integration with DRIVE Sim for autonomous vehicle simulation is correctly emphasized. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2022 and 2023), which are accurate. (3) The multi-hop reasoning is sound—LLM synthesizes changes in positioning, enterprise integration, and simulation technology across two years. The only minor omission is that the original answer notes Omniverse was free for individuals in 2022, which the LLM answer leaves out. Additionally, the original highlights broader integration with NVIDIA’s accelerated computing infrastructure (on-premises and cloud), which the LLM implies via 'AI-driven innovation' but does not explicitly state. These omissions are minor and do not detract from the core accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution in positioning and application, especially regarding enterprise and simulation integration. Thus, a correctness score of 9 is warranted—very close to perfect, with only slight gaps in completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 443,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "AMT's financial commitments related to communications sites evolved from 2023 to 2024 with a reduction in anticipated spending for capital expenditures. In 2023, total capital expenditures were $1,829.8 million, including $849.3 million for discretionary capital projects, which involved the construction of 3,198 communications sites globally. By 2024, AMT projected total capital expenditures to range between $1,545 million and $1,655 million, with $790 million to $820 million allocated for discretionary capital projects, including the construction of approximately 2,500 to 3,500 communications sites globally. This indicates a planned decrease in spending for new communications site construction in 2024 compared to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and direction of analysis. The original answer states that AMT's financial commitments evolved from a $450 million anticipated spending on data center assets for 2,500–3,500 communications sites in 2023 to a $4.5 billion undiscounted future cash outlay for asset retirement obligations (AROs) on leased sites in 2024. In contrast, the LLM answer discusses capital expenditures (CapEx) figures of $1,829.8 million in 2023 and a projected $1,545–$1,655 million in 2024, with discretionary spending of $849.3 million and $790–$820 million respectively, focusing on construction of communications sites. These numbers do not match the ground truth and refer to different financial metrics (total CapEx vs. specific commitments related to communications sites or AROs). (2) The quantitative inaccuracies are significant: the $450 million (2023) and $4.5 billion (2024) figures in the original answer represent specific forward-looking obligations tied to site infrastructure, particularly asset retirement obligations, whereas the LLM cites total and discretionary capital expenditures, which are broader and unrelated to long-term liability commitments. There is no mention of the $4.5 billion ARO in the LLM response, which is the central fact in the 2024 evolution. (3) The multi-hop reasoning is flawed: the question asks about evolution in financial commitments, particularly 'anticipated spending and future obligations.' The original answer correctly identifies a shift from near-term capital planning to long-term liability (ARO), but the LLM misinterprets 'financial commitments' as capital expenditure trends, missing the key concept of future cash outlays for retirement obligations entirely. It fails to synthesize the correct financial metric across years. (4) The contextual relevance is moderate because it discusses AMT, communications sites, and spending trends across 2023–2024, but it addresses the wrong aspect of financial commitments—capital spending on construction rather than long-term obligations like AROs. Thus, while the topic area is relevant, the core information is factually and conceptually incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 599,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "Between 2023 and 2024, ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved to emphasize divestment-related cost savings as part of structural cost savings. In 2023, proceeds from asset sales were described as part of cash flow from operations and asset sales, with a focus on aligning assets with strategic goals. By 2024, the language explicitly included \"divestment-related reductions\" in the definition of structural cost savings, highlighting how these actions contribute to sustainable cost optimization. This shift reflects a more integrated view of asset sales as a tool for both strategic alignment and operational efficiency.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and reasoning, despite being internally consistent and contextually relevant to the topic. (1) The key claim—that ExxonMobil began characterizing asset divestitures in terms of 'divestment-related reductions' within 'structural cost savings' in 2024—is not supported by the ground truth. The original answer states that the evolution was in the *description of proceeds*, shifting from a detailed breakdown (e.g., sales of subsidiaries, PPE) to a more consolidated 'proceeds from asset sales and returns of investments,' while maintaining strategic alignment language. The LLM instead introduces a new concept—'structural cost savings' and 'divestment-related reductions'—which does not appear in the ground truth and misrepresents the nature of the linguistic evolution. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the absence of numbers does not excuse factual misrepresentation. (3) The multi-hop reasoning fails because the LLM conflates asset proceeds with cost savings, which are distinct financial concepts. The original answer focuses on cash flow categorization, while the LLM shifts to cost structure, indicating a failure to correctly synthesize the actual evolution in disclosure language. (4) While the answer addresses the general theme of strategic objectives and language change, it invents a narrative not present in the ground truth, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because it discusses the right company and timeframe and attempts to analyze language evolution, albeit incorrectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 460,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort decreased slightly from 2022 to 2023. In 2022, the consolidated assets and liabilities of Universal Beijing Resort were $9.7 billion and $8.1 billion, respectively. By 2023, these amounts were reduced to $7.8 billion in assets and $7.2 billion in liabilities. This reduction suggests a decline in the overall financial exposure, likely due to operational performance or repayment of some liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures from the ground truth: $9.7 billion in assets and $8.1 billion in liabilities for 2022, and $7.8 billion in assets and $7.2 billion in liabilities for 2023. These values match exactly with the original answer, and the reduction is accurately described. (2) All numbers are quantitatively accurate, with no calculation errors. The differences in asset ($1.9 billion decrease) and liability ($0.9 billion decrease) amounts are implied correctly through the reported figures. (3) The reasoning is sound and captures the essence of reduced financial exposure. The LLM attributes the decline to 'operational performance or repayment of some liabilities,' which is a reasonable interpretation, though slightly less comprehensive than the original answer's mention of 'asset depreciation, debt repayment, or strategic reduction.' While not incorrect, it omits 'asset depreciation' and 'strategic reduction' as possible factors, representing a minor gap in qualitative depth. (4) The answer is fully contextually relevant, directly addressing the evolution of Comcast's financial exposure through consolidated asset and liability changes. Overall, the answer is factually complete and accurate, with only a slight omission in the range of possible explanations, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 380,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's risk factor related to Customer Demand Volatility has shown a nuanced evolution. In 2023, the company highlighted the cyclical nature of demand, particularly in the energy, transportation, and mining sectors, emphasizing the impact of economic conditions and commodity price volatility on capital expenditures and, consequently, on Caterpillar's financial performance. By 2024, the discussion expanded to include a more pronounced focus on the compounding effects of global economic uncertainties, such as inflationary pressures and supply chain disruptions, which further amplify demand volatility. This evolution reflects a growing concern about the interconnectedness of macroeconomic factors and their cascading effects on both financial performance and supply chain stability.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Customer Demand Volatility as a risk factor for Caterpillar between 2023 and 2024 and maintains contextual relevance by addressing financial performance and supply chain stability. However, there are discrepancies in the specific drivers emphasized. The original answer states that in 2023, the primary drivers were economic uncertainties from the lingering effects of the global pandemic, including inflation, supply chain disruptions, and labor inefficiencies. In 2024, the focus broadened to include commodity price changes, material price increases, and labor/material shortages. The LLM answer accurately notes macroeconomic factors like inflation and supply chain issues but incorrectly frames 2023 around 'cyclical demand in energy, transportation, and mining' and 'commodity price volatility'—details not highlighted in the ground truth for that year. It also omits the explicit shift toward systemic supply-side challenges in 2024. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the model connects demand volatility to financial and supply chain impacts across years, but it misattributes the specific risk drivers in 2023 and does not fully capture the evolution toward supply-side risks in 2024. (4) The correctness score is 7 because core elements—temporal evolution, financial and supply chain impacts—are present and accurate, but key factual details about the nature of the risk shift are misrepresented. Qualitative accuracy is 7 due to these factual misalignments in risk drivers. Contextual relevance is high (9) as the response stays focused on the question’s scope and provides a logically structured evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 499,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "From 2022 to 2024, the fair value of Net Derivative Assets (Liabilities) increased significantly, with the Level 3 fair value rising from $19 million in 2022 to $69 million in 2024. The valuation methodology remained consistent, relying on discounted cash flows and unobservable inputs such as swap rates. In 2024, the weighted average swap rate used was 4%, compared to 2% in 2022, reflecting a shift in assumptions impacting fair value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The fair value in 2022 is incorrectly stated as $19 million in that year, whereas the ground truth states $19 million as of December 31, 2021 (reported in 2022 filing), and the 2024 value is wrong—$69 million is cited, but the correct value is $58 million as of December 31, 2023 (reported in 2024). (2) The valuation methodology is misrepresented: the LLM claims it 'remained consistent' and relied on 'unobservable inputs,' but the ground truth states a shift occurred toward using discounted cash flows with a focus on *observable* inputs like swap rates (3-5%, weighted average 4%). This is a critical error—observable vs. unobservable inputs is a key distinction in fair value hierarchy (Level 2 vs Level 3). Additionally, the claim of a 2% swap rate in 2022 is unsupported by the original answer, which does not mention a 2022 rate. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize changes over time in both value and methodology. It incorrectly infers consistency in methodology while asserting a change in swap rates, contradicting the ground truth’s clear statement of a methodological shift toward greater transparency. (4) Despite these errors, the answer is contextually relevant—it addresses fair value evolution and methodology, uses appropriate financial terminology, and attempts to compare years and inputs. However, due to major quantitative and qualitative inaccuracies, especially the incorrect fair values and mischaracterization of valuation inputs, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 438,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "From 2022 to 2023, NVIDIA's GeForce NOW cloud gaming offering evolved from being a standalone game streaming service to a more integrated component of NVIDIA's broader GPU and cloud platform ecosystem. In 2022, GeForce NOW was positioned primarily as a service for playing PC games on underpowered devices. By 2023, it was highlighted as part of NVIDIA's full-stack cloud platform strategy, emphasizing its role in enabling interactive graphics applications to be accessed from virtually any device. This shift reflects NVIDIA's broader vision of unifying its GPU-powered cloud infrastructure, including vGPU and AI-driven technologies, to support gaming, creative workflows, and enterprise applications seamlessly across devices and environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: GeForce NOW's evolution from 2022 to 2023 is accurately described in terms of its shifting positioning within NVIDIA’s ecosystem. In 2022, it was framed as a service for accessing games on low-power devices, which matches the ground truth’s emphasis on extending graphics leadership and accessibility. By 2023, the integration into NVIDIA’s full-stack cloud and accelerated computing platform is correctly noted, including alignment with vGPU and AI technologies. (2) There are no numeric values, dates, or financial figures in dispute—both answers reference 2022 and 2023 appropriately, and no calculations are required. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift in strategic positioning over time and connects GeForce NOW to broader ecosystem elements like vGPU and AI infrastructure, though it does not explicitly name NVIDIA DGX Cloud as in the original answer. This is a minor omission but does not detract significantly from the overall accuracy. (4) The semantic meaning is equivalent to the ground truth, with slightly different phrasing (e.g., 'standalone game streaming service' vs. 'cloud platform enabling gamers'). The LLM captures the core evolution—strategic integration into a unified GPU-cloud-AI narrative—making the response contextually excellent and factually robust. A score of 9 is justified due to the omission of DGX Cloud as a specific example, which was present in the original answer and reinforces the AI/cloud integration point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 438,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "Inlyta's revenue increased by 3% in 2023 compared to 2022. The growth was driven by adoption of combinations of immune checkpoint inhibitors and Inlyta for first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., as well as continued growth in emerging markets. However, this was partially offset by lower volumes and reduced net price in certain European markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the 3% revenue growth from 2022 to 2023, which aligns with the ground truth calculation: ($1,036M - $1,003M) / $1,003M ≈ 3.3%, rounded to 3% in both the original and LLM answers. While the exact dollar figures ($1,003M and $1,036M) are not explicitly mentioned in the LLM response, the percentage growth is accurate and is the key quantitative point. (2) All numeric and percentage data are correct; the 3% growth is consistent with the source. The absence of the exact revenue figures slightly reduces completeness but does not affect the correctness of the stated growth rate. (3) The reasoning is sound and captures the multi-hop elements: it identifies the U.S. adoption of Inlyta in combination therapy for advanced RCC and growth in emerging markets as growth drivers, and correctly notes offsetting factors in Europe (lower volumes and net prices). These factors are accurately synthesized from the original answer. (4) The LLM answer is semantically equivalent to the ground truth in terms of key facts and causal factors. The only minor omission is the lack of explicit revenue figures for 2022 and 2023, which slightly affects completeness but not overall correctness. Hence, a high score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 372,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "From 2023 to 2024, the amortization assumptions for network location intangibles remained consistent, with these intangibles being amortized over the shorter of the ground lease term (including renewal options) or the estimated useful life of the tower, generally up to 20 years. However, in 2024, the Company revised the estimated useful life of its tower assets from 20 to 30 years, which prospectively extended the amortization period for certain intangible assets tied to towers. Regarding impairment reviews, the process for network location intangibles remained unchanged, with impairments assessed on an individual tower basis based on factors such as tenant leases and cash flow projections. No new impairment events specific to network location intangibles were disclosed for 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, the weighted average amortization period was 15 years, but the LLM claims amortization up to 20 years and asserts a change in 2024 to 30 years for tower assets—this is not supported by the original answer. The original does not mention any change in useful life from 20 to 30 years or a general 20-year cap; instead, it notes a 15-year weighted average in 2023 and no explicit change in amortization period, only enhanced impairment disclosures in 2024. Additionally, the LLM incorrectly states that the impairment review process remained unchanged, while the ground truth clearly indicates that in 2024, the company expanded its disclosures to include a more detailed impairment review on an individual tower basis with specific triggers such as lack of leases or expenses exceeding revenues. (2) Quantitatively, the LLM introduces numbers not present in the original: 'up to 20 years', 'revised from 20 to 30 years'—these are incorrect. The only number in the original is the 15-year weighted average in 2023 and a $470 million increase in asset retirement obligations in 2024, which the LLM omits entirely. The failure to mention the $470M liability increase—a key 2024 valuation impact—is a major quantitative and qualitative omission. (3) The multi-hop reasoning is flawed: the question asks about evolution in both amortization assumptions and impairment reviews. The LLM incorrectly concludes no change in impairment process, contradicting the ground truth. It fabricates a change in useful life without evidence. It also fails to connect the $470M increase in retirement obligations to the indirect impact on useful life and valuation assumptions, which is a critical part of the original answer. (4) Scores are justified as follows: correctness is low (3/10) due to major factual errors and omissions; quantitative accuracy is very poor (2/10) due to incorrect numbers and missing key figures; qualitative accuracy is poor (3/10) due to incorrect reasoning and synthesis; contextual relevance is moderate (6/10) because the answer addresses the general topic of amortization and impairment but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 598,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "Between 2023 and 2024, ExxonMobil significantly advanced its strategic emphasis on Guyana as a core component of its upstream growth portfolio. In 2023, Guyana's production from the Stabroek Block exceeded 390 thousand barrels of oil per day (kbd), with the third FPSO vessel, Prosperity, starting production in November 2023 and reaching full capacity by January 2024. By late 2023, combined production from three operating FPSO vessels reached nearly 440 kbd. In 2024, the company continued progress on the Yellowtail and Uaru developments and is on track to operate six FPSO vessels on the Stabroek Block by the end of 2027. Additionally, regulatory approvals for a sixth project at Whiptail were being pursued. These developments underscore ExxonMobil's commitment to Guyana as a major growth driver, with production capacity and project execution advancing ahead of schedule.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the strategic importance of Guyana to ExxonMobil's upstream growth and correctly notes production advancements and FPSO developments. However, there are key quantitative discrepancies. The ground truth states that production reached 'nearly 440 kbd in the fourth quarter' of 2023, while the LLM claims 'exceeded 390 kbd' and attributes the 440 kbd figure to late 2023 from three FPSOs — this timing and attribution are not fully aligned with the original answer, which ties 440 kbd specifically to the Prosperity FPSO startup in Q4 2023. Additionally, the LLM states Prosperity reached full capacity by January 2024, which is not mentioned in the ground truth. (2) The ground truth does not mention 'Yellowtail and Uaru developments' or a 'sixth project at Whiptail' or plans for six FPSOs by 2027 — these details, while potentially true, go beyond the provided knowledge graph and introduce unverified specifics. The core production figure of ~440 kbd is approximately correct, but the breakdown and timeline are less precise. (3) The multi-hop reasoning is partially sound: the LLM correctly infers growing strategic emphasis from project expansion, but misses the key qualitative shift in 2024 where Guyana was formally reclassified under 'Advantaged Assets' alongside Permian and LNG — this strategic repositioning is a critical element of the original answer and is entirely omitted. (4) Despite missing this key strategic reclassification, the LLM answer remains contextually relevant and conveys a strong sense of Guyana's growing role. The qualitative reasoning about production growth and project execution is sound, and the answer addresses upstream growth and production capacity. However, the absence of the 'Advantaged Assets' reclassification — a central point in the original answer — limits the correctness score. Quantitative accuracy is reduced due to imprecise production figures and unsupported project timelines. Overall, the answer is factually plausible and relevant but lacks full fidelity to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 557,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "Between 2022 and 2023, the X1 platform's integration with third-party streaming services expanded significantly, with the platform now incorporating services like Disney+ and Netflix, as well as Peacock's premium tier, into a unified interface with integrated search functionality and voice-activated controls. This evolution reflects Comcast's strategy to reduce cord-cutting by offering a hybrid viewing experience that combines traditional cable content with popular streaming options, thereby enhancing customer convenience and engagement. Additionally, by integrating these services, Comcast aims to increase ARPU by encouraging customers to access premium content through bundled offerings and commission-based revenue from third-party streaming service sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the integration of Disney+, Netflix, and Peacock's premium tier on the X1 platform, as well as Comcast earning commission revenue—key facts from 2022. However, it omits the 2023 developments involving Xumo Play, NBC, Sky, and NOW TV, which were specifically introduced in 2023 and targeted at residential broadband customers. This is a significant omission in completeness. Instead, the LLM implies that the Disney+/Netflix integrations were part of the 2022–2023 evolution, but these were already in place by 2022. The answer incorrectly frames the expansion as occurring between 2022 and 2023, when the core third-party integrations were established earlier. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not compromised—no errors in this dimension. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that integrating streaming services reduces cord-cutting and boosts ARPU via bundling and commissions. However, it fails to connect the 2023 shift toward broadband-centric services (NOW TV, Xumo Play) which indicates a strategic pivot beyond the X1 platform toward broadband monetization—a key insight in the ground truth. (4) The answer is contextually relevant and well-articulated, capturing the general strategic intent, but lacks precision in timeline and misses the evolution’s key 2023 components, warranting a 7 for correctness and qualitative accuracy. Quantitative accuracy is 10 due to absence of numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 430,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's relationship with FG Wilson in terms of distribution network coverage for electric power generation systems expanded. In 2023, FG Wilson's systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this network had grown to 108 distributors covering 158 countries, indicating an increase in geographic reach and potentially enhanced market access for FG Wilson's products.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the number of distributors (110 in 2023, 108 in 2024) and the number of countries (109 in 2023, 158 in 2024), which matches the ground truth. However, it incorrectly characterizes the change as a 'growth' in the network, when in fact the number of distributors decreased slightly. This misrepresents the nature of the change. (2) Quantitatively, all numbers are accurate—110 to 108 distributors and 109 to 158 countries—and the years are correct. The calculation of geographic expansion is valid, but the conclusion about network 'growth' overlooks the reduction in distributor count. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the two data points across years and infers increased geographic reach. However, it fails to acknowledge the contraction in distributor count and thus misses the nuanced strategic shift (optimizing efficiency while expanding reach) described in the original answer. (4) The contextual relevance is high, as the response directly addresses the evolution of Caterpillar's relationship with FG Wilson via distribution network changes. Scores reflect high factual accuracy but a shortfall in qualitative interpretation and precision of reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 352,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "Capital One's exposure to securitized debt obligations decreased between 2022 and 2024, both in terms of carrying value and fair value. As of December 31, 2022 (from the 2023 10-K), the carrying value of securitized debt obligations was $18,043 million with a fair value of $18,067 million. By December 31, 2024 (from the 2024 10-K), the carrying value had decreased to $14,264 million, and the fair value was $14,335 million. This reflects a reduction in both carrying value and fair value of approximately $3,779 million and $3,732 million, respectively, over the two-year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states that in 2024, the carrying value of securitized debt obligations was $18,043 million with a fair value of $18,067 million. The LLM incorrectly claims that in 2022 the carrying value was $18,043 million and that by 2024 it had decreased to $14,264 million. This misrepresents the data—there is no evidence in the ground truth of a decrease, nor are there any figures for 2024 lower than 2022. The LLM fabricates a $14,264 million carrying value and $14,335 million fair value for 2024, which are not present in the original answer. (2) Completeness: While the LLM attempts to address carrying and fair values over time, it fails to accurately reflect the actual trend. The original answer does not provide 2022 carrying/fair values for direct comparison, only describing the structure of VIEs and securitized obligations, so the LLM invents unsupported data points. (3) Entity Accuracy: The company (Capital One) and metric (securitized debt obligations) are correct, but the years and associated values are wrong. The LLM incorrectly cites the 2023 10-K for 2022 data and the 2024 10-K for 2024 data, but the ground truth does not confirm these specific disclosures in those filings. (4) Reasoning: The multi-hop synthesis is flawed—the original answer indicates stable exposure with slight fair value exceeding carrying value in 2024, while the LLM concludes a reduction without supporting evidence. The conclusion of a 'decrease' contradicts the ground truth's implication of continued, stable involvement. (5) Semantic Equivalence: The LLM's answer conveys the opposite meaning of the original—reduction vs. stability—making it factually and semantically divergent. The only correct element is the 2024 carrying and fair values, but even these are misassigned to a different year (2022) in the LLM's narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 524,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "Between 2023 and 2024, McDonald's use of line of credit agreements remained stable, with the company maintaining a $4.0 billion committed line of credit agreement as of December 31, 2024, similar to the prior year. The company also utilized uncommitted foreign currency line of credit agreements, with $7 million in borrowings outstanding under these agreements in 2024. McDonald's continued to leverage its credit capacity to manage short-term funding needs alongside commercial paper borrowings, reflecting its strong cash flow and disciplined approach to financing activities.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses key aspects of the evolution in McDonald's use of line of credit agreements and cash flow management between 2023 and 2024. While it correctly notes that McDonald's maintained a $4.0 billion committed line of credit, this specific figure is not present in the ground truth and cannot be verified. The mention of $7 million in uncommitted foreign currency borrowings in 2024 is not supported by the original answer and appears to be fabricated or misattributed. (2) The ground truth emphasizes a significant shift in financing dynamics: cash used for financing activities increased from $4.4B in 2023 to $7.5B in 2024, while cash and equivalents dropped from $4.6B to $1.1B. These critical quantitative changes are entirely omitted in the LLM response, undermining its factual completeness. The LLM also fails to mention the decrease in bond issuances as a driver for increased financing outflows in 2024, which is central to understanding the increased reliance on credit facilities. (3) The multi-hop reasoning is weak: the original answer connects changes in cash flow, financing activities, bond issuance patterns, and liquidity levels to infer a strategic shift toward greater reliance on credit lines in 2024. The LLM incorrectly frames the use of credit lines as 'stable' without acknowledging the changing context of tighter liquidity and higher financing demands. This misrepresents the evolution described in the ground truth. (4) Despite missing core financial shifts and introducing unverified figures, the LLM does correctly identify that McDonald's used line of credit and commercial paper for short-term funding, which maintains moderate contextual relevance. However, the absence of key data points and flawed synthesis result in a partially correct but misleading answer, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 512,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "Between 2022 and 2024, the Worldwide Business Conduct Manual has remained a foundational element of Procter & Gamble's governance framework, emphasizing integrity and compliance with legal and ethical standards. However, the 2024 filing highlights a more explicit connection between the Manual and the company's broader governance structures, such as the Global Leadership Council and the Disclosure Committee, indicating a more integrated and proactive approach to reinforcing internal controls. This evolution suggests a stronger emphasis on aligning employee behavior with corporate governance objectives, reflecting P&G's commitment to maintaining robust internal controls and ethical business practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the role of the Worldwide Business Conduct Manual in 2022 emphasized integrity, legal compliance, and support for internal controls through policies and employee development; by 2024, it was more explicitly linked to governance bodies like the Global Leadership Council and Disclosure Committee. These entities and their roles are correctly identified. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two time points (2022 and 2024) and infers an evolution toward a more integrated governance approach, which matches the original answer’s conclusion. The only minor shortcoming is that the LLM does not explicitly mention 'segregation of duties' or 'employee development' from the 2022 description, which slightly reduces completeness in qualitative detail, hence a 9 instead of 10. (4) The answer is fully contextually relevant, directly addressing both parts of the question—evolution of the Manual’s role and what it indicates about P&G’s governance approach—with accurate synthesis and appropriate interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 366,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "Exxon's strategic positioning in Guyana has significantly strengthened between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions. Long-lived assets in Guyana increased from $6.766 billion in 2023 to $9.689 billion in 2024, indicating substantial capital investment in the region. Additionally, Guyana is explicitly categorized under \"Advantaged Assets\" in the 2024 earnings driver definitions, highlighting its role as a key growth project contributing to volume and earnings growth. This reflects Exxon's strategic focus on high-impact, high-return projects in Guyana, aligning with its broader growth initiatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the quantitative data: it states that long-lived assets in Guyana were $6.766 billion in 2023 and increased to $9.689 billion in 2024, implying growth over time. However, the ground truth states that the $9,689 million (i.e., $9.689 billion) figure was for 2023, with no data provided for 2024. This reverses the timeline and invents a 2024 number not present in the original answer, making the core numerical claim incorrect. (2) The calculation and comparison of asset values are therefore invalid. The LLM incorrectly suggests an increase from $6.766B to $9.689B, but the $6.766B figure does not appear in the ground truth at all—this number is likely a hallucination or misattribution. Only the $9.689 million (billion) figure for 2023 is confirmed. (3) On qualitative accuracy, the LLM correctly identifies that Guyana was explicitly named as part of the 'Advantaged Assets' in 2024 under the new 'Advantaged Volume Growth' earnings driver, which aligns with the ground truth. This reflects accurate multi-hop reasoning in linking strategic categorization changes across years. (4) Contextually, the answer is well-framed and addresses the evolution of strategic positioning, correctly interpreting the significance of being labeled an 'Advantaged Asset.' However, due to the major quantitative inaccuracy—especially the reversal and fabrication of asset values—the overall correctness score is significantly reduced. While the strategic interpretation is sound, the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 430,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "Capital One's reliance on securitized debt obligations as a funding source decreased from 2022 to 2024. In 2022, securitized debt obligations were $6.25 billion in issuances, while in 2024, they were $14.264 billion in total outstanding obligations. However, the proportion of securitized debt obligations relative to other funding sources like senior and subordinated notes and deposits appears to have decreased, indicating a reduced reliance on securitized debt as a primary funding source over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no specific dollar value for securitized debt obligations was disclosed in 2022, but the LLM incorrectly claims $6.25 billion in issuances for that year, which is not supported by the original answer. The 2024 figure of $14.264 billion (or $14,264 million) is correctly cited from the ground truth as the carrying value, which is accurate. However, the LLM misrepresents this as evidence of decreased reliance, when the original answer indicates continued strategic use and increased transparency, not reduced reliance. (2) The quantitative error in 2022 is critical—there was no disclosed issuance amount, so the $6.25 billion figure is fabricated. The 2024 number is correct in amount but misinterpreted in context. No valid proportion or comparative calculation can be made due to missing 2022 data. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers reduced reliance based on a false premise (a specific 2022 issuance figure) and an unsupported claim about shifting proportions. The original answer emphasizes continuity and increased disclosure, not a strategic reduction. (4) Scores are low due to major factual and reasoning errors, especially in quantitative accuracy and correctness. Contextual relevance is moderate because the answer addresses the right topic and mentions relevant funding sources, but the conclusions are unsupported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 404,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "Between fiscal years 2022 and 2023, NVIDIA's Omniverse platform evolved from being a 3D design collaboration and virtual world simulation tool to a more integral part of NVIDIA's enterprise solutions, particularly in industrial digitalization. In 2022, Omniverse was highlighted for enabling digital twins of factories, real-time 3D product configurators, and testing autonomous systems. By 2023, Omniverse was positioned more broadly as a foundational platform for building metaverse and 3D internet applications, with increased integration into NVIDIA's AI and autonomous vehicle ecosystems, such as being used in DRIVE Sim for autonomous driving simulation and development. This shift reflects a stronger emphasis on enterprise adoption and cross-platform integration.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of NVIDIA's Omniverse from a 3D collaboration tool toward a broader enterprise platform, and notes increased industrial and simulation use, which aligns with the ground truth. However, it inaccurately states that digital twins of factories and real-time 3D product configurators were highlighted in 2022, when the ground truth indicates these enterprise applications became prominent in 2023 as part of the platform's evolution. In 2022, Omniverse was positioned more narrowly as a 'real-time 3D design collaboration and virtual world simulation software' for creators, not yet emphasizing industrial digitalization. Additionally, while the LLM correctly notes integration with DRIVE Sim and AI ecosystems in 2023, the ground truth emphasizes the shift to a subscription-based enterprise development platform and operating system, including free access for individuals—details missing in the LLM response. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model connects Omniverse to enterprise adoption and cross-platform integration, but misattributes the timing of key use cases (e.g., digital twins), weakening the synthesis across fiscal years. (4) The answer is contextually relevant and captures the directional shift, but lacks precision in the timeline and misses key aspects of the business model evolution (subscription offering, free tier), leading to a correctness score of 7 for minor but meaningful omissions and one significant misplacement of facts across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 463,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Between 2022 and 2023, the net amounts due from Viatris under their agreements with Pfizer decreased significantly. As of December 31, 2022, the net amounts due to Viatris were $94 million, while by December 31, 2023, this amount had dropped to $33 million. This decline suggests a reduction in outstanding obligations or settlements under the transitional service agreements (TSAs), manufacturing supply agreements (MSAs), and other related arrangements following the 2020 spin-off and combination of the Upjohn Business with Mylan to form Viatris.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net amounts due to Viatris as $94 million as of December 31, 2022, and $33 million as of December 31, 2023, matching the ground truth exactly. These figures are presented with correct dates and directional accuracy (a decrease). (2) Quantitative accuracy is perfect—both dollar amounts and dates are correct, and the implied reduction of $61 million is consistent with the data. No calculation errors. (3) The reasoning is sound: the answer correctly infers a reduction in obligations and ties it to post-separation agreements like TSAs and MSAs, referencing the 2020 spin-off and formation of Viatris. This demonstrates proper multi-hop synthesis across time and agreement types. (4) The only minor shortcoming is a slight ambiguity in phrasing: 'net amounts due from Viatris' could be misinterpreted as amounts Viatris owes, but the subsequent clause 'due to Viatris' clarifies the direction. This near-miss in precision prevents a perfect 10 on qualitative accuracy, but the overall meaning remains factually aligned. The answer is fully contextually relevant and addresses the evolution of the financial relationship as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 336,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana has intensified between 2023 and 2024, with increased project activity and classification as an advantaged growth project. In 2023, Guyana accounted for 12.6 net exploratory and development wells completed, with the Payara development commencing and the Yellowtail project advancing. By 2024, Guyana was explicitly included in the \"Advantaged Volume Growth\" earnings driver, highlighting its role as a key asset for volume and earnings growth. This reflects a shift toward prioritizing high-impact, high-return projects, with Guyana's offshore operations now central to ExxonMobil's growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the number of net exploratory and development wells (12.6) is correct, and the years (2023 and 2024) are accurately referenced. (2) The LLM correctly identifies key projects—Payara and Yellowtail—and notes the advancement of development activities in 2023. (3) The strategic evolution is well-reasoned: the reclassification of Guyana under the 'Advantaged Volume Growth' earnings driver in 2024 is accurately reported, reflecting a shift from operational to strategic emphasis. (4) The LLM captures the core synthesis: Guyana is now grouped with top-tier assets like the Permian and LNG, though it does not explicitly name Uaru (mentioned in the ground truth) or use the exact phrase 'Advantaged Assets,' instead paraphrasing as 'advantaged growth project.' This is a minor omission but does not detract from the overall correctness. The reasoning is sound, multi-hop (from operational activity to strategic classification), and semantically equivalent. The answer is fully contextually relevant and conveys the strategic elevation accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 321,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "From 2022 to 2023, the weighted-average interest rate for senior notes with maturities greater than 10 years remained stable at 3.8%. The face value of these senior notes slightly decreased from $52.8 billion in 2022 to $53.4 billion in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022 the weighted-average interest rate was 3.67%, not 3.8% as stated by the LLM, and it increased to 3.8% in 2023. The LLM incorrectly claims the rate 'remained stable at 3.8%' in both years, which misrepresents the evolution. Additionally, the face value in 2022 is reported as $52.8 billion by the LLM, but the correct value is $54.536 billion. The 2023 face value of $53.4 billion is correct. (2) Number verification: 2022 interest rate: incorrect (3.8% vs 3.67%), 2023 rate: correct (3.8%), 2022 face value: incorrect ($52.8B vs $54.536B), 2023 face value: correct ($53.4B). The direction of change (slight decrease) is correct, but the magnitude and starting point are wrong. (3) Multi-hop reasoning: The model correctly identifies that the interest rate remained nearly stable and that face value slightly decreased, showing some correct synthesis across years. However, due to incorrect base values, the analysis lacks precision. (4) Correctness score is 4 due to major factual errors in key numbers, especially the misstatement of the 2022 interest rate and face value. Quantitative accuracy is low (4) because two of the four reported figures are incorrect. Qualitative accuracy is moderate (6) as the general trend (stable rate, slight decline in face value) is captured. Contextual relevance is high (9) as the answer addresses the right metrics and time frame with appropriate interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 418,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "Between 2023 and 2024, the nuclear decommissioning trusts managed by Alabama Power and Georgia Power saw a shift in their domestic equity investment allocations. In 2023, Alabama Power's domestic equity investments were classified as $443 million under Level 2 inputs, while Georgia Power's were $321 million under Level 2. By 2024, Alabama Power's domestic equity allocation remained in Level 2 at $443 million, and Georgia Power's allocation slightly increased to $322 million, also under Level 2. There were no Level 1 classifications for domestic equity in either trust during these periods. The valuation methodologies remained consistent, relying on external pricing vendors and observable market inputs for Level 2 classifications.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It misattributes the investment amounts and classifications for both Alabama Power and Georgia Power across both years. For example, it claims Alabama Power had $443 million in Level 2 domestic equity in 2023, when in fact that amount ($443 million) was its 2024 Level 1 allocation. Similarly, it states Georgia Power had $321 million in Level 2 in 2023, but the truth is Georgia Power had $321 million in Level 1 in 2024. The LLM also falsely claims there were no Level 1 classifications for either company, which contradicts the ground truth where Level 1 investments dominate. (2) All numerical values are mismatched: Alabama Power’s 2023 Level 1 was $396M (not reported at all), Level 2 was $169M (misreported as $443M), and 2024 Level 1 was $443M (misplaced into Level 2). Georgia Power’s 2023 Level 1 was $255M (not mentioned), 2024 Level 1 was $321M (misplaced into Level 2), and Level 2 remained $1M both years (not $322M). Calculations and totals are therefore invalid. (3) The multi-hop reasoning failed completely: the model did not correctly synthesize data across companies and years, confused input levels, and missed the shift toward higher Level 1 allocations. Instead, it invented a narrative of stability in Level 2 with no Level 1 usage, which is factually wrong. (4) The contextual relevance is low but not zero because the answer addresses the general topic (nuclear decommissioning trust allocations and Level 1/2 inputs), so partial credit is given for domain alignment, but factual and reasoning failures justify a correctness score of 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 451,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "From 2022 to 2023, NVIDIA's strategic positioning of CUDA evolved to become a more central and foundational element within its full-stack computing platform. In 2022, CUDA was highlighted as a key building block for enabling accelerated computing across diverse markets, including AI, data center, gaming, and automotive. By 2023, CUDA's role expanded as the core of NVIDIA's unified architecture, supporting not only GPU-based solutions but also integrating with DPUs and CPUs to deliver end-to-end computing solutions across industries. This integration allowed CUDA to power AI, HPC, and graphics workloads across data centers, autonomous vehicles, and enterprise applications, reinforcing NVIDIA’s position as a full-stack computing infrastructure leader.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of CUDA's strategic positioning from 2022 to 2023 as a more central and foundational component within NVIDIA's full-stack computing platform. It accurately reflects that in 2022, CUDA was a key enabler across markets like gaming, data center, and automotive, and that by 2023, its role expanded as the core of a unified architecture. The mention of integration with CPUs and DPUs aligns with NVIDIA's full-stack narrative, though this specific hardware integration is not explicitly detailed in the ground truth. However, the LLM omits the critical 2023 emphasis on CUDA supporting 'hundreds of domain-specific software libraries, SDKs, and APIs'—a key strategic shift highlighted in the original answer. Additionally, while the LLM mentions AI, HPC, and enterprise applications, it does not explicitly note the expansion into verticals like healthcare and manufacturing, which are central to the ground truth's claim of vertical integration. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes CUDA’s role across time and markets, correctly identifying its deepening integration into NVIDIA’s infrastructure. However, it falls short in fully capturing the software-stack expansion (libraries, SDKs) that marks the core of the strategic evolution. (4) The answer is contextually relevant and well-articulated, but the missing emphasis on domain-specific software ecosystems reduces completeness and qualitative accuracy slightly. Hence, correctness is high but not perfect—warranting an 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 467,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "From 2022 to 2023, Pfizer's financial obligations and contractual relationships with Viatris, particularly under transitional service agreements (TSAs) and master service agreements (MSAs), evolved as follows: \n\n- Services under TSAs were largely completed by December 31, 2023, with no material amounts recorded in 2023 under these agreements. \n- The net amounts owed to Viatris under these agreements decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. \n\nThis reflects the winding down of transitional obligations following the 2020 spin-off of the Upjohn Business and its combination with Mylan to form Viatris.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the net amounts owed to Viatris decreased from $94 million in 2022 to $33 million in 2023, and TSA services were completed by December 31, 2023. These figures match the original answer exactly, satisfying quantitative accuracy. (2) The statement that 'no material amounts were recorded in 2023' is consistent with the original answer's assertion that TSA services were fully completed and no longer material. (3) The reasoning correctly links the reduction in obligations to the wind-down following the 2020 spin-off of Upjohn into Viatris, showing sound multi-hop synthesis across time and entities. (4) The only minor shortcoming is that the LLM omits the explicit mention that TSA services were 'largely completed by the end of 2022'—a detail present in the original—which slightly affects completeness but does not undermine the overall correctness. This justifies a 9 in qualitative accuracy. Contextual relevance is perfect, as all information directly addresses the evolution of financial obligations and contractual relationships between Pfizer and Viatris.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 329,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "From 2022 to 2023, Duke Energy's environmental regulation compliance costs have evolved in response to increasing regulatory pressures and the company's clean energy transition goals. In 2022, the company highlighted the need for supportive policies to manage costs related to environmental regulations, including coal combustion residuals (CCR) management and carbon reduction initiatives. By 2023, Duke Energy emphasized the growing influence of federal and state climate change regulations, which could impose additional costs for emissions reductions and infrastructure changes. The company also noted the importance of regulatory cost recovery mechanisms to offset these expenses, though uncertainties remained regarding full cost recovery and the timing of such recovery. Overall, the relationship between retail deregulation pressures and environmental compliance costs reflects a continued focus on navigating regulatory complexity while advancing sustainability objectives.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increasing regulatory pressures on Duke Energy related to environmental compliance from 2022 to 2023 and mentions relevant issues such as coal combustion residuals (CCR) and carbon reduction. However, it fails to accurately capture the core of the original answer, which centers on the interaction between retail deregulation and cost recovery challenges for environmental compliance. Specifically, the LLM omits the key mechanism in 2022—unrecovered costs from above-market purchased power commitments under PURPA due to retail deregulation—and does not mention QFs or PURPA at all. In 2023, while the LLM notes increased regulatory pressure, it misses the specific mention of EPA regulations on CO2 emissions and cooling water intake structures, as well as state-level carbon goals more aggressive than Duke’s own plans. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, the absence of specific figures does not detract from the issue, as the original answer also contains no numbers. Thus, the LLM does not introduce any factual numerical errors. (3) The multi-hop reasoning is partially sound—the LLM connects environmental compliance costs with regulatory recovery mechanisms—but it fails to synthesize the critical link between retail deregulation and hindered cost recovery, which is the central analytical thread in the ground truth. This represents a significant gap in qualitative accuracy. (4) The answer is contextually relevant and discusses Duke Energy’s environmental compliance and regulatory challenges, but it does not fully address the evolving relationship between deregulation and cost recovery as required by the question. Hence, while the general direction is correct, key factual and conceptual components are missing, warranting a moderate score of 6 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 514,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a loss of 1.7 share points. This decline contrasts with the pricing strategy applied to Skoal during 2023, which included multiple price increases (e.g., $0.09 to $0.10 per can) aimed at offsetting cost pressures and maintaining profitability. Despite these price hikes, Skoal's market share continued to decline, likely due to competition from oral nicotine pouches and shifting consumer preferences.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in retail share from 9.3% in 2023 to 7.6% in 2024, accurately reflecting a 1.7 percentage point decline. This matches the ground truth. However, the pricing details are partially inaccurate: while the LLM mentions 'multiple price increases (e.g., $0.09 to $0.10 per can)', it omits the specific $0.11 increase effective January 23, 2024 (announced in 2023), and incorrectly generalizes the amounts. The ground truth specifies exact prior increases in 2022 ($0.09, $0.09, $0.08), but the LLM does not reference these or their timing, nor does it clarify that the $0.11 increase was announced in 2023 for 2024 implementation—this is a key part of the 2023 pricing strategy. (2) The calculation of the 1.7 percentage point drop is correct (9.3% - 7.6% = 1.7%). However, the dollar amounts for price increases are approximated and lack precision—e.g., stating '$0.09 to $0.10' as a range rather than listing discrete, documented increases. (3) The multi-hop reasoning is sound: the model correctly contrasts declining market share with a pricing strategy involving increases, and infers a plausible impact on demand. It adds relevant context about competition from nicotine pouches and shifting preferences, which, while not in the original answer, is reasonable and does not contradict the ground truth. (4) The correctness score is 8 because core facts (share change, direction of trend, general pricing strategy) are accurate, but specific quantitative details of the price increases are imprecise. Quantitative accuracy is 7 due to the lack of exact figures and dates for the price hikes. Qualitative accuracy is 8 due to correct synthesis and logical inference. Contextual relevance is 10—response directly addresses both parts of the question and remains focused.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 494,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen's investment in 'Other short-term interest-bearing securities' increased slightly from $138 million as of December 31, 2023, to $135 million as of December 31, 2024. This minimal change suggests that Amgen maintained a relatively stable allocation to these types of short-term investments during the period. Given that all interest-bearing securities mature in one year or less and the company's investment strategy emphasizes safety of principal, liquidity, and acceptable risk levels, the slight decrease indicates a consistent approach to managing short-term liquidity needs without significant shifts in strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the numerical values: it states that Amgen's investment decreased from $138 million in 2023 to $135 million in 2024, while the ground truth confirms the amount remained unchanged at $138 million in both years. This misrepresents the trend and undermines the core of the answer. (2) The quantitative accuracy is severely compromised—while the 2023 figure is correct ($138M), the 2024 figure is incorrectly reported as $135M. This introduces a false decrease of $3M, which does not exist in the original data. No calculation is needed beyond comparison, and even this basic comparison is flawed. (3) The reasoning about Amgen maintaining a stable strategy is partially sound and aligns with the ground truth interpretation, but it is based on incorrect data. The mention of safety, liquidity, and short-term maturities adds relevant context about Amgen’s investment policy, showing some correct qualitative understanding. However, the conclusion that a 'slight decrease' indicates consistency is misleading because there was no decrease. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution and strategic implication) and discusses the right metric and time frame. Despite correct framing and relevant contextual knowledge, the answer fails on factual correctness due to the erroneous 2024 value, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 397,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "General Dynamics' involvement in Abrams Main Battle Tank Upgrades increased in both scope and value from 2022 to 2024. In 2022, the Combat Systems segment reported a contract award of $360 million for Abrams tank upgrades, mission control units, and technical support. By 2024, this had expanded to a $350 million contract for Abrams main battle tank upgrades, including engineering, logistics support, and sustainment technical services, with broader support for international customers such as Romania. This reflects an expanded role in modernization and sustainment efforts, as well as increased international demand for upgraded Abrams tanks.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $360 million 2022 contract and the $350 million 2024 contract for Abrams upgrades and support services, which aligns with the ground truth. However, it omits the separate $285 million contract awarded in 2024 for producing Abrams tanks in the SEPv3 configuration for Romania, a critical component of the evolution in contract scope and value. This omission significantly affects completeness and underrepresents the expansion into production (not just upgrades) and the total increase in contract value. (2) Quantitatively, the $360M and $350M figures are accurate and correctly attributed to their respective years and services. The format and values match the ground truth, though the absence of the $285M contract means the total value evolution is understated. There are no calculation errors in what is reported, but the full financial picture is incomplete. (3) The reasoning correctly infers an expanded role in modernization and sustainment and notes increased international demand, which is supported by the Romania reference. However, the multi-hop synthesis is incomplete—it fails to connect the two 2024 contracts to demonstrate a strategic shift from upgrade-focused work to include new production, which is a key point in the original answer. (4) The answer is contextually relevant and well-structured, addressing the evolution in scope and value. Due to the missing $285M production contract, the qualitative and correctness scores are reduced, but the core facts that are present are accurate and reasonably interpreted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 435,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "From 2023 to 2024, AIG's financial relationship with Corebridge underwent significant changes, particularly in borrowing arrangements and income recognition. In 2023, Corebridge had debt obligations not guaranteed by AIG, including $200 million in CRBGLH notes, $227 million in junior subordinated debt, and $1,500 million in a DDTL facility. By 2024, AIG deconsolidated Corebridge, recognizing a $4.8 billion loss primarily due to accumulated comprehensive losses. Post-deconsolidation, AIG's retained interest in Corebridge was accounted for under the fair value option, with changes in Corebridge's stock price and dividends impacting AIG's net investment income. In the fourth quarter of 2024, AIG sold a 21.6% stake in Corebridge, generating a $282 million gain.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies and omits key elements from the ground truth. While it correctly identifies a shift in AIG's relationship with Corebridge, it introduces specific debt figures ($200M, $227M, $1.5B) and instruments (CRBGLH notes, junior subordinated debt, DDTL) not mentioned in the original answer, with no support from the ground truth. The $4.8 billion loss and $282 million gain from a 21.6% stake sale in Q4 2024 are not present in the original answer and contradict the more general transformation described. (2) Quantitatively, the numbers provided in the LLM answer cannot be verified against the ground truth and appear fabricated or misattributed. The original answer does not include any specific dollar amounts related to debt or gains/losses, only dates (February 25, 2025, and June 9, 2024). The LLM incorrectly adds precise financials that undermine accuracy. (3) The multi-hop reasoning is partially sound in that it recognizes a shift from a consolidated borrowing relationship to a post-deconsolidation equity-based one. However, it mischaracterizes the nature of the 2023 arrangement as specific debt instruments rather than a general borrowing ability, and incorrectly frames the 2024 change as deconsolidation and fair value accounting, whereas the original specifies equity method income recognition tied to stock price and dividends starting June 9, 2024. (4) Contextual relevance is high because the answer addresses the evolution of the financial relationship, borrowing, and income recognition. However, correctness and qualitative accuracy are low due to unsupported specifics and misrepresentation of accounting methods. The core shift is acknowledged, but with significant factual and conceptual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 484,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Solar Roof product has evolved to emphasize production scalability and strategic partnerships to address prior challenges. In 2022, the company highlighted ongoing production challenges and supplier dependencies, noting the complexity of ramping up manufacturing and ensuring component availability. By 2024, Tesla shifted focus toward improving installation efficiency and expanding collaboration with real estate developers and builders to integrate Solar Roof into new home construction, indicating progress in overcoming earlier production bottlenecks and a more strategic alignment with broader market adoption efforts.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the timeline and strategic emphasis. According to the ground truth, in 2022 Tesla was actively selling the Solar Roof and improving installation efficiency through partnerships with builders—this is incorrectly portrayed in the LLM answer as a 2024 development. Conversely, the LLM claims that in 2022 Tesla was already highlighting production challenges and supplier dependencies, which the ground truth assigns to 2024, not 2022. This reversal of the timeline undermines the core reasoning. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution of Tesla’s strategy over time. Instead of showing a shift from sales and installation focus (2022) to production dependency concerns (2024), it reverses the narrative, suggesting production issues were central in 2022 and that progress was made by 2024—opposite to the documented shift in emphasis. (4) Contextual relevance is high because the answer addresses the right product, time frame, and general themes (production, partnerships), but the qualitative inaccuracy in the sequence and nature of strategic focus severely limits correctness. The answer conveys a plausible but factually inverted story, warranting a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 406,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "The retail share of Skoal in the U.S. oral tobacco market decreased from 9.3% in 2023 to 7.6% in 2024, indicating a loss of market share. This decline suggests that Skoal is facing increased competition, particularly from oral nicotine pouches like on!, which saw growth in its category, and reflects broader challenges in the MST (moist smokeless tobacco) segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Skoal's retail share decreased from 9.3% in 2023 to 7.6% in 2024, matching the ground truth exactly. These numbers are accurate and properly contextualized. (2) The quantitative accuracy is perfect—percentages and years are correct, and no calculations are required beyond the stated values. (3) The reasoning is sound: the decline is correctly interpreted as a loss of market share and linked to increased competition, particularly from on!, which is mentioned in the ground truth as growing from 6.8% to 8.3%. While the LLM does not explicitly cite on!'s exact growth numbers, it correctly infers competitive pressure from that product and references the broader MST segment challenges, which aligns with the implied competitive dynamics. (4) The answer is contextually relevant and addresses both parts of the question: the change in market share and its implication for competitive positioning. The only minor shortcoming is the omission of on!'s specific market share figures, which slightly reduces completeness but does not detract from the overall correctness. Hence, a score of 9 is justified—excellent accuracy with minimal information gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 339,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "The risk associated with the concentration of device share among premium tier companies has increased between 2023 and 2024, with potential negative implications for Qualcomm's pricing power and revenue stability. The 2024 filing highlights a continued and potentially worsening concentration of device share among a few companies, particularly at the premium tier, which heightens the purchasing power of these companies and could lead to lower prices for Qualcomm's products. Additionally, geopolitical tensions, such as the U.S. revoking Qualcomm's license to export certain products to Huawei in May 2024, have further exacerbated the risk, directly impacting Qualcomm's revenue (approximately $560 million in fiscal 2024 from Huawei). The increased vertical integration by key customers, such as Apple and Chinese OEMs, also poses a growing threat to Qualcomm's revenue stability by reducing reliance on its products.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the risk from concentration of device share among premium tier companies has persisted and potentially intensified from 2023 to 2024, affecting Qualcomm's pricing power and revenue stability—this aligns with the ground truth. It accurately captures the core qualitative evolution: increased customer concentration leading to greater pricing pressure and revenue fluctuation. However, the LLM introduces a specific quantitative claim not present in the original answer: that Qualcomm lost approximately $560 million in revenue from Huawei in fiscal 2024 due to the U.S. revoking its export license in May 2024. This figure and event, while potentially factual in real-world context, are not included in the provided ground truth and thus represent an unsupported addition. Since the ground truth does not mention Huawei, the license revocation, or any dollar figures related to it, this constitutes a factual overreach. (2) The $560 million figure and May 2024 date are not verifiable from the original answer and introduce quantitative inaccuracies by inference. The original answer mentions Chinese OEMs generally but does not name Huawei or provide revenue impact numbers. (3) The multi-hop reasoning is mostly sound: the LLM correctly synthesizes the idea that customer concentration increases pricing pressure and that vertical integration (e.g., Apple, Chinese OEMs) threatens revenue stability. It also correctly infers that reliance on a few customers increases risk. However, the addition of Huawei-specific data goes beyond the provided knowledge graph, suggesting either hallucination or use of external knowledge. (4) The correctness score is 7 because the core qualitative assessment matches the ground truth—risk has persisted and possibly intensified, impacting pricing and revenue. The contextual relevance is high (9) as the answer directly addresses the question’s focus. Qualitative accuracy is 8 due to strong reasoning but minor overreach. Quantitative accuracy is 6 because while no incorrect calculation is made, a specific dollar amount and event are introduced without basis in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 582,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Amgen's allocation to money market mutual funds increased between 2023 and 2024. As of December 31, 2023, the fair value of money market mutual funds was $10,266 million, while as of December 31, 2024, it rose to $10,354 million. This reflects a slight increase in Amgen's short-term liquidity allocation to this category.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Amgen's allocation to money market mutual funds increased from $10,266 million in 2023 to $10,354 million in 2024. The ground truth explicitly states that the allocation remained unchanged at $10,266 million in both years. This is a critical factual error. (2) The quantitative values are incorrect—the LLM introduces a figure of $10,354 million for 2024 that does not appear in the ground truth. There is no mention of any increase, so the calculation or comparison of values is invalid. (3) The reasoning is flawed: the LLM concludes a 'slight increase' based on incorrect data, failing to correctly synthesize the multi-hop information that the values were identical across both years. The core of the question hinges on detecting no change, which the model misses entirely. (4) While the context and entity (Amgen, money market mutual funds, short-term liquidity) are correctly identified and relevant, the answer fails on factual and quantitative accuracy, warranting a very low correctness and quantitative accuracy score. The qualitative accuracy is slightly higher because the model understands the type of information being asked, but the reasoning is unsound. Contextual relevance is high as the response stays on topic and references appropriate financial instruments and time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 380,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "General Dynamics' participation in the Capital Construction Fund (CCF) remained consistent in terms of the deferred tax liability related to qualified ships, with a balance of $57 million in both 2022 and 2023. However, the amount of U.S. government accounts receivable pledged to the CCF increased from $295 million at the end of 2022 to $315 million at the end of 2023, and further to $333 million by the end of 2024, indicating a gradual increase in the value of receivables pledged to the fund over this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increasing trend in U.S. government accounts receivable pledged to the Capital Construction Fund (CCF), with accurate figures of $295 million at the end of 2022 (referring to Dec 31, 2021, as in the original answer), $315 million at the end of 2023, and $333 million at the end of 2024. These numbers match the ground truth exactly and reflect proper multi-hop synthesis across years. (2) However, the LLM introduces a detail not present in the original answer—'deferred tax liability of $57 million in both 2022 and 2023'—which is factually unverified against the ground truth and potentially misleading, as the original answer does not mention this metric. This affects quantitative and qualitative accuracy slightly. (3) The reasoning regarding the increasing value of receivables pledged is sound and correctly infers growing participation in the CCF, aligning with the conclusion in the original answer. The timeline and entity (General Dynamics, CCF) are accurate. (4) The answer is contextually fully relevant and mostly factually correct, but the addition of an unsupported figure (deferred tax liability) prevents a top score. The core of the question—evolution of pledged receivables—is addressed accurately with correct numbers and trend analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 367,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "AIG's financial relationship with Corebridge evolved significantly between 2023 and 2024, particularly following the IPO and subsequent deconsolidation. In 2023, Corebridge was partially deconsolidated from AIG's tax group due to AIG's ownership dropping below 80%, resulting in Corebridge's tax attributes being separated and no longer available for AIG's tax benefits. By 2024, AIG fully deconsolidated Corebridge on June 9, 2024, recognizing a $4.8 billion loss primarily from accumulated comprehensive losses. Post-deconsolidation, AIG accounted for its retained interest in Corebridge using the fair value option, with changes in Corebridge's stock price and dividends impacting AIG's net investment income. Tax implications were further affected by AIG's secondary sales of Corebridge shares, including a $282 million gain in Q4 2024 from a sale to Nippon Life.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of AIG's financial relationship with Corebridge and correctly identifies key events such as the ownership drop below 80%, tax deconsolidation, and shift in accounting treatment. However, there are significant factual inaccuracies that reduce correctness. First, the IPO date was September 19, 2022 (not in 2023), and tax deconsolidation occurred in 2023 when ownership fell below 80%, not on June 9, 2024—this date marks full deconsolidation for financial reporting, not tax purposes. The $4.8 billion loss from accumulated comprehensive losses is not mentioned in the ground truth and appears to be fabricated or misattributed. The $282 million gain from a sale to Nippon Life in Q4 2024 is also absent from the original answer and unverified. The original answer states AIG reported equity method income from June 10, 2024, but the LLM claims AIG used the 'fair value option'—a contradiction in accounting treatment. The ground truth specifies equity method accounting; fair value option is incorrect. While the tax implications of lost tax benefits and separation of attributes are qualitatively correct, the LLM omits key details like the five-year restriction on consolidated filings and retention of NOLs by Corebridge. The mention of 'secondary sales' adds new information not in the original, potentially conflating events. Quantitative accuracy is low due to incorrect dates and unverified dollar amounts. Qualitative accuracy is moderate—core reasoning about deconsolidation and changing relationship is sound, but incorrect accounting method and events reduce fidelity. Contextual relevance is high as the response stays focused on the question's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 463,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "From 2022 to 2024, Tesla's approach to Solar Roof production has evolved to emphasize localized procurement, installation efficiency, and collaboration with real estate developers to reduce costs and time. In 2022, the focus was on improving installation capabilities and price efficiencies by onboarding and training new installers. By 2024, Tesla had expanded this strategy by integrating Solar Roof into new home developments and enhancing its online ordering experience to streamline the retrofit solar energy business. Supply chain challenges, such as global component constraints, remained a concern in 2022, but Tesla's operational strategy in 2024 reflects a more structured effort to scale production and address bottlenecks through localized supply chain optimization and partnerships.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's 2022 focus on installer onboarding and training, as well as collaboration with real estate developers to reduce costs and installation time, which aligns with the ground truth. It also correctly notes the continuation and expansion of these efforts into 2024, including integration into new home developments and online ordering improvements. However, the LLM introduces the concept of 'localized procurement' and 'localized supply chain optimization' in 2024, which is not present in the original answer; instead, the ground truth emphasizes global component procurement risks, supplier failures, and inflationary pressures—broader systemic supply chain challenges rather than a shift to localization. This misrepresents the nature of Tesla's evolved supply chain strategy. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors in this regard, scoring 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes Tesla's evolving operational strategy across years, but fails to accurately reflect the shift from installer-focused development to systemic supply chain and scalability concerns. Instead, it implies a strategic focus on localization and optimization, which is not supported by the ground truth. (4) The answer is contextually relevant and addresses both operational strategy and supply chain challenges across the 2022–2024 timeframe. While the core facts about installation improvements and partnerships are correct, the characterization of 2024 supply chain strategy is inaccurate, leading to a correctness score of 7—core facts are right, but key strategic evolution is misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 483,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "From 2022 to 2023, Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina decreased from $8 billion to $9 billion in 2022 to $7 billion to $8 billion in 2023. This reduction, along with the completion of excavations at several sites, indicates progress under the Coal Ash Act, as the company continues to comply with regulatory requirements and manage costs through settlement agreements and phased closure plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the evolution of Duke Energy's estimated total cost to close coal ash basins, stating a decrease from $8 billion to $9 billion in 2022 to $7 billion to $8 billion in 2023, which matches the ground truth. It also correctly implies progress under the Coal Ash Act. However, it omits the specific detail about the amount spent increasing from $3.1 billion through 2021 (as reported in 2022) to $4 billion through 2023, which is a relevant data point for measuring progress. (2) All numeric values and ranges are accurate and match the original answer; no calculation errors are present. Format variations are acceptable and correctly interpreted. (3) The multi-hop reasoning is sound: the model correctly synthesizes cost estimates across two years and links the downward adjustment to progress under the Coal Ash Act. The omission of the cumulative spend data slightly weakens completeness but does not impair the core reasoning. (4) The answer is contextually fully relevant, addresses the main trend in cost evolution, and draws a reasonable conclusion about regulatory progress. The missing spent amount detail prevents a perfect score, but overall factual accuracy and synthesis are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 349,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024, indicating a strengthening market position within the oral tobacco product segment during this period. This growth in share occurred despite an overall decline in the MST (moist snuff tobacco) category and highlights the product's growing traction in the expanding nicotine pouch segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the retail share increase for 'on!' from 6.8% in 2023 to 8.3% in 2024, matching the ground truth exactly. These numbers are accurate and properly contextualized as an increase in market share. (2) Quantitative accuracy is perfect—both percentages and years are correct, and no calculations are required beyond the implied increase of 1.5 percentage points, which is accurate. (3) The reasoning is mostly sound: the LLM correctly infers that the product strengthened its market position. However, it introduces information not present in the ground truth—specifically mentioning the 'MST (moist snuff tobacco) category' and the 'nicotine pouch segment'—which were not part of the original data. While these may be contextually plausible, they represent an unsupported inference not grounded in the provided knowledge graph. Additionally, the LLM fails to mention the key comparative fact from the ground truth: that the total oral tobacco product segment declined from 42.5% to 37.5%, which directly supports the divergence argument. This omission reduces completeness and weakens the multi-hop synthesis. (4) Despite missing the explicit comparison with the overall segment’s decline, the LLM still captures the core trend of 'on!' gaining share in a challenging environment. Hence, the correctness score is 8—core facts and numbers are correct, but there is a notable omission of a key comparative data point and some introduction of external context. Quantitative accuracy is 10, qualitative accuracy is 8 due to partial reasoning and unsupported inferences, and contextual relevance is 10 as the answer directly addresses the question’s focus on market position evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 468,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "Qualcomm's reliance on Chinese OEMs for revenue has remained significant from 2023 to 2024, with continued concentration in a small number of Chinese OEMs, as highlighted in both years' 10-K filings. However, there is increased risk due to geopolitical tensions, such as the U.S. revoking Qualcomm's license to export certain products to Huawei in May 2024, which had contributed $560 million in fiscal 2024 revenues prior to the revocation. Additionally, pressures from the Chinese government's \"Made in China 2025\" initiative and potential vertical integration by Chinese OEMs pose threats to Qualcomm's revenue stability. These factors, combined with trade and national security tensions, could negatively impact Qualcomm's business stability by reducing access to key customers and increasing regulatory and operational uncertainties.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Qualcomm's reliance on Chinese OEMs remained significant from 2023 to 2024, which aligns with the ground truth. It also correctly notes ongoing risks from U.S./China tensions and regulatory challenges. However, it introduces specific claims not present in the original answer or not verifiable from the provided ground truth: namely, the May 2024 revocation of Qualcomm's license to export to Huawei and the $560 million in revenue attributed to Huawei in fiscal 2024. These specific figures and events are not mentioned in the ground truth and cannot be confirmed from the provided knowledge graph, making them factually unsupported. (2) The $560 million figure and the May 2024 license revocation are precise quantitative and temporal claims that are not corroborated by the original answer, which only generally references U.S./China trade tensions without citing specific revenue amounts or regulatory actions in 2024. This significantly impacts quantitative accuracy. (3) The multi-hop reasoning is partially sound—Qualcomm’s revenue concentration and geopolitical risks are correctly synthesized from the two-year filings—but the addition of unverified specifics (Huawei license, $560M) reflects overreach or hallucination, undermining the reasoning integrity. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of reliance and implications for stability—and uses appropriate context like 'Made in China 2025' and vertical integration. However, the inclusion of unsupported specifics reduces factual correctness, warranting a moderate overall score of 6. Qualitative accuracy is decent due to correct entity identification (Qualcomm, Chinese OEMs, geopolitical risks) and logical implications, but penalized for unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 500,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "Between 2022 and 2023, Amgen's total available-for-sale investments evolved significantly in terms of security types held. In 2022, the portfolio included $1,676 million in U.S. Treasury bills, $2,659 million in money market mutual funds, and no other short-term interest-bearing securities, totaling $4,335 million. By 2023, the U.S. Treasury bills were entirely removed, while money market mutual funds increased to $10,266 million, and $138 million was added in other short-term interest-bearing securities, resulting in a total of $10,404 million. This shift reflects a move away from short-term Treasury instruments toward a larger allocation in money market funds and other short-term securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the composition of Amgen's 2022 investments. According to the ground truth, in 2022, Amgen held $1,676 million in marketable securities (not U.S. Treasury bills specifically) and $2,659 million in cash and cash equivalents — not money market mutual funds. However, the LLM incorrectly states that the $2,659 million was in money market mutual funds in 2022, which contradicts the original data. Additionally, it falsely claims there were 'no other short-term interest-bearing securities' in 2022, which is unsupported. (2) While the 2023 figures are correct — $10,266 million in money market mutual funds, $138 million in other short-term interest-bearing securities, totaling $10,404 million — the 2022 breakdown is wrong, leading to an incorrect comparison. The total for 2022 ($4,335 million) is accurate, but the components are misattributed. (3) The multi-hop reasoning is partially sound in identifying a shift in investment composition, but the synthesis is flawed due to incorrect source data interpretation. The conclusion about a strategic shift is reasonable, but based on wrong premises. (4) The contextual relevance is high because the answer addresses the evolution of investment types over time and attempts to interpret the strategic change. However, due to major quantitative and qualitative errors in the 2022 composition, the correctness and accuracy scores are low. Minor terminology issues (e.g., conflating marketable securities with U.S. Treasury bills) further undermine reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 434,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "Shake Shack is listed as a tenant at the Las Vegas Outlets in 2023 (page 35 of SPG_10k_2023.pdf) but is not mentioned in any of the 2022 property tenant lists. This indicates that Shake Shack entered SPG's premium outlet properties in 2023, specifically at the Las Vegas Outlets.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies and omits key information. (1) It correctly identifies that Shake Shack was present at a Las Vegas outlet in 2023, which aligns with the ground truth (Las Vegas Outlets North Premium). However, it fails to mention that Shake Shack was already a tenant in 2022 at Woodbury Common Premium Outlets, incorrectly stating that it was not mentioned in any 2022 property lists. This omission misrepresents the evolution as a new entry rather than an expansion. (2) There are no numerical calculations in this question, but the temporal facts (presence in 2022 vs. 2023) are critical and inaccurately portrayed. The LLM denies 2022 presence, which contradicts the ground truth. (3) The multi-hop reasoning is flawed: the model should have compared tenant lists across both years and recognized continuity at Woodbury Common plus expansion to Las Vegas. Instead, it only identifies the 2023 presence and assumes no prior presence, failing to synthesize across both years. (4) While the answer is contextually relevant—focusing on Shake Shack’s presence in SPG outlets and citing a specific document—it misses the core narrative of expansion due to incorrect entity-year linkage. Thus, the correctness and qualitative accuracy scores are low despite proper formatting and partial factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 378,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "Between 2022 and 2024, retirement annuity contracts remained classified within Level 3 of the fair value hierarchy, with their fair value decreasing from $35 million in 2021 to $22 million in 2024. This consistent classification in Level 3 indicates that GD continues to value these assets using significant unobservable inputs, likely due to the lack of active market data for such contracts. The reduction in fair value may reflect changes in the overall asset allocation strategy, including a shift toward liability-hedging assets as plans approach funded status targets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that retirement annuity contracts remained in Level 3 from 2022 to 2024, it introduces dollar amounts ($35 million in 2021, $22 million in 2024) that are not present in the ground truth and are factually unsupported by the provided information. There is no mention of these specific values in the original answer, nor is there any indication of a decrease in fair value being part of the classification evolution. (2) The quantitative inaccuracies are severe: the years referenced (2021 and 2024) do not align with the question’s focus on 2022–2024 evolution, and the dollar figures are entirely fabricated. This undermines the credibility of the response. (3) The reasoning partially captures the persistence in Level 3 classification and correctly infers that unobservable inputs are still used, which aligns with the qualitative aspect of the ground truth. However, it completely misses the key point about improved disclosure practices in 2024—specifically, the inclusion of investments valued using NAV as a practical expedient in reconciliation tables, which was not explicitly stated in 2022. This refinement in transparency is the central evolution in reporting, not a change in value or asset allocation. (4) The contextual relevance is moderate because the answer addresses the fair value hierarchy and valuation methodology, but it distracts with irrelevant speculation about asset allocation shifts and liability-hedging strategies not supported by the original data. The qualitative accuracy is limited due to missing the core disclosure improvement point, though the Level 3 consistency is correctly noted. Overall, the answer is partially correct on classification but fails on key facts and misses the main insight about disclosure refinement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 503,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge underwent significant changes. In 2023, AIG owned 52.2% of Corebridge and engaged in secondary offerings, selling shares and recording changes in equity. By 2024, AIG deconsolidated Corebridge after reducing its ownership to 48.4%, resulting in a $4.8 billion loss primarily due to accumulated comprehensive losses. Post-deconsolidation, AIG accounted for its retained interest using the fair value option, recognizing gains from subsequent share sales, including a $282 million gain from selling a 21.6% stake to Nippon in December 2024. By year-end 2024, AIG's ownership in Corebridge had further decreased to 22.7%.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of AIG's financial relationship with Corebridge between 2023 and 2024 as described in the ground truth. (1) Key facts are incorrect: The ground truth states that the potential equity dilution mechanism tied to Blackstone’s exchange right was terminated due to Corebridge’s IPO on September 19, 2022—before 2023—yet the LLM implies ongoing dilution concerns in 2023. The LLM introduces specific ownership percentages (52.2%, 48.4%, 22.7%) and a $4.8 billion loss from deconsolidation not present in the original answer, nor supported by the provided truth. There is no mention in the ground truth of a $282 million gain from selling a stake to Nippon in December 2024, nor any ownership reduction to 22.7% by year-end 2024. (2) Quantitative accuracy is poor: none of the numbers in the LLM answer (e.g., 52.2%, $4.8B loss, $282M gain, 21.6% stake) appear in the ground truth, and no such figures are inferable from it. The only correct date mentioned in the LLM—2024—is generic. (3) Reasoning is flawed: the LLM incorrectly frames the shift as a deconsolidation-driven fair value accounting change due to ownership drop below 50%, while the ground truth describes a shift to equity method accounting based on dividends and stock price changes starting June 9, 2024. The core concept of transitioning from potential dilution (pre-IPO) to equity income (post-IPO) is entirely missing. (4) Contextual relevance is moderate because the answer discusses AIG and Corebridge and attempts to describe a financial evolution, but it fabricates key events and mechanisms, failing the multi-hop synthesis required—especially around the IPO’s impact on dilution rights and the nature of income recognition post-2023. Overall, the answer is largely incorrect and misrepresents the financial relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 509,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort has slightly decreased from 2022 to 2024. As of December 31, 2024, Universal Beijing Resort had $3.4 billion of debt outstanding, compared to $3.5 billion as of December 31, 2023, and $3.6 billion as of December 31, 2022. Comcast consolidates Universal Beijing Resort, and its maximum risk of financial loss is limited to its 30% interest. The debt is secured by the resort's assets and equity interests, and there are no additional liquidity arrangements or guarantees from Comcast.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it misstates the timing of the debt disclosures. The original answer states that the $3.6 billion debt figure was as of December 31, 2021 (disclosed in 2022), and $2.5 billion as of December 31, 2020 — not $3.6 billion as of December 31, 2022 as the LLM claims. Similarly, the 2024 disclosure reports $3.4 billion as of December 31, 2024, and $3.5 billion as of December 31, 2023 — which the LLM correctly reports but misattributes to the wrong years in its summary. (2) The LLM incorrectly implies a continuous decline in debt from 2022 to 2024, but the ground truth shows debt increased from $2.5B (2020) to $3.6B (2021), then decreased to $3.5B (2023) and $3.4B (2024), which is not a monotonic decrease. The LLM also omits the key point that debt levels stabilized after earlier fluctuations. (3) The LLM incorrectly states that Comcast's risk is limited to its 30% interest and that there are no guarantees — this contradicts the consolidation treatment. The original answer clarifies that Universal Beijing Resort is now consolidated as a VIE, meaning Comcast includes 100% of its assets ($7.3B) and liabilities ($7.0B) on its balance sheet, implying full financial exposure, not limited to 30%. This is a major error in reasoning and entity treatment. (4) While the LLM attempts to address financial exposure and debt trends, it fails on core multi-hop synthesis: it does not correctly link the debt figures to the correct years, misrepresents the consolidation impact, and omits the balance sheet magnitude. The contextual relevance is fair because it discusses debt and exposure, but the qualitative and quantitative inaccuracies severely undermine correctness. Quantitative accuracy is scored moderately because some numbers are present but misaligned; qualitative accuracy is low due to flawed reasoning about consolidation and risk. Correctness is 4 due to partial data presence but major factual and conceptual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 543,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "Between 2022 and 2023, the structure of aircraft trade-in commitments remained largely consistent in terms of customer eligibility, as they continued to apply to some Gulfstream customers holding options to trade in aircraft as partial consideration for new-aircraft transactions. However, there was no specific mention of changes in eligibility criteria. In terms of risk exposure, the documentation indicated that trade-in commitments structured to guarantee a predetermined trade-in value present more risk in the event of adverse market conditions, and this risk structure did not change between the two years. Additionally, the estimated change in fair market values from the date of the commitments was not material in both 2022 and 2023, indicating no significant increase in risk exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about customer eligibility. The ground truth states that in 2022, trade-in options were available to 'some customers' broadly, but in 2023 they were narrowed to 'some Gulfstream customers,' indicating a restriction in eligibility. However, the LLM incorrectly asserts that eligibility 'remained largely consistent' and applied to 'some Gulfstream customers' in both years, which contradicts the original answer and misrepresents the change in structure. This is a significant qualitative error in multi-hop reasoning and entity-specific detail. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations, hence a score of 10. (3) The multi-hop reasoning is flawed: the model failed to correctly synthesize the shift in customer scope from general to Gulfstream-specific, which is central to the question. It also missed the point that the 2023 framing introduced a more specific risk concentration on Gulfstream, implying a strategic or risk focus, which the LLM did not acknowledge. (4) Contextual relevance is high because the answer addresses trade-in commitments, risk exposure, and fair value changes, and correctly notes that the estimated change in fair market value was not material in both years. However, due to the major inaccuracy in customer eligibility evolution, the overall correctness and qualitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 414,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Tesla Semi has evolved from being in the planning and development phase to entering pilot production. In 2022, the Semi was listed among future commercial electric vehicles without specific production details. By 2024, the Semi is noted as being in \"pilot production\" at the Nevada Gigafactory, indicating progress toward commercialization. Strategically, the Semi is positioned as part of Tesla's broader product roadmap to expand into commercial and industrial markets, leveraging the company's advancements in battery technology and autonomous driving. This shift reflects Tesla's growing focus on diversifying its product lineup and capturing market share in the electric heavy-duty vehicle segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: in 2022, the Tesla Semi was in planning/development, and by 2024 it entered 'pilot production' at the Nevada facility—this matches the original answer exactly. There are no numeric values to verify (e.g., dates are correct as 2022 and 2024), so quantitative accuracy is perfect. (2) The answer is complete, addressing both production status evolution and strategic positioning within Tesla's product lineup. It correctly identifies the strategic intent to expand into commercial markets using battery and autonomy tech. (3) Multi-hop reasoning is sound: the model synthesizes information across time (2022 vs 2024) and infers strategic intent from production milestones. (4) The only minor gap is that the original answer emphasizes the shift from 'conceptual' phase to market preparation more explicitly, while the LLM adds some plausible strategic context (e.g., autonomous driving, market share) not explicitly confirmed in the ground truth. This slightly extends beyond the provided knowledge but does not contradict it. Thus, qualitative accuracy is slightly reduced due to minor extrapolation, but overall the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 359,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "The valuation allowance related to Altria's investment in Cronos decreased from $379 million at the end of 2022 to $397 million at the end of 2023, and further to $402 million at the end of 2024. This minimal increase indicates that Altria continues to maintain a valuation allowance against the deferred tax assets associated with its investment in Cronos, suggesting the company remains uncertain about the realizability of these assets. The slight changes in the valuation allowance reflect adjustments based on the evolving financial performance and fair value of the investment, but the overall trend indicates ongoing caution regarding the ability to realize the associated tax benefits.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of change in the valuation allowance. The ground truth states the allowance increased from $379M in 2022 to $402M in 2024, but the LLM incorrectly claims it decreased from $379M in 2022 to $397M in 2023, which contradicts the data. While the 2024 figure ($402M) is correct, the intermediate 2023 value ($397M) is unsupported by the ground truth, which does not provide a 2023 figure. (2) The quantitative inaccuracies are significant: the claim of a 'decrease' followed by a 'minimal increase' misrepresents the trend. The ground truth indicates a steady increase, but the LLM implies a drop in 2023, which is factually wrong. (3) The qualitative reasoning about Altria's uncertainty and cautious stance is aligned with the ground truth and shows correct interpretation of what a valuation allowance implies about realizability of deferred tax assets. However, the reasoning is based on flawed data, undermining the conclusion. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of allowance and implications for realizability) and uses appropriate financial terminology. Despite correct framing and relevant logic, the answer fails on core factual accuracy, especially in the numerical trend, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 376,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "Amgen changed the financial treatment of its investment in BeiGene in the first quarter of 2023 by switching from the equity method of accounting to recording the investment at fair value, with changes in fair value recognized in earnings. This change resulted in gains being recognized in 2023, contributing to the increase in \"Other income (expense), net.\" In 2024, the impact of this change continued, but the year saw net unrealized losses on strategic equity investments, including BeiGene, leading to a significant decrease in \"Other income (expense), net\" compared to 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly identifies the key event: Amgen's change in accounting method for its BeiGene investment in 2023 from the equity method to fair value, with gains recognized in earnings. This matches the original answer's claim about revaluation gains in 2023. (2) It accurately states that in 2024, the investment contributed net unrealized losses within 'Other income (expense), net,' reflecting a reversal from gains to losses—consistent with the ground truth. (3) The multi-hop reasoning is sound: the answer synthesizes information across two years, correctly linking the accounting change in 2023 to its financial impact and showing how market or valuation changes led to losses in 2024. (4) All entities—Amgen, BeiGene, 'Other income (expense), net'—are correctly identified, and the timeline (2023 change, 2024 impact) is precise. There are no numerical inaccuracies; while no specific dollar amounts are mentioned in either answer, the qualitative financial impacts (gains in 2023, losses in 2024) are correctly conveyed. The LLM provides slightly more context (e.g., specifying the change occurred in Q1 2023 and linking the impact to strategic equity investments), enhancing clarity without introducing error. Semantic equivalence is strong, and all aspects of the question are addressed thoroughly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 384,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "Between 2023 and 2024, Disney+ Hotstar's positioning and market strategy evolved by consolidating services in Latin America and enhancing regional branding in key markets. In June 2024, Disney+ replaced the separate Star+ service in Latin America with a unified Disney+ product, streamlining offerings and improving user experience. Additionally, Disney+ Hotstar maintained its distinct branding in India and Southeast Asia, emphasizing localized content and regional relevance to cater to diverse audiences. These changes reflect a strategic shift toward simplifying service structures while reinforcing regional identity to drive subscriber growth and engagement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the June 2024 consolidation of Star+ and Disney+ in Latin America into a single Disney+ service is accurately reported, as is the continued use of the Disney+ Hotstar brand in India and Southeast Asia. (2) There are no numeric values requiring verification (e.g., financial figures), but the date 'June 2024' matches the ground truth's 'by the end of June 2024'—this is semantically equivalent and acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about regional branding (India/SEA vs. Latin America) and infers a strategic shift toward consolidation and localization, which is supported by the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention that Disney+ Hotstar was part of Disney’s broader Direct-to-Consumer portfolio in 2023, which adds slight context to its strategic positioning. However, this omission does not detract from the core accuracy. Wording differs but meaning is preserved, and the answer fully addresses the evolution in positioning, branding, and service structure. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 366,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "Between 2023 and 2024, PayPal's approach to its Protection Programs evolved in terms of risk exposure and loss recovery mechanisms by enhancing its fraud detection and prevention measures to address the increasing complexity and scale of fraudulent activities. The company acknowledged the risks associated with erroneous transactions, insufficient funds in linked accounts, and fraudulent merchants, which led to substantial losses. PayPal's protection programs aim to reduce these risks by offering purchase and seller protection, but the company noted that recoveries from merchants or other sources may be insufficient. Additionally, PayPal emphasized the need to adapt to evolving fraud schemes and regulatory changes, which could impact the scope of coverage and increase exposure to losses. These developments indicate a more proactive and adaptive approach to managing risk exposure and improving loss recovery mechanisms in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in PayPal's approach to Protection Programs between 2023 and 2024, noting increased risk exposure due to fraud and merchant insolvency, challenges in loss recovery, and the impact of regulatory changes. It accurately reflects that PayPal faced substantial losses and that recoveries from merchants may be insufficient. However, it omits a key detail from the original answer: in 2023, PayPal did not treat protection programs as a separate service and recorded costs under 'transaction and credit losses' at the time of payment—this specific accounting treatment is missing in the LLM response. (2) There are no numeric values, percentages, or dollar amounts in either the question or ground truth, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2023 vs 2024), identifies shifts in risk acknowledgment, and connects fraud, merchant recovery challenges, and regulatory impacts. The logic aligns with the ground truth, though the absence of the 2023 accounting policy slightly weakens completeness. (4) The correctness score is 8 because core facts and evolution are accurately conveyed with only a minor omission. Qualitative accuracy is 8 due to strong reasoning but partial missing context. Quantitative accuracy is 10 (no numbers, no errors). Contextual relevance is 10—response directly addresses the question’s focus on risk exposure and loss recovery evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 421,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "NextEra Energy's relationship with solar generation facilities from 2022 to 2024 has evolved through strategic ownership and financial structure changes. In 2022, NextEra Energy Resources (NEER) sold differential membership interests in solar and solar-plus-storage facilities to third-party investors, retaining controlling interests and classifying these as noncontrolling interests. By 2024, NEER continued to consolidate numerous Variable Interest Entities (VIEs) related to solar generation, including entities with approximately 3,485 MW of solar capacity, while managing financial exposure through third-party debt secured by asset liens. This structure allowed NEER to maintain operational control and optimize returns while mitigating direct financial risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that in 2022, NextEra sold a 100% ownership interest in a 100 MW Arizona solar facility and a 90% interest in a portfolio of four solar facilities. The LLM answer incorrectly generalizes this as selling 'differential membership interests' without mentioning the specific transactions or ownership percentages. More critically, the LLM claims that by 2024, NEER consolidated VIEs with approximately 3,485 MW of solar capacity, which directly contradicts the ground truth stating 765 MW across eight VIEs. This is a major quantitative error. (2) The financial exposure description in the LLM answer mentions 'third-party debt secured by asset liens' but omits the key point in the original answer about guarantees and credit support as mechanisms of increased financial exposure. The LLM also fails to mention the 10% direct ownership interest in additional solar facilities, a key detail in the ownership structure shift. (3) While the LLM captures the high-level strategic shift from ownership to VIE-based structures, it misrepresents the scale and specifics of the VIE consolidation. The reasoning around maintaining control and optimizing returns is plausible but not fully aligned with the ground truth's emphasis on a shift to diversified, financially leveraged stakes. The multi-hop synthesis is partially correct but based on incorrect data. (4) The contextual relevance is high because the answer addresses the evolution in ownership and financial exposure over time and correctly identifies VIEs and noncontrolling interests as key mechanisms. However, due to major quantitative inaccuracies and missing specific transaction details, the correctness and qualitative accuracy scores are significantly reduced. The answer conveys a similar strategic narrative but with incorrect supporting facts, leading to a correctness score of 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 532,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "ACN's investment in Mutual Fund Debt Securities for Non-U.S. Plans decreased from $484,182 in 2021 to $379,989 in 2022. The valuation methodology for these securities remained consistent in both years, with all amounts classified under Level 2 of the fair value hierarchy, indicating they were valued using quoted prices for similar instruments or model-derived valuations with observable inputs.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in several key aspects. It discusses data for 2021 and 2022, but the question specifically asks about the evolution from 2022 to 2023. The ground truth states that in 2022, ACN's Mutual Fund Debt Securities were valued at $379,989 (Level 2), and in 2023, they decreased to $253,025 (still Level 2). The LLM instead reports a decrease from $484,182 in 2021 to $379,989 in 2022, which is irrelevant to the question's timeframe. (2) The numbers cited in the LLM answer do not match the required years: $484,182 is not part of the ground truth for this question, and no data for 2021 was requested. The correct change is a decrease from $379,989 (2022) to $253,025 (2023), a reduction of $126,964. The LLM fails to report the 2023 value entirely. (3) The reasoning is flawed because it does not perform the required multi-hop comparison between 2022 and 2023. While it correctly notes that valuations remained in Level 2 (consistent with ground truth), this point is made about the wrong years. (4) The contextual relevance is partial—it discusses the right type of investment and valuation level, but applies it to incorrect years and values. Thus, despite correct mention of Level 2 classification, the core of the answer (evolution from 2022 to 2023) is missing. Quantitative accuracy is low due to wrong figures and years; qualitative accuracy is slightly higher because the concept of Level 2 valuation is correctly described; contextual relevance is moderate as the topic is on-point but misaligned in time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 429,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron's financial stake in Tengizchevroil (TCO) increased slightly between 2022 and 2023, with its investment carrying value rising from $26,534 million in 2022 to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO rose from $4,386 million in 2022 to $3,375 million in 2023, indicating a continued strong financial involvement in the joint venture.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Chevron's carrying value in Tengizchevroil was $23,727 million in 2022, not $26,534 million as stated. The 2023 carrying value is also incorrect—while the LLM claims $26,954 million, the original answer does not provide a specific updated carrying value but instead notes a qualitative difference (an $80 million premium over equity in net assets). Additionally, the LLM reports equity in earnings of $4,386 million in 2022 and $3,375 million in 2023, which contradicts the ground truth of $1,238 million in 2022 and no specific 2023 earnings figure. (2) The numbers are entirely inconsistent with the source data—both carrying values and earnings are off by billions of dollars. There is no indication in the ground truth that earnings exceeded $4 billion in 2022. (3) The reasoning is flawed: the LLM suggests a slight increase in stake based on incorrect figures, while the original answer emphasizes a qualitative shift in valuation approach and a major new loan of $4,500 million to fund TCO’s FGP/WPMP projects—information completely omitted in the LLM response. This loan represents a key evolution in financial involvement, which the LLM fails to mention. (4) The contextual relevance is moderate because the answer addresses Chevron’s stake in TCO across 2022–2023, but due to severe quantitative errors and omission of critical qualitative developments (especially the loan and valuation complexity), the overall correctness is very low. The qualitative accuracy is slightly higher because the general direction (continued involvement) is plausible, but the reasoning and data synthesis are unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 467,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "Between 2023 and 2024, Disney's relationship with the ABC Network has evolved to strengthen its strategic positioning within Disney's broader entertainment ecosystem. ABC Network remains a central component of Disney's Linear Networks business, providing primetime, news, and sports programming, with ESPN programming the sports daypart as \"ESPN on ABC.\" The network continues to serve as a key distribution channel for Disney's content, reaching nearly 100% of U.S. television households through its affiliated stations and owned stations in major markets. Additionally, ABC's integration with Disney's Direct-to-Consumer platforms, such as Disney+ and Hulu, enhances cross-promotion and content synergy, reinforcing ABC's role in Disney's multi-platform strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies ABC Network as part of Disney's Linear Networks and mentions its integration with Disney+ and Hulu, which aligns with the ground truth. However, it omits the key strategic shift between 2023 and 2024—specifically, the change in ABC's role from being emphasized in linear distribution and affiliate fees in 2023 to being repositioned for digital integration in 2024, with content available on Hulu one day after linear airing. This evolution is central to the question and is not clearly articulated in the LLM response. While the answer notes integration with DTC platforms, it lacks the comparative, time-based strategic shift that defines the evolution. (2) There are no numeric values in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present, hence a score of 10. (3) The multi-hop reasoning is partially sound: the model connects ABC to Disney’s Linear Networks and acknowledges integration with Hulu/Disney+, but fails to synthesize the change over time (2023 vs 2024) in strategic emphasis from linear to streaming contribution. The ground truth highlights a pivot in business focus (from affiliate fees to streaming synergy), which the LLM does not capture. (4) Contextual relevance is high because the answer addresses ABC’s role in Disney’s ecosystem and mentions relevant platforms and programming. However, the absence of the temporal strategic evolution—core to the question—reduces qualitative and overall correctness. The answer reads more like a static description than an analysis of change over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 441,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "Between 2022 and 2023, General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio remained relatively consistent, as it continued to be highlighted as a versatile tracked combat vehicle offered by European Land Systems (ELS). However, the 2023 document shows a slight shift in focus toward expanding production capacity for other programs, such as the M10 Booker and increased investment in munitions and artillery production through OTS. This suggests a strategic reallocation of resources to meet growing demand in next-generation combat vehicles and artillery systems, potentially at the expense of slower growth or maintenance-level investment in the ASCOD program.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about General Dynamics' positioning of the ASCOD vehicle. The ground truth states that in 2022, GD was 'producing and upgrading' ASCOD, but by 2023 only 'offering' it—indicating a reduction in active investment. The LLM incorrectly asserts that the positioning 'remained relatively consistent,' which contradicts the documented shift in language and implied strategic de-emphasis. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in this regard, hence a score of 10. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the significance of the change in disclosure language between years, which is central to the ground truth. Instead, it introduces unrelated programs like the M10 Booker and OTS munitions investment, which are not mentioned in the original answer and are not tied to ASCOD’s portfolio evolution. This reflects a failure to synthesize the correct inference from the change in wording. (4) While the answer is contextually relevant—discussing GD’s Land Systems portfolio and potential investment shifts—it misses the key insight about ASCOD’s declining emphasis and introduces unsupported details, reducing its factual accuracy. The correctness score is low due to the central factual inaccuracy regarding the evolution of ASCOD's positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 391,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "PayPal's utilization of European customer balances for credit activities decreased from $3.0 billion in 2023 to $2.0 billion in 2024, representing a reduction from 39% to 26% of European customer balances available for corporate use. This decline suggests a strategic shift or potential constraints in leveraging European customer funds for credit-related purposes, possibly due to regulatory, liquidity, or operational considerations. The reduction may indicate a more conservative approach to credit funding or a reallocation of resources to other priorities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all quantitative facts: the decrease in approved European customer balances from $3.0 billion (39%) in 2023 to $2.0 billion (26%) in 2024 is accurate and matches the ground truth. There are no errors in numbers, percentages, or years.\n\n2) Quantitative accuracy is perfect. All dollar amounts and percentages are correct and consistent with the original answer. The comparison between years is accurately represented.\n\n3) The reasoning is mostly sound but lacks a key element of multi-hop synthesis present in the ground truth. While the LLM correctly identifies a strategic shift, it does not mention PayPal's multi-year agreement to sell consumer installment receivables—a critical piece of evidence supporting the strategic shift. The ground truth links the reduced use of customer balances to an increase in external financing via receivables sales ($20.8B in 2024 vs $5.5B in 2023), which the LLM omits. This weakens the qualitative depth and inferential support.\n\n4) Contextual relevance is high—the answer directly addresses both parts of the question: the evolution between 2023 and 2024 and the implication for credit funding strategy. However, the explanation of the strategic shift is less precise without referencing the receivables sales program, which is central to the conclusion in the ground truth. The LLM offers plausible alternative explanations (regulatory, liquidity, conservative approach) not confirmed in the source, slightly reducing qualitative accuracy.\n\nOverall, the answer is factually correct and relevant but misses a critical data point needed for full multi-hop reasoning, warranting a high but not top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 458,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "Between 2022 and 2024, the valuation and categorization of equity securities within NEE's Special Use Funds showed an increase in the total fair value, with equity securities rising from $5,511 million in 2022 to $6,164 million in 2024. This increase indicates a shift in the investment composition, with a higher allocation to equity securities and a corresponding rise in Level 3 categorization for some equity investments, reflecting greater complexity or less observable inputs in valuation. This evolution suggests a potential decrease in transparency for certain portions of the fund's equity holdings and a strategic reallocation toward potentially higher-risk or less liquid equity investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, in 2022, NEE's Special Use Funds held $906 million in equity securities (carrying amount) with a fair value of $907 million, and FPL held $672 million. By 2024, NEE held $2,614 million in Level 1 equity securities and FPL held $1,028 million in Level 1, with additional disclosures for Level 2 and Level 3. The LLM incorrectly states total equity securities as $5,511 million in 2022 and $6,164 million in 2024—values not present in the ground truth and not supported by any summation of the provided data. (2) The quantitative values are entirely incorrect. There is no mention of $5.5B or $6.1B in the original answer, nor can these totals be derived from the NEE and FPL figures provided. The LLM also misrepresents the evolution of valuation levels, claiming an increase in Level 3 categorization, while the ground truth emphasizes a shift to more granular disclosures including Level 1, 2, and 3, with specific emphasis on Level 1 growth. (3) The reasoning is flawed: the LLM concludes a 'decrease in transparency' due to higher Level 3 categorization, which contradicts the ground truth indicating improved transparency through more detailed reporting. The multi-hop synthesis failed—instead of comparing 2022's lack of categorization to 2024's structured Level 1/2/3 breakdown, the model invented a narrative around rising Level 3 and declining transparency. (4) The contextual relevance is moderate because the answer addresses valuation changes and transparency, but the factual foundation is incorrect, leading to a completely reversed qualitative conclusion. Correctness and quantitative accuracy are very low due to fabricated numbers and mischaracterized trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 482,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, the scope and utilization of Accenture's share purchase program showed a significant increase in shares acquired under the public program, while employee-related transactions remained relatively consistent. In fiscal 2022, under the public program, Accenture purchased 1,964,612 shares for $576 million, with an aggregate available authorization of $3,129 million as of August 31, 2022. By fiscal 2023, the total available authorization had increased to $6,129 million following an additional $3,000 million repurchase authority approved in September 2022. Employee-related transactions, such as share withholding for payroll tax obligations, remained a smaller component, with 97,251 shares acquired in fiscal 2022 and a similar pattern expected in fiscal 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that in fiscal 2022, Accenture purchased 1,964,612 shares for $576 million under the public program and acquired 97,251 shares through employee-related transactions, it incorrectly claims that the public share purchase program saw increased activity in fiscal 2023. The ground truth explicitly states that there is no mention of shares purchased under the public program in fiscal 2023, indicating reduced or no activity. The LLM instead asserts a 'significant increase' in public program acquisitions, which is directly contradicted by the evidence. (2) The LLM introduces a $3,000 million repurchase authorization approved in September 2022 and claims total available authorization rose to $6,129 million in fiscal 2023. However, this information is not present in the original answer and cannot be validated from the provided ground truth. While such a board authorization may exist in external filings, the original answer does not reference it, and the LLM's inference that this led to increased share purchases is unsupported. The original answer emphasizes the absence of reported public purchases in 2023, making the LLM's quantitative claims about increased scope factually incorrect. (3) The multi-hop reasoning is flawed. The question asks how the scope and utilization evolved. The correct inference from the ground truth is a decline in public program utilization while employee-related acquisitions continued. The LLM incorrectly infers increased public program activity based on authorization increases, failing to distinguish between authorization (capacity) and actual utilization (execution). This reflects a fundamental misunderstanding of share repurchase programs. (4) Despite correct citation of 2022 numbers and proper identification of employee-related transactions, the core conclusion is inverted from the truth. The contextual relevance is moderate because the answer addresses the right entities and time periods, but the qualitative and quantitative inaccuracies severely undermine correctness. Minor formatting variations in numbers are acceptable, but here the error is in directionality and magnitude of change, warranting a low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 605,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC (CPChem) remained consistent between 2022 and 2023. Chevron maintains a 50 percent equity ownership interest in CPChem, and CPChem is accounted for using the equity method in Chevron's consolidated financial statements. The summarized financial data for CPChem shows that it was not consolidated into Chevron's financials but rather reflected as an investment, with its results impacting Chevron's earnings proportionally based on its ownership stake.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim that Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC (CPChem) remained consistent between 2022 and 2023. According to the ground truth, there was a significant change: in 2022, CPChem was consolidated into Chevron’s financial statements, as evidenced by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among consolidated subsidiaries. However, in 2023, Chevron explicitly stated that CPChem was accounted for using the equity method and was no longer consolidated. The LLM incorrectly asserts that CPChem was always accounted for under the equity method and never consolidated, which contradicts the 2022 consolidation status. This represents a major factual and conceptual error in both entity treatment and multi-hop reasoning across years. While the statement about Chevron’s 50% ownership interest may be factually accurate (and thus some contextual relevance is retained), the central accounting treatment is wrong. There are no numerical calculations in this question, so quantitative accuracy is assessed on correct use of years and reporting methods—only the years 2022 and 2023 are correctly referenced, but their associated accounting treatments are reversed. The reasoning fails to identify the transition, showing no synthesis of changes over time. Thus, the answer fails on correctness and qualitative accuracy despite being on-topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 408,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "In 2022, the Combat Systems segment received a $175 million contract from the U.S. Army for the production of Hydra-70 rockets. By 2023, the role of Hydra-70 rockets expanded significantly as part of broader production capacity enhancements within the Ordnance and Tactical Systems (OTS) business unit. OTS received awards to scale its production capabilities, increasing metal parts production from 18,000 to 86,000 rounds per month by 2025 and propellant capacity from 4 million to 16 million pounds per year by 2028, directly supporting the U.S. Army’s efforts to accelerate artillery production.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $175 million 2022 contract for Hydra-70 rockets is accurately reported, and the production capacity expansion from 18,000 to 86,000 rounds per month by 2025 is correctly stated. The mention of OTS (Ordnance and Tactical Systems, not Orbital Technologies Corporation as in the original, but correctly identified as part of Combat Systems) is contextually accurate. (2) Quantitative accuracy is perfect: dollar amounts, production figures, and timeframes match the ground truth. The additional detail about propellant capacity increasing from 4 million to 16 million pounds per year by 2028 is not in the original answer but does not contradict it and may reflect broader OTS enhancements; it does not detract from correctness. (3) Multi-hop reasoning is sound: the answer synthesizes contract involvement in 2022 with capacity expansion in 2023 and links Hydra-70 rockets to broader munitions production scaling. The only minor issue is the use of 'Ordnance and Tactical Systems' instead of 'Orbital Technologies Corporation'—though OTS is the correct business unit, the parent entity name is slightly misstated, but this does not affect functional accuracy. (4) The answer is contextually relevant, complete, and conveys the evolution of the Hydra-70 role effectively. Thus, a score of 9 is warranted due to near-perfect factual and reasoning alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 408,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "Between the 2023 and 2024 filings, PayPal's Global Restricted Stock Unit Award Grant Notice and Agreement under the 2015 Equity Incentive Award Plan remained documented in both years (referenced in Exhibit 10.07+). However, in the 2024 filing, the Global Performance Based Restricted Stock Unit Award Grant Notice and Agreement (Exhibit 10.08+) was amended and restated, with the updated version filed on April 30, 2024, indicating a revision to the performance-based component of the equity awards. The standard Global Restricted Stock Unit Award Grant Notice itself did not show evidence of amendment during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained unchanged between 2023 and 2024 and continued to reference the 2015 Equity Incentive Award Plan, incorporated by reference from the May 14, 2015 10-12B/A filing. The LLM correctly notes that the standard RSU notice was not amended. (2) Quantitative accuracy is perfect: the LLM correctly identifies the April 30, 2024 filing date for the updated Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), matching the ground truth. (3) Multi-hop reasoning is sound: the model synthesizes information across years and exhibit numbers, correctly distinguishing between the static base RSU notice and the updated performance-based variant. (4) The only minor omission is that the LLM does not explicitly mention that the performance-based notice is now linked to the 'amended and restated plan'—a detail present in the original answer—but it does state the notice was 'amended and restated,' which implies the plan update. This slight lack of specificity prevents a perfect 10, but the core factual and comparative analysis is excellent. Wording differs but meaning is semantically equivalent. Contextual relevance is full, as all parts of the question are addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 380,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within Bristol-Myers Squibb's portfolio has evolved both in terms of revenue performance and regulatory approvals. Revenue for Opdivo remained relatively stable, with $7,523 million in 2022 and consistent figures in the following years. However, its strategic importance has grown due to multiple new regulatory approvals in 2024, including FDA approval for Opdivo Qvantig (a subcutaneous formulation) and expanded indications in urothelial carcinoma, colorectal cancer, and combination therapies, reinforcing its position as a key immunotherapy product in BMS's oncology portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Opdivo's 2022 revenue of $7,523 million, which matches the ground truth, and correctly notes stable revenue performance—consistent with the original answer stating no significant revenue increase. However, the LLM introduces new regulatory approvals not fully supported by the ground truth: while the March 2024 FDA approval for urothelial carcinoma (in combination with cisplatin and gemcitabine) is accurate, the mention of 'Opdivo Qvantig' (subcutaneous formulation), approvals in colorectal cancer, and other combination therapies are not present in the ground truth and thus constitute factual overreach. (2) Quantitatively, the $7,523 million figure is accurate and properly attributed to 2022. No incorrect calculations are made, and the claim of stable revenue aligns with the original answer’s implication of no significant increase. (3) The multi-hop reasoning is partially sound—linking revenue data and regulatory developments to assess portfolio evolution—but overstates the breadth of 2024 approvals. The core evolution (expanded indication in urothelial carcinoma reinforcing strategic importance) is correctly inferred, but additional unverified approvals undermine factual accuracy. (4) The answer is contextually relevant and well-structured, addressing both revenue and regulatory aspects of the question. However, the inclusion of unsupported approvals reduces qualitative and overall correctness. A score of 6 reflects mostly correct core facts with significant embellishment on regulatory developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 430,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "Between 2022 and 2023, Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC (CPChem) evolved with continued investment in expansion projects and joint ventures. In 2022, CPChem advanced projects to expand its normal alpha olefins business and made final investment decisions on a new C3 splitter unit and a second 1-hexene unit, both expected to start up in 2023. By 2023, Chevron's equity in earnings from CPChem increased from $867 million in 2022 to $608 million, reflecting ongoing financial support and project progress. Additionally, CPChem continued engineering efforts for the Ras Laffan Petrochemical Project in Qatar and worked toward final investment decisions for the U.S. Gulf Coast II Petrochemical Project.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omits key information from the ground truth. While it correctly notes CPChem's 2022 project expansions (e.g., C3 splitter and 1-hexene unit), it fails to mention Chevron's 50% ownership in CPChem, which is central to understanding the investment structure. Crucially, the LLM incorrectly states that Chevron's equity in earnings from CPChem increased from $867 million in 2022 to $608 million in 2023 — this is factually wrong as $608M is less than $867M, so it reflects a decrease, not an increase. This error undermines quantitative and qualitative accuracy. Moreover, the ground truth highlights a major evolution in 2023: Chevron provided a direct $387 million loan for the Golden Triangle Polymers Project, signaling a shift to more direct financial support. This critical development is entirely missing from the LLM answer. Instead, the LLM mentions unrelated projects like the Ras Laffan and U.S. Gulf Coast II Petrochemical Projects, which were not part of the original answer and may be confused with other filings. (2) The numeric values are partially correct — the 2022 and 2023 earnings figures appear to come from actual data but are misinterpreted and misused in context. The $387 million loan, a key financial figure, is omitted. Dates (2022–2023) and project timelines (start-up in 2023) are generally accurate. (3) The multi-hop reasoning is flawed: the model fails to connect Chevron’s shift from passive equity ownership to active project financing, which is the core of the question. It does not synthesize the change in investment structure, missing the significance of the direct loan as a strategic evolution. (4) The answer is contextually relevant in discussing CPChem projects and Chevron's involvement, but due to major factual errors and omission of the key financial mechanism (the loan), the correctness score is low. The qualitative accuracy is moderate because some project details are accurate, but reasoning and entity relationships are misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 551,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, PayPal's protection programs saw an increase in financial commitments, as reflected in the allowance for transaction losses, which rose from $64 million at the end of 2023 to $86 million at the end of 2024. Additionally, the allowance for negative customer balances increased from $218 million in 2023 to $256 million in 2024. These reserves are established to cover potential financial losses from fraud and counterparty performance issues under PayPal's consumer and merchant protection programs. The disclosures highlight a higher provision for transaction losses in 2024 ($1,114 million) compared to 2023 ($1,192 million), indicating a strategic adjustment in anticipating and managing risk associated with these programs.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increases in the allowance for transaction losses ($64M to $86M) and negative customer balances ($218M to $256M), which matches the ground truth. However, it introduces a critical error in stating that the 'provision for transaction losses' was $1,114 million in 2024 compared to $1,192 million in 2023 — this specific 'provision' figure is not mentioned in the original answer and contradicts the upward trend in reserves, implying lower risk provisioning in 2024 despite higher allowances. This is a significant quantitative inaccuracy. (2) The dollar amounts for the allowances are correct and properly attributed to the right years. But the additional provision figures appear fabricated or misattributed, with no support from the original answer, and their inclusion undermines the factual integrity. (3) The reasoning is otherwise sound: the model correctly infers increased financial commitments and links reserves to fraud and protection programs, showing proper multi-hop synthesis between disclosures and risk exposure. (4) Contextual relevance is high — the answer directly addresses the evolution of protection programs in terms of financial commitments and disclosures. Due to the incorrect provision numbers affecting key interpretation, the quantitative accuracy is reduced to 6, pulling the overall correctness to 7 despite strong performance on other aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 396,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "Between 2022 and 2024, McDonald's has reinforced franchising as the core of its business model, emphasizing its role in driving profitability and consistency across its global operations. In 2024, the company explicitly states that franchising is \"paramount to delivering great-tasting food, locally relevant customer experiences and driving profitability,\" highlighting its strategic importance. Additionally, McDonald's has expanded its co-investment initiatives with franchisees to modernize restaurants and improve performance, particularly in conventional franchise arrangements where the company and franchisees collaborate on capital improvements. This reflects a more active and supportive role in franchisee development compared to earlier years, aiming to enhance brand value and operational standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in McDonald's strategic framing between 2022 and 2024. It correctly identifies the shift to describing franchising as 'paramount' in 2024, aligning with the ground truth, and accurately reflects the emphasis on franchisee co-investment as a driver of performance and modernization. The answer conveys the strategic, value-laden framing in 2024 versus the more neutral, structural language in 2022, even if it does not explicitly contrast the 2022 language as 'neutral' or 'descriptive.' All entities (McDonald's, franchisees, co-investment, franchising model) and time periods (2022, 2024) are correct. There are no numerical figures in the question or answer, so quantitative accuracy is not applicable but assumed perfect. The reasoning is sound and synthesizes the multi-hop requirement across years and strategic themes. The only minor shortcoming is the lack of explicit mention of the 2022 neutral tone, which slightly reduces qualitative accuracy, but the overall semantic meaning and strategic shift are correctly conveyed. Contextual relevance is excellent, directly addressing the question's focus on strategic framing and co-investment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 339,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "Between 2022 and 2023, the FDA's authorization of Marlboro HeatSticks progressed with the approval of three new tobacco-flavored varieties in March 2023, indicating regulatory progress for Altria's heated tobacco products. However, the products remained subject to the FDA's post-market surveillance requirements, and their marketing was impacted by a prior ITC cease-and-desist order due to a patent dispute. This suggests that while Altria achieved some authorization milestones, regulatory and legal challenges continued to affect the product's market availability.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the date of FDA authorization—ground truth states January 2023, but the LLM claims March 2023, which is incorrect. This affects quantitative accuracy. Additionally, the original answer does not mention a patent dispute or ITC cease-and-desist order, which introduces unverified information not present in the ground truth, reducing factual correctness. (2) The number of authorized varieties (three) and their flavor type (tobacco-flavored) are correctly stated, which supports partial quantitative accuracy. However, the incorrect month undermines precision. The absence of any dollar amounts or complex calculations means the main quantitative issue is the date. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that FDA authorization represents regulatory progress for Altria, aligning with the original answer’s interpretation. However, introducing external legal challenges (ITC order) not in the source data reflects unsupported reasoning and detracts from qualitative accuracy. (4) Despite the error in date and added details, the core idea—that Altria made regulatory progress with FDA authorization of new HeatStick varieties—is conveyed, maintaining contextual relevance and a reasonable interpretation of the significance. The answer addresses both parts of the question (evolution and implications), but with factual inaccuracies that prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 404,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "The valuation of mutual fund equity securities held by ACN in non-U.S. pension plans decreased from $273,541 in 2021 to $239,293 in 2022. This decline suggests a reduction in the market value of these investments during the period, potentially reflecting broader market volatility or a strategic shift toward lower-risk assets like debt securities and insurance contracts, as outlined in the investment strategies section. The shift indicates a more conservative investment positioning in 2022, aligning with the goal of matching asset duration to liabilities and minimizing exposure to market fluctuations.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It reports a decrease from $273,541 million in 2021 to $239,293 million in 2022, but the question and ground truth focus on the 2022 to 2023 evolution, not 2021 to 2022. The correct figures are $239,293 million in 2022 and $196,226 million in 2023, with a reduction of $43,067 million. The LLM does not mention 2023 at all, nor the correct decline in mutual fund equity securities during the requested period. (2) The numbers cited ($273,541 and $239,293) may be factually accurate for 2021 and 2022, but they are irrelevant to the question, which asks about 2022–2023. The calculation of a decline is correct in principle but applies to the wrong time frame. (3) The reasoning is flawed because it fails the multi-hop requirement: it does not track the valuation change from 2022 to 2023 as required. Instead, it discusses a prior period and introduces information about non-U.S. pension plans and strategic shifts toward debt securities and insurance contracts that are not present or verifiable in the ground truth. (4) The contextual relevance is partially met because it discusses mutual fund equity securities and investment positioning, but the incorrect time frame and entities undermine the response. The qualitative analysis about conservative positioning may be plausible but is unsupported by the provided ground truth. Thus, the answer is mostly incorrect and fails to address the core question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 409,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "Chevron's involvement in Angola LNG Limited remained consistent from 2022 to 2023, with the company maintaining a 36.4 percent interest in the entity, which operates an onshore natural gas liquefaction plant in Soyo, Angola. In both years, Chevron's operational focus centered on supporting the plant's processing capacity of 1.1 billion cubic feet of natural gas per day, sourced primarily from associated gas byproducts of crude oil production. In 2022, efforts were directed toward developing non-associated gas in offshore Angola to supply the Angola LNG plant, and this focus continued into 2023, with no significant changes in investment emphasis reported.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron maintained a 36.4% interest in Angola LNG Limited in both 2022 and 2023, which matches the ground truth. It also accurately describes the operational focus on processing associated gas and developing non-associated gas resources. However, it fails to capture the key evolution highlighted in the original answer: the shift in disclosure emphasis from operational development in 2022 to financial stake and portfolio integration in 2023. Instead, the LLM claims there was 'no significant changes in investment emphasis reported,' which contradicts the ground truth's assertion of a clear shift in focus in disclosures. (2) All numeric values (36.4%, 1.1 billion cubic feet per day) are factually correct and consistent with known data; no calculations were required. (3) The multi-hop reasoning is partially sound—while the model correctly identifies Chevron’s continued ownership and operational role, it misses the nuanced but important shift in how Chevron reported its involvement, which requires synthesizing changes in disclosure tone and emphasis across years. This reflects a failure in qualitative interpretation despite quantitative accuracy. (4) The answer is contextually relevant and well-structured, but the absence of the key point about shifting disclosure focus significantly undermines its correctness. Hence, the correctness and qualitative accuracy scores are moderate, while quantitative accuracy is perfect and relevance remains high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 417,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "From 2022 to 2023, MMM's investment in Certificates of Deposit/Time Deposits increased from $21 million to $49 million, representing a change of $28 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 value: it states $21 million instead of the correct $14 million from the ground truth. The 2023 value is correct at $49 million. The calculated change of $28 million is therefore incorrect; the actual increase is $35 million ($49M - $14M). The percentage increase (approximately 250%) is missing from the LLM answer, which reduces completeness. (2) Quantitative accuracy is partially correct: while $49 million in 2023 is accurate, the $21 million figure for 2022 is wrong, leading to an incorrect delta. The correct increase is $35 million, not $28 million. (3) The reasoning shows basic multi-hop understanding—comparing two years and computing a difference—but fails due to incorrect input data. The model identifies the correct metric and time frame, indicating proper entity and metric alignment, but the wrong starting value undermines the calculation. (4) Contextual relevance is high—the answer addresses the evolution and magnitude of change directly, uses appropriate financial terms, and focuses on the right company (MMM) and investment type. However, the incorrect base value and resulting miscalculation significantly reduce overall correctness, warranting a score of 4. The answer is partially right but contains a critical numerical error that affects the core conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 380,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "Between 2021 and 2024, the percentage of franchised restaurants in McDonald's system increased from 93% to 95%. This indicates a strengthening of McDonald's reliance on its franchise model during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the percentage of franchised McDonald's restaurants increased from 93% in 2021 to 95% in 2024, matching the ground truth exactly in terms of numbers and years. (2) All quantitative values are accurate—93% and 95% are correctly cited with no calculation errors. The time frame (2021 to 2024) is also correctly referenced. (3) The reasoning is sound: the increase from 93% to 95% is correctly interpreted as a strengthening of McDonald's reliance on the franchise model, which aligns with the multi-hop synthesis required to assess the evolution of the relationship. The LLM captures the strategic implication, though it omits the phrase 'deliberate shift' and 'core business model' from the original, slightly reducing qualitative depth. (4) The answer is semantically equivalent to the ground truth, with only minor conciseness in explanation. No irrelevant or incorrect information is included, and all entities (McDonald's, franchised restaurants, correct years) are accurate. The contextual relevance is perfect as it directly addresses the evolution in franchise percentage and its implication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 326,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective March 31, 2021, as noted in the 2022 filing. Between 2022 and 2023, the plan was further amended and restated effective October 26, 2022, as referenced in the 2023 filing. These amendments likely updated the structure or terms of the plan to align with evolving governance practices or regulatory requirements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the 2022 filing correctly references the March 31, 2021 effective date of the amended plan, and the 2023 filing correctly notes the new effective date of October 26, 2022. (2) There are no numerical or date inaccuracies—both dates are reported exactly as in the original answer, with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings to show the evolution of the plan’s effective date and structure, demonstrating an understanding of how the plan changed over time. (4) The LLM adds minor interpretive context (e.g., alignment with governance or regulatory practices), which is reasonable and does not introduce inaccuracies. The answer is semantically equivalent to the ground truth, addresses all parts of the question, and maintains high precision, completeness, and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 282,
        "total_tokens": 1481
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "Between fiscal years 2022 and 2023, Accenture's financial relationship with Duck Creek Technologies evolved in terms of investment valuation and reported financial impact. As of August 31, 2022, the carrying amount of Accenture's equity method investment in Duck Creek Technologies was $138,902, with an estimated fair value of $223,166 for its approximately 16% ownership. In fiscal 2023, Accenture reported a $253 million investment gain related to its investment in Duck Creek Technologies, indicating a significant increase in the investment's valuation and a positive financial impact on its earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts from the ground truth: the fiscal 2022 carrying amount ($138,902), fair value ($223,166), ~16% ownership, equity method accounting, and the $253 million gain in fiscal 2023. All numbers and entities are accurate, with acceptable formatting (e.g., $253 million vs $253M). (2) Quantitative accuracy is perfect—each dollar amount, percentage, and time reference matches the original. The fiscal year alignment (August 31, 2022, as end of FY2022) is consistent with standard SEC reporting practices. (3) The reasoning correctly infers a significant valuation increase and positive financial impact, aligning with the ground truth’s interpretation of a shift toward financial realization. However, the LLM does not explicitly mention the impact on adjusted earnings per share and effective tax rate—key qualitative details in the original answer—slightly weakening the completeness of the financial impact explanation. (4) Despite this minor omission, the answer is highly relevant, factually correct, and synthesizes multi-hop information (carrying value, fair value, ownership percentage, and subsequent gain) across fiscal years accurately. The contextual relevance is full, and the qualitative reasoning is strong, justifying a 9/10 in that category.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 367,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "Between 2022 and 2024, Breyanzi's therapeutic application has expanded significantly, particularly in the treatment of B-cell malignancies. In 2024, specific new indications approved for Breyanzi include:\n\n1. **Relapsed or Refractory Follicular Lymphoma (FL)**: Approved by the FDA in May 2024 for adult patients with relapsed or refractory FL who have received at least two prior lines of systemic therapy.\n2. **Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)**: Accelerated approval by the FDA in March 2024 for adult patients with relapsed or refractory CLL/SLL who have received at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor.\n3. **Relapsed or Refractory Marginal Zone Lymphoma (MCL)**: Approved by the FDA in May 2024 for adult patients with relapsed or refractory MCL who have received at least two prior lines of systemic therapy, including a Bruton tyrosine kinase inhibitor.\n\nThese approvals expand Breyanzi's market potential by addressing additional patient populations with B-cell malignancies, thereby broadening its therapeutic reach and commercial opportunities.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the expansion of Breyanzi's therapeutic applications between 2022 and 2024 and accurately reports two key new indications approved in 2024: relapsed or refractory follicular lymphoma (FL) in May 2024 and relapsed or refractory CLL/SLL in March 2024. The dates and patient criteria (adults, at least two prior lines of therapy) align with the ground truth. However, the LLM introduces a third indication—relapsed or refractory marginal zone lymphoma (MCL)—which is factually incorrect. MCL is not a correct indication, and the approval for MCL does not exist in the ground truth; this appears to be a confusion with another lymphoma type or fabricated information. Additionally, the inclusion of specific prior therapies (Bruton tyrosine kinase inhibitor and BCL-2 inhibitor) for the CLL/SLL indication, while plausible clinically, is not mentioned in the original answer and represents an over-specification not supported by the ground truth. This introduces inaccuracies in both quantitative and qualitative accuracy. While the core expansion narrative and two correct indications support partial correctness, the addition of a false indication and unsupported details significantly undermines factual reliability. The reasoning is mostly sound in structure but fails in accurate synthesis due to hallucination. Contextual relevance is high as the response directly addresses the evolution and market expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 398,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "Between 2022 and 2023, 3M increased its accruals for respirator mask/asbestos liabilities by $57 million in 2023, reflecting a more cautious estimate of probable losses due to factors such as higher costs to resolve claims involving serious injuries like mesothelioma and black lung disease. Additionally, the insurance receivables related to these liabilities remained immaterial in 2023, with 3M continuing efforts to seek coverage from certain insurers, though most of its remaining insurance coverage for these claims is expected to be collected once those claims for coverage are resolved.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct context about 3M's respirator mask/asbestos liabilities and insurance receivables but fails to accurately address the core of the question—how the *approach to estimating and recording insurance receivables under ASC 450* evolved between 2022 and 2023. The ground truth emphasizes a methodological shift: in 2023, 3M explicitly adopted the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30, incorporating analysis of policy terms, case law, and claim nature—information entirely missing from the LLM response. Instead, the LLM focuses on accrual increases and materiality, which were not the focus of the question. (2) The $57 million increase in accruals is not present in the ground truth and cannot be verified; no such figure is mentioned in the original answer. The claimant numbers (4,028 to 4,042) are correct in the ground truth but omitted in the LLM answer, representing a failure to include key quantitative data. (3) The multi-hop reasoning is flawed: the question requires comparing 3M’s accounting methodology across two years with reference to specific ASC standards, but the LLM does not reference any change in methodology or cite ASC 610-30. It incorrectly shifts focus to accrual amounts and materiality, which are related but not responsive to the evolution of estimation practices. (4) While the LLM answer is contextually relevant—discussing 3M, asbestos/respirator litigation, insurance receivables, and ASC-related topics—it misses the central qualitative and technical evolution described in the ground truth. The absence of the key methodological change and introduction of unverified financial figures significantly undermines factual correctness. Hence, the correctness score is low despite some topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 493,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "In the first quarter of 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners, retaining a 39% noncontrolling interest in a newly formed joint venture, Tropicana Brands Group (TBG), which operates across North America and Europe. By 2023, PepsiCo continued to act as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers with chilled direct-store-delivery in the United States. Thus, PepsiCo's operational involvement shifted from direct ownership to a distribution role, while its financial stake remained at 39%.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PepsiCo sold its Tropicana, Naked, and other juice brands to PAI Partners in 2022 and retained a 39% noncontrolling interest in the newly formed joint venture, Tropicana Brands Group (TBG). This aligns with the ground truth. However, the key error lies in the description of operational involvement in 2023. The LLM claims that PepsiCo 'continued to act as the exclusive distributor' in 2023, which directly contradicts the ground truth stating that PepsiCo 'no longer directly distributed Naked products' by 2023. This is a major factual inaccuracy that undermines the core of the question about evolution in the relationship. (2) Quantitatively, the 39% stake and 2022 transaction timing are correct. The reference to 'first quarter of 2022' is more specific than the ground truth but not necessarily incorrect—minor enhancement, not a flaw. All numbers and percentages are accurate. (3) The multi-hop reasoning fails because the model does not correctly synthesize the change in operational role from 2022 to 2023. It incorrectly assumes continuity in distribution, missing the shift from active involvement to purely financial stake. This breaks the logical chain required for accurate multi-hop understanding. (4) While the answer is contextually relevant and addresses both operational and financial aspects of the relationship, the critical error in depicting ongoing distribution in 2023 reduces correctness significantly. The financial stake is accurately reported, but the operational evolution is misrepresented, leading to a partial credit score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 441,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "Between 2023 and 2024, the accounting treatment and disclosure for the ExtraBucks Rewards program remained consistent in terms of recognizing revenue and determining performance obligations. In both years, the Company recognized that ExtraBucks Rewards represent a performance obligation at the time of the initial transaction. The transaction price was allocated between the initial transaction and the rewards based on the relative standalone selling price, informed by historical redemption patterns. Revenue related to ExtraBucks Rewards was recognized as the rewards were redeemed, with unredeemed rewards reflected as a contract liability at the end of each period. There were no material changes in the accounting treatment or disclosure between the two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the accounting treatment for the ExtraBucks Rewards program in both 2023 and 2024, with correct references to performance obligations, allocation of transaction price based on standalone selling prices, revenue recognition upon redemption, and contract liabilities for unredeemed rewards. There are no numerical inaccuracies (quantitative accuracy is perfect), and the entities (ExtraBucks Rewards program, revenue recognition, performance obligations, contract liabilities) are correctly identified and contextually relevant. However, the LLM incorrectly concludes that there were 'no material changes' in accounting treatment or disclosure between 2023 and 2024, which directly contradicts the ground truth. The original answer specifies that while the core treatment remained consistent, the 2024 filing included more refined language linking performance obligations to customers with historical spending patterns and introduced more structured disclosures around price allocation and standalone selling price evaluation—indicating a more mature and formalized approach. The LLM failed to capture this evolution in disclosure sophistication and nuance, which was the central focus of the question. This omission represents a significant qualitative inaccuracy in multi-hop reasoning, as the model did not synthesize the subtle but important progression in disclosure detail and accounting formalization across the two years. Thus, while the individual components are correct, the overall conclusion is misleading, warranting a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 445,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "Between 2023 and 2024, Netflix's reliance on integrated payment partners, as reflected in the cost of revenues section, remained consistent in terms of categorization but showed an overall increase in cost of revenues. In 2023, cost of revenues was $19.7 billion (58% of total revenues), while in 2024, it increased to $21 billion (54% of total revenues). The 2024 increase was primarily driven by a $1.1 billion rise in content amortization, but no specific mention of changes in payment processing fees or integrated payment partner costs was provided, indicating no significant shift in reliance on these partners during the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses the core focus of the question. While it correctly identifies that payment processing fees were part of the cost of revenues and categorized under other operating costs, it incorrectly shifts focus to overall cost of revenues and content amortization, which were not the subject of the question. The original answer emphasizes a change in disclosure strategy—specifically, that granular details about payment partner fees were reduced in 2024—not a change in actual costs. The LLM instead infers 'no significant shift in reliance' based on lack of mention, which misinterprets the nature of the change (disclosure vs. operational). (2) Quantitatively, the LLM provides cost of revenues figures: $19.7B in 2023 and $21B in 2024. These numbers are plausible but not present in the ground truth, which does not include any dollar amounts related to payment processing fees or total cost of revenues. Therefore, introducing these figures is unsupported and distracts from the actual qualitative disclosure change. The percentages (58%, 54%) and the $1.1B increase in content amortization are not mentioned in the ground truth and appear to be fabricated or misattributed. (3) The multi-hop reasoning is flawed. The question asks about evolution in reliance based on details in the cost of revenues section. The correct inference requires recognizing that while the categorization remained the same, the level of detail decreased—indicating a disclosure shift. The LLM fails to identify this nuance and instead defaults to absence of mention = no change in reliance, which is an incorrect logical leap. It also introduces unrelated financial data, suggesting confusion in synthesis. (4) Correctness is scored low (4) because the answer misses the key point about reduced disclosure granularity and incorrectly introduces unsupported financial data. Quantitative accuracy is moderate (6) because the numbers may be factually correct in external context but are not part of the provided ground truth and are misapplied here. Qualitative accuracy is low (4) due to flawed reasoning and misinterpretation of the evidence. Contextual relevance is fair (7) as the answer stays within Netflix’s financial reporting and cost of revenues, but it addresses the wrong aspect of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 625,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "From 2022 to 2023, 3M's approach to managing PFAS contamination in Minnesota evolved in response to regulatory changes and new health-based standards. In 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS, prompting 3M to evaluate the potential impact on its obligations under the 2007 Settlement Agreement and Consent Order (SACO). Additionally, in January 2024, the Minnesota Pollution Control Agency (MPCA) issued a draft Clean Water Act permit for 3M's Cottage Grove facility with significantly revised PFAS limits, some below the limit of quantification, requiring 3M to engage in ongoing discussions with MPCA. These developments reflect 3M's increased focus on compliance with evolving standards and collaboration with regulators to address PFAS-related obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key developments in 3M's approach to PFAS contamination in Minnesota from 2022 to 2023, with a focus on regulatory changes and new health-based standards. It correctly identifies the January 2024 issuance of updated, more stringent Health Based Values (HBVs) for PFOA and PFOS by the Minnesota Department of Health and notes 3M's evaluation of the impact on its obligations under the SACO. It also accurately references the January 2024 draft Clean Water Act permit from MPCA for the Cottage Grove facility with stricter PFAS limits. However, the LLM answer omits several important details from the original answer: (1) the status of remediation work in 2022 (substantial completion at Cottage Grove, ongoing operations at Oakdale and Woodbury); (2) the December 2022 MPCA order on stormwater at Cottage Grove; and (3) the March 2023 Notice of Violation at the Hutchinson facility. Additionally, while the LLM correctly mentions the January 2024 HBV update, it incorrectly implies it occurred in 2023, which affects temporal accuracy. The draft permit is correctly dated to January 2024, but the answer does not clarify that the regulatory pressure built throughout 2022–2023, culminating in these 2024 actions. Despite these omissions and minor chronological misplacement, the core reasoning and synthesis across regulatory developments are sound, and the entities (MPCA, MDH, SACO, Cottage Grove) are correctly identified. The answer is contextually relevant and conveys the evolving regulatory landscape and 3M’s responsive posture. Quantitative accuracy is high—dates and events are mostly correct, though the conflation of 2023 and early 2024 timing slightly undermines precision. Overall, the answer is factually strong but lacks completeness in multi-hop details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 491,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "PepsiCo's use of foreign currency derivatives increased from a notional value of $2.8 billion in 2022 to $3.8 billion in 2023, indicating a more active approach to managing foreign exchange risk. This growth suggests that PepsiCo is expanding its hedging strategies to address greater exposure from international operations, likely due to increased global operations or currency volatility. The company continues to use forward contracts and net investment hedges to mitigate risks from foreign subsidiaries and currency fluctuations, reflecting a consistent and proactive risk management approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in notional value from 2022 to 2023 and the strategic intent behind the expansion in derivative use, which aligns with the ground truth. However, the 2022 notional value is incorrect: the LLM states $2.8 billion, while the ground truth reports $3.0 billion. This is a material quantitative error affecting accuracy. The 2023 value ($3.8 billion) is correct. (2) The calculation of growth is affected by the incorrect base year value, leading to an overstated increase. The actual increase is $0.8 billion (from $3.0B to $3.8B), while the LLM implies a $1.0 billion increase. Other financial metrics and years are correctly referenced. (3) The reasoning and multi-hop synthesis are sound: the LLM correctly infers that increased derivative use reflects a more active FX risk management strategy, likely due to greater international exposure or volatility. It also accurately notes the use of forward contracts and net investment hedges, which is consistent with PepsiCo’s disclosed practices. However, it omits the key qualitative point from the original answer that there was no material net impact on earnings in 2023 due to effective offsetting—this is a notable omission in completeness. (4) Despite the numerical inaccuracy in the 2022 figure and the missing earnings impact detail, the overall direction, trend, and strategic interpretation are correct, warranting a score of 7 for correctness. The answer remains contextually relevant and qualitatively strong, with only one major factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 430,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "Between 2022 and 2023, ExxonMobil shifted its focus in capitalizing on improving living standards by advancing chemical production capacity additions in strategic geographic regions. In 2022, the company emphasized restarting U.S. Gulf Coast projects to meet growing demand for high-value chemical products. By 2023, the focus expanded to significant capacity additions in China, with the development of a new petrochemical complex in the Dayawan Petrochemical Industrial Park. This complex, designed to produce high-performance polyethylene and polypropylene, reflects ExxonMobil's strategy to more efficiently serve the rapidly growing domestic demand in China, which has traditionally relied on imports.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic shift from U.S.-focused projects in 2022 to expanded focus on China in 2023, which aligns with the ground truth. It correctly identifies the Dayawan Petrochemical Industrial Park project in China and its purpose to serve growing domestic demand. However, it omits key quantitative details from 2022: the completion of the joint venture ethane cracker near Corpus Christi, Texas, and the planned 500,000 metric tons per year of advanced recycling capacity in Baytown by 2026. In 2023, the LLM mentions the China complex but fails to include the specific capacity of over 2.5 million metric tons per year of polyethylene and polypropylene, and does not mention the expansion of performance polymers and linear alpha olefins in Baytown, Texas. (2) Quantitative accuracy is partially correct: while no incorrect numbers are stated, several key figures from the original answer (500,000 metric tons, 2.5 million metric tons) are missing, reducing precision. The LLM does not fabricate numbers but lacks specificity. (3) The multi-hop reasoning is sound in identifying a strategic evolution from domestic U.S. projects to foreign investment in China, reflecting adaptation to improving living standards. However, the synthesis is incomplete—missing the 2022 Baytown recycling plans and the dual focus in 2023 on both China and continued U.S. high-performance polymer expansions. (4) The contextual relevance is high as the answer addresses the evolution in geographic focus and capacity additions. Qualitative accuracy is strong due to correct entity identification (ExxonMobil, Dayawan, China, U.S. Gulf Coast) and logical reasoning, but the omission of specific projects and capacities reduces completeness and quantitative accuracy, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 495,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "From 2022 to 2023, 3M's investment in Certificates of Deposit/Time Deposits increased significantly, from $21 million to $49 million. This shift suggests a strategic move toward allocating more short-term liquidity into these low-risk, interest-bearing instruments, likely to preserve capital and generate modest returns in a potentially volatile market environment. The increase indicates a cautious approach to short-term investment management, prioritizing safety and liquidity over higher-yield but potentially riskier alternatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the dollar amounts for Certificates of Deposit/Time Deposits in both 2022 ($21 million) and 2023 ($49 million), matching the ground truth exactly. The statement that the investment 'increased significantly' is accurate and conservative; the actual increase is more than double, which the LLM does not exaggerate. 2) Quantitatively, all numbers are correct, and the comparison across years is valid. No calculations (e.g., percentage change) were required, but the directional change (increase from $21M to $49M) is accurately presented. 3) The reasoning is sound: the LLM correctly infers a strategic shift in short-term investment behavior, emphasizing safety, liquidity, and capital preservation. While the original answer mentions 'reallocating short-term cash holdings into more stable or higher-yielding instruments,' the LLM's interpretation—focusing on low-risk, interest-bearing instruments and cautious management—is semantically equivalent and well-reasoned. The only minor gap is that the LLM does not explicitly note the 'more than doubling' magnitude, which slightly weakens the strength of the strategic shift description, but this does not constitute a factual error. 4) The answer is fully relevant to the question, addressing both the evolution of the investment and its implication for 3M’s short-term strategy. Entities (3M, Certificates of Deposit/Time Deposits, years 2022–2023) are accurate. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for not emphasizing the magnitude of the increase.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 453,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "Mastercard's approach to proprietary insights evolved from 2022 to 2023 by emphasizing data responsibility and trust-building language. In 2022, the focus was on leveraging consumer and merchant data to provide insights while maintaining principled use. By 2023, the language shifted to highlight secure, responsible data use and reinforcing trust, indicating a stronger commitment to ethical standards and transparency in data practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Mastercard's language around proprietary insights from 2022 to 2023. It correctly identifies the shift from 'principled use' in 2022 to 'responsible and secure' data use in 2023, aligning with the ground truth. While the exact phrase 'principled and responsible use of secure consumer and merchant data' from 2023 is paraphrased, the semantic meaning is preserved. The LLM correctly attributes the change to a growing emphasis on trust, security, and ethical standards. There are no numerical values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is slightly reduced because the answer does not explicitly quote the precise terminology from the filings, which could matter in strict compliance contexts, but the reasoning and synthesis across years are sound. Contextual relevance is perfect—the response directly addresses the question about evolution in language, data responsibility, and trust-building.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 288,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "Between 2022 and 2023, the factors influencing the accounting estimates for pension and retiree medical plans evolved in response to the broader economic environment. In 2022, the external environment was shaped by the lingering effects of the COVID-19 pandemic, which introduced uncertainties in assumptions such as discount rates and future cash flows. By 2023, the focus shifted to the impacts of ongoing conflicts in Ukraine and the Middle East, as well as a high-interest-rate and inflationary cost environment. These macroeconomic factors increased the complexity of estimating future obligations and required more conservative assumptions, reflecting a more volatile and uncertain financial landscape. This evolution indicates a transition from pandemic-related uncertainties to a challenging geopolitical and economic climate affecting long-term financial planning for these plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: the shift from 2022's pandemic-related uncertainties to 2023's geopolitical and macroeconomic factors (conflicts in Ukraine and the Middle East, high interest rates, inflation) is accurately described. There are no numeric values in the question or answer that require verification (e.g., percentages, dollar amounts), so quantitative accuracy is not compromised. (2) The answer addresses all parts of the multi-hop question: it explains how the factors evolved between 2022 and 2023 and interprets what this shift indicates about the changing external environment. (3) Multi-hop reasoning is sound—correctly synthesizing a shift in external risk factors from health-related (COVID-19) to broader macroeconomic and geopolitical concerns. The use of terms like 'discount rates', 'future cash flows', and 'conservative assumptions' adds appropriate financial context not in the original but semantically consistent and correct. (4) The only minor deviation is that the LLM elaborates slightly more on the financial implications (e.g., 'increased complexity', 'conservative assumptions') which are reasonable inferences but not explicitly stated in the ground truth. However, these do not detract from accuracy and enhance clarity. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 398,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 32,441 gross thousand acres (15,838 net) at year-end 2022 to 30,773 gross thousand acres (15,012 net) at year-end 2023. This reduction suggests that the company may have relinquished or sold some acreage, or advanced certain areas into development. Despite the decline, the region still holds a substantial undeveloped acreage position, indicating continued exploration potential, particularly in countries like Guyana and Brazil, where long-term exploration and production rights are in place.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numeric values provided. According to the ground truth, ExxonMobil's undeveloped acreage in the Other Americas region was 25,096 gross and 11,977 net thousand acres in 2022, decreasing to 24,221 gross and 11,548 net thousand acres in 2023. However, the LLM reports 32,441 gross (15,838 net) in 2022 and 30,773 gross (15,012 net) in 2023—values that are substantially higher and incorrect. These numbers do not align with the ground truth data, indicating a failure in retrieving accurate figures from the correct source. (2) The calculation of the decrease is numerically consistent within the LLM’s own incorrect numbers (a drop of ~1,668 gross and ~826 net thousand acres), but since the base figures are wrong, the entire quantitative foundation is flawed. (3) The qualitative reasoning about the implications of the decrease—such as possible relinquishment, transition to development, and continued exploration potential in Guyana and Brazil—is plausible and aligns with the type of analysis expected. This shows some correct multi-hop reasoning in interpreting what a reduction might indicate, even if based on incorrect data. (4) Contextually, the answer addresses both parts of the question: the evolution of acreage and its implications for exploration potential. While the directional trend (decrease) is correct, the magnitude and absolute values are not. Due to the critical importance of accurate financial and operational figures in SEC-based analysis, the high quantitative error severely undermines the answer’s correctness, warranting a low score despite partially sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 457,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "From 2022 to 2023, 3M continued using foreign currency contracts not designated in hedging relationships to offset the impacts of changes in value of non-functional currency denominated items, such as intercompany financing balances. In 2022, the gross notional amount of these contracts was $2.8 billion, while in 2023, it decreased to $1.0 billion. The fair value gains and losses on these contracts are recorded directly in earnings, and in 2023, they resulted in a $9 million loss, compared to a $76 million loss in 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2022, the gross notional amount of foreign exchange contracts not designated in hedging relationships was $3.7 billion, but the LLM incorrectly reports it as $2.8 billion. Additionally, the LLM claims the amount decreased to $1.0 billion in 2023, which is not supported by the original answer—no such figure is provided in the ground truth for 2023. Furthermore, the LLM introduces specific loss figures—$76 million loss in 2022 and $9 million loss in 2023—which are entirely absent from the original answer and thus factually unsupported. (2) These numerical errors severely undermine the quantitative accuracy. While the format of numbers is acceptable (e.g., $2.8 billion vs $2.8B), the values themselves are incorrect or fabricated. There is no mention in the ground truth of actual gains or losses from these contracts in either year, so reporting $76M and $9M losses constitutes a major factual deviation. (3) On qualitative reasoning, the LLM correctly identifies that 3M used non-designated foreign currency contracts to manage exposure on non-functional currency items like intercompany balances, which aligns with the original. It also correctly notes that gains and losses impact earnings directly—a point implied in the ground truth by mentioning derivatives not designated as hedging instruments. However, it fails to capture the key evolution described in the original: a strategic shift from designated hedging strategies to a more direct financial exposure management approach. Instead, the LLM focuses on notional amounts and P&L impacts that aren't in the source, missing the conceptual shift entirely. (4) Contextually, the answer is relevant—it addresses foreign currency contracts, non-functional currency items, and their financial treatment—but the inclusion of false specifics reduces its reliability. The correctness score is low due to major factual and numerical errors, despite some structurally accurate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 560,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "Between 2022 and 2023, the role and emphasis of Cyber and Intelligence Solutions within Mastercard's value proposition evolved to become a more integral part of the company's broader strategy to enhance transaction security and trust. In 2022, Cyber and Intelligence Solutions were highlighted as part of Mastercard's value-added services, primarily focused on fraud prevention and transaction safety. By 2023, these solutions were emphasized more prominently as a core component of Mastercard's multi-layered approach to protecting the global payments ecosystem. The 2023 document underscores their role in enabling secure, confident, and seamless transactions, aligning with Mastercard's broader investments in open banking and digital identity solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Cyber and Intelligence Solutions were part of value-added services, and by 2023, they were elevated to a core component of Mastercard’s value proposition focused on secure and confident transactions. The description of the 2023 emphasis on enabling secure, confident, and seamless transactions matches the original answer’s 'secure, easy, and confident transactions.' (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years, identifying the shift in positioning of the service line from a supporting to a strategic role. It appropriately infers the increased strategic importance and connects it to broader company initiatives like open banking and digital identity, which is contextually valid and enhances the answer without contradicting the ground truth. (4) The only minor deviation is that the LLM adds a detail about 'fraud prevention' in 2022 and links to 'open banking and digital identity' in 2023, which are not explicitly mentioned in the original answer. However, these are reasonable inferences consistent with Mastercard’s known strategy and do not detract from factual accuracy. Overall, the answer is semantically equivalent, complete, and contextually appropriate, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 419,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "The treatment and disclosure of Income Tax Expense and Accruals in PepsiCo's critical accounting policies remained consistent between 2022 and 2023. In both years, the policy emphasizes that the annual tax rate is based on income, statutory tax rates, and tax structures across jurisdictions. Significant judgment is required in determining the tax rate and evaluating tax positions, with reserves established for positions that may be challenged. Adjustments to these reserves are made based on changing facts, such as tax audits or new laws. The 2023 filing did not introduce any material changes to the 2022 disclosure on this topic.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that there was no material change in the treatment or disclosure of Income Tax Expense and Accruals between 2022 and 2023. The ground truth states that while the item remained a critical accounting policy, it was restructured in 2023 to be presented under a more organized framework with explicit references to detailed notes like Note 5 - Income Taxes, indicating enhanced transparency and structural evolution. The LLM incorrectly asserts consistency and absence of material changes, which contradicts the documented shift toward more detailed and structured reporting. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default due to absence of numerical errors. Entity accuracy is partially correct: PepsiCo is not mentioned in the original question or ground truth, so its introduction is an unsupported assumption, but the years (2022, 2023) are correct. The reasoning is flawed because the model fails to recognize the multi-hop nuance of structural evolution in disclosure format and presentation, despite the topic remaining listed. The answer is contextually relevant to the topic of tax disclosures but misses the key evolution in presentation, leading to a low correctness score despite appropriate terminology use.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 373,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "Between 2023 and 2024, Intel advanced the Universal Chiplet Interconnect Express (UCIe) standard as a key enabler of its systems of chips strategy. In 2023, Intel demonstrated UCIe in silicon, showcasing its capability for high-performance communication between interconnected chiplets. By 2024, the company emphasized UCIe as a foundational standard for optimizing system performance and power consumption, aligning with its broader push to deliver advanced packaging and systems capabilities for AI and other high-growth applications. This evolution reflects Intel's commitment to driving industry-wide adoption of chiplet-based architectures through standards and ecosystem collaboration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Intel introduced and demonstrated UCIe in silicon in 2023 and advanced to production and broader integration in 2024 as part of its systems of chips strategy. The LLM correctly identifies the evolution from demonstration to strategic implementation. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is unaffected; dates (2023, 2024) are correct. (3) The multi-hop reasoning is sound—linking UCIe's technical demonstration to its role in Intel's broader strategy involving advanced packaging, system-level standards, and ecosystem collaboration. The LLM captures the strategic intent (optimizing performance, enabling customer designs) though it does not explicitly mention 'advanced semiconductor assembly and test offerings' as in the original. (4) Semantic equivalence is strong: the LLM conveys that UCIe evolved from a demonstrated technology to a foundational industry standard within Intel's strategy, emphasizing performance, power efficiency, and AI applications. The only minor omission is the explicit mention of 'production based on this standard' in 2024, which is implied but not stated directly. This small gap prevents a perfect 10 on qualitative accuracy, but overall the response is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 393,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "Between 2023 and 2024, the accounting treatment for CVS's Accelerated Share Repurchase (ASR) transactions evolved slightly. In 2023, the ASR with Morgan Stanley was accounted for as an initial treasury stock transaction and a forward contract, with the forward contract classified as an equity instrument recorded within capital surplus. The remaining shares were received and the forward contract reclassified to treasury stock in February 2023. In 2024, the ASR with Morgan Stanley followed a similar structure but the remaining 15% of shares were received in March 2024, extending the completion timeline by one month compared to prior years. The accounting treatment remained consistent, with the initial 85% of shares recorded as treasury stock and the forward contract reclassified upon final settlement.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the 2023 ASR was with Morgan Stanley, when the ground truth specifies Citibank. This is a critical entity error. Second, the LLM claims the 2023 ASR was completed in February 2023, which is correct, but fails to mention the initial 17.4 million shares and final 5.4 million shares, omitting key quantitative details. For 2024, it correctly identifies Morgan Stanley as the counterparty and notes the final settlement in March 2024, but omits the initial 31.4 million shares and additional 8.3 million shares, again missing key numbers. The LLM correctly states that 85% of shares were delivered initially in 2024, but incorrectly implies that 2023 also had an 85% delivery, when it was actually 80% (17.4M out of 22.8M total). (2) Quantitative accuracy is compromised: total 2023 ASR was $2.0B, 2024 was $3.0B — these dollar amounts are missing in the LLM answer. The share numbers and percentages are either missing or incorrect. The timeline comparison (February 2023 vs March 2024) is partially correct, but the conclusion that 2024 took 'one month longer' is speculative without stating the start dates; ground truth notes 2023 took one month, 2024 took two months — a detail not captured. (3) Reasoning is partially sound: the LLM correctly identifies that accounting treatment remained consistent — forward contract reclassified from capital surplus to treasury stock upon completion — which reflects accurate multi-hop synthesis of accounting policy. However, due to entity and numerical errors, the comparative evolution is flawed. (4) Contextual relevance is high — the answer addresses both accounting treatment and timeline evolution as asked. Despite incorrect entities and missing numbers, it attempts the correct comparison and correctly notes consistency in accounting and slight extension in timeline. However, due to significant factual and quantitative errors, the correctness score is reduced to 6 — partially correct but with major omissions and inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 559,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "From 2022 to 2023, UPS's financial exposure and reporting approach related to the Central States Pension Fund (CSPF) evolved in terms of actuarial estimates and sensitivity analysis as follows: In 2022, UPS recorded a $5.1 billion pre-tax gain related to a reduction in its best estimate of potential coordinating benefits for the CSPF, while in 2023, the sensitivity analysis showed the projected benefit obligation for pension plans was highly sensitive to changes in discount rates, with a 25 basis point decrease increasing the obligation by $1.6 billion. This highlights a shift in focus from specific CSPF-related actuarial adjustments in 2022 to broader sensitivity to market-driven assumptions in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, UPS disclosed a $2.3 billion pre-tax actuarial *loss* related to potential coordinating benefits for the Central States Pension Fund. However, the LLM incorrectly reports a $5.1 billion pre-tax *gain*, which is both the wrong direction (gain vs. loss) and an incorrect amount ($5.1B vs. $2.3B). This is a critical error in both magnitude and interpretation. In 2023, the ground truth indicates UPS shifted to sensitivity analysis focused on a 25 basis point change in expected and actual returns on assets, with a cross-reference to Note 5. The LLM instead claims the sensitivity was to discount rates and quantifies the impact as a $1.6 billion increase from a 25 bps decrease, which is not supported by the original answer. While the general idea of a shift toward sensitivity analysis is correct, the specific drivers (returns on assets vs. discount rates) and associated figures are wrong. (2) Number verification: $5.1B gain (incorrect) vs. $2.3B loss (correct); $1.6B sensitivity impact (fabricated) vs. no specific dollar sensitivity provided in original; 25 bps is correctly mentioned but applied to wrong assumption (discount rate vs. return on assets). (3) Multi-hop reasoning: The LLM correctly identifies a shift in reporting approach from a specific actuarial estimate in 2022 to sensitivity analysis in 2023, showing some understanding of evolving disclosure strategy. However, it fails to accurately synthesize the correct financial figures and underlying assumptions from the two years, undermining the validity of the conclusion. (4) Justification: The correctness score is low (2/10) due to major factual and directional errors in financial figures and misrepresentation of key assumptions. Quantitative accuracy is severely compromised. Qualitative accuracy is slightly higher because the model captures the directional shift in reporting focus, though with incorrect details. Contextual relevance is moderate as the response stays on topic and addresses the evolution in disclosure approach, even if factually flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 575,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "Between 2022 and 2023, Mastercard enhanced the positioning of its Cyber and Intelligence Solutions by emphasizing their role in enabling secure, confident, and efficient transactions across the global payments ecosystem. In 2022, the focus was on leveraging these solutions to allow stakeholders to transact \"easily and with confidence.\" By 2023, the value proposition evolved to highlight how these solutions, along with investments in open banking and digital identity, support and strengthen Mastercard's broader payment and services offerings, reinforcing a multi-layered approach to ecosystem security and stakeholder trust.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution in Mastercard's messaging around Cyber and Intelligence Solutions between 2022 and 2023. It correctly identifies the 2022 emphasis on enabling stakeholders to transact 'easily and with confidence,' aligning with the original answer. In 2023, the LLM accurately reflects the expanded value proposition by linking cyber solutions to strategic investments in open banking and digital identity, and positioning them as integral to ecosystem security and trust. The only minor shortcoming is that it does not explicitly mention the 'principled use of consumer and merchant data' from 2022 or the framing of cyber solutions as part of 'value-added services,' which were present in the ground truth. However, the core evolution in positioning—broadening from transactional confidence to a foundational role in infrastructure and ecosystem security—is correctly conveyed. There are no numerical or date inaccuracies (quantitative accuracy is perfect), and the reasoning demonstrates sound multi-hop synthesis across years and strategic themes. The answer is fully contextually relevant and semantically equivalent to the original, with only slight omissions in granular detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 344,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In PepsiCo's 2022 SEC filing, the 4.450% Senior Note due 2046 was referenced as Exhibit 4.11, incorporated by reference to a Form 8-K filed on October 14, 2015. By 2023, the note was still listed as Exhibit 4.11, but the associated documentation date remained unchanged, continuing to reference the October 14, 2015 filing. No new exhibit referencing or updated documentation was provided for this specific note in the 2023 filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in the 2022 filing, the note was listed as Exhibit 4.12 (not 4.11 as stated by the LLM), and in the 2023 filing, it was reclassified as Exhibit 4.13 (not retained as 4.11). Additionally, the LLM incorrectly claims the documentation date remained October 14, 2015 in 2023, while the ground truth states it changed to February 24, 2016. These errors affect both exhibit numbers and key dates. (2) Quantitatively, the percentage (4.450%) and maturity year (2046) are correct, but exhibit numbers and filing dates are wrong—critical data points for this question. The LLM fails to report the actual shift in exhibit numbering and referencing, which is the core of the question. (3) The multi-hop reasoning is flawed: the model fails to recognize the reclassification and update in documentation between years, instead asserting no change occurred. This contradicts the ground truth and shows a failure in synthesizing the evolution across filings. (4) Contextual relevance is moderate—the response addresses exhibit referencing and documentation dates as asked, but with incorrect data, undermining the usefulness. While the structure of the answer is relevant, factual correctness is severely lacking, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 373,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Between 2023 and 2024, Intel's engagement with Positive Technologies remained consistent under OFAC licensing following U.S. sanctions. In both years, Intel disclosed that it resumed and continued communications with Positive Technologies, a sanctioned Russian IT security firm, to coordinate disclosure of security vulnerabilities identified by the firm. These activities were conducted under a license issued by OFAC and did not generate any gross revenues or net profits for Intel.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entities, timeline, and regulatory context: Intel engaged with Positive Technologies under an OFAC license in both 2023 and 2024, communications involved vulnerability disclosure, and no revenues or profits were generated—this aligns with the ground truth. Quantitatively, there are no numerical inaccuracies, so the quantitative accuracy is perfect. However, the LLM misses a key qualitative evolution highlighted in the original answer: in 2023, Intel disclosed *past* communication and resumption under license, while in 2024, it expressed a *forward-looking intent* to continue the relationship, indicating a shift toward a more sustained and intentional partnership posture. The LLM describes the engagement as 'remained consistent,' which underrepresents this evolution and fails to capture the nuanced progression from retrospective disclosure to proactive continuation. This omission affects the depth of multi-hop reasoning—while the model correctly identifies the facts across years, it does not synthesize the change in tone and strategic posture. Contextual relevance is high, as the answer stays focused on the question and includes all relevant entities and regulatory framework. Thus, the correctness and qualitative accuracy scores are reduced slightly for missing this key developmental nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 376,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5,000 million between 2023 and 2024, as shown in the long-term debt summaries of both years. This indicates that the company has not refinanced or redeemed these notes, suggesting a stable component within its long-term debt structure. The continued presence of these high-yield notes reflects CVS's strategy of maintaining a diversified mix of long-term debt maturities to manage interest costs and liquidity over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5,000 million in both 2023 and 2024, which matches the ground truth exactly. All numeric values (interest rate, maturity date, dollar amount, years) are accurate. (2) Quantitative accuracy is perfect: $5,000 million is correctly reported, and no erroneous calculations are made. Format is consistent with ground truth. (3) The multi-hop reasoning is sound—LLM correctly infers that the stability of this debt instrument indicates no refinancing or redemption, aligning with the ground truth's implication of selective debt management. However, the LLM adds that these are 'high-yield notes' and emphasizes a 'diversified mix of long-term debt maturities' as a strategic choice. While plausible, this specific strategic interpretation is not present in the ground truth, which instead contrasts the stability of this note with the reduction in another (2.7% senior notes due 2040), highlighting active refinancing elsewhere. This contrast is missing in the LLM answer, resulting in a minor omission in qualitative completeness. (4) Despite this, the LLM captures the core factual evolution and its implication accurately. The answer is contextually relevant, factually correct, and well-reasoned, warranting a high score. The only reason for not giving a 10 is the lack of comparative context with other senior notes, which was a key element in the ground truth's explanation of debt structure dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 420,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "The 0.835% Notes due 2032 (XOM32) were listed as securities registered pursuant to Section 12(b) of the Exchange Act in both the 2022 and 2024 SEC filings, indicating they remained outstanding and publicly traded on the New York Stock Exchange during both periods. There is no indication in the provided pages that the status of these notes changed between 2022 and 2024, such as through redemption, maturity, or restructuring.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 0.835% Notes due 2032 (XOM32) were listed in both the 2022 and 2024 SEC filings as registered securities under Section 12(b), which is factually accurate and matches the ground truth. The trading symbol XOM32 is correctly associated with the notes. However, the LLM answer omits a key comparative insight present in the original answer: the disappearance of the 0.142% Notes due 2024 (XOM24B) in the 2024 filing, which provides context for changes in Exxon’s debt structure. While the status of the 2032 notes themselves may not have changed, the evolution of the broader debt portfolio — particularly the removal of the 2024 notes — is part of the 'evolution' asked about in the question. (2) Quantitatively, all numbers (0.835%, 2032, XOM32) are correct and consistent with the ground truth. There are no calculations, but the dates and percentages are accurately reported. (3) The reasoning is sound in concluding that the 2032 notes remained outstanding, but it fails to perform the full multi-hop synthesis: comparing the presence/absence of other notes (like XOM24B) across filings to infer changes in the debt composition. This limits the depth of the 'evolution' analysis. (4) The answer is highly relevant and factually correct regarding the 2032 notes, but incomplete in addressing the comparative evolution between filings. Hence, correctness is reduced to 7 for missing contextual nuance, though quantitative accuracy remains perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 413,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "Between 2022 and 2024, American Express significantly reduced its investment in U.S. Government treasury obligations, with the fair value dropping from $1,704 million in 2021 to $287 million in 2024. The maturity distribution also shifted, with 2024 showing a concentration of treasury obligations due within one year ($189 million) compared to 2021, which had a broader maturity spread. This suggests a strategic shift toward shorter-term holdings, likely to manage interest rate risk amid rising rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly references 2021 data ($1,704 million) instead of 2022, which undermines the entire comparison. The ground truth states that in 2022, American Express held $477 million in short-term U.S. Treasury obligations, not $1,704 million in 2021. The 2024 fair value is reported as $287 million in the LLM answer, but the correct total is $287 million only if summing $189 million (short-term) and $98 million (intermediate-term), which the LLM fails to mention as intermediate-term. Instead, it mischaracterizes the 2024 holdings as solely within one year, omitting the new intermediate-term allocation entirely. (2) The quantitative inaccuracies are severe: the use of 2021 instead of 2022 data breaks the temporal comparison; the $1,704 million figure does not appear in the ground truth at all; and while $189 million in short-term for 2024 is correct, the absence of the $98 million intermediate-term component results in an incomplete and misleading total. The LLM also fails to note that 2022 had *exclusively* short-term holdings with *no* long-term exposure, a key strategic shift. (3) The multi-hop reasoning is flawed: the model does not correctly synthesize the evolution from a short-term-only strategy in 2022 to a diversified maturity profile in 2024. Instead, it infers a 'shift toward shorter-term holdings' when the actual shift was toward *longer* maturities (adding 1–5 year instruments), which is the opposite conclusion. This indicates a failure in logical inference and synthesis across years. (4) Despite incorrect facts and reasoning, the answer is contextually relevant—it addresses investment strategy, fair value, and maturity distribution over time—so moderate relevance is scored. However, due to major factual and interpretive errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 507,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "Amazon introduced the 2.500% Note due 2050 in June 2020, as detailed in the 2022 10-K filing under Exhibit 4.6. By 2024, the note remained outstanding and was included in the listing of Amazon's long-term debt instruments in the 2024 10-K filing under Exhibit 4.6, indicating no material changes in its terms or status during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the introduction of the 2.500% Note due 2050 in June 2020 and its continued presence in Amazon's debt structure through 2024, with no material changes. This aligns with the ground truth. However, there is a discrepancy in the exhibit citation: the original answer states the note was listed in Exhibit 4.5 in 2022 (referencing the 2020 Officers' Certificate), while the LLM claims it was in Exhibit 4.6 in the 2022 10-K. The ground truth clarifies that Exhibit 4.6 in 2024 was a replication of Exhibit 4.5 from 2020, not 2022. Thus, the LLM misattributes the exhibit number and year of reference. (2) Quantitatively, all dates (June 2020), percentages (2.500%), and maturities (2050) are accurate. No calculations are involved, so numerical precision is maintained. (3) The reasoning is mostly sound—correctly inferring continuity of the note’s terms based on its reappearance in filings—but fails the multi-hop nuance of tracing the exhibit lineage (Exhibit 4.5 in 2020 → referenced in 2022 → replicated as Exhibit 4.6 in 2024). The LLM oversimplifies this evolution by stating it was in Exhibit 4.6 in 2022, which contradicts the ground truth. (4) Despite the exhibit error, the core message—that the note was introduced in 2020 and remained unchanged through 2024—is factually correct and contextually relevant. Hence, correctness is reduced to 7 due to the exhibit misattribution, which affects qualitative accuracy, but not enough to undermine the overall conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 417,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "Between 2022 and 2023, the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement increased from eight to twelve. In 2022, the agreement had amendments labeled 10.8.1 through 10.8.8, indicating eight amendments. By 2023, additional amendments (10.8.9 through 10.8.12) were added, bringing the total to twelve amendments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the number of amendments increased from eight in 2022 to twelve in 2023, which aligns with the ground truth indicating the Eighth Amendment in 2022 and the Twelfth Amendment in 2023. However, the LLM introduces a detail not present in the ground truth—amendments labeled '10.8.1 through 10.8.8' and '10.8.9 through 10.8.12'—which is unsupported by the original answer and potentially misleading. There is no mention of such labeling in the knowledge graph, so this appears to be an invention or misinterpretation. (2) The quantitative claim of four additional amendments (from 8 to 12) is correct, but the specific filing dates—March 10, 2022, and October 11, 2023—are omitted in the LLM answer, which weakens its factual completeness. These dates are key for verifying the timeline. (3) The reasoning is partially sound: the model correctly infers an increase of four amendments, demonstrating basic multi-hop understanding. However, it fails to reference actual filing dates or events, instead relying on assumed numbering, which undermines the reliability of the synthesis. (4) The answer is contextually relevant and addresses the evolution of amendment count, but the invented labeling scheme reduces quantitative and qualitative accuracy. While the core numerical progression (8 to 12) is correct, the lack of verifiable details and introduction of unverified structure leads to a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 406,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "NVIDIA's approach to CUDA has evolved significantly between 2022 and 2024, particularly in terms of integration with new computing architectures and software ecosystems. In 2022, CUDA was positioned as a foundational parallel programming model for NVIDIA GPUs, enabling accelerated computing across AI, data analytics, and scientific workloads. By 2024, CUDA's role expanded with the introduction of the Blackwell architecture, which integrates GPUs, CPUs, DPUs, and advanced networking to deliver data-center-scale solutions optimized for generative AI and other compute-intensive applications. Additionally, CUDA-X, a collection of acceleration libraries, APIs, and SDKs, has been further developed to support domain-specific frameworks, enhancing CUDA's versatility across AI, HPC, and graphics workloads. This evolution reflects NVIDIA's broader strategy to unify its computing platforms and strengthen its ecosystem for diverse applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: CUDA's foundational role in 2022 across AI, data analytics, and scientific computing is accurately described, and by 2024, its expansion into a full-stack platform with CUDA-X libraries, APIs, and SDKs is correctly noted. The integration with heterogeneous architectures (GPUs, CPUs, DPUs) is properly emphasized, reflecting NVIDIA's strategic shift. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the answer synthesizes CUDA’s evolution across time (2022 to 2024), architectural integration (Blackwell, CPUs, DPUs), and software ecosystem expansion (CUDA-X, domain-specific frameworks). The mention of the Blackwell architecture, while not in the original answer, is contextually appropriate for 2024 advancements and does not contradict the ground truth; it adds timely detail without introducing error. (4) The only minor gap is that the original answer specifically notes CPUs were introduced in fiscal 2024, which the LLM answer implies but does not explicitly state. Otherwise, semantic equivalence is strong, and the response fully addresses the question’s focus on architectural and ecosystem integration. Thus, the correctness score is 9 due to this slight omission, but all other dimensions are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 408,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial relationship with Paxlovid underwent a significant transformation. In 2023, Paxlovid contributed $1,279 million in revenue, but this was heavily impacted by a $3.5 billion non-cash revenue reversal in the fourth quarter due to the expected return of EUA-labeled U.S. government inventory. By 2024, Paxlovid's revenue surged to $5,716 million, driven by a favorable $771 million adjustment from returned EUA-labeled treatment courses and the transition to commercial market sales, including $442 million in revenue from supplying the U.S. Strategic National Stockpile (SNS) at no cost. Contractual obligations also evolved, with amended agreements facilitating the shift from government contracts to commercial markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the reported 2024 revenue figure of $5,716 million, which is not supported by the ground truth. The original answer does not state total 2024 Paxlovid revenue, only that a $771 million favorable adjustment and $442 million from SNS supply were recorded. The LLM incorrectly implies total revenue of $5.7 billion, which is a major quantitative error. Additionally, the claim that Paxlovid revenue 'surged' in 2024 contradicts the ground truth, which indicates reduced commercial activity. (2) The $1.279 billion 2023 revenue and $3.5 billion non-cash reversal are correctly stated (with acceptable formatting as $1,279 million). The $771 million favorable adjustment and $442 million SNS revenue are also accurate. However, the synthesis of these into a total revenue figure is unsupported and incorrect. The remaining performance obligation of $1 billion in 2024 is omitted entirely, a key contractual obligation detail. (3) The multi-hop reasoning is partially sound—linking the 2023 reversal to 2024 adjustment and recognizing the shift from government to commercial markets—but fails to accurately synthesize the full financial picture. The omission of the $1 billion in remaining obligations undermines the contractual analysis. (4) The contextual relevance is high as the answer addresses revenue recognition and contractual evolution, but the severe quantitative inaccuracies and missing core data (remaining obligations) limit correctness. The qualitative reasoning is partially accurate but overstated in its conclusions about revenue growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 448,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "The availability of shares under the 2003 Incentive Program decreased from 65,754,069 shares available in 2022 to 47,000,000 shares available by the end of 2024. The structure of the program remained consistent, with awards including restricted stock, stock options, and stock appreciation rights, and vesting periods typically spanning three to ten years. The reduction in available shares reflects the issuance of awards over this period, particularly with increased activity in 2024 due to the Pioneer acquisition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that the availability of shares decreased from 65,754,069 in 2022 to 47,000,000 in 2024, which misrepresents the ground truth. While it is correct that 47 million shares remained available by the end of 2024, the total maximum number of shares under the program was increased to 220 million — a critical expansion that the LLM completely omits. Instead, the answer frames the change as a simple reduction due to usage, missing the key structural increase. Additionally, the LLM incorrectly implies a continuous decline in availability without acknowledging the program's expansion. (2) Quantitatively, the 65,754,069 figure for 2022 is correct, and 47 million available in 2024 is approximately correct (though should be precise: 47 million vs. exact figure if specified). However, the failure to mention the increase to a 220 million share cap is a major omission. The restricted stock units granted increasing from 9,392 thousand to 10,393 thousand is entirely omitted. (3) The reasoning is flawed: the LLM attributes the lower available shares solely to issuance and the Pioneer acquisition, which is speculative and not supported in the ground truth. It fails to perform the necessary multi-hop synthesis — recognizing that the program was expanded despite moderate growth in grants. (4) Contextual relevance is moderate because the answer discusses share availability and program structure, which are relevant, but the incorrect emphasis on reduction and missing expansion severely undermine accuracy. The structure description (award types, vesting) may be factually consistent but is not confirmed in the ground truth, so it cannot be credited fully.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 473,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "Between 2022 and 2024, AdSense's role within Google's advertising revenue streams has evolved as part of the broader Google Network, which includes AdMob, Google Ad Manager, and AdSense. While AdSense has historically contributed to Google's advertising revenue, the 2024 report highlights a decline in AdSense-related impressions, partially offset by growth in AdMob. This shift reflects Google's ongoing focus on expanding and optimizing its advertising technology portfolio, leveraging AI advancements and product innovations to enhance ad formats and delivery across platforms. AdSense remains a component of the Google Network's contribution to advertising revenue but is increasingly complemented by other technologies driving growth in the broader advertising ecosystem.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual alignment but introduces inaccuracies. The ground truth states that in 2022, AdSense contributed to an $8.6 billion year-over-year revenue increase in the Google Network (alongside AdMob and Google Ad Manager), but the LLM answer omits this key quantitative figure and instead claims a 'decline in AdSense-related impressions' in 2024, which is not supported by the original answer. This is a significant factual deviation. (2) Quantitatively, the LLM fails to mention the $8.6 billion YoY growth in 2022, a central data point in the ground truth. No numbers are provided in the LLM response, and the claim of declining impressions is unsupported, leading to a low quantitative accuracy score. (3) Qualitatively, the LLM correctly identifies AdSense as part of the Google Network and acknowledges the rising importance of AI-powered tools (e.g., Demand Gen, Performance Max in the original), though it does not name them. However, it misrepresents the evolution by implying AdSense is declining rather than becoming a mature, foundational offering. The reasoning around portfolio optimization and AI integration is directionally plausible but lacks the correct strategic framing of a shift in emphasis, not performance. (4) Contextually, the answer is relevant and addresses the evolution of AdSense within Google's ad tech portfolio, but the incorrect emphasis on declining impressions undermines factual correctness. The synthesis across years and products is attempted but flawed, resulting in a mid-range correctness score due to partial alignment with the original answer's narrative but significant factual omissions and inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 462,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "The UPS Retirement Plan ceased future benefit accruals for non-union participants effective January 1, 2023. This change meant that non-union participants hired prior to July 1, 2016, no longer earned additional retirement benefits based on future service or compensation. Instead, beginning in 2023, non-union employees received retirement contributions of 5% to 8% of eligible compensation to the UPS 401(k) Savings Plan, based on years of vesting service.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key change — the cessation of benefit accruals for non-union participants effective January 1, 2023 — which aligns with the ground truth. It also accurately references the eligibility cutoff date (hired before July 1, 2016). However, the ground truth does not mention the 5% to 8% 401(k) contributions beginning in 2023 as a replacement, which is an addition not present in the original answer. While this may be factually accurate in a broader context, it was not part of the provided ground truth from the knowledge graph, making it an unsupported addition. (2) Quantitatively, the dates (January 1, 2023, and July 1, 2016) are correct, and the percentages (5%–8%) are plausible, but since they are not in the original answer, their accuracy cannot be verified from the knowledge graph. Their inclusion introduces information beyond the source, reducing quantitative fidelity. (3) The reasoning correctly captures the multi-hop element — the plan’s transition from active accrual to a closed status for non-union employees — and connects 2022’s announcement to 2023’s implementation. However, it adds a layer (the 401(k) shift) that wasn’t in the original synthesis, suggesting either external knowledge or inference not supported by the provided truth. (4) The contextual relevance is high because the answer directly addresses the evolution and specific changes. The core factual claim about the accrual freeze is correct, but the added detail about 401(k) contributions reduces qualitative and quantitative accuracy relative to the ground truth. Hence, correctness is 7 — mostly accurate but with unverified additions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 456,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "Between 2022 and 2024, Amazon's short-term credit facilities evolved in several key ways. First, the secured revolving credit facility, which was $1.0 billion in 2022, was repaid and terminated by 2024. Second, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, replacing the prior 364-day agreement from November 2023, with interest based on the Secured Overnight Financing Rate (SOFR) plus 0.45%. Additionally, the interest rate terms for short-term credit facilities improved, with the new facility having a lower spread compared to the prior secured facility, which had a spread of 1.25% over SOFR. Outstanding borrowings under short-term credit facilities remained low, with $147 million and $151 million as of December 31, 2023, and 2024, respectively. Overall, Amazon shifted to a more unsecured and cost-effective short-term credit structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It incorrectly states that Amazon had a $1.0 billion secured revolving credit facility in 2022 that was repaid and terminated by 2024. According to the ground truth, Amazon had a $7.0 billion unsecured revolving credit facility in 2022, not secured, and there is no mention of a $1.0 billion secured facility. The LLM also misrepresents the prior 364-day agreement as being from November 2023, which is not mentioned in the original answer. (2) Quantitative accuracy is low: the $7.0 billion 2022 facility is misrepresented as $1.0 billion and 'secured', while the interest rate is incorrectly stated as SOFR plus 1.25% (ground truth does not specify the rate on a prior 364-day facility, only that the new one is SOFR + 0.45%). The LLM correctly reports the $147 million and $151 million borrowings under other short-term facilities in 2023 and 2024, and the $5.0 billion 364-day facility in October 2024, but fails to mention the major expansion to a $15.0 billion unsecured revolving facility in 2024, a critical omission. (3) Multi-hop reasoning is partially sound—the LLM recognizes a shift toward unsecured, lower-cost facilities and correctly identifies the new $5.0 billion 364-day facility and increasing small borrowings. However, it misses the core evolution: the doubling of the main credit facility from $7.0B to $15.0B and the reduction in commitment fees (0.04% to 0.03%), which are central to the structural evolution. (4) Contextual relevance is high as the answer addresses credit capacity, interest rates, and borrowings, but the factual errors and omissions significantly undermine correctness. The qualitative accuracy is moderate due to correct identification of trends in cost and structure, but based on incorrect premises. Overall, the answer captures a partial and distorted view of Amazon's credit evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 514,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "Costco's use of variable-priced contracts for energy purchases remained consistent between 2022 and 2023, as both filings indicate the company uses variable-priced contracts for some electricity, natural gas, and fuel purchases on an index basis. This approach, combined with fixed-price contracts, reflects Costco's balanced commodity price risk management strategy, aiming to partially mitigate exposure to price fluctuations while maintaining operational flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that Costco used variable-priced contracts for electricity, natural gas, and fuel on an index basis in both 2022 and 2023, which matches the original answer. There are no numeric values to verify, so quantitative accuracy is 10. (2) The answer correctly identifies the entities (Costco), time periods (2022–2023), and energy types (natural gas, fuel, electricity), satisfying entity accuracy. (3) The reasoning is sound: it recognizes the continuation of the strategy and infers a balanced risk management approach. However, it adds that fixed-price contracts are part of the strategy, which, while plausible, is not mentioned in the ground truth and introduces information not confirmed by the source. This slightly reduces qualitative accuracy. (4) The answer addresses both parts of the question—evolution (consistency) and strategic implication (balanced risk management)—and remains highly relevant. The minor overreach in inferring a 'balanced' strategy with fixed-price contracts (not explicitly stated) prevents a perfect score, but the core facts and synthesis are correct, warranting a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 340,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "Between 2022 and 2024, NVIDIA AI Enterprise evolved from a comprehensive AI software suite to becoming a more integral and strategic component of NVIDIA's data center offerings. In 2022, it was positioned as an operating system for enterprise AI applications, emphasizing its role in simplifying the development and deployment of AI solutions. By 2024, NVIDIA AI Enterprise was highlighted as a core element of the full-stack data center platform, integrated with hardware, networking, and software solutions such as DGX Cloud, NIM, NeMo, and AI Blueprints. This evolution reflects NVIDIA's broader strategy to provide end-to-end AI infrastructure and tools, reinforcing its leadership in AI-driven computing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of NVIDIA AI Enterprise from 2022 to 2024 with accurate qualitative details. It correctly identifies the product's growing strategic importance within NVIDIA's data center offerings. However, it inaccurately states that in 2022 it was positioned as an 'operating system for enterprise AI applications,' which is not supported by the ground truth; instead, the original answer specifies it was part of the 'Compute & Networking segment' and a 'foundational role in AI and accelerated computing strategy.' The 2024 characterization is largely correct—highlighting integration with DGX Cloud, NIM, NeMo, and AI Blueprints aligns with the 'comprehensive suite of enterprise-grade AI software' and integration into broader data center solutions. (2) There are no numeric values, dates, or calculations in either answer beyond the years 2022 and 2024, which are correctly used in both responses—thus quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 vs 2024) and connects the product's evolution to broader strategic moves in NVIDIA’s data center platform. It correctly infers increased commercial and strategic importance, though it adds specific software names (NIM, NeMo, AI Blueprints) not mentioned in the ground truth, which, while plausible, go beyond the provided information. (4) The correctness score is 8 because the core factual trajectory—increased strategic and commercial role—is accurate, and the timeline is correct, but there is a minor misrepresentation of the 2022 positioning. Qualitative accuracy is slightly reduced for this over-interpretation, but contextual relevance is full as the answer directly addresses the evolution in strategic and commercial positioning as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 497,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "Between 2023 and 2024, Pfizer's contractual obligations related to Paxlovid evolved significantly. In 2023, Paxlovid revenues were primarily driven by government contracts, with a large portion tied to the U.S. government's Emergency Use Authorization (EUA) program. A $3.5 billion non-cash revenue reversal was recorded in Q4 2023 due to expected returns of EUA-labeled Paxlovid inventory. By 2024, the product transitioned to traditional commercial markets in the U.S., with negotiated pricing and a copay assistance program. This shift is reflected in Paxlovid's 2024 revenue of $5.7 billion compared to $1.3 billion in 2023, indicating stronger commercial market adoption and improved revenue expectations for the product.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies the $3.5 billion non-cash revenue reversal in Q4 2023 related to EUA-labeled Paxlovid returns from the U.S. government, it incorrectly states that Paxlovid generated $5.7 billion in revenue in 2024 compared to $1.3 billion in 2023. The ground truth does not provide 2024 Paxlovid revenue figures—instead, it states that remaining performance obligations as of December 31, 2024, were approximately $1 billion. The LLM fabricates a revenue comparison that is not supported by the original answer. Additionally, the claim that 2023 revenue was $1.3 billion is not in the ground truth and contradicts known public data (Pfizer reported ~$18.8 billion in Paxlovid revenue in 2022 and ~$5.1 billion in 2023 globally). (2) The calculation of revenue growth from $1.3B to $5.7B is therefore invalid and unsupported. The only correct number is the $3.5B reversal in Q4 2023. The $1B forward-looking obligation is mentioned in the ground truth but misrepresented in the LLM answer as implied revenue rather than contractual obligations. (3) The reasoning about a shift from government to commercial markets in 2024 is plausible and contextually sound, and the LLM correctly infers improved demand expectations. However, it fails to mention the key point from the ground truth: that the $1B remaining performance obligation (not actual revenue) indicates stabilization after the uncertainty of the 2023 reversal. This is a critical multi-hop synthesis failure—the LLM confuses contractual obligations with realized revenue. (4) The contextual relevance is high because the answer addresses the evolution of contractual obligations and revenue expectations. However, due to major quantitative errors and misrepresentation of performance obligations as revenue, the correctness score is limited to 5. The qualitative reasoning is partially sound but based on incorrect data, warranting a 6. Quantitative accuracy is low (4) due to fabricated revenue numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 561,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "Between 2022 and 2024, Google's exposure to new regulatory costs in international markets evolved in both scope and nature. In 2022, the focus was on general regulatory challenges, such as foreign policy changes, data transfer regulations between the EU and UK, and potential new customer requirements. By 2024, the scope expanded to include more specific and complex geopolitical risks, such as sanctions, export controls, and conflicts in regions like the Middle East and Ukraine, which directly impacted business continuity and regulatory compliance. Additionally, the nature of the challenges became more acute, with increased emphasis on regulatory uncertainty, evolving foreign policy landscapes, and the potential for litigation and new regulatory costs due to heightened geopolitical tensions and local legal complexities.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution in Google's regulatory exposure from 2022 to 2024, noting an expansion in scope and increased complexity. It accurately reflects that in 2022, Google cited foreign policy changes, EU-UK data transfers, and customer requirements as sources of regulatory cost—matching the ground truth. The 2024 developments are partially accurate: while the LLM correctly notes increased regulatory uncertainty and geopolitical risks, it introduces specific elements not present in the original answer—such as sanctions, export controls, and conflicts in the Middle East and Ukraine—which are not mentioned in the ground truth. The original answer emphasizes 'uncertainty regarding regulatory outcomes' and 'liabilities under local laws lacking due process or precedent' as new 2024 risks, rather than geopolitical conflicts per se. Thus, while the general direction of increased complexity and uncertainty is correct, the specific nature of the expanded risks is mischaracterized. There are no numerical values to verify, so quantitative accuracy is 10 by default. Qualitative accuracy is reduced due to the introduction of unsupported specifics, though core reasoning about broadening scope is sound. Contextual relevance remains high as the response directly addresses the comparative evolution in regulatory challenges.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 375,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "UPS's approach to funding postretirement medical benefits remained consistent between 2022 and 2023, with expected benefit payments being funded from both plan trusts and corporate assets. There is no indication of a change in the sources used for these payments during the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that UPS's funding approach for postretirement medical benefits remained unchanged between 2022 and 2023, with expected benefit payments funded from both plan trusts and corporate assets—this matches the original answer exactly in substance. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the years (2022 and 2023) are correctly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesized that the funding sources were the same in both years and inferred no change, which requires comparing disclosures across two annual reports. (4) The answer is concise, contextually relevant, and captures the key conclusion—no change in funding sources—without introducing inaccuracies or omissions. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 268,
        "total_tokens": 1438
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "NVIDIA AI Enterprise, introduced in 2022 as part of the Compute & Networking segment, has evolved significantly by 2024 to become a more comprehensive and integrated solution for enterprises. Initially positioned as a suite of enterprise-grade AI software, it now includes advanced tools such as NVIDIA NIM for enhanced token throughput, NVIDIA NeMo for model customization and evaluation, and AI Blueprints for secure, pre-built deployment templates. This expansion reflects NVIDIA's broader strategy to provide end-to-end AI solutions, supporting both generative AI and traditional machine learning applications across diverse industries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: NVIDIA AI Enterprise was introduced in 2022 under the Compute & Networking segment as an enterprise AI software suite, and by 2024 evolved to include NVIDIA NIM, NVIDIA NeMo, and AI Blueprints. The answer correctly identifies the platform's expansion into a full-stack solution supporting generative AI and traditional ML. (2) Quantitative accuracy is perfect—while the LLM does not explicitly mention the '2.5x increase in token throughput' from the ground truth, it correctly references 'enhanced token throughput' in connection with NVIDIA NIM, implying awareness of the performance improvement without misstating any numbers. No incorrect figures or dates are presented. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 to 2024), identifies the evolution in scope and integration, and correctly links new components to functional improvements. (4) The only minor omission is the lack of explicit mention of the '2.5x' performance gain, which slightly reduces completeness but does not affect factual correctness. Wording differs but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the evolution in role and scope as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 365,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "From 2022 to 2024, ExxonMobil's proved reserves through equity companies increased significantly, with total oil-equivalent reserves rising from 1,481 million barrels in 2024 (as detailed in the 10-K) to a higher level compared to 2022, which showed fewer equity company reserves. This growth is primarily driven by additions in Asia, where equity company reserves accounted for the majority of the increase. This indicates a strategic focus on expanding reserves in the Asia-Pacific region, likely through joint ventures and partnerships, to strengthen ExxonMobil's long-term resource base and maintain a competitive position in key growth markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and misrepresents the data. According to the ground truth, in 2022, ExxonMobil's proved reserves from equity companies were 14 million barrels gross (1 million net), not implied 'fewer' as vaguely stated. The LLM incorrectly states that '1,481 million barrels' were reported in 2024, which is entirely fabricated and does not match any sum of the actual 2024 figures (467 million barrels crude oil, 120 million barrels NGLs, and 5,367 Bcf gas). There is no indication in the ground truth of a total oil-equivalent figure like 1,481 million barrels. (2) The quantitative inaccuracies are severe: the LLM invents a number not present in the original answer and misstates the direction of comparison (claims 2024 number is 1,481M without providing 2022 equivalent). The actual 2022 figure is 14M barrels gross, so the growth is from 14M to a combined hydrocarbon base in 2024, but the LLM misrepresents both the baseline and the endpoint. (3) The qualitative reasoning partially captures the strategic shift toward Asia, which is correct per the original answer, and correctly infers that joint ventures or partnerships (equity companies) are part of the strategy. This shows some valid multi-hop inference about regional strategic positioning. (4) Contextually, the answer addresses both parts of the question—evolution of reserves and strategic implications—so it is relevant. However, due to major numerical errors and fabrication of data, the correctness score is low. The qualitative accuracy is moderate because the directional insight (Asia focus) is correct, but the foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 457,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "Between 2022 and 2024, Google Network Partners have remained a significant contributor to Alphabet's revenue generation, particularly through advertising on their properties. Google reports advertising revenues from Google Network properties on a gross basis, meaning the amounts billed to customers are recorded as revenues, while amounts paid to Google Network partners are recorded as cost of revenues. While the document does not provide specific figures for changes in revenue or cost structure related to Google Network Partners during this period, it does indicate that Google Network partners are primarily responsible for cost of revenues for ads displayed on their properties. The evolution of this relationship is likely influenced by Alphabet's broader financial trends, such as increased investment in technical infrastructure and AI, which may impact both the scale of advertising and the associated costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Google reports advertising revenues from Google Network properties on a gross basis and that payments to partners are recorded as cost of revenues, which aligns with the 2022 portion of the ground truth. However, it fails to capture the key evolution highlighted in the original answer — the shift in financial reporting emphasis by 2024 toward framing payments to partners as a primary use of cash from operating activities and a more cost-centric narrative. This missing insight significantly weakens the qualitative accuracy. (2) There are no numerical figures in either answer, so quantitative accuracy is not compromised; the LLM does not fabricate or misstate any numbers, earning full marks here. (3) The multi-hop reasoning is partially sound — it correctly synthesizes the role of Google Network Partners in revenue and cost structure — but it does not fully bridge the change over time (2022 to 2024) as required. The original answer emphasizes a shift in reporting perspective and financial framing, which the LLM overlooks. (4) Contextual relevance is high because the response stays on topic and discusses the financial relationship, revenue generation, and cost structure, but the lack of temporal evolution limits completeness and reasoning quality, justifying a moderate overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 381,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "Between 2022 and 2023, the financial impact of undesignated foreign currency forward contracts on UPS's earnings volatility decreased significantly. In 2023, UPS recognized a loss of $7 million in \"Investment income and other\" related to these contracts, compared to a much larger loss of $69 million in 2022. This reduction suggests a more stable foreign currency exchange risk management strategy in 2023, with less volatility in earnings due to non-hedging derivative activities.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and misrepresents the evolution of UPS's foreign currency exchange risk management strategy between 2022 and 2023. (1) The original answer (ground truth) focuses on qualitative changes in disclosure practices and transparency—specifically, that UPS enhanced its reporting by providing a more structured, side-by-side presentation of fair value changes and settlements for undesignated foreign currency forward contracts, and emphasized their link to earnings volatility in 2023. However, the LLM answer fabricates specific financial figures—$7 million loss in 2023 and $69 million loss in 2022—that are not present in the ground truth and cannot be verified from the provided context. (2) There is no mention in the original answer of actual loss amounts or a reduction in losses; thus, the quantitative claims are unsupported and likely false. The comparison of 'Investment income and other' impacts is invented. (3) The multi-hop reasoning fails because the LLM does not synthesize disclosure evolution or transparency improvements, but instead invents a narrative around earnings volatility reduction based on phantom data. (4) While the LLM attempts to address earnings volatility and risk management strategy, it misses the core point about disclosure evolution and introduces inaccurate specifics, severely undermining factual correctness. The contextual relevance is moderate because it discusses the right topic (foreign currency forwards and earnings volatility) but with incorrect details and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 423,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Between 2022 and 2023, Costco's membership format continued to play a central role in its profitability strategy by reinforcing member loyalty and generating stable fee revenue. In 2022, membership fee revenue increased by 9% to $4,224 million, driven by new member sign-ups, Executive membership upgrades, and higher renewal rates. By 2023, membership fee revenue further grew by 5% to $4,828 million, primarily from new member sign-ups and Executive upgrades, though growth was partially offset by one fewer week of operations in the 2024 fiscal year. This evolution highlights Costco's sustained focus on expanding its membership base and enhancing member value, which supports long-term profitability through recurring fee income and increased shopping frequency.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims membership fee revenue increased from $4,224 million in 2022 to $4,828 million in 2023 (a 14.3% increase, not 5%), but the actual figures from Costco's 10-K filings are approximately $3.98 billion in 2022 and $4.42 billion in 2023, representing a ~11% increase. The stated 9% and 5% growth rates are incorrect, and the reference to 'one fewer week of operations in the 2024 fiscal year' is irrelevant and confusing in the context of comparing 2022 and 2023. (2) These numerical errors severely undermine the answer's credibility. The LLM fabricates precise figures that do not align with the ground truth or actual filings. (3) Qualitatively, the answer correctly identifies that membership growth, Executive upgrades, and renewals are key to Costco's profitability and that fee revenue supports long-term profitability. However, it completely misses the evolution in narrative tone and strategic concern highlighted in the ground truth: the shift in language from 'significant effect on profitability' in 2022 to 'integral to profitability' in 2023, and the new mention in 2023 of risks related to lower renewal rates in newer markets affecting the global renewal rate. This is a critical multi-hop insight that the LLM fails to capture. (4) While the answer stays on topic and addresses member loyalty and fee revenue, the severe quantitative inaccuracies and omission of key qualitative shifts in strategy and risk disclosure result in a low correctness score. Contextual relevance is moderate because the general theme is addressed, but the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 463,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "Between 2022 and 2024, NVIDIA's approach to CUDA has evolved significantly, with greater integration into its broader data center platform and software ecosystem. In 2022, CUDA was highlighted as a foundational programming model for enabling accelerated computing across diverse markets, including AI, data analytics, and scientific computing. By 2024, CUDA had expanded to support a full-stack data center infrastructure, now integrated with CPUs, DPUs, and advanced networking solutions, forming the backbone of the NVIDIA Blackwell architecture. This evolution reflects CUDA's role in enabling scalable AI and high-performance computing workloads, including generative AI, while also supporting NVIDIA's AI Enterprise software suite and cloud-based offerings like DGX Cloud.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of CUDA between 2022 and 2024. It accurately captures the shift from CUDA as a foundational programming model in 2022—used across AI, data analytics, and scientific computing—to a more deeply integrated component of a full-stack data center platform by 2024. The mention of integration with CPUs, DPUs, and networking solutions reflects the correct trajectory of CUDA’s expansion into heterogeneous computing infrastructure. The reference to NVIDIA Blackwell architecture and DGX Cloud, while not explicitly in the ground truth, is contextually plausible for 2024 developments and does not contradict known information. However, the LLM omits specific details present in the original answer, such as the 3 million developers, the Deep Learning Institute, Inception program, and the explicit framing of CUDA as the foundation of CUDA-X libraries and domain-specific frameworks. These omissions reduce completeness and precision in the qualitative synthesis, though the core reasoning about strategic evolution remains sound. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is highly relevant to the question. The reasoning reflects a correct multi-hop understanding of CUDA’s expanding role, even if some supporting evidence from the ground truth is missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 385,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "Pfizer's financial commitment and contractual obligations related to Paxlovid evolved significantly from 2023 to 2024. In 2023, Paxlovid contributed $1,279 million in revenue, a sharp decline from $18,933 million in 2022, reflecting a shift from government contracts to commercial markets. In 2024, Paxlovid revenue rose to $5,716 million as commercialization expanded. Contractually, remaining performance obligations for Paxlovid were $1 billion as of December 31, 2024, with delivery expected through 2028. Additionally, in 2024, Pfizer supplied 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) at no cost, recognizing $442 million in revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, Pfizer recorded a $3.5 billion non-cash revenue reversal due to expected returns of Paxlovid from U.S. government inventory, not $1,279 million in revenue as claimed. The LLM incorrectly reports positive revenue figures for 2023 and 2024, while the original answer emphasizes a revenue reversal and shift in contractual obligations, not commercial revenue growth. The $1 billion remaining performance obligation figure for 2024 is correct and matches the ground truth, as is the delivery timeline through 2028. However, the mention of $5,716 million in 2024 revenue and $442 million recognized from a no-cost SNS delivery is not supported by the original answer and contradicts the narrative of revenue reversals and uncertain government returns. (2) Quantitative accuracy is severely compromised: the $3.5 billion reversal is entirely omitted, replaced with incorrect positive revenue numbers. The $1 billion forward obligation is correct, but the additional revenue figures and the $442 million item are unsupported. (3) Multi-hop reasoning is flawed: the LLM fails to connect the 2023 revenue reversal to the shift in contractual risk and instead fabricates a commercial revenue recovery story. It does not explain the evolution from uncertain returns (2023) to firm contracts (2024 onward) as required. The synthesis is incorrect because it introduces unrelated commercial revenue data not present in the ground truth. (4) Contextual relevance is moderate because the answer discusses Paxlovid obligations and timelines, but it misrepresents the core financial evolution. The focus on commercial revenue growth distracts from the actual shift from government inventory returns to long-term contractual delivery. Correctness is low due to major factual and directional errors in financial interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 518,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana has significantly intensified between 2022 and 2024, as evidenced by its reporting of reserves development and inclusion of Guyana as a key component of its \"advantaged assets.\" In 2022, Guyana was highlighted in the context of reserves additions, particularly with discoveries and extensions in the country contributing to proved undeveloped reserves. By 2024, Guyana is explicitly categorized under ExxonMobil's \"advantaged assets,\" which are central to its growth strategy and high-return projects. This shift reflects a more integrated and strategic focus on Guyana as a core asset for long-term volume and earnings growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Guyana's role in reserves growth in 2022 (adding ~1.3 billion oil-equivalent barrels) is accurately reflected in the description of discoveries and extensions contributing to proved undeveloped reserves. While the exact number '1.3 billion GOEB' is not explicitly mentioned, the qualitative description of Guyana’s contribution to reserves via discoveries and extensions is consistent with the original answer. (2) The 2024 update correctly identifies Guyana being explicitly listed as an 'advantaged asset' in ExxonMobil's earnings drivers, signaling a strategic shift toward volume and earnings growth. The LLM captures this evolution accurately. (3) Multi-hop reasoning is sound—synthesizing information across 2022 (reserves focus) and 2024 (advantaged asset/earnings focus) to show strategic progression. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly state the transition from 'reserves growth region' to 'source of advantaged production and earnings visibility' using those precise conceptual terms, though the meaning is effectively conveyed. No quantitative errors; all dates and metrics are correctly used. The answer is fully contextually relevant and addresses both reserves development and advantaged asset reporting as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 381,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "From 2022 to 2024, the planned utilization of the ATR 72-600F aircraft decreased significantly, with 24 planned deliveries through 2025 in 2022, dropping to just 10 planned deliveries through 2025 by 2024. This reduction indicates that the ATR 72-600F is playing a diminished role in FedEx's fleet strategy, as the company is shifting focus toward larger, more fuel-efficient aircraft like the B767F and B777F, which are expected to provide long-term operating savings and replace older aircraft.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that the number of ATR 72-600F units was projected to decrease from 11 in 2023 to 1 by 2026 in the 2022 plan, but by 2024, the projection shifted to 7 units in 2025 and 3 in 2026—indicating a slower phase-out. The LLM instead claims '24 planned deliveries through 2025 in 2022' dropping to '10 planned deliveries through 2025 by 2024', which contradicts the ground truth. There is no mention of 'deliveries' in the original answer, nor are the numbers aligned with the fleet size projections. (2) The numbers are entirely inaccurate: 24 and 10 do not appear in the ground truth; the correct figures are 11, 7, 3, and 1 across years. The LLM confuses 'planned deliveries' with 'planned units in fleet', which is a critical error. (3) The multi-hop reasoning is flawed—the LLM fails to capture the evolution from a steep decline to a more sustained role. Instead, it interprets the trend as a straightforward reduction in deliveries, missing the nuance that the aircraft’s role became more stable than initially expected. (4) While the LLM attempts to address fleet strategy and mentions a shift to larger aircraft (contextually plausible), this inference is not supported by the provided ground truth and introduces unverified details (e.g., FedEx, B767F, B777F). Thus, the answer fabricates key data and misrepresents the strategic implication. Correctness and quantitative accuracy are severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 421,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "Between 2022 and 2024, NVIDIA's approach to offering Omniverse evolved significantly in terms of integration with AI and simulation platforms. In 2022, Omniverse was primarily positioned as a virtual world simulation and collaboration platform for 3D workflows, with a focus on enterprise use and individual access. By 2024, Omniverse had expanded into a more comprehensive development platform and operating system for building and running virtual world simulation applications, with deeper integration into NVIDIA's AI ecosystem, including AI model training and autonomous vehicle development via DRIVE Constellation and DRIVE Sim. Additionally, Omniverse was increasingly used in data center-based simulation solutions and digital twin applications, reflecting a broader and more interconnected role within NVIDIA's AI and simulation infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 description of Omniverse as a 3D collaboration and simulation platform for enterprise and individual use is accurate; the 2024 evolution into a comprehensive development platform and operating system for virtual world simulations is correctly stated. The shift toward digital twins, industrial applications, and deeper integration with AI and simulation platforms is well captured. (2) There are no numeric values, dates, or financial figures in dispute—both answers reference 2022 and 2024 appropriately, and no calculations are required. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution of Omniverse’s purpose and integration, connecting it to NVIDIA’s broader AI ecosystem, including DRIVE Constellation and DRIVE Sim, which are relevant simulation platforms for autonomous vehicles. While the original answer does not explicitly name DRIVE Constellation or DRIVE Sim, these are plausible and accurate examples of integration that support the broader claim of deeper AI/simulation platform integration. (4) The only minor gap is that the LLM emphasizes 'data center-based simulation solutions' and 'AI model training' slightly more than the original answer, which focuses on digital twins for factories and robotics testing. However, these are contextually consistent expansions, not inaccuracies. Overall, the answer is semantically equivalent, highly relevant, and factually correct, warranting a 9/10 due to slight elaboration beyond the ground truth without contradiction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 445,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "Between 2022 and 2023, Google Play's role in generating non-advertising revenue continued to grow as part of Alphabet's broader expansion into non-advertising revenue streams. In 2023, Google Play remained a key contributor to \"Google subscriptions, platforms, and devices\" revenue, which includes sales of apps and in-app purchases. While specific revenue figures for Google Play are not provided, the overall increase in Google Services revenue by $19.0 billion (8%) year-over-year suggests a positive contribution from Google Play. Additionally, the 2023 filing emphasizes continued investment in platforms like Google Play, reflecting its importance in Alphabet's diversification strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Google Play's role in non-advertising revenue and its inclusion in the 'subscriptions, platforms, and devices' category in 2023, which aligns with the ground truth's emphasis on its evolving strategic role. However, the ground truth specifies a structural evolution in categorization—Google Play transitioning into a more defined 'platforms' revenue stream—while the LLM answer does not explicitly mention this re-categorization or strategic refinement, missing a key qualitative nuance. (2) The LLM introduces a $19.0 billion YoY increase in Google Services revenue as supporting evidence, which may be factually accurate but is not directly tied to Google Play’s performance and is absent from the original answer. This figure, while plausible, is not verifiable from the ground truth and risks implying a quantitative link that isn’t substantiated. No calculation errors are present, but the use of this aggregate figure slightly undermines quantitative precision in context. (3) The multi-hop reasoning is partially sound: the model connects Google Play to broader non-ad revenue efforts and infers continued importance from investment trends. However, it fails to fully synthesize the shift in strategic framing—from diversification component to structured monetization platform—as emphasized in the original. (4) Scores reflect strong factual alignment and relevance, with minor gaps in qualitative depth and slight overreliance on external-seeming aggregate data not in the ground truth, reducing completeness and reasoning accuracy by a degree.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 439,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "AIG's use of expected loss ratio methods in workers' compensation reserving for guaranteed cost and excess of deductible business evolved between 2022 and 2023 by extending the period of significant weight given to these methods. In 2023, expected loss ratio methods for excess of deductible business were applied to the most recent five accident years, compared to prior years where they were primarily used for the most recent accident year in guaranteed cost business. This shift reflects a greater reliance on expected loss ratios for newer, high-deductible policies, which have slower claim emergence patterns. Additionally, the proportion of large deductible business has increased, further influencing the slower reporting of claims and the need for more forward-looking reserving techniques like expected loss ratios.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that in 2023, expected loss ratio methods for excess of deductible business were applied to the most recent five accident years 'compared to prior years where they were primarily used for the most recent accident year in guaranteed cost business.' This misrepresents the timeline and direction of change. According to the ground truth, in 2022, AIG already applied expected loss ratio methods to the most recent five accident years for excess of deductible business, not starting in 2023. The LLM implies a shift or expansion in 2023 that did not occur. Additionally, the claim that there was a 'shift' or 'evolution' toward greater reliance on expected loss ratios in 2023 is unsupported—the original answer states the methodology remained 'broadly consistent.' (2) There are no explicit numerical values (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is assessed on temporal and structural accuracy. The years and application periods (e.g., 'most recent accident year' vs. 'five accident years') are critical data points. The LLM reverses the comparative framing, incorrectly suggesting a change over time when the ground truth emphasizes consistency. (3) The multi-hop reasoning is flawed. The LLM fails to correctly synthesize the continuity between 2022 and 2023, instead inventing a methodological evolution that contradicts the source. It also conflates the impact of large deductible business on claims reporting with a change in methodology, while the original answer treats this as a consistent trend, not a change. (4) Despite these errors, the answer is contextually relevant—it addresses the right companies, lines of business, and general reserving concepts. It correctly identifies the relevance of claim emergence patterns and the role of large deductible policies. However, the core factual claim about methodological evolution is incorrect, warranting a low correctness score. The qualitative accuracy is low due to flawed reasoning, but quantitative accuracy is moderate because the error is in temporal attribution rather than numeric precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 586,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024 by consolidating and reorganizing its categories. In fiscal 2022, the categories were Secure, Agile Networks; Internet for the Future; Collaboration; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, these were simplified into Networking, Security, Collaboration, and Observability. The Collaboration category saw a slight revenue increase of 2% in fiscal 2024 compared to fiscal 2023, driven by growth in offerings other than Meetings, following a 9% decline in fiscal 2023 compared to fiscal 2022 due to declines in Collaboration Devices and Meetings.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the evolution in Cisco's product category segmentation from six categories in fiscal 2022 to four in fiscal 2024, and accurately lists the 2022 categories including 'Collaboration' and the 2024 categories (Networking, Security, Collaboration, Observability). This aligns with the ground truth and shows correct entity identification and structural understanding. However, the LLM introduces quantitative claims not present in the original answer or question focus: specifically, a '2% revenue increase in fiscal 2024 compared to fiscal 2023' and a '9% decline in fiscal 2023 compared to fiscal 2022'. These figures are not mentioned in the ground truth and were not requested by the question, which focused on structural evolution, not financial performance. (2) The quantitative inaccuracies are significant because they introduce unsupported data, failing the quantitative accuracy criterion. There is no verification that these percentages are correct, and their inclusion misrepresents the scope of the answer. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes the change in category structure across years and retains Collaboration as a consistent category. However, it incorrectly shifts focus to revenue trends, which were not part of the original question or ground truth, indicating a deviation in reasoning. (4) The contextual relevance is high because the core of the answer addresses the segmentation evolution directly. Qualitative accuracy is moderate due to correct categorization but flawed extension into unrequested financial analysis. Correctness score is reduced due to unsupported numerical claims, though the structural description remains accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 474,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "Amgen's disclosure regarding the 3.125% 2025 Notes remained consistent in terms of the stated coupon rate from 2022 to 2023, with both years reporting a $1,000 million principal amount. However, in 2023, there was a notable addition of new notes issued in connection with the acquisition of Horizon, including the 5.25% 2025 Notes with a $2,000 million principal amount, which expanded the overall interest rate framework for 2025 maturities. This indicates a broader and more complex debt structure for 2025 in 2023 compared to 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states the $1,000 million principal amount for the 3.125% 2025 Notes in both years, it incorrectly introduces '5.25% 2025 Notes with a $2,000 million principal amount' related to the Horizon acquisition, which is not part of the ground truth and confuses the subject of the question. This misrepresents the evolution of disclosure for the specific 3.125% 2025 Notes. (2) Quantitatively, the $1,000 million carrying value is accurate for 2022, but the answer fails to mention that in 2023, the key change was the disclosure of the interest rate framework as SOFR + 2.1%, not the addition of new notes. There are no calculations in the answer, but the introduction of false financial figures (e.g., $2,000 million 5.25% notes) severely undermines quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks about the evolution in disclosure and interest rate framework for a specific note, but the model shifts focus to a different note and acquisition context not mentioned in the ground truth. It fails to recognize that the core evolution is from no interest rate framework disclosed in 2022 to SOFR + 2.1% being explicitly stated in 2023. (4) Contextual relevance is partially met as it discusses Amgen and the 3.125% 2025 Notes, but the erroneous expansion into unrelated debt instruments and acquisition-related notes distracts from the actual disclosure evolution. The answer does not reflect the actual shift from purely quantitative to enhanced qualitative-quantitative disclosure as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 445,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 764 billion cubic feet (BCF) at the end of 2021 to 296 BCF at the end of 2024. This decline indicates a strategic shift away from natural gas in that region, with the company focusing more on other areas like the Lower 48 and Canada. The reduction in reserves is partly attributed to downward revisions due to lower prices and changes in development plans, suggesting a reduced emphasis on natural gas exploration and development in Asia Pacific/Middle East.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that COP's natural gas reserves increased from 764 BCF in 2021 to 296 BCF in 2024, which is incorrect on multiple levels. The ground truth reports reserves of 326 BCF in 2022 (not 2021) and 296 BCF in 2024, showing a decrease—not an increase—from a much lower starting point. The 764 BCF figure appears to be entirely fabricated or misattributed. (2) Quantitative accuracy is severely compromised: the starting value (764 vs 326), the year (2021 vs 2022), and the direction of change are all wrong. While the 2024 number (296 BCF) is correct, the comparison is invalid due to incorrect baseline data. (3) The reasoning partially aligns with the ground truth in interpreting the decline as a strategic shift, which is a plausible conclusion given the reduction. However, the multi-hop synthesis fails because it uses incorrect data points and timeframes. The mention of 'Lower 48 and Canada' is contextually relevant but not supported or required by the original question. (4) The contextual relevance is moderate because the answer addresses the strategic implication question, but the flawed data undermines the validity of the conclusion. Correctness is low due to major numerical and temporal errors, despite identifying a real trend (decline) in the right region.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 376,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "Alphabet's repurchase activity of Class C Capital Stock increased from $52.6 billion in 2022 to $52.9 billion in 2023, indicating a slight rise in the company's commitment to returning value to shareholders. This consistent level of repurchases suggests that Alphabet remains focused on capital allocation strategies that prioritize share buybacks as a means to enhance shareholder value, particularly amid strong cash flow generation and a large cash reserve.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported repurchase amounts. The ground truth states that Alphabet repurchased $59.3 billion in 2022 and $62.2 billion in 2023, while the LLM incorrectly reports $52.6 billion and $52.9 billion, respectively. These numbers are materially off by several billion dollars, which undermines the quantitative foundation of the response. Additionally, the LLM fails to mention the key detail that the repurchases include both Class A and Class C shares (not just Class C), and omits the critical information about the April 2023 $70.0 billion authorization and the $36.3 billion remaining as of year-end 2023. (2) The calculations or comparisons implied (a slight rise from $52.6B to $52.9B) are numerically accurate within the LLM's own incorrect framework, but the actual year-over-year increase should be from $59.3B to $62.2B, which is a more substantial increase than portrayed. (3) The reasoning about capital allocation strategy—emphasizing shareholder returns via buybacks—is directionally correct and aligns with the ground truth interpretation. However, the multi-hop synthesis is flawed because the model does not integrate the new authorization or the remaining capacity, which are essential for assessing the strategic expansion of buybacks. (4) The contextual relevance is fair because the answer addresses the question’s intent regarding changes in repurchase activity and strategic implications, but due to major numerical errors and missing key facts, the overall correctness score is low. The qualitative reasoning is partially sound but built on incorrect data, leading to a misleading portrayal of the scale and trajectory of Alphabet's buyback program.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 475,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "Between 2022 and 2023, AIG's use of frequency/severity methods has evolved in terms of the lines of business where they are applied and the reasoning behind their usage. In 2022, the focus was on short-tail classes such as U.S. Property, where frequency/severity methods, loss development methods, and IBNR factor methods were used alone or in combination. The IBNR factor method was particularly used for low-frequency/high-severity losses, with factors adjusted for current cost levels and emerging claim experience.\n\nIn 2023, the application of these methods expanded to include more nuanced considerations. For U.S. Workers' Compensation, a long-tail line of business, AIG used a combination of loss development, frequency/severity, and expected loss ratio methods. The reasoning for using frequency/severity methods in 2023 was driven by the need to account for risk-sharing features in policies, such as high deductibles and retrospective rating, which altered claim reporting patterns and required more detailed segmentation by deductible size and claim handling. This evolution reflects AIG's adaptation to changing risk profiles and the need for more precise reserve estimation in complex and evolving underwriting environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, AIG used frequency/severity methods primarily for short-tail lines like U.S. Property and avoided them for aviation due to high severity and claim volatility—this is correctly reflected. In 2023, the expansion to U.S. Workers' Compensation, a long-tail line, using a combination of methods including frequency/severity, loss development, and expected loss ratio, is accurately reported. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable in terms of arithmetic, but all temporal references (2022, 2023) and business lines are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes over time across different lines of business and explains the reasoning behind methodological shifts, including the impact of risk-sharing features like large deductibles and retrospective rating. (4) The only minor shortcoming is that the original answer explicitly mentions AIG avoided frequency/severity for aviation exposures in 2022, which the LLM omits. While the LLM correctly describes the 2022 usage in short-tail lines, the specific exclusion for aviation is missing, slightly reducing completeness. Otherwise, the reasoning, entity accuracy (AIG, U.S. Workers' Compensation, U.S. Property), and contextual relevance are excellent. The answer fully addresses the evolution in application and rationale, making it semantically equivalent with only a minor omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 432,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "Amgen's financial relationship with BeiGene from 2022 to 2023 shows a decline in cost recovery, with net costs recovered from BeiGene for oncology product candidates decreasing from $199 million in 2022 to $109 million in 2023. Product sales from Amgen to BeiGene increased from $64 million in 2022 to $125 million in 2023, while profit and loss share expenses decreased from $53 million in 2022 to $40 million in 2023. As of December 31, 2023, amounts owed from BeiGene for product sales were $16 million, and net amounts owed from BeiGene for cost recoveries and profit and loss share payments were $44 million, compared to $6 million and $47 million, respectively, as of December 31, 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects: cost recovery decreased from $199M to $109M, product sales increased from $64M to $125M, and profit and loss sharing expenses decreased from $53M to $40M—all figures are correct and properly attributed to 2022 and 2023. The additional detail about amounts owed as of December 31, 2023, and 2022 ($16M vs $6M for product sales; $44M vs $47M for cost recoveries and P&L) is consistent with the knowledge graph and adds contextual depth without contradicting the original answer. The reasoning correctly identifies the trend: declining cost recovery and P&L expenses alongside rising product sales, indicating maturation of the collaboration. The only minor limitation is that the LLM does not explicitly state the interpretive conclusion about 'maturation of the collaboration' as in the original answer, though the data presented fully supports it. This omission does not detract significantly from the qualitative accuracy. All entities (Amgen, BeiGene), time periods (2022, 2023), and financial metrics (cost recovery, product sales, profit and loss sharing) are correctly identified and synthesized. The answer demonstrates strong multi-hop reasoning by integrating data across years and financial categories. Wording differs slightly but maintains semantic equivalence. No calculation errors; number formats are consistent and acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 395,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "From 2022 to 2024, COP's natural gas reserves in the Asia Pacific/Middle East region experienced the following changes:\n\n- **Revisions**: In 2024, there were minor upward revisions of 6 BCF in the Asia Pacific/Middle East region due to technical updates and development plan adjustments, though these were relatively small compared to other regions. In 2023, the region faced downward revisions, primarily due to infrastructure constraints and sales demand revisions, while in 2022, upward revisions were driven by higher prices and improved regional LNG market dynamics.\n\n- **Production**: Natural gas production in the Asia Pacific/Middle East region reduced reserves by 25 BCF in 2023 and 24 BCF in 2022, reflecting ongoing extraction activities.\n\n- **Purchases**: There were no significant purchases in the Asia Pacific/Middle East region in 2024 or 2023. However, in 2022, purchases in equity affiliates were due to the acquisition of additional affiliate interest in the Asia Pacific region.\n\nOverall, the region's natural gas reserves remained relatively stable, with changes primarily influenced by production and minor revisions rather than major acquisitions or discoveries.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. The ground truth states that COP's natural gas reserves decreased from 326 BCF in 2022 to 296 BCF in 2024, implying a net reduction of 30 BCF. However, the LLM does not report the starting and ending reserve levels, which is a key part of the question. Instead, it focuses on intermediate activity without synthesizing the overall trend correctly. (2) Quantitative inaccuracies include: (a) claiming 6 BCF upward revisions in 2024, whereas the truth states 9 BCF revisions in 2023 (not 2024), and no mention of 2024 revisions; (b) reporting production of 25 BCF in 2023 and 24 BCF in 2022, while the truth specifies 25 BCF subtracted in 2024 (not 2023 or 2022); (c) incorrectly stating production occurred in 2022 and 2023, when the truth only mentions production impact in 2024. (3) The multi-hop reasoning is partially sound in structure—addressing revisions, production, and purchases—but fails to align the data across years correctly. It introduces unsupported claims like 'downward revisions in 2023' and 'upward revisions in 2022' not present in the original answer. The mention of 2022 purchases due to affiliate acquisitions contradicts the ground truth, which does not mention any purchases affecting the region in 2022. (4) Despite these errors, the answer is contextually relevant and attempts to address all components of the question (evolution of reserves, revisions, production, purchases). The qualitative reasoning framework is appropriate, even if the data is misaligned. However, the failure to report the actual reserve levels and misattribution of figures across years significantly undermines factual correctness. Minor formatting variations are acceptable, but the core numbers and their temporal assignment are incorrect, leading to a low quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 514,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "From 2022 to 2024, FedEx's planned usage of the B767F aircraft decreased significantly. In 2022, FedEx had committed to purchasing 38 B767F aircraft across 2023 and 2024, but by 2024, the total number of B767F aircraft planned for purchase was reduced to 14, with deliveries scheduled only in 2025. This reduction indicates a strategic shift in fleet planning, likely driven by evolving operational needs, fuel efficiency considerations, or financial optimization, as FedEx prioritized other aircraft types like the Cessna SkyCourier 408 and ATR 72-600F for regional and mid-size freight operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that FedEx projected using 14 B767F aircraft in 2023 and 2024 (with a reduction to 10 by 2025) in 2022, and by 2024, the projection changed to 11 for 2025 and only 3 by 2026. The LLM incorrectly claims that FedEx 'committed to purchasing 38 B767F aircraft across 2023 and 2024' in 2022, which is not supported by the ground truth. There is no mention of a purchase commitment of 38 aircraft in the original answer, nor is there any indication that purchases were scheduled only in 2025. The number '38' is entirely fabricated. The LLM also misrepresents the timeline and nature of the projections, confusing planned usage with purchase commitments. (2) Quantitative accuracy is severely lacking: the numbers 38, 14 (used incorrectly as a reduced purchase number), and the absence of correct figures like 14 (planned usage in 2023–2024), 10 (2025 plan in 2022), 11 (2025 revised), and 3 (2026) are either wrong or misplaced. The calculation and comparison of fleet size changes are therefore invalid. (3) The multi-hop reasoning is flawed. The original answer requires synthesizing how projections evolved across two reporting years (2022 vs 2024) for future fleet size (2023–2026). The LLM fails this synthesis, inventing a narrative about purchase commitments and delivery schedules not present in the ground truth. It also introduces unrelated aircraft types (Cessna SkyCourier 408, ATR 72-600F) that are not mentioned in the original answer, adding speculative reasoning unsupported by evidence. (4) While the general direction of 'reduction' and 'strategic shift' aligns with the original, the incorrect data, invented details, and flawed logic severely undermine correctness. Contextual relevance is moderate because the topic and high-level conclusion (fleet reduction) are relevant, but the answer is factually unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 520,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "Between 2022 and 2023, AIG's use of Expected Loss Ratio Methods evolved in terms of the lines of business and the reasoning behind their application. In 2022, these methods were primarily used for newer accident years in short-tail lines, such as U.S. Property and Special Risks, where there was limited historical loss data or inconsistent loss development patterns. The reasoning was to provide reliable reserve estimates by leveraging expected loss ratios adjusted for rate changes, inflation, and market conditions.\n\nIn 2023, the application of Expected Loss Ratio Methods expanded to include more recent accident years across a broader range of lines, including U.S. Excess Casualty and U.S. Workers' Compensation, where loss emergence was slower or data was sparse. The reasoning remained consistent with 2022, emphasizing the need to account for emerging trends, inflation, and market dynamics, particularly in lines with high severity and long-tail characteristics. This evolution reflects AIG's continued focus on adapting its reserving methodologies to align with changing risk profiles and market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains key inaccuracies in entity identification and reasoning synthesis compared to the ground truth. (1) Correct elements: The general evolution of Expected Loss Ratio (ELR) methods from 2022 to 2023 is acknowledged, including use in newer accident years and expansion into lines with sparse data or long-tail characteristics. The reasoning around inflation, market conditions, and data limitations is contextually relevant. (2) Quantitative accuracy: There are no explicit numbers (e.g., percentages, dollar amounts) in either the original or LLM answer, so no numeric errors exist—this aspect is accurate by default. (3) Multi-hop reasoning assessment: The LLM correctly identifies a methodological shift over time but misattributes the specific lines of business. The ground truth specifies aviation exposures in 2022 and U.S. Workers' Compensation in 2023 as a key expansion, while the LLM incorrectly emphasizes U.S. Property and Special Risks in 2022 (not mentioned in truth) and includes U.S. Excess Casualty without support. More critically, the original answer highlights a conceptual shift—from high-severity short-term forecasting (aviation) to long-tail, structurally complex lines (Workers' Comp with risk-sharing features)—which the LLM only partially captures. (4) The LLM answer generalizes the reasoning ('emerging trends, inflation') but misses the core nuance: in 2023, ELR was used specifically to handle extended loss emergence and complex policy features in long-tail lines, not just sparse data. This reflects a failure to fully synthesize the multi-hop insight about structural complexity. Thus, while the direction of evolution is correct, the specific business lines and underlying rationale are not fully aligned with the truth, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 496,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "Cisco's positioning around Enterprise Data Center Transformation from 2022 to 2024 has evolved to emphasize strategic alliances and adapt to a more competitive landscape. In 2022, Cisco highlighted its strategic alliances with companies like Google, Microsoft, and Amazon Web Services to drive innovation and market expansion. By 2024, the company expanded its focus on these partnerships to address the convergence of computing, networking, storage, and software in the enterprise data center, while also acknowledging that some alliance partners may compete in other areas. This evolution reflects a more nuanced strategy to leverage alliances for competitive advantage while navigating an increasingly complex and competitive environment marked by technological convergence and rising competition from both traditional and emerging players.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant omissions and inaccuracies in the qualitative synthesis compared to the ground truth. (1) Correct elements: The answer correctly identifies Cisco's focus on enterprise data center transformation and the role of strategic alliances between 2022 and 2024. It appropriately notes the technological convergence (computing, networking, storage, software) and acknowledges the complexity of partners acting as competitors—this aligns with the 2022 context. The contextual relevance is high as it addresses the evolution of positioning, alliances, and competitive landscape. (2) Quantitative accuracy is 10 because there are no numerical claims to verify or refute—dates (2022, 2024) are used correctly. (3) However, the multi-hop reasoning is flawed: the LLM fabricates specific alliances with Google, Microsoft, and AWS that are not mentioned in the original answer, which only states that partners were 'acquiring or aligning with competitors'—a different dynamic. More critically, the LLM omits the key 2024 shift: Cisco's updated competitive landscape now explicitly includes Nvidia Corporation as a new entrant, signaling a shift in market dynamics. This is a crucial factual omission. Additionally, the original emphasizes that by 2024, alliances were focused on 'industry advancement and new market creation'—a strategic evolution not captured in the LLM response. (4) The correctness score is 6 due to these significant gaps in entity accuracy and reasoning: while the general direction is right, the failure to identify Nvidia as a new competitor and the invention of specific partnerships undermine the factual integrity. Qualitative accuracy is 6 because core themes are present but key details and logical connections from the knowledge graph are missing or distorted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 495,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "The effective interest rate for the 3.125% 2025 Notes increased from LIBOR + 1.8% in 2022 to SOFR + 2.1% in 2023, reflecting a shift from LIBOR to SOFR-based swaps. The notional amount remained unchanged at $1,000 million for both years.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, the notional amount was $5.2 billion (not $1.0 billion), and there is no mention of LIBOR + 1.8% as the effective rate—this figure is entirely absent from the original answer. The shift from LIBOR to SOFR is plausible contextually but not explicitly stated in the ground truth. In 2023, the notional amount correctly decreased to $1.0 billion with an effective rate of SOFR + 2.1%, which the LLM correctly identifies. However, claiming the notional amount 'remained unchanged' at $1.0 billion for both years is factually wrong, as it dropped from $5.2B to $1.0B. (2) Quantitative accuracy fails on the 2022 notional amount ($5.2B vs claimed $1.0B) and the 2022 effective rate (unspecified in ground truth vs claimed LIBOR + 1.8%). The 2023 values are correct. (3) Multi-hop reasoning is flawed: the model fails to recognize the reduction in hedged exposure from $5.2B to $1.0B, a key point in the original answer, and invents a prior rate not present in the data. (4) Scores reflect major factual errors in numbers and synthesis, though the answer addresses the right question and gets the 2023 data partially right, warranting minimal credit.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 352,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "Cisco's strategic positioning of AppDynamics has evolved from 2022 to 2024 by being integrated more prominently into its observability offerings. In 2022, AppDynamics was highlighted as a key element in delivering full-stack observability from applications to infrastructure. By 2024, AppDynamics, along with ThousandEyes and the Splunk acquisition, was explicitly grouped under the new Observability product category, which saw a 27% revenue increase in 2024 compared to 2023. This reflects a stronger emphasis on observability as a core component of Cisco's strategy to provide comprehensive insights and intelligence for hybrid and multicloud environments.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Cisco's strategic positioning of AppDynamics from 2022 to 2024, noting its increasing integration into a formalized Observability category. The core narrative — that AppDynamics was a key part of full-stack observability in 2022 and became part of a newly reported 'Observability' segment by 2024 — aligns with the ground truth. However, the LLM introduces a specific revenue growth figure of '27% in 2024 compared to 2023' for the Observability category, which is not present in the original answer and cannot be verified from the provided ground truth. This introduces a quantitative inaccuracy. (2) The mention of Splunk's acquisition is contextually plausible (as Cisco acquired Splunk in 2023–2024), but the original answer does not include Splunk in the 2024 Observability grouping, making this an addition not supported by the ground truth. The 27% revenue increase is a significant unsupported numeric claim, failing the quantitative accuracy check. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift from AppDynamics as a standalone APM tool in a broader strategy to being part of a formal product category. It correctly infers increased strategic emphasis through organizational reporting changes. (4) Despite the unsupported revenue figure and mention of Splunk, the qualitative reasoning and strategic interpretation are strong and semantically aligned with the ground truth. The answer is highly relevant and addresses all parts of the question. The correctness score is reduced due to the unverified quantitative claim, but not severely, as the core strategic evolution is accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 464,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The effective interest rate for the 4.663% 2051 Notes increased from 5.6% in 2022 to 5.6% in 2023, remaining unchanged. The notional amount associated with these notes was $1,500 million in both 2022 and 2023, indicating no change in the notional amount during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. It claims the effective interest rate was 5.6% in both 2022 and 2023, which contradicts the ground truth stating that in 2023 the effective rate was SOFR + 4.3%, with no mention of a 5.6% rate in either year. The original 4.663% appears to be the coupon rate, not the effective rate, and the LLM incorrectly reports a flat 5.6% for both years. The notional amount is stated as $1.5 billion (or $1,500 million) in 2023 in both answers, which matches the ground truth, but the LLM falsely claims this amount was also present in 2022. The ground truth indicates that in 2022, the 2051 Notes were part of a broader $5.2 billion hedged portfolio, not a standalone $1.5 billion notional amount. (2) Quantitative accuracy fails: the effective interest rate numbers (5.6%) are fabricated, and the notional amount for 2022 is wrong. Only the 2023 notional amount is correct. (3) Multi-hop reasoning is absent: the LLM fails to recognize that the 2022 data refers to a larger hedged portfolio and that the 2023 data reflects a more granular disclosure after restructuring. It does not explain the evolution in terms of hedging strategy changes or rate benchmark shifts (e.g., from fixed to SOFR-based). (4) The answer is contextually relevant in that it attempts to address the evolution of rate and notional amount, but factual inaccuracies and missing synthesis severely undermine correctness. Thus, the correctness score is very low due to major factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 420,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods has evolved with a continued focus on long-tail lines of business such as U.S. Workers' Compensation and U.S. Excess Casualty. In 2023, the segmentation criteria have become more refined, particularly for U.S. Workers' Compensation, where guaranteed cost and excess of deductible business are analyzed separately by state and industry subset. Additionally, AIG has increased its use of expected loss ratio methods for recent accident years, incorporating adjustments for rate changes, loss trends, and market conditions. This evolution reflects a more granular and dynamic approach to reserving, especially in response to external factors like inflation and judicial trends.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of AIG's use of expected loss ratio methods from 2022 to 2023, noting increased granularity and application to U.S. Workers' Compensation, which aligns with the ground truth. However, it introduces 'U.S. Excess Casualty' as a line of business to which the method was applied in 2023, which is not mentioned in the original answer and cannot be verified from the provided ground truth, representing an overextension. Additionally, the original answer does not mention 'recent accident years', 'adjustments for rate changes, loss trends, and market conditions', or 'inflation and judicial trends' as part of the 2023 evolution—these are plausible contextual additions but not supported by the ground truth, thus reducing qualitative accuracy. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised; all references to years (2022, 2023) are correct. (3) The multi-hop reasoning is partially sound: the model correctly infers a trend toward more granular segmentation, especially by state and industry subset, which matches the ground truth. However, it adds segmentation criteria ('guaranteed cost and excess of deductible') not explicitly stated in the original, and omits key criteria mentioned in the ground truth such as 'deductible size' and 'claim handling entities'. (4) The answer is contextually relevant and captures the core evolution—increased structure and detail in 2023—but includes unverified details that reduce factual precision. Hence, correctness is scored 7 for being mostly accurate with minor but notable factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 456,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "Between 2023 and 2024, PepsiCo's engagement with the 2.850% Senior Notes due 2026 reflected a broader strategy of diversifying its debt issuance, particularly through the introduction of additional notes in 2024. In 2023, the company issued the 5.125% Senior Notes due 2026, indicating a focus on higher-yield, shorter-term debt. By 2024, PepsiCo expanded its debt portfolio by issuing the 2.850% Senior Notes due 2026, signaling a shift toward lower coupon rates and longer-term maturities as part of its capital structure optimization. This evolution suggests PepsiCo's aim to balance cost efficiency and maturity diversification in its debt strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that PepsiCo issued the 5.125% Senior Notes due 2026 in 2023, which contradicts the ground truth—no such issuance is mentioned, and the 2.850% Senior Notes due 2026 were already in existence and referenced as part of PepsiCo's existing debt portfolio. More critically, the LLM falsely claims that PepsiCo 'issued' the 2.850% Senior Notes due 2026 in 2024, when in fact these notes were not newly issued in that year; the ground truth indicates they were already outstanding and referenced in 2023. (2) The quantitative inaccuracies are severe: the 5.125% note is entirely fabricated in the context provided, and the sequencing of issuance (higher yield in 2023, lower in 2024) misrepresents the actual strategy. The ground truth highlights new higher-yielding instruments in 2024 (e.g., 7.00% due 2029, 5.50% due 2035), not lower-yielding ones. (3) The multi-hop reasoning is flawed: instead of correctly synthesizing that PepsiCo maintained the 2.850% notes while adding longer-term, higher-yield debt in 2024, the LLM reverses the logic, suggesting a shift to lower coupons and misrepresenting the strategic evolution. (4) Contextual relevance is moderate—the answer addresses debt strategy evolution and mentions the correct note (2.850% due 2026)—but the incorrect causal and temporal narrative undermines the response. Due to major factual and directional errors in both numbers and strategy interpretation, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 423,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Cisco's exposure to channel partner financing guarantees increased slightly between fiscal years 2022 and 2024, with the maximum potential future payments rising from $155 million in 2022 to $188 million in 2024. This modest increase suggests that Cisco has maintained a relatively stable approach to its channel partner financing programs, facilitating working capital for partners while limiting its guarantees to a controlled level. The company's financial risk management strategy appears to emphasize careful oversight, as the guarantees remain a small portion of the overall financing arrangements, and payments under these guarantees have historically been immaterial. This indicates a measured and conservative approach to managing credit risk associated with channel partners.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in fiscal year 2022, the volume of channel partner financing was $27.9 billion, with $1.4 billion subject to guarantees as of July 30, 2022. However, the LLM incorrectly states that 'maximum potential future payments' were $155 million in 2022 and $188 million in 2024—these figures do not appear in the original answer and are factually incorrect. The ground truth explicitly states that by fiscal year 2024, Cisco no longer disclosed specific quantified amounts for channel financing or guarantees, making any precise comparison impossible. (2) The quantitative inaccuracies are severe: the LLM invents numbers not present in the source (e.g., $155M, $188M), misrepresents the scale of exposure (billions vs. millions), and falsely implies continuity in disclosure when transparency actually decreased. There are no calculations in the LLM answer, but the comparison between years is based on fabricated data. (3) The multi-hop reasoning is flawed. The question requires synthesizing changes in disclosure practices and interpreting their implications for risk management. The LLM fails this by asserting a precise increase in exposure despite the absence of 2024 data in the original answer, thus missing the key point about reduced transparency. It incorrectly concludes a 'measured and conservative approach' based on non-existent figures, whereas the ground truth emphasizes uncertainty due to lack of updated disclosures. (4) Contextual relevance is moderate—the LLM addresses the right topic (channel financing guarantees and risk management) and attempts to interpret strategy—but the analysis is built on false premises. Due to major factual and quantitative errors, the correctness score is low at 2, with similarly low scores for quantitative (2) and qualitative accuracy (3). Contextual relevance is scored 6 because the structure and intent align with the question, even if the content does not.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 542,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "The 2.45% 2030 Notes remained outstanding with a principal amount of $1,250 million in both 2022 and 2023, indicating no change in the principal balance. Additionally, in 2023, an interest rate swap contract with a notional amount of $1,000 million was in place, converting the fixed-rate coupon to SOFR + 1.3%. This swap was also in place in 2022, with the same notional amount and a similar structure (LIBOR + 1.0% in 2022). Thus, the interest rate structure remained consistent, transitioning from LIBOR to SOFR-based swaps, while the principal and hedging strategy for the 2.45% 2030 Notes remained unchanged between 2022 and 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The principal amount of the 2.45% 2030 Notes is stated as $1,250 million, but the ground truth specifies $1.0 billion ($1,000 million), which is a significant discrepancy. Additionally, the LLM claims the 2022 swap was structured as 'LIBOR + 1.0%', but the original answer states the swap converted the fixed rate to a 'floating LIBOR-based coupon' without specifying a spread; the 1.3% spread is only mentioned in the 2023 SOFR context. Thus, introducing 'LIBOR + 1.0%' is an unsupported detail. (2) The notional amount of the swap is correctly identified as $1,000 million (i.e., $1.0 billion), which matches the ground truth. The transition from LIBOR to SOFR in 2023 is correctly captured, as is the new rate of SOFR + 1.3%. However, the claim that the swap was 'also in place in 2022 with the same notional amount and similar structure' overstates the continuity, as the original answer does not confirm the exact spread in 2022. (3) The multi-hop reasoning is partially sound—the model correctly infers that the note remained outstanding and that the interest rate structure evolved due to benchmark transitions (LIBOR to SOFR). However, it incorrectly assumes continuity in the spread and misstates the principal amount, undermining the synthesis. (4) The contextual relevance is high because the answer addresses both the status and interest rate evolution. However, due to key numerical errors and unsupported specifics, the correctness score is reduced to 5, with quantitative accuracy penalized more heavily (4), while qualitative reasoning and contextual alignment remain moderate to strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 466,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "Between 2022 and 2023, FedEx's relationship with Pass-Through Certificates remained consistent in terms of financial guarantees and obligations. In both years, FedEx Express issued $970 million of Pass-Through Certificates, Series 2020-1AA, with a fixed interest rate of 1.875% due in February 2034. These Certificates are secured by 19 Boeing aircraft, with a net book value of $1.8 billion in 2022 and $1.7 billion in 2023. Crucially, the payment obligations under these Certificates are fully and unconditionally guaranteed by FedEx in both years, indicating no material change in the nature or extent of FedEx's guarantees or obligations during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding FedEx's financial guarantees. The ground truth states that in 2023, FedEx clarified that pass-through certificates were *not* direct obligations nor guaranteed by FedEx or FedEx Express, marking a shift from 2022 when they *were* fully and unconditionally guaranteed. The LLM incorrectly claims the guarantees remained 'fully and unconditionally guaranteed by FedEx in both years,' which directly contradicts the ground truth. (2) Quantitatively, the LLM correctly reports the $970 million issuance, the 19 Boeing aircraft, and the net book values ($1.8B in 2022, $1.7B in 2023), which aligns with acceptable formatting variations. However, it introduces a specific interest rate (1.875%) and maturity date (February 2034) not present in the original answer, which cannot be verified against the ground truth and may be hallucinated. (3) The multi-hop reasoning is flawed: the question asks about the *evolution* of the relationship, requiring synthesis of changes in guarantees over time. The LLM fails this by asserting consistency where there was a material change, missing the key shift from guaranteed to non-guaranteed status. (4) Contextual relevance is moderate because the answer discusses the correct entities and timeframe, but the core conclusion about financial obligations is factually wrong, severely undermining correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 400,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "From 2023 to 2024, Mastercard's use of risk mitigation arrangements to manage gross settlement exposure increased from $12,167 million to $13,466 million, while gross settlement exposure itself rose from $75,023 million to $78,385 million. This indicates that the company enhanced its risk management strategy by applying more robust risk mitigation measures as its exposure grew, reflecting a proactive approach to safeguarding against potential settlement failures and maintaining financial stability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: gross settlement exposure in 2023 ($75,023 million) and 2024 ($78,385 million), and risk mitigation amounts in 2023 ($12,167 million) and 2024 ($13,466 million) are correctly reported with no calculation errors. (2) The answer is complete, addressing both the evolution of risk mitigation arrangements and the implication for Mastercard's risk management strategy. (3) Entities—Mastercard, the correct years (2023 to 2024), and financial metrics (gross settlement exposure and risk mitigation arrangements)—are accurately identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that increasing mitigation in parallel with rising exposure indicates a more robust and proactive risk management strategy. The semantic meaning is equivalent to the original answer, with slightly enhanced wording around 'proactive approach' and 'financial stability,' which are reasonable interpretations consistent with the data. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 317,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Between 2022 and 2024, Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments decreased from $48 million as of May 31, 2022, to $146 million as of May 31, 2024. This change indicates a shift in the fair value of these hedging instruments, likely due to fluctuations in foreign currency exchange rates and changes in the notional amounts of the hedging contracts. The decrease in liabilities suggests that the company's hedging strategy may have become more favorable in terms of its foreign currency exposures during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. According to the ground truth, Nike's total liabilities for foreign exchange forwards and options designated as hedging instruments increased from $48 million in 2022 to $115 million in 2024. However, the LLM incorrectly states that liabilities decreased from $48 million to $146 million — both the direction and magnitude are wrong. The $146 million figure does not appear in the original answer and is factually incorrect. (2) Quantitative accuracy is severely compromised: the 2024 total is misstated as $146M instead of $115M, and the components ($110M under accrued liabilities and $5M under deferred income taxes) are not mentioned at all. The LLM also falsely claims a 'decrease' when the actual change is an increase of $67 million. (3) The reasoning is flawed due to incorrect data. The conclusion that 'liabilities decreased' leads to an incorrect interpretation that the hedging strategy became 'more favorable,' whereas the ground truth suggests increased exposure or strategic shift due to higher liabilities. The model fails to correctly synthesize the multi-hop information across years and liability categories. (4) Despite the factual errors, the answer is contextually relevant — it addresses the right topic (hedging instruments, foreign exchange risk, strategy implications) and attempts to interpret the financial meaning, which supports a moderate relevance score. However, correctness and accuracy scores are low due to fundamental errors in numbers and logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 424,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "In the 2022 10-K filing, Bounty is listed as part of the Baby, Feminine & Family Care segment under the \"Family Care\" sub-category, alongside Charmin and Puffs. The 2023 10-K filing maintains this structure, with Bounty still included in the Family Care sub-category within the same segment. However, in the 2023 filing, the segment's description specifies that Bounty holds over 40% North America market share, indicating a consistent and strong regional presence. This suggests that Bounty maintains a prominent position within P&G's portfolio and has stable brand visibility, particularly in North America.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the 2023 10-K specifies Bounty's market share as 'over 40% North America market share.' This quantitative claim is not present in the ground truth and is unsupported by the provided evidence. The original answer explicitly states that no market share or sales figures are provided in either filing to quantify Bounty's visibility. Therefore, this is a major factual error. (2) The LLM introduces a specific percentage (over 40%) that does not appear in the ground truth, failing the quantitative accuracy check. There are no calculations in the response, but the introduction of a false metric severely undermines accuracy. (3) While the LLM correctly identifies that Bounty is part of the Family Care sub-category within the Baby, Feminine & Family Care segment in both years, it misrepresents the evolution: the key change in the 2023 filing is the explicit listing of Bounty as a major brand, not the disclosure of market share. The multi-hop reasoning is partially sound in tracking Bounty across filings, but the conclusion about 'stable brand visibility' contradicts the ground truth implication of increased visibility due to explicit mention. The reasoning is thus flawed due to reliance on fabricated data. (4) Contextually, the answer addresses the right segment and brand, and attempts to interpret strategic implications, so it remains relevant. However, the inclusion of false quantitative data and incorrect reasoning significantly reduces correctness. A score of 3 reflects that while some structural elements are correct, core factual and quantitative claims are wrong, undermining the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 458,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "Between fiscal 2022 and fiscal 2023, Oracle's hardware business, particularly Oracle Engineered Systems, saw a slight decline in revenue, with hardware revenues remaining at 6% of total revenues in both fiscal years. In terms of strategic emphasis, Oracle continued to focus on improving existing hardware products and developing new ones, while also investing in research and development. The hardware business is characterized by lower operating margins compared to the cloud and license business due to higher production and support costs. Oracle also highlighted the challenges in predicting hardware revenues due to factors like manufacturing delays and customer demand shifts toward cloud infrastructure.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct contextual information about Oracle's hardware business, such as its low revenue contribution (6% of total revenue) and lower operating margins compared to cloud and license segments. However, it fails to address the core aspects of the question—specifically, the evolution in revenue recognition practices and strategic emphasis between fiscal 2022 and 2023. The original answer highlights a key shift in 2023 toward treating hardware and software as a combined performance obligation with point-in-time revenue recognition, which is entirely missing from the LLM response. Additionally, the increased emphasis on R&D and innovation in 2023 is mentioned in the ground truth but only vaguely echoed in the LLM answer without proper temporal contrast. (2) The quantitative claim that hardware revenue remained at 6% in both years may be factually accurate (and consistent with known filings), but this is not the focus of the question and does not compensate for missing the revenue recognition changes. No calculations were required, but the use of percentages is acceptable if accurate. (3) The multi-hop reasoning is flawed—the question requires synthesis across two fiscal years and two dimensions (revenue recognition and strategy), but the LLM does not demonstrate understanding of how Oracle’s accounting or strategic narrative evolved. Instead, it provides general background facts without comparative analysis. (4) Scores are justified as follows: correctness is low (3/10) because the answer misses the primary developments in revenue recognition and misrepresents the strategic shift; quantitative accuracy is moderate (4/10) because while the 6% figure may be correct, other numbers like margins are mentioned without sourcing or verification; qualitative accuracy is poor (3/10) due to failure in reasoning and entity-year linkage; contextual relevance is moderate (6/10) because the topic is relevant but the focus is misplaced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 537,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "Between 2022 and 2023, sales of ERLEADA increased by 26.9%, from $1.881 billion to $2.387 billion. This significant growth indicates a strong market trajectory for ERLEADA, driven by continued share gains and market expansion in the treatment of Metastatic Castration-Resistant Prostate Cancer.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: ERLEADA sales were $1,881 million (=$1.881 billion) in 2022 and $2,387 million (=$2.387 billion) in 2023, with a 26.9% growth rate, correctly calculated and reported. (2) Quantitative accuracy is perfect—numbers are presented in equivalent formats (billions vs. millions), and the percentage increase is accurate: (2387 - 1881) / 1881 ≈ 0.269 or 26.9%. (3) The multi-hop reasoning is sound: the model correctly synthesized sales data across two years and inferred a strong market trajectory, consistent with the ground truth. The additional detail about 'continued share gains and market expansion in the treatment of Metastatic Castration-Resistant Prostate Cancer' adds context without contradicting or distorting the original conclusion. (4) Entity accuracy is correct—product name (ERLEADA), years (2022, 2023), and financial metric (sales) are all properly identified. The answer addresses both parts of the question: evolution of sales performance and interpretation of market trajectory. All scores are maximized due to complete factual correctness, accurate synthesis, and relevant, precise communication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 344,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "CMCSA's relationship with local broadcast television stations from 2023 to 2024 has shown increased dependency and competitive tension, particularly in securing programming rights and distribution agreements. In 2023, the company emphasized competition with local broadcast stations for content acquisition and distribution, especially for sports rights and affiliations necessary for nationwide broadcast reach. By 2024, the dependency on local broadcast stations has grown more pronounced, with retransmission consent and carriage agreements becoming more critical as traditional multichannel video providers face subscriber declines. Additionally, the 2024 filing highlights the potential for increased programming expenses due to demands from local stations for payment and concessions, underscoring a more competitive and costly environment for content distribution.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of CMCSA's relationship with local broadcast television stations from 2023 to 2024. It accurately captures the shift from competition to increased dependency, particularly through retransmission consent and carriage agreements, which is consistent with the original answer. The mention of rising programming expenses and competitive tension in 2024 adds contextual detail supported by typical dynamics in such relationships, though this specific point about 'increased programming expenses due to demands' is not explicitly stated in the ground truth, representing a minor addition rather than a factual error. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is slightly reduced because the LLM emphasizes 'competitive tension' persisting or increasing, whereas the ground truth frames the shift more clearly as a move from competition to dependency—implying reduced direct competition. However, the core multi-hop reasoning—synthesizing a change in relationship nature over time based on distribution mechanisms and strategic positioning—is sound. Contextual relevance is perfect, as the response directly addresses competitive positioning and dependency in content distribution across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 375,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "The value of Held-to-Maturity (HTM) securities held by Mastercard (MA) decreased significantly between 2023 and 2024, from $306 million in 2023 to $38 million in 2024. This shift suggests a strategic reallocation of investments, likely in response to changing market conditions or a shift in the company's liquidity management approach. The reduction in HTM securities, which are typically long-term in nature, may indicate a move toward more flexible or short-term investment vehicles, such as available-for-sale securities, to enhance liquidity or capitalize on investment opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the quantitative values of HTM securities for MA in 2023 ($306 million) and 2024 ($38 million), matching the ground truth exactly. There are no calculation errors, and the significant decrease is accurately portrayed. (2) All numeric values are correct and properly attributed to the right years and company (MA/Mastercard), satisfying quantitative accuracy. Format is consistent and clear. (3) The reasoning is sound and aligns with the ground truth: the reduction in HTM securities indicates a strategic shift, likely toward more liquid or short-term investments. The LLM appropriately infers a move toward flexibility, possibly into available-for-sale securities, which is a reasonable interpretation of the data. While the original answer emphasizes 'sharp reduction in long-term held securities,' the LLM expands slightly with plausible context (market conditions, liquidity management), which is acceptable and adds value without introducing error. (4) The answer fully addresses both parts of the question: the evolution of HTM value and the strategic implication. It synthesizes information across years correctly (multi-hop reasoning) and maintains semantic equivalence with the original answer. The only minor difference is slightly more speculative phrasing (e.g., 'likely in response to changing market conditions'), but this does not detract from factual accuracy. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 430,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "Between 2022 and 2023, the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment underwent a notable repositioning in terms of product categorization. In 2022, Always was listed under the \"Feminine Care\" sub-category alongside \"Adult Incontinence,\" while \"Family Care\" was a separate sub-category. By 2023, the structure was revised, with Always being specifically highlighted under the \"Menstrual Care\" sub-category within Feminine Care, which was further distinguished as a key sub-category with over 25% global market share. Additionally, \"Adult Incontinence\" was separated into its own sub-category under Feminine Care, now branded behind Always Discreet. This change reflects a more refined and targeted categorization of Always products, emphasizing its leadership in the menstrual care segment and a clearer distinction between its product lines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Always was under Feminine Care in 2022 with Adult Incontinence as a sub-category, and in 2023 it was more specifically aligned with Menstrual Care. The repositioning to emphasize a targeted focus is correctly identified. (2) There are no numeric inaccuracies—though the LLM mentions 'over 25% global market share,' this detail is not present in the ground truth. However, since the ground truth does not contradict this and market share data may be inferred or supplementary, it does not constitute a factual error but rather an addition. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of categorization across years and identifies the strategic refinement in sub-category alignment. (4) The LLM adds contextual detail (e.g., Always Discreet branding for Adult Incontinence) that enhances clarity and reflects deeper insight, though not explicitly in the original answer. This does not deviate from the truth and supports the explanation. The only reason for not scoring a 10 is that the original answer does not mention market share or Always Discreet, so while plausible, these additions slightly exceed the verified knowledge. Overall, the answer is factually consistent, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 375,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "Between 2022 and 2023, Oracle's Oracle Engineered Systems remained a component of its hardware business, which contributed approximately 6% of total revenues in both fiscal years. The hardware business, including Engineered Systems, involves revenue recognition at the point of delivery when ownership transfers to the customer. While the hardware business is strategically positioned to support Oracle's broader cloud and infrastructure offerings, it historically has lower operating margins compared to Oracle's cloud and license business due to production and distribution costs. There is no indication of a significant strategic shift or change in financial contribution for Oracle Engineered Systems between the two periods based on the provided information.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Oracle's hardware business, including Engineered Systems, represented 6% of total revenue in both fiscal 2023 and 2024 (as reported in 2023), but incorrectly implies this percentage was also disclosed for 2022. The ground truth clarifies that no specific percentage was provided for 2022 — this is a significant factual error. The revenue recognition policy (at point of delivery) is accurately described for both years. However, the LLM fails to note the key evolution: in 2022, Engineered Systems were embedded in hardware revenues without a disclosed share, whereas in 2023, Oracle began explicitly quantifying the hardware segment’s contribution (6% of total revenue), marking a shift in transparency and strategic reporting. (2) The 6% figure is correctly cited, but its application to both 2022 and 2023 is inaccurate — it was only reported starting in 2023. There are no calculation errors, but the misattribution of the percentage to 2022 undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound — the model connects Engineered Systems to hardware and tracks revenue recognition — but it fails to synthesize the critical change in disclosure practice between years, which is central to the question about evolution in positioning and contribution. The strategic emphasis on R&D and factors affecting predictability (e.g., manufacturing partners, cloud competition) mentioned in the ground truth are omitted. (4) Contextual relevance is high because the answer addresses revenue contribution, recognition, and strategic role. However, due to the incorrect retroactive assignment of the 6% figure and omission of key strategic developments in 2023, the qualitative and quantitative accuracy scores are moderate. The answer gives the impression of stability where there was actually a notable shift in transparency and strategic framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 518,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "Comcast's relationship with representation firms in advertising sales strategy remained largely consistent between 2023 and 2024. In both years, the company worked with representation firms as an extension of its sales force to sell a portion of allocated advertising units, recording revenue net of agency commissions. There were no significant changes in this strategy as outlined in the 2023 and 2024 10-K filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that Comcast's relationship with representation firms remained largely consistent between 2023 and 2024. The ground truth states there was a clear evolution—from a co-selling model in 2023 to formal representation agreements in 2024, indicating a strategic shift. The LLM incorrectly claims no significant changes occurred, which contradicts the original answer. (2) There are no numeric values, percentages, or dollar amounts in either the question or answers, so quantitative accuracy is not applicable; however, the years 2023 and 2024 are correctly referenced, earning full points here. (3) The multi-hop reasoning is flawed: the model failed to synthesize the change in strategic relationship over time, missing the key development that Comcast moved from using representation firms as an extension of its sales force (2023) to entering formal agreements where they sell on behalf of third parties (2024). This reflects a failure in qualitative reasoning and entity-year-metric linkage. (4) While the answer addresses the topic and timeframe correctly, it draws the wrong conclusion about continuity versus change, severely undermining factual correctness. Contextual relevance is moderate because it discusses the right companies and general strategy, but the core claim is false.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 377,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Between fiscal 2022 and fiscal 2023, Oracle's approach to its industry-specific hardware offerings remained relatively consistent in terms of revenue recognition and strategic emphasis. Revenue recognition for hardware products and related software is generally recognized at the point in time when the hardware and its associated software are delivered to the customer and ownership is transferred. Hardware support contracts are recognized ratably over the contractual term. Strategically, Oracle continued to focus on providing a broad range of hardware products and support services, emphasizing their integration with Oracle's software and cloud offerings. However, the hardware business represented a smaller portion of Oracle's total revenues (6% in both fiscal 2024 and 2023), and Oracle's strategic emphasis appeared to be more on its cloud and license offerings, which accounted for a larger share of revenue and growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses key aspects of Oracle's evolution between fiscal 2022 and 2023. While it correctly states that revenue recognition occurs at the point of delivery for hardware and related software, it fails to highlight the key change in fiscal 2023: Oracle introduced a more detailed explanation of combined performance obligations (hardware plus software) in revenue recognition, which was not present in 2022. This nuance is central to the original answer and is omitted, leading to a significant factual gap. Additionally, the LLM incorrectly implies continuity in strategic emphasis, whereas the ground truth shows a shift in 2023 toward greater strategic focus on R&D and innovation in hardware, contrasting with the more general description in 2022. The LLM instead suggests that Oracle's strategic emphasis remained on cloud and license offerings, downplaying the increased R&D emphasis in hardware. (2) Quantitatively, the LLM mentions that hardware represented 6% of total revenues in fiscal 2023 and 2024, which may be accurate but is not part of the original answer and introduces data not requested or verified in the ground truth. Since the question did not ask for revenue percentages and the original answer does not include them, this is extraneous but not incorrect per se. No calculation errors are present. (3) The multi-hop reasoning is flawed: the model fails to synthesize the evolution in both revenue recognition detail and strategic emphasis across the two fiscal years. Instead, it asserts consistency where there was change, indicating a failure to correctly interpret the progression in Oracle’s disclosures. (4) Correctness is scored at 4 due to major omissions in strategic shift and revenue recognition clarification. Quantitative accuracy is 8 because no numbers are wrong, but some are irrelevant. Qualitative accuracy is 4 due to incorrect reasoning about strategic continuity. Contextual relevance is 7 because the answer addresses the general topic and structure of the question but misses the core evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 564,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "Between 2022 and 2023, IMBRUVICA (ibrutinib) sales declined by 13.7%, from $3.78 billion in 2022 to $3.26 billion in 2023. This decrease was primarily driven by global competitive pressures from novel oral agents in the oncology space.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the sales decline of IMBRUVICA from $3.78 billion in 2022 to $3.26 billion in 2023, which aligns with the ground truth values of $3.784 billion and $3.264 billion (rounded appropriately). The 13.7% decline is accurately calculated: (3.784 - 3.264) / 3.784 ≈ 0.137. Minor rounding in reported figures ($3.78B vs $3.784B, $3.26B vs $3.264B) is acceptable and common in financial reporting.\n\n2) The answer addresses the sales performance evolution quantitatively and identifies competitive pressures from novel oral agents as a key factor, which is consistent with the original answer. However, it omits additional contextual factors mentioned in the ground truth: pandemic-related delays in new patient starts (noted as affecting 2022 performance) and possible market saturation or treatment shifts in 2023. While the core reasoning is sound, this omission slightly reduces completeness in explaining the multi-year trend.\n\n3) Entity accuracy is perfect: drug name (IMBRUVICA/ibrutinib), years (2022–2023), and financial metric (sales) are all correctly identified and synthesized. The reasoning correctly infers sustained competitive pressure as a driver, though it doesn’t fully trace the multi-hop evolution from 2022 dynamics to 2023 outcomes.\n\n4) The answer is semantically equivalent in its core claim and highly contextually relevant. The missing nuance about pandemic impacts and potential market saturation prevents a perfect score, but the main facts and calculation are correct. Thus, correctness is rated 9/10, with high marks across all subcategories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 437,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "Comcast's involvement with Universal Beijing Resort from 2023 to 2024 shows a slight reduction in debt levels, with debt outstanding decreasing from $3.5 billion in 2023 to $3.4 billion in 2024. Comcast maintains a 30% ownership stake, and the resort remains consolidated under Comcast's Theme Parks segment. Financial risk exposure remains limited to Comcast's equity interest, as there are no guarantees or liquidity arrangements between Comcast and Universal Beijing Resort.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, and Comcast maintains a 30% ownership stake. The answer correctly notes the consolidation under Comcast’s Theme Parks segment, consistent with VIE consolidation. (2) The answer accurately reflects that Comcast’s financial risk exposure remains limited to its equity interest, with no guarantees or liquidity arrangements—this matches the ground truth’s emphasis on stable risk profile. (3) The only minor omission is the lack of specific mention of the term loan reduction from $3.1 billion to $3.0 billion, which is part of the debt composition detail in the original answer. While the total debt change is correctly reported, this component-level detail is missing, slightly reducing completeness. (4) The reasoning is sound: the model correctly synthesizes Comcast’s ongoing consolidation, ownership stability, and risk limitation across years. Wording differs slightly (e.g., 'no guarantees or liquidity arrangements' vs 'maximum financial risk exposure remains limited to its 30% equity interest') but is semantically equivalent. Overall, the answer is factually correct, contextually relevant, and demonstrates proper multi-hop understanding of debt, ownership, and risk evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 380,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "From 2022 to 2023, the financial commitment related to future lease payments for build-to-suit facilities and equipment decreased significantly from approximately $3.4 billion to $0.9 billion. This reduction suggests that FedEx either delayed or scaled back its plans for new build-to-suit facilities and equipment, indicating a more conservative or strategic adjustment in its leasing approach during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reduction in future lease commitments from $3.4 billion in 2022 to $0.9 billion in 2023, matching the ground truth exactly in both figures and direction of change. All numeric values are accurate and properly contextualized. (2) The calculation of a significant decrease is logically sound and consistent with the data; no mathematical errors are present. Format variations are not needed here as the figures are presented clearly and correctly. (3) The reasoning correctly infers a strategic shift in FedEx's leasing behavior, aligning with the ground truth's interpretation of a move toward fewer long-term build-to-suit commitments. However, the LLM answer omits the detail about the extended timeline for commencement (from 2023–2024 in 2022 to 2025–2027 in 2023), which is a minor but relevant aspect of the strategic evolution. This omission slightly weakens the qualitative depth but does not invalidate the overall conclusion. (4) The answer is highly relevant, directly addressing both parts of the question—evolution of financial commitment and implications for leasing strategy. The scores reflect full quantitative accuracy, excellent contextual relevance, and strong qualitative reasoning with a minor deduction for incomplete synthesis of the timeline shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 371,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "Mastercard acquired Dynamic Yield LTD in April 2022 for $325 million, aiming to enhance its capabilities in data-driven personalization and decisioning. Between 2023 and 2024, there is no indication of a significant change in the relationship with Dynamic Yield, as no further acquisitions or divestitures involving this entity are mentioned in the 2024 10-K. This suggests that the integration of Dynamic Yield has been completed, and the focus has shifted toward leveraging the acquired capabilities to support Mastercard's strategic goals in digital transformation and fraud prevention.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Mastercard acquired Dynamic Yield LTD in April 2022 for $325 million, which matches the ground truth. It also accurately notes no further activity involving Dynamic Yield in 2023–2024, indicating completed integration. However, it omits the specific detail that $200 million of goodwill was attributed to synergies, a quantitatively and contextually relevant point from the original answer. Additionally, while the LLM correctly infers a strategic focus on digital transformation and fraud prevention, it misses the explicit strategic pivot to cybersecurity via the 2024 acquisition of Recorded Future, which is a key indicator in the ground truth. (2) All numbers and dates provided (April 2022, $325 million) are factually correct and match the ground truth; no calculations were required. (3) The multi-hop reasoning is mostly sound—linking acquisition, integration completion, and strategic focus—but fails to fully synthesize across all entities by omitting Recorded Future as a signal of strategic shift. This weakens the conclusion slightly. (4) Scores reflect high factual accuracy and relevance, with minor deductions for missing key details that affect completeness and depth of strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 355,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "The Severance Plan for Senior Officers at Lowe's was amended and restated on May 26, 2022, as indicated in Exhibit 10.28 of the 2024 filing. There is no evidence of further amendments to this plan between 2022 and 2024 based on the provided documents. The 2024 filing incorporates the 2022 version of the plan without noting any subsequent changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that the Severance Plan for Senior Officers at Lowe's was amended and restated on May 26, 2022, and filed as Exhibit 10.28 in the 2024 filing. This aligns with the ground truth, which confirms the May 26, 2022 amendment and the November 27, 2024 filing date (though the LLM does not mention the exact November 2024 filing date, it correctly references the 2024 filing, which is contextually sufficient). The LLM accurately notes no further amendments between 2022 and 2024, which is consistent with the ground truth indicating the 2022 amendment was the most recent. The only minor omission is the lack of reference to the prior version (amended May 29, 2020, filed August 26, 2020, Exhibit 10.29), which the original answer includes for context. However, since the question focuses on the evolution between 2022 and 2024, the LLM captures the key update. All dates and exhibit numbers mentioned are accurate. The reasoning is sound, and the answer is contextually relevant and semantically aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 303,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This decline in fair value indicates that market perceptions of the company's debt have worsened over this period, likely due to factors such as higher interest rates, economic uncertainty, or concerns about Netflix's financial health.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of the change in fair value. It states that the fair value 'increased from $999 million to $872 million', which is incorrect—the value actually decreased. This misstatement undermines the quantitative accuracy. The correct movement is a decrease from $999 million to $872 million, so while the numbers themselves are accurate, the comparison is logically flawed. (2) The numeric values—$999 million as of December 31, 2021, and $872 million as of December 31, 2023—are correct and match the ground truth. However, the use of 'increased' when the value clearly declined by $127 million is a major error in interpretation and calculation logic. (3) The reasoning about market perceptions worsening is consistent with a decline in fair value, so the qualitative interpretation is sound *if* the direction of change were correctly stated. The mention of higher interest rates, economic uncertainty, or financial health concerns as possible drivers shows reasonable inference and contextual understanding, supporting multi-hop synthesis. (4) Despite correct individual numbers and plausible reasoning, the fundamental error in describing an increase instead of a decrease severely impacts correctness. The answer contradicts itself by citing a lower dollar amount as an 'increase'. Thus, correctness and quantitative accuracy scores are low, while qualitative reasoning and relevance remain moderate to high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 409,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "Between 2022 and 2023, IMBRUVICA (ibrutinib) sales declined by 13.7%, from $3.784 billion to $3.264 billion. This decline was primarily driven by global competitive pressures in the oncology segment, indicating a weakening market position for IMBRUVICA as newer therapies gained traction.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, IMBRUVICA sales were $4,369 million in 2022, but the LLM incorrectly states $3.784 billion (or $3,784 million), which is $585 million lower than the actual figure. The 2023 sales figure of $3,264 million is correct in the LLM answer. However, due to the incorrect 2022 value, the calculated decline of 13.7% is wrong. The correct decline is (4,369 - 3,264) / 4,369 = 25.2%, as stated in the ground truth. (2) The calculation error undermines the quantitative accuracy: even though the 2023 number is correct, the starting point is wrong, leading to an incorrect percentage change. (3) Qualitatively, the LLM correctly identifies the decline in sales and attributes it to competitive pressures in the oncology segment, which aligns with the weakening market position indicated in the ground truth. It also correctly infers that newer therapies are gaining traction, which is consistent with the context of DARZALEX and ERLEADA growing during the same period. However, the LLM fails to mention these specific comparative products, missing a key multi-hop element that strengthens the conclusion about market position. (4) Contextual relevance is high because the answer addresses both parts of the question—sales evolution and market position—and provides a plausible explanation. However, the major numerical inaccuracy in the 2022 sales figure and resulting percentage decline severely impacts overall correctness, warranting a low-to-mid score on correctness and poor quantitative accuracy despite reasonable reasoning and context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 454,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve decreased from $168 million to $222 million. These changes had implications for net earnings, with a 10% change in the shrink reserve affecting net earnings by approximately $31 million in 2022 and $32 million in 2024, and a 10% change in the LCNRV reserve impacting net earnings by approximately $13 million in 2022 and $17 million in 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the LCNRV reserve 'decreased from $168 million to $222 million', which is incorrect—the reserve actually increased from $168M to $222M. This misstatement undermines the quantitative accuracy. The shrink reserve increase from $414M to $427M is correct. (2) The impact on net earnings is partially accurate: the 2024 figures are correct ($32M for shrink and $17M for LCNRV), but the LLM incorrectly introduces 2022 impact values ($31M and $13M) that are not present in the original answer and not supported by the ground truth. The original answer only provides 2024 sensitivity figures. (3) The multi-hop reasoning is partially sound—LLM correctly identifies the two reserves and their sensitivity impacts, but fails to accurately represent the direction of change in the LCNRV reserve and fabricates earlier-year sensitivity data. (4) The contextual relevance is high as the answer addresses both reserves and earnings implications, but the quantitative inaccuracies—especially the reversal of an increase into a decrease and the addition of unsupported historical sensitivity numbers—reduce correctness and quantitative accuracy significantly. The core message about growing reserve sensitivity is partially preserved, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 371,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "Qulipta's status and financial contribution evolved significantly from 2022 to 2023, with its net revenues increasing by more than 100% in 2023, primarily driven by strong market share uptake and market growth. This growth was further supported by the regulatory approval of Qulipta for the preventive treatment of chronic migraine in adults in April 2023 and its approval in the European Union as Aquipta in August 2023. These developments marked Qulipta's successful transition from a new product in 2022 to a key contributor in AbbVie's Neuroscience portfolio in 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omits key facts from the ground truth. While it correctly identifies Qulipta's transition from development to commercialization, it introduces incorrect details not present in the original answer. Specifically, it claims a 'more than 100% increase in net revenues' in 2023 and cites regulatory approvals in April 2023 (U.S.) and August 2023 (EU). However, the ground truth states that Qulipta contributed to the reclassification of $1.0 billion in intangible assets in 2022 upon approval, implying prior U.S. approval (which actually occurred in 2021), not 2023. There is no mention of a 100% revenue increase or EU approval in the original answer; instead, the 2023 revenue figures are specified as $405 million (U.S.) and $3 million (international), totaling $408 million. The LLM fails to report these exact figures, which are central to the financial contribution aspect of the question. (2) The quantitative inaccuracies are significant: no revenue numbers from 2022 are provided in the LLM answer to support the 'more than 100% increase' claim, and the approval dates are factually incorrect. The ground truth does not mention EU approval or the Aquipta name, making that addition speculative or erroneous. (3) The reasoning partially captures the multi-hop evolution—transition from development to commercialization—but does so with incorrect supporting evidence. It conflates timeline and geography of approvals and invents a growth percentage unsupported by the data provided. (4) The contextual relevance is high because the answer addresses the evolution of Qulipta’s status and commercial role. However, due to major factual and numerical errors, especially the invented revenue growth and wrong approval dates, the correctness score is limited to 5. The qualitative accuracy is moderate because the general narrative direction is plausible, but the quantitative accuracy is low due to missing and fabricated numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 537,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "Between 2022 and 2023, Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent, with quarterly reimbursements of $140 million in both years. However, the recorded receivable from Resideo increased from $157 million in 2022 to $187 million in 2023, indicating higher environmental costs incurred by Honeywell during 2023. This suggests that while the cap on reimbursements remains in place, Honeywell's exposure to environmental liabilities has slightly increased, relying more on Resideo to offset these costs. This dependency highlights an ongoing risk for Honeywell if Resideo is unable to meet its obligations under the agreement.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Resideo is obligated to pay up to $140 million *per year*, not *quarterly*, which the LLM incorrectly claims as 'quarterly reimbursements of $140 million'. This is a critical error, inflating the potential annual reimbursement by a factor of four. Additionally, while the LLM correctly notes that Honeywell's dependency remains consistent in structure, it introduces receivable figures ($157M in 2022, $187M in 2023) that are not present in the original answer and cannot be verified from the provided ground truth. These numbers may be plausible but are not supported by the source, making their inclusion factually unsupported. (2) The calculation of environmental cost trends based on receivables is speculative and not mentioned in the original answer. The original emphasizes consistency in the indemnification terms, not increasing exposure. The $140 million cap is annual in the truth, but the LLM misrepresents it as quarterly, leading to a severe quantitative inaccuracy. (3) The multi-hop reasoning is partially sound—linking Resideo's payments to Honeywell's risk exposure is valid—but the conclusion that risk exposure 'slightly increased' is not supported by the ground truth, which explicitly states the arrangement and risk mitigation strategy 'has not changed'. The LLM overinterprets unverified receivable data to suggest a shift in risk, which contradicts the original. (4) Contextual relevance is high because the answer addresses the right entities (Honeywell, Resideo), topic (environmental liabilities), and time frame (2022–2023). However, due to major quantitative errors and unsupported claims, the overall correctness is low despite some structural alignment with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 490,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target's definition of 'original maturity' for cash equivalents has remained consistent between 2022 and 2024, with both years defining cash equivalents as highly liquid investments with an original maturity of three months or less from the time of purchase. However, the composition of cash and cash equivalents has shifted, with a notable decrease in short-term investments from $4,985 million in 2022 to $3,893 million in 2024. This reduction may indicate a more conservative cash management strategy, potentially prioritizing liquidity and reducing exposure to market fluctuations in short-term investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Target's definition of 'original maturity' for cash equivalents remained at three months or less from 2022 to 2024, which aligns with the ground truth. However, the LLM introduces financial data about short-term investments decreasing from $4,985 million in 2022 to $3,893 million in 2024, which is not present in the original answer and cannot be verified from the provided ground truth. This quantitative claim is unsupported and potentially misleading, as the original answer focuses on disclosure evolution, not portfolio composition changes. (2) While the numbers themselves may be factually accurate in some external context, they are not part of the ground truth and were not requested in the question, making their inclusion a significant deviation. The question asks about the definition or treatment of 'original maturity' and implications for cash management strategy, not investment balances. (3) The multi-hop reasoning is partially sound—correctly identifying consistency in the maturity threshold—but fails to capture the key evolution noted in the original answer: the expanded discussion around fair value measurements in 2024, indicating a broader financial framework. Instead, the LLM infers a 'more conservative cash management strategy' based on unverified balance changes, which is not supported by the provided evidence. (4) The correctness score is 5 due to partial factual accuracy (definition consistency) but major omission of the actual qualitative evolution in disclosure and introduction of unsupported quantitative data. Quantitative accuracy is 6 because the numbers cited may be real but are irrelevant to the specific question and unverified in context. Qualitative accuracy is 5 due to correct identification of the definition but flawed reasoning in drawing strategic implications from incorrect data. Contextual relevance is 7 because the answer stays on topic regarding cash equivalents and strategy but misdirects with off-point financials.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 544,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "The valuation of NVDA's 3.50% Notes Due 2040 decreased slightly from $870 million in 2023 to $851 million in 2024, indicating a minor decline in fair value. These notes are classified as Level 2 liabilities and are carried at their original issuance value, net of unamortized debt discount and issuance costs. The slight reduction in valuation suggests stable long-term debt management, with no significant refinancing or restructuring activity observed during this period. This reflects a consistent approach to maintaining long-term debt obligations without material changes in strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, the valuation of NVDA's 3.50% Notes Due 2040 increased from $851 million (as of January 28, 2024, reflecting 2023 fiscal year) to $1,000 million (as of January 26, 2025, reflecting 2024 fiscal year), not a decrease from $870M to $851M as claimed. The LLM incorrectly states a decline in valuation, when in fact there was a substantial increase of $149 million. Additionally, the LLM invents a figure of $870 million for 2023 that does not appear in the ground truth. (2) The ground truth includes an effective interest rate of 3.54% and remaining term of 15.2 years in 2024, which the LLM omits entirely. The classification as Level 2 is correctly mentioned, but the LLM misrepresents the direction and magnitude of valuation change. (3) The multi-hop reasoning is flawed: the question asks about evolution between 2023 and 2024, requiring comparison across two reporting periods. The LLM fails this synthesis, incorrectly asserting a decrease and missing the strategic implication of increased long-term debt valuation. The conclusion about 'stable long-term debt management' contradicts the ground truth's indication of a strategic emphasis on expanding long-term financing. (4) Scores are low due to major quantitative inaccuracies and incorrect interpretation of trend. Contextual relevance is moderate because the answer addresses the right topic (debt notes, classification, strategy), but factual correctness is severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 423,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Between 2022 and 2023, Venclexta's total global revenue increased by 15%, with U.S. revenue growing by 8% and international revenue rising by 22%. This growth was driven by continued market expansion across all indications, increased market share, and favorable pricing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Venclexta's total global revenue was $2,009 million in 2022 and $2,288 million in 2023, representing a year-over-year growth rate of 13.9% in 2023 (not 15% as stated by the LLM). The actual growth rate from 2022 to 2023 is (2,288 - 2,009) / 2,009 = 13.89%, which rounds to 13.9%, not 15%. Additionally, the LLM introduces U.S. and international revenue growth figures (8% and 22%) that are not present in the original answer and cannot be verified from the provided ground truth. (2) The quantitative inaccuracies are critical: the reported 15% overall growth is incorrect, and the breakdown into U.S. and international segments appears fabricated or misattributed, as the original answer does not mention such a breakdown. The correct absolute revenues ($2,009M and $2,288M) are entirely omitted. (3) While the LLM attempts multi-hop reasoning by attributing growth to market expansion, market share, and pricing, these drivers are not mentioned in the original answer and thus represent unsupported qualitative additions. The model fails to correctly synthesize the core financial performance metrics—total revenue and growth rate—over the two years. (4) The contextual relevance is moderate because the answer addresses the general topic of Venclexta’s financial performance evolution, but it misses the key requested metrics (exact revenue figures and correct growth rates). Due to major numerical errors and unsupported details, the correctness score is low at 3, quantitative accuracy is very poor (2), qualitative reasoning is partially sound but based on incorrect data (4), and relevance is acceptable but not sufficient (6).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 473,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "Between 2022 and 2023, Netflix amended its Executive Severance and Retention Incentive Plan, with the most recent version being effective January 1, 2024, as disclosed in the 2023 filing. This represents an update from the 2022 filing, which referenced the Amended and Restated Executive Severance and Retention Incentive Plan dated September 10, 2021, without indicating further changes in 2022. The 2023 filing also introduced a new \"Netflix, Inc. Executive Officer Severance Plan\" disclosed on December 8, 2023, suggesting a more tailored approach to executive severance.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key plan amendment from the 2023 filing — the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024' — and accurately cites the December 8, 2023 filing date, aligning with the ground truth. It also correctly references the prior 2021-amended plan mentioned in the 2022 filing, noting no further changes in 2022. However, the LLM introduces a fact not present in the ground truth: the 'Netflix, Inc. Executive Officer Severance Plan' disclosed on December 8, 2023. This specific plan name is not mentioned in the original answer, and its introduction suggests a new plan rather than a further amendment to the existing one, which misrepresents the evolution. The ground truth emphasizes continuity in the same plan (amended again), not the creation of a new plan. This is a significant qualitative error affecting the reasoning and entity accuracy. Quantitatively, all dates and effective periods are correct (September 10, 2021; December 8, 2023; January 1, 2024), so numerical accuracy is high. Contextually, the answer is highly relevant and addresses the evolution between 2022 and 2023 filings. The core facts about plan amendments and effective dates are correct, but the erroneous introduction of a new plan name undermines full accuracy, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 378,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "Lowe's Benefit Restoration Plan, as detailed in the 2024 10-K (page 78), was amended and restated as of January 1, 2025, indicating a formal update to its structure. While the 2022 10-K (page 70) only briefly mentions the plan as a supplement to the 401(k) Plan, the 2024 filing provides more explicit documentation of the plan's existence and amendments. This evolution suggests that Lowe's is refining its retirement benefits to better support employees whose benefits are limited by IRS regulations, reflecting a continued commitment to competitive and comprehensive retirement offerings for its workforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that the Benefit Restoration Plan was amended and restated effective January 1, 2025, as shown in the 2024 10-K (exhibit 10.3), which matches the original answer. The reference to the 2022 10-K (page 70) and 2024 10-K (page 78) supports the evolution in documentation. Quantitatively, all dates and references are correct. The answer captures the key evolution: from brief mention in 2022 to formal restatement in 2024. It correctly infers that this reflects a strategic refinement in retirement benefits for employees affected by IRS limits. The only minor shortcoming is that it does not explicitly mention the inclusion of both employee deferrals and employer match components under the plan (noted in the ground truth), which slightly reduces completeness in qualitative accuracy. However, the core reasoning and multi-hop synthesis across years and filings are sound, and the conclusion about Lowe's strategic approach is logically supported and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 305,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "NVDA's financial obligations related to the 0.584% Notes Due 2024 were fully repaid in fiscal year 2025, as indicated by the note repayment details in the 2025 10-K. Specifically, the 0.584% Notes Due 2024 had a net carrying amount of $1,250 million as of January 28, 2024, but were repaid in full during fiscal year 2025, with no balance remaining as of January 26, 2025. This reflects the evolution of the obligation from being outstanding in fiscal year 2024 to being settled in fiscal year 2025.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The ground truth states that NVDA's 0.584% Notes Due 2024 were fully repaid by fiscal year 2024, as reported in the 2024 10-K. However, the LLM claims repayment occurred in fiscal year 2025, based on a '2025 10-K', which is incorrect and anachronistic—fiscal year 2025 has not occurred as of the knowledge cutoff, and no such filing exists. This misrepresents the timeline and source document. (2) Quantitatively, the LLM reports a carrying amount of $1,250 million as of January 28, 2024, but the ground truth states $1,185 million in fiscal year 2023. The $1,250M figure is incorrect and not supported by the original data. Additionally, the repayment date and balance zeroing out in 2025 are factually wrong. (3) The multi-hop reasoning is flawed: the model incorrectly infers that notes due in 2024 were repaid in 2025, which contradicts standard debt maturity logic and the actual filing. It also fabricates a 2025 10-K, failing to correctly synthesize information across the correct documents and time periods. (4) While the answer addresses the general structure of the question (evolution of debt), the core facts—timing, amounts, and sources—are incorrect, leading to a low correctness score. Contextual relevance is moderate because the response attempts the right type of analysis but with invalid data and timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 387,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Between 2022 and 2023, Mavyret's global revenue performance showed a slight decline, with total net revenues decreasing by 7.2%. In the United States, Mavyret's revenue decreased by 12.7%, while internationally, it saw a minor decline of 1.9%. This indicates a stronger market presence in the U.S., where the decline was more pronounced, compared to the international markets, which experienced a more modest decrease.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the percentage declines in U.S. (12.7%) and international (1.9%) markets, which match the ground truth. However, it omits the actual dollar amounts for revenue in both years ($1,541M in 2022, $1,430M in 2023, and respective regional breakdowns), which are key components of the original answer. While the 7.2% global decline is accurate (calculated as (1,541 - 1,430)/1,541 ≈ 7.2%), this figure was not explicitly stated in the ground truth and is an inference, though a correct one. (2) All percentages are accurate and calculations are correct where applied. The absence of absolute revenue figures reduces completeness and quantitative precision slightly. (3) The reasoning is sound: the model correctly infers that the U.S. decline was more pronounced than the international one, and links this to overall global performance. It synthesizes the trend information correctly across regions, though without citing the exact figures, the multi-hop support is partially incomplete. (4) Scores reflect high accuracy in trends and percentages, minor deduction for missing dollar amounts, which are important for full completeness in financial reporting context. Contextual relevance is perfect as all parts of the question are addressed in spirit, with only data granularity missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 371,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "Between 2022 and 2024, Netflix remained in compliance with the covenant limitations related to its Senior Notes. In 2022, the company had $15,393 million in outstanding notes, with covenants restricting activities such as incurring liens, engaging in sale-leaseback transactions, and merging or consolidating. By 2024, the outstanding notes increased slightly to $15,583 million, and the covenants remained largely consistent, including limitations on liens, mergers, and additional indebtedness. Notably, in 2024, Netflix expanded its revolving credit facility from $1 billion to $3 billion, adding a new covenant requiring a minimum EBITDA-to-interest expense ratio of 3.0 to 1.0. Despite these changes, Netflix was in compliance with all covenants as of both December 31, 2022, and December 31, 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details and key aspects of covenant evolution. While it correctly states that Netflix remained in compliance with covenants in both 2022 and 2024, it misrepresents the debt amounts and introduces incorrect information about covenant changes. The ground truth specifies €5,170 million in euro-denominated Senior Notes, whereas the LLM claims $15,393 million and $15,583 million in outstanding notes—figures not supported by the original answer and likely conflated with other debt instruments or total liabilities. These numbers are materially off and undermine quantitative accuracy. (2) The LLM incorrectly states that Netflix expanded its revolving credit facility to $3 billion with a new EBITDA-to-interest covenant in 2024. This detail is absent from the ground truth and represents a fabrication or misattribution not present in the source data. Additionally, the original answer notes a narrowing of covenant scope—specifically, the removal of sale-leaseback restrictions in some 2024 notes—but the LLM incorrectly implies these restrictions still exist. (3) The multi-hop reasoning is partially sound in that the model attempts to compare covenant terms across years and note compliance status, but it fails to accurately synthesize the evolution of restrictions. It misses the key point that certain covenants (sale-leaseback) were dropped, which is central to the question about 'scope of restrictions.' Instead, it invents a new covenant not in the original data. (4) The contextual relevance is moderate because the answer addresses compliance, repayment, and covenant scope—but the incorrect figures and invented credit facility details severely reduce factual reliability. The repayment of $400 million in 5.750% notes in 2024—a key event in the original—is entirely omitted. Overall, the answer gets the high-level compliance status right but fails on critical specifics, calculations, and entity accuracy, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 553,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "Between 2022 and 2023, Honeywell's approach to the Safety and Retail product line evolved through a structural realignment within the Safety and Productivity Solutions segment. In July 2022, the Safety and Retail business unit, which included the gas detection and safety business, was combined with the Advanced Sensing Technologies business unit to form the Sensing and Safety Technologies business unit. This realignment reflects a shift toward consolidating related offerings under a unified structure to enhance operational focus and efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the structural change in Honeywell's organization involving the Safety and Retail unit and its merger with Advanced Sensing Technologies to form Sensing and Safety Technologies. It accurately notes the timing of the change (July 2022) and the segment (Safety and Productivity Solutions). The only minor omission is the specific 2022 revenue figure of $2,387 million for the Safety and Retail unit, which was included in the ground truth but not mentioned in the LLM response. This affects completeness but not core correctness. (2) All quantitative elements are accurate: the July 2022 timing is correctly stated as when the change occurred, and though the revenue number is missing, no incorrect figures are presented. Format consistency is not an issue as no numbers are misstated. (3) The multi-hop reasoning is sound—the model correctly synthesizes information about organizational structure changes across time (2022 to 2023) and links the structural change to strategic intent (consolidation for efficiency and focus), which aligns with the ground truth’s interpretation. The fact that the change was implemented in July 2022 but reported in the 2023 filing is implied, though not explicitly clarified. (4) The scores reflect high accuracy: full points for quantitative accuracy and contextual relevance, a 9 for qualitative accuracy due to strong reasoning with slight omission of financial detail, and a 9 overall because the core answer is factually correct and well-reasoned despite missing one data point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 431,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "The status and role of Class B-2 Common Stock evolved significantly between 2023 and 2024, primarily due to its newfound convertibility into Class A Common Stock. In 2023, Class B-2 Common Stock had no outstanding shares and no earnings per share, as indicated by a dash in the financial tables. By 2024, however, 49 shares of Class B-2 Common Stock were outstanding, and they became convertible under the U.S. retrospective responsibility plan, which activates upon the final resolution of covered litigation. This convertibility implies a potential dilution of voting power for existing Class A Common Stockholders and could impact the market price of Class A shares if significant conversions occur. Additionally, the introduction of Class B-2 Common Stock into the capital structure adds another layer of complexity to corporate governance, as it may influence decision-making on major corporate actions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, no shares of Class B-2 Common Stock were outstanding in 2023, and by 2024, they remained non-outstanding prior to the Class B-1 exchange offer. However, the LLM incorrectly states that there were 'no outstanding shares' in 2023 (partially correct) but then falsely claims that '49 shares were outstanding' in 2024, which directly contradicts the ground truth. This is a critical error in both direction and magnitude. (2) The numeric claim of '49 shares' is unsupported and incorrect; the original answer states no shares were outstanding, so any assertion of positive issuance is false. Additionally, the mention of 'U.S. retrospective responsibility plan' and 'covered litigation' appears fabricated or misattributed, with no basis in the provided truth. (3) The multi-hop reasoning is flawed: instead of recognizing the phase-out or elimination of Class B-2 shares as part of a strategic equity shift, the model invents a new convertibility mechanism and governance role, reversing the actual trend of diminishing influence. The correct reasoning should show a reduction in role due to non-outstanding status, not an expansion. (4) While the LLM attempts to address convertibility and governance impact—topics relevant to the question—the invented details and reversed facts severely undermine correctness. The contextual relevance is moderate because it discusses the right themes (convertibility, dilution, governance), but the qualitative and quantitative inaccuracies make the answer largely incorrect. Hence, low scores for correctness and quantitative accuracy, slightly above minimum for qualitative due to thematic alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 473,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "Between 2023 and 2024, The Home Depot enhanced its ease of shopping experience by expanding both digital and in-store capabilities. In 2024, the company made significant investments in digital platforms, improving mobile app functionality, and enhancing the \"shopability\" of online products with more detailed information and fulfillment options. Additionally, in-store improvements included expanded self-checkout options, electronic shelf labels, and mobile tools like hdPhones and Computer Vision to improve associate productivity and customer navigation. The company also continued to invest in its supply chain, including same-day and next-day delivery capabilities, and leveraged its stores as fulfillment centers to support a seamless, interconnected shopping experience.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates and initiatives mentioned, with no incorrect numbers or entities (quantitative accuracy is perfect as no specific figures were in the original and none were fabricated). It correctly identifies The Home Depot's efforts in both 2023 and 2024, including digital enhancements like mobile app functionality, electronic shelf labels, self-checkout, and digital platform improvements. However, the LLM answer misses the nuanced evolution between the two years emphasized in the ground truth: while it mentions 2024 digital investments, it does not clearly articulate the strategic shift toward personalized experiences using customer data—such as product review summaries and enhanced product content driven by data insights—which is a key differentiator in 2024. Additionally, the mention of 'hdPhones' and 'Computer Vision' tools, while plausible, are not present in the original answer and introduce unverified specifics, slightly affecting qualitative accuracy. The answer remains contextually relevant and captures the broad direction of improvement in digital and in-store capabilities. The multi-hop reasoning is partially sound—linking digital and in-store improvements across years—but fails to fully synthesize the strategic pivot toward personalization and data-driven shopping experiences highlighted in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 381,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "From 2022 to 2024, the Target Corporation Long-Term Incentive Plan evolved by introducing new forms of equity awards. In 2022, the plan included Restricted Stock Units (RSUs), Performance-Based RSUs, and Performance Share Units. By 2024, the plan expanded to include additional award structures such as Cliff-Vested RSUs and Performance Award Performance Share Units, reflecting a broader approach to long-term incentive compensation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution of Target Corporation's Long-Term Incentive Plan from 2022 to 2024. It accurately identifies the introduction of Cliff-Vested RSUs and Performance Award Performance Share Units by 2024, which reflects the expansion in equity award types. The dates (2022 and 2024) are correct, and there are no numerical inaccuracies, as the response avoids specific dollar amounts or counts that could introduce error. However, the LLM omits several equity award forms present in 2022 according to the ground truth, such as Non-Qualified Stock Options, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director RSUs. While the core forms (RSUs, Performance-Based RSUs, Performance Share Units) are correctly mentioned, the omission of other components reduces completeness and nuance. The reasoning is sound in identifying an expansion in award types, and the semantic meaning aligns with the ground truth—namely, that the plan broadened its equity compensation vehicles. Wording differences are acceptable and do not affect factual integrity. Thus, the answer is factually accurate on the key developments but slightly incomplete in detailing the full 2022 structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 352,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "Qulipta was FDA approved in September 2021 for the preventive treatment of episodic migraine in adults. By 2023, its net revenues increased by more than 100%, driven by strong market share uptake and market growth, following its additional approval in April 2023 for the preventive treatment of chronic migraine in adults and its EC approval in August 2023 for migraine treatment in the EU.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qulipta's FDA approval in September 2021 and mentions strong commercial growth by 2023, which aligns with the ground truth. However, it omits specific revenue figures ($405M U.S., $3M international, $408M total in 2023) and fails to mention the $158M U.S. revenue in 2022 or zero revenue in 2021, which are critical for showing the evolution. Instead, it states revenues 'increased by more than 100%'—a claim not directly supported by the ground truth data (from $158M to $408M is ~158% growth, so directionally correct but not explicitly verified from disclosed % changes). (2) The LLM introduces new information not in the ground truth: an April 2023 FDA approval for chronic migraine and an August 2023 EC approval in the EU. While potentially true, these are not part of the original answer derived from AbbVie's financial disclosures and may conflate regulatory milestones with commercial performance. These additions affect factual accuracy because they are used to explain revenue growth but aren't substantiated in the provided truth. (3) The multi-hop reasoning is partially sound—linking approval to commercial performance—but fails to synthesize the key financial progression across years (2021→2022→2023) as required by the question. The answer lacks the stepwise evolution of revenue, which is central to assessing commercial performance. (4) Scores reflect that core facts (approval date, growth trend) are correct, but major quantitative omissions and unsupported regulatory claims reduce correctness. The answer is contextually relevant and reasonably accurate in direction, but lacks precision and completeness on financial disclosure details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 466,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "Between the 2022 and 2024 SEC filings, Netflix's treatment and disclosure of the 2020 Stock Plan remained structurally consistent, as it continued to be described as a stockholder-approved plan providing for equity awards to employees, directors, and consultants. However, in 2024, there was a notable shift in equity compensation activities: the company ceased granting new stock options and RSUs in 2023 and 2022, and only a limited number of RSUs were granted in 2024, with no new stock options issued that year. Additionally, stock-based compensation expenses decreased significantly from $575 million in 2022 to $273 million in 2024, reflecting reduced activity under the plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both factual content and reasoning. (1) The original answer states that in 2022, the 2020 Stock Plan was only referenced in the exhibit list with no detailed description, while in 2024 it was explicitly described and linked to active equity compensation activities including incentive stock options, nonstatutory stock options, and RSUs with vesting and performance criteria. The LLM answer falsely claims that Netflix ceased granting stock options and RSUs in 2022 and 2023 and only issued a limited number in 2024, which contradicts the ground truth that the plan was more actively described and utilized in 2024. (2) The LLM introduces specific dollar figures—$575 million in 2022 and $273 million in 2024 for stock-based compensation—which are not present in the original answer and cannot be verified against the provided ground truth. Since the ground truth does not mention any financial figures or trends in compensation expense, these numbers are unsupported and likely hallucinated. (3) The multi-hop reasoning is flawed: the question asks about the evolution in disclosure and structural description, but the LLM shifts focus to alleged changes in grant activity and expense trends not present in the ground truth. It fails to recognize the key evolution from passive documentation (2022) to active, detailed disclosure (2024). (4) While the LLM attempts to address Netflix and the 2020 Stock Plan over the correct time frame, its core claims about reduced activity and financial figures are unsupported, leading to a low correctness score. The contextual relevance is moderate because it discusses the right topic and entities, but the substance is factually misaligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 474,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "Between 2022 and 2023, the company maintained its use of derivative instruments for aluminum purchase agreements, classifying them as derivative instruments for accounting purposes due to their pricing and offsetting nature based on market prices. However, there was a notable shift in the notional amounts and fair values of these instruments. In 2023, the notional amount of commodity contracts decreased from $412 million in 2022 to $115 million, while the fair value of these contracts also declined. Additionally, the company continued to use these agreements to address long-term strategic sourcing and non-U.S. business needs, but there was no significant change in their strategic use compared to 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures—$412 million in 2022 and $115 million in 2023 for notional amounts—that are not present in the original answer (ground truth) and cannot be verified from the provided context. These numbers appear fabricated or misattributed, severely undermining factual accuracy. The ground truth does not mention any dollar amounts related to notional or fair values of contracts, so their inclusion is incorrect. (2) While the LLM correctly identifies that aluminum purchase agreements were classified as derivative instruments and used for strategic sourcing and non-U.S. business needs in both years, it fails to capture the key evolution described in the original answer: the 2023 clarification that contract quantities 'offset each other' and are priced at 'prevailing market prices,' indicating a more refined strategy around market alignment and risk mitigation. This is the central qualitative shift in the company's approach, which the LLM only partially reflects by mentioning 'pricing and offsetting nature' without linking it to a strategic evolution. (3) The multi-hop reasoning is partially sound—connecting the use of derivatives across years and recognizing continuity in purpose—but fails to synthesize the nuanced change in disclosure and strategy emphasized in the ground truth. Instead, it invents financial metrics that distract from the actual evolution. (4) The contextual relevance is moderate because the answer addresses the right topic and instruments but introduces irrelevant quantitative details not supported by the source. Correctness is low due to unsupported numbers and omission of the core strategic refinement; qualitative accuracy is moderate due to correct classification and purpose; quantitative accuracy is poor due to unverified figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 498,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "Between 2023 and 2024, the Directors' Code of Conduct remained accessible on the company’s website, with no changes to its availability. However, the 2024 filing provided a slightly updated URL for the Directors' Code of Conduct (https://www.bny.com/...), suggesting a minor update in the web location or formatting for easier navigation. The scope of the code, which applies to all directors and includes provisions for amendments and waivers to be disclosed on the website, remained consistent between the two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Directors' Code of Conduct remained accessible online and notes a URL change in 2024, which aligns with the ground truth. However, it fails to mention the significant addition of the new 'INSIDER TRADING POLICIES AND PROCEDURES' section in 2024, which is a key expansion in scope. This omission severely undermines the completeness and qualitative accuracy of the response. (2) The URL update is acknowledged, though the LLM only vaguely references 'https://www.bny.com/...' instead of providing the full, correct 2024 URL as in the ground truth. While minor formatting differences are acceptable, the lack of specificity reduces precision. (3) The multi-hop reasoning is partially sound—accessibility across years is correctly assessed—but the model fails to synthesize the critical evolution in content scope, indicating a breakdown in deeper comparative analysis. (4) The contextual relevance is fair because the answer addresses accessibility and general consistency, but the absence of the insider trading policy expansion means it misses a core aspect of the scope evolution, leading to a low correctness and qualitative score despite acceptable structure and partial factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 351,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "Between 2023 and 2024, the structure and value of HD's 4.95% Senior Notes evolved significantly. In 2023, HD had $750 million in 4.95% Senior Notes due September 2026, with a net carrying amount of $744 million. By 2024, HD issued an additional $1.75 billion in 4.95% Senior Notes due June 2034 as part of a larger June 2024 debt issuance to fund the SRS acquisition. This indicates a strategic shift toward longer-term debt to finance large-scale acquisitions and manage liquidity, while maintaining a diversified maturity profile to reduce refinancing risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023 HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million, resulting in a carrying amount of $748.4 million (not $744 million as stated). By 2024, the carrying amount was $747 million as of February 2, 2025 — consistent with amortization of the discount. However, the LLM incorrectly claims HD issued an additional $1.75 billion in 4.95% notes due June 2034 in June 2024 to fund the SRS acquisition, which is not supported by the original answer. Instead, the ground truth states that HD issued $980 million in 4.95% senior notes due 2052 — a critical fact entirely missing from the LLM response. (2) The quantitative inaccuracies are severe: incorrect issuance amount ($1.75B vs $980M), wrong maturity date (June 2034 vs September 2052), incorrect initial carrying amount ($744M vs $748.4M), and no mention of the actual 2052 notes. These errors undermine the financial accuracy of the response. (3) The multi-hop reasoning is flawed. The LLM fails to correctly synthesize the evolution of HD’s 4.95% notes — particularly the extension to a 2052 maturity, which is central to the long-term debt strategy. Instead, it fabricates a June 2034 issuance for an acquisition not referenced in the ground truth, leading to an incorrect strategic interpretation. (4) While the LLM attempts to address the question’s intent — analyzing structural evolution and strategy — its factual foundation is unsound. The contextual relevance is moderate because it discusses debt strategy and maturity extension, but the incorrect entities and numbers severely limit accuracy. The conclusion about longer-term debt and refinancing risk is directionally plausible but based on false premises, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 504,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "Between 2021 and 2023, Intel recognized $471 million in observable price adjustments for its investment in Beijing Unisoc Technology Ltd. in 2021. As of December 30, 2023, the net book value of this investment remained stable at $1.1 billion, consistent with its value as of December 31, 2022. No further observable price adjustments were reported for Unisoc in 2022 or 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $471 million observable price adjustment in 2021 and the $1.1 billion net book value as of December 30, 2023 (matching December 31, 2022) are accurately reported. The dates and dollar amounts are precise and consistent with the original answer, with acceptable formatting. (2) The answer is complete, addressing both the 2021 observable price adjustment and the valuation treatment in 2023, including the stability of the net book value and the classification as a non-marketable equity security (implied by the absence of further observable price adjustments). (3) Entity accuracy is correct: Intel, Beijing Unisoc Technology Ltd., and the relevant years (2021–2023) are properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: it connects the 2021 adjustment with the subsequent accounting treatment and stable valuation through 2023, correctly inferring that no further adjustments imply continued non-marketable status. (5) The semantic meaning is equivalent to the original answer, with slightly more concise wording but no loss of key information. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 345,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "In 2022, Qulipta was not yet approved, as no mention of its regulatory status is found in the 2022 filing. By April 2023, AbbVie received FDA approval for Qulipta for the preventive treatment of chronic migraine in adults, and in August 2023, the European Commission approved Aquipta (Qulipta) for migraine prevention in adults with four or more migraine days per month. This indicates a significant advancement in Qulipta's regulatory and commercial development from 2022 to 2023, with successful approvals in key markets and the initiation of commercialization.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory milestones for Qulipta in 2023—FDA approval in April 2023 and EC approval in August 2023—which aligns with the ground truth. However, it incorrectly states that there was 'no mention of its regulatory status' in the 2022 filing, which contradicts the ground truth that Qulipta was part of a group of products leading to the reclassification of $1.0 billion in intangible assets in 2022. This omission of a key financial and regulatory development in 2022 represents a significant qualitative gap. (2) All dates and dollar amounts are accurate or correctly implied; the $1.0 billion reclassification is missing from the LLM answer, but no incorrect numbers are presented. The approval dates (April and August 2023) are correct. (3) The multi-hop reasoning is partially sound: the model correctly connects 2022 (lack of approval) to 2023 (approvals), but fails to incorporate the critical 2022 asset reclassification, which is central to understanding the evolution of AbbVie's engagement. This weakens the synthesis across years. (4) The answer is contextually excellent and clearly addresses the regulatory and commercial evolution, but the missing 2022 financial reclassification reduces completeness and factual accuracy, warranting a score of 8 for correctness. Quantitative accuracy is high (9) due to correct dates and no incorrect numbers. Qualitative accuracy is 8 due to sound reasoning on approvals but a key omission. Contextual relevance is perfect (10) as the response directly addresses the question's focus on regulatory and commercial development.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 447,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "Between 2022 and 2023, Boeing's framing of 'upgrades and conversions' within the Global Services segment remained consistent in its description of the services offered, as both filings list it as part of the full spectrum of services provided to commercial and defense customers. However, the 2023 filing places a slightly more strategic emphasis on the integration of these services within the broader lifecycle of aerospace platforms, highlighting their role in sustaining and enhancing customer value across fleet operations. This subtle shift reflects a more customer-centric and lifecycle-oriented strategic narrative in 2023 compared to the more general description in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that in 2022, 'upgrades and conversions' were part of a broader list of services with a general description, and in 2023, the framing evolved to emphasize integration within the lifecycle of aerospace platforms. While the LLM does not explicitly mention the specific services grouped with 'upgrades and conversions' in 2022 (e.g., supply chain logistics, training systems), this omission is minor and does not affect the core correctness. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift in strategic emphasis across two years and segments, identifying the move from a general to a more integrated, lifecycle-oriented narrative. The conclusion about a more customer-centric and strategic framing in 2023 aligns with the ground truth's assertion of a 'more deliberate positioning' as a core capability. (4) The answer is highly contextually relevant, directly addressing the evolution in language and strategic emphasis. The only reason for not scoring a 10 is the slight lack of specificity regarding the 2022 service grouping, which the original answer includes for completeness. Overall, the response captures the essential evolution accurately and concisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 393,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Intel's investment in Beijing Unisoc Technology Ltd. remained relatively stable in valuation between 2021 and 2023. As of December 30, 2023, the net book value of the investment was $1.1 billion, unchanged from December 31, 2022. In 2021, Intel recognized $471 million in observable price adjustments for the investment, indicating a valuation increase that year. No significant impairments or gains from sales were reported for Unisoc during 2022 or 2023, suggesting a consistent but non-fluctuating recognition of the investment's value over the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.1 billion net book value for Intel's investment in Beijing Unisoc Technology Ltd. as of the end of 2023 and notes its stability compared to the prior year. It accurately reports the $471 million in observable price adjustments recognized in 2021. However, there is a minor date discrepancy: the original answer specifies the 2021 valuation point as December 25, 2021 (from the 2022 filing), while the LLM references December 31, 2022, as the prior-year anchor, which misaligns with the ground truth timeline. The LLM implies the $1.1 billion was unchanged from 2022 to 2023, but the ground truth compares 2021 to 2023 directly, with no explicit confirmation of 2022's value. (2) All numeric values—$1.1 billion and $471 million—are correct in amount and context. The calculation and comparison of values across years are logically sound, though the missing explicit confirmation of 2022's value introduces a small gap. (3) The multi-hop reasoning is mostly sound: the model correctly synthesizes information about valuation stability and the absence of reported impairments or gains in 2022–2023, inferring consistency. However, it does not explicitly note that the 2023 filing did not mention observable price adjustments (a key contrast to 2021), which slightly weakens the qualitative synthesis. (4) The answer is highly relevant and conveys the core evolution of the financial relationship. The minor date misstatement and omission of the explicit absence of 2023 adjustments prevent a top score, but the overall factual and conceptual accuracy remains strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 444,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "Between 2023 and 2024, the role of Self-Service Lockers within Home Depot's interconnected shopping experience has evolved to enhance convenience and streamline customer fulfillment. In 2023, self-service lockers were introduced at the front entrance of many stores to enable convenient online order pickup options. By 2024, these lockers continued to be a key component of the interconnected retail strategy, complementing services like curbside pickup and supporting the growing demand for efficient and flexible order fulfillment. This expansion reflects Home Depot's ongoing commitment to optimizing the customer experience through technology-driven solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the general evolution of Self-Service Lockers from a convenience feature in 2023 to a more integrated role in 2024 within Home Depot's interconnected shopping experience. It accurately notes their use for online order pickup and alignment with broader fulfillment strategies. However, it omits key factual details present in the ground truth, most notably the specific statistic that approximately 50% of U.S. online orders were fulfilled through stores in 2024, which is a critical quantitative indicator of the lockers' operational significance. Additionally, while it mentions curbside pickup, it fails to reference the specific interconnected retail programs (BOSS, BOPIS, BODFS, BORIS) that contextualize the strategic integration of lockers into fulfillment workflows. (2) There are no numeric inaccuracies because the LLM does not introduce any incorrect numbers—it simply omits the 50% fulfillment statistic. Thus, quantitative accuracy is high by default. (3) The multi-hop reasoning is partially sound: the model infers a strategic shift based on contextual cues, but it does not fully synthesize the 2023 and 2024 data points to demonstrate how the role evolved from a customer-facing convenience to a core fulfillment node supported by measurable operational integration. The absence of program names and the key percentage weakens the depth of synthesis. (4) The correctness score is 6 due to significant omissions in key details that define the evolution—especially the lack of the 50% fulfillment metric and specific omnichannel program references—though the overall direction of the answer is accurate. Qualitative accuracy is moderate for similar reasons. Quantitative accuracy is 10 because no numbers are wrong, only missing. Contextual relevance is high as the response stays focused on the question and provides a coherent narrative of evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 518,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "From 2023 to 2024, Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities remained largely consistent in terms of detail and specificity. Both years explain that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions, and note that these estimates are subject to significant adjustments if future occurrences differ from assumptions. However, the 2024 disclosure added a brief mention of the Company's wholly-owned captive insurance subsidiary and reinsurance program, providing slightly more context on risk management mechanisms. Overall, the level of detail and specificity did not significantly evolve.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. The original answer states that Costco significantly expanded its disclosure in 2024, adding specific details about estimation factors (historical claims, demographic factors, severity factors, actuarial assumptions) and discussing the unpredictability of claims and potential for significant differences between actual and recorded liabilities—none of which were present in 2023. In contrast, the LLM claims that both years included these details, which is false. The LLM reverses the direction of change: it incorrectly asserts that the disclosures were largely consistent and that 2024 only added a minor mention of the captive and reinsurance program, when in fact it was 2023 that mentioned the captive and reinsurance, and 2024 that introduced the detailed estimation methodology. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution of disclosures across years. It misattributes the content of the disclosures, conflating what was disclosed in 2023 versus 2024, and thus reaches the opposite conclusion of the ground truth. This represents a failure in entity-time mapping (what was said in which year). (4) While the LLM answer is relevant to the question and uses appropriate terminology, its factual inaccuracies—especially the reversal of disclosure content between years—severely undermine correctness. The conclusion that 'the level of detail did not significantly evolve' is directly contradicted by the ground truth, which states there was a 'meaningful increase in transparency and specificity.' Hence, the correctness and qualitative accuracy scores are low, despite perfect quantitative accuracy and moderate contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 517,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "The financial impact of the Aldevron acquisition on inventory-related costs increased from 2022 to 2023. In 2022, the Aldevron acquisition increased cost of sales by $59 million due to fair value adjustments to inventory. In 2023, the impact was more significant, with $87 million in charges primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a worsening impact on inventory-related costs following the acquisition.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the $59 million inventory-related cost in 2022 due to fair value adjustments from the Aldevron acquisition and the $87 million charge in 2023 related to excess inventory in the Biotechnology segment. These numbers and their contexts are factually accurate. (2) Quantitatively, all dollar amounts and their attributions are correct—$59M in 2022 and $87M in 2023—with no calculation errors. (3) However, the reasoning is flawed: the LLM incorrectly implies that the 2023 $87 million charge is a continuation or worsening of the Aldevron acquisition impact, when in fact the original acquisition-related inventory adjustment was a one-time 2022 event that did not recur in 2023. The 2023 charge is unrelated to Aldevron and instead stems from operational issues (excess inventory due to reduced demand). This misrepresents the evolution of the financial impact. The original answer correctly identifies a shift from acquisition-driven to operationally driven inventory costs; the LLM instead suggests a direct escalation of acquisition-related costs, which is factually incorrect. (4) Therefore, while the individual facts and numbers are accurate (earning high quantitative and relevance scores), the qualitative reasoning is significantly flawed, leading to a misleading conclusion. The correctness score is moderate because the answer contains key facts but fails the multi-hop reasoning by conflating two distinct financial events.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 407,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "Between 2023 and 2024, Costco's treatment and recognition of shop card liabilities remained consistent, with liabilities accounted for as a shop card liability, net of estimated breakage, and included in other current liabilities in the consolidated balance sheets. The recognition of breakage is based on historical redemption data, indicating a conservative and data-driven approach to estimating unclaimed balances. This consistency suggests that Costco maintains a reliable methodology for managing shop card liabilities and accounts for unclaimed balances prudently, reflecting its disciplined financial reporting practices.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and consistent with the ground truth in terms of entity, year, and accounting treatment. It correctly states that Costco accounts for shop card liabilities net of estimated breakage, based on historical redemption data, and includes them in other current liabilities—details that align with the knowledge graph. There are no numeric inaccuracies (quantitative accuracy is perfect), and the context of the question is fully addressed (contextual relevance is strong). However, the LLM emphasizes 'consistency' between 2023 and 2024, which slightly downplays the evolution noted in the original answer: the increased emphasis on 'estimated breakage' and refinement of methodology in 2024. While the LLM does not contradict this, it fails to explicitly acknowledge the progression toward a more formalized or refined approach, which was a key point in the ground truth. This omission affects qualitative accuracy, as the multi-hop reasoning should have captured not just consistency but also the nuanced enhancement in estimation techniques. Thus, while the answer is largely correct and semantically aligned, it lacks full completeness in conveying the evolution aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 341,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "From 2022 to 2023, Intel's Foundry Services (IFS) evolved significantly in strategic partnerships and customer engagement. In 2022, IFS launched the Accelerator Ecosystem Alliance program and secured foundational agreements. By 2023, the program had doubled to over 40 strategic agreements, including multigenerational partnerships with ARM and a definitive agreement with Synopsys, enhancing IP and EDA support for customers. Additionally, IFS expanded its RAMP-C program partnerships and secured four design wins on Intel 18A, including a major high-performance computing customer, reflecting growing customer confidence and engagement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the expansion of the IFS Accelerator Ecosystem Alliance to over 40 strategic agreements, the multigenerational agreements with ARM and Synopsys, the four design wins on Intel 18A (including a major HPC customer), and five new advanced packaging design wins in 2023. The LLM correctly notes the launch of the Accelerator program in 2022 and its growth by 2023. (2) Quantitative accuracy is perfect: 'over 40' agreements, 'four design wins', and correct naming of partners (ARM, Synopsys) match the ground truth. The LLM omits the specific mention of 'five new design wins in advanced packaging' but compensates by referencing expanded RAMP-C partnerships, which is contextually relevant though not explicitly stated in the original. (3) Multi-hop reasoning is sound—correctly synthesizing evolution from strategic intent (2022) to execution (2023) across partnerships and customer engagements. (4) The answer is contextually excellent, directly addressing the evolution in partnerships and customer engagement. The only minor omission is the explicit mention of AI-related designs in advanced packaging, which slightly affects completeness but does not detract from the core accuracy. Hence, a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 372,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "Between 2022 and 2023, DHR's relationship with Aldevron remained consistent in terms of goodwill and net cash consideration. In 2022, the Aldevron acquisition was recorded with $6.1 billion of goodwill and a net cash consideration of $9.56 billion. In 2023, the goodwill related to Aldevron remained unchanged at $6.1 billion, and the net cash consideration was still $9.56 billion, indicating no significant changes in the financial impact of the acquisition during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that both goodwill and net cash consideration remained unchanged between 2022 and 2023. According to the ground truth, while $6.1 billion of goodwill was preliminarily recorded in 2022, the net cash consideration in 2023 increased to $9.561 billion, indicating a revised or more detailed financial assessment. The LLM incorrectly states that net cash consideration was already $9.56 billion in 2022, which contradicts the original answer implying an evolution in financial impact. (2) Quantitatively, the $6.1 billion goodwill figure is correct for 2022, but the attribution of $9.56 billion net cash consideration in 2022 is unsupported by the original answer, which only specifies the 2023 figure. The original does not state what the 2022 net cash consideration was, so asserting it as $9.56 billion is an unwarranted assumption. The LLM also rounds $9.561 billion to $9.56 billion without acknowledging the increase. (3) The multi-hop reasoning is flawed: the question asks how the financial impact evolved, requiring recognition of change over time. The LLM concludes there was no change, directly contradicting the ground truth’s emphasis on a 'significant increase in financial commitment' and 'revised financial assessment.' This shows a failure to synthesize the implication of increased net cash consideration by 2023. (4) Scores are low because the core claim of no change is false, and key financial evolution is misrepresented. Contextual relevance is moderate because the answer addresses the right entities and metrics but draws the opposite conclusion of the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 452,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The maturity date of the AT&T Inc. 1.800% Global Notes has remained unchanged between the 2022 and 2024 SEC filings, with both documents listing the maturity date as September 5, 2026. This consistency suggests that there has been no refinancing or restructuring of this particular debt instrument during this period, indicating stability in this segment of AT&T's debt structure. However, the overall debt profile shows a continued focus on long-term obligations, with many notes maturing well beyond 2026, reflecting the company's strategy of maintaining a long-duration debt portfolio to match its capital needs and cash flow timelines.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the maturity date remained unchanged. According to the ground truth, the maturity date changed from September 5, 2026 (2022 filing) to September 14, 2039 (2024 filing), a shift of over 13 years. The LLM incorrectly claims no change, which contradicts the verified data. (2) The quantitative accuracy is extremely low: the key dates are wrong, and the conclusion that there was no refinancing is false given the actual extension of maturity. The calculation of a 13+ year extension is accurate in the ground truth but entirely missed in the LLM response. (3) The multi-hop reasoning failed completely — the model did not detect or synthesize the change between two filings for the same debt instrument, which is the core of the question. Instead, it fabricated consistency and drew incorrect conclusions about stability. (4) Contextual relevance is partially met as the answer discusses debt structure and maturity strategy, but the factual foundation is so flawed that the reasoning collapses. The mention of long-term obligations is generic and does not compensate for the central inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 329,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target remained in compliance with its debt leverage covenant in both 2023 and 2024, as stated in both the 2023 and 2024 10-K filings. However, in 2024, Target modified its credit facility structure by obtaining a new $1.0 billion 364-day unsecured revolving credit facility in October 2024, which replaced the prior 364-day facility and extended the expiration of its existing $3.0 billion five-year facility to October 2028. These changes likely enhanced Target's liquidity and flexibility, supporting continued compliance with its debt leverage covenant.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy regarding the extension of the five-year facility. According to the ground truth, the $3.0 billion five-year facility was already set to expire in October 2028 in 2023, and it remained unchanged in 2024—there was no extension of this facility in 2024. The LLM incorrectly states that the five-year facility was 'extended to October 2028' in 2024, which implies a change that did not occur. However, the LLM correctly identifies the renewal of the $1.0 billion 364-day facility with an expiration now in October 2025 (implied by being renewed in October 2024), and correctly notes Target's continued compliance with the debt leverage covenant in both years. The qualitative reasoning about enhanced liquidity and flexibility due to the credit facility renewal is sound and aligns with the ground truth. All dollar amounts ($1.0 billion, $3.0 billion) and facility types (364-day, five-year) are accurate. The answer addresses both parts of the question: covenant compliance over time and changes in credit structure. The error is limited to an incorrect implication of a change in the five-year facility’s maturity, which was actually unchanged. This is a factual error but does not undermine the core conclusion about compliance and flexibility. Hence, the answer is strong but not fully accurate on quantitative details, warranting a score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 389,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023 through a more ambitious and structured RISE strategy, with a stronger emphasis on external collaboration. In 2022, Intel focused on digital readiness through its Intel Digital Readiness Programs, such as AI for Youth and AI for Workforce, in partnership with governments and institutions. By 2023, the company expanded these efforts under the RISE Technology Initiative, which aimed to build deeper relationships with customers and partners to create shared value. Additionally, Intel launched the Alliance for Global Inclusion, creating a global Inclusion Index to benchmark diversity and inclusion practices across industries, and increased its focus on expanding digital readiness for millions globally through collaborative initiatives.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies Intel's RISE strategy and external collaboration focus, and mentions the Alliance for Global Inclusion and the Inclusion Index, which aligns with the original answer. However, it misrepresents the timeline and nature of key developments. Specifically, it incorrectly states that the Alliance for Global Inclusion was 'launched' in 2023, while the ground truth indicates it was already active in 2022. It also fails to mention the critical evolution in 2023: the publication of the third global inclusion index survey and the formal recognition system for organizations scoring 50% or higher, with Intel being one of 18 recognized out of 27 respondents. These quantitative benchmarks are missing entirely, undermining the multi-hop synthesis. (2) The original answer includes specific numbers (18 recognized organizations, 27 respondents, 50% threshold) that are absent in the LLM response, resulting in a quantitative accuracy score of 6—some context is correct, but key metrics are missing. (3) The reasoning is partially sound in that it traces a progression from collaboration to broader initiatives, but it fails to accurately represent the shift from framework-building to performance measurement and recognition, which is the core of the evolution. The LLM invents programs like 'AI for Youth' and 'AI for Workforce' not mentioned in the ground truth, introducing factual inaccuracies. (4) Contextual relevance is high because the answer addresses digital readiness, the RISE strategy, and collaboration, but correctness and qualitative accuracy are reduced due to factual omissions and misattributions. The answer captures the general direction but not the specific, evidence-based evolution described in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 496,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson's relationship with Micromine evolved from a planned acquisition to a terminated agreement between 2023 and 2024. In 2022, AspenTech (a subsidiary of Emerson) agreed to acquire Micromine for approximately $623 million, but the transaction was terminated on August 1, 2023, due to regulatory uncertainties in Russia. No financial implications, such as termination fees or material losses, were associated with this change, as AspenTech did not incur any costs related to the termination.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It incorrectly states that the agreement was made in 2022, while the ground truth confirms it was in 2023. It also misrepresents the financial implications by claiming 'no financial implications' and 'no costs related to termination', which directly contradicts the ground truth: Emerson (via AspenTech) recorded a $24 million mark-to-market gain in 2023 from foreign currency forward contracts tied to the acquisition, and in 2024, those contracts were terminated. The deal value is correctly stated as ~$623 million (matching AU$900 million), so that numeric value is accurate. However, the date of termination (August 1, 2023) is plausible but not verifiable from the ground truth provided, which does not specify an exact date. (2) Quantitative accuracy is low due to the omission of the $24 million gain and incorrect timing (2022 vs 2023). The $623 million figure is correct and matches the conversion from AU$900 million. (3) The multi-hop reasoning is partially sound—linking Emerson to AspenTech to Micromine is correct, and recognizing regulatory issues in Russia as the cause is accurate. However, the model fails to synthesize the financial consequences across 2023 and 2024, particularly the gain and the contract terminations, which are central to the financial implications. (4) Contextual relevance is high because the answer addresses the evolution of the relationship and attempts to discuss financial outcomes. However, the qualitative accuracy is reduced due to key omissions and one significant factual error (2022 vs 2023 timeline), leading to a correctness score of 4—partially correct but with major gaps in financial implications and timeline accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 475,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) decreased from 17 million shares in 2022 to 15 million shares in 2023. Additionally, the average purchase price of shares during the fiscal year under the ESPP decreased from $305.14 in 2022 to $277.19 in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the share availability decreased from 17 million in 2022 to 15 million in 2023, and the average purchase price decreased from $305.14 to $277.19. These values exactly match the original answer. (2) The answer is complete, addressing both parts of the question—changes in share availability and average purchase price—across the two fiscal years. (3) Entity accuracy is correct: The Home Depot, U.S. ESPP, and the fiscal years 2022 and 2023 are properly identified. (4) The reasoning is sound and correctly synthesizes multi-hop information by comparing two data points across years. Although the LLM omits the detail that approximately one million shares were purchased in both years, this information is not directly asked in the question, which focuses on availability and average price. Thus, the omission does not affect correctness. The answer is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 292,
        "total_tokens": 1500
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "Between 2022 and 2023, the pattern of impairment triggers and associated charges across DHR's business segments indicates a shift in risks affecting its intangible asset portfolio. In 2023, impairment triggers were identified in the Biotechnology and Diagnostics segments, resulting in a $77 million charge, primarily related to technology-based intangible assets. In contrast, 2022 saw no impairment charges, while 2021 had a smaller $10 million charge in the Diagnostics segment. This evolution suggests increased vulnerability in the Biotechnology segment's intangible assets, likely driven by market or operational challenges, while the Diagnostics segment continues to face periodic risks. The absence of impairments in 2022 reflects relative stability before the renewed pressures in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It states that there were no impairment charges in 2022, but the ground truth clarifies that the 2022 filing reported a $10 million charge from Q1 2021 (for comparative purposes). More critically, the LLM incorrectly implies that the $77 million charge occurred in 2023 as a single event, while the ground truth specifies that the $77 million total in the 2023 filing resulted from multiple triggers across Q2 and Q4 2023 in Biotechnology and Diagnostics segments. The LLM also fails to note that the 2021 Diagnostics charge was included in both filings for comparison, misrepresenting the timeline. (2) Quantitative accuracy is compromised: while $10 million and $77 million figures are correct, their attribution to years is flawed. The $77 million was incurred in 2023 (correct), but the $10 million was from 2021, not 2022. The LLM incorrectly frames 2022 as having no charges, when the 2022 filing did report the 2021 charge. (3) The reasoning is partially sound—identifying increased risk in Biotechnology and ongoing risk in Diagnostics aligns with the ground truth—but it misses the multi-hop nuance that the 2023 filing revealed a broadening of impairment triggers across multiple quarters and segments, not just a simple year-over-year comparison. The absence of 2022 impairments is misinterpreted as stability, when the filings are reporting impairments from prior years. (4) Contextual relevance is high—the answer addresses the evolution of impairment patterns and links them to shifting risks in intangible assets. However, due to key factual and temporal inaccuracies, especially around the timing and distribution of charges, the correctness score is limited to 6, reflecting partial accuracy with significant omissions and misstatements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 494,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023, indicating a significant rise in the company's involvement in business transactions tied to trade contracts during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023, which matches the ground truth exactly. The interpretation — that this indicates a significant rise in the company's involvement in trade-related business transactions — is semantically equivalent to the original answer's conclusion of 'growing involvement or expansion.' (2) All numeric values are accurate: $362 million (2022) and $598 million (2023), with no calculation required beyond recognition of increase; format is consistent and acceptable. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers increased financial commitment via letters of credit as an indicator of expanded trade activity, aligning with standard financial interpretation. (4) All aspects of the question are addressed: the change in value between two years and its implication on business involvement. The answer is fully factually aligned, contextually appropriate, and logically coherent, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 324,
        "total_tokens": 1473
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "The 0.300% Notes due 2028 were first disclosed in IBM's 2023 SEC filing as part of the company's financial instruments, with the instrument defining their terms filed as Exhibit 4.1 to Form 8-K on February 10, 2020. In the 2024 SEC filing, these notes are listed again under the company's registered securities, indicating continued relevance in IBM's capital structure. This evolution in disclosure reflects IBM's consistent and transparent reporting of its debt instruments, ensuring investors are informed about the terms and status of its outstanding obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 0.300% Notes due 2028 and the February 10, 2020 filing date of Exhibit 4.1, which matches the ground truth. These quantitative elements (percentage, year, date) are accurate. However, the LLM fails to mention the key evolution in the 2024 filing: the notes are now listed as actively issued under the trading symbol IBM28B and registered on the New York Stock Exchange. This omission is significant because it represents a material change in the instrument's status—from a disclosed obligation to an actively traded security. (2) All numbers and dates provided (0.300%, 2028, February 10, 2020) are factually correct and match the original answer. No calculations are required, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound: the model connects the 2023 and 2024 disclosures but misses the critical synthesis point—the shift to active trading status on NYSE under a ticker symbol. This reflects a failure to fully interpret the evolution in disclosure significance. The conclusion about 'consistent and transparent reporting' is reasonable but misses the deeper implication of increased market engagement or liquidity suggested by the ground truth. (4) The answer is contextually relevant and addresses the general evolution of disclosure, but lacks the specific financial market development that defines the true evolution. Hence, correctness and qualitative accuracy are reduced due to incomplete synthesis and missed implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 417,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "Between 2023 and 2024, IBM's 1.750% Notes due 2031 were consistently disclosed as being registered on the New York Stock Exchange (NYSE). In both the 2023 and 2024 10-K filings, the notes are listed under the securities registered on the NYSE, with the ticker symbol \"IBM31.\" There is no indication of material changes in the treatment, registration status, or disclosure requirements for these notes between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that the 1.750% Notes due 2031 were registered on the NYSE in both 2023 and 2024. According to the ground truth, in 2023, IBM only disclosed the notes with the instrument incorporated by reference from a 2019 filing—there was no indication of formal registration or listing on the NYSE at that time. The key evolution occurred in 2024, when the notes were explicitly registered and assigned the trading symbol IBM31 on the NYSE, marking a shift from passive disclosure to active listing. The LLM incorrectly states that the registration status was the same in both years, which contradicts the multi-hop insight that the treatment evolved. While the ticker symbol 'IBM31' and the note details (1.750%, due 2031) are correctly identified, and the quantitative elements (percentages, years) are accurate, the reasoning and synthesis across years are flawed. The model failed to detect the change in status over time, misrepresenting a static situation instead of the dynamic progression described in the ground truth. This undermines the qualitative accuracy and overall correctness, despite correct entity naming and numerical values. Contextual relevance is moderate as the answer addresses the right topic but with incorrect temporal dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 361,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "Eli Lilly's financial relationship with Zyprexa evolved significantly between 2023 and 2024, primarily through the sale of the rights for the olanzapine portfolio, which includes Zyprexa. In 2023, the sale of these rights contributed $1.615 billion in revenue outside the U.S., significantly boosting overall revenue for that year. By 2024, the impact of this transaction was reflected in the business model approach, as the collaboration and other revenue category included proceeds from the sale of these rights. This shift indicates a strategic move toward monetizing legacy products through rights sales, thereby influencing revenue recognition patterns and reducing ongoing revenue dependency on Zyprexa.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key shift in Eli Lilly's financial relationship with Zyprexa—from direct product sales to revenue via collaboration and other arrangements—driven by the sale of rights to the olanzapine portfolio. This reflects accurate qualitative understanding of the business model evolution. However, the reported revenue amount is incorrect: the LLM states $1.615 billion in 2023, while the ground truth is $1.45 billion. This is a significant quantitative error, especially given the precision implied. (2) The numbers do not match: $1.615B vs $1.45B is a difference of $165 million, which is material. No acceptable format variation explains this discrepancy. (3) The multi-hop reasoning is partially sound—the model correctly infers that the sale of rights led to a change in revenue recognition and business model, shifting from product sales to collaboration revenue. It also correctly links the 2023 transaction to 2024 reporting. However, it fails to explicitly state that Zyprexa was no longer reported in product sales in 2024, a key detail in the ground truth. (4) The contextual relevance is high—the answer addresses the evolution in revenue recognition and business model. The qualitative accuracy is moderate due to correct logic but missing nuance about post-sale royalty or profit-sharing. The correctness score is reduced primarily due to the major numerical inaccuracy, despite otherwise reasonable reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 406,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "The Mobility Preferred Interests were fully repurchased by AT&T in April 2023, eliminating any redemption obligations in 2024. In 2023, prior to repurchase, these interests were classified as a liability and impacted diluted earnings per share calculations by adding approximately 72 million dilutive potential common shares. By 2024, with no remaining Mobility Preferred Interests, there was no further effect on earnings per share calculations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the full repurchase of Mobility Preferred Interests in April 2023 and the elimination of redemption obligations in 2024, which aligns with the ground truth. However, it introduces a specific number—'72 million dilutive potential common shares'—that is not present in the original answer and cannot be verified from the provided ground truth, making it factually unsupported. Additionally, the LLM claims there was 'no further effect on earnings per share calculations' in 2024, which contradicts the ground truth stating that under ASU 2020-06, the ability to settle in stock was reflected in diluted EPS for periods *prior* to repurchase—implying retrospective accounting treatment still had relevance in 2024 financial reporting. (2) The dollar amounts ($2,670 in current and noncurrent liabilities, $5,414 total repurchase cost) from the original answer are entirely omitted in the LLM response, representing a significant quantitative gap. The introduction of the 72 million shares figure without corroboration reduces quantitative accuracy. (3) The reasoning correctly follows the timeline and reclassification logic but fails in the multi-hop synthesis regarding the ongoing *accounting impact* in 2024. The model misunderstands the nature of the retrospective application of ASU 2020-06, which continues to affect how prior periods are presented or computed even after the instrument is retired. (4) Contextual relevance is high because the answer addresses both redemption obligations and EPS impact. Qualitative accuracy is moderate due to correct entity identification (AT&T, Mobility Preferred Interests, 2023 repurchase) and logical flow, but penalized for incorrect conclusion about 2024 EPS. Quantitative accuracy is low due to missing verified figures and inclusion of unverified ones. Correctness score reflects partial accuracy with key omissions and one major factual deviation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 525,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "Between 2023 and 2024, IBM's 0.875% Notes due 2030 remained listed on the New York Stock Exchange (NYSE) under the trading symbol IBM30A. In 2023, the notes were disclosed in the 10-K under the listing of securities, and in 2024, they were similarly included in the updated list of registered securities under Section 12(b) of the Exchange Act, confirming no change in their registration or listing status.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) It claims the 0.875% Notes due 2030 were 'listed on the NYSE under the trading symbol IBM30A' in 2023, but the original answer states they were only incorporated by reference in 2023 and not explicitly listed or registered until 2024. This misrepresents the core evolution of the disclosure and registration status. (2) The LLM asserts there was 'no change in their registration or listing status' between 2023 and 2024, which directly contradicts the ground truth indicating a clear shift from referenced disclosure to full listing and registration. (3) While the trading symbol IBM30A and NYSE registration in 2024 are correctly mentioned, the timeline and nature of the change are fundamentally wrong. (4) The multi-hop reasoning fails: the model did not correctly synthesize the progression from incorporation by reference (2023) to explicit listing (2024), which is the central point of the question. The answer incorrectly assumes continuity rather than change. Quantitative accuracy is partially preserved (correct symbol, correct note details), but the critical temporal and procedural evolution is misrepresented, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 349,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "From 2023 to 2024, the structure and distribution terms of the Telco Preferred Interests evolved through the addition of new classes and adjustments to existing terms. In 2023, the Telco LLC had cumulative preferred interests totaling $7,250, with Telco Class A-1 paying 4.25% annually and Telco Class A-2 and A-3 paying 6.85% annually, both subject to reset every seven years. In 2024, AT&T further restructured the Tower Holdings Preferred Interests, introducing a mix of fixed and floating rate distributions, with the fixed rate at 5.90% and the floating rate tied to SOFR plus 250 basis points. Additionally, in October 2024, AT&T announced plans to issue $2,250 of new Telco Class A-4 interests with a 5.94% initial distribution rate, subject to reset every four years. These changes indicate that AT&T is adopting a more flexible and diversified approach to financing through preferred equity instruments, allowing for better alignment with market conditions and potentially optimizing the cost of capital.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 (4.25%) and $5,250 of Class A-2/A-3 (6.85%), totaling $7,250. The LLM incorrectly states that the total was $7,250 in 2023 but misrepresents the composition and implies no change from 2023 to 2024 in structure, when in fact the $5,250 for A-2/A-3 was newly issued in April 2023. More critically, the LLM fabricates details about 2024 changes: it claims AT&T introduced fixed and floating rates (5.90%, SOFR + 250 bps) and plans to issue $2,250 of Class A-4 at 5.94%, resetting every four years. These instruments and terms do not appear in the ground truth. The actual 2024 update was that the structure remained unchanged, with no new classes issued, and the key new disclosure was about distribution payment flexibility. (2) Quantitative accuracy is poor: while the total $7,250 is correct, the breakdown and new issuance amounts ($2,250 A-4) are incorrect. The interest rates cited (5.90%, 5.94%, SOFR-based) are entirely fabricated. The reset period is wrong (four years vs. seven years in truth). (3) Multi-hop reasoning fails: the model invents a narrative of diversification and rate flexibility not supported by the data. The actual reasoning should have emphasized consistency in structure and increased reliance on preferred equity, not structural innovation. (4) Contextual relevance is moderate—the answer addresses financing strategy and evolution of terms—but the factual foundation is flawed, undermining the conclusion. The indication about AT&T’s financing approach is thus based on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 461,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Between 2022 and 2023, Capital One's risk exposure under loss sharing agreements with government-sponsored enterprises (GSEs) related to multifamily commercial real estate loans increased. As of December 31, 2023, the liability recognized on the consolidated balance sheets for these agreements was $137 million, compared to $82 million as of December 31, 2022. This increase reflects a rise in the estimated credit losses or risk exposure associated with these multifamily commercial real estate loans sold to GSEs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: Capital One's liability under loss sharing agreements for multifamily commercial real estate loans increased from $82 million in 2022 to $137 million in 2023, indicating higher risk exposure. (2) Quantitative accuracy is perfect: both dollar amounts ($82M and $137M) and the time periods (December 31, 2022 and December 31, 2023) match the original answer exactly. No calculations are required beyond the implied comparison, which is correctly interpreted as an increase in risk. (3) The multi-hop reasoning is sound—information about loan origination, sale to GSEs, and associated loss sharing liabilities across two years is correctly synthesized. The LLM correctly infers that the rising liability reflects increased risk exposure, aligning with the original conclusion. (4) The answer is contextually relevant, directly addressing the evolution of Capital One's involvement and risk exposure. Minor wording differences (e.g., 'estimated credit losses' vs 'financial obligations') do not affect factual accuracy and are reasonable interpretations. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 344,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "Amazon's co-branded credit card programs experienced an increased strategic significance and regulatory risk from 2022 to 2023 due to evolving compliance obligations. In 2023, the company faced new and more stringent regulations, including enhanced authentication processes and data security requirements, which increased compliance costs and could reduce the ease of use of its payment products. Additionally, potential changes in payment card association rules and the risk of non-compliance could result in fines, higher transaction fees, and loss of payment processing capabilities, all of which could adversely affect operating results. The potential termination or renewal of these programs on less favorable terms further underscored the heightened regulatory and operational risks in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increased strategic significance and regulatory risks for Amazon's co-branded credit card programs from 2022 to 2023 and notes potential impacts on operating results, which aligns with the original answer. However, it misses the key new compliance obligation highlighted in the ground truth—data localization rules introduced in 2023, particularly affecting international operations and cross-border data transfers. Instead, the LLM mentions 'enhanced authentication processes' and 'more stringent data security requirements' as new in 2023, which were already present in 2022 per the original answer (data security was a 2022 risk). This misattributes the evolution of regulatory risks. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the model correctly infers increased regulatory burden and operational risk, but fails to accurately synthesize the shift from domestic payment rules in 2022 to broader international data governance laws in 2023. The reasoning is plausible but factually misaligned with the documented change in compliance obligations. (4) Contextual relevance is high as the response addresses strategic significance, regulatory risks, compliance costs, and impact on operating results. However, the absence of data localization—a critical new 2023 obligation—and the introduction of factually unsupported new requirements (like enhanced authentication) reduce qualitative and overall correctness. Hence, correctness and qualitative accuracy are scored moderately at 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 457,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "Between 2022 and 2024, PM's financial relationship with RBH evolved significantly due to the deconsolidation of RBH in March 2019 under the CCAA proceedings. As of 2022, RBH was no longer consolidated in PM's financial statements, and its results were presented as a deconsolidated entity. By 2024, PM continued to hold an equity investment in RBH, which was accounted for as an equity security without readily determinable fair value. Valuation considerations became more complex as PM recorded a $2,316 million non-cash impairment charge in 2024, reflecting a decline in the estimated fair value of its investment in RBH due to developments in the CCAA proceedings and the allocation of a global settlement.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the deconsolidation of RBH due to CCAA proceedings and PM's ongoing equity investment by 2024, which aligns with the ground truth. It also captures the shift from consolidation to impairment analysis, addressing the evolution in financial relationship. However, there are critical factual inaccuracies: the $2,316 million impairment charge in 2024 is not mentioned in the original answer and contradicts the ground truth, which does not specify any such charge. Additionally, the original answer highlights a CAD 3.1 billion litigation exposure related to RBH in 2022, which the LLM omits entirely. The deconsolidation date is inaccurately attributed to March 2019 in the LLM answer, while the original only states CCAA proceedings began in 2019 without specifying March. (2) Quantitative accuracy is low because the $2,316 million figure is unsupported by the ground truth and appears fabricated. The CAD 3.1 billion litigation allocation—a key financial figure—is missing. (3) The multi-hop reasoning is partially sound: the model correctly infers a shift from consolidation to equity accounting and recognizes increased valuation complexity. However, it fails to connect the litigation risk in 2022 as a driver of valuation considerations in 2024, weakening the synthesis. (4) Contextual relevance is high as the response stays focused on the financial relationship evolution. Qualitative accuracy is moderate due to correct conceptual framing but undermined by incorrect specifics. Correctness score is 6 due to partially correct narrative with significant factual and quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 449,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "Baqsimi's revenue contribution increased significantly between 2023 and 2024, with revenue rising from $677.6 million in 2023 to $1.60 billion in 2024, primarily due to the sale of the rights for Baqsimi in 2023. This strategic move positioned Baqsimi as a key asset within LLY's portfolio, highlighting its value and contributing to diversified revenue streams through business development activities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. While it correctly states Baqsimi's 2023 revenue as $677.6 million, it falsely claims revenue increased to $1.60 billion in 2024. The ground truth states that Baqsimi was no longer reported as a direct revenue contributor in 2024 due to the sale of rights, meaning it did not generate direct product sales revenue for LLY in 2024. Thus, the $1.60 billion figure is incorrect and misleading. (2) The calculation and interpretation of revenue are fundamentally wrong. The increase to $1.60 billion is not supported by the data; instead of growing, Baqsimi's direct revenue contribution ceased. The mention of the 2023 sale of rights is correct, but the financial impact is misrepresented—divestiture led to removal from product revenue, not a large increase. (3) The multi-hop reasoning is flawed. The model fails to correctly synthesize the cause-effect relationship: selling the rights should lead to reduced or no direct revenue, not a massive increase. It incorrectly interprets the strategic move as enhancing Baqsimi’s role in the portfolio, when in fact LLY divested it, removing it from direct commercialization. (4) Contextual relevance is moderate—the answer addresses revenue and strategic positioning as asked, but with incorrect facts and logic. Due to severe quantitative and qualitative errors, especially the fabricated revenue number and inverted conclusion, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 407,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "From 2022 to 2024, the composition of Union Pacific's Total Highway Revenue Equipment shifted significantly in favor of owned equipment. In 2022, the company owned 78,837 units (83.2% of total highway revenue equipment) and leased 16,004 units (16.8%). By 2024, the owned units decreased slightly to 50,731 (97.2% of total highway revenue equipment), while leased units dropped to 1,485 (2.8%). This indicates a substantial reduction in leased containers and chassis, with a corresponding increase in the proportion of owned equipment.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer gets some key numbers correct—owned units in 2022 (78,837) and 2024 (50,731), leased units in 2022 (16,004) and 2024 (1,485)—but misrepresents the composition and trend. It incorrectly states that the proportion of owned equipment increased to 97.2% in 2024, which implies a relative increase in ownership, but fails to note the massive absolute reduction in both owned and leased equipment. More critically, it omits the breakdown between containers and chassis, which is central to the question. The original answer highlights that leased containers dropped from 1,856 to 288 and owned chassis from 29,875 to 4,356—key details entirely missing in the LLM response. (2) While the total owned and leased unit counts are accurate, the percentages are miscalculated: in 2024, total equipment is 50,731 + 1,485 = 52,216; thus, owned share is 50,731 / 52,216 ≈ 97.16% (acceptable rounding), and leased ≈ 2.84%. So the percentages are numerically correct. However, the interpretation is misleading because the narrative suggests a strategic shift toward more ownership, whereas the ground truth emphasizes an overall asset reduction, especially in chassis and leased containers. (3) The multi-hop reasoning is partially sound—synthesizing totals across years—but fails to incorporate the critical distinction between containers and chassis, which is required for full comprehension of the composition change. The LLM treats 'highway revenue equipment' as a monolithic category, missing the nuanced shift within subcomponents. (4) The correctness score is 5 due to accurate totals but major omissions in sub-equipment trends; quantitative accuracy is 6 because numbers are correct but contextually incomplete; qualitative accuracy is 5 due to flawed reasoning about strategic intent; contextual relevance is 9 as the answer addresses the general topic and timeframe appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 514,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "Between 2022 and 2023, Capital One's use of securitized debt obligations increased from $16.973 billion to $18.043 billion, reflecting a $1.07 billion growth in these instruments. Within the company's overall funding structure, securitized debt obligations remained a relatively stable component, representing approximately 4% of total funding sources in both years. This growth was driven by ongoing activity in the company's securitization programs, though deposits continued to serve as the primary funding source, accounting for the majority of liabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains partially correct quantitative information but introduces a figure not present in the ground truth: the 2022 securitized debt obligation amount of $16.973 billion. The original answer does not provide this number, so its inclusion is unsupported. While the 2023 carrying value of $18.043 billion is accurate, the claimed $1.07 billion growth cannot be verified and appears to be an incorrect calculation ($18.043B - $16.973B = $1.07B, but the source for $16.973B is missing). The claim that securitized debt represented approximately 4% of total funding in both years is not mentioned or inferable from the ground truth and thus lacks support. (2) The only verifiable number — $18.043 billion in 2023 — is correct. However, the absence of the 2022 value in the original answer makes the comparison invalid. No calculation of percentage of total funding can be confirmed. (3) The multi-hop reasoning is flawed: the LLM infers stability and proportional consistency (4%) without evidence, and misses the key qualitative shift highlighted in the original answer — the reclassification to Level 2 in the fair value hierarchy, which indicates a structural change in how these obligations are valued and managed. This evolution in role and transparency is central to the question but entirely omitted. (4) While the answer addresses the funding structure context and correctly identifies deposits as primary, it fabricates metrics and omits the critical conceptual evolution (valuation methodology shift), leading to a materially incomplete and partially inaccurate response. Hence, correctness and qualitative accuracy are low despite some contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 457,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "The nature of LLY's revenue from Zyprexa evolved significantly between 2023 and 2024, primarily due to the sale of the rights for the olanzapine portfolio, which includes Zyprexa. In 2023, Zyprexa generated $79.4 million in U.S. revenue and $1,615.4 million from outside the U.S. However, in 2024, Zyprexa's revenue is no longer reported as a product sale but is instead included in \"collaboration and other revenue\" due to the 2023 sale of these rights. This shift reflects a change from product sales revenue to revenue recognition related to the sale of intellectual property rights, as outlined in Note 2 of the 2024 10-K.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key qualitative shift in revenue recognition for Zyprexa—from product sales in 2023 to collaboration and other revenue in 2024 due to the sale of rights to the olanzapine portfolio. This aligns with the ground truth and reflects accurate multi-hop reasoning across time and accounting categories. The mention of Note 2 in the 2024 10-K adds contextual support. (2) However, the quantitative accuracy is severely flawed. The LLM provides specific revenue figures for Zyprexa in 2023: $79.4 million (U.S.) and $1,615.4 million (outside U.S.), totaling approximately $1.7 billion. These numbers are not present in the ground truth and are factually incorrect. Zyprexa’s revenue in 2023 was not broken down in this way in the source data, and such a high figure is inconsistent with known financial disclosures—Zyprexa is an older drug with declining sales, and these numbers appear fabricated or misattributed. No revenue figures were provided in the original answer, so introducing them undermines factual correctness. (3) The reasoning is otherwise sound: the model correctly infers that the 2023 sale of rights led to a change in revenue classification in 2024, moving from product sales to collaboration revenue. This demonstrates proper synthesis across years and accounting methods. (4) The contextual relevance is perfect—the answer directly addresses the evolution in source and recognition method. Due to the significant numerical inaccuracy, the correctness score is reduced to 7: the core conceptual and qualitative understanding is correct, but the inclusion of false quantitative data prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 457,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "The valuation methodology for Federal Government Securities in the pension plan remained consistent from 2022 to 2024, as they continued to be classified as Level 2 investments and valued using a bid evaluation process with bid data from independent pricing sources. However, the classification and allocation evolved significantly, with the proportion of Federal Government Securities increasing as part of a broader shift toward a more conservative asset allocation. In 2022, the plan held 742 million in Federal Government Securities, while by 2024, this amount had grown to 1,448 million, reflecting the plan's de-risking strategy that increased debt securities to 70–80% of total assets by 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Federal Government Securities were classified as Level 2 in both 2022 and 2024 and that valuation uses a bid evaluation process with independent pricing sources, it introduces incorrect quantitative data: the 2024 value of $1,448 million and the claim of growth from $742 million to $1,448 million are not supported by the ground truth. The original answer does not mention any change in dollar amounts between 2022 and 2024, nor does it state any shift in allocation percentages or a de-risking strategy increasing debt to 70–80%. These are fabrications or hallucinations. (2) Quantitative accuracy is low because the only verified number is the $742 million in 2022; the $1,448 million figure in 2024 is incorrect and unsupported. There is no mention of such an increase in the ground truth. (3) The reasoning partially captures the continuity in classification (Level 2) and the clarification of methodology in 2024, which reflects correct synthesis. However, it fails on multi-hop accuracy by inventing asset allocation shifts and valuation changes not present in the source. The core evolution—continued Level 2 classification with added methodological clarity—is overshadowed by irrelevant and false financial figures and strategic narratives. (4) Contextual relevance is moderate because the answer addresses valuation methodology and classification over time, but distracts with irrelevant details about asset allocation and unverified totals. The qualitative accuracy is mid-range because the conceptual understanding of Level 2 and bid evaluation is correct, but the synthesis includes unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 468,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "Capital One's credit score data utilization for product segmentation decisions remained consistent from 2022 to 2023, as both years showed 53% of auto loans originated to borrowers with FICO scores above 660. This consistency suggests a stable credit risk modeling strategy focused on maintaining a balanced portfolio by extending credit to borrowers with strong credit profiles while managing risk exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth states that Capital One updated its credit score data for product segmentation from using 2020–2021 distributions in 2022 to using 2022–2023 distributions in 2023, indicating a shift toward more current data. The LLM instead claims the strategy 'remained consistent' based on a specific percentage (53% of auto loans to borrowers with FICO >660), which is not mentioned in the ground truth and appears fabricated or misattributed. (2) The quantitative claim of '53%' is unsupported by the original answer and cannot be verified from the provided context; no such percentage appears in the ground truth, making the quantitative accuracy low. There are no calculations in the LLM answer, but the use of a precise figure without basis undermines credibility. (3) The multi-hop reasoning is flawed: the question asks about the evolution in data utilization and what it indicates about risk modeling strategy. The LLM fails to recognize the shift in data recency (from older to newer credit score distributions) and instead asserts stability based on an irrelevant metric. It does not mention Table 21, the update in time periods used, or the strategic move toward dynamic, up-to-date risk modeling. (4) The contextual relevance is moderate because the answer discusses credit score usage in product segmentation and risk strategy, which are relevant themes, but it misses the core evolution and strategic implication entirely. Thus, while the topic area is appropriate, the substance is factually and logically unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 444,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "From 2022 to 2023, Amazon's strategic positioning of AWS evolved to emphasize its role as a critical driver of long-term growth and technological innovation within the company. In 2022, AWS was highlighted as a key investment area to support a variety of product and service offerings, particularly in expanding technology infrastructure. By 2023, AWS was positioned more prominently as a foundational pillar of Amazon's operations, serving developers and enterprises of all sizes with a broad set of on-demand technology services. This shift reflects AWS's growing importance in Amazon's broader business strategy, with increased focus on leveraging its capabilities to enhance customer experience, support new business initiatives, and maintain competitive advantage.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the essential evolution in AWS's strategic positioning from 2022 to 2023. (1) It correctly identifies that in 2022, AWS was a key investment area focused on technology infrastructure, and by 2023, it had become a foundational pillar of Amazon's operations. The description of AWS serving developers and enterprises with on-demand services aligns with the ground truth. (2) There are no numeric values, dates, or financial figures in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes a shift in strategic emphasis over time. However, the LLM omits a key factual detail from the ground truth: that by 2023, AWS was formally elevated to one of Amazon's three core business segments (alongside North America and International), which is a critical structural and strategic change. This omission prevents a top score. (4) Despite this, the answer remains contextually relevant and semantically close to the original, conveying the correct trajectory and strategic importance. The reasoning is logical and well-aligned with the source, just missing a specific structural detail about segment classification. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 367,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International's (PMI) financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved significantly, particularly in terms of accounting treatment and potential financial exposure. In 2022, RBH was deconsolidated from PMI's financial statements due to its filing for protection under the Companies' Creditors Arrangement Act (CCAA) in Canada, which led to a stay of tobacco-related litigation against RBH and other defendants. By 2024, PMI recorded a non-cash impairment charge of $2,316 million (representing a diluted EPS charge of $1.49 per share) related to its investment in RBH, following the filing of a proposed settlement plan in the CCAA proceedings that could require RBH to pay a significant portion of a CAD 32.5 billion global settlement. This impairment reflects the increased financial exposure and uncertainty surrounding the allocation of the settlement amount among RBH and its co-defendants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: RBH was deconsolidated in 2022 due to CCAA restructuring, litigation stayed until March 31, 2022, and in 2024 PMI recorded a $2,316 million non-cash impairment charge due to a proposed CAD 32.5 billion settlement. The numbers—$2,316 million, CAD 32.5 billion, and the EPS impact of $1.49—are all factually correct and match the source data. (2) Quantitative accuracy is perfect: all figures are reported accurately with proper units and context; format variations (e.g., $2,316 million) are acceptable and clear. (3) The multi-hop reasoning is sound: the model correctly links RBH’s CCAA filing → deconsolidation → litigation stay → emergence of settlement proposal → reassessment of investment → impairment charge. It captures the evolution from deconsolidation to equity method accounting with appropriate cause-effect logic. (4) The only minor omission is that the original answer specifies the shift to an 'equity investment model' explicitly, while the LLM implies it through the impairment of an 'investment' but doesn’t state the change in accounting treatment as clearly. This slightly weakens the qualitative score, though the implication is correct. Overall, the answer is contextually excellent, directly addressing the evolution in accounting treatment and financial exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 385,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, Biktarvy's commercial significance for Gilead has evolved as follows: \n\nIn 2022, Biktarvy contributed $8,624 million in product sales, a decrease from $8,624 million in 2021 but still representing a major portion of Gilead's HIV product revenue. By 2024, Biktarvy's revenue had declined further to $7,259 million, indicating a reduction in its market dominance, potentially due to competition and market dynamics. \n\nProduct risks associated with Biktarvy include potential market share gains by competitive products, including generics, and the need to introduce new HIV medications to remain competitive. Additionally, if nucleoside-based therapeutics like TAF (a component of Biktarvy) lose their preferred status in treatment paradigms, Biktarvy's sales could be significantly impacted.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. While it correctly states that Biktarvy generated $8,624 million in 2022 (matching the ground truth), it falsely claims that revenue declined to $7,259 million in 2024. The original answer explicitly states that 'specific revenue figures are not provided' for 2024, making this fabricated number a major error. Additionally, the claim that 2022 revenue was a 'decrease from $8,624 million in 2021' introduces data not present in the ground truth and cannot be verified from the provided information. (2) The calculation and comparison of revenue across years are therefore invalid. The ground truth does not support any 2024 revenue figure or trend assertion—only risk disclosures. The LLM invents precise numbers where none exist, failing the quantitative accuracy test. (3) On qualitative reasoning, the LLM correctly identifies key product risks such as competition, generics, and the vulnerability of TAF-based therapies, which aligns with the ground truth's emphasis on treatment paradigm shifts and reliance on TAF. It also correctly frames Biktarvy as a major revenue driver, showing some sound multi-hop synthesis between revenue importance and risk exposure. However, the reasoning is undermined by the false precision in unsupported financial projections. (4) Contextually, the answer addresses both revenue contribution and product risks as required by the question, and the structure follows a logical evolution from 2022 to 2024. Despite the incorrect numbers, the overall framing of evolving commercial significance due to market and regulatory pressures is directionally consistent with the ground truth. Hence, while contextually relevant and partially accurate in reasoning, the severe quantitative inaccuracies—especially fabricating 2024 revenue—drastically reduce the correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 518,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 to $1.9 billion in 2024, reflecting a growing investment in the joint venture. Additionally, car hire expenses from TTX rose from $375 million in 2021 to $432 million in 2024, indicating higher operational reliance on TTX's rail car services over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and years are accurate: Union Pacific's financial stake in TTX increased from $1.6 billion in 2021 to $1.9 billion in 2024, and car hire expenses rose from $375 million in 2021 to $432 million in 2024. These values match the original answer exactly, with acceptable formatting. (2) The answer is complete, addressing both the investment value and car hire expenses over the specified period, even though the question references 2022–2024, correctly using 2021 as the baseline year as reported in the 2022 filing. (3) Entity accuracy is correct—Union Pacific Railroad (UPRR) and TTX are properly identified, and the financial metrics (financial stake, car hire expenses) are accurately used. (4) The reasoning is sound: the LLM correctly infers growing investment and operational reliance based on increasing financial stake and expenses, demonstrating proper multi-hop synthesis across time and financial dimensions. (5) The semantic meaning is equivalent to the original answer, with slightly rephrased but factually consistent language. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 332,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "From 2022 to 2023, Tesla shifted its approach to scaling Solar Roof production by enhancing installer training initiatives and improving supply chain risk management. In 2022, the company focused on onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. By 2023, Tesla expanded these efforts through the launch of specialized training programs, such as the Engineering Development Program in collaboration with Austin Community College, aimed at equipping early-career engineers with skills in high-demand technologies. Additionally, Tesla emphasized localized procurement and supply chain resilience to mitigate global component constraints, reflecting a more structured and strategic approach to managing production risks.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's 2022 focus on installer onboarding, training, and collaboration with real estate developers to reduce costs and installation time, which aligns with the ground truth. However, it introduces a specific program—the Engineering Development Program with Austin Community College—that is not mentioned in the original answer and cannot be verified from the provided ground truth. This addition, while plausible, is factually unsupported and represents a fabrication or over-specificity. Additionally, the original answer emphasizes a strategic shift in 2023 from installer-focused growth to managing supply chain risks, including supplier reliability, global component constraints, and cost-effective manufacturing, with an explicit warning about production ramp delays. The LLM captures the supply chain focus but misrepresents the nature of the shift by suggesting 'expanded' training efforts in 2023, whereas the ground truth indicates a pivot away from installer-centric initiatives toward risk mitigation. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes a change in strategy across years and identifies relevant themes (installer training, supply chain), but fails in accurately representing the direction of change—portraying continuity and expansion of training rather than a strategic shift away from it. (4) The contextual relevance is high because the answer addresses both installer training and supply chain risk management across the two years. However, the qualitative accuracy is reduced due to the introduction of unverified programs and mischaracterization of the strategic shift, leading to a correctness score of 6—partially correct but with significant factual and interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 524,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "Between 2022 and 2023, The Coca-Cola Company continued to manufacture fountain syrups in the United States and sell them directly to fountain retailers or through authorized fountain wholesalers and bottling partners. This process remained part of the Company's North America operating segment. There is no indication of significant changes to this structure in the provided documents, suggesting that the relationship with fountain retailers and the distribution model for fountain syrups remained consistent during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in stating that The Coca-Cola Company manufactures fountain syrups in the U.S. and sells them to fountain retailers and authorized wholesalers or bottling partners. However, it incorrectly concludes that there was no significant change between 2022 and 2023, which contradicts the ground truth. The original answer highlights a key evolution: in 2022, U.S. bottlers were generally not authorized to manufacture fountain syrups and the Company sold directly to wholesalers and some retailers; by 2023, the Company explicitly included bottling partners in the distribution chain, clarifying a tiered model. This represents a qualitative shift in how the distribution network was described and potentially structured, indicating a more defined role for bottling partners in distribution. The LLM failed to identify this nuance, missing the core of the multi-hop comparison across years. While all entities (Coca-Cola Company, fountain retailers, bottling partners) and time periods (2022–2023) are correctly identified and no numerical inaccuracies exist (hence full quantitative accuracy), the reasoning is flawed in asserting consistency when the ground truth shows a meaningful clarification or expansion of the distribution model. Thus, the answer lacks completeness and correct synthesis across time points, leading to a low correctness and qualitative accuracy score despite good contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 397,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "From 2022 to 2024, IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved in terms of classification and registration. In 2022, the Notes were disclosed as part of IBM's broader debt instruments without specific classification details. By 2024, the Notes were explicitly listed under \"Securities registered pursuant to Section 12(b) of the Act\" with the ticker symbol \"IBM25B\" and classified as a registered security traded on the New York Stock Exchange. This reflects a more detailed and formalized disclosure of the Notes' registration and market listing in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were initially disclosed in earlier filings (referenced in 2022 via an 8-K with Exhibit 4.1 from 2017), and by 2024 they were formally registered under Section 12(b) with the ticker 'IBM25B' on the NYSE. The LLM correctly identifies the evolution from disclosure to formal registration and trading. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), ticker symbol (IBM25B)—are all accurate. No calculations are required, but the dates and identifiers match the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 to 2024), identifies the change in disclosure practice, and correctly infers increased formality in classification. The only minor gap is that the LLM does not explicitly mention the May 22, 2017, filing date of Exhibit 4.1, which is part of the original answer, though this detail is background context rather than central to the evolution. (4) The answer is contextually relevant, directly addressing classification and registration changes. Wording differs but meaning is semantically equivalent. A score of 9 is justified due to full factual alignment with only a minor omission of a supporting detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 367,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "Gilead's strategic positioning of Biktarvy from 2022 to 2024 has emphasized maintaining its competitive differentiation in the HIV treatment market by leveraging its efficacy and tolerability profile, which supports its role as a preferred regimen. However, the company faces heightened financial risk exposure due to increasing pricing pressures from government programs, such as the Inflation Reduction Act of 2022, which could impact profitability through mandated rebates and Medicare price negotiations. Additionally, competition from generics and new entrants remains a challenge, necessitating ongoing innovation and market access strategies to sustain Biktarvy's market position.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in key aspects of strategic evolution. (1) Correct elements: The answer correctly identifies Biktarvy's competitive differentiation through efficacy and tolerability, and acknowledges financial risks from competition and pricing pressures. It also appropriately references the 2022 Inflation Reduction Act, which is contextually relevant. (2) Quantitative accuracy: There are no specific numerical claims (e.g., revenue figures, percentages) in either the LLM or original answer, so no numeric inaccuracies are present—this aspect is neutral but does not detract. (3) Multi-hop reasoning assessment: The LLM fails to capture the core multi-hop insight from the ground truth—that GILD's strategic concern evolved from commercial strength in 2022 to explicit financial risk in 2024 due to reliance on TAF-based therapies and potential paradigm shifts away from nucleoside regimens. Instead, the LLM attributes financial risk primarily to the Inflation Reduction Act and pricing pressures, which, while plausible, is not supported by the provided ground truth. The shift in therapeutic paradigms and the internal concern over TAF-based regimen sustainability are entirely omitted. (4) The answer is contextually relevant and well-structured, addressing both financial risk and competitive differentiation, but misses the specific evolution in GILD’s strategic narrative as reflected in the knowledge graph. Thus, while semantically plausible, it substitutes external policy risks for the internally reported scientific and portfolio-level risks, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 453,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin continued its strategy of reducing defined benefit pension obligations by transferring them to insurance companies, thereby shifting financial risk and reducing volatility in its financial results. In 2022, the company executed a significant pension obligation transfer, purchasing group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and related plan assets for approximately 13,600 U.S. retirees and beneficiaries. This transaction resulted in a noncash pension settlement charge of $1.5 billion in the second quarter of 2022. In 2023, the company further reduced its pension obligations by making $414 million in lump-sum settlement payments to approximately 6,500 former employees who had not yet commenced receiving their vested benefits. These actions contributed to a reduction in the unfunded status of the pension plans, decreasing from $5,470 million in 2022 to $6,159 million in 2023, despite a decrease in the discount rate in 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key actions Lockheed Martin took in 2022 and 2023 regarding pension obligations: in 2022, transferring $4.3 billion in pension obligations via group annuities with a $1.5 billion noncash settlement charge, and in 2023, making $414 million in lump-sum payments to ~6,500 former employees. These figures match the ground truth exactly, and the shift in strategy from insurer transfers to individual settlements is accurately described, though the LLM slightly mischaracterizes the 2023 action as a continuation of the same strategy rather than a strategic evolution, which weakens the qualitative accuracy. (2) Quantitatively, all dollar amounts ($4.3 billion, $1.5 billion, $414 million), participant counts (13,600 retirees in 2022, ~6,500 in 2023), and timeframes (Q2 2022 charge) are correct. However, the LLM introduces a factual error in stating that the unfunded status decreased from $5,470 million in 2022 to $6,159 million in 2023—this is incorrect because $6,159 million is larger than $5,470 million, so the unfunded status actually increased, not decreased. This calculation/comparison error undermines quantitative accuracy. Additionally, this number does not appear in the original answer, suggesting hallucination. (3) The multi-hop reasoning is mostly sound—linking 2022 annuity transfers to 2023 lump-sum payments as part of a broader de-risking strategy is valid. However, the conclusion about the unfunded status improvement contradicts the data and is not supported by the ground truth, which does not mention this metric at all. This reflects a failure in synthesis and introduces misleading context. (4) The answer is highly relevant to the question and covers both years, the nature of the transfers, and financial impacts. The core strategic shift is conveyed, but the inclusion of an incorrect quantitative claim about the unfunded status reduces overall correctness. Hence, a score of 7 is justified: key facts are correct, but a significant error in financial interpretation prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 559,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "Between 2022 and 2024, the composition of IBM's debt instruments maturing in 2025 remained consistent regarding the 2.875% Notes due 2025. In both the 2022 and 2024 10-K filings, the 2.875% Notes due 2025 are listed as registered securities, with the trading symbol \"IBM 25A\" and listed on the New York Stock Exchange. There is no indication of changes to the terms or issuance status of these notes during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in noting that the 2.875% Notes due 2025 (IBM 25A) were present in both 2022 and 2024, which aligns with the ground truth. However, it fails to mention the key change in debt composition — the disappearance of the 0.875% Notes due 2025 (IBM 25C) by 2024 — which is central to the question about 'evolution' in composition. This omission fundamentally undermines the correctness of the response. (2) Quantitatively, the percentages (2.875%, 0.875%, etc.) and years (2025) are accurate, and the trading symbol 'IBM 25A' is correctly referenced. However, the LLM incorrectly implies no change occurred, contradicting the ground truth that IBM 25C was delisted. There are no numerical calculations in this question, so accuracy hinges on correct identification of instruments and their presence/absence across years. (3) The multi-hop reasoning is flawed: the question requires comparing IBM’s 2025-maturing debt instruments across 2022 and 2024 filings to detect changes. The LLM only confirms continuity of one instrument but misses the discontinuity of another, failing to synthesize the full picture. The conclusion that 'composition remained consistent' is factually incorrect based on the removal of IBM 25C. (4) Contextual relevance is moderate — the answer addresses the right company, time frame, and instrument, but misses the core analytical point about shifting composition. Hence, while contextually aligned, it lacks the necessary depth and accuracy. Correctness score is low due to critical omission of a key factual change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 435,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "Based on the information provided in the 2022 and 2024 SEC 10-K filings, Biktarvy has grown in strategic importance within Gilead's HIV portfolio, driven by its continued growth and resilience amid competitive pressures and the loss of exclusivity for Truvada and Atripla. In 2022, Biktarvy's sales increased due to higher demand and a favorable pricing environment, partially offsetting declines in other HIV products. By 2024, Biktarvy remains a key driver of the HIV business, with ongoing efforts to expand its use, such as the approval of a pediatric formulation in 2021. However, the risk profile has evolved as competitive pressures persist, and the treatment paradigm for HIV continues to shift, with the development of long-acting therapies like lenacapavir and islatravir. These developments highlight both the growing importance of Biktarvy and the need for continued innovation to maintain its market position.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but misrepresents the core evolution of Biktarvy's strategic importance and risk profile from 2022 to 2024, leading to a partially incorrect conclusion. (1) Correctly identifies Biktarvy as a key product in both years and references competitive pressures and treatment paradigm shifts, including long-acting therapies like lenacapavir and islatravir. It also correctly notes the loss of exclusivity for Truvada and Atripla as context. However, the original answer emphasizes a shift in Biktarvy's positioning—from a growth driver in 2022 to a more vulnerable asset in 2024 due to overreliance on TAF and exposure to nucleoside-based therapy disruption. The LLM incorrectly frames Biktarvy as having 'grown in strategic importance' by 2024, which contradicts the ground truth that its risk profile has increased and its strategic position has become more precarious. (2) Quantitatively, no specific numbers are misstated—the LLM does not fabricate revenue figures or percentages and avoids making incorrect claims about sales growth beyond general statements. The mention of a pediatric formulation approved in 2021 is factually plausible but not confirmed in the ground truth, so it neither adds nor detracts significantly. (3) The multi-hop reasoning is partially sound: the model connects Biktarvy to broader portfolio dynamics and recognizes external threats. However, it fails to synthesize the critical insight from the 2024 10-K that Gilead’s reliance on TAF-containing products (like Biktarvy) introduces material risk if the treatment paradigm shifts away from nucleoside analogs. This is a key multi-hop inference missing in the LLM response. (4) Contextual relevance is high—the answer addresses competitive pressures, treatment paradigm changes, and time-based evolution. But due to the incorrect directional assessment of strategic importance (growth vs. increasing vulnerability), the qualitative accuracy and overall correctness are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 539,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "Between the end of fiscal year 2022 and the end of fiscal year 2023, the balance of the U.S. litigation escrow account increased from $1,449 million to $1,764 million. During fiscal 2023, the Company deposited $1,000 million into the U.S. litigation escrow account, while making payments of $685 million to opt-out merchants. In fiscal 2022, the balance increased from $1,449 million to $1,764 million, with $850 million deposited and $301 million in payments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, the U.S. litigation escrow account balance increased from $1,449 million at the end of FY2022 to $3,089 million at the end of FY2023. However, the LLM incorrectly states the FY2023 balance as $1,764 million, which is both numerically wrong and inconsistent with the claimed deposits. Additionally, the LLM claims that in FY2023, $1,000 million was deposited, but the ground truth states $1,500 million was deposited during that year. The LLM also incorrectly states that the balance increased from $1,449M to $1,764M in FY2022 — this is impossible because the starting and ending balances are swapped and contradict the timeline. (2) Number verification: Ground truth — FY2022 balance: $1,449M, FY2023 balance: $3,089M; FY2022 deposit: $1,000M, FY2023 deposit: $1,500M. LLM claims FY2023 balance: $1,764M (off by $1,325M), FY2023 deposit: $1,000M (understated by $500M), and misattributes balance changes to the wrong fiscal year. Calculations are therefore fundamentally flawed. (3) Multi-hop reasoning failure: The question requires tracking the evolution of the escrow balance across two fiscal years and reporting deposits for each. The LLM confuses the years, misstates balances, invents payments not asked about, and fails to correctly synthesize the required data points. It incorrectly implies the balance was $1,764M at the end of both years, which contradicts itself. (4) Scores justified: Correctness is low (2/10) due to major factual and numerical errors. Quantitative accuracy is poor (2/10) — most numbers are wrong. Qualitative accuracy is slightly higher (3/10) because the model attempts to discuss the right concept (escrow account, deposits), but reasoning is flawed. Contextual relevance is moderate (6/10) — it addresses the topic but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 507,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "Between 2022 and 2023, the role of fountain syrups in Coca-Cola's North America operating segment remained consistent, as the company continued to manufacture fountain syrups in the United States and sell them to fountain retailers or authorized wholesalers and bottling partners. These sales were included in the North America operating segment in both years. There is no indication of a significant change in Coca-Cola's manufacturing or distribution responsibilities related to fountain syrups during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Coca-Cola continued to manufacture fountain syrups in the U.S. and sell them to retailers, wholesalers, and bottling partners in both 2022 and 2023, which aligns with the ground truth. It also correctly notes no significant change in manufacturing or distribution responsibilities within North America, which is consistent with the original answer's observation of operational continuity in North America. However, the LLM answer omits a key nuance highlighted in the ground truth: in 2023, Coca-Cola began explicitly stating that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. While the question focuses on North America, the evolution in the company's disclosure reflects a broader strategic shift that contextualizes the North American operations by contrast. The LLM’s omission of this shift results in a less complete picture of how the company's overall role in fountain syrup manufacturing evolved, even if North America itself did not change. (2) There are no numerical values in this question, so quantitative accuracy is not applicable—scored as 10 by default due to absence of numbers. (3) The reasoning is sound within the scope of North America and correctly synthesizes information across years, but it fails to acknowledge the multi-hop nuance that the 2023 update about non-U.S. manufacturing authorization indirectly informs the relative centrality of Coca-Cola's direct U.S. manufacturing role. This limits the depth of the evolution analysis. (4) The answer is contextually relevant and factually accurate for North America, but slightly underrepresents the full evolution in the company's disclosed model. Hence, correctness and qualitative accuracy are penalized slightly, while contextual relevance remains high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 501,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "Between 2022 and 2024, the composition of IBM's debt instruments maturing in 2025 changed slightly. In 2022, IBM listed the 0.950% Notes due 2025 (IBM 25B) among other 2025-maturing instruments, including the 2.875% Notes due 2025 (IBM 25A) and 7.00% Debentures due 2025 (IBM 25). By 2024, the 0.950% Notes due 2025 (IBM 25B) remained listed, but the 2.875% Notes due 2025 (IBM 25A) were still present, while the 7.00% Debentures due 2025 (IBM 25) were also retained. Thus, the 0.950% Notes due 2025 remained a consistent component of IBM's 2025 debt maturity profile during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, IBM had three notes maturing in 2025: 2.875% (IBM 25A), 0.950% (IBM 25B), and 0.875% (IBM 25C). However, the LLM incorrectly lists a '7.00% Debentures due 2025 (IBM 25)' instead of the 0.875% Notes (IBM 25C). This is a major error in entity identification and composition. Furthermore, the LLM claims that by 2024, the 2.875% Notes and 7.00% Debentures were still present, which contradicts the ground truth stating that only the 2.875% and 0.950% Notes remained, with the 0.875% Notes removed. The LLM incorrectly implies that the 7.00% Debentures remained, which is not supported by the original data. (2) Quantitatively, the percentages and instrument names are wrong: 7.00% vs. 0.875% is a large discrepancy in interest rates, and 'Debentures' vs. 'Notes' may reflect a misclassification. The correct evolution involves the removal of the 0.875% instrument, not the retention of a high-yield 7.00% debenture. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the change in composition over time. It incorrectly suggests continuity in the 7.00% Debentures and does not note the actual reduction in diversity due to the disappearance of the 0.875% Notes. The conclusion that the composition 'changed slightly' and that the 0.950% Notes remained consistent is partially correct but framed within an incorrect overall structure. (4) Scores reflect major factual errors in entities and financial instruments, leading to a low correctness score. Contextual relevance is moderate because the answer addresses the right topic and timeframe but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 463,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "Disney's strategic approach to cruise ships evolved between 2022 and 2024 by emphasizing fleet expansion and enhancing the cruise experience. In 2022, the focus was on resuming operations post-pandemic and managing health and safety measures. By 2024, Disney announced plans to expand its fleet of cruise ships and highlighted the opening of a new Disney Cruise Line destination in 2024 at Lighthouse Point on Eleuthera, indicating a shift toward growth and new market opportunities.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct and captures the key evolution in Disney's strategic approach to cruise ships between 2022 and 2024, but misses some critical nuances from the ground truth. (1) Correct elements: The shift from operational recovery in 2022 to growth and expansion in 2024 is accurately framed. The mention of fleet expansion and the Lighthouse Point destination opening in 2024 aligns with Disney's disclosed plans and reflects a strategic growth focus. These details are contextually relevant and factually consistent with the direction of the 10-K disclosures. (2) Quantitative accuracy is high: no specific dollar amounts or percentages are misstated, and the 2024 timing for Lighthouse Point is accurate. The years (2022 and 2024) are correctly attributed. (3) However, the qualitative accuracy is slightly lower because the LLM answer introduces details not present in the ground truth—specifically, the claim that 2022 was focused on 'resuming operations post-pandemic and managing health and safety measures'—which is plausible but not mentioned in the provided ground truth. The ground truth emphasizes a general dependence on consumer demand for out-of-home entertainment in 2022, not pandemic recovery. Additionally, the LLM omits the key point about increased costs and uncertain returns associated with fleet expansion in 2024, which signals a more capital-intensive strategy and risk awareness. (4) The reasoning is sound in identifying a strategic shift, but the multi-hop synthesis is incomplete—it does not fully reflect the evolution from passive dependence on demand to active investment and risk disclosure. Despite these omissions and minor overreach, the core message of strategic growth via fleet expansion is correct, warranting a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 487,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "From 2022 to 2023, Lockheed Martin continued its strategic approach to pension risk transfer transactions, aiming to reduce the volatility of its pension obligations and associated financial impacts. In 2022, the company had already executed significant transactions, such as the August 2021 purchase of group annuity contracts (GACs) for $4.9 billion in pension obligations, which transferred risk to insurers and eliminated PBGC premiums for approximately 95,000 retirees. By 2023, the company expressed its intent to continue exploring additional risk transfer opportunities, acknowledging that future transactions could result in material noncash settlement charges. Strategically, these actions aimed to stabilize pension liabilities and reduce the sensitivity of financial results to actuarial assumptions and market fluctuations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Lockheed Martin's pension risk transfer strategy from 2022 to 2023. Quantitatively, it accurately reports the $4.9 billion pension obligation transfer via group annuity contracts (GACs) from August 2021 (discussed in the 2022 filing), and correctly notes the impact on approximately 95,000 retirees. It also correctly identifies the strategic continuity into 2023, including the expectation of potential future noncash settlement charges. However, it omits the specific $1.7 billion noncash pension settlement charge from the 2021 transaction, which is a key financial impact highlighted in the original answer. Additionally, the LLM answer fails to mention the new risk disclosure in 2023 regarding potential residual liability if insurers default on GACs—a critical evolution in strategic framing that reflects a more cautious tone. While the strategic intent and financial motivations are well-articulated, the absence of the $1.7 billion charge and the nuanced shift toward acknowledging residual liability reduces completeness and qualitative accuracy. The reasoning is sound and contextually relevant, synthesizing information across years and strategic objectives, but the missing details prevent a top score. All entities (Lockheed Martin, GACs, pension obligations, retirees) and timeframes are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 384,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "Between 2022 and 2023, Tesla's relationship with its financing partners has evolved in terms of accounts receivable management and leasing program risks. In 2022, Tesla highlighted that accounts receivable balances can fluctuate significantly due to factors such as government rebates, which can take up to a year to collect, and the timing of payments from financing partners. By 2023, Tesla noted continued exposure to residual value risks in its leasing programs, particularly as actual resale values may differ from pre-determined amounts, potentially impacting profitability. Additionally, Tesla emphasized the importance of managing credit risks associated with its financing programs, especially in the context of economic downturns or other catastrophic events that could lead to customer defaults.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution in Tesla's financing relationships but introduces inaccuracies and omits key details. It correctly identifies residual value risks in 2023 and mentions credit risks, aligning with the ground truth's emphasis on increased complexity. However, it incorrectly states that government rebates can take up to a year to collect—a detail not present in the original answer and unsupported by the knowledge graph. The original specifies that in 2022, receivables from financing partners take up to approximately two weeks to settle, not a year. This major factual error undermines quantitative accuracy. (2) The original answer specifies a two-week settlement period for financing partner payments in 2022; the LLM misrepresents this by focusing on government rebates with a one-year collection timeline, which is both a wrong entity (rebates vs. partner payments) and incorrect duration. No other numbers or calculations are involved, but this timing discrepancy is significant. (3) The multi-hop reasoning is partially sound: the model connects 2022 accounts receivable timing to 2023 leasing risks, showing an understanding of evolving concerns. However, it fails to accurately synthesize the specific nature of the 2022 issue (contractual payment timing with partners affecting liquidity) and instead conflates it with rebate collections, breaking the logical chain. The shift from operational cash flow timing to broader risk management in 2023 is partially reflected but weakened by incorrect premises. (4) Correctness is scored 6 due to partial factual alignment but major error in a key detail. Quantitative accuracy is low (5) because of the incorrect time frame attribution. Qualitative accuracy is 7 as the reasoning structure is reasonable but based on flawed input. Contextual relevance is high (9) because the response stays on topic and addresses both accounts receivable and leasing risks across the two years, even if with inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 540,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "Between 2022 and 2023, Coca-Cola shifted its fountain syrup distribution strategy by increasing the role of its finished product operations, which generated 42% of net operating revenues in 2023 compared to 44% in 2022. In the U.S., the Company directly manufactures and sells fountain syrups to retailers and authorized wholesalers or bottling partners. Outside the U.S., bottling partners typically manufacture fountain syrups using concentrates and sell them to fountain retailers or authorized wholesalers. This evolution reflects a strategic emphasis on expanding direct control and optimizing distribution channels for fountain products.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but introduces significant inaccuracies. It correctly notes that outside the U.S., bottlers typically manufacture fountain syrups using concentrates and sell them to retailers or wholesalers, which aligns with the 2023 strategy in the ground truth. However, it incorrectly implies this arrangement was already in place in 2022, failing to capture the shift over time. The answer omits the key 2022 model where Coca-Cola directly sold to fountain wholesalers (including some bottlers), and bottlers were generally not authorized to manufacture fountain syrups in the U.S. The evolution from a centralized to a more integrated model is mentioned only implicitly and inaccurately. (2) The quantitative claim that 'finished product operations generated 42% of net operating revenues in 2023 compared to 44% in 2022' is not present in the original answer and appears fabricated or misattributed. This data point is irrelevant to the question about distribution strategy changes and is unsupported by the ground truth. No such percentages were mentioned in the original, so this is a factual error. (3) The multi-hop reasoning is flawed: the model fails to contrast the 2022 and 2023 strategies clearly and misrepresents the role evolution of bottlers. It conflates current international practices without showing the transition. While it identifies bottlers' increased role internationally, it does not correctly frame this as a change from 2022 to 2023. The U.S. model is oversimplified and inaccurately described as selling 'to retailers'—the original specifies sales to wholesalers, not direct to retailers. (4) Correctness is scored 5 due to partial factual alignment on international bottler roles but major omissions and fabrication of revenue percentages. Quantitative accuracy is low (4) due to the introduction of unsupported metrics. Qualitative accuracy is moderate (6) because some correct entities and concepts are used, but reasoning and synthesis are flawed. Contextual relevance is high (8) as the answer addresses the general topic and structure of the question, despite factual shortcomings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 579,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV showed an increase in receivables, rising from $9 million to $12 million, indicating higher sales or delayed payments from the JV. Additionally, AMD made a $17 million equity contribution to the ATMP JV in 2024, reflecting new investment activity aligned with its existing 15% ownership stake. The carrying value of AMD's investment in the ATMP JV also increased from $99 million to $149 million during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that AMD's receivables from the ATMP JV increased from $9 million in 2023 to $12 million in 2024, it incorrectly claims a $17 million equity contribution and an increase in the carrying value of AMD's investment from $99 million to $149 million. The ground truth states there was no direct investment or loan by AMD in 2023, and in 2024, AMD entered into a $100 million one-year term loan — not an equity contribution. The $17M equity and $99M–$149M investment carrying value figures are entirely fabricated and contradict the original answer. (2) Quantitative accuracy is very low: only the receivables numbers ($9M to $12M) are correct. The $17M investment, $100M loan omission, and $50M increase in carrying value are all wrong. The model reports a different type of financial activity (equity vs. debt), which is a critical error. (3) The multi-hop reasoning is flawed. The model fails to recognize that the new financial activity in 2024 is a loan (debt), not an equity investment, which changes the nature of the relationship incorrectly. It also invents a carrying value change not present in the original data, indicating poor synthesis or hallucination. (4) Contextual relevance is moderate because the answer addresses receivables and investment trends, but the incorrect characterization of the $100M loan as a $17M equity injection and the invention of carrying value figures severely undermine factual correctness. The conclusion about deeper financial integration is partially valid but based on wrong premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 444,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin continued its strategy of reducing the volatility and size of its pension obligations by settling nonqualified defined benefit pension liabilities. In 2023, the company made $414 million in lump-sum settlement payments to approximately 6,500 former employees who had not yet begun receiving their vested benefits. This action led to a corresponding reduction in the pension obligation but did not impact the 2023 FAS pension income. In 2022, the company had executed a larger settlement by purchasing group annuity contracts to transfer $4.3 billion of pension obligations to an insurance company, which resulted in a noncash pension settlement charge of $1.5 billion. The 2023 settlements were smaller in scale and did not trigger a similar noncash charge.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: in 2022, Lockheed Martin transferred $4.3 billion in pension obligations via group annuity contracts and recognized a $1.5 billion noncash settlement charge; in 2023, it made $414 million in lump-sum payments to ~6,500 former employees. These numbers match the original answer exactly, with acceptable formatting. (2) The quantitative accuracy is perfect—dollar amounts ($4.3 billion, $1.5 billion, $414 million), years (2022, 2023), and participant count (~6,500) are all correct. (3) The qualitative reasoning is sound: the LLM correctly identifies the strategic shift from a large-scale annuity transfer in 2022 to smaller, targeted settlements in 2023, and notes the absence of a settlement charge in 2023, which is consistent with accounting rules for smaller settlements. (4) The answer addresses all parts of the question—evolution of approach, pension obligation settlements, and financial impacts—demonstrating strong multi-hop synthesis across years and transaction types. Wording differs slightly but maintains semantic equivalence. No errors in entities, metrics, or logic. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 347,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "Between 2023 and 2024, AMD increased its investment in the ATMP JV by contributing $17 million in August 2024, raising its carrying value from $99 million as of December 30, 2023, to $149 million as of December 28, 2024. Additionally, AMD's equity income from the ATMP JV rose from $16 million in 2023 to $33 million in 2024, reflecting improved performance or returns from its 15% equity stake in the joint venture.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $16 million and $33 million equity income figures for 2023 and 2024 are correct; the carrying value of $99 million in 2023 and $149 million in 2024 is accurate; and the $17 million additional contribution in 2024 aligns with the increase in carrying value ($99M + $17M = $116M, with the remainder attributable to equity income and other adjustments, consistent with accounting principles). The specific dates (December 30, 2023, and December 28, 2024) are plausible fiscal year-ends and do not contradict the annual reporting context. (2) The answer is complete, addressing both AMD's investment evolution (additional contribution and carrying value change) and equity income change—both key parts of the question. (3) Entity accuracy is correct: AMD, ATMP JV, and the 15% equity stake (additional detail not in ground truth but not contradicted) are properly identified. (4) The reasoning is sound: the LLM correctly infers increased investment and improved returns, synthesizing data across two years and two financial metrics (carrying value and equity income). The mention of the 15% stake adds context without introducing error. (5) Semantic equivalence is strong—the LLM conveys the same core information with slightly more detail (e.g., specific dates, ownership percentage), enhancing clarity without deviation from truth. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 412,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson's ownership of Kenvue transitioned from retaining a 9.5% equity stake post-exchange offer in August 2023 to fully divesting its remaining shares in May 2024 through a Debt-for-Equity Exchange. In 2023, the exchange offer resulted in a non-cash gain of $21.0 billion, including $2.8 billion from the retained Kenvue shares. By 2024, the remaining shares were exchanged for commercial paper, leading to a $0.4 billion loss recorded in Other (income) expense. Thus, Johnson & Johnson no longer held any ownership in Kenvue by the end of 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key facts from the ground truth: Johnson & Johnson retained a 9.5% stake in Kenvue in 2023 valued at $4.3 billion, recognized a $21.0 billion non-cash gain (including $2.8 billion on retained shares), and fully exited its ownership in 2024 via a Debt-for-Equity Exchange, incurring a $0.4 billion loss. All numeric values—percentages, dollar amounts, and the sequence of events—are accurate. (2) Quantitative accuracy is perfect: $21.0 billion gain, $2.8 billion component from retained shares, $0.4 billion loss, 9.5% stake, and the characterization of the 2024 transaction as a Debt-for-Equity Exchange are all factually correct. The mention of commercial paper as the consideration is consistent with the nature of such exchanges, even if not in the original answer; it does not contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of ownership from partial retention in 2023 to full divestiture in 2024, linking financial impacts (gains and losses) to the correct years and transactions. The only minor shortcoming is the omission of the exact number of shares (182,329,550) divested in 2024, which is a detail present in the ground truth but not essential to the core narrative. (4) The answer is contextually fully relevant, directly addressing the evolution of the financial stake, retained equity, and associated gains/losses. Wording differs slightly (e.g., 'commercial paper' not in original) but does not introduce inaccuracy. Overall, this is a highly accurate, well-reasoned response missing only a minor quantitative detail, warranting a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 482,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. was included in historical guarantee agreements, such as the guaranty of certain obligations of Southwestern Bell Telephone Co. referenced in the 2022 filing (Exhibit 4-b to Form 10-K for the period ending December 31, 2011). However, there is no specific indication in the 2023 filing that this guarantee relationship changed or was modified between 2022 and 2023. Therefore, it appears that the inclusion of Southwestern Bell Telephone Co. in guarantee agreements remained consistent during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly concludes that there was no change in the guarantee relationship between 2022 and 2023, which aligns with the ground truth. However, it introduces a significant factual error by citing Exhibit 4-b from a 2011 filing (Form 10-K for period ending December 31, 2011) as the source for the 2022 guarantee, which is incorrect. The ground truth states that the 2022 guarantee was listed in Exhibit 4-c, not 4-b, and makes no reference to a 2011 filing. This misrepresentation undermines the quantitative and qualitative accuracy. (2) The dates and exhibit numbers are factually wrong—Exhibit 4-c (not 4-b) in both 2022 and 2023 filings is the correct reference. The mention of a 2011 filing is irrelevant and erroneous, suggesting confusion in source attribution. (3) While the model attempts multi-hop reasoning by comparing two years, it fails to correctly identify the supporting documents for each year. It incorrectly relies on outdated information (2011 filing) to support a 2022 claim, indicating flawed synthesis across time periods and filings. (4) Despite the incorrect sourcing, the final conclusion about consistency in the guarantee relationship is correct, which prevents the score from being lower. Contextual relevance is high because the answer addresses the core question about evolution and inclusion in agreements, but factual inaccuracies in exhibits and dates reduce correctness and qualitative scores significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 406,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "Lockheed Martin's involvement in hypersonics programs evolved significantly from 2022 to 2023, with the company strengthening its strategic positioning as a key player in this emerging domain. In 2022, the company emphasized its participation in multiple hypersonics programs with the U.S. Air Force and Army, focusing on design, development, and production of hypersonic strike weapons. By 2023, the company noted that several of these programs had advanced, with testing and evaluation activities progressing and expectations that multiple programs would enter early production phases by 2026. This reflects a shift from development to production readiness, aligning with the company's broader strategy to capitalize on next-generation defense technologies and programs of record.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in entity identification and reasoning compared to the ground truth. (1) Correct elements: The general evolution of Lockheed Martin's hypersonics involvement from development toward production is contextually relevant, and the mention of U.S. military branches (Army, Air Force) aligns broadly with the original answer. There are no numeric values to verify, so quantitative accuracy is scored as 10. (2) However, the LLM incorrectly states that in 2022, Lockheed Martin was already actively designing, developing, and producing hypersonic weapons for the Air Force and Army. According to the ground truth, in 2022, hypersonics were still described as a 'growth area' contingent on government funding and authorization—not an active program of record. This misrepresents the strategic positioning in 2022. (3) The multi-hop reasoning is flawed: the original answer highlights a shift from being a 'potential growth area' in 2022 to being a 'major program under the Space segment' in 2023, indicating formalization and increased responsibility. The LLM instead frames it as a progression from active development to production, which overstates the 2022 status. Additionally, the LLM introduces forward-looking production timelines (e.g., 'early production phases by 2026') not present in the original answer, adding unsupported detail. (4) Despite these issues, the answer remains contextually relevant and captures a directional evolution, warranting a moderate correctness score of 6. Qualitative accuracy is low due to incorrect characterization of program maturity in 2022 and unsupported claims about program timelines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 460,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "The balance of the U.S. litigation escrow account increased from $1.4 billion as of September 30, 2022, to $3.1 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while $1.5 billion was deposited during fiscal year 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the starting balance of $1.4 billion as of September 30, 2022, and reported an increase in the escrow account balance, which aligns with the ground truth. However, the ending balance was stated as $3.1 billion instead of the accurate $3.089 billion. While this is a minor rounding difference, the deposit amount for fiscal year 2023 is significantly incorrect: the LLM reports $1.5 billion deposited, whereas the ground truth is $1.0 billion. The fiscal year 2022 deposit of $850 million is correct. (2) Number verification: $1.4B (correct), $3.1B vs $3.089B (acceptable rounding), $850M (correct), but $1.5B vs $1.0B (major error). The incorrect deposit leads to a flawed understanding of the account's evolution. (3) Multi-hop reasoning: The model correctly structured the response to address both balance evolution and annual deposits across two fiscal years, showing proper synthesis of time-series financial data. However, the erroneous 2023 deposit amount undermines the quantitative reasoning. (4) Correctness score is 6 due to one major factual error in a key number (2023 deposit), despite correct framing and partial accuracy. Quantitative accuracy is penalized heavily (5/10) for the $500M overstatement. Qualitative accuracy is moderate (7/10) as the logic and structure are sound. Contextual relevance is perfect (10/10) — the answer directly addresses all parts of the question with appropriate context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 404,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "From 2022 to 2024, Outdoor Garden has maintained a consistent classification within the Hardlines major product line, but its performance metrics show a slight decline in its share of net sales. In 2022, Outdoor Garden accounted for 6.8% of total net sales, which decreased to 6.5% in 2024. This suggests a modest reduction in its relative importance within HD's product strategy, despite continued inclusion as a key merchandising department.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Outdoor Garden accounted for 6.8% of total net sales in 2022 (matching the ground truth), it incorrectly claims that the share decreased to 6.5% in 2024 — this figure is not supported by the original answer, which does not provide any 2024 performance metric. More critically, the LLM asserts that Outdoor Garden was 'consistently classified within the Hardlines major product line' from 2022 to 2024, which directly contradicts the ground truth: in 2022, it was a distinct, standalone product line, and only in 2024 was it grouped under the broader 'Hardlines' department. This misrepresents a key strategic shift as continuity. (2) Quantitative accuracy is partially correct for the 2022 percentage but fails on the 2024 percentage, which is fabricated or inferred without basis. No dollar amount for 2024 is provided in either answer, but the LLM introduces an unsupported performance trend. (3) The multi-hop reasoning is flawed: the question asks about evolution in role and positioning, which hinges on the reclassification from standalone to integrated — a change the LLM denies. Instead of identifying a structural repositioning, it frames the evolution as a minor performance dip within a stable category, which is incorrect. (4) Contextual relevance is moderate because the answer addresses the general topic and timeframe, and mentions relevant concepts like net sales share and merchandising departments, but the core factual claims undermine its validity. The conclusion about 'modest reduction in relative importance' is based on incorrect premises and misses the actual strategic integration point. Therefore, the answer is mostly incorrect despite some surface-level alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 488,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD has maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024 by reinforcing its culture of innovation, inclusivity, and respect, as highlighted in its 2024 10-K. The company conducts annual engagement surveys, fosters diversity and inclusion through employee resource groups, and prioritizes flexible work arrangements, including hybrid and remote options. These efforts, combined with robust leadership development, mentoring programs, and competitive total rewards, suggest a proactive talent retention strategy aimed at sustaining high employee engagement and attracting top talent in the competitive semiconductor industry.",
      "correctness_score": 4,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific initiatives such as annual engagement surveys, employee resource groups, flexible work arrangements, leadership development, mentoring programs, and competitive rewards. However, these details are not present in the original ground truth answer derived from the knowledge graph. The ground truth does not mention any specific programs or policies beyond the repeated cultural statement. Therefore, while the general theme of maintaining an open and engaging environment is correct, the specific mechanisms cited by the LLM are unsupported by the provided data. (2) Quantitatively, the LLM fails to include or reference the actual workforce numbers (26,000 in 2023, 28,000 in 2024) or the 7.7% growth, which are central to the original answer. No calculations or numerical data are provided, making the quantitative accuracy very low. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that cultural emphasis supports talent retention in a competitive industry—but it fabricates implementation details rather than drawing on the documented consistency of AMD’s messaging across years. The synthesis should have focused on the repetition of identical language despite workforce growth, not on unverified programs. (4) Contextually, the answer addresses the question about cultural maintenance and talent retention, so relevance is high. However, the lack of factual grounding in the source data significantly undermines correctness. The answer appears plausible but is not aligned with the evidence in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 435,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "AT&T's guarantee obligations related to The Ohio Bell Telephone Company, as disclosed in the 2022 and 2023 filings, remain unchanged, with no new information indicating any evolution in these obligations between the two years. The guarantees are part of historical obligations under previous indentures, and there is no mention of modifications or releases of these guarantees during the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that AT&T's guarantee obligations related to The Ohio Bell Telephone Company remained unchanged between 2022 and 2023, with no modifications or releases reported. It correctly identifies that these are historical obligations under prior indentures, which aligns with the ground truth referencing Exhibit 4-c originally filed in 2011. The answer does not contradict any facts in the original answer and captures the stability of the relationship. However, it omits a key detail present in the ground truth: the update in exhibit reference from 'Exhibit 4-c' to reflect current documentation practices in 2023. While the substance of the guarantee is correctly deemed stable, this omission of the exhibit update reduces completeness and nuance in the multi-hop synthesis—specifically, the evolution in documentation even if not in substance. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (AT&T, The Ohio Bell Telephone Company, time frame) are correctly identified. The reasoning is sound but slightly less detailed than required for full credit on qualitative accuracy. Contextual relevance is strong as the response directly addresses the question about evolution in the relationship and guarantee obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 361,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "Between 2023 and 2024, the financial impact of GE's relationship with AerCap, in terms of gains on retained and sold ownership interests, significantly declined. In 2023, GE reported gains of $5.778 billion, primarily related to its AerCap and GE HealthCare investments. However, in 2024, these gains decreased by $5.2 billion, contributing to a $2.5 billion decline in continuing earnings compared to 2023. This decrease was a major factor in the overall reduction in corporate operating profit for 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the significant decline in gains on retained and sold ownership interests between 2023 and 2024, with the primary driver being AerCap and GE HealthCare, which aligns with the ground truth. However, there is a minor quantitative inaccuracy: the original answer states a $5.7 billion increase in corporate operating profit in 2023, while the LLM reports $5.778 billion—this specific figure does not appear in the ground truth and is likely an over-precise or incorrect value. The $5.2 billion decrease in 2024 is correctly reported. (2) The calculation of the year-over-year change is not directly verifiable because the absolute gain in 2024 is not provided in either answer, but the statement that gains decreased by $5.2 billion matches the ground truth. The LLM adds that this contributed to a $2.5 billion decline in continuing earnings, which is not mentioned in the original answer—this is an extraneous detail that may be contextually accurate but is unsupported by the provided ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes the financial impact across years and attributes the changes to the correct entities (AerCap and GE HealthCare). It captures the evolution of the financial impact as required by the question. (4) The answer is contextually relevant and semantically close to the original, with only minor over-specification of numbers and inclusion of unverified details. The core facts—direction, magnitude, and drivers of change—are correct, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 435,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "Between 2022 and 2024, Home Depot has strategically evolved its use of HD Supply to better serve professional customers and expand its MRO (Maintenance, Repair, and Operations) services. HD Supply, a subsidiary of Home Depot, has been leveraged to provide MRO products and value-added services to multifamily, hospitality, healthcare, and government housing facilities. In 2024, the company further strengthened its position in the professional market by acquiring SRS, a residential specialty trade distributor, which expanded its offerings to Pros such as roofers, landscapers, and pool contractors. This acquisition, combined with continued investments in differentiated fulfillment options, trade credit programs, and enhanced order management systems, reflects Home Depot's focus on deepening its capabilities to serve the complex needs of professional customers through HD Supply and its broader ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies HD Supply's role in serving professional customers through MRO services in multifamily, hospitality, healthcare, and government housing sectors, which aligns with the 2024 ground truth. It also accurately reflects Home Depot's strategic focus on Pros. However, the LLM introduces the 2024 acquisition of SRS, which is not mentioned in the original answer and cannot be verified from the provided ground truth; this addition, while contextually plausible, introduces unverified information. Additionally, the original answer emphasizes a shift from integration challenges in 2022 to strategic maturity in 2024, a contrast that the LLM downplays by omitting any mention of 2022 integration risks. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—no errors in this regard. (3) The multi-hop reasoning is partially sound: the LLM correctly synthesizes HD Supply’s role in MRO and Pro services, but fails to contrast the evolution from 2022 concerns to 2024 strategy, which is central to the question. The addition of SRS, while potentially true, is extraneous and not supported by the ground truth, weakening the qualitative accuracy. (4) The correctness score is 7 because the core strategic use of HD Supply in 2024 is accurately conveyed, but the omission of 2022 integration challenges and introduction of unverified acquisitions reduce completeness and fidelity. Quantitative accuracy is 10 due to absence of numerical errors. Qualitative accuracy is 7 due to partial reasoning and unsupported additions. Contextual relevance is 9 because the answer stays focused on the topic and addresses the professional customer and MRO aspects well, despite missing the temporal contrast.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 488,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "Between 2023 and 2024, AMD's patent portfolio slightly expanded, with the number of issued U.S. patents remaining at approximately 7,500, while the total worldwide patent matters increased from 18,500 to 18,800. The number of pending U.S. patent applications decreased slightly from 2,000 to 1,900. AMD continues to rely on cross-licensing and technology exchange agreements, which are common in the semiconductor industry, to both transfer and receive intellectual property rights. This suggests that AMD maintains a strategic approach to leveraging its growing patent portfolio for collaborative innovation and competitive advantage in technology exchange.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding U.S.-specific patent data not present in the original answer. The ground truth provides worldwide patent figures only: 18,500 total in 2023 (12,800 issued, 5,600 pending) and 18,800 in 2024 (13,200 issued, 5,600 pending). The LLM incorrectly introduces 'issued U.S. patents at approximately 7,500' and 'pending U.S. applications' decreasing from 2,000 to 1,900—data absent from the original and unsupported by the knowledge graph. These fabricated numbers severely impact quantitative accuracy. (2) While the total worldwide patent matters (18,500 to 18,800) are correctly reported, the breakdown into issued vs. pending is omitted and replaced with incorrect U.S.-only figures. The LLM fails to note that pending applications remained stable at 5,600 globally, instead implying a decrease in U.S. filings. (3) The reasoning about AMD's continued reliance on cross-licensing is qualitatively sound and aligns with the original's emphasis on strategic importance. The conclusion that a growing portfolio enhances leverage in technology exchange is logically consistent, though less explicitly tied to the increased issued patents than in the original. (4) Contextual relevance is high—the response addresses patent portfolio evolution and implications for cross-licensing as asked. However, the introduction of unverified U.S.-specific data and omission of correct global issued/pending breakdowns reduce factual reliability. Correctness score is moderate due to partial accuracy on total portfolio size but major errors in detail and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 447,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "From 2023 to 2024, Johnson & Johnson's financial stake in Kenvue evolved significantly. In 2023, following Kenvue's IPO and an exchange offer, Johnson & Johnson retained a 9.5% stake in Kenvue, valued at $4.3 billion. By 2024, the Company executed a Debt-for-Equity Exchange in May, using its remaining 182.3 million Kenvue shares to satisfy $3.6 billion in commercial paper. This resulted in Johnson & Johnson no longer owning any Kenvue shares and recording a $0.4 billion loss on the exchange. Thus, the strategic relationship transitioned from partial ownership to full divestiture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Johnson & Johnson's stake in Kenvue from 2023 to 2024. All key facts are accurate: the 9.5% stake valued at $4.3 billion in 2023, the May 2024 debt-for-equity exchange using 182.3 million shares (rounded from 182,329,550), the $3.6 billion commercial paper satisfaction, the $0.4 billion loss, and the complete exit from Kenvue. (2) Quantitative accuracy is excellent: the percentages, dollar amounts, and share count (with acceptable rounding) match the ground truth. The $0.4 billion loss and expense are correctly reported, though the original answer notes a $0.4 billion expense in 2023 and a $0.4 billion loss in 2024—the LLM combines these as a loss on exchange, which is contextually acceptable. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2023 retention and 2024 disposal), entities (J&J, Kenvue), and financial mechanisms (exchange offer, debt-for-equity). The strategic shift from partial ownership to full divestiture is correctly inferred. (4) The only minor shortcoming is the omission of the detail that the 2023 $0.4 billion was an expense due to valuation changes (recorded in other assets), whereas the 2024 $0.4 billion is a loss on the exchange. While the LLM correctly reports the loss, it does not distinguish the two separate $0.4 billion items by year and nature, which slightly affects qualitative precision. However, this does not undermine the overall correctness. Hence, a score of 9 is justified—excellent accuracy with a minor nuance missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 433,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the subsidiaries guaranteed under AT&T's debt obligations in the 10-K filing. However, in 2023, Indiana Bell Telephone Co. Inc. was no longer explicitly included in the list of guaranteed subsidiaries, indicating a reduction in its inclusion in AT&T's guarantee disclosures.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) According to the ground truth, Indiana Bell Telephone Co. Inc. was included in AT&T's guarantee disclosures in both 2022 and 2023 under Exhibit 4-d, with no change in status. The LLM incorrectly states that the company was 'no longer explicitly included' in 2023, which contradicts the original answer. (2) There are no numeric values in the question or answer requiring calculation, but the temporal facts (2022 vs 2023) are misstated. The LLM falsely claims a reduction in disclosure in 2023, when in fact the guarantee remained unchanged. (3) The multi-hop reasoning failed: the model should have compared the guarantee disclosures across both years and concluded no change, but instead invented a change that did not occur. (4) Contextual relevance is low because the answer addresses the right topic (guarantee disclosures) and entities (AT&T and Indiana Bell), but draws the opposite and incorrect conclusion. The qualitative and quantitative accuracy scores are very low due to the factual reversal. Only minimal credit is given for addressing the correct companies and time frame.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 319,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "From 2023 to 2024, GE's financial relationship with AerCap evolved primarily through investment gains and cash transactions. In 2023, GE held equity and a note receivable from AerCap, with the equity securities valued at $944 million. By 2024, GE sold its remaining equity shares in AerCap, contributing to a $5.2 billion decrease in gains on retained and sold ownership interests, which impacted continuing earnings. Additionally, GE paid net cash of $203 million to AerCap in 2023 for ongoing activities, but no further cash involvement was explicitly noted in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key elements of GE's evolving relationship with AerCap from 2023 to 2024, including the $203 million net cash payment to AerCap in 2023 and the $5.2 billion decrease in gains on retained and sold ownership interests in 2024. It accurately notes the shift from operational involvement to investment-based returns, and correctly states that GE sold its remaining equity in AerCap in 2024. However, the LLM introduces a specific valuation of equity securities at $944 million in 2023, which is not present in the original answer and cannot be verified from the provided ground truth—this is an over-specific addition that risks inaccuracy. (2) Quantitatively, the $203 million cash payment and $5.2 billion decrease in gains are correctly reported with accurate figures and years. The $944 million equity valuation is the only unsupported number, but it does not contradict the ground truth directly. Calculations and comparisons are not required beyond these values, so no computational errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes the transition from cash and operational involvement in 2023 to investment gains and divestment in 2024, aligning with the strategic shift described in the original. The conclusion about reduced gains being tied to AerCap and GE HealthCare is partially accurate, though the LLM attributes the entire $5.2 billion decrease solely to AerCap, while the original answer attributes it to both AerCap and GE HealthCare—this is a minor misattribution. (4) The answer is highly contextually relevant, directly addressing cash involvement and investment gains as asked. The core facts are correct, with only minor over-specification and slight misattribution of the gain decrease, warranting a high but not perfect correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 501,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "From 2022 to 2024, The Home Depot has evolved its approach to store appearance and competition by enhancing the interconnected shopping experience, integrating digital tools, and improving store layouts to elevate customer experience. In 2022, the company focused on store refreshes, wayfinding signage, and self-service tools like lockers and curbside pickup. By 2024, these efforts expanded with further investments in store navigation, electronic shelf labels, and redesigned checkout areas to increase convenience and speed. Additionally, the company emphasized digital integration by improving mobile app functionality and enhancing the online shopping experience with personalized content and fulfillment options, reinforcing its competitive edge through a seamless blend of in-store and digital capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of The Home Depot's strategy from 2022 to 2024, noting the shift from physical store appearance (e.g., store refreshes, signage, self-service tools) to a more integrated, digitally enhanced shopping experience. The mention of electronic shelf labels, redesigned checkout, and improved navigation matches the broader trend toward digital integration and ease of shopping. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time (2022 vs 2024), connects store appearance to competition, and integrates digital and physical elements. The only minor gap is that the LLM does not explicitly use the term 'interconnected shopping experience' as highlighted in the 2024 report, though it describes the concept accurately. (4) The answer is contextually excellent—directly addresses the evolution in store appearance, customer experience, and digital integration. The added details (e.g., mobile app, personalized content) are consistent with the direction of the original answer. Overall, the response is factually correct, comprehensive, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 376,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved with increased resales and a new financial arrangement. In 2023, AMD recorded $14 million in resales to the ATMP JV, which rose to $121 million in 2024. Additionally, in October 2024, AMD entered into a $100 million one-year term loan agreement with one of the ATMP JVs, providing funds for general corporate purposes and secured by the ATMP JV's receivable balance due from AMD.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: $14 million in resales in 2023, increasing to $121 million in 2024, and the October 2024 $100 million one-year term loan to an ATMP JV for general corporate purposes. These numbers and dates are factually consistent with the original answer. (2) Quantitative accuracy is perfect—values are correctly reported with no calculation or formatting errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2023 vs 2024) and across financial dimensions (resales and new loan arrangement). (4) The only minor discrepancy is that the LLM adds a detail not present in the ground truth—specifically, that the loan was 'secured by the ATMP JV's receivable balance due from AMD.' This detail is plausible but not confirmed in the original answer, slightly reducing qualitative accuracy. However, it does not contradict the ground truth and is contextually relevant. Overall, the answer is complete, factually correct, and directly addresses the evolution in AMD's financial relationship with the ATMP JV.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 321,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson enhanced its privacy compliance programs in response to evolving privacy laws and international data flow regulations. In 2023, the Company emphasized its established privacy compliance programs and controls to manage risks related to data collection, use, and international data transfers. By 2024, the Company expanded its focus, highlighting increased enforcement of privacy laws and the introduction of new regulations, particularly around data localization and cross-border data flows. Additionally, the frequency of updates to the Regulatory Compliance & Sustainability Committee increased from twice a year in 2023 to quarterly in 2024, reflecting a more proactive approach to monitoring and adapting to the regulatory landscape.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its portrayal of Johnson & Johnson's evolving privacy compliance programs between 2023 and 2024, with accurate emphasis on international data flows, data localization, and increased regulatory scrutiny. The quantitative claim about the Regulatory Compliance & Sustainability Committee meeting frequency increasing from twice a year to quarterly in 2024 is specific and plausible, but this detail is not present in the original ground truth answer and cannot be verified from the provided knowledge graph—introducing unconfirmed information, which affects qualitative accuracy. The core elements—expansion of focus from 'other territories' to 'globally,' heightened attention to cross-border data flows, and anticipation of new privacy laws—are semantically aligned with the original answer. However, the LLM omits the 2024 emphasis on evolving technology, data-driven initiatives, and third-party vendor management, which are key aspects of the updated compliance posture. While the reasoning is logical and contextually relevant, the addition of unverified specifics and the omission of key details from the ground truth reduce completeness and fidelity in multi-hop synthesis. Wording and structure are otherwise contextually appropriate and factually consistent where aligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 365,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "Between 2023 and 2024, GE's financial exposure to Bank BPH decreased in terms of estimated borrower litigation losses, which fell from $2,669 million to $2,461 million. Additionally, the related valuation allowances also decreased, with the total valuation allowances against financing receivables held for sale dropping from $1,963 million in 2023 to $1,594 million in 2024. These reductions reflect a partial resolution of the ongoing litigation through a settlement program implemented in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numerical values. According to the ground truth, in 2023, the valuation allowance was $1,712 million and in 2024 it was $1,517 million. However, the LLM incorrectly reports these as $1,963 million and $1,594 million, respectively—values that do not appear in the original data. This misrepresentation severely undermines the quantitative accuracy. The total estimated losses are correctly stated as decreasing from $2,669 million to $2,461 million. (2) The calculation of the difference in total losses is accurate, but the valuation allowance figures provided by the LLM are both incorrect and do not sum to the total liabilities as they should (e.g., $1,517M + $944M = $2,461M in 2024 per ground truth). The LLM’s use of fabricated numbers for valuation allowances suggests a failure in data retrieval or synthesis. (3) While the LLM correctly identifies the trend of decreasing exposure and references a settlement program, it omits the critical qualitative point that by 2024, the valuation allowance fully offset the financing receivables balance—a key indicator of strategic shift mentioned in the original answer. This missing insight weakens the qualitative reasoning. (4) Despite incorrect numbers, the answer remains contextually relevant by addressing the evolution of GE’s exposure, citing litigation losses and valuation allowances, and referencing the settlement program. However, due to major quantitative errors and incomplete synthesis of the financial implications, the overall correctness is significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 441,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024 by maintaining a consistent share of net sales within the Hardlines major product line, while experiencing a slight decline in its percentage contribution. In 2022, Indoor Garden accounted for 10.3% of net sales within the Hardlines category, and by 2024, this share slightly decreased to 6.6%. Despite this, the product line remained a key component of the Hardlines segment, which includes Hardware, Outdoor Garden, and Tools. The reclassification of merchandising departments in 2024 did not impact the overall positioning of Indoor Garden, which continued to be a core offering within the broader Hardlines category.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, the Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of HD's *total* revenue, not 10.3% of the Hardlines category as the LLM claims. The LLM incorrectly frames Indoor Garden as a subcategory of Hardlines in 2022, but the ground truth indicates it was a standalone category at that time. Furthermore, the LLM states that by 2024, Indoor Garden's share decreased to 6.6%, which is not supported by the original answer—no such percentage is mentioned for 2024, and there is no indication of a decline in performance. (2) The quantitative inaccuracies are severe: the $15,546 million figure is omitted entirely, and the percentages are misattributed to the wrong revenue base (Hardlines vs. total revenue). The 6.6% figure appears fabricated. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the key evolution—Indoor Garden went from being a significant standalone category in 2022 to being reclassified under Hardlines in 2024, indicating a strategic shift. Instead, the LLM assumes it was always part of Hardlines and that its positioning remained unchanged, contradicting the ground truth. (4) The contextual relevance is moderate because the answer discusses merchandising departments and performance trends, but the incorrect data and reasoning undermine the conclusion. The core insight about reclassification is missed, and the answer falsely suggests stability rather than strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 430,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "From 2022 to 2024, Colgate-Palmolive has continued to manage cost volatility, particularly from commodity price fluctuations, through sourcing strategies, cost containment measures, and selective use of commodity hedging contracts. In 2022, the company emphasized using sourcing strategies and productivity initiatives to mitigate raw material cost increases, with limited use of futures contracts, primarily in the Hill's Pet Nutrition segment. By 2024, the company maintained a similar approach, leveraging sourcing strategies and ongoing productivity initiatives to manage exposure, while continuing to use commodity contracts selectively to hedge against price volatility in key raw materials such as essential oils, resins, and tropical oils. The evolution reflects a consistent strategy but with a heightened focus on adapting to ongoing inflationary pressures and supply chain disruptions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Colgate-Palmolive's use of sourcing strategies and cost containment measures from 2022 to 2024 and notes the selective use of hedging instruments. It accurately references key commodities such as essential oils, resins, and tropical oils (aligned with 'resins, essential oils, and soybeans' in the ground truth). However, it introduces 'futures contracts' and specifies their use primarily in the Hill's Pet Nutrition segment in 2022, which is not mentioned in the original answer and represents an unsupported detail. The ground truth emphasizes derivative instruments and local currency borrowings as part of a broader risk management framework in 2022, which the LLM omits. In 2024, the LLM correctly notes continued use of sourcing and productivity initiatives but underemphasizes the shift toward more defensive tactics due to geopolitical and climatic disruptions, a key evolution highlighted in the original. (2) There are no numerical values, percentages, or dates requiring verification; all timeframes (2022, 2024) are correct. (3) The multi-hop reasoning is partially sound—information is synthesized across years and strategies, but the LLM adds unverified specifics (e.g., Hill's Pet Nutrition, futures contracts) and misses the expanded risk context (geopolitical/climatic) and broader financial instruments (derivatives, local currency borrowings) from the original. (4) The correctness score is 7 due to accurate core facts and timeline but with minor factual additions and omission of key strategic shifts. Quantitative accuracy is 10 as no numbers are incorrect. Qualitative accuracy is 7 due to partial reasoning and entity synthesis. Contextual relevance is 9 as the response stays focused and relevant throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 485,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "Between 2023 and 2024, TREMFYA's sales increased by 16.6%, from $3.15 billion in 2023 to $3.67 billion in 2024. This growth was driven by market expansion, share gains, and continued strength in treating Psoriasis and Psoriatic Arthritis. Additionally, TREMFYA's performance was supported by its expanding label, including new indications for Ulcerative Colitis and Crohn's Disease, which contributed to its strong sales growth during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the sales figures for TREMFYA in 2023 ($3.15 billion) and 2024 ($3.67 billion), which align with the ground truth values of $3,147 million and $3,670 million, respectively. The 16.6% growth rate is accurately calculated and matches the ground truth. Number formats are acceptably varied (e.g., $3.15 billion vs $3,147 million). (2) All quantitative elements are correct: the percentage increase, dollar amounts, and implied calculation ((3,670 - 3,147) / 3,147 ≈ 16.6%) are precise. (3) The reasoning is sound and captures key drivers from the original answer: market expansion, strength in PsO/PsA, and share gains. It adds value by including new indications—Ulcerative Colitis and Crohn’s Disease—as contributing factors, which are consistent with TREMFYA’s label expansion and plausibly support growth, even if not explicitly mentioned in the ground truth. However, the original answer emphasizes 'favorable patient mix' and breaks down the 16.6% growth into an 18.1% change from operations and a -1.5% currency impact, which the LLM omits. This is a minor gap in qualitative completeness but does not invalidate the overall reasoning. (4) The answer is highly relevant, directly addressing both parts of the question—sales performance evolution and contributing factors—with accurate, synthesized information. The omission of currency impact and operational change breakdown prevents a perfect score, but the core facts and multi-hop synthesis are correct. Thus, scores reflect near-perfect accuracy with minor qualitative nuance missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 436,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "The structural change in Disney's relationship with A&E from 2022 to 2023 involved Disney reducing its ownership stake in A+E Networks from 50% to 49%, with Hearst increasing its stake from 50% to 51%. This shift did not significantly alter Disney's reporting of subscriber numbers for A+E channels, as the domestic subscriber counts for A&E, HISTORY, and Lifetime remained consistent at around 69 million in 2022 and 58 million in 2023. However, the financial stake in A+E was reduced, impacting Disney's equity income from the investment.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) Quantitatively, it incorrectly states that Disney reduced its stake in A+E from 50% to 49% and Hearst increased to 51%, which contradicts the ground truth: Disney maintained a 50% equity stake in A+E in 2023. This is a major factual error. The subscriber numbers (69 million in 2022 and 58 million in 2023) are correctly cited, but the LLM incorrectly claims subscriber counts remained 'consistent' despite a 11-million drop, misrepresenting the trend. (2) The answer fails on completeness and reasoning: it misses the key structural shift from a partnership to a joint ownership model and mischaracterizes the reporting change. The ground truth emphasizes that Disney moved from reporting A&E as a partner to classifying A+E as a significant equity investment with financial results included under 'Equity in the income of investees'—a critical accounting change the LLM omits. (3) Entity accuracy is partially correct (A&E, Disney, years), but the misrepresentation of the ownership structure and financial reporting impact shows flawed multi-hop reasoning. (4) Contextual relevance is moderate because the answer addresses subscriber numbers and financial stake, but with incorrect details and reasoning. Overall, the answer is mostly incorrect due to core factual and conceptual errors in ownership structure and reporting implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 392,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "Between 2023 and 2024, the financial impact of GE's relationship with AerCap shifted significantly. In 2023, GE reported a realized and unrealized gain of $129 million related to its investment in and note with AerCap. However, in 2024, this position was fully monetized, as GE sold its remaining AerCap shares, leaving only an AerCap senior note. As a result, there were no further gains or losses reported for AerCap in 2024, indicating the conclusion of this investment relationship.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but significant factual inaccuracies. It correctly identifies the $129 million gain in 2023 from GE's investment in and note with AerCap, aligning with the ground truth. However, it incorrectly states that there were 'no further gains or losses reported for AerCap in 2024' due to full monetization. The ground truth indicates that instead of no gains, there was a $5.2 billion decrease in gains on retained and sold ownership interests in 2024 compared to 2023, with AerCap being a primary contributor. This means GE did report financial activity—specifically a sharp decline or loss—not an absence of gains. (2) The $129 million figure is accurate, but the characterization of 2024 is wrong: the $5.2 billion drop is a critical quantitative point missing in the LLM answer. The model fails to report this major year-over-year change, which is central to the question. (3) The multi-hop reasoning is flawed: the model infers that selling shares ended the financial impact, but the ground truth shows a significant negative financial effect in 2024, implying either losses on sale or devaluation prior to sale. The synthesis across years is incorrect. (4) Scores reflect that core 2023 data is right (supporting moderate quantitative and qualitative scores), but the failure to capture the $5.2 billion decline—a key multi-hop, comparative financial fact—severely undermines correctness. Contextual relevance is high because the answer addresses the right entities and timeframe, even if factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 429,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "Between 2022 and 2024, Mastercard enhanced its multi-layered security approach by explicitly addressing risks associated with third-party service providers, as noted in the 2024 10-K. The evolution includes increased monitoring and response to threats linked to third-party services, indicating a strategic shift toward a more proactive and comprehensive cybersecurity posture. This reflects Mastercard's commitment to safeguarding the global payments ecosystem against emerging threats, particularly as reliance on external partners grows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Mastercard's multi-layered security approach evolved between 2022 and 2024 by explicitly incorporating third-party service provider risk management, which was not explicitly mentioned in 2022 but was in 2024. The answer captures the core evolution: increased monitoring and response to third-party-related threats, and correctly infers the strategic shift toward a more proactive, ecosystem-wide cybersecurity posture. All entities (Mastercard, 2022, 2024, third-party service providers) and timeframes are accurate. There are no numerical values in the question or answer, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is 9 because while the LLM conveys the main point, it omits a minor but relevant detail from the ground truth: the use of public-private partnerships and cross-organizational experts in managing third-party risks in 2024. This does not undermine the overall correctness but slightly reduces completeness in multi-hop synthesis. Contextual relevance is perfect—the response directly addresses all parts of the question with appropriate focus and scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 338,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "Between 2022 and 2023, Target Corporation remained in compliance with its debt leverage covenant under its credit facilities. In 2022, Target had a $3.0 billion unsecured revolving credit facility expiring in October 2026, and in 2023, it obtained a new $1.0 billion 364-day unsecured revolving credit facility expiring in October 2024 while extending its existing $3.0 billion facility to October 2028. Despite changes in credit facilities, the company confirmed in both years that it was in compliance with all covenants, including the debt leverage covenant, and expects to remain so.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Target's compliance with the debt leverage covenant in both 2022 and 2023 is correctly stated. (2) Quantitative accuracy is perfect: the $3.0 billion unsecured revolving credit facility (originally expiring in October 2026, extended to October 2028), and the new $1.0 billion 364-day facility expiring in October 2024 are all correctly cited with accurate dollar amounts and dates. Format variations are acceptable and consistent. (3) Multi-hop reasoning is sound: the answer synthesizes information across two years and multiple credit facility changes, correctly concluding that despite structural changes, covenant compliance was maintained. (4) The response addresses all parts of the question—evolution of compliance and changes to credit facilities—and conveys the same conclusion as the original: consistent adherence to covenants amid financing evolution. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 297,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "From 2023 to 2024, the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, has evolved to include increased ethical, regulatory, and operational challenges. In 2023, the risks primarily focused on the general ethical issues and potential reputational harm from AI's impact on human rights, privacy, and employment. By 2024, the risks had expanded to include more specific concerns around the development and deployment of generative AI, such as accuracy, bias, toxicity, privacy, and data provenance. Additionally, the regulatory landscape had intensified, with new laws and frameworks like the EU's AI Act and the Digital Services Act imposing stricter requirements on AI content generation and governance. These developments necessitated greater investment in compliance, governance, and the ethical implementation of AI to mitigate potential harm and ensure regulatory adherence.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of the evolution of Salesforce's AI-related risks from 2023 to 2024, with accurate contextual framing and relevant details. However, there are some discrepancies when compared to the ground truth. In 2023, the original answer specifies that the primary risk was not general ethical concerns about human rights, privacy, or employment, but rather potential legal liabilities from third-party integrations and unmet customer warranty expectations—this is a key factual difference. The LLM answer incorrectly characterizes 2023 risks as broader ethical and reputational issues, which were not emphasized in the ground truth for that year. In 2024, the LLM correctly identifies expanded risks around accuracy, bias, privacy, and regulatory frameworks like the EU AI Act and Digital Services Act, which aligns with the original answer’s mention of ethical concerns, regulatory scrutiny, and legal liabilities from AI-generated content. The LLM also appropriately notes increased investment in governance and compliance, matching the original’s point about higher costs for AI governance and testing. There are no numerical values to assess, so quantitative accuracy is 10 by default. The reasoning is logically structured and contextually relevant, but the misrepresentation of 2023 risks reduces qualitative accuracy. The answer synthesizes multi-hop information well but bases part of its reasoning on an inaccurate premise for 2023, affecting overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 417,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "Between fiscal years 2023 and 2024, Lowe's delivery capability for parcel-eligible items improved significantly. In fiscal 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal 2024, this was enhanced to ensure most parcel-eligible items could be delivered within two business days or less at standard shipping rates. Additionally, Lowe's expanded its gig provider network nationwide to enable same-day delivery for certain products and introduced the capability to deliver major appliances next-day in almost every U.S. zip code.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all timeframes and delivery speeds are correct: 'within two business days' for fiscal 2023 and 'two business days or less' for fiscal 2024 are accurately reported. The expansion to next-day delivery for major appliances in 'almost every U.S. zip code' matches the original answer's 'nearly every zip code.' (2) The LLM adds a detail not present in the ground truth—'expanded its gig provider network nationwide to enable same-day delivery for certain products.' While plausible and contextually consistent, this specific enhancement (same-day delivery via gig providers) is not mentioned in the original answer and thus introduces a minor overstatement. However, it does not contradict the source and may be inferred as part of 'delivery within two business days or less,' though not explicitly confirmed. (3) The multi-hop reasoning is sound: the model correctly compares delivery capabilities across fiscal years and synthesizes improvements in speed and coverage. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: evolution between 2023 and 2024 and specific improvements. The only reason for not scoring a 10 is the addition of a plausible but unverified detail (same-day delivery via gig providers) not present in the ground truth. Overall, the core facts, numbers, and reasoning are correct, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 411,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "The financial impact of the Dermstore LLC sale on Target's consolidated revenues and operating income was minimal in both 2022 and 2023. Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both years. The pretax gain of $335 million recognized in 2021 did not have a material ongoing impact on 2022 or 2023 financial results.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Dermstore represented less than 1% of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023; the $335 million pretax gain occurred in 2021 and had no material ongoing impact. (2) Quantitative accuracy is perfect: the $335 million figure and 'less than 1 percent' are correctly reported with no calculation errors. (3) Multi-hop reasoning is sound—the model correctly synthesizes that the sale occurred in 2021 and therefore did not affect 2022–2023 operating results, and that the business was immaterial in both years. (4) The answer fully addresses the evolution of financial impact (i.e., no change due to minimal contribution), making it contextually complete and precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 243,
        "total_tokens": 1446
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "Between 2023 and 2024, Data Cloud's strategic positioning within Salesforce has evolved to become a more central and integrated component of the Customer 360 platform, emphasizing its role in unifying and leveraging enterprise data across multiple service offerings. In 2023, Data Cloud was described as a \"hyperscale, trusted data engine\" that consolidates disconnected enterprise data to deliver a 360-degree view of customers. By 2024, its role was further emphasized as a foundational element of the Einstein 1 Platform, enabling AI-powered automation and analytics across Salesforce's CRM, marketing, commerce, and service offerings. This evolution reflects a broader strategic shift toward embedding Data Cloud as a key enabler of AI-driven customer experiences and cross-functional data integration within Salesforce's ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Data Cloud's strategic positioning between 2023 and 2024 and accurately reflects its role as a unifying data engine within Salesforce's ecosystem. It correctly notes the 2023 description of Data Cloud as a 'hyperscale, trusted data engine' and its function in delivering a 360-degree customer view. The answer also appropriately highlights increased integration with Salesforce offerings like CRM, marketing, and AI via the Einstein 1 Platform in 2024, which aligns with the broader trend of deeper platform embedding.\n\nHowever, the LLM answer omits key qualitative shifts emphasized in the original answer, particularly the strategic risks and competitive landscape changes highlighted in 2024. Specifically, it fails to mention that Salesforce acknowledged the 'relatively new and uncertain' nature of the market for Data Cloud and the increasing competitive pressure from evolving AI and data platforms. Additionally, it does not reference Salesforce's stated limited experience in pricing consumption-based models—a critical strategic vulnerability noted in the 2024 filing. These omissions represent a significant gap in capturing the full strategic evolution, which includes not just technological integration but also emerging business model and competitive challenges.\n\nWhile the LLM provides a coherent and contextually relevant narrative focused on technical integration and AI enablement, it misses the shift in tone from product promotion in 2023 to risk disclosure in 2024. This reflects a partial failure in multi-hop reasoning, as the answer synthesizes forward-looking integration trends but overlooks the risk and monetization dimensions present in the 2024 filing. There are no numerical inaccuracies (hence a perfect quantitative score), and the entities (Data Cloud, Salesforce, Einstein, Customer 360) and years are correct. The contextual relevance is high because the answer addresses the core question about strategic positioning, but the qualitative accuracy is reduced due to incomplete synthesis of the competitive and strategic risk aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 567,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, LOW's treatment and accounting of forward interest rate swap contracts showed a significant shift in hedge designation and financial impact. In 2023, forward interest rate swaps with a notional amount of $1,290 million were designated as cash flow hedges, resulting in a pre-tax gain of $311 million recorded in other comprehensive income. However, by 2024, all forward interest rate swap contracts were fully settled, with no remaining notional amounts designated as cash flow hedges. This change led to a pre-tax loss of $14 million recorded in other comprehensive loss for 2024, reflecting the financial impact of these settlements and a shift away from using such instruments for hedging purposes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, LOW had forward interest rate swap contracts with a notional amount of $2.0 billion (not $1,290 million), and it received $247 million upon settlement (not a $311 million pre-tax gain). The LLM incorrectly states the notional amount and the financial impact. Furthermore, the ground truth indicates that in 2024, LOW shifted to accounting for fixed-to-floating interest rate swaps as fair value hedges using the shortcut method, not that all forward swaps were settled. The LLM incorrectly claims that all contracts were settled by 2024 and reports a $14 million pre-tax loss, which is not supported by the original answer. (2) Quantitative accuracy is poor: $1,290 million vs. $2.0 billion, $311 million gain vs. $247 million received, and a fabricated $14 million loss. None of these numbers align with the ground truth, and no correct calculations are presented. (3) The multi-hop reasoning is flawed. The LLM fails to recognize the evolution in hedge designation—from cash flow hedges in 2023 to fair value hedges in 2024—and instead asserts that the instruments were discontinued due to settlement, which contradicts the original answer’s emphasis on a change in accounting treatment. The shift in hedge type and its implications (e.g., no earnings impact due to shortcut method) are entirely missed. (4) Contextual relevance is moderate because the answer addresses the general topic of hedge accounting evolution and financial impact, but the incorrect facts and reasoning severely undermine its validity. The structure follows the question’s intent, but the content is largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 465,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "From 2022 to 2023, Target's strategy around its owned brands has evolved to place greater emphasis on strengthening and expanding its owned brands portfolio as a key differentiator. In 2022, the focus was on differentiating through owned and exclusive brands to offer a curated assortment. By 2023, the strategy explicitly highlights delighting guests with newness, style, and value by enhancing owned brands, curating national brands, and expanding signature partnerships. This reflects a more proactive and growth-oriented approach to owned brands, aligning them with broader objectives of expanding relevancy, driving traffic, and increasing market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) There are no numeric values in the question or answers that require verification—both responses focus on qualitative strategic evolution, so quantitative accuracy is not applicable beyond correct use of years (2022 and 2023), which are accurate. (2) The LLM correctly captures the shift from 2022, where Target emphasized differentiation through owned and exclusive brands with a curated assortment, to 2023, where the company elevated its owned brands as part of a strategic initiative to 'delight with newness, style, and value'—a phrase accurately reflected in both answers. (3) The multi-hop reasoning is sound: the model synthesizes a strategic evolution across two years, correctly identifying the shift from descriptive presence to proactive differentiation. The LLM adds slight rewording (e.g., 'expanding signature partnerships') not in the original, but this does not contradict the ground truth and may reflect additional context from Target’s 2023 report. (4) The core strategic shift—positioning owned brands as a growth driver for traffic, sales, and market share—is fully preserved. One minor point preventing a perfect 10 is that the LLM slightly overemphasizes 'expanding signature partnerships' as part of the owned brand strategy, which is adjacent but not central to the original answer’s focus. Otherwise, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 404,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "From 2022 to 2023, GM's approach to software-enabled services has evolved significantly, with a stronger emphasis on expanding service offerings and deploying scalable digital platforms. In 2022, GM highlighted its suite of software-enabled services, including OnStar, Super Cruise, and its end-to-end software platform, which began rolling out across its product lineup. By 2023, the company emphasized the broader deployment of its end-to-end software platform, enabling over-the-air updates for features, performance, and driver assistance systems. This indicates a growing investment in scalable digital solutions, as GM aims to enhance customer experiences through software-defined vehicles and expand its ecosystem of active safety, infotainment, and connectivity services.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of GM's software-enabled services from 2022 to 2023 and correctly identifies key offerings like Super Cruise and over-the-air updates. However, it inaccurately states that in 2022, GM already highlighted its 'end-to-end software platform' and that it 'began rolling out across its product lineup'—this level of specificity and platform deployment is only documented in the 2023 filing according to the ground truth. The original answer clarifies that in 2022, GM only mentioned software-enabled services in general terms, not specific platforms or rollouts. This misrepresents the timeline and maturity of GM's approach. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not heavily applicable; however, the use of years (2022 vs 2023) is critical. The LLM incorrectly attributes 2023-level details to 2022, which is a factual error in temporal attribution. (3) The multi-hop reasoning is partially sound—the LLM correctly infers increased investment in scalable digital solutions based on platform expansion. However, it fails to accurately contrast the 2022 'general' description with the 2023 'specific' deployment, which is the core of the evolution. The ground truth emphasizes a shift from general involvement to concrete platform use in 2024 models like Cadillac LYRIQ and Silverado EV, which the LLM omits. (4) The contextual relevance is high because the answer addresses service offerings, platform deployment, and investment implications. Qualitative accuracy is reduced due to incorrect synthesis of when specific platform details were disclosed. Correctness score is 6 due to significant but not fundamental errors in factual chronology and omission of key model examples that demonstrate scalability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 501,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category increased by 11% between fiscal years 2022 and 2023, driven by growth in ThousandEyes and Intersight offerings, partially offset by a decline in AppDynamics offerings. In fiscal 2024, the Observability category (which includes ThousandEyes) saw a 27% revenue increase compared to 2023, primarily due to continued growth in the ThousandEyes offering.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that ThousandEyes' revenue contribution increased by 11% between FY2022 and FY2023, but the ground truth shows that the 11% growth occurred in FY2022 (not as a change between 2022 and 2023), and in FY2023, the Observability category grew by 14%. The LLM incorrectly frames the 11% as a comparative growth rate between years rather than annual growth within FY2022. Additionally, the LLM introduces FY2024 data (27% increase), which is not part of the question or the ground truth, making it irrelevant and incorrect. (2) The dollar amounts ($75M in 2022, $80M in 2023) are completely omitted, which are critical for assessing the evolution of revenue contribution. The mention of 'decline in AppDynamics' is unsupported in the ground truth, which does not reference AppDynamics at all. (3) The multi-hop reasoning is flawed: the question asks for evolution between FY2022 and FY2023, requiring comparison of ThousandEyes' contribution in both years. The LLM fails to extract and compare the correct growth figures (11% in 2022 vs 14% in 2023) and instead misattributes the 11% as a delta between years. It also introduces incorrect future-year data, indicating a failure in temporal reasoning and synthesis. (4) While the answer is somewhat contextually relevant—focusing on ThousandEyes and the Observability category—the severe quantitative errors, omission of key financial figures, introduction of non-existent data, and incorrect reasoning justify a low correctness score. Minor credit is given for correctly identifying ThousandEyes as a growth driver.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 449,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "In the 2023 10-K filing, Amendment No. 4 to the Lockheed Martin Executive Severance Plan was listed as Exhibit 10.34 and incorporated by reference from the Quarterly Report on Form 10-Q for the quarter ended September 25, 2022. By the 2024 10-K filing, it remained as Exhibit 10.36, maintaining its inclusion in the disclosure. This consistency indicates that the company continues to formally disclose amendments to its executive severance plan as part of its transparency strategy, ensuring stakeholders are informed about changes to executive compensation policies.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Amendment No. 4 was listed as Exhibit 10.34 in the 2023 10-K and was incorporated from the September 2022 10-Q, which the LLM correctly states. However, the LLM incorrectly claims that in the 2024 10-K, Amendment No. 4 remained as Exhibit 10.36. The ground truth states that Amendment No. 4 is no longer listed as a standalone exhibit in the 2024 10-K but is instead included as part of a sequence of amendments (Nos. 2, 3, 4, and 5), indicating a consolidation. The LLM's assertion of continued standalone status (Exhibit 10.36) is factually wrong. (2) The date 'September 25, 2022' is consistent with the September 2022 10-Q reference and is acceptable, though not explicitly confirmed in the ground truth. No calculations were required, so quantitative accuracy is only affected by the incorrect exhibit number. (3) The multi-hop reasoning is flawed: the question asks about the evolution in treatment between 2023 and 2024 and what it indicates about disclosure strategy. The LLM fails to recognize the shift from standalone to integrated disclosure, which is central to the correct interpretation. Instead, it concludes there is 'consistency,' which contradicts the actual change in presentation. (4) The contextual relevance is moderate because the answer discusses the right document (10-K), amendment, and incorporation method, but misses the key evolution and strategic implication—consolidation versus continued standalone disclosure—leading to a low correctness score despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 442,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "From 2023 to 2024, JPMorgan's Tier 1 leverage ratio remained stable at 7.2%, meeting the regulatory requirement of 4.0%. The Standardized CET1 capital ratio increased slightly from 15.0% in 2023 to 15.7% in 2024, reflecting improved capital adequacy amid evolving regulatory buffers and capital conservation requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies JPMorgan and the relevant capital ratios (Tier 1 leverage ratio and Standardized CET1 capital ratio) and addresses the 2023–2024 timeframe. However, it introduces a 2024 Standardized CET1 ratio of 15.7%, which is not present in the ground truth; the original answer only provides the 2023 value (15.0%) and does not mention 2024. This is a significant factual inaccuracy. The Tier 1 leverage ratio of 7.2% in 2024 and requirement of 4.0% are correctly stated, but the LLM falsely implies this ratio was also 7.2% in 2023, while the ground truth does not provide the 2023 Tier 1 leverage ratio at all. (2) Quantitative accuracy is compromised: the 15.7% CET1 figure for 2024 is unsupported by the original data, and the claim of stability in the Tier 1 leverage ratio lacks evidence since 2023 data for that metric is not in the ground truth. (3) The multi-hop reasoning is partially sound—JPMorgan is correctly identified, and the regulatory context is reasonably interpreted—but the model fabricates data to fill gaps, failing to acknowledge missing information. (4) Contextual relevance is high as the answer directly addresses capital ratio compliance over time, but correctness is reduced due to invented figures. The original answer emphasizes compliance in each year using available data without extrapolation, whereas the LLM overreaches by asserting trends not supported by the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 399,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "Between 2022 and 2023, GM Financial remained a distinct reportable segment within General Motors' consolidated financial statements, with its performance evaluated through EBT-adjusted due to the significance of interest income and expense in its operations. The segment's financial presentation and integration into the consolidated statements remained consistent, with its results included in the broader consolidated financial framework while reflecting its unique operational focus on automotive financing services.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative changes in GM Financial's financial presentation between 2022 and 2023. (1) It correctly identifies GM Financial as a reportable segment in both years and notes its role in automotive financing, which aligns with the original answer. However, it fails to capture the evolution in disclosure: in 2023, there was a more detailed emphasis on adjustments related to deferred tax positions and income tax provisions due to inclusion in the consolidated tax return—this is a critical change highlighted in the ground truth. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable; the response contains no incorrect numbers, earning full marks by default. (3) The multi-hop reasoning is weak: while the LLM acknowledges integration into consolidated statements, it does not synthesize the specific change in accounting disclosure regarding tax adjustments, which is central to the evolution described in the original answer. Instead, it asserts consistency in presentation, which contradicts the ground truth’s emphasis on increased detail and explicit focus on tax integration. (4) Contextual relevance is high because the answer addresses the segment status and integration of GM Financial within GM’s financials, but the lack of specificity on the 2023 disclosure changes limits its accuracy. The answer gives a plausible but overly static view of the situation, missing the nuanced evolution in financial reporting emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 419,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "Between 2022 and 2024, the treatment and disclosure of step-rent provisions in lease accounting remained consistent in recognizing such provisions on a straight-line basis over the original lease term and any extension options reasonably certain to be exercised. In both years, periodic rent increases based on price indices or sales volume were recognized as variable lease payments. No significant changes in accounting treatment or additional disclosures specific to these provisions were noted in the 2024 filing compared to 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the accounting treatment remained consistent between 2022 and 2024. The ground truth indicates a clear shift: in 2022, step-rent provisions with increases based on price indices or sales volume were accounted for on a straight-line basis, but by 2024, these were reclassified as variable lease payments and no longer straight-lined. The LLM incorrectly claims no significant changes occurred, which contradicts the documented evolution. (2) While there are no explicit numerical values (e.g., dollar amounts or percentages) to verify, the temporal references (2022 and 2024) are correctly identified, but the treatment attributed to each year is wrong. The LLM falsely states that variable lease treatment was already in place in 2022, when it was actually the straight-line method. (3) The multi-hop reasoning fails because the model does not correctly synthesize the change over time. It should have detected the shift in policy from straight-line to variable treatment, but instead asserts consistency, missing the core of the question. (4) The contextual relevance is moderate because the answer addresses lease accounting and the relevant factors (price indices, sales volume), but the conclusion is fundamentally flawed. Due to major factual and reasoning errors, the correctness score is low at 2, with similarly low scores for qualitative and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 399,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "From 2023 to 2024, the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans show a slight increase in the amount expected to be paid out in 2025, rising from $1,860 million in 2023 to $1,800 million in 2024. Over the long-term period from 2029 to 2033 in 2023, the projected payments were $10,020 million, which decreased slightly to $9,990 million for the period 2030 to 2034 in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the 2025 projected payment for 2024: it states $1,800 million instead of the correct $1,860 million. This is a factual inaccuracy that undermines the quantitative correctness. All other numbers are correct: the 2023 projection for 2025 is correctly stated as $1,860 million, and the long-term projections of $10,020 million (2029–2033) and $9,990 million (2030–2034) are accurate. (2) The calculation and comparison of long-term obligations are correctly interpreted as a slight decrease, which aligns with the ground truth. However, the erroneous drop in the 2025 payment from $1,860M to $1,800M (instead of remaining flat at $1,860M) introduces a false trend. (3) The multi-hop reasoning is partially sound—information is synthesized across two years and two time horizons (short-term 2025 and long-term 2029–2033 vs 2030–2034)—but the incorrect number leads to flawed conclusion about a decrease in near-term obligations. (4) Contextual relevance is high as the structure and intent of the response match the question, and the long-term trend analysis is accurate. However, the key numerical error in the 2025 projection significantly reduces overall correctness. Quantitative accuracy is low due to the incorrect dollar figure; qualitative accuracy is moderate due to correct logic and entity identification; contextual relevance remains strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 390,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "Between 2023 and 2024, JPMorgan Chase's disclosures on resolution plan obligations showed a more detailed emphasis on liquidity risk management strategies and funding cost considerations. In 2023, the company outlined general factors affecting liquidity, such as market stress, regulatory changes, and funding source constraints. By 2024, JPMorgan Chase provided more specific strategies for managing liquidity under resolution plan obligations, including actions to satisfy liquidity coverage and net stable funding ratio requirements, as well as addressing pre-positioning of liquidity in subsidiaries. Additionally, the 2024 disclosures highlighted the potential impact of resolution plan obligations on funding costs, particularly when accessing alternative funding sources due to constraints on traditional, lower-cost funding.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies JPMorgan Chase and the relevant years (2023 and 2024), and accurately references key liquidity risk management components such as the liquidity coverage ratio (LCR) and net stable funding ratio (NSFR), as well as liquidity pre-positioning in subsidiaries and constraints on traditional funding sources like deposits and Federal Home Loan Bank borrowings. These elements are consistent with the original answer. However, the LLM answer omits a critical evolution highlighted in the ground truth: the 2024 expansion to include how resolution plan obligations interact with dynamic regulatory expectations and systemic events, particularly changes in laws and regulations in response to macroeconomic or systemic shocks. This broader contextual framing is a key differentiator in the original answer and is missing in the LLM response. (2) There are no numerical values, percentages, or dollar amounts in either the question or answers, so quantitative accuracy is not applicable—no errors in this regard, scoring 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes information across two years and identifies evolving disclosure themes. However, it fails to fully capture the nuanced shift in 2024 toward linking resolution planning with regulatory evolution and macroeconomic uncertainty, which represents a higher-order synthesis present in the ground truth. (4) The correctness score is 7 because the core facts about liquidity management and funding costs are accurate and well-articulated, but a significant qualitative enhancement in the 2024 disclosures is omitted. Qualitative accuracy is 7 for this reason. Contextual relevance is high (9) as the answer stays focused on the question and provides relevant details, just missing a key dimension of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 504,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Between 2022 and 2023, the financial structure of Optum Rx's pharmacy care services showed notable changes in revenue recognition and accounts receivable. Revenue recognition remained consistent with prior years, as product revenues were recognized when prescriptions were dispensed, and services revenues were recognized as services were performed or made available to customers. However, accounts receivable increased from $7.1 billion in 2022 to $8.6 billion in 2023, reflecting a rise in outstanding balances related to products and services. This increase could indicate either growth in Optum Rx's pharmacy care services or a slight elongation in the time it takes to collect receivables.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key elements of Optum Rx's financial structure evolution between 2022 and 2023. It accurately states that revenue recognition remained consistent—revenue was recognized at the point of prescription dispensing for products and as services were performed, aligning with the gross revenue model described in the ground truth. The accounts receivable figures are exactly correct: $7.1 billion in 2022 and $8.6 billion in 2023. (2) Quantitative accuracy is perfect—both dollar amounts and years match the ground truth, and the increase of $1.5 billion is implicitly correct. No calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes information about revenue recognition practices and changes in accounts receivable across two years. It correctly infers that the increase in receivables may reflect either higher transaction volume or slower collections, which is consistent with the ground truth’s interpretation. (4) The only minor shortcoming is that the LLM does not explicitly mention the rationale for gross revenue reporting (i.e., Optum Rx's primary obligation to pay network pharmacies regardless of collection), which is a key qualitative detail from the original answer. However, the core facts, numbers, and implications are accurately conveyed, and the omission does not distort the overall meaning. Hence, correctness is rated 9/10, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to the slight omission of structural reasoning behind revenue recognition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 439,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "Between 2022 and 2024, UPS has maintained a strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps, primarily as cash flow hedges of forecasted payment obligations. In 2022, UPS reported a reclassified loss of $5 million from accumulated other comprehensive income (AOCI) to interest expense related to interest rate contracts. By 2024, this reclassified amount remained relatively stable at $5 million, indicating a consistent exposure and management strategy. Additionally, UPS continued to utilize these swaps to hedge against variability in cash flows, with $146 million of pre-tax gains deferred in AOCI as of December 31, 2024, expected to be reclassified to income within the next 12 months. This evolution reflects a measured and stable approach to interest rate risk management over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps. The LLM answer does not mention this key quantitative exposure and instead references a $5 million reclassified loss from AOCI to interest expense, which is not part of the original answer and misrepresents the disclosed data. By 2024, the ground truth highlights a strategic shift in UPS's approach to managing interest rate risk, but the LLM incorrectly claims a 'stable' strategy with a consistent $5 million reclassification, which contradicts the evolution described in the original answer. The LLM introduces a new figure—$146 million of pre-tax gains deferred in AOCI as of 2024—which is not present in the ground truth and appears fabricated or misattributed. (2) Quantitative accuracy is severely lacking: the only number in the original answer is $28 million in 2022; the LLM invents or misreports $5 million (twice) and $146 million with no basis in the provided truth. There are no correct calculations because the inputs themselves are incorrect. (3) Multi-hop reasoning is flawed: the question asks about the evolution of both quantitative exposure and strategic approach. The LLM fails to report the $28 million notional amount in 2022 and misses the strategic shift entirely, instead asserting consistency where the ground truth describes a meaningful evolution. The synthesis across years is incorrect. (4) Contextual relevance is moderate—the LLM stays on topic regarding interest rate swaps and risk management—but the factual foundation is wrong, undermining the entire response. The mention of cash flow hedges and AOCI is contextually plausible but does not align with the specific disclosures in the ground truth. As a result, the correctness score is low due to major factual and quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 519,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "Between 2022 and 2023, GM's financial relationship with LG Energy Solution (LGES) evolved in terms of joint venture activities and recall-related costs. The joint venture, Ultium Cells LLC, continued to progress with plans for battery cell production in the U.S., including a fourth plant planned by mid-decade. Regarding recall-related costs, GM incurred significant expenses related to the Chevrolet Bolt EV and EUV battery recall, which expanded to include all 2017-2022 model years. By December 31, 2023, GM had accrued a total of $2.6 billion for these recall costs, with $0.6 billion remaining, while recognizing $1.6 billion in receivables from LG for reimbursement. The commercial negotiations with LG also resolved other matters related to the joint venture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $2.6 billion total recall accrual, $1.6 billion in receivables from LG, and the remaining $0.6 billion (which implies $2.0 billion paid or recognized, consistent with $2.6B - $1.6B = $1.0B, with $0.6B still accrued). These figures match the original answer. (2) The joint venture Ultium Cells LLC is correctly identified, and its role in battery production is accurately described. The mention of a fourth plant, while not in the ground truth, does not contradict it and reflects plausible forward-looking statements from GM. (3) The shift from strategic collaboration to cost-driven dynamics due to the Bolt recall is well captured, including the resolution of commercial negotiations, which adds context beyond the ground truth but is factually consistent. (4) Multi-hop reasoning is sound: the answer synthesizes joint venture activities (strategic) with recall liabilities (financial), showing evolution over time. The only minor gap is that the original emphasizes the 'transition' more explicitly as a shift in relationship tone, while the LLM focuses on facts without highlighting the conceptual shift as clearly—hence a 9 on qualitative accuracy. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 376,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Observability product category increased from fiscal 2022 to fiscal 2023. Specifically, revenue in the Observability category grew by 14% in fiscal 2023 compared to fiscal 2022, driven by growth in ThousandEyes and monitoring and analytics offerings. In fiscal 2024, revenue in the Observability category increased by 27% compared to fiscal 2023, with growth in the ThousandEyes offering being a key contributor.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Observability revenue grew by 14% in fiscal 2023 compared to fiscal 2022, while the ground truth reports a 27% increase ($176 million) in fiscal 2023. Additionally, it falsely claims that fiscal 2024 data is available, which is not mentioned in the original answer and is outside the question's scope. The only correct qualitative point is that ThousandEyes contributed to growth, which aligns with the original answer. (2) Quantitative errors are severe: the 14% growth figure is incorrect (should be 27% in FY2023), and the mention of fiscal 2024 introduces a non-existent time period. The original answer notes $80M growth in FY2022 and $176M (27%) in FY2023, with a 15% organic growth after excluding Splunk—none of which are accurately reflected. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution from FY2022 to FY2023, omits the critical context of Splunk's inclusion, and invents data for FY2024, indicating a failure in logical and factual synthesis. (4) Scores reflect major factual and numerical errors (correctness: 3/10), very poor quantitative accuracy (2/10), weak reasoning and entity handling (3/10), but partial relevance to the topic of ThousandEyes' revenue contribution (6/10 for contextual relevance).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 380,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "Between 2022 and 2024, the redemption terms and interest payment structure for UPS's 7.620% Debentures remained consistent. The debentures, with a maturity of April 1, 2030, are redeemable at UPS's option at any time, with the redemption price being the greater of the principal amount plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Interest is paid semi-annually in April and October, and no changes to these terms were noted in the 2024 filing compared to 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the maturity date (April 1, 2030), interest payment frequency (semi-annual in April and October), and the redemption formula involving the greater of principal plus accrued interest or present value discounted at benchmark treasury yield plus five basis points. The dollar amounts ($276 million principal, $280 million carrying value) are not mentioned in the LLM answer, which omits key quantitative details from the original answer. However, no incorrect numbers are stated, so quantitative accuracy is high. (2) The main factual error lies in the interpretation of how the terms evolved: the original answer states that in 2022, only basic details (principal, maturity, carrying value) were provided, while in 2024, UPS clarified the redemption terms and interest payment schedule — indicating an evolution in disclosure. The LLM incorrectly asserts that 'no changes to these terms were noted' and that the terms 'remained consistent', which contradicts the ground truth that the *disclosure and specificity* of the terms evolved significantly. This misrepresents the nature of the change — from less detailed to more detailed — as no change at all. (3) The multi-hop reasoning is partially sound: the model correctly identifies the debenture terms in 2024 and references 2022 data, but fails to synthesize the evolution in disclosure clarity and detail over time, which is the core of the question. It treats 'terms' as static legal conditions rather than recognizing that the company's reporting and clarification of those terms constitutes an evolution in the relationship. (4) Correctness is scored at 5 due to this significant qualitative error in interpreting the evolution of the relationship, despite accurate numbers and structure. Quantitative accuracy is high (9) due to correct dates, percentages, and redemption mechanics. Qualitative accuracy is moderate (5) because the reasoning mischaracterizes the nature of change. Contextual relevance is strong (8) as the answer addresses the right instruments and time frame with relevant details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 564,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "From 2022 to 2023, the total fair value of Fixed Maturity Securities AFS held by MET increased slightly from $6,802 million to $6,714 million. The composition showed a decrease in U.S. government bonds, which fell from $1,507 million to $1,575 million, while corporate securities increased from $3,001 million to $3,083 million. This indicates a shift in allocation toward corporate securities and away from U.S. government bonds during the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in numbers and trends. According to the ground truth, the 2022 carrying amount was $2,164 million (as of December 31, 2021), not $6,802 million as stated in the LLM response. The LLM incorrectly claims a 'slight decrease' from $6,802M to $6,714M, when in fact the fair value increased dramatically from $2,164M to $6,714M — a more than 3x growth. Additionally, the LLM states U.S. government bonds 'fell from $1,507M to $1,575M', which is logically inconsistent (a rise, not a fall), and these figures are not supported by the original data, which only provides 2023 values ($1,575M for U.S. government bonds, $3,083M for corporate securities) without 2022 breakdowns for comparison. (2) The quantitative inaccuracies are severe: incorrect base year value, fabricated prior-year figures for U.S. government and corporate securities, and wrong directional change. While the 2023 values for corporate securities ($3,083M) and U.S. government bonds ($1,575M) are correct, the 2022 comparisons are not present in the ground truth and are thus hallucinated. (3) The multi-hop reasoning is flawed — the model invents a year-over-year comparison that cannot be made from the provided data. The original answer does not give 2022 fair values for U.S. government bonds or corporate securities, so the LLM cannot validly claim increases or decreases. It also misidentifies the 2022 figure as a fair value when it is actually a carrying amount from the prior year (2021). (4) Contextual relevance is moderate because the answer addresses the right topic (composition and total value changes in AFS securities) and mentions the correct categories and 2023 values, but the core numerical claims and trends are incorrect, undermining the overall correctness. The conclusion about a shift toward corporate securities lacks support due to missing 2022 composition data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 518,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "From 2022 to 2023, General Motors' relationship with Ultium Cells LLC evolved with increased financial involvement and regulatory implications. In 2022, GM invested $0.5 billion in Ultium Cells LLC as part of its strategic focus on electric vehicle (EV) technology. By 2023, GM faced regulatory scrutiny related to its joint venture with Ultium Cells LLC, as it self-disclosed potential violations of the Toxic Substances Control Act (TSCA) to the EPA. This led to a settlement in November 2023 involving civil penalties estimated at approximately $5.1 million, which were jointly and severally assessed on GM and Ultium Cells LLC. These developments highlight both the financial commitment and regulatory challenges associated with GM's collaboration with Ultium Cells LLC during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $0.5 billion investment in 2022, the self-disclosure of TSCA violations in February 2023, the November 2023 settlement, and the $5.1 million joint civil penalties are all accurately reported. Number formats and dates match or are semantically equivalent. (2) Quantitative accuracy is perfect—dollar amounts and years are correct, and no calculations are required beyond what is stated. (3) The multi-hop reasoning is sound: the answer synthesizes financial data (investment) with regulatory developments (TSCA disclosure and settlement), correctly inferring increased operational entanglement. The only minor shortcoming is that the LLM does not explicitly characterize the evolution as a shift from 'passive investment' to 'operationally integrated partnership' as in the original, though the implication is clearly conveyed through the cited events. (4) Contextual relevance is excellent—the response directly addresses both financial involvement and regulatory implications across 2022 and 2023. Overall, the answer is factually complete and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction for less explicit conceptual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 362,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "Between 2022 and 2024, the company continued to use variable-priced contracts for natural gas and fuel purchases, primarily for gas stations and certain facilities in the U.S. and Canada. These contracts are based on an index and qualify for the \"normal purchases and normal sales\" exception, meaning they do not require mark-to-market adjustments. There is no indication of a significant change in the company's strategy or volume related to these contracts during the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the use of variable-priced contracts based on an index and their qualification for the 'normal purchases and normal sales' exception, which avoids mark-to-market adjustments—this information is correctly reported and aligns with the original answer. There are no numerical inaccuracies, and the entities (contract types, commodities, accounting treatment) are correctly identified, supporting a high quantitative accuracy score. However, the LLM answer states there is 'no indication of a significant change' in strategy or volume, which contradicts the original answer's key insight that by 2024, the company had more formally recognized these contracts as derivative instruments under accounting frameworks, indicating a strategic or procedural evolution in their management and accounting. This represents a failure in multi-hop reasoning: the model did not synthesize the implication that explicitly aligning variable-priced contracts with derivative characteristics—even if exempt—signals a more formalized or strategic approach over time. Thus, while the surface facts are correct, the qualitative analysis misses a critical evolution in the company's approach, leading to an incomplete interpretation of the change between 2022 and 2024. The answer remains contextually relevant and factually sound on explicit details but lacks the inferential depth required for full accuracy on the evolution aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 410,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Cisco's financial reporting approach for the APJC segment remained consistent between fiscal 2022 and fiscal 2023 in terms of the expense categories excluded from segment performance measurement. Both years excluded research and development, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements and other contingencies, charges related to asset impairments and restructurings, and certain other charges from the gross margin measurement for the APJC segment. There is no indication of a change in the treatment of these excluded categories during the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Cisco's financial reporting approach for the APJC segment remained consistent between fiscal 2022 and 2023, with no changes in the expense categories excluded from segment performance measurement. (2) The excluded expenses listed—research and development, sales and marketing, general and administrative, amortization and impairment of acquisition-related intangible assets, share-based compensation, significant litigation settlements, asset impairments, restructurings, and certain other charges—match the ground truth in scope and specificity. While the original answer structures the information by first stating the 2022 exclusions and then noting the 2023 expansion, the LLM correctly identifies that the full set of exclusions was effectively the same in both years, which aligns with the conclusion of consistency. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the exclusion framework did not change year-over-year, which is the core of the question. (4) All entities (Cisco, APJC segment, fiscal 2022 and 2023) are accurate, and the answer directly addresses the evolution (or lack thereof) in reporting approach. Minor wording differences (e.g., 'other contingencies' and 'certain other charges') do not affect factual accuracy and are acceptable as semantic variations. No calculation or date errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 402,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "From 2022 to 2023, UNH's approach to managing medical cost trends, particularly rising outpatient procedure costs for seniors, evolved by focusing on care engagement strategies. In 2023, the company observed increased care patterns, especially for outpatient procedures among seniors, and emphasized mitigating these costs by working with physicians and consumers to promote clinically sound, high-quality, and affordable care choices. This reflects a continued effort to address cost trends through care coordination and informed decision-making, building on prior strategies to manage medical costs through underwriting, provider contracts, and care management programs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the evolution from 2022 to 2023 in UNH's approach: while it does not explicitly mention 'deferred care during the pandemic' or 'risk-based arrangements' from 2022, it correctly identifies the shift toward proactive, data-driven engagement with physicians and consumers in 2023 to address rising outpatient costs for seniors. (2) There are no numeric values, dates, or financial figures in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes UNH's changing strategy across years and focuses on outpatient cost trends for seniors, correctly identifying the targeted intervention in 2023. However, it omits the specific 2022 context of pandemic-related deferred care and chronic condition management, which weakens the contrast between years. Instead, it refers vaguely to 'prior strategies,' missing the nuance of a shift from general concern to targeted action. (4) Despite this omission, the core of the answer—UNH’s 2023 focus on data-driven engagement to guide care decisions—is factually accurate and contextually relevant. The answer stays focused on the question and conveys a semantically close representation of the original answer, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 380,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "Between 2022 and 2024, UPS has expanded its time-definite delivery services by enhancing its global smart logistics network and integrating advanced technologies such as RFID in its Smart Package Smart Facilities. In 2022, the focus was on optimizing the existing network and leveraging digital tools to improve customer experience and service scope. By 2024, UPS had further integrated its air and ground services through a more sophisticated system, enabling greater end-to-end visibility and efficiency. Additionally, UPS expanded its healthcare logistics capabilities, including cold-chain solutions, to better serve high-priority sectors. The company also insourced the UPS SurePost service to maintain greater control over delivery reliability, reflecting a strategic shift toward higher-yielding, service-reliable operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in UPS's time-definite delivery services between 2022 and 2024, including the insourcing of UPS SurePost to gain greater control over delivery reliability, which aligns with the ground truth. It also accurately reflects UPS's focus on network integration and service enhancement. However, it introduces details not present in the ground truth, such as 'RFID in Smart Package Smart Facilities' and 'healthcare logistics capabilities, including cold-chain solutions,' which were not mentioned as part of the evolution in time-definite delivery services between those years. While these may be true developments, they are not part of the documented evolution specific to time-definite delivery in the provided knowledge base. Additionally, the ground truth highlights specific service expansions in 2024—same-day pickup seven days a week and returns in ~150 countries—which are missing from the LLM response. (2) There are no numeric values, dates, or calculations in either answer that conflict; all date references (2022, 2024) are accurate and consistent. Thus, quantitative accuracy is high. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift toward control and reliability via insourcing SurePost. However, it adds unverified expansions (e.g., healthcare logistics) and omits key customer-centric service expansions (same-day pickup, global returns), weakening the completeness of the synthesis. (4) The correctness score is 7 because core facts (network integration, SurePost insourcing) are accurate, but important elements from the ground truth are missing and some extraneous details are added. Quantitative accuracy is 10 due to correct use of years and absence of numerical errors. Qualitative accuracy is 7 due to partial fidelity in reasoning and entity relevance. Contextual relevance is 9 because the response stays focused on the evolution of time-definite services, even if not fully complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 543,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "In the 2022 annual filing, the 2.50% Notes maturing in April 2026 were referenced in the Thirteenth Supplemental Indenture dated April 20, 2016, as part of the indenture framework between Lowe's Companies, Inc. and U.S. Bank National Association. In the 2023 annual filing, the 2026 notes were not modified in terms of their structure or maturity date, but they were included in the Twenty-Second Supplemental Indenture dated March 30, 2023, which added new notes and updated the indenture with U.S. Bank Trust Company, National Association as the successor trustee. Thus, the treatment of the 2.50% Notes remained consistent, but the trustee was updated in 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but diverges significantly from the ground truth in key aspects of reasoning and factual synthesis. (1) Quantitatively, the dates (April 20, 2016, and March 30, 2023), interest rate (2.50%), and maturity (April 2026) are accurate, and the trustee update is plausible, earning high marks for numerical and date accuracy. (2) However, the core evolution described in the original answer—a shift from historical/reference treatment in 2022 to active recognition as issued debt in 2023—is not captured. Instead, the LLM claims the 2026 notes were included in the Twenty-Second Supplemental Indenture in 2023, which contradicts the ground truth that they were already documented under the Thirteenth Supplemental Indenture and not re-issued. This reflects a failure in multi-hop reasoning: the model incorrectly infers administrative activity (new indenture, trustee change) as altering the treatment of the 2026 notes, when the actual evolution was in disclosure emphasis, not legal or structural changes. (3) The entity identification (Lowe's, U.S. Bank, indenture dates) is mostly correct, but the reasoning misattributes the significance of the 2023 filing update. (4) While contextually relevant and addressing the question's focus on treatment evolution, the answer misrepresents the nature of that evolution, leading to a moderate correctness score due to partial factual alignment but significant conceptual inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 403,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "The impact of sovereign debt crises on Costco's merchandise sourcing and cost structure from 2022 to 2024 remained relatively consistent, with both years highlighting the potential for such crises to affect demand for products, require changes in product mix, and influence the cost of purchasing inventory. In 2022, the 10-K noted that sovereign debt crises could impact the cost of or ability to purchase inventory, particularly due to trade-related actions and tariffs. By 2024, the 10-K reiterated similar concerns, emphasizing that sovereign debt crises could still affect demand and inventory costs, though with a slight increase in international operations (from 27% to 28% of net sales) that could amplify exposure to these risks.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses a critical evolution in tone and severity between 2022 and 2024. In 2022, sovereign debt crises were described as part of a broader set of macroeconomic risks that 'could' adversely affect Costco, while in 2024, the language escalated to explicitly state they 'negatively impact' the business, financial condition, and operations. This shift from potential to actual negative impact is a key factual difference that the LLM answer fails to capture, instead claiming the impact 'remained relatively consistent,' which contradicts the ground truth. (2) The quantitative claim about international operations increasing from 27% to 28% of net sales is not present in the original answer and cannot be verified from the provided ground truth; however, no incorrect numbers are used in isolation (e.g., no wrong dates or fabricated dollar amounts), so quantitative accuracy is moderately high. (3) The multi-hop reasoning is flawed: the model fails to synthesize the escalation in risk characterization over time and omits the 2024 emphasis on broader supply chain risks (supplier standards, supply constraints, geopolitical instability) that link sovereign debt crises to sourcing and cost predictability. Instead, it downplays the change and introduces an unsupported detail about international sales. (4) While the answer addresses the general topic of sourcing and cost structure, it misrepresents the evolution of risk, leading to a low correctness and qualitative accuracy score. Contextual relevance is acceptable because it stays on topic and references relevant aspects of the 10-K disclosures, but it lacks precision in conveying the changing risk posture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 471,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "The number of shares available for future grants under the 2020 Stock Incentive Plan decreased from 64 million in 2021 to 53 million in 2023. This reduction indicates that UnitedHealth Group has issued share-based awards over this period, which diminishes the pool of shares available for future grants. However, the company still maintains a substantial capacity to issue new share-based awards, suggesting continued commitment to equity compensation for employees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the number of shares available for future grants in 2021 (64 million) and 2023 (53 million), matching the ground truth exactly. The decrease of 11 million shares is accurately implied. (2) All numeric values and years are correct, with no calculation or formatting errors. (3) The multi-hop reasoning is sound: the model correctly infers that the reduction in available shares indicates issuance of awards over time, which aligns with the underlying logic in the original answer. It adds a reasonable interpretation that the company still has substantial capacity for future awards, which is contextually valid given that 53 million shares remain—this does not contradict the original answer but adds nuance. (4) The only reason for not scoring a 10 is that the original answer does not include the 'substantial capacity' or 'continued commitment' interpretation, so while reasonable, it slightly extends beyond the provided ground truth. However, this addition is not factually incorrect and enhances context, so the answer remains highly accurate. All parts of the question are addressed: the change in shares and its implication on future award capacity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 339,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "Between 2022 and 2024, the expiration date of the IAM National Pension Fund / National Pension Plan relationship with UPS was extended from July 31, 2024, to July 31, 2029, following the ratification of a new National Master Agreement in July 2024. Additionally, in 2024, UPS reached an agreement to withdraw from the District 9 IAM Pension Trust, transferring impacted employees to the UPS Pension Plan and recording a $19 million withdrawal liability. Contributions to the IAM National Pension Fund / National Pension Plan increased from $48 million in 2022 to $53 million in 2024, reflecting ongoing obligations under the extended collective bargaining agreement.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly identifies the extension of the expiration date from July 31, 2024, to July 31, 2029, which aligns with the ground truth, it introduces incorrect details not present in the original answer. Specifically, the claim that UPS reached an agreement to withdraw from the District 9 IAM Pension Trust and recorded a $19 million withdrawal liability is not mentioned in the ground truth and appears to be extraneous or misattributed information. Additionally, the LLM states that contributions increased from $48 million in 2022 to $53 million in 2024, but the original answer does not provide specific dollar amounts—only that UPS contributed more than 5% of total plan contributions for 2019–2021 and continued to do so for 2022–2024. These specific dollar figures ($48M, $53M) are unsupported by the ground truth and thus factually incorrect. (2) The dates (July 31, 2024, and July 31, 2029) are accurate and correctly reflect the extension. However, the financial figures and the withdrawal liability are not corroborated by the original answer and appear to be hallucinated or drawn from unrelated data. (3) The multi-hop reasoning is partially sound—the model correctly infers a continuation of UPS's significant contribution and the extension of the agreement—but it fails to accurately represent the nature of the contribution significance (percentage-based, not absolute dollar amounts) and introduces irrelevant details about another pension trust. (4) The correctness score is 4 due to major quantitative inaccuracies despite some correct high-level trends. Quantitative accuracy is low (3) because of unsupported dollar figures. Qualitative accuracy is moderate (5) as the core idea of extension and ongoing significance is correct, but with flawed supporting details. Contextual relevance is 7 because the answer addresses the evolution of the relationship, though with extraneous information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 535,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "Between fiscal years 2022 and 2023, the terms and availability under LOW's 2020 Credit Agreement evolved as follows: In September 2023, the 2020 Credit Agreement was amended and restated to extend its term from March 2025 to September 2028. Additionally, the combined availability under the Credit Agreements (including the Third Amended and Restated Credit Agreement) remained at $4.0 billion as of February 2, 2024. No borrowings were outstanding under the 2020 Credit Agreement during this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in terms: the 2020 Credit Agreement was amended and restated in September 2023, extending the maturity from March 2025 to September 2028, and maintains the $2.0 billion availability under the new 2023 Credit Agreement. It also correctly states that the combined availability under all credit agreements remained at $4.0 billion. However, the LLM omits explicit mention that the $2.0 billion availability was unchanged from 2022 to 2023 under the 2020/2023 Credit Agreement, instead focusing on the combined $4.0 billion figure. The statement about no borrowings being outstanding is factually accurate but not part of the original question or ground truth, making it extraneous but not incorrect. (2) Quantitatively, all numbers and dates are correct: September 2023 amendment, March 2025 to September 2028 extension, and $4.0 billion combined availability. The $2.0 billion individual facility amount is implied but not explicitly restated in the LLM answer, which may reduce completeness. (3) The multi-hop reasoning is sound—LLM correctly links the amendment of the 2020 agreement into the 2023 version and recognizes continuity in availability. However, it does not fully synthesize that the $2.0 billion was maintained *specifically under the amended agreement*, relying instead on the combined total. (4) The answer is highly relevant and conveys most of the ground truth information with accurate terminology and context. The minor omission of explicitly confirming the $2.0 billion carryover from 2022 to 2023 under the 2020/2023 Credit Agreement prevents a perfect score, but core facts and synthesis are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 461,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "MDLZ's notional amounts for Net Investment Hedge (NIH) derivative contracts increased significantly between 2022 and 2024. As of December 31, 2022, the aggregate notional value of NIH derivative contracts was $7.5 billion, rising to $8.6 billion by December 31, 2024. This reflects a growth of $1.1 billion over the two-year period, indicating an expanded use of these contracts to hedge against exchange rate movements for non-U.S. operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and dates. According to the ground truth, the notional amounts reported in the 2022 filing were for December 31, 2021 ($3,915 million) and December 31, 2020 ($4,551 million), not December 31, 2022. The LLM incorrectly states a value of $7.5 billion as of December 31, 2022, which contradicts the ground truth. The correct 2023 and 2024 figures are $7,456 million and $8,647 million, respectively—close to the LLM's $7.5B and $8.6B, but still inaccurate. (2) The calculation of a $1.1 billion increase is approximately correct (actual: $8,647M - $7,456M = $1,191M), but the starting point is wrong. The LLM uses 2022–2024 growth, while the ground truth shows data from 2023–2024, with earlier years reported retrospectively in the 2022 filing. (3) The multi-hop reasoning is partially sound—the model recognizes a trend of increasing notional amounts and links it to hedging non-U.S. operations—but fails to correctly interpret the reporting lags (i.e., 2022 filing reports prior years' data). It misattributes the timeline, suggesting direct 2022–2024 evolution when the data points are not directly comparable due to reporting delays. (4) Scores reflect major quantitative errors (especially misstated years and figures), partial qualitative accuracy in identifying the trend, and high contextual relevance as the overall theme (increased use of NIH contracts) is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 402,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "Between 2022 and 2024, Microsoft 365's integration with AI technologies evolved significantly, transitioning from AI-backed tools to becoming an \"AI first platform.\" In 2024, Microsoft introduced **Copilot for Microsoft 365**, which combines AI with business data in the Microsoft Graph and Microsoft 365 applications to enhance productivity and collaboration. Specific new capabilities in 2024 included **role-based Copilots** (e.g., Copilot for Sales, Copilot for Service, and Copilot for Finance), which provide role-specific insights and workflow assistance, and **Copilot Pro**, a consumer subscription service offering faster and more powerful AI assistance in Microsoft 365 apps and on the web. These advancements aim to streamline business processes and deliver insights more efficiently.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Microsoft 365 evolved into an 'AI first platform' by 2024, and Copilot for Microsoft 365 was introduced, combining AI with Microsoft Graph and M365 apps. Role-specific Copilots (Sales, Service, Finance) are correctly identified. (2) There are no numeric values requiring verification (e.g., dates like 2022 and 2024 are correct and consistent with the original answer), so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—correctly synthesizing the evolution from 2022's AI-backed tools to 2024's AI-first platform with new capabilities. The only minor addition not present in the ground truth is 'Copilot Pro,' which, while a real product, is not mentioned in the original answer and pertains more to consumer offerings than enterprise productivity and collaboration as emphasized in the question. This does not introduce inaccuracy but adds slight over-specificity. (4) The answer is contextually excellent, directly addressing both the evolution and the 2024 capabilities. The semantic meaning matches the original answer, with slightly enhanced detail. Thus, correctness is 9/10 due to the minor addition of Copilot Pro, which doesn't contradict but extends beyond the provided truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 365,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "Between 2022 and 2024, 3M's approach to PFAS discharge characterization in its wastewater permits at the Decatur, Alabama facility evolved from acknowledging incomplete characterization and taking corrective actions to formalizing obligations under a regulatory agreement. In 2022, 3M disclosed that its NPDES permit for the Decatur facility did not fully characterize PFAS discharges and had submitted an application to add additional PFAS to the permit, while also implementing wastewater treatment controls. By 2024, 3M and the Alabama Department of Environmental Management (ADEM) had agreed to an interim Consent Order, which required 3M to provide reports, perform analytical studies, and make capital improvements to address PFAS discharges and emissions. This reflects a shift from voluntary corrective measures to a structured, regulatory framework for ongoing compliance and remediation.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of 3M's approach to PFAS discharge characterization at the Decatur facility between 2022 and 2024 and correctly identifies key elements such as the 2022 disclosure of incomplete characterization, the permit modification application to ADEM, and implementation of wastewater treatment controls. However, there is a significant factual discrepancy in the 2024 portion: the LLM claims that by 2024, 3M and ADEM had entered into an 'interim Consent Order' requiring reports, studies, and capital improvements. This is not supported by the ground truth, which states that ADEM had not yet acted on the permit modification request. Instead, 3M was independently installing and optimizing treatment controls. The introduction of a 'Consent Order' implies a regulatory enforcement or agreement outcome that is not present in the original answer, representing a major qualitative error. While the timeline (2022–2024) and entities (3M, ADEM, Decatur facility, NPDES permit) are accurate, and the shift from identification to action is correctly framed, the incorrect portrayal of regulatory action undermines the reasoning. The answer is contextually relevant and well-structured, but the core 2024 update is factually misaligned, leading to a partial correctness score. Quantitative accuracy is high as there are no numerical claims requiring verification, and the years are correctly used.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 393,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "Lowe's Companies, Inc. issued the 4.550% Notes as part of the Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049. Between 2022 and 2023, there were no changes or additional issuances related to these specific 4.550% Notes, as the subsequent supplemental indentures in 2022 and 2023 involved different note offerings with distinct coupon rates and maturity dates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes were issued under the Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049. It correctly states that between 2022 and 2023, there were no changes or new issuances related to this specific note. (2) Quantitative elements—dates (April 5, 2019, and April 5, 2049) and coupon rate (4.550%)—are accurate and match the original answer exactly. (3) The reasoning is sound: it correctly infers that subsequent supplemental indentures in 2022 and 2023 did not affect this particular note, which demonstrates proper multi-hop synthesis across time and documents. (4) The only minor shortcoming is that the original answer explicitly mentions that the same indenture was referenced in both years, reinforcing continuity, while the LLM implies it by stating no changes occurred. This slight omission in narrative completeness prevents a perfect 10, but the semantic meaning and factual core are equivalent. Overall, the response is highly relevant, precise, and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 320,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "Between 2022 and 2024, MDLZ's financial relationship with KDP evolved significantly in terms of gains recognized from changes in accounting for the investment. In 2022, MDLZ's ownership in KDP was above 5%, and it was accounted for under the equity method. However, in the first quarter of 2023, MDLZ's ownership in KDP fell below 5%, prompting a change in accounting to treat the investment as a marketable security with readily determinable fair value. This change resulted in a pre-tax gain of $493 million in 2023. Subsequently, MDLZ sold the remainder of its KDP shares in 2023, generating total proceeds of $2.4 billion and recognizing a total pre-tax gain of $593 million on the marketable securities sold during the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in timing and magnitude of gains. The ground truth states that the $493 million pre-tax gain ($368 million after-tax) was recorded in 2024, not in 2023 as claimed by the LLM. Additionally, the LLM introduces a total pre-tax gain of $593 million from marketable securities sold in 2023, which is not mentioned in the original answer and contradicts the timeline. The 2022 gain of $71 million (pre-tax) is correctly identified in the original but omitted entirely in the LLM response. (2) Quantitative accuracy is low: the LLM misplaces the $493 million gain in 2023 instead of 2024, adds an unsupported $593 million total gain not in the original, and fails to report the 2022 gain. The $2.4 billion in proceeds is plausible but not verifiable from the original answer and distracts from the core question about gains from accounting changes. (3) The qualitative reasoning partially captures the multi-hop concept—change in ownership triggering a change in accounting treatment—but incorrectly frames the entire gain as realized through sale, whereas the original emphasizes a change in accounting method (from equity method to fair value) leading to the $493 million gain. The LLM conflates the accounting change gain with subsequent sale gains, which is not supported by the ground truth. (4) Contextual relevance is high because the answer addresses the evolution of MDLZ's relationship with KDP and focuses on gains from accounting changes, but the factual errors undermine correctness. The structure and intent align with the question, but the details are significantly off.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 454,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "Between 2022 and 2024, the scale and positioning of Xbox Game Pass have significantly evolved. In 2022, Xbox Game Pass was described as a subscription service with access to a curated library of over 100 first- and third-party console and PC titles. By 2024, the service had expanded to include a library of over 400 titles, reflecting Microsoft's strategic emphasis on growing its gaming ecosystem and attracting a broader user base through diverse content, community engagement, and cloud gaming capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Xbox Game Pass had over 100 titles in 2022 and over 400 in 2024, matching the ground truth exactly. These numbers are critical and accurately reported. (2) All quantitative elements—'over 100' and 'over 400' titles—are factually correct and consistent with the original answer. No calculations were required, but the comparison in scale is accurately conveyed. (3) The reasoning is sound: the LLM correctly infers a significant expansion in scale and links it to Microsoft's strategic goals, including ecosystem growth, community engagement, and cloud gaming. While the original answer explicitly calls Xbox Game Pass the 'cornerstone' of Microsoft's gaming platform, the LLM captures the same strategic elevation using equivalent phrasing like 'growing its gaming ecosystem' and 'attracting a broader user base.' (4) The answer is contextually complete and relevant, addressing both the quantitative evolution and strategic repositioning. The only minor shortcoming is the slightly less precise characterization of strategic emphasis compared to the original's use of 'cornerstone,' which represents a small loss in qualitative precision. However, the core meaning is preserved, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 353,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "The structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan has not shown significant changes from 2022 to 2024. In both years, the agreements are disclosed as part of the equity compensation plans approved by security holders, with details provided under the \"Non-employee director deferred stock units\" category in the equity compensation plans information. The 2022 filing (MMM_10k_2022.pdf) and the 2024 filing (MMM_10k_2024.pdf) both reference the form of Deferred Stock Unit Award Agreement for deferred stock units granted to non-employee directors under the 2016 plan, with no indication of substantive amendments to the structure or terms of these agreements during the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately states that there were no significant changes in the structure or disclosure of the Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan from 2022 to 2024. It correctly identifies that both the 2022 and 2024 filings reference the same agreement form and that no substantive amendments were indicated, which matches the ground truth assertion of no change in effective date or structure. The quantitative accuracy is perfect: no incorrect dates, numbers, or entities are cited. The entity accuracy is strong—3M Company, 2016 Long-Term Incentive Plan, non-employee directors, and correct filing years (2022 and 2024) are all properly identified. However, the LLM answer omits a key detail present in the original answer: the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the plan was maintained through amendments as of May 8, 2023. This reflects a minor gap in completeness and qualitative depth, particularly in multi-hop reasoning—while the LLM correctly infers no structural change, it does not acknowledge the procedural update in disclosure linkage, which is part of the evolution in *how* the agreement is referenced. Despite this omission, the core facts and reasoning are sound, and the answer remains contextually relevant and factually accurate on the main point of structural continuity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 409,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "Between 2023 and 2024, the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio showed a slight decline in origination costs, with direct origination costs decreasing from $100 million in 2023 to $112 million in 2024. Additionally, the geographic concentration in California decreased marginally, from 43% in 2023 to 42% in 2024, while maintaining consistent performance with the overall portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in describing the trend of origination costs. It states that 'origination costs decreased from $100 million in 2023 to $112 million in 2024', which is logically and factually incorrect—$112 million is an increase, not a decrease. This misrepresents the direction of change, a key part of the question. The California concentration correctly notes a drop from 43% to 42%, which is accurate. (2) Quantitatively, the dollar amounts ($100M in 2023, $112M in 2024) and percentages (43% to 42%) are correctly cited, but the interpretation of the cost change is wrong, leading to a significant deduction in quantitative accuracy. No actual calculation is required beyond correct directional comparison, which the model fails. (3) The multi-hop reasoning is partially sound—the model identifies both time points and both metrics (costs and geographic concentration) and attempts to compare them. However, the flawed logic in interpreting an increase as a decrease undermines the reasoning. The mention of 'consistent performance' is not supported by the original answer and introduces unverified information. (4) Contextual relevance is high because the answer addresses both parts of the question (origination costs and California concentration) and focuses on the correct portfolio and time frame. However, due to the major error in interpreting the cost trend, the correctness and quantitative accuracy scores are low. A score of 4 reflects partial credit for correct numbers but significant error in interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 432,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Based on the language in the product research and development sections of Nike's 10-K filings, Nike's strategic emphasis on Dri-FIT technology between fiscal 2023 and fiscal 2024 appears to have remained consistent, with a continued focus on leveraging the technology across product categories to meet consumer preferences. Both years highlight the proliferation of Dri-FIT technology as part of Nike's dedication to innovation and designing products that enhance performance and comfort. There is no explicit indication of a shift in strategic emphasis during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that Nike's strategic emphasis on Dri-FIT technology remained consistent between fiscal 2023 and 2024, which aligns with the ground truth. It accurately reflects that Dri-FIT was part of Nike’s ongoing innovation strategy in both years, with no shift in emphasis. The answer correctly identifies the continuity in language and strategic focus, though it does not explicitly state that the *exact same language* was used in both 10-K filings, which is a minor omission from the original answer. However, this does not affect the core factual correctness. There are no numerical values to verify, so quantitative accuracy is scored as 10. The qualitative reasoning is sound, correctly synthesizing the information across the two fiscal years and interpreting the lack of textual change as stability in strategy. Contextual relevance is strong, as the response directly addresses the evolution (or lack thereof) in strategic emphasis. The answer is semantically equivalent to the ground truth, with only slight differences in specificity regarding verbatim repetition of text.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 313,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "Mondelez International has enhanced its investment in backup and disaster recovery from 2022 to 2024 in response to increasing cybersecurity threats. In 2022, the company emphasized dedicating focused resources to network security, backup, and disaster recovery, along with workforce training and threat monitoring. By 2024, Mondelez further augmented its cybersecurity program with advanced measures such as enhanced identity and access management, multi-factor authentication, privileged access management, and 24/7 security operations to monitor and detect threats. These developments reflect a more robust and proactive approach to cybersecurity and business continuity in response to the evolving threat landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Mondelez International's investment in backup and disaster recovery from 2022 to 2024. (1) The key facts are accurate: in 2022, Mondelez dedicated focused resources to backup and disaster recovery amid heightened cybersecurity threats, and by 2024, it expanded its efforts as part of a broader cybersecurity program. The dates (2022 and 2024) and company (Mondelez International) are correctly identified. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time points and infers increased investment over time in response to evolving threats. However, the LLM adds specific cybersecurity measures (e.g., identity and access management, multi-factor authentication, 24/7 security operations) that, while plausible, are not mentioned in the original answer. The ground truth emphasizes 'enhanced backup and disaster recovery solutions' and threats from state-sponsored actors and AI, which the LLM omits. These omissions and additions slightly reduce qualitative accuracy. (4) Despite these nuances, the answer remains contextually relevant and captures the core progression and intent of the original response. The semantic meaning is sufficiently equivalent, warranting a high correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 408,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "Microsoft's financial commitment and engagement with Black and African American-owned suppliers significantly evolved from fiscal year 2022 to fiscal year 2024. In fiscal year 2022, the company reported reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft achieved its full goal, spending $500 million with double the number of Black- and African American-owned suppliers. Additionally, in 2024, the company provided 162 low- or no-interest loans to small to medium-sized partners, further demonstrating its deepened commitment to supporting these suppliers.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that in FY2022, Microsoft reached more than 90% of its $500 million goal with double the number of Black and African American-owned suppliers, and that by FY2024 it achieved the $500 million goal. These key financial figures and milestones are accurate. However, the LLM introduces new information not present in the ground truth: '162 low- or no-interest loans to small to medium-sized partners'—this detail is absent from the original answer and cannot be verified against the knowledge graph, making it a factual addition unsupported by the source. (2) Quantitatively, the $500 million figure and the 90% progress in FY2022 are correctly reported. The achievement of the full $500 million in FY2024 is also correct. However, the absence of the $150 million allocation to Minority Depository Institutions and funds supporting Black and African American-owned small businesses—a key expansion of commitment in FY2024 per the original answer—represents a significant omission. This weakens the completeness and accuracy of the financial evolution narrative. (3) The multi-hop reasoning is partially sound: the model correctly tracks progress toward the $500M goal across years and infers deepening commitment. However, it fails to synthesize the critical new $150M investment, which represents a strategic evolution beyond the initial goal. Instead, it substitutes with unverified loan data, indicating a potential hallucination or misattribution. (4) The contextual relevance is high—the response directly addresses the evolution of Microsoft’s supplier engagement. The qualitative accuracy is reduced due to the omission of a major financial commitment and the introduction of unsupported details. The correctness score is 7 because core financial facts are accurate, but significant strategic developments are missing or replaced, affecting completeness and fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 518,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "The availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees decreased from 10,638,639 shares as of December 31, 2021, to 8,565,087 shares as of December 31, 2023. This reduction suggests that Abbott has been utilizing shares under the plan for employee purchases over the period, reflecting an active stock-based incentive strategy to engage and reward non-U.S. employees through discounted stock purchases.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the two key figures—10,638,639 shares available as of December 31, 2021, and 8,565,087 as of December 31, 2023—matching the ground truth exactly. The dates are accurately tied to the respective reporting years (2022 and 2023 filings), and the reduction in available shares is correctly noted. (2) All numeric values and dates are factually accurate, with no calculation or formatting errors. The difference of 2,073,552 shares is implied and correct. (3) The multi-hop reasoning is sound in identifying the change over time and linking it to employee stock purchase activity. However, the interpretation diverges from the ground truth: while the LLM frames the reduction as evidence of an 'active' incentive strategy (i.e., ongoing utilization), the original answer interprets it as a 'tightening or adjustment,' suggesting a more conservative or strategic reduction. This difference in qualitative inference affects the conclusion about Abbott’s strategic intent. (4) The answer is highly relevant and factually precise, but the qualitative interpretation lacks neutrality and introduces a potentially optimistic spin not present in the ground truth, which only notes a reduction without asserting increased activity. Thus, while quantitatively perfect, the reasoning score is reduced due to partial misalignment in strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 386,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike's treatment of Nike Air technology remained consistent as a core innovation within its product development strategy. The 2023 and 2024 filings both highlight Nike Air as one of the key technologies that exemplify Nike's dedication to innovation, used across footwear and incorporated into product designs to enhance performance and consumer experience. There is no indication of a strategic shift in the use or emphasis of Nike Air technology during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that there was no strategic shift in Nike Air's treatment between fiscal 2023 and 2024. The ground truth clearly indicates a shift in how Nike Air was positioned — from being highlighted as part of innovative product design in 2023 to being grouped with mature technologies like Zoom, Free, and React in 2024, signaling its transition to a foundational, integrated component rather than a distinct innovation driver. The LLM fails to capture this evolution and instead claims consistency, which contradicts the evidence. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the absence of numbers does not affect scoring, and the response does not introduce any incorrect figures, hence a score of 10. (3) The multi-hop reasoning is flawed: the task required synthesizing the change in narrative tone and categorization of Nike Air across two fiscal years. The LLM correctly identifies that Nike Air was mentioned in both years as a key technology but fails to recognize the contextual shift in its classification — from innovative offering to mature, embedded technology — which is central to the correct interpretation. This represents a failure in qualitative reasoning and synthesis. (4) Contextual relevance is moderate: the answer discusses Nike Air in the context of product development and cites both years, so it is on-topic, but it misses the core nuance of strategic evolution, leading to a misleading conclusion. Thus, while relevant, it lacks critical insight.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 438,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "Between 2022 and 2023, Abbott has emphasized Osmolite as a key component of its enteral feeding portfolio within the Nutritional Products segment. In both years, Osmolite is listed among the primary enteral feeding products, but in 2023, there is a more explicit focus on its role in healthcare institutions, suggesting a strategic effort to strengthen its positioning in clinical settings. This aligns with broader initiatives to enhance the enteral feeding portfolio through product innovation and market expansion.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces unsupported claims that deviate from the ground truth. (1) Correct elements: Osmolite is accurately identified as part of Abbott's enteral feeding portfolio in both 2022 and 2023, and the context of healthcare institutions is correctly mentioned. There are no numerical inaccuracies, so quantitative accuracy is high. (2) However, the LLM incorrectly asserts a 'more explicit focus' and 'strategic effort to strengthen its positioning in clinical settings' in 2023, which is not supported by the original answer. The ground truth states that Abbott's product listing remained 'largely consistent' with no indication of repositioning, innovation, or market expansion specific to Osmolite. (3) The multi-hop reasoning fails because the model infers strategic intent (e.g., 'effort to strengthen') not present in the data, despite having the correct entities and timeframes. (4) Contextual relevance is strong as the answer addresses enteral feeding, institutional use, and product strategy, but qualitative accuracy is reduced due to speculative interpretation. Thus, the correctness score is moderate—core facts are right, but key strategic claims are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 339,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "Between 2022 and 2024, 3M's regulatory engagement and remediation obligations related to PFAS discharge in Minnesota and Alabama have evolved significantly, reflecting increased scrutiny and regulatory action. In Minnesota, 3M continues to work with the Minnesota Pollution Control Agency (MPCA) under the 2007 Settlement Agreement and Consent Order to address PFAS contamination at its Cottage Grove facility and former disposal sites in Washington County. In 2024, the MPCA issued a revised draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for PFAS, which could impact the facility's operations. Additionally, 3M received a Notice of Violation in March 2023 for PFAS discharge at its Hutchinson facility and is addressing stormwater discharge concerns at Cottage Grove.\n\nIn Alabama, 3M entered into a voluntary remedial action agreement with the Alabama Department of Environmental Management (ADEM) to remediate PFAS contamination at its Decatur facility. In 2020, 3M and ADEM agreed to an interim Consent Order to address all PFAS-related wastewater discharges and air emissions from the Decatur facility, which includes commitments for ongoing site operations and remediation activities. In 2024, 3M continued to work with ADEM and the EPA to address compliance issues, including submitting applications to modify its NPDES permit to include additional PFAS and implementing wastewater treatment controls. These developments indicate a continued focus on compliance and remediation, with increasing regulatory pressure and operational adjustments to meet evolving standards.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of 3M's regulatory engagement and remediation obligations related to PFAS in Minnesota and Alabama between 2022 and 2024, with mostly accurate facts and good contextual framing. However, there are some discrepancies and omissions compared to the ground truth. Quantitatively, the LLM correctly references key dates such as the 2007 Settlement Agreement, the 2020 Interim Consent Order with ADEM, and the 2024 draft permit developments. It also accurately notes increased regulatory scrutiny by 2024. However, it introduces a 'Notice of Violation in March 2023 for PFAS discharge at its Hutchinson facility'—a detail not present in the original answer and unsupported by the provided ground truth, which could mislead. This is a factual overreach. Additionally, the LLM mentions a 'voluntary remedial action agreement' in Alabama, whereas the ground truth specifies only the July 2020 Interim Consent Order remaining in effect, with no mention of a new voluntary agreement. This misrepresents the nature of the regulatory obligation. The LLM correctly notes ongoing work with ADEM and EPA in 2024 and efforts like NPDES permit modifications and wastewater treatment controls, which align with the original answer’s mention of expected additional operating costs and capital expenditures. The original answer includes more precise regulatory developments, such as the December 2024 revised draft permit after stakeholder input and updated HBVs from MDH in January 2024 and proposed HRLs in October 2024—details missing in the LLM response. These omissions reduce completeness and qualitative accuracy. The multi-hop reasoning is generally sound, connecting past agreements to evolving standards, but the addition of unverified details (Hutchinson NOV, voluntary agreement) undermines full factual reliability. Wording and structure are clear and contextually relevant, effectively addressing the question's scope. Overall, the answer is substantially correct but contains notable inaccuracies and missing nuances that prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1783,
        "completion_tokens": 556,
        "total_tokens": 2340
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "Between 2022 and 2024, The Coca-Cola Company's investment in Coca-Cola HBC AG remained classified as an equity method investment. As of December 31, 2024, The Coca-Cola Company owned a 22% stake in Coca-Cola HBC AG, with a carrying value of $1,147 million. The fair value of Coca-Cola HBC AG's shares, based on quoted market prices, was $2,675 million as of the same date, resulting in a difference of $1,528 million between fair value and carrying value. There is no indication of impairment or changes in classification for this investment during the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Coca-Cola's investment in Coca-Cola HBC AG remained under the equity method from 2022 to 2024 and accurately states the 22% ownership stake as of December 31, 2024, which aligns with the ground truth. However, the ground truth does not mention the carrying value ($1,147 million), fair value ($2,675 million), or the difference ($1,528 million) — these figures are absent from the original answer and were likely pulled from external data not referenced in the provided evidence. Since the question is based solely on the knowledge graph evidence, including unverified financial figures reduces factual accuracy. (2) While the 22% stake is correct and properly dated, the additional quantitative details are not supported by the original answer, making the quantitative accuracy score lower despite correct formatting. There is no indication in the ground truth about fair value, carrying value, or impairment, so their inclusion introduces unsupported information. (3) The multi-hop reasoning is sound in recognizing the continuity of equity method accounting and the evolution of stake disclosure from unspecified (2022) to explicit (2024). The LLM correctly synthesizes the classification stability and increased transparency in ownership percentage. However, it goes beyond the evidence by introducing valuation metrics not present in the original answer, which reflects a failure in information filtering. (4) The contextual relevance is perfect — the answer directly addresses the evolution of the financial relationship, investment classification, and stake percentage. The qualitative reasoning is strong, but the inclusion of unsupported numbers prevents a higher correctness and quantitative score. A score of 7 reflects accurate core facts with significant but non-central additions of unverified data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 504,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Oracle's strategic emphasis on hybrid deployments between fiscal 2022 and fiscal 2024 has shown a continued focus on providing customers with flexible deployment options, particularly through Oracle Cloud@Customer. In fiscal 2022, Oracle highlighted its commitment to hybrid models as a key component of its growth strategy, emphasizing interoperability and customer choice. By fiscal 2024, this emphasis remained strong, with Oracle continuing to invest in hybrid deployment integration, such as enabling customers to deploy Oracle Cloud in their own data centers. In terms of product development investment, Oracle increased its research and development spending, which rose from $7.2 billion in fiscal 2022 to $10.5 billion in fiscal 2024, reflecting ongoing innovation in hybrid and cloud-based technologies. This evolution underscores Oracle's strategy to support customer transitions to cloud environments while maintaining compatibility with existing on-premise systems.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's strategic focus on hybrid deployments, particularly through Oracle Cloud@Customer, and accurately notes the emphasis on interoperability, customer choice, and integration with on-premise systems. However, a critical factual error undermines the quantitative foundation: while the ground truth states R&D investment was $7.2 billion in fiscal 2022, the LLM claims it increased to $10.5 billion in fiscal 2024 — this figure is not supported by the ground truth, which does not provide a 2024 R&D number. This unsupported extrapolation constitutes a major quantitative inaccuracy. (2) The $7.2 billion figure for fiscal 2022 is correct and matches the original answer, but the $10.5 billion for fiscal 2024 is fabricated or misattributed, as no such number appears in the ground truth. There is no indication in the original answer that R&D spending increased to that level, so the calculation or reporting is invalid. (3) The qualitative reasoning is sound in describing the evolution from development focus to integrated deployment model, and the multi-hop synthesis across fiscal years and strategic themes is generally appropriate. The LLM captures the essence of Oracle’s strategic continuity and maturation in hybrid offerings. (4) Contextual relevance is high, as the response directly addresses both product development investment and deployment model integration. However, due to the significant error in the R&D spending figure for fiscal 2024, the correctness score is reduced to 6 — partially correct but with a major factual flaw. Quantitative accuracy is low (4) due to the unsupported number, qualitative accuracy is solid (7) for correct reasoning and entity identification, and contextual relevance is strong (9) as all aspects of the question are addressed appropriately except for the erroneous data point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 509,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "The filing status of the Wells Fargo & Company Mandatory Clawback Policy was first disclosed as effective as of October 2, 2023, in the 2023 SEC 10-K (Exhibit 97). In the 2024 SEC 10-K, the policy remains referenced under Exhibit 97, indicating no change in its effective date or filing status, suggesting it was carried forward without material amendments.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the Mandatory Clawback Policy was included in the 2023 10-K as Exhibit 97 and referenced again in the 2024 10-K under the same exhibit number, which aligns with the ground truth. The effective date of October 2, 2023, is factually accurate and consistent with known disclosures. However, the LLM mischaracterizes the nature of the change in filing status. The ground truth states that in 2024, the policy was 'incorporated by reference' from the prior year rather than filed directly, indicating a procedural shift. The LLM interprets this as 'no change in filing status' and 'carried forward without material amendments,' which misses the key procedural evolution explicitly highlighted in the original answer. (2) Quantitatively, all dates and exhibit numbers are correct (Exhibit 97, October 2, 2023), and no numerical calculations are required. (3) The multi-hop reasoning is partially sound—information is synthesized across two years of filings—but the conclusion drawn about the lack of change in 'filing status' contradicts the ground truth, which emphasizes a shift from direct filing to incorporation by reference. This reflects a failure to accurately interpret the regulatory disclosure mechanism change. (4) While the answer is contextually relevant and includes accurate entities (Wells Fargo & Company, SEC 10-K, Exhibit 97, correct years), it omits the critical distinction in disclosure method, leading to a misleading conclusion about continuity. Hence, correctness is reduced due to this qualitative inaccuracy despite strong factual grounding in other aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 446,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher Scientific acquired CorEvitas, LLC in August 2023 as part of its Laboratory Products and Biopharma Services segment, paying $910 million in cash and debt settled. This acquisition expanded the segment's portfolio by adding real-world evidence solutions to enhance drug development processes. The financial implications included a significant use of cash in 2023, with $0.91 billion allocated to the acquisition, contributing to the $5.14 billion net cash used in investing activities for that year. The acquisition also added $627 million in goodwill, which is not tax deductible, and intangible assets with weighted-average amortization periods of 17 years.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the acquisition of CorEvitas, LLC by Thermo Fisher in 2023 for $0.91 billion (stated as $910 million), which matches the ground truth. It accurately notes the integration into the Laboratory Products and Biopharma Services segment and the strategic rationale involving real-world evidence for drug development. However, the LLM states the acquisition occurred in 'August 2023,' which is more specific than the ground truth and not verifiable from the provided information, introducing a potential inaccuracy. Additionally, the LLM mentions 'debt settled' as part of the payment, which is not mentioned in the ground truth. The goodwill amount of $627 million and the 17-year amortization period are not present in the ground truth; instead, the ground truth specifies a weighted average amortization period of 18 years. These numerical discrepancies affect quantitative accuracy. (2) The $0.91 billion acquisition cost is correctly reported (equivalent to $910 million). However, the $627 million goodwill and 17-year amortization are specific figures not found in the ground truth and contradict the stated 18-year period, indicating either a data mismatch or incorrect synthesis. The net cash used in investing activities of $5.14 billion is not mentioned in the ground truth, though the broader context of capital expenditures and financing (e.g., $5.94 billion in notes issued) is partially aligned. (3) The multi-hop reasoning is strong: the LLM connects the acquisition to segment integration, financial outflows, and accounting treatment of intangibles and goodwill. It synthesizes investment activity with broader financial strategy, though some added details (e.g., debt settlement, exact goodwill) appear to be hallucinated or sourced from external data. (4) The contextual relevance is excellent—the answer directly addresses the evolution of the relationship and financial implications. The qualitative accuracy is high due to correct entity identification and logical flow, but quantitative accuracy is reduced due to incorrect or unverified numbers. Correctness score is 8 because core facts (acquisition, amount, segment, strategic intent) are correct, but specific financial figures and amortization period are inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 611,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolved between 2022 and 2023 in terms of timing and capitalization treatment as follows: In 2022, these payments were categorized under \"Other commercial aerospace commitments\" and were expected to be capitalized as collaboration intangible assets as payments were made. By 2023, the expected maturity schedule showed a shift in timing, with a significant portion of the obligations moving to later years, particularly \"Thereafter,\" indicating a longer-term outlook. The capitalization treatment remained consistent, with payments being capitalized as collaboration intangible assets upon payment.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual inaccuracy regarding the evolution of RTX's payment obligations between 2022 and 2023. The ground truth states there was no change in the magnitude or timing of obligations between the two years, with consistent contingent payment structures tied to flight hours through June 2027 and unchanged capitalization treatment. However, the LLM incorrectly claims that in 2023 there was a 'shift in timing' with obligations moving to later years, particularly 'Thereafter,' suggesting a change in maturity schedule. This contradicts the original answer, which explicitly notes no indication of change in timing or magnitude. The capitalization treatment is correctly described as consistent—payments capitalized as collaboration intangible assets—which aligns with the ground truth. While the entities (RTX, Rolls-Royce, 2012 agreement), financial classification ('Other commercial aerospace commitments'), and general framework (contingent on flight hours through June 2027) are accurate, the erroneous claim about timing evolution undermines the correctness. There are no numerical values to verify, so quantitative accuracy is based on consistency of timeframes, which is partially correct. The reasoning fails on multi-hop synthesis because it incorrectly infers a change in obligation timing without evidence, despite both years reporting the same structure. The answer is contextually relevant and addresses the question's focus on timing and capitalization, but the core conclusion about evolution is unsupported and incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 429,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "The Coca-Cola Company's contingent payment liability tied to performance milestones for fairlife has significantly evolved from 2022 to 2024. In 2022, the contingent consideration liability related to fairlife was $3,017 million, based on fairlife's performance through 2024. By 2024, this liability had increased to $6,126 million, reflecting updated expectations of fairlife's financial performance and the application of discounted cash flow analyses. The fair value of this liability is remeasured quarterly and is subject to changes based on fairlife's operating results and macroeconomic conditions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the reported contingent liability amounts—$3,017 million in 2022 and $6,126 million in 2024—are completely fabricated and not supported by the ground truth. The original answer states that Coca-Cola did not disclose any ongoing contingent payments in 2022, and only in 2024 was there a disclosure of a remaining milestone payment (amount unspecified) contingent on performance through 2024, to be paid in 2025. There is no mention of specific dollar figures or liabilities in the ground truth. (2) The claim that the liability was 'remeasured quarterly' and subject to DCF analyses introduces technical details not present or verifiable from the original answer. (3) Qualitatively, the LLM misrepresents the evolution: the original answer describes a shift from no mention of contingent payments in 2022 to a disclosure of a pending milestone in 2024, not an increasing liability tracked over time. The LLM invents a financial narrative unsupported by the source. (4) Contextually, while the answer addresses contingent payments and performance milestones, it fails the core requirement of factual accuracy. The multi-hop reasoning is flawed—the model appears to hallucinate financial data rather than report disclosed information. The correct answer emphasizes disclosure practices and the existence (or lack thereof) of contingent obligations, not quantitative liability trends. Thus, the answer is mostly incorrect with major factual and numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 427,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "Between 2022 and 2024, Oracle's strategic positioning of Oracle Cloud Services has evolved to emphasize deeper integration with enterprise applications and infrastructure technologies. In 2022, Oracle highlighted its comprehensive portfolio of applications and infrastructure technologies, emphasizing flexibility and interoperability across deployment models (on-premise, cloud-based, and hybrid). By 2024, Oracle further emphasized the integration of Oracle Cloud Infrastructure (OCI) with Oracle Fusion SaaS Applications, leveraging OCI to power internal business processes and enhance performance, security, and cost-effectiveness. Oracle also expanded its focus on advanced technologies such as machine learning, AI, and IoT, embedding these capabilities into its cloud offerings to drive automation and innovation for customers. This evolution reflects Oracle's commitment to providing a unified, secure, and scalable cloud ecosystem that supports enterprise-wide digital transformation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution between 2022 and 2024. It accurately captures Oracle's shift toward deeper integration of cloud services with enterprise applications and infrastructure. The mention of flexibility and interoperability across deployment models (on-premise, hybrid, cloud) in 2022 matches the original answer. In 2024, the LLM correctly identifies increased emphasis on integration between OCI and Fusion SaaS, as well as the use of AI, ML, and IoT for automation—consistent with the ground truth's reference to a more mature, integrated platform. However, the LLM omits the specific strategic pivot from promoting individual innovations like the Autonomous Database in 2022 to a holistic platform narrative in 2024, which is a key nuance in the original answer. While the LLM mentions AI/ML, it does not explicitly tie machine learning to the Autonomous Database as a flagship 2022 offering, slightly weakening the multi-hop synthesis. There are no numerical inaccuracies (quantitative accuracy is perfect by default, as no numbers are misstated), and the contextual relevance is strong—directly addressing the evolution in strategic positioning. The reasoning is sound but misses a subtle but important shift in messaging emphasis, warranting a slight deduction in qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 386,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "The Key/Specified Employee Policy was first incorporated by reference in the 2018 SEC filing (Exhibit 10(r)). Between 2023 and 2024, there is no indication of any amendments or updates to this policy. In both filings, the policy remains referenced to the same exhibit and source document, suggesting no substantive changes to its documentation or incorporation by reference during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that there were no amendments or updates to the Key/Specified Employee Policy between 2023 and 2024 and that it continues to be referenced via incorporation by reference to the same historical exhibit. This aligns with the ground truth regarding the policy's ongoing status and lack of documentation changes. However, there is a critical error in the exhibit number and year: the LLM claims the policy was incorporated in the '2018 SEC filing (Exhibit 10(r))', while the ground truth specifies 'Exhibit 10(v)' from the 2018 filing. This discrepancy in exhibit designation affects factual precision. Additionally, the original answer notes the policy was 'introduced' in the 2023 filing as part of disclosures, whereas the LLM implies it was first incorporated in 2018, which may misrepresent the timeline of disclosure practice. (2) The dates (2018, 2023, 2024) are correct, but the exhibit number is inaccurate (10(r) vs 10(v)), which is a material detail in SEC filings. (3) The multi-hop reasoning is sound in synthesizing continuity across years and recognizing incorporation by reference, but fails to capture the nuance that the 2023 filing marked the first disclosure/introduction of the policy in that form, even if referencing an older exhibit. (4) The contextual relevance is high as it directly addresses the evolution (or lack thereof) in documentation and incorporation. Qualitative accuracy is strong due to correct logic and structure, but quantitative accuracy is reduced due to the incorrect exhibit number, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 439,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The aggregate principal balance of the 6.700% notes due 2028 remained unchanged at $285 million between 2022 and 2023, as shown in the long-term debt sections of both years. This stability suggests that RTX did not refinance or retire this specific debt issue during the period, indicating a strategy of maintaining existing long-term obligations without immediate restructuring. It reflects a measured approach to debt management, potentially prioritizing financial flexibility or cost considerations for this particular note.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the aggregate principal balance remained unchanged at $285 million. According to the ground truth, the balance was $115 million in 2022 and increased to $285 million in 2023 — a significant increase, not stability. This misstatement undermines the entire response. (2) Quantitative accuracy is severely compromised: the 2022 figure is wrong (claims $285M vs. actual $115M), and the change over time is misrepresented (no change vs. an increase of $170M). The calculation of the difference is entirely missing or incorrect. (3) The multi-hop reasoning fails because the model did not correctly synthesize the data across the two years. Instead of identifying an increase and inferring a strategic expansion of debt, it incorrectly assumes stability and draws an invalid conclusion about maintaining existing obligations. The reasoning is internally logical but based on false premises. (4) Contextual relevance is moderate — the answer addresses the right metric (aggregate principal balance), the correct note (6.700% due 2028), and attempts to interpret RTX's debt strategy. However, due to the core factual error, the conclusion is misleading. A correct analysis would have noted the more than doubling of the principal as indicative of active debt issuance or retention strategy, not stability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 380,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "The carrying value of TMO's 1.95% 12-Year Senior Notes increased from $749 million at December 31, 2023, to $725 million at December 31, 2024. The effective interest rate for these notes rose slightly from 2.08% in 2023 to 2.07% in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both carrying value and effective interest rate trends. According to the ground truth, the carrying value in 2023 was $773 million, not $749 million as stated by the LLM, and it decreased to $725 million in 2024. The LLM incorrectly claims the carrying value 'increased' when it actually decreased. Additionally, the effective interest rate declined slightly from 2.08% to 2.07%, but the LLM incorrectly states it 'rose' from 2.08% to 2.07%, which is logically and factually wrong since 2.07% is lower than 2.08%. (2) Quantitative accuracy is poor: the 2023 carrying value is off by $24 million ($749M vs $773M), while the 2024 value ($725M) is correct. The interest rate numbers are numerically close but the directional change is misrepresented. (3) The reasoning is flawed: the model fails to correctly interpret the direction of change in both variables, indicating a failure in multi-hop synthesis and trend analysis. It incorrectly infers an increase in carrying value and a rise in interest rate despite the numbers showing the opposite. (4) Contextual relevance is high because the answer addresses the right financial instrument (TMO's 1.95% 12-Year Senior Notes) and the correct time frame (2023–2024), but factual inaccuracies severely undermine correctness. Minor note: the phrase 'rose slightly from 2.08% to 2.07%' is self-contradictory, further indicating reasoning failure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 403,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "The change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings reflects a shift in transparency and accessibility. In 2022, the Code of Conduct and Directors' Code of Conduct were referenced as being available on the company's website, but no specific details were provided about their content or governance oversight. In 2024, the filing emphasizes the availability of the Directors' Code of Conduct as part of broader corporate governance materials, including committee charters and guidelines, which are accessible on the company's website. This evolution suggests a stronger commitment to corporate governance by making these materials more explicitly available, thereby enhancing accountability and aligning with best practices for board transparency.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the nature of the change in disclosure between 2022 and 2024. The original answer states that in 2022, BNY Mellon provided a direct URL link to the Directors' Code of Conduct and explicitly discussed it in the context of ethics and governance, whereas in 2024, it was listed among other governance documents without a direct link or specific mention of updates—indicating reduced visibility. In contrast, the LLM incorrectly claims that in 2022 'no specific details were provided' and that the 2024 presentation reflects a 'stronger commitment' and 'enhanced accountability,' which contradicts the ground truth that the change may reduce transparency. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in dates or formats, hence a score of 10. (3) The multi-hop reasoning is flawed: the LLM fails to correctly interpret the direction of the change (from more explicit to less prominent disclosure) and draws an opposite conclusion about governance implications. It mischaracterizes the 2022 disclosure as vague and the 2024 as improved, when the original answer suggests a potential decline in transparency. (4) While the LLM addresses the general topic of corporate governance implications and references the correct company and years, its qualitative inaccuracy in describing the nature of the change and its effects severely undermines the correctness. The contextual relevance is moderate because it discusses governance materials and website availability, but the interpretation is factually inverted. Correctness is scored at 4 due to partial entity and context accuracy but major reasoning and factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 479,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "Amazon's Short-Term Credit Agreement evolved between 2023 and 2024 in the following ways: \n\n1. **Facility Size**: The facility size remained consistent at $5.0 billion in both years.  \n2. **Maturity Date**: The maturity date shifted from October 2024 (established in November 2023) to October 2025 (established in October 2024), effectively extending the term by one year.  \n3. **Timing of Establishment**: The agreement was established in November 2023 and replaced in October 2024 with a new agreement that extended the maturity date.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: All numbers and dates are correct — facility size of $5.0 billion in both years, maturity dates of October 2024 (for the 2023 agreement) and October 2025 (for the 2024 agreement), and establishment in November 2023 and October 2024. These align precisely with the original answer. (2) Completeness: The response addresses all three components of the question — facility size, maturity date, and timing of establishment — with no omissions. (3) Entity accuracy: Amazon is correctly identified, and the years (2023 and 2024) and financial terms (revolving credit facility, maturity, establishment) are used appropriately. (4) Reasoning: The LLM correctly infers that the agreement was renewed procedurally, noting the consistent size and one-year extension of maturity, even without explicitly stating 'procedural renewal' — the logic is sound and factually grounded. (5) Semantic equivalence: The answer conveys the same information as the original, with clear, accurate phrasing. Minor wording differences (e.g., not mentioning 'unsecured' or 'replacing prior agreement') do not detract from factual correctness or completeness. All key facts are present and correctly synthesized across the two years, satisfying the multi-hop requirement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 373,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "AMD's APU strategy evolved significantly from 2022 to 2024, shifting toward deeper integration of AI capabilities and targeting the emerging AI PC segment. In 2022, AMD emphasized balanced computing platforms with integrated CPUs and GPUs for performance and efficiency in traditional and blockchain markets. By 2024, AMD introduced dedicated neural processing units (NPUs) on the same SoC as x86 CPUs, such as the Ryzen AI 300 Series, to enable next-generation AI PCs. This shift positions AMD to capture growing demand for AI-enhanced consumer and commercial notebooks, enhancing its revenue potential in the AI PC segment by offering differentiated, high-performance solutions tailored for AI workloads at the edge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AMD's APU strategy from 2022 to 2024, noting the shift from integrated CPU-GPU platforms to inclusion of dedicated NPUs in 2024, specifically citing the Ryzen AI 300 Series. This aligns with the ground truth that AMD became the first to integrate an NPU on the same SoC as an x86 CPU for AI PCs. The target market shift toward AI PCs and edge AI workloads is accurately reflected. However, the LLM slightly misrepresents AMD’s 2022 focus by mentioning 'blockchain markets'—which is not in the original answer and lacks support in the ground truth. The original emphasizes data center and cloud AI/HPC via Instinct MI200 and Radeon PRO GPUs, not blockchain. This is a minor factual overreach but does not undermine the core accuracy. (2) There are no numeric values, dates, or calculations in either answer beyond '2022' and '2024', which are used correctly in both. No quantitative inaccuracies. (3) The multi-hop reasoning is sound: the model correctly synthesizes a strategic shift over time (2022 → 2024), identifies the technological change (adding NPUs), links it to target market evolution (AI PCs), and infers revenue implications. The only gap is the unsupported mention of blockchain, which weakens the precision of the 2022 characterization. (4) The answer is contextually highly relevant, directly addressing product integration, target markets, and revenue implications. The core message about enhanced revenue potential through differentiation in AI PCs matches the original. The minor error in 2022 focus prevents a perfect 10, but the answer is otherwise factually strong and semantically equivalent in intent and substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 465,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic remained consistent. Dividends are generally subject to a 25% Irish dividend withholding tax unless exemptions apply, such as providing a valid U.S. Certification of Residence (Form 6166) or an Irish Non-Resident Form V2. If the withholding tax applies, it discharges any Irish income tax liability, provided the shareholder reports the withholding to Irish Revenue authorities. No significant changes were noted in the 2024 filing compared to 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same essential information as the ground truth. (1) All key facts are correct: the 25% Irish dividend withholding tax rate, the availability of exemptions via Form 6166 or Form V2, the discharge of Irish income tax liability upon withholding, and the requirement to report to Irish Revenue. There is no change between 2023 and 2024, which is correctly noted. (2) Quantitative accuracy is perfect: the 25% rate is correctly stated, and no erroneous calculations are present. (3) The reasoning is sound and reflects proper multi-hop synthesis across years and tax provisions. The only minor omission is that the original answer specifies that U.S. shareholders not holding shares through an Irish branch generally have no liability when exempt—this nuance is missing in the LLM response, slightly reducing completeness. (4) Despite this, the answer is contextually fully relevant, directly addressing the evolution (or lack thereof) in tax treatment. Wording differs but meaning is semantically equivalent. A score of 9 is justified due to high accuracy with a minor detail omitted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 319,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "The risk disclosure around new products and services evolved between 2022 and 2024 to include specific mention of the company's transition to a platforms operating model. In 2024, the risk factors explicitly highlight the potential failure to realize expected benefits from this strategic initiative, indicating a more detailed and targeted risk assessment compared to 2022, where the focus was broader on risks related to new products and initiatives without specific reference to the platforms operating model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately captures the evolution of risk disclosure from a general focus on new products and strategic initiatives in 2022 to a specific mention of the 'transition to a platforms operating model' in 2024. The key factual elements—timing (2022 vs 2024), shift from broad to specific risk language, and the explicit concern about failing to realize expected benefits—are all correctly conveyed. There are no numeric values to verify, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is 9 because while the core reasoning and entity identification (BNY Mellon, platforms operating model, risk disclosure evolution) are correct, the LLM omits the exact phrasing that the 2024 filing states the company 'may not realize some or all of the expected benefits,' which slightly weakens the precision of the synthesis. However, the semantic meaning is preserved. Contextual relevance is perfect—the response directly addresses the question about risk disclosure evolution and the platforms operating model initiative. Minor omission does not detract from overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 330,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "Amazon's 3.600% Note due 2032 was disclosed in both the 2023 and 2024 10-K filings under the Supplemental Indenture dated April 13, 2022 (Exhibit 4.2). In both years, the note was listed among other debt instruments, indicating no material change in its terms or structure between 2023 and 2024. The disclosure remained consistent, with no additional amendments or events related to the note reported in the 2024 filing.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 3.600% Note due 2032 and the Supplemental Indenture dated April 13, 2022, as well as its consistent disclosure in both 2023 and 2024 filings, which aligns with the ground truth. The exhibit number (4.2) is an acceptable addition if supported by filings, though not in the original answer. However, the LLM fails to capture a key qualitative evolution: the trustee transition from Wells Fargo Bank, National Association (prior trustee) to only Computershare Trust Company, National Association as successor trustee in 2024. This procedural change in administration is a central point in the ground truth and reflects a meaningful shift in the debt instrument's governance structure, even if terms remained unchanged. (2) Quantitatively, all dates and percentages (3.600%, 2032 maturity, April 13, 2022 indenture) are accurate, and no numerical errors are present. (3) The reasoning is partially sound—while the model correctly notes consistency in terms and absence of amendments, it misses the multi-hop synthesis required to recognize that the trustee update constitutes an evolution in the relationship, as evidenced by the removal of Wells Fargo from the 2024 disclosure. This reflects a failure in deeper qualitative analysis of administrative changes despite factual consistency in surface-level disclosures. (4) The correctness score is 6 due to accurate numbers and context but significant omission of a key factual evolution; quantitative accuracy is 10 as all numbers are correct; qualitative accuracy is 5 due to flawed reasoning on institutional changes; contextual relevance is 9 as the response is highly relevant but incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 461,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "From 2023 to 2024, MDLZ's treatment and disclosure of net investment hedge (NIH) derivative contracts showed notable changes in financial impact and presentation. In 2023, NIH contracts were reported as $163 million in asset derivatives and $382 million in liability derivatives, with an after-tax loss of $185 million on these contracts. By 2024, the asset value increased to $305 million and the liability value decreased to $50 million, indicating a more favorable position. The after-tax gain/(loss) on NIH contracts shifted to a gain of $255 million in 2024, reflecting improved hedge effectiveness and market conditions. Additionally, the presentation in 2024 included more detailed breakdowns of fair value inputs, emphasizing Level 2 valuations for NIH contracts, which remained consistent with prior years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, MDLZ disclosed $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets for derivative assets and liabilities related to net investment hedges as of December 31, 2023 and 2022, respectively. The LLM incorrectly reports asset derivatives as $163 million and liability derivatives as $382 million in 2023, and $305 million and $50 million in 2024—none of which match the ground truth. Additionally, the LLM introduces after-tax gains/losses of $185 million loss in 2023 and $255 million gain in 2024, which are not mentioned or supported in the original answer. (2) The quantitative values are entirely incorrect—no alignment with disclosed fair values or balance sheet placements. There is no mention in the ground truth of 'after-tax gain/loss' on NIH contracts, nor any shift in asset/liability values as described. (3) The multi-hop reasoning is flawed: the original answer emphasizes a shift in disclosure focus—from balance sheet fair value in 2023 to income statement impact (specifically 'Other income, net') in 2024. The LLM instead fabricates balance sheet trends and performance improvements without evidence, missing the core conceptual shift in presentation emphasis. (4) While the LLM attempts to address the evolution of treatment and disclosure, it invents data and misrepresents the nature of the change. The contextual relevance is moderate because it discusses NIH derivatives and attempts to compare years, but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 454,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "From 2023 to 2024, the Abrams Main Battle Tank's modernization strategy has advanced significantly, with the U.S. Army announcing the development of the M1E3 Abrams, a major engineering upgrade aimed at enhancing lethality, survivability, and mobility against future threats. Technologically, the M1E3 incorporates a modernized systems architecture for faster technology integration and reduced sustainment requirements. Internationally, demand for Abrams tanks remains strong, particularly among NATO allies and partners in Europe, the Middle East, and the Indo-Pacific, reflecting continued confidence in the platform's capabilities and the company's global support infrastructure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key technological developments in the Abrams modernization strategy, including the M1E3 Abrams with modernized systems architecture, improved lethality, survivability, and reduced sustainment—consistent with the ground truth. It accurately reflects strong international demand across NATO, Europe, the Middle East, and the Indo-Pacific. However, it omits specific mention of the SEPv3 upgrades (communications, power generation, fuel efficiency, optics, armor) that were a central focus in 2023 according to the original answer. Additionally, while it attributes the M1E3 development to the U.S. Army, the ground truth specifies General Dynamics as the company announcing it, which is a minor entity misattribution. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is mostly sound: the LLM synthesizes technological evolution and international demand across years, though it underrepresents the 2023 technical roadmap emphasis on SEPv3 and overemphasizes the M1E3 as the primary focus. (4) The answer is contextually relevant and conveys the strategic shift toward future readiness and global demand. Due to the omission of SEPv3 details and slight misattribution of the announcing entity, the correctness and qualitative accuracy scores are slightly reduced, but overall the answer is factually aligned and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 408,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "Between 2022 and 2024, AMD's role in the development and positioning of APUs has evolved to emphasize their integration and performance benefits across a broader range of market segments. In 2022, APUs were highlighted as a key part of balanced computing platforms, combining CPUs and GPUs on a single chip to deliver visual processing for value and mainstream PCs. By 2024, AMD strategically emphasized APUs within its reportable segments, particularly in the Client and Embedded segments, showcasing their role in delivering performance and efficiency for notebooks, desktops, and embedded systems. The strategic emphasis also shifted toward leveraging APUs in heterogeneous computing and AI/ML workloads, reflecting a broader market segmentation approach to meet growing demands in both consumer and enterprise applications.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains key inaccuracies in entity identification and reasoning compared to the ground truth. (1) Correct elements: The general evolution of APUs from a PC-focused product in 2022 to a more strategically emphasized component by 2024 is consistent with the original answer. The mention of integration into notebooks, desktops, and embedded systems aligns with the Client and Embedded segments. The strategic shift toward AI/ML and heterogeneous computing is contextually plausible, though not explicitly stated in the ground truth. (2) Quantitative accuracy: There are no numeric values in the question or answers, so this dimension is neutral; no errors present. (3) Multi-hop reasoning assessment: The LLM incorrectly states that APUs were emphasized in the 'Embedded' segment in 2024, while the ground truth specifies they were included in the 'Data Center' and 'Client' segments—not Embedded. This is a significant error in entity and segment mapping. Additionally, the ground truth highlights a structural change in AMD’s reportable segments where APUs were explicitly listed in Data Center (alongside AI accelerators, CPUs, GPUs, DPUs), indicating a strategic repositioning into data center solutions, which the LLM answer omits entirely. Instead, it fabricates emphasis on 'Embedded' without evidence. (4) The answer captures the directional trend—increased strategic emphasis and segmentation—but fails on precise entity accuracy and reasoning fidelity. Due to the misattribution of segments and omission of the Data Center inclusion, which is central to the multi-hop insight, the qualitative accuracy is reduced. However, the response remains contextually relevant and semantically aligned in broad strokes, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 487,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries remained consistent from 2023 to 2024. In both years, the company noted that the Act allows the Irish Minister for Finance to restrict financial transfers between Ireland and third countries, with such restrictions being subject to ongoing change. Additionally, transfers involving countries under United Nations or EU sanctions may also be restricted under Irish law. There were no material changes in the nature or scope of this disclosure between the two periods.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Medtronic's disclosure remained consistent between 2023 and 2024. The ground truth indicates a notable evolution: while both years acknowledged the Financial Transfers Act 1992 and the Minister’s authority to restrict transfers, the 2024 disclosure no longer emphasized the dynamic nature of the list of restricted countries—a key change the LLM failed to recognize. Instead, the LLM incorrectly asserts there were 'no material changes,' directly contradicting the ground truth’s indication of a shift in emphasis suggesting potential stabilization. (2) There are no numeric values, dates, or calculations in this question, so quantitative accuracy is not applicable; however, the years 2023 and 2024 are correctly referenced, earning full marks here. (3) The multi-hop reasoning is flawed: the question requires comparing disclosures across two years to identify evolution, but the LLM concludes no change when the ground truth identifies a meaningful shift in tone and focus. This reflects a failure in comparative analysis and synthesis. (4) Contextual relevance is high because the answer addresses the correct company, law, jurisdiction, and time frame, and includes related regulatory context (UN/EU sanctions), even if it mischaracterizes the evolution. However, the core failure to detect a change in disclosure renders the answer substantially inaccurate despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 403,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "In 2023, General Dynamics (GD) disclosed that the ultra-long-range G700 aircraft was expected to enter service following FAA certification in early 2024. By 2024, GD reported that production of new Gulfstream models, including the G700, had ramped up, with deliveries of the G700 beginning in the second quarter of 2024. This indicates that the G700 transitioned from the certification and pre-delivery phase in 2023 to active production and delivery in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: in 2023, the G700 was expected to enter service after FAA certification in early 2024; by 2024, deliveries began in Q2. These details match the original answer exactly. (2) There are no numerical values requiring calculation, but the timeframes (early 2024 for certification, Q2 2024 for deliveries) are correctly stated and consistent with the ground truth. (3) The multi-hop reasoning is sound—information from two different time points (2023 outlook vs. 2024 outcome) is synthesized to show progression from pre-certification to active delivery. (4) The answer is contextually relevant, directly addressing the evolution of the G700’s status and production outlook. Wording differs slightly but maintains semantic equivalence, including accurate use of 'ramped up production' as a reasonable interpretation of transition to active delivery. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 289,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "The nature of PMI's relationship with KT&G evolved from 2023 to 2024 by extending their collaboration through a renewed and exclusive, worldwide agreement (excluding South Korea) for the commercialization of KT&G's smoke-free products. This long-term arrangement, effective until January 29, 2038, enhances PMI's strategic dependency on KT&G's innovation pipeline and expands PMI's product portfolio with KT&G's smoke-free devices and consumables, including offerings for low- and middle-income markets. The agreement reflects a stronger alignment in product commercialization, with PMI gaining exclusive access to KT&G's brands and innovation, subject to regulatory approvals and quality standards.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: the 15-year exclusive agreement between PMI and KT&G, effective until January 29, 2038, covering worldwide commercialization (excluding South Korea), and inclusion of smoke-free devices and consumables targeting low- and middle-income markets. These details match the ground truth. However, the LLM mischaracterizes the evolution from 2023 to 2024. While the original answer notes a shift in 2024 from exclusive distribution to deeper integration—specifically that KT&G's products were incorporated into PMI's heat-not-burn portfolio—the LLM implies the agreement was 'renewed' in 2024, which is not supported; the agreement was announced in 2023 and runs through 2038. There is no evidence of a renewal in 2024. (2) Quantitative accuracy is perfect: the end date January 29, 2038, is correctly cited, and no other numbers (percentages, dollar amounts) are involved. (3) The multi-hop reasoning is partially sound—LLM connects PMI’s strategic dependency and product expansion to KT&G’s pipeline—but fails to capture the nuanced evolution in 2024 where KT&G’s products became part of PMI’s own portfolio, indicating operational integration beyond distribution. This key qualitative shift is underemphasized. (4) Contextual relevance is high as the response directly addresses strategic dependency and product commercialization. The correctness score is 7 because core facts and dates are accurate, but the reasoning about the evolution of the relationship contains a subtle but important misrepresentation (implied renewal vs. integration), missing the deeper strategic shift highlighted in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 457,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "From 2022 to 2024, AMD's approach to semi-custom SoC products has evolved by integrating these products more strategically into broader AI and high-performance computing ecosystems. In 2022, AMD emphasized the importance of semi-custom SoC revenue, which depends on third-party product success and design inclusion. By 2024, AMD positioned semi-custom SoCs as part of its broader adaptive computing strategy, leveraging them in gaming consoles and AI-driven platforms while expanding into data center and embedded solutions. This shift reflects a more ecosystem-focused approach, aligning semi-custom SoCs with AMD's leadership in AI, cloud, and edge computing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in AMD's semi-custom SoC strategy from 2022 to 2024. It correctly identifies the 2022 dependency on third-party product success and design inclusion as a key characteristic, aligning with the original answer's emphasis on revenue tied to external factors and associated risks. By 2024, the LLM accurately reflects the strategic shift toward integration within broader ecosystems, specifically mentioning AI-driven platforms, gaming consoles, data centers, and embedded solutions—consistent with the ground truth's mention of AI PCs, cloud services, and multi-industry embedded systems. The LLM correctly highlights the alignment with AI, cloud, and edge computing, reflecting AMD's product leadership strategy. While the original answer includes specific technical details such as the integration of an NPU with an x86 CPU in AI PCs, the LLM answer omits this granular detail but still conveys the essential strategic shift. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default (no errors possible). The reasoning is sound, demonstrating multi-hop synthesis across years and strategic themes. The answer is contextually fully relevant and semantically equivalent to the ground truth, with only minor omission of a specific architectural detail (NPU + x86 CPU). Thus, the correctness score is 9 due to high accuracy with a slight gap in technical specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 406,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax on dividends paid to U.S. residents remained largely unchanged, with dividends generally subject to a 25% Irish dividend withholding tax unless exemptions applied. U.S. residents holding shares through the Depository Trust Company (DTC) continued to be exempt from withholding tax if their addresses were correctly recorded with their brokers. Additionally, U.S. residents who provided valid certification (e.g., Form 6166 or Form V2) were also exempt. Irish income tax liability on dividends was generally not applicable to U.S. residents meeting these exemptions and not conducting trade in Ireland. The 2024 filing reiterated these rules without indicating new changes to exemptions or obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution between 2023 and 2024 as described in the ground truth. (1) Quantitatively, the 25% withholding tax rate is correctly stated, and the general exemption framework is accurate. However, the LLM introduces specific details not present in the original answer—such as the Depository Trust Company (DTC), Form 6166, and Form V2—which are not mentioned in the ground truth and cannot be verified from it, raising concerns about hallucination. (2) The original answer focuses on Medtronic’s disclosures and the evolving clarity in tax treatment, particularly around post-withholding procedures and the condition of not holding shares through an Irish branch. The LLM fails to mention the 2024 clarification about furnishing a statement to Irish Revenue to discharge further liability, which is a key development. (3) The multi-hop reasoning is weak: while the LLM correctly identifies continuity in the 25% rate and general exemptions, it does not synthesize the progression in disclosure clarity or the structured conditions introduced in 2024. Instead, it asserts 'no new changes,' which contradicts the ground truth’s emphasis on enhanced procedural clarity. (4) Contextually, the answer is relevant and addresses Irish withholding tax and exemptions, but it substitutes entity-specific procedural details (DTC, IRS forms) not present in the source, reducing qualitative accuracy. The core financial fact (25% rate) is correct, and the general principle of exemption for non-connected U.S. residents is preserved, justifying a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 442,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "From 2023 to 2024, General Dynamics' Marine Systems segment experienced cost pressures on the Virginia-class and DDG-51 programs, which contributed to a slight decline in operating earnings and margin in 2023. In 2024, the segment's revenue is expected to increase to approximately $12.8–12.9 billion, with an operating margin of around 7.6%, indicating some margin improvement. The Columbia-class submarine initiative continued to drive ship construction revenue in both years, with 2024 outlooks reflecting sustained growth and improved operational efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the cost pressures on the Virginia-class and DDG-51 programs in 2023, the decline in operating margin (referred to as 'slight decline in operating earnings and margin'—semantically equivalent to the 110 basis point drop), and the 2024 revenue projection of $12.8–12.9 billion with a 7.6% operating margin are all precisely stated. (2) Quantitative accuracy is perfect: dollar amounts, margin percentage, and the implied margin improvement align with the original. The 110 basis point decline is not explicitly quantified in the LLM answer, but the qualitative description of a 'slight decline' is reasonable and does not contradict the truth. (3) Multi-hop reasoning is sound: the answer correctly links 2023 cost pressures to margin impact, identifies the Columbia-class as a revenue driver, and contrasts this with improved 2024 outlook, showing synthesis across time and programs. (4) The answer is fully contextually relevant, addressing all parts of the question—financial performance changes, cost pressures, and revenue outlook. The only minor omission is the explicit mention of 'supply chain disruptions' and 'cost overruns' as specific causes, but 'cost pressures' serves as a valid umbrella term. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 395,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "Based on the provided information, BKNG's financial dependency on Booking.com for accommodation reservations remained stable between 2022 and 2023. In both years, approximately 89% of the company's total revenue was derived from online accommodation reservation services, with the majority of merchant revenues and substantially all agency revenues coming from Booking.com. This indicates that there was no significant change in the proportion of revenue attributed to accommodation reservations during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that 89% of BKNG's revenue from accommodation reservations came from Booking.com in both 2022 and 2023, which matches the ground truth. The key quantitative data (89%, years 2022 and 2023) are accurate. (2) All numbers and dates are correct—89% in both years—and the conclusion that the proportion remained stable is factually sound. There are no calculation errors. (3) The multi-hop reasoning is solid: the model correctly synthesizes that Booking.com is the primary source of BKNG's accommodation revenue and that this dependency did not change year-over-year. However, the LLM slightly underrepresents the nuance in the original answer by not explicitly stating that the dependency 'slightly increased' or 'remained high but unchanged,' instead focusing only on stability. The original answer emphasizes sustained concentrated dependency, which the LLM captures in spirit but not fully in emphasis. (4) The answer is contextually relevant, directly addressing the evolution of financial dependency. Quantitative accuracy is perfect. Qualitative accuracy is high but not full due to the subtle difference in interpretation of 'unchanged' versus 'slightly increased'—though factually the percentage did not change, the original answer interprets this as a continued high dependency, which the LLM acknowledges but with slightly less precision in framing. Correctness score is 9 due to full factual alignment but minor omission of the interpretive nuance in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 419,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "The company's Swiss Franc note, which was listed as CHF250 million (approximately $283) at December 31, 2023, was fully repaid by December 31, 2024, as it no longer appears in the 2024 long-term debt listing. This indicates that the company successfully settled its Swiss Franc-denominated obligation within the year, reducing its foreign currency exposure. The repayment suggests effective management of foreign currency liabilities and alignment with the company's broader debt refinancing and restructuring efforts.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Swiss Franc note obligation was fully removed by 2024, aligning with the ground truth that the $299 million obligation was completely eliminated. However, the LLM reports the 2023 amount as CHF250 million (~$283 million), which does not match the ground truth value of $299 million. This discrepancy affects quantitative accuracy, though the direction (repayment of a ~$300M obligation) is in the right range. (2) The numbers are close but not exact: CHF250 million converting to $283 million assumes an exchange rate of ~1.132, while the actual rate may have differed; more importantly, the disclosed obligation in USD terms was $299 million per the original answer, so the LLM’s figure is off by $16 million. This is a material difference in a financial context. (3) The reasoning is sound: the LLM correctly infers that the absence of the note in 2024 implies repayment or restructuring and connects this to foreign currency exposure management. It also appropriately links the event to broader debt management strategy, adding contextual insight without overreaching. (4) The answer is contextually excellent—addresses both parts of the question (evolution and implication), uses correct entities (Swiss Franc note, 2023–2024 timeline), and provides meaningful interpretation. The core conclusion (obligation eliminated, reducing FX exposure) matches the ground truth. The quantitative inaccuracy prevents a higher score, but the qualitative and contextual reasoning is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 424,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "Goldman Sachs introduced new Non-Employee Director RSU Award Agreements in the 2024 10-K filing, including a standard form (Exhibit 10.32) and a cash-settled version (Exhibit 10.33), which were not explicitly listed in the 2023 10-K. These updates reflect modifications or additions to the structure of director compensation arrangements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and exhibits. According to the ground truth, in the 2023 10-K, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8. In the 2024 10-K, the company retained that reference and introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18. However, the LLM claims that Goldman Sachs introduced two new agreements in 2024: a standard form as Exhibit 10.32 and a cash-settled version as Exhibit 10.33—exhibits and agreements that are not mentioned in the ground truth and appear to be fabricated. There is no mention of Exhibits 10.32 or 10.33 in the original answer, nor is there any indication of a 'cash-settled version' being introduced. The LLM fails to note the retention of the pre-2015 agreement and misrepresents the nature of the new disclosure (amendments, not new forms). While the general direction—'Goldman Sachs updated its treatment of non-employee director RSU agreements in 2024'—is contextually relevant, the specific entities, exhibit numbers, and types of agreements are factually wrong. This constitutes major errors in both quantitative (exhibit numbers, years) and qualitative accuracy (mischaracterization of the nature of the change). The answer does not reflect the actual evolution described in the ground truth, which focused on amendments and expanded disclosures, not new award forms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 407,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "Between 2023 and 2024, PM's financial relationship with Swedish Match AB, particularly in terms of long-term debt obligations tied to the acquisition, evolved as follows: In 2023, PMI had a €5.5 billion senior unsecured term loan facility to finance the acquisition, which included a €3.0 billion tranche due in 2025 and a €2.5 billion tranche due in 2027. By November 21, 2024, PMI prepaid the €3.0 billion tranche, leaving the €2.5 billion tranche outstanding as of December 31, 2024. Additionally, the preliminary purchase price allocation for the acquisition was adjusted during this period, leading to a decrease in goodwill for the Swedish Match segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timeline compared to the ground truth. The original answer states that long-term debt obligations were $6,121 million in 2023 and decreased to $2,610 million in 2024. However, the LLM answer cites €5.5 billion in total debt (approx. $6.0 billion at 2023 exchange rates), which is close but not exact, and breaks it into €3.0B and €2.5B tranches—details not present in the ground truth. More critically, the LLM claims a prepayment occurred on November 21, 2024, reducing the debt to €2.5B (~$2.7B), which does not align with the reported $2,610 million figure in 2024. While directionally consistent (a large reduction), the specific amounts and dates are not verifiable from the ground truth and appear fabricated or misaligned. (2) The calculation of debt reduction in the original answer is $6,121M → $2,610M = $3,511M reduction. The LLM implies a €3.0B (~$3.3B) repayment, which is in the same ballpark but uses euros instead of dollars and lacks alignment with the exact reported figures. Additionally, the use of 'PMI' instead of 'PM' introduces entity inconsistency. (3) The multi-hop reasoning is partially sound—the model attempts to explain the evolution of debt and links repayment behavior to reduced financial exposure—but relies on unverified tranches and dates rather than the actual reported totals. It adds granular detail (e.g., tranche maturities, prepayment date) not supported by the ground truth, undermining reliability. (4) Despite incorrect specifics, the answer captures the general trend—debt decreased significantly due to repayment—so some qualitative and contextual accuracy is preserved. However, quantitative inaccuracy severely limits correctness. The mention of goodwill adjustment is extraneous and not responsive to the question about debt obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 507,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "BMY's strategic positioning around KRAS inhibition evolved significantly from 2023 to 2024 with the acquisition of Mirati in January 2024. This acquisition added Krazati, a best-in-class KRAS G12C inhibitor, to BMY's portfolio, which was FDA-approved for second-line NSCLC and is in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. The acquisition also provided access to other clinical assets, including MRTX1719, a potential first-in-class PRMT5 inhibitor. This move strengthened BMY's oncology pipeline and expanded its capabilities in KRAS-targeted therapies, aligning with its broader strategy to enhance its presence in precision oncology.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution of BMY's strategic positioning around KRAS inhibition from 2023 to 2024, including the key event—the acquisition of Mirati in January 2024—and the addition of Krazati to BMY's portfolio. It accurately notes Krazati's FDA approval for second-line NSCLC and its development in first-line NSCLC with a PD-1 inhibitor. However, it omits the 2024 FDA approval of Krazati for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, which is a significant expansion of its therapeutic footprint and part of the ground truth. This omission reduces completeness. (2) Quantitatively, the answer does not mention the $4.8 billion acquisition price, which is a missing factual detail from the original answer. All other dates (January 2024 acquisition) are accurate. The absence of this dollar amount affects quantitative completeness, though no incorrect numbers are stated. (3) The multi-hop reasoning is sound: the model correctly links BMY’s pre-2024 lack of KRAS assets (implied), the acquisition as a strategic inflection point, and the resulting enhancement in precision oncology. It also correctly identifies Krazati as a KRAS G12C inhibitor and references other pipeline assets like MRTX1719, which adds depth, though this detail is not in the ground truth. (4) The answer is highly contextually relevant and well-structured. Despite missing two key facts (colorectal cancer approval and acquisition cost), it conveys the main strategic shift accurately. Hence, correctness is high but not perfect—warranting an 8. Quantitative accuracy is 9 due to one missing dollar figure; qualitative accuracy is 8 due to partial omission of therapeutic indications; contextual relevance is 10 as the response directly and appropriately addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 495,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan remained largely consistent between 2023 and 2024, as both filings reference the same document—Exhibit 10.3 (2023) and Exhibit 10.4 (2024)—indicating no material changes to the plan itself. However, in 2024, the firm introduced a new Clawback Policy effective December 1, 2023, which was filed as Exhibit 10.1 in the 2024 10-K. This policy, while not directly tied to the Restricted Partner Compensation Plan, reflects a broader governance enhancement that could impact compensation structures, including those of partners, by enabling recoupment of compensation under certain circumstances. Thus, while the Restricted Partner Compensation Plan itself did not evolve, the introduction of the Clawback Policy in 2024 signifies a strengthening of compensation governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the Restricted Partner Compensation Plan is correctly identified as Exhibit 10.3 in 2023 and Exhibit 10.4 in 2024, with no material changes noted. The introduction of the Clawback Policy as Exhibit 10.1 in the 2024 filing is accurately reported, including its effective date of December 1, 2023. (2) Quantitative accuracy is perfect: exhibit numbers, years, and dates match the original answer. (3) The multi-hop reasoning is sound—correctly linking the static nature of the plan with the broader governance shift via the new Clawback Policy. The only minor omission is that the LLM does not explicitly mention the 'repositioning' of the plan’s placement in the exhibit list (from early in 2023 to later in 2024), which was a key point in the original answer about disclosure strategy. However, this does not undermine the overall correctness. (4) The answer is contextually excellent, directly addressing the evolution in disclosure and governance, and correctly infers the strategic implication of the Clawback Policy on compensation governance. The wording differs slightly but maintains semantic equivalence. Thus, a score of 9 is justified—very close to full accuracy with only a minor detail missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 366,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) evolved its approach to heat-not-burn (HNB) products by reclassifying them under a broader \"smoke-free products\" category, which also includes e-vapor and oral nicotine products. In 2023, PMI further integrated HNB products into its business strategy by expanding the smoke-free segment to include wellness and healthcare products, reflecting a strategic shift toward diversification beyond nicotine. This integration is evident in the 2023 financial reporting, where HNB products are grouped with other smoke-free offerings, and the company emphasized growth in heated tobacco unit (HTU) shipments across all regions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately captures the key evolution in PMI's approach: the reclassification of heat-not-burn (HNB) products under the broader 'smoke-free products' category in 2023, which now includes e-vapor, oral nicotine, and even wellness and healthcare offerings. It correctly notes the integration of HNB into a broader strategic framework and mentions HTU shipment growth, which is contextually relevant. However, the LLM answer omits a specific detail present in the original answer: the inclusion of licensed KT&G heat-not-burn products in 2023, which signifies a strategic expansion beyond internally developed products. This is a meaningful nuance in business integration that enhances completeness. There are no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect numbers are presented), and the reasoning is sound and logically structured. The answer is highly contextually relevant, directly addressing the evolution in categorization and integration. The omission of the KT&G licensing point prevents a full 9–10 on correctness and qualitative accuracy, but the core facts and strategic shift are correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 340,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "Between 2023 and 2024, Bristol-Myers Squibb maintained its compliance with the SEC Consent Order by continuing the established procedures, including the role of the business risk and disclosure group. The 2024 filing reaffirms the company's adherence to the Consent Order's requirements, such as limiting sales to direct customers based on expected demand and maintaining a governance process to monitor compliance. There is no indication of significant changes to the role or structure of the business risk and disclosure group during this period, suggesting a consistent approach to SEC Consent Order compliance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately states that Bristol-Myers Squibb maintained the business risk and disclosure group between 2023 and 2024 with no significant changes, which matches the original answer's conclusion that the group remained a central component of governance. The mention of continued adherence to the SEC Consent Order and the governance process is factually consistent. However, the LLM omits key details from the 2023 setup: specifically, that the group was *established* in 2023 to comply with the Consent Order, the implementation of a formal review and certification process, the retention of an outside consultant, and the explicit purpose of escalating compliance issues. These omissions reduce completeness and qualitative accuracy, though the core timeline and continuity are correctly conveyed. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response remains highly relevant to the question. The reasoning is sound but lacks full multi-hop synthesis—while it captures the 2024 status correctly, it does not fully trace the evolution from establishment in 2023 to integration in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 335,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "Between 2023 and 2024, UNP maintained a consistent asset allocation strategy for its pension plan, with equity securities allocated between 20% and 30% and debt securities between 70% and 80%. The expected long-term rate of return on plan assets remained unchanged at 5.25%. However, the discount rate increased from 5.00% in 2023 to 5.61% in 2024, reflecting improved market conditions and impacting the actuarial assumptions used to determine the projected benefit obligation. This increase in the discount rate led to a reduction in the projected benefit obligation, as higher discount rates lower the present value of future liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the core of the question. (1) The question asks about the evolution in UNP's *treatment of the relationship* between expected return and asset allocation mix in narrative/disclosure terms between 2023 and 2024, not quantitative assumptions like the expected return rate or discount rate. The ground truth focuses on a shift in *disclosure language*—from a multifactor explanation (asset mix, historical returns, market conditions) in 2023 to a narrower 'depends on' asset allocation in 2024. The LLM instead discusses unchanged expected return (5.25%) and changes in discount rate (5.00% to 5.61%), which are not mentioned in the original answer and are irrelevant to the actual query. (2) Quantitatively, while the LLM provides numbers (e.g., 5.25%, 5.00%, 5.61%), these do not appear in the ground truth and cannot be verified as correct in this context; the only numeric in the original is the 6% *actual* return in 2023, which the LLM omits entirely. (3) The reasoning is flawed: it fails the multi-hop requirement to compare *disclosure language* across years and instead fabricates a narrative around actuarial assumptions unrelated to the question. (4) The answer is contextually misaligned—asset allocation ranges (20%-30% equities) may be factually accurate but are not the focus; the question is about *how* UNP explains the link between expected return and asset mix, not the mix itself. Thus, the answer misses the conceptual shift entirely, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 423,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon enhanced the accessibility and integration of its Directors' Code of Conduct by explicitly listing it among the corporate governance materials available on its website. In 2022, the Code was mentioned as being available online but was not highlighted as part of broader governance disclosures. By 2023, the Directors' Code of Conduct was explicitly included in the list of governance-related documents accessible on the company’s website, alongside other key governance materials such as the Corporate Governance Guidelines and committee charters, thereby improving its visibility and integration within the corporate governance reporting framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, the Directors' Code of Conduct was mentioned as being available online and applicable to directors, but not prominently integrated into the governance document list; by 2023, it was explicitly listed alongside other key governance materials like Corporate Governance Guidelines and committee charters. The LLM correctly captures this evolution in accessibility and integration. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023) are correct. (3) The multi-hop reasoning is sound—comparing disclosure practices across two years and synthesizing changes in presentation and integration within governance reporting. The only minor shortcoming is that the LLM slightly downplays the 2022 context where the Code was referenced in broader governance disclosures (e.g., Board Meetings and Committee Information), which the original answer notes. This nuance is omitted but does not distort the overall accuracy. (4) The answer is contextually relevant, directly addressing the question about evolution in accessibility and integration. Semantic equivalence is strong, with clear, concise restatement of the key progression in disclosure approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 373,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database between 2023 and 2024 has emphasized enhanced deployment flexibility and deeper integration with engineered systems, reflecting a stronger focus on cloud migration and hybrid IT environments. The company has expanded deployment options for Oracle Database, including on-premise, Oracle Cloud, Oracle Exadata Cloud@Customer, and OCI Dedicated Region, allowing customers to choose deployment models that best suit their needs. Additionally, Oracle has integrated Oracle Database with engineered systems like Oracle Exadata, which improves performance, scalability, and operational efficiency. This evolution indicates Oracle's commitment to supporting hybrid and multicloud strategies while facilitating seamless cloud migration for customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of deployment models and strategic direction. It correctly identifies Oracle's emphasis on deployment flexibility in 2023–2024, including on-premise, Oracle Cloud, Exadata Cloud@Customer, and OCI Dedicated Region (which is consistent with the ground truth's mention of hybrid and multicloud options). The integration with engineered systems like Oracle Exadata is accurately noted. However, the LLM answer lacks the nuanced evolution described in the ground truth—specifically, the shift from flexible deployment of standalone database services in 2023 to deeper integration within optimized, holistic engineered systems like Oracle Exadata Database Machine in 2024. While the LLM mentions integration and engineered systems, it does not explicitly convey the strategic maturation from flexibility to performance-optimized, tightly integrated infrastructure packages, which is central to the original answer. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are presented), and all entities (Oracle, Exadata, OCI, Cloud@Customer) are correctly named and contextualized. The reasoning is sound but slightly less detailed in synthesizing the strategic implication of the shift. Contextual relevance is high as it directly addresses deployment flexibility, integration, cloud migration, and hybrid IT. Minor omission of the 'Roving Edge Infrastructure' and the conceptual contrast between 2023 and 2024 positioning prevents a top score, but core facts and implications are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 438,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "Between 2023 and 2024, the implementation of the formal review and certification process of annual and quarterly SEC reports remained consistent with the measures established under the 2004 SEC Consent Order. Both years emphasized a structured governance process for compliance monitoring, including escalation of potential concerns to management and regular policy adherence checks. In 2024, the procedures were reiterated with a focus on maintaining compliance with the Consent, particularly through DSAs with U.S. pharmaceutical wholesalers and estimating inventory levels. No significant evolution in the process was noted, but continued emphasis was placed on ensuring transparency and adherence to the Consent terms.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the formal review and certification process was established under a '2004 SEC Consent Order', while the ground truth specifies it was established in 2023 as part of a Consent agreement. This misrepresents the timeline and evolution of the process. Additionally, the LLM claims 'no significant evolution' occurred between 2023 and 2024, which directly contradicts the ground truth that describes a clear shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks (e.g., sales policies) in 2024. (2) The dates are factually wrong—2004 is not mentioned in the original answer and is irrelevant; the correct years of focus are 2023 (implementation) and 2024 (integration and continued monitoring). There are no numerical values to verify, but the temporal references are critical and incorrect. (3) The multi-hop reasoning fails because the model does not correctly identify the progression across years. It overlooks the key evolution from establishment to integration, missing the synthesis of governance procedures being embedded into company-wide sales policies in 2024. Instead, it focuses on DSAs and inventory estimation, which are not mentioned in the ground truth. (4) The contextual relevance is moderate because the answer discusses compliance monitoring and governance procedures related to SEC filings, which is relevant, but the incorrect historical framing and missing evolution undermine accuracy. Due to major factual and reasoning errors, the correctness score is low at 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 450,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) has continued to position heat-not-burn (HNB) products as a core component of its reduced-risk product (RRP) strategy, emphasizing their potential to present less risk to smokers compared to combustible cigarettes. In 2023, PMI reported a 14.7% increase in heated tobacco unit (HTU) shipments globally, reflecting strong growth in key markets like Europe and Japan. The company categorizes HNB products under its smoke-free portfolio, which includes heat-not-burn, e-vapor, and oral nicotine products, and highlights their role in transitioning adult smokers away from combustible tobacco. This evolution underscores PMI’s ongoing commitment to expanding its RRP offerings and reinforcing their market presence as alternatives to traditional cigarettes.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of PMI's market positioning of heat-not-burn (HNB) products from 2022 to 2023, noting their inclusion in the smoke-free product segment and alignment with reduced-risk messaging. It accurately reflects the strategic emphasis on transitioning adult smokers away from combustible cigarettes. However, it introduces a specific quantitative claim—'14.7% increase in heated tobacco unit (HTU) shipments globally'—that is not present in the original ground truth and cannot be verified from the provided knowledge graph. This number may be factually accurate but is not supported by the source answer, making it an unsupported addition. (2) The original answer does not include any numerical data or growth figures, so the inclusion of 14.7% reduces quantitative accuracy despite plausible context. No other numbers are present to cross-validate. (3) The multi-hop reasoning is partially sound: the LLM correctly synthesizes the re-categorization of HNB products under the broader smoke-free umbrella alongside e-vapor and oral nicotine products, which aligns with the 2023 shift described in the ground truth. It also correctly identifies the continuity in reduced-risk positioning from 2022 to 2023. However, it misses the key detail about PMI including licensed KT&G heat-not-burn products in its portfolio—a significant indicator of expanded partnerships and strategic broadening that is central to the original answer. This omission affects completeness and qualitative accuracy. (4) The answer remains contextually relevant and conveys much of the correct strategic narrative, but the addition of unverified quantitative data and the omission of the KT&G partnership detail prevent a higher score. The overall meaning is semantically close but not fully equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 495,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database between 2023 and 2024 has emphasized enhanced deployment flexibility and deeper integration with other Oracle technologies. In 2024, Oracle has expanded deployment options, offering Oracle Database through on-premise, cloud-based (OCI), and hybrid models, including Oracle Exadata Cloud@Customer and OCI Dedicated Region. Additionally, Oracle has strengthened integration with its Oracle Cloud Infrastructure (OCI) and Oracle Autonomous Database, enabling seamless operations, automated management, and support for AI and machine learning. These advancements reflect Oracle's focus on providing customers with scalable, secure, and flexible solutions across diverse IT environments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution between 2023 and 2024. It accurately captures Oracle's continued emphasis on deployment flexibility (on-premise, cloud, hybrid) and deeper integration with Oracle technologies like OCI and Exadata. The mention of Oracle Exadata Cloud@Customer and OCI Dedicated Region reflects accurate deployment models introduced or emphasized in 2024, which supports the shift toward integrated engineered systems. The integration with Oracle Autonomous Database, AI, and machine learning is contextually relevant and consistent with Oracle's strategic direction. However, the LLM answer does not explicitly contrast 2023's focus on perpetual licensing and customer choice with standalone deployment flexibility, which was a key differentiator in the original answer. Additionally, while it mentions integration with OCI and Autonomous Database, it does not clearly articulate the evolution of Oracle Database becoming a foundational component within engineered systems like Oracle Exadata Database Machine as a core strategic shift. These omissions reduce completeness in the multi-hop synthesis between years and strategic positioning. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited), and all entities (OCI, Exadata, Autonomous Database) are correctly identified with appropriate context. The reasoning is sound but slightly less precise in capturing the nuance of the strategic shift from flexibility to integration. Semantic equivalence is high, though not complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 440,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "BMY's strategic relationship with Krazati evolved significantly in 2024 through the acquisition of Mirati, a commercial-stage targeted oncology company, which provided BMY with the rights to commercialize Krazati (adagrasib), a KRAS G12C inhibitor approved for second-line non-small cell lung cancer (NSCLC) and in development for first-line NSCLC in combination with a PD-1 inhibitor. The acquisition, finalized in January 2024, involved a total consideration of $4.8 billion, including $4.1 billion net of cash acquired, and also included contingent value rights (CVRs) potentially worth up to $1.0 billion tied to the FDA acceptance of an NDA for Mirati’s PRMT5 Inhibitor within seven years. This acquisition reflects BMY's commitment to strengthening its oncology portfolio and expanding its presence in targeted therapies.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, all numbers are accurate: the $4.8 billion total acquisition cost, $4.1 billion net of cash (implied to be part of the total consideration), and the $1.0 billion in contingent value rights (CVRs) tied to FDA NDA acceptance for the PRMT5 Inhibitor within seven years are all correctly reported. The timing (acquisition finalized in January 2024) aligns with the 2024 evolution. (2) The answer addresses both parts of the question: it describes the evolution from 2023 (Krazati as part of BMY's portfolio via Mirati) to 2024 (full acquisition), and specifies the financial commitments in 2024. (3) Entities are accurate: BMY, Mirati, Krazati (adagrasib), KRAS G12C inhibitor, NSCLC indications (second-line and first-line), PD-1 combination, PRMT5 Inhibitor, FDA, EMA. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects BMY’s acquisition of Mirati to obtaining Krazati, links the approvals and development status, and explains the strategic rationale (strengthening oncology portfolio in targeted therapies). The mention of CVRs as a contingent commitment further demonstrates accurate synthesis of future financial obligations. Wording differs slightly from the original answer but maintains full semantic equivalence and adds helpful detail (e.g., mechanism of action, combination therapy) without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 398,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "The 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were registered under Section 12(b) of the Exchange Act in both 2022 and 2023, with the trading symbol BK/P on the New York Stock Exchange. In both years, the securities were fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. There is no indication of a change in their status or treatment between 2022 and 2023 based on the provided filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the securities are correctly identified as 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV, registered under Section 12(b) of the Exchange Act in both 2022 and 2023, listed on the NYSE under symbol BK/P, and fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. (2) There are no numeric or date inaccuracies; the percentage (6.244%) and years (2022, 2023) match exactly. No calculations were required, but the synthesis of status across years is accurate. (3) The multi-hop reasoning is sound—comparing the treatment of the securities across two years based on SEC filings—and correctly concludes no change occurred. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in status or treatment. Wording differs slightly (e.g., 'no indication of a change' vs. 'there was no change'), but the meaning is equivalent given the context of filing-based analysis. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 322,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "From 2022 to 2023, PMI's short-term credit arrangements increased from approximately $2.3 billion to $2.7 billion, while borrowings under these arrangements rose slightly from $225 million to $283 million. This increase in available credit suggests that PMI has enhanced its near-term liquidity posture, potentially to support working capital needs, strategic initiatives, or to provide a buffer for operational flexibility. The unchanged committed credit facilities and the absence of borrowings under these facilities further indicate a strong liquidity position.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, PMI's short-term credit capacity was $1.9 billion in 2022, but the LLM states $2.3 billion—a material overstatement. Additionally, the ground truth reports utilization decreased from $295 million to $283 million, whereas the LLM claims utilization increased from $225 million to $283 million. These errors affect both the starting capacity and utilization figures, undermining the factual basis of the response. (2) Calculations and comparisons are therefore incorrect: the LLM implies both capacity and utilization increased, while the truth shows capacity increased and utilization slightly decreased. This misrepresents the trend in liquidity usage. (3) The reasoning and synthesis are partially sound—the conclusion that increased capacity suggests improved liquidity posture is reasonable and aligns with the ground truth’s interpretation. However, the LLM incorrectly frames rising utilization as a factor, when in fact utilization declined, weakening the accuracy of the inference. The mention of 'unchanged committed credit facilities' and 'absence of borrowings' introduces details not in the original answer and may reflect confusion between different credit facilities. (4) Despite incorrect numbers, the answer addresses all parts of the question (capacity, utilization, liquidity implications) and attempts correct multi-hop reasoning. Semantic equivalence fails on key metrics, but the general direction of the conclusion (improved liquidity buffer) is consistent. Hence, partial credit is given for structure and intent, but significant deductions apply for factual and numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 467,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "Between 2023 and 2024, Oracle has enhanced the positioning of its Autonomous Database by emphasizing deeper integration with other Oracle Cloud services and expanding automation capabilities. The 2024 documentation highlights improved integration with services like Java Cloud and Oracle APEX, enabling developers to build modern, cloud-native applications on an open platform. Additionally, Oracle has expanded the automation features of the Autonomous Database, leveraging machine learning for diagnostics, fault prediction, and self-driving operations, which reduces human error and lowers administrative costs. These advancements reflect Oracle's focus on delivering a more seamless, scalable, and intelligent cloud ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: the evolution from 2023 to 2024 is accurately portrayed, with Oracle enhancing Autonomous Database positioning through deeper integration with Oracle Cloud services such as Java Cloud and Oracle APEX, which matches the original answer. Automation capabilities powered by machine learning—specifically diagnostics, fault prediction, and self-driving operations—are correctly identified and consistent with the 2024 emphasis on ML-driven automation including error handling and threat detection. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; thus, quantitative accuracy is 10 as no inaccuracies exist. (3) The multi-hop reasoning is sound: the model synthesizes Oracle's shifting focus across years and correctly infers the strategic direction involving integration and automation. The only minor omission is that the 2024 positioning also emphasized open interfaces and native machine learning for data lake houses and real-time analytics, which the LLM answer does not explicitly mention. While 'modern cloud-native application development' is referenced, the specific mention of analytics and data lake houses adds contextual depth missing in the LLM response. (4) Despite this slight incompleteness, the answer captures the core evolution accurately, uses semantically equivalent language, and remains fully relevant to the question. Hence, correctness is 9 due to high accuracy with a minor gap in completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 435,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "Between 2023 and 2024, GM's financial relationship with Ultium Cells Holdings LLC remained stable in terms of capital involvement, with GM contributing $0.7 billion in 2024 and $0.8 billion in 2023 to the joint venture. Strategically, GM continued its commitment to Ultium Cells as part of its electrification efforts, though the documents do not indicate any significant changes in the partnership's positioning during this period. The committed capital contributions and GM's exposure to Ultium Cells remained consistent, reflecting ongoing support for battery cell production to meet GM's EV goals.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly characterizes GM's capital involvement as stable, stating contributions of $0.8 billion in 2023 and $0.7 billion in 2024. However, the ground truth clarifies that the 2023 amount was a *contingent commitment*, not an actual contribution, while the 2024 amount represents a *realized investment*. This misrepresents the nature of the financial relationship. (2) Quantitatively, the dollar amounts ($0.8B and $0.7B) are numerically accurate and in correct years, so number accuracy is partially correct. However, the interpretation of these figures—as actual contributions in both years—is factually wrong. The 2023 figure was a contingent liability, not a realized outflow. (3) The reasoning is flawed: the LLM concludes the relationship 'remained stable' and that there was 'no significant change', which directly contradicts the ground truth that identifies a strategic shift from a variable interest entity (VIE) with no control to a direct investment implying greater influence. This fails the multi-hop synthesis—linking changes in capital structure to strategic positioning. (4) Contextual relevance is moderate: the answer addresses GM’s relationship with Ultium Cells and mentions electrification strategy, but misses the core evolution in financial structure and control. The conclusion downplays a key strategic shift, rendering the overall assessment incorrect despite relevant topic coverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 400,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "Between 2022 and 2024, the financial impact of the Litigation Management Deed evolved as follows: in 2022, Visa released $3.5 billion of as-converted value and issued 176,655 series A preferred shares during the Sixth Anniversary Release. By 2024, the Eighth Anniversary Release resulted in $2.7 billion of as-converted value being released, with the issuance of 99,264 series A preferred shares. This reflects a decrease in both the as-converted value released and the number of series A preferred shares issued compared to 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $3.5 billion and 176,655 shares in 2022, and $2.7 billion and 99,264 shares in 2024. These values exactly match the original answer, with no discrepancies in dollar amounts or share counts. (2) The answer is complete, addressing both parts of the question: the evolution of as-converted value released and the number of series A preferred shares issued across the two years. (3) Entity accuracy is correct—Visa is the responsible company, the years (2022 and 2024) are correctly tied to the sixth and eighth anniversary releases, respectively, and the financial instruments (as-converted value, series A preferred stock) are properly identified. (4) The reasoning is sound: the LLM correctly infers a decrease in both value and shares issued, indicating reduced financial burden, which aligns with the multi-hop synthesis required from two separate data points. (5) Semantic equivalence is achieved—though wording differs slightly, the meaning, facts, and implications are identical to the ground truth. No errors in calculation, logic, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 331,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "Between 2023 and 2024, the financial and strategic relationship between 3M and the Aearo Entities evolved significantly due to litigation impacts and business segment adjustments. In 2022, 3M deconsolidated the Aearo Entities through a voluntary Chapter 11 bankruptcy, but reconsolidated them in 2023 after the bankruptcy was dismissed. This reconsolidation affected financial reporting and segment adjustments, particularly in the Safety and Industrial and Transportation and Electronics segments. Litigation related to Combat Arms Earplugs and respirator mask/asbestos claims led to significant charges, including a $1.2 billion pre-tax charge in 2022 and a $4.2 billion pre-tax charge in 2023 under the CAE Settlement. In 2024, the Aearo Entities were fully integrated back into 3M's operations, and the CAE Settlement implementation began, with 3M committing $6.0 billion through 2029 to resolve claims. These developments impacted 3M’s financial structure and segment operating income, particularly through special items and litigation costs.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The $1.2 billion pre-tax charge in 2022 and $4.2 billion in 2023 for the CAE Settlement are not supported by the ground truth, which does not specify these exact figures or attribute a $1.2B charge to 2022. The $6.0 billion commitment through 2029 is also absent from the original answer, making these numbers unverified and likely incorrect. (2) The timeline is partially correct: the deconsolidation in 2022 and reconsolidation in 2023 are accurately noted, as is the dismissal of bankruptcy enabling reconsolidation. However, the original answer emphasizes that the reconsolidation had an immaterial income statement impact, which contradicts the LLM's implication of significant financial charges directly tied to reconsolidation. (3) The qualitative reasoning shows partial multi-hop synthesis: the LLM correctly links litigation (Combat Arms Earplugs) to the CAE Settlement and notes segment reporting impacts. However, it mischaracterizes the 2024 status by claiming the Aearo Entities were 'fully integrated back' and that settlement implementation began, whereas the ground truth only notes their mention in divestiture/acquisition effects in the Transportation and Electronics segment. The shift from litigation to strategic financial treatment is partially captured but overstated. (4) Contextual relevance is strong—the answer addresses both litigation impact and business segment adjustments as asked. However, the inclusion of unsupported financial figures and overstatement of integration efforts reduces factual reliability. The mention of 'respirator mask/asbestos claims' introduces a topic not present in the original answer, adding potential confusion. Thus, while the structure and intent align with the question, key facts and numbers are incorrect or unsubstantiated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 513,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "Between 2022 and 2024, the financial treatment and structure of Class C Common Stock evolved primarily through changes in its conversion features and earnings per share (EPS) performance. In 2024, the introduction of Class B-2 Common Stock via an exchange offer altered the capital structure, with Class B-2 shares having conversion rates that adjust with double the impact of Class B-1 shares. Class C Common Stock, which has no transfer restrictions, maintained its higher EPS compared to other classes, increasing from $38.97 in 2024 to $33.17 in 2023 and $28.03 in 2022, reflecting its smaller share count and higher income allocation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the EPS values and their direction over time. The ground truth states that in 2024, Class C Common Stock had a basic EPS of $33.17 and diluted EPS of $33.13, compared to Class A's $8.29 and $8.28. However, the LLM incorrectly claims EPS for Class C was $38.97 in 2024, $33.17 in 2023, and $28.03 in 2022—this trend is reversed and unsupported by the ground truth. Additionally, no mention of EPS for Class C in 2022 or 2023 exists in the original answer, so the LLM fabricated a time series. (2) The introduction of Class B-2 Common Stock via an exchange offer is not mentioned in the original answer and appears to be hallucinated. The original makes no reference to changes in conversion features or transfer restrictions for Class C stock. (3) The multi-hop reasoning is flawed: while the original answer contrasts Class C and Class A EPS in 2024 and references governance roles in 2022, the LLM invents structural changes and misrepresents financial performance trends. It fails to correctly synthesize the actual evolution—stable governance role but improved relative financial performance. (4) Despite incorrect numbers and invented details, the LLM does attempt to address the core question about Class C stock’s financial treatment and EPS performance relative to other classes, which supports a moderate contextual relevance score. However, due to major quantitative and qualitative errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 418,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "Qualcomm's involvement in the development and commercialization of ADAS/AD technology from fiscal 2022 to fiscal 2024 has evolved significantly, with a notable increase in strategic focus and revenue contributions. In fiscal 2022, ADAS/AD was mentioned as part of the automotive industry's long design-in timeframes and high regulatory requirements, indicating Qualcomm's early-stage engagement. By fiscal 2024, ADAS/AD was explicitly included in the automotive revenue stream under QCT, with automotive revenues rising from $1,509 million in 2022 to $2,910 million in 2024, reflecting expanded product offerings in connectivity, digital cockpit, and ADAS/AD solutions. This growth underscores Qualcomm's strategic investment in automotive technologies and its increasing commercialization of ADAS/AD capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Qualcomm's ADAS/AD involvement from development in fiscal 2022 to commercialization by fiscal 2024, aligning with the ground truth. It accurately identifies the shift from strategic investment to revenue generation and ties ADAS/AD to the automotive product line. However, the specific revenue figures cited—$1,509 million in 2022 and $2,910 million in 2024—are not present in the original answer and cannot be verified against the provided ground truth, which does not include any numerical revenue data. This introduces unverified quantitative claims, reducing confidence in quantitative accuracy. (2) While the original answer mentions the re-categorization of ADAS/AD under automotive revenue streams as evidence of commercialization, it does not provide specific revenue numbers or growth metrics. Therefore, the inclusion of precise dollar amounts in the LLM response, though plausible, is unsupported by the ground truth and constitutes a factual overreach. (3) The multi-hop reasoning is sound: the model correctly infers increased commercialization from the inclusion of ADAS/AD in revenue streams and contextualizes it within broader automotive growth. It also correctly identifies QCT (Qualcomm CDMA Technologies) as the segment reporting automotive revenues, which aligns with typical SEC filing structures. (4) Despite the unsupported numbers, the core qualitative narrative—evolution from development to commercialization via strategic investment and product categorization changes—is factually consistent with the ground truth. The answer is highly relevant and synthesizes the required information logically, earning high marks for qualitative accuracy and contextual relevance. The correctness score is reduced slightly due to the introduction of unverified financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 503,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa's U.S. Retrospective Responsibility Plan evolved by significantly increasing the U.S. litigation escrow account balance, from $1.4 billion in 2022 to $3.089 billion in 2024, reflecting additional deposits of $1.5 billion in 2024 and $1.0 billion in 2023. The plan's mechanisms, including the escrow account, class B stock conversion feature, and loss-sharing agreements, remained consistent in structure but were more actively funded to address ongoing litigation risks. This evolution suggests that Visa is proactively managing litigation risk by setting aside larger reserves, indicating a cautious and structured approach to ensuring financial preparedness for potential liabilities in covered litigation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth does not mention specific escrow account balances of $1.4 billion in 2022 or $3.089 billion in 2024, nor does it reference $1.5 billion or $1.0 billion deposits in 2024 and 2023. These numbers are entirely fabricated and not supported by the original answer. While the qualitative evolution toward a more structured plan is partially captured, the LLM misrepresents the nature of the evolution as primarily financial (increased funding) rather than structural (addition of new legal and financial mechanisms). (2) The quantitative claims are incorrect: no dollar amounts for the escrow account or deposits are present in the original answer, so the LLM's specific figures and implied calculations (e.g., $1.4B + $1.0B + $1.5B = $3.9B, which doesn't match $3.089B anyway) are invalid. This indicates a serious failure in factual reporting. (3) The multi-hop reasoning is flawed. The original answer emphasizes the introduction of new interrelated legal mechanisms (e.g., omnibus agreement, makewhole agreements, interchange judgment sharing), which the LLM only partially acknowledges (mentions class B conversion and loss-sharing but omits indemnification, interchange judgment sharing, and omnibus agreements). The LLM fails to capture the structural complexity added to the plan, instead reducing the evolution to increased funding, which is not stated in the ground truth. (4) The contextual relevance is fair—the answer addresses litigation risk and the escrow account, which are relevant—but the emphasis on unverified financial figures and omission of key structural changes severely undermines accuracy. Correctness is scored low due to invented numbers and incomplete mechanism coverage; qualitative accuracy is moderate because some correct concepts are mentioned but not fully or correctly explained.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 524,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "Merck's financial stake in Lynparza, as reflected in alliance revenue, increased by 9% in 2024 compared to 2023, primarily driven by higher demand in most international markets. This growth suggests that Lynparza maintained strategic importance for Merck, particularly outside the U.S., despite challenges in other areas of its portfolio. Additionally, the approval of Lynparza in China in January 2025 for adjuvant treatment of early breast cancer indicates a potential for further growth, reinforcing its ongoing significance in Merck's oncology portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 9% growth in alliance revenue for Lynparza in 2024 compared to 2023, which matches the ground truth. It also accurately references the January 2025 China approval for adjuvant treatment in early breast cancer. However, it omits the specific $1.5 billion net intangible asset reported by Merck in 2023, which was a key part of the financial stake and present in the original answer. This is a minor omission but affects completeness. (2) All numbers and dates are correct: 9% revenue growth and January 2025 approval are accurately stated. No calculations are required, but the comparison across years is sound. (3) The multi-hop reasoning is strong—linking revenue growth, international demand, and regulatory expansion to strategic importance is valid and supported by the ground truth. The synthesis across financial performance and regulatory developments is logically coherent. (4) The answer is contextually highly relevant, directly addressing the evolution of Merck's stake and indicators of performance/strategic importance. The omission of the $1.5B asset prevents a perfect score, but all other elements are factually and semantically aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 346,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "Skoal's market position within Altria's oral tobacco products segment weakened between 2022 and 2024, as its shipment volume declined from 163.1 million packs in 2023 to 147 million packs in 2024, and its retail share dropped from 9.3% to 7.6%. This decline was driven by retail share losses in the moist smokeless tobacco (MST) category, as competition intensified from oral nicotine pouches like on!, which saw increased market penetration. While on! gained share within the nicotine pouch category, Skoal's performance was further impacted by a non-cash impairment of the Skoal trademark in 2024, signaling a strategic shift toward newer product categories.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the key figures are accurate: Skoal's retail share decline from 9.3% in 2022 to 7.6% in 2024 is correctly stated. The mention of shipment volumes (163.1 million packs in 2023 to 147 million in 2024) is factually consistent with external data, though not included in the original answer; this adds detail without contradicting the ground truth. (2) The competitive dynamics are accurately portrayed: on! increased in share, and the shift toward nicotine pouches is correctly identified as a driver. However, the original answer includes additional context—Altria's total oral segment share dropped from 42.5% to 37.5%, and Copenhagen declined from 23.5% to 19.1%—which the LLM omits, missing a key comparative dimension. (3) The reasoning is sound: the LLM correctly infers that Skoal underperformed relative to on! and attributes the decline to category shifts and the 2024 non-cash trademark impairment, which is a valid strategic signal. (4) While the LLM introduces shipment volume and impairment details not in the original, these do not contradict but rather supplement the answer. However, the absence of direct comparison with Copenhagen and total segment performance limits completeness on the multi-hop aspect of competitive performance. Overall, the answer is factually accurate and contextually relevant, but slightly less comprehensive in comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 402,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "The revenue contribution from Dynamics 365 within Microsoft Cloud increased from $4.687 billion in fiscal year 2022 to $6.481 billion in fiscal year 2023, reflecting a growth of approximately 38.1%. This growth is attributed to the continued adoption of Dynamics 365, which includes a suite of intelligent, cloud-based applications across ERP, CRM, and other business solutions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces specific numerical figures not present in the original answer or ground truth. (1) Quantitative Accuracy: The LLM claims Dynamics 365 revenue was $4.687 billion in FY2022 and $6.481 billion in FY2023, with 38.1% growth. However, the original answer does not provide exact revenue figures for Dynamics 365 in either year. It only states that Dynamics 365 grew 39% in FY2022 and is part of the broader Microsoft Cloud revenue ($91.2B in FY2022, $111.6B in FY2023). There is no mention of a 38.1% growth or exact dollar amounts for Dynamics 365 in FY2023. These numbers are fabricated or hallucinated. (2) Completeness: While the question asks about the evolution of revenue contribution, the LLM invents precise data rather than acknowledging the partial information available, failing to reflect the uncertainty in the 2023 growth rate as noted in the ground truth. (3) Entity Accuracy: The companies (Microsoft, Dynamics 365), product lines (ERP, CRM), and fiscal years (2022, 2023) are correctly identified. (4) Reasoning: The multi-hop synthesis is flawed. The original answer infers sustained growth based on inclusion in Microsoft Cloud but does not quantify FY2023 growth. The LLM incorrectly assumes precise figures and calculates a false growth rate. (5) Semantic Equivalence: The LLM answer is not semantically equivalent—it asserts concrete numbers and growth where the ground truth explicitly lacks them. The contextual relevance is moderate because it addresses the right topic and trend (growth in Dynamics 365), but the factual foundation is unsound. Correctness score is low due to major quantitative inaccuracies and hallucination of data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 462,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "Merck's Balance Sheet Risk Management Program for foreign exchange exposure in 2024 shows a continuation of its 2023 approach, with forward exchange contracts remaining the primary hedging instruments to offset the effects of foreign exchange volatility on monetary assets and liabilities. The scope of hedging activities in 2024 remains focused on major currencies such as the euro, Swiss franc, Japanese yen, and Chinese renminbi, consistent with 2023. However, in 2024, Merck expanded its interest rate risk management by entering into an additional interest rate swap contract in January 2025, which was not mentioned in the 2023 disclosures, indicating a slight evolution in its broader risk management strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and omits key aspects of Merck's evolution in foreign exchange risk management. While it correctly notes the continued use of forward exchange contracts and the focus on major currencies (euro, Swiss franc, Japanese yen, Chinese renminbi), it fails to mention the introduction of purchased local currency put options and collar options in 2024, which is a central part of the ground truth. Instead, it incorrectly shifts focus to interest rate risk management, citing an 'additional interest rate swap contract in January 2025'—a detail not present in the original answer and irrelevant to the question about foreign exchange exposure. (2) The date 'January 2025' is factually incorrect in context, as the question asks about developments from 2023 to 2024; referencing a 2025 event is both chronologically inconsistent and unrelated to the actual evolution in hedging instruments. There are no numerical values to verify, but the misrepresentation of instruments and timing undermines quantitative accuracy. (3) The multi-hop reasoning is flawed: the model fails to synthesize the correct evolution in instruments (from forwards only to including options) and misattributes changes to interest rate instruments instead of foreign exchange tools. It also misses the strategic layering of hedges over time based on cost-benefit assessments, a key qualitative shift in 2024. (4) The contextual relevance is moderate because the answer addresses Merck and foreign exchange hedging broadly, but the incorrect pivot to interest rate swaps and omission of critical new instruments (put and collar options) severely limits accuracy. The core evolution described in the ground truth is not captured, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 488,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "PayPal's involvement with merchant receivables between 2022 and 2024 shows growth in its merchant financing products, with the outstanding balance increasing from $1.2 billion in 2023 to $1.5 billion in 2024. In terms of credit loss provisions, the allowance for credit losses on merchant receivables decreased from $160 million at the end of 2023 to $113 million by the end of 2024, primarily due to an improvement in the credit quality of the PayPal Business Loan (PPBL) portfolio. This reflects PayPal's active monitoring and management of credit risk in its merchant financing offerings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly notes the increase in outstanding merchant receivables from $1.2 billion in 2023 to $1.5 billion in 2024, it introduces a specific credit loss provision figure of $160 million in 2023 and $113 million in 2024, which are not present in the original answer and contradict the ground truth. The original answer discusses a principal and interest coverage ratio of 9% as of December 31, 2021 (down from 23% in 2020), but the LLM does not mention this key metric at all. Instead, it fabricates allowance amounts not supported by the ground truth. (2) The quantitative accuracy is low because the LLM invents precise dollar figures for credit loss allowances that are not in the original data. The only correct number is the $1.5 billion outstanding balance in 2024 and the $1.2 billion in 2023. The $1.8 billion in receivables purchased in 2024 — a key point in the original — is entirely missing. (3) The reasoning is partially sound in identifying increased involvement in merchant financing, but it fails the multi-hop synthesis by not connecting PayPal’s shift from risk disclosure in 2022 to active investment in 2024. The mention of PPBL credit quality improvement is speculative and not in the original. The strategic shift involving products like PPWC and PPBL as a move from passive risk assessment to active investment is omitted. (4) Contextual relevance is high because the answer addresses merchant receivables, credit loss provisions, and financing products. However, due to significant factual errors and omission of core elements (e.g., 2022 methodology, $1.8B purchases, coverage ratios), the correctness and quantitative accuracy scores are low. The answer appears plausible but misrepresents the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 489,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "From 2022 to 2024, the financial significance of smokeable products to MO (Altria) remained relatively stable in terms of goodwill allocation, with $99 million in 2022 and $99 million in 2024. However, operating income performance for smokeable products increased from $10,670 million in 2023 to $10,821 million in 2024, indicating improved profitability despite a slight decline in net revenues. This suggests that smokeable products remained a core, stable contributor to Altria's financial performance during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the goodwill allocated to smokeable products was $99 million in 2024. The original answer (ground truth) explicitly states that no updated goodwill figure is disclosed for smokeable products in 2024. By asserting a specific $99M figure for 2024, the LLM incorrectly implies continuity or disclosure that does not exist, which undermines the quantitative and qualitative accuracy. All other numbers are correct: the 2022 goodwill of $99M is accurate, and the operating income increase from $10,670M in 2023 to $10,821M in 2024 is correctly reported. (2) Calculations: The income difference of $151M is implied and accurate, but no explicit calculation error is made. However, the erroneous repetition of the 2022 goodwill into 2024 constitutes a false quantitative claim. (3) Multi-hop reasoning: The model attempts to synthesize goodwill and operating income trends across years, which aligns with the question’s requirements. However, it fails on the critical point of 2024 goodwill disclosure status—instead of noting it is undisclosed (as per ground truth), it fabricates or assumes unchanged allocation, which breaks the reasoning chain. The ground truth interprets the lack of disclosure as a potential shift in reporting focus, a nuance entirely missed in the LLM answer. (4) Contextual relevance is high because the answer addresses both goodwill and operating income over the requested timeframe and draws a reasonable conclusion about financial significance. However, due to the major factual inaccuracy regarding 2024 goodwill, the correctness score is significantly reduced. Quantitative accuracy is medium because half the numbers are correct but one key figure is wrong. Qualitative accuracy suffers due to flawed reasoning about asset valuation reporting. Final scores reflect partial correctness with a major factual flaw.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 518,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "The revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud increased from $13.6 billion in fiscal year 2022 to $14.9 billion in fiscal year 2023, representing a growth of approximately $1.3 billion or 9.5%.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The original answer (ground truth) states that Microsoft Cloud revenue — which includes the commercial portion of LinkedIn — was $91.2 billion in FY2022 and $111.6 billion in FY2023. The LLM incorrectly reports the revenue contribution specifically from the commercial portion of LinkedIn as $13.6B and $14.9B for those years, which is not supported by the ground truth. There is no breakdown in the original answer isolating LinkedIn’s commercial revenue, so the LLM fabricated specific figures without basis. (2) The numbers $13.6B, $14.9B, $1.3B growth, and 9.5% increase are all quantitatively inaccurate because they do not appear in or follow from the ground truth. The actual Microsoft Cloud revenue growth was $20.4B (from $91.2B to $111.6B), or about 22.4%, but this includes all commercial cloud services (Azure, Office 365, etc.), not just LinkedIn. (3) The multi-hop reasoning failed: the model should have recognized that LinkedIn’s commercial revenue is embedded within Microsoft Cloud but not separately disclosed in the provided data. Instead, it falsely disaggregated the data, committing a significant factual error. (4) The contextual relevance is moderate because the answer addresses revenue evolution in the right timeframe and domain, but correctness and quantitative accuracy are extremely low due to invented metrics. Qualitative accuracy is low because the reasoning and entity usage (misrepresenting LinkedIn's revenue) are flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 421,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "Between 2023 and 2024, the commercialization and market expansion of Lynparza evolved with geographic approvals and revenue growth. In May 2023, Lynparza received FDA approval in combination with abiraterone and prednisone for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC), based on the PROpel trial. This was followed by Japan's MHLW approval in August 2023 for the same indication. By 2024, Lynparza's alliance revenue grew by 9%, driven by higher demand in most international markets. In January 2025, Lynparza received NMPA approval in China as adjuvant treatment for germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, further expanding its geographic reach and contributing to revenue growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: FDA and Japan MHLW approvals in 2023 for BRCA-mutated mCRPC based on the PROpel trial, 9% alliance revenue growth in 2024 due to international demand, and China NMPA approval in January 2025 for early breast cancer based on OlympiA. The specific months (May 2023 for FDA, August 2023 for MHLW) are additional details not contradicted by the original answer and consistent with public knowledge, so they do not reduce accuracy. (2) All quantitative elements are correct: the 9% revenue growth is accurately reported, and the timeline (2023 approvals, 2024 growth, January 2025 China approval) matches the original. No calculations were required, but temporal and percentage data are precise. (3) Multi-hop reasoning is sound—LLM synthesizes regulatory approvals across geographies (US, Japan, China), ties them to clinical trial data (PROpel, OlympiA), and links to revenue impact, showing understanding of commercialization evolution. (4) The only minor limitation is that the original answer does not specify the exact months of the 2023 approvals, so including May and August, while plausible, introduces slightly more detail than supported by the ground truth. However, this does not constitute an error, just a small over-precision. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 397,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "Between 2023 and 2024, the Powder Metal Matter had a notable impact on RTX's future income tax benefits. In 2023, the Powder Metal Matter contributed $644 million to future income tax benefits, as listed under deferred tax assets and liabilities. By 2024, this amount decreased to $455 million, indicating a reduction in the associated tax benefits. This decline suggests that the financial impact of the Powder Metal Matter on RTX's future tax positions diminished over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the dollar amounts for future income tax benefits in both 2023 ($644 million) and 2024 ($455 million), which matches the ground truth. It also accurately notes the decrease in value, though it does not explicitly calculate the $189 million difference or the 29.3% decline. These omissions affect completeness but do not make the answer factually incorrect. (2) Quantitatively, the numbers are accurate and properly attributed to the correct years. However, the answer fails to mention the key shift in financial treatment from 'reduction in sales' in 2023 to 'future income tax benefit' in 2024, which is a critical qualitative change described in the original answer. This omission limits the depth of the response. (3) The multi-hop reasoning is partially sound — the model correctly retrieves and compares tax benefit figures across years but misses the conceptual evolution in accounting treatment (from sales impact to tax asset), which is central to how the Powder Metal Matter's financial treatment evolved. (4) Scores reflect high factual accuracy in numbers (quantitative accuracy: 8), moderate gap in capturing full conceptual shift and synthesis (qualitative accuracy: 7), full relevance to the question (contextual relevance: 10), and an overall correct but incomplete picture (correctness: 7).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 378,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "The borrowing capacity and terms of the Paidy Credit Agreement evolved from 2022 to 2024 as follows: In February 2022, the Paidy Credit Agreement initially provided for an unsecured revolving credit facility of ¥60.0 billion. This was modified in September 2022 to increase the borrowing capacity by ¥30.0 billion, bringing the total to ¥90.0 billion (approximately $574 million as of December 31, 2024). By December 31, 2024, the full ¥90.0 billion had been drawn down, leaving no available borrowing capacity. The terms included interest at the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60%, based on the company's public debt rating.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that in February 2022, the Paidy Credit Agreement was an unsecured facility of ¥60.0 billion. The ground truth indicates that in 2022, the facility was secured and had a capacity of approximately $198 million (not ¥60.0 billion), with $98 million outstanding as of December 31, 2021. The LLM also misrepresents the timeline by claiming a September 2022 modification increased capacity by ¥30.0 billion to ¥90.0 billion, which is not supported by the original answer. The original does not specify when the increase occurred, only that by 2024 the capacity was ¥90.0 billion (~$574 million). Additionally, the LLM claims the full ¥90.0 billion was drawn down by December 31, 2024, leaving no available capacity—this detail is absent from the ground truth and thus unsupported. (2) Quantitatively, the $574 million equivalent for ¥90.0 billion in 2024 is consistent with the original answer and acceptable. However, the use of ¥60.0 billion and ¥30.0 billion in 2022 is incorrect—the original does not express the 2022 amount in yen, nor does it mention a September 2022 amendment. The interest rate (TIBOR + 0.40%–0.60%) is correctly reported, though the LLM adds a detail about the margin being based on public debt rating, which is not in the original. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution from a secured $198M facility in 2022 to an unsecured ¥90B (~$574M) facility in 2024. It invents specific yen amounts and amendment dates not present in the source, and omits key changes such as the shift from secured to unsecured and the introduction of a consolidated leverage ratio covenant. (4) Despite these errors, the answer is contextually relevant and attempts to address the evolution of borrowing capacity and terms. The interest rate and final capacity are correct, and the focus on changes over time is appropriate. However, major factual and structural inaccuracies reduce correctness significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 553,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "Between 2022 and 2024, Altria's reliance on long-term senior unsecured notes as part of its capital resources remained a key component, though with some changes in structure and amounts. In 2022, Altria had $28.0 billion in total debt, with long-term senior unsecured notes forming a significant portion. By 2024, total long-term debt had decreased to $24.9 billion, reflecting debt repayments and refinancing activities. Notably, in 2024, Altria issued $1.0 billion in new senior unsecured notes to refinance maturing debt, indicating a continued strategic use of long-term senior unsecured notes to manage its capital structure and liquidity needs.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies compared to the ground truth. While it correctly identifies that Altria continued to rely on long-term senior unsecured notes between 2022 and 2024, it introduces specific total debt figures—$28.0 billion in 2022 and $24.9 billion in 2024—that are not present in the original answer and cannot be verified from the provided ground truth. The ground truth emphasizes changes in cash and cash equivalents ($4.5B in 2022 vs $3.1B in 2024) and implies increased reliance on external financing due to reduced cash reserves, but the LLM omits this key point entirely. Additionally, the LLM mentions a $1.0 billion note issuance in 2024 for refinancing, which is plausible but not confirmed in the original answer. (2) Quantitative accuracy is low because the dollar amounts for total debt and new issuances are unsupported by the ground truth. The only verifiable numbers in the original are cash balances, which the LLM fails to mention. (3) The reasoning is partially sound—recognizing continued use of senior unsecured notes is correct—but it misses the multi-hop insight that declining cash reserves suggest increased reliance on external financing, which is central to the original answer. The LLM focuses on debt reduction and refinancing rather than evolving reliance due to lower internal liquidity. (4) Contextual relevance is high because the answer addresses the core topic—Altria’s use of long-term senior unsecured notes over time—and discusses structural changes appropriately. However, the lack of alignment with key facts and omission of critical comparative data (cash levels) limits correctness. Overall, the answer provides plausible qualitative context but fails on key quantitative and inferential elements from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 491,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "RTX's financial treatment of the Powder Metal Matter evolved from a $5.4 billion net sales charge in 2023 to a reduced $2.5 billion net reduction in cost of sales in 2024, primarily reflecting partners' shares. This indicates that the matter's impact on future income tax benefits diminished, as the deferred tax asset related to the Powder Metal Matter decreased from $644 million in 2023 to $455 million in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in the deferred tax asset from $644 million in 2023 to $455 million in 2024, which matches the ground truth and supports the conclusion about diminishing future income tax benefits. However, the LLM introduces financial figures—$5.4 billion net sales charge in 2023 and $2.5 billion net reduction in cost of sales in 2024—that are not present in the original answer and are not corroborated by the ground truth. These figures appear to conflate other aspects of financial treatment (possibly from different contexts) and are factually unsupported in this response. (2) The key tax-related numbers ($644M → $455M) are accurate and correctly cited, but the additional dollar amounts (5.4B, 2.5B) are unverified and likely incorrect, significantly undermining quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly links the decline in deferred tax assets to reduced future tax benefits, showing valid synthesis. However, the inclusion of unverified operational charges introduces flawed reasoning and distracts from the core tax-focused evolution. (4) Despite the extraneous and inaccurate financial figures, the answer captures the essential truth about declining tax benefits and correctly interprets the implication. Hence, the correctness score is 7—core facts about tax benefits are right, but significant inaccuracies in ancillary details prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 405,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "PayPal's utilization of the Paidy Credit Agreement evolved significantly between 2022 and 2024. In 2022, the Paidy Credit Agreement had a borrowing capacity of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the agreement was modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and the full amount was drawn down, leaving no available borrowing capacity. This indicates a substantial increase in both borrowing capacity and actual drawdown from 2022 to 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $198 million borrowing capacity in 2022, $98 million outstanding as of December 31, 2021 (correctly contextualized for 2022 usage), and by 2024, the increased capacity of ¥90.0 billion (~$574 million) with full drawdown are all correctly reported. The conversion to $574 million is appropriately noted with the date (December 31, 2024), which aligns with typical reporting practices. (2) The answer is complete, addressing both borrowing capacity and actual drawdown for both time points, and captures the evolution over time. (3) Entities—PayPal, Paidy Credit Agreement, correct years (2022, 2024), and financial metrics—are accurately identified and used. (4) The reasoning is sound: it correctly infers increased reliance due to expanded capacity and full utilization, synthesizing multi-hop information (change in facility size and usage over time). (5) Semantic equivalence is maintained—wording differs slightly but conveys identical meaning and factual content. No errors in logic, calculation, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 320,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "From 2023 to 2024, the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. remained largely consistent, with noncontrolling interests held by current and former members of Accenture Leadership being less than 1% as of August 31, 2024. Holders of Accenture Canada Holdings Inc. exchangeable shares retained the right to exchange their shares for Accenture plc Class A ordinary shares on a one-for-one basis, and Accenture plc maintained the ability to redeem Class X ordinary shares to align with outstanding exchangeable shares. No significant changes were reported in the noncontrolling interests or the mechanics of the exchangeable shares during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports that noncontrolling interests were less than 1% as of August 31, 2024, which aligns with the ground truth. It also accurately describes the one-for-one exchange right of Accenture Canada Holdings Inc. exchangeable shares for Accenture plc Class A ordinary shares and references Class X shares. However, it incorrectly states that 'no significant changes were reported' and that the structure 'remained largely consistent,' which directly contradicts the ground truth that the equity relationship became more formalized and structured in 2024 with specific provisions around Class X shares and exchange mechanics. (2) Quantitatively, all numbers and dates (e.g., <1%, August 31, 2024) are accurate, and no calculations are required. (3) The multi-hop reasoning is flawed: while the LLM identifies the correct entities and some correct mechanics, it fails to synthesize the evolution from a simpler 2023 disclosure to a more structured 2024 framework. The ground truth emphasizes evolution and formalization, which the LLM denies. (4) The answer is contextually relevant and uses correct terminology, but the core conclusion about 'no significant changes' undermines factual correctness, leading to a moderate correctness score despite accurate individual facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 365,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "Between 2022 and 2024, Merck's approach to managing balance sheet risk through forward exchange contracts has evolved in terms of currencies and cost-benefit considerations. In 2022, Merck primarily focused on hedging exposures in the euro, Japanese yen, and Chinese renminbi, using forward contracts for developed and selected developing country currencies based on cost-benefit analysis. By 2024, the company expanded its hedging scope to include the Swiss franc, Japanese yen, and Chinese renminbi, with a continued emphasis on cost-benefit assessments to determine the economic viability of hedging instruments. The 2024 disclosures also highlight a preference for shorter-term contracts (average maturities of less than six months) to mitigate spot-forward differences, reflecting a more dynamic and responsive strategy to foreign exchange volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, Merck used forward exchange contracts for both developed and developing country currencies, specifically mentioning the Chinese renminbi, with hedging decisions based on a cost-benefit analysis considering exposure magnitude, volatility, and cost. By 2024, the detailed discussion of cost-benefit analysis and specific mention of the renminbi in developing markets was omitted, suggesting a shift or simplification. However, the LLM answer incorrectly claims that in 2024, Merck 'expanded its hedging scope to include the Swiss franc' and continued to emphasize cost-benefit assessments—this is not supported by the ground truth. There is no mention of the Swiss franc in the original, nor any indication of expansion; instead, the trend was a reduction in detail and specificity. Additionally, the LLM introduces new details not present in the original, such as 'shorter-term contracts (average maturities of less than six months)' and 'preference for shorter-term contracts to mitigate spot-forward differences,' which are entirely fabricated. (2) No numeric values (e.g., percentages, dollar amounts, maturities) appear in the original answer, so the LLM's introduction of 'less than six months' average maturity is an unsupported quantitative claim, reducing quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks for evolution in approach, and the correct inference from the original is a move away from detailed justification and specific currency mentions (like renminbi), implying a potential simplification. The LLM instead infers an expansion and refinement of strategy, which contradicts the evidence. (4) Contextual relevance is moderate because the answer addresses balance sheet risk, forward contracts, currencies, and cost-benefit considerations—but the factual foundation is incorrect, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 535,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "The change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggests a reduction in its financial impact on future income tax benefits. In 2023, the Powder Metal Matter contributed $644 million to future income tax benefits, while in 2024, this amount decreased to $455 million. This decline indicates that the anticipated tax benefits from this matter are diminishing, likely due to resolution or reduced expectations of future tax deductions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in future income tax benefits from $644 million in 2023 to $455 million in 2024, which matches the ground truth. However, it omits a key part of the multi-hop reasoning: in 2023, the Powder Metal Matter was primarily disclosed as a $5.3 billion net sales charge impacting operational revenue at Pratt & Whitney, not initially as a future income tax benefit. The shift from an operational loss to a tax asset is central to the question’s intent, but the LLM incorrectly states that in 2023 it 'contributed $644 million to future income tax benefits,' which misrepresents the nature of the 2023 disclosure. (2) Quantitatively, the $644M and $455M figures are accurate and correctly compared as decreasing, but the LLM misattributes the 2023 tax benefit as a concurrent item with the sales charge, when the ground truth implies a reclassification—meaning the $644M tax asset may have existed alongside or separately from the sales charge, but was not highlighted in the same way. (3) The reasoning is partially sound in noting diminishing tax benefits, but fails to capture the full multi-hop synthesis: the change in disclosure reflects a shift in accounting treatment from operational impact to tax asset recognition, suggesting resolution progress. The LLM interprets the decline in tax benefit as reduced expectations, while the ground truth suggests a reclassification and deferral, not necessarily diminished recovery. (4) Scores reflect high quantitative accuracy and relevance, but docked for incomplete and slightly incorrect qualitative reasoning due to misrepresentation of 2023 disclosure context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 456,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "PayPal expanded its merchant finance offerings between 2022 and 2024, with the outstanding balance of merchant loans, advances, and interest and fees receivable increasing from $1.2 billion in 2023 to $1.5 billion in 2024. The company continued its partnership with a U.S. partner institution to purchase receivables related to credit extended to merchants, acquiring $1.8 billion in 2024 compared to $1.7 billion in 2023. The credit quality of the merchant receivables improved, as evidenced by a decrease in delinquencies and a reduction in the allowance for credit losses from $160 million in 2023 to $113 million in 2024, primarily due to improvements in the PPBL portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in merchant receivables purchased ($1.7B to $1.8B) and the growth in outstanding balance ($1.2B to $1.5B), which aligns with the ground truth. However, it introduces a fact not present in the original answer — the allowance for credit losses decreasing from $160M to $113M and improved delinquencies — which is unsupported by the provided ground truth and thus factually incorrect in this context. Additionally, the LLM claims credit quality improved, but this inference is not in the original data and cannot be verified from the source. (2) The dollar amounts for receivables purchased and outstanding balances are accurate and correctly attributed to 2023 and 2024. However, the allowance figures and the claim about credit quality are not in the original answer, making them hallucinations. These quantitative inaccuracies reduce confidence in the response. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the evolution of PayPal’s scale in merchant finance and its ongoing relationship with a partner institution. However, it fails to mention WebBank specifically in 2022 or the structure of the program agreement (e.g., purchase and sale back of participation interests), which were key qualitative elements in the original answer. The evolution of the participation interest sold ($44M to $53M) is entirely omitted, weakening the completeness of the institutional collaboration narrative. (4) Despite missing key structural details and introducing unsupported data, the LLM captures the core trend of growth in scale and ongoing partnership, making it contextually relevant and mostly accurate in direction, but flawed in full factual fidelity. Hence, a score of 7 is justified for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 488,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Merck's alliance revenue from Lynparza increased by 9% in 2024 compared to 2023, and by 7% in 2023 compared to 2022. The growth in 2024 was primarily driven by higher demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for adjuvant treatment of certain early breast cancer, which is expected to further support its revenue growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that Merck's alliance revenue from Lynparza was $989 million in 2022 and grew by 9% by 2024. However, the LLM claims a 9% increase from 2023 to 2024 and a 7% increase from 2022 to 2023, which introduces data not present in the original answer and misrepresents the timeline. There is no mention in the ground truth of a 7% growth in 2023 or year-over-year breakdowns for 2023. The 9% growth is stated as occurring between 2022 and 2024, not just in 2024 alone. (2) The approval in China in January 2025 is correctly mentioned, but the LLM frames it as a future event that will support growth, while the original answer presents it as a contributing factor already reflected in the 2024 growth narrative—this is a subtle but important distinction in causality and timing. (3) The qualitative reasoning is partially sound: the LLM correctly identifies increased international demand and the China approval as growth drivers, showing multi-hop synthesis of market trends and regulatory developments. However, it fabricates an additional growth rate (7%) without support from the source, indicating flawed reasoning in deriving or recalling financial trends. (4) Contextual relevance is high—the answer addresses both parts of the question (revenue evolution and contributing factors), uses correct entities (Merck, Lynparza, China approval, international demand), and maintains focus. However, the invented intermediate growth figure undermines factual correctness, warranting a moderate score of 5/10 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 445,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "PayPal's involvement in merchant receivables evolved between 2022 and 2024 with increased financial exposure and a more active operational role. By 2024, the total outstanding balance of merchant loans, advances, and interest and fees receivable rose to $1.5 billion from $1.2 billion in 2023, reflecting expanded credit offerings like PPWC and PPBL. The company also took a more active role in underwriting and risk management, using internal models to assess merchant creditworthiness and monitor delinquency trends. Additionally, PayPal entered into agreements to purchase receivables from partner institutions, increasing its servicing responsibilities and financial exposure to merchant credit performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in PayPal's involvement in merchant receivables from 2022 to 2024. It correctly identifies the increase in outstanding balance from $1.2 billion to $1.5 billion and references expanded products like PPWC and PPBL, aligning with the ground truth. The operational shift—such as taking on servicing responsibilities and using internal models for underwriting and risk—is accurately reflected, indicating deeper engagement. However, the LLM omits the specific data point about PayPal purchasing $1.8 billion in receivables in 2024 (vs $1.7 billion in 2023), which is a key quantitative indicator of growing financial exposure. While it mentions purchasing receivables from partner institutions, it does not quantify the 2024 purchase amount, leading to a partial loss in quantitative accuracy. The years 2022 and 2024 are addressed thematically, though the 2022 context (CECL, credit losses, net charge-offs) is underdeveloped compared to the original. The reasoning is sound and synthesizes multi-hop elements (financial exposure, operational role, product expansion), but the missing 2024 purchase figure reduces completeness. Wording is semantically equivalent in most places and contextually relevant throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 355,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "Merck's involvement in the development and commercialization of Lynparza from 2022 to 2024 has shown regulatory progress and revenue growth. In 2022, Lynparza was under regulatory review for new indications, including adjuvant treatment for BRCA-mutated, HER2-negative early-stage breast cancer, with a PDUFA date set for the first quarter of 2022. By 2024, Lynparza's alliance revenue grew by 9%, driven by higher demand in most international markets. Additionally, in January 2025, China's National Medical Products Administration (NMPA) approved Lynparza as adjuvant treatment for germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating continued regulatory expansion and commercial success.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key facts from the ground truth. It accurately states that in 2022, Lynparza was under FDA review for adjuvant treatment of BRCA-mutated, HER2-negative early-stage breast cancer with a PDUFA date in Q1 2022. It correctly reports the 9% growth in alliance revenue in 2024 due to international demand. It also accurately notes the January 2025 approval in China by the NMPA (referred to as China's regulatory body) for the same indication, based on the OlympiA trial. (2) All quantitative elements are correct: the 9% revenue growth and the January 2025 approval date are consistent with the original answer. There are no calculation errors. (3) The multi-hop reasoning is sound—information is synthesized across time (2022 to 2024/2025), geography (U.S. regulatory context to China approval), and commercial performance (revenue growth). The mention of the OlympiA trial correctly links clinical data to regulatory decisions. (4) The only minor deviation is the phrasing of the Chinese regulator as 'NMPA' rather than stating 'China approval' as in the original, but this is more precise and still semantically equivalent. The LLM adds slight specificity (e.g., 'germline BRCA-mutated') not in the original but consistent with known facts and does not introduce inaccuracies. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 397,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "Between 2022 and 2024, Boeing extended the risk management horizon for its commodity purchase contracts, with hedging now covering forecasted transactions through 2028, up from previous periods. Additionally, the financial exposure related to these contracts remained relatively stable, as a 10% market price fluctuation would impact unrealized losses by approximately $46 million in 2022 and continued to be offset by gains or losses on the underlying transactions, ensuring no material market risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Boeing's extended risk management horizon and references the $46 million exposure from a 10% price change in 2022, which matches the ground truth. However, it incorrectly states that hedging now covers transactions through 2028, whereas the original answer specifies coverage through 2031—a significant three-year discrepancy in the risk management horizon. This undermines the accuracy of the evolution claim. (2) The $46 million figure is correctly cited, and the concept that gains/losses offset exposure (no material market risk) is consistent with the ground truth. However, the 2028 end date is factually incorrect compared to the documented 2031 horizon, which is a critical error in the temporal scope of Boeing’s strategy. (3) The reasoning correctly infers a strategic extension in hedging duration and connects it to risk management, but fails to capture the full multi-hop evolution from short-term hedging (2022) to a multi-decade outlook (through 2031), which reflects deeper integration with long-term production planning. The LLM answer mentions 'previous periods' without specifying 2022, weakening the comparative analysis. (4) The answer is contextually relevant and captures the essence of Boeing’s strategy shift and financial exposure stability, but the incorrect end year (2028 vs. 2031) and omission of the explicit link to production planning cycles reduce factual accuracy. Hence, correctness is partially compromised despite strong qualitative and contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 425,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "Between 2021 and 2024, Schwab's exposure to PALs (Portfolio Allowance Loans) remained fully collateralized, with securities pledged in amounts exceeding the borrowings as of December 31, 2021, and presumably continuing through 2024 based on the absence of any allowance for credit losses. In 2021, no allowance for credit losses was required for PALs due to full collateralization, and by 2024, the Company continued to maintain strong credit quality metrics, with no allowance for credit losses reported for PALs. This indicates that Schwab's credit risk associated with PALs remained minimal and effectively managed through collateralization throughout the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that in 2021, PALs were fully collateralized and no allowance for credit losses was required, which aligns with the ground truth. However, it incorrectly claims that no allowance for credit losses was reported in 2024 due to continued full collateralization. The ground truth states that by 2024, there was a decrease in the allowance for credit losses (implying one existed or was measured), driven by lower projected loss rates and improved credit quality—not solely by collateralization. This misrepresents the evolution of Schwab's risk management approach. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2021, 2024) are correct. (3) The multi-hop reasoning is partially flawed: while the model correctly identifies the 2021 condition, it fails to recognize the shift in credit risk assessment methodology by 2024—from reliance on collateralization to a broader credit quality and loss projection framework. This is a key analytical point in the original answer that the LLM misses. (4) The answer is contextually relevant and addresses the question’s focus on collateralization and credit risk, but omits and misstates the 2024 development regarding the allowance for credit losses, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 382,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "Between 2022 and 2024, Boeing's financial treatment and strategic positioning of the 777X program evolved significantly due to increasing cost impacts and rising research & development (R&D) investments. In 2022, R&D expenses for the 777X program were relatively lower at $278 million, but by 2023, these costs increased to $315 million, and further rose to $377 million in 2024, reflecting higher spending on product development. Concurrently, the 777X program began to contribute to cost overruns, as evidenced by the 2024 cost of sales, which included reach-forward losses on the 777X and 767 programs. This indicates a shift from R&D investment to financial strain due to production and delivery challenges, impacting Boeing’s overall profitability and strategic focus.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Boeing increased R&D spending by $525 million in 2023 over 2022 and by $435 million in 2024 over 2023, but the LLM fabricates specific annual R&D figures ($278M, $315M, $377M) that are not in the original answer and contradict the provided data. These numbers are quantitatively wrong and not supported by the ground truth. (2) The original answer does not specify absolute R&D amounts per year but emphasizes year-over-year increases ($525M in 2023, $435M in 2024), which the LLM misrepresents with invented figures. There is no mention of $278M or $377M in the ground truth, making the quantitative claims entirely incorrect. (3) The reasoning is flawed: the LLM interprets rising R&D and cost overruns as a 'shift to financial strain', while the ground truth describes a strategic shift from cost burden to investment priority, indicating improved strategic positioning despite earlier losses. The LLM incorrectly frames the evolution as deteriorating, whereas the original answer shows progression toward strategic focus. (4) Contextually, the answer addresses the 777X program and R&D trends, so it remains relevant, but the incorrect numbers, mischaracterized trend, and failure to reflect the actual multi-hop synthesis (from loss recognition to increased investment signaling strategic repositioning) severely undermine accuracy. The conclusion about 'financial strain' contradicts the ground truth's emphasis on strategic prioritization. Thus, while the topic is addressed, core facts and logic are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 443,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Between 2022 and 2024, Schwab's exposure to and risk management of Portfolio Against Loans (PALs) remained relatively stable in terms of methodology but showed growth in the portfolio. The credit loss allowance for PALs continued to rely on a practical expedient based on collateral maintenance provisions, recognizing that the portfolio is collateralized by marketable securities with liquid markets and is over-collateralized. This methodology limits inherent credit risk. The PALs portfolio grew from $17,024 million in 2024 to $17,024 million, indicating no change in the total portfolio size, but the 2024 data shows a breakdown of $16,726 million within one year, reflecting increased short-term exposure. Overall, Schwab maintained its risk management approach while managing a stable and collateralized PALs portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims the PALs portfolio was $17,024 million in both years, stating 'grew from $17,024 million in 2024 to $17,024 million', which implies no growth and is logically incoherent. This contradicts the ground truth, which notes portfolio growth with a slight decrease in 2023 but overall growth by 2024. The specific figure of $17,024 million is not mentioned in the ground truth, nor is the breakdown of $16,726 million, making these numbers unsupported and likely incorrect. (2) The ground truth emphasizes that the allowance for credit losses decreased as a ratio to year-end loans in 2024 due to improved credit quality and lower projected loss rates — a key evolution in risk management — but this is entirely missing from the LLM response. Instead, the LLM incorrectly suggests the methodology 'remained relatively stable', which contradicts the documented shift in allowance ratio and risk profile. (3) The multi-hop reasoning is flawed: the question asks for evolution between 2022 and 2024, requiring synthesis of changes in both exposure (portfolio growth) and risk management (allowance methodology). The LLM fails to capture the dynamic changes — particularly the reduced risk profile despite growth — and instead asserts stability, missing the core insight. (4) While the LLM correctly identifies the use of the practical expedient and over-collateralization in 2022, and mentions daily monitoring and collateral types, these accurate qualitative points are outweighed by the incorrect numerical claims and failure to report the evolving risk profile. The contextual relevance is moderate because it addresses PALs, collateral, and allowance methodology, but the incorrect data and reasoning undermine correctness. Quantitative accuracy is low due to fabricated numbers and illogical comparisons; qualitative accuracy is partial due to correct concepts but incorrect synthesis; contextual relevance is fair as it stays on topic but misses key developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 559,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "MDLZ's value of British pound sterling notes decreased from $360 million in 2022 to $0 in 2023, as no value was reported for 2023. This shift indicates that the company may have settled or restructured its British pound sterling hedges during the year, reflecting an active approach to managing foreign exchange risk by adjusting its hedging positions in response to market conditions or strategic priorities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that MDLZ's value of British pound sterling notes increased from $3 million in 2022 to $45 million in 2023. In contrast, the LLM claims a decrease from $360 million to $0, which misrepresents both the starting value and the trend. These numbers do not match any variation of the correct data and are significantly off. (2) The quantitative inaccuracies are severe: the 2022 value is overstated by a factor of 120 (claiming $360M vs actual $3M), and the 2023 value is reported as $0 instead of $45M. This results in a completely reversed narrative—decrease vs. actual large increase. Calculations and comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed because the model fails to retrieve the correct values from the knowledge base, leading to incorrect synthesis. Instead of identifying an increased exposure to GBP as indicated by the real data, the model concludes a complete elimination of exposure, which contradicts the ground truth. The reasoning about active risk management may be plausible in isolation, but it is based on false premises. (4) The contextual relevance is moderate because the answer addresses foreign exchange risk management strategy as asked, and the general structure responds to both parts of the question (change in value and strategic implication). However, due to the severe factual and quantitative errors, the qualitative accuracy and overall correctness are very low. Minor credit is given for attempting the correct type of analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 447,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "In both the 2022 and 2024 filings, Amgen's 3.125% 2025 Notes are disclosed as having interest rate swap contracts that convert the fixed-rate coupon to a floating-rate SOFR-based rate. In 2022, the effective interest rate was LIBOR + 1.8%, while in 2024, it was updated to SOFR + 2.1%. This shift from LIBOR to SOFR reflects Amgen's adaptation to the transition away from LIBOR to more robust reference rates. The consistent use of interest rate swaps for these notes indicates Amgen's ongoing strategy to manage interest rate risk by balancing fixed and floating rate debt exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its core claims. The ground truth states that in 2022, the 3.125% 2025 Notes had a fixed interest rate with no variable rate terms, but the LLM incorrectly claims that interest rate swaps were already in place in 2022, converting the fixed rate to a floating rate based on LIBOR + 1.8%. This is factually wrong—there was no mention of variable rate terms in 2022. Additionally, the shift from LIBOR to SOFR is fabricated; the ground truth indicates a shift from a fixed rate to SOFR + 2.1% in 2024, not a transition from LIBOR to SOFR. (2) Quantitatively, the 3.125% fixed rate is correctly identified, and SOFR + 2.1% in 2024 matches the ground truth. However, the mention of LIBOR + 1.8% in 2022 is entirely unsupported and incorrect. There is no evidence in the ground truth of any LIBOR-based rate or interest rate swaps in 2022. (3) The multi-hop reasoning is flawed. The LLM assumes the existence of interest rate swaps in both years and frames the change as a benchmark transition (LIBOR to SOFR), when in reality the fundamental change is from a fixed-rate instrument to a floating-rate structure—likely due to refinancing or repricing. The model fails to recognize the structural shift in debt financing and instead invents a narrative around risk management via swaps that is not supported by the original answer. (4) The contextual relevance is moderate because the answer discusses interest rate disclosures and attempts to explain Amgen’s debt strategy, but the factual inaccuracies and invented details severely undermine correctness. The qualitative reasoning is poor due to incorrect entity relationships and unsupported inferences. Thus, the correctness score is low at 3 due to major factual and reasoning errors, despite partial recognition of the SOFR adjustment in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 500,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 as a response to market disruptions and rising interest rates. In 2022, the company faced liquidity challenges due to rapid interest rate hikes, which led to client reallocations of cash out of sweep accounts into higher-yielding alternatives. This necessitated the use of higher-cost supplemental funding sources, including commercial paper, to meet liquidity needs. By 2024, Schwab continued to maintain its commercial paper issuance program as part of its diversified funding strategy, especially amid ongoing market volatility and regulatory changes. However, the company also emphasized the importance of maintaining sufficient liquidity to address potential disruptions in the credit markets and rising borrowing costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately captures Schwab's increased reliance on the Commercial Paper Issuance Program between 2022 and 2024 as a response to rising interest rates and market disruptions. The explanation of client cash outflows due to rate hikes—specifically reallocations from sweep accounts into higher-yielding alternatives—is consistent with the original answer's reference to 'higher client cash outflows' outpacing internal cash generation. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022 and 2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM correctly links rising rates → client behavior → liquidity pressure → use of commercial paper. However, it omits specific mention of other funding mechanisms like FHLB advances and repurchase agreements, which the original answer notes were used alongside commercial paper by 2024. It also does not explicitly state that the program was *introduced* in 2022 as a new tool, nor does it mention credit rating downgrade risks affecting access to financing—details present in the ground truth. (4) Despite these minor omissions, the core facts, timeline, causality, and strategic rationale are preserved, and the answer remains contextually rich and relevant. Hence, the correctness and qualitative accuracy scores are high but not perfect due to incomplete synthesis of all funding sources and risk factors mentioned in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 442,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "The 3.625% Notes due 2022 were fully redeemed in 2021, as indicated by their absence in the 2024 disclosures. In 2022, the 3.625% Notes due 2024 were hedged with interest rate swaps converting their fixed-rate coupons to SOFR-based floating rates (SOFR + 3.4% in 2023). By 2024, these swaps were adjusted to SOFR + 3.4%, and the notes were repaid, reflecting a strategic shift to manage interest rate risk and optimize debt cost. This evolution indicates the company's proactive approach to debt management, leveraging hedging instruments to mitigate exposure to rate fluctuations and align with its financial objectives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It incorrectly states that the 3.625% Notes due 2022 were redeemed in 2021, but the ground truth refers to 3.625% 2024 Notes, not 2022 Notes. The LLM confuses the maturity year and redemption timeline. The ground truth confirms the 3.625% 2024 Notes had a $1,400 million carrying value in 2022 and were paid off by 2024. The LLM incorrectly claims these notes were hedged with swaps converting to SOFR + 3.4% in 2023 and 2024, but the ground truth does not mention interest rate swaps or specific SOFR spreads. (2) Quantitative inaccuracies include the absence of the correct $1,400 million carrying value in 2022 and the incorrect implication that the notes were already gone by 2022. The LLM fabricates swap terms (SOFR + 3.4%) not present in the original answer. (3) The multi-hop reasoning is partially sound in that it identifies a shift in debt strategy involving floating rates, but it misrepresents the mechanism (hedging via swaps vs. actual issuance of floating rate debt) and timeline. The conclusion about proactive debt management aligns thematically with the ground truth, but the supporting facts are incorrect. (4) The contextual relevance is fair because the answer addresses debt management strategy and interest rate evolution, but the factual foundation is flawed. Correctness score is low due to major errors in dates, amounts, and financial instruments. Quantitative accuracy is poor due to missing and fabricated numbers. Qualitative accuracy is moderate due to correct strategic interpretation despite incorrect details. Contextual relevance is acceptable as the response stays on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 458,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "Between 2022 and 2024, Schwab's approach to providing financial or other support to variable interest entities (VIEs) has remained consistent in terms of intent and conditions for funding commitments. As of December 31, 2021 (2022 10-K) and December 31, 2020 (2024 10-K), Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs beyond what was contractually required. The funding of remaining commitments to these VIEs, primarily related to Community Reinvestment Act (CRA) and Low-Income Housing Tax Credit (LIHTC) investments, is contingent upon the occurrence of certain conditions, and Schwab expects to fulfill these commitments between 2022 and 2025. There is no indication of a change in Schwab's intent or conditions for funding during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Schwab's approach remained consistent between 2022 and 2024. The ground truth states there was a clear shift: in 2022, Schwab did not intend to provide support beyond contractual obligations, but by 2024, it acknowledged it may choose to provide support to proprietary funds under market stress, indicating a more proactive stance. The LLM incorrectly asserts no change occurred. (2) Quantitatively, the LLM mentions dates (December 31, 2021, and December 31, 2020) and a funding timeline (2022–2025) related to CRA and LIHTC investments, which may be factually accurate in isolation but are misapplied here—they pertain to specific VIEs but do not reflect the broader evolution in policy toward discretionary support. The use of '2024 10-K' referring to December 31, 2020, is erroneous—this would be the 2020 filing, not 2024. This misdating undermines the analysis. (3) The multi-hop reasoning fails: the question requires comparing Schwab’s evolving intent and conditions for VIE support across 2022 and 2024 disclosures. The LLM incorrectly synthesizes the data, missing the key 2024 policy shift despite referencing the correct document year. It conflates funding of specific CRA/LIHTC commitments with overall intent toward VIEs, which are distinct issues. (4) The contextual relevance is moderate because it discusses VIEs and funding commitments, but it misses the central qualitative shift in Schwab’s disclosed intent, rendering the answer misleading. The conclusion contradicts the ground truth, warranting a low correctness score despite some accurate peripheral details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 453,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "Between 2022 and 2023, MDLZ's financial relationship with JDE Peet's evolved primarily through the impact of its equity method investment, which contributed positively to liquidity and capital structure. In 2023, MDLZ reported a gain of $740 million on equity method investment transactions, compared to a $989 million gain in 2022, indicating continued, though slightly reduced, positive contributions from JDE Peet's. Additionally, the investment provided financial flexibility, as noted in the 2023 10-K, supporting MDLZ's liquidity through proceeds from JDEP share sales and enhancing its capital structure by reducing reliance on debt financing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The reported gains of $740 million in 2023 and $989 million in 2022 from equity method investments are not supported by the ground truth and appear fabricated or misattributed. The original answer makes no mention of specific dollar amounts related to gains from JDE Peet's, nor does it reference any share sales or proceeds. These numbers are critical errors that undermine the answer's validity. (2) There is no verification of these figures in the ground truth, which focuses on the qualitative shift in relationship classification (from 'Has_Stake_In' to 'Invests_In') and its implications for financial flexibility. The LLM invents precise financial data that cannot be corroborated, failing the quantitative accuracy test. (3) On qualitative reasoning, the LLM correctly identifies that the investment impacts liquidity and capital structure and notes increased financial flexibility, which aligns with the 2023 characterization. However, it misses the core multi-hop insight: the reclassification of the relationship type in the accounting framework, which is central to understanding the evolution. Instead, it substitutes this with unsupported transactional gain data. (4) Contextually, the answer addresses MDLZ's liquidity and capital structure, remaining focused on the question’s intent. While the direction of reasoning (investment supports flexibility) is consistent with the truth, the reliance on incorrect numbers and omission of the key classification change significantly reduce correctness. The answer reflects partial understanding but fails on factual precision and core conceptual evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 471,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "The interest rate hedging strategy for the 3.125% 2025 Notes remained consistent between 2022 and 2024, with the interest rate under the swap agreements being SOFR plus 2.1% in both periods. This indicates that the hedging structure for these notes did not change during the timeframe.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the interest rate under the swap agreements was SOFR+2.1% in both 2022 and 2024. According to the ground truth, in 2022, the company terminated existing swaps and entered into new ones, but the exact rate for the 3.125% 2025 Notes was not disclosed. Therefore, asserting a specific rate (SOFR+2.1%) for 2022 is unsupported and false. The rate SOFR+2.1% is only confirmed for 2024. (2) Quantitatively, the LLM incorrectly assigns a rate to 2022 that is not in the original data. While the $1,000 million notional amount is consistent and implied in the ground truth, the LLM does not mention it, missing a key quantitative anchor. More critically, the rate attribution is wrong. (3) The multi-hop reasoning is flawed: the question asks how the strategy evolved, requiring recognition of a change (termination and reentry of swaps in 2022) and a progression to a disclosed SOFR-based rate in 2024. The LLM instead asserts no change, contradicting the documented evolution. (4) Contextual relevance is high because the answer addresses the right instrument (3.125% 2025 Notes), the right concept (swap agreements), and the right timeframe. However, the core factual claim about rate consistency is false, leading to a low correctness score despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 371,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million as of January 31, 2022, to $4,414 million as of January 31, 2023. This represents a decrease of $1,405 million, or approximately 24.16%, over the fiscal year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values. According to the ground truth, Walmart's fair value of equity investments using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, a decline of $249 million. However, the LLM incorrectly reports the 2023 value as $4,414 million and calculates a decrease of $1,405 million, which is factually wrong. The fiscal years and metric (Level 2 equity investments) are correctly identified, and the direction of change (decrease) is accurate, but the magnitude is severely overstated. (2) The calculation of the change is based on incorrect inputs: $5,819M - $4,414M = $1,405M is mathematically correct, but since the $4,414M value is wrong, the entire quantitative conclusion is invalid. The percentage decline of 24.16% is also incorrect due to the wrong base and ending values. (3) The multi-hop reasoning appears structurally sound—the model attempts to compare two fiscal years and compute the difference—but it fails due to reliance on incorrect data. It correctly identifies the need to compare Level 2 equity investments across fiscal years, but the synthesis is based on erroneous figures. (4) The contextual relevance is high because the answer addresses the right company, metric, time frame, and type of change. However, the correctness score is low due to major quantitative inaccuracies. The qualitative accuracy is slightly higher because the reasoning framework is intact, but the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 428,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "Apple's characterization of its reliance on marketing abilities remained consistent between its 2023 and 2024 10-K filings. In both years, the company emphasized that while it holds a broad portfolio of intellectual property, its success is primarily driven by the innovative skills, technical competence, and marketing abilities of its personnel. There is no notable evolution in how Apple describes its reliance on marketing abilities in the provided sections of the filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Apple's characterization of its reliance on marketing abilities 'remained consistent' between 2023 and 2024. The ground truth shows a clear evolution in language: from 'relies primarily' on innovative skills, technical competence, and marketing abilities in 2023, to 'depends heavily' on the same factors in 2024, with added strategic context about ensuring a 'continual and timely flow' of competitive offerings. This shift indicates a stronger, more strategically framed emphasis on these capabilities, including marketing, due to competitive pressures. The LLM incorrectly concludes there is 'no notable evolution,' missing the nuanced but important change in tone and strategic framing. While no numeric data is involved (so quantitative accuracy is 10), the qualitative accuracy is very low due to failure in multi-hop reasoning and misinterpretation of textual evolution. Contextual relevance is moderate as the answer addresses the right documents and general topic, but fails to capture the key change the question asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 310,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "The notional amount for the 3.625% 2024 Notes remained unchanged at $1,400 million between 2022 and 2024. However, the interest rate structure changed from being hedged at SOFR + 3.4% in 2023 to being fully repaid by 2024, with associated interest rate swap contracts maturing in connection with the repayment. This indicates that Amgen's hedging strategy involved using interest rate swaps to convert fixed-rate debt to floating-rate SOFR-based debt, and the termination of these swaps in 2024 suggests the completion of the hedging activity for this specific debt issuance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the notional amount remained unchanged at $1,400 million between 2022 and 2024, which contradicts the ground truth: in 2022, Amgen terminated swaps on a $5.2 billion notional amount (including the 3.625% 2024 Notes), and by 2024, the notional for this specific note dropped to $0 from $1,400 million in 2023. The LLM incorrectly implies continuity in the notional amount, missing the full unwind by 2024. (2) Quantitative accuracy is poor: the $5.2 billion swap termination in 2022 is entirely omitted, and the drop from $1,400 million to $0 by end-2024 is misrepresented as a repayment without acknowledging the hedging unwind. The interest rate of SOFR+3.4% in 2023 is correctly mentioned, but the absence of any hedging activity in 2024 is mischaracterized. (3) Reasoning is partially sound in linking swap termination to debt maturity, but fails the multi-hop synthesis: it does not connect the 2022 termination of $5.2B swaps across multiple notes with the subsequent re-hedging and final de-hedging of the 3.625% 2024 Notes specifically. The conclusion about hedging strategy is plausible but based on incorrect premises. (4) Contextual relevance is fair—the answer addresses hedging strategy and interest rate structure—but core factual errors undermine correctness. The answer misses the dynamic nature of the hedging program and misrepresents the timeline and scale of notional changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 408,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "Schwab's integration of the iRebal portfolio rebalancing solution from 2022 to 2023 evolved from retaining it as part of its Advisor Services offerings post-TD Ameritrade acquisition to fully incorporating it into its platform for independent advisor clients. This integration reflects Schwab's strategic focus on enhancing its Advisor Services capabilities, leveraging TD Ameritrade's strengths to provide more robust tools for RIAs. This move strengthens Schwab's competitive positioning in the RIA market by offering a customizable, efficient rebalancing solution, thereby deepening client relationships and supporting its goal of being a trusted leader in investment services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Schwab retained iRebal in 2022 as part of its TD Ameritrade Institutional integration and fully incorporated it into its platform by 2023. The evolution from retention to full integration is accurately described. (2) There are no numeric values in the question or answer that require verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the answer correctly links Schwab's acquisition of TD Ameritrade, the initial retention of iRebal, and its later integration as a strategic enhancement for RIAs. It also correctly infers that this strengthens Schwab’s competitive positioning, aligning with the ground truth’s emphasis on differentiation and appeal to independent advisors. The only minor omission is the specific mention of $1.6 trillion in assets and 15 million accounts transitioned by 2023, which adds contextual depth but does not alter the core correctness. (4) The answer is highly relevant, directly addressing both the evolution of iRebal integration and its implications for Schwab’s RIA market positioning. Wording differs slightly but meaning is preserved. Thus, correctness is 9 due to the omission of specific integration scale metrics, but all critical elements are present and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 390,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "Between 2023 and 2024, Apple's approach to the iMac product line evolved as part of broader updates to its Mac lineup. In the first quarter of 2024, Apple announced a new iMac model, indicating a focus on refreshing its desktop offerings. This aligns with the overall increase in Mac net sales in 2024, driven primarily by higher sales of laptops, suggesting a coordinated strategy to enhance the entire Mac product portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but misses the core insight from the ground truth. (1) It correctly identifies that Apple updated the iMac in 2024, mentioning a new model in Q1 2024, which aligns with the increased strategic focus implied in the original answer. However, it fails to reference any specific disclosures from the 10-K filings, particularly the key shift in how Apple described the iMac in the MD&A section—elevating it to a major product announcement alongside the MacBook Pro and iPad Pro. This omission represents a significant gap in qualitative accuracy. (2) There are no explicit numbers (e.g., sales figures, percentages) in either the original or LLM answer, so quantitative accuracy is not heavily applicable; the mention of 'increase in Mac net sales' is vague but not incorrect, hence a moderate score. (3) The multi-hop reasoning is partially sound—linking iMac updates to broader Mac portfolio strategy—but does not fully synthesize the evolution in disclosure tone and categorization between 2023 and 2024, which is central to the question. (4) The answer is contextually relevant and addresses Apple’s evolving approach, but lacks the evidence-based reasoning from the 10-K text that defines the ground truth. Thus, while not factually wrong, it is incomplete and misses the key nuance of strategic repositioning through disclosure language.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 382,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "RTX issued the 2.820% Notes Due 2051 in August 2021 with a principal balance of $1,000 million to refinance maturing debt. These notes remained outstanding in 2024 with no changes in principal, indicating they are a stable component of the company's long-term debt structure. This reflects RTX's strategy of maintaining long-dated debt to manage maturity profiles and reduce refinancing risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the issuance date of the 2.820% Notes Due 2051, stating they were issued in August 2021, while the ground truth indicates the note was first reported in 2022 with a $1,000 million principal. This misstatement affects the timeline of RTX's debt evolution. However, the principal amount ($1,000 million) and the fact that it remained unchanged through 2024 are correctly reported. (2) Quantitative accuracy is partially correct: the $1,000 million principal is accurate and consistently referenced, but the issuance date (2021 vs. 2022) is incorrect, and the LLM omits key quantitative context about the broader long-term debt increase from $40,078 million to $41,146 million between 2022 and 2024. This omission weakens the assessment of RTX's overall debt structure evolution. (3) The reasoning is sound in interpreting the stability of the 2051 notes as part of a long-term debt strategy, and the conclusion about managing maturity profiles is reasonable. However, the answer fails to perform the necessary multi-hop synthesis between the specific note and the aggregate long-term debt trend, missing the insight that while this note was stable, overall debt grew—indicating new issuances elsewhere. (4) The contextual relevance is high, as the answer addresses the core elements of the debt instrument and its role in long-term structure, but the lack of comparative debt data and the incorrect issuance date reduce factual correctness. The answer captures qualitative strategy but lacks quantitative completeness required for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 442,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "Between 2022 and 2023, Schwab's IDA agreement evolved by transitioning from LIBOR-based reference rates to alternative benchmark rates following the phase-out of LIBOR. Additionally, the service fee on client cash deposits held at the TD Depository Institutions was reduced from 25 basis points to 15 basis points as part of an amended agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and captures all key elements from the ground truth. (1) Quantitatively, the numbers are accurate: the service fee reduction from 25 to 15 basis points in 2022 and the 2023 transition from LIBOR to alternative benchmarks are correctly stated. No calculations are required, and all figures match the original answer. (2) The answer is complete, addressing both aspects of the question: changes in service fees and reference rate adjustments. (3) Entity accuracy is strong—'Schwab', 'IDA agreement', 'TD Depository Institutions', and the correct time frame (2022–2023) are properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: it combines information about fee changes in one year and reference rate updates in another, correctly attributing each to the appropriate year. The only minor shortcoming is that the LLM does not explicitly note that the fee reduction occurred via an amendment in 2022 or that the rate transition was part of a broader regulatory shift, which slightly reduces qualitative depth compared to the original. However, the core facts and their implications are accurately conveyed. Semantic equivalence is maintained, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 348,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "The change in Filorga's financial treatment—from being a standalone reporting unit with $221 million in goodwill in 2023 to being listed among other trademarks within broader segments in 2024—suggests a reassessment of its strategic importance and valuation approach. This shift likely reflects a decision to integrate Filorga more closely with other brands in its segment, potentially signaling a reduced standalone strategic emphasis or a reevaluation of its distinct market position. The company may also be streamlining its reporting structure to better align with evolving business strategies or to simplify the valuation process by grouping similar intangible assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key change in Filorga's financial treatment from 2023 to 2024, accurately stating that it was a standalone reporting unit with $221 million in goodwill in 2023 and was grouped within broader segments in 2024 without separate disclosure. All factual elements—goodwill amount, years, and reporting structure—are correct. (2) Quantitative accuracy is perfect: the $221 million goodwill figure and the years 2023 and 2024 are correctly cited with no calculation errors. (3) The reasoning is sound and captures the multi-hop implication: integrating Filorga into broader segments suggests a strategic shift in brand management or valuation approach. The LLM correctly infers reduced standalone emphasis and possible streamlining of reporting, aligning with the ground truth. However, it omits a specific mention of how this affects impairment analysis and future strategic decisions like divestiture or investment, which slightly reduces completeness in qualitative depth. (4) The answer is contextually highly relevant, directly addressing the question about strategic importance and valuation approach. Minor deduction in qualitative accuracy due to missing nuance around impairment and strategic decision impact, but overall semantic equivalence is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 366,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "The change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflects a more detailed and forward-looking reporting strategy. In the 2024 filing, Apple explicitly mentions the iPhone 16 Pro in the context of its product announcements, signaling a shift toward emphasizing new product launches as key drivers of business performance. This evolution in disclosure aligns with Apple's broader focus on innovation and product differentiation, particularly in response to competitive pressures and evolving consumer demand. The increased transparency about flagship product development highlights Apple's strategic emphasis on technological advancements and market positioning.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that in the 2023 10-K, the iPhone 16 Pro was disclosed as part of the 'Fourth Quarter 2024 product lineup', indicating future planning, and in the 2024 10-K, it is listed among existing products like iPhone 15 and 14, indicating it has become an established product. The LLM incorrectly frames this as a move toward 'more detailed and forward-looking reporting' in 2024, when in fact the shift is from forward-looking (2023) to retrospective/inclusionary (2024), reflecting product maturity, not increased forward disclosure. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no numbers to verify, thus scored as 10 by default. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the lifecycle progression (planned → launched → established) and misinterprets the direction of change in disclosure strategy. Instead of identifying the transition from planning to established status, it claims Apple is emphasizing new launches more in 2024, which contradicts the evidence. (4) The contextual relevance is moderate because the answer discusses Apple’s product reporting and strategy, which is relevant, but the factual misrepresentation of the disclosure change severely undermines accuracy. The qualitative accuracy is low due to incorrect synthesis of the filings’ content and mischaracterization of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 409,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "Between 2022 and 2023, the company enhanced its use of Economic Value of Equity (EVE) simulations to assess interest rate risk by incorporating the impact of derivative instruments and updating assumptions related to non-maturity deposit behavior and client cash allocation changes. In 2023, the Company also began utilizing interest rate swap derivative instruments to manage interest rate risk, which were integrated into EVE analyses. Additionally, liability duration shortened significantly due to rising interest rates, leading to a shift in the EVE sensitivity profile as liability duration became shorter than asset duration.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but introduces significant inaccuracies not present in the ground truth. It correctly notes changes in modeling assumptions related to non-maturity deposits and client cash allocation, which aligns with the 2023 evolution mentioned in the original answer. However, it incorrectly claims that derivative instruments (specifically interest rate swaps) were integrated into EVE analyses in 2023—this is not supported by the ground truth. The original answer makes no mention of derivatives or their use in EVE simulations. Additionally, the claim about liability duration shortening significantly due to rising rates and becoming shorter than asset duration is absent from the ground truth and represents a factual overreach not substantiated by the provided information. (2) There are no explicit numbers, percentages, or dollar amounts in either the question or ground truth, so quantitative accuracy is not heavily applicable—however, the dates (2022–2023) are used correctly, supporting a moderate score in this category. (3) The multi-hop reasoning is partially sound in that the model attempts to compare changes across years and identify evolving modeling assumptions. However, it fails to accurately represent the actual evolution described in the ground truth—specifically, the expansion of EVE to include client cash allocation changes and dynamic deposit beta updates in declining rate environments. Instead, it fabricates the use of derivatives and misrepresents balance sheet dynamics with unsupported duration comparisons. (4) The correctness score is low due to the introduction of unsupported claims, despite some accurate mentions of updated assumptions. The qualitative accuracy is penalized for incorrect entity relationships and reasoning flaws. Contextual relevance is moderate because the answer stays within the domain of interest rate risk and EVE modeling, but drifts into irrelevant details about derivatives and duration shifts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 542,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 enhanced its competitive positioning by expanding its product portfolio into edge networking, allowing it to offer end-to-end solutions in the broader networking market. This move strengthened its ability to capitalize on growing demand for 5G and Wi-Fi 6/6E technologies, positioning Qualcomm as a more integrated player in both semiconductor and networking product markets. By vertically integrating into wireless access point production, Qualcomm could better align its offerings with its foundational connectivity technologies, improving differentiation and scalability in the evolving edge networking landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Qualcomm shifted from enabling wireless access point technologies in 2022 to directly producing them in 2023. The mention of 5G and Wi-Fi 6/6E adoption is consistent with the original answer's reference to Wi-Fi 6 and 5G driving edge networking growth. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022 and 2023) are correctly used. (3) The multi-hop reasoning is sound: the model correctly synthesizes Qualcomm’s strategic evolution and infers its implications on competitive positioning and product breadth. It captures the shift from component supplier to full-system provider, though it does not explicitly name competitors like Broadcom and Intel as in the original answer. This is a minor omission affecting completeness but not core accuracy. (4) The LLM conveys semantic equivalence—'end-to-end solutions' corresponds to 'full-system solutions,' and 'vertically integrating into production' reflects the expanded portfolio. The answer is contextually relevant, directly addressing how the shift affected competitive positioning and product breadth. One point is deducted from qualitative accuracy for not explicitly referencing the broader networking product suite (e.g., routers, network processors) or direct competition, but the overall reasoning remains strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 407,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "The interest-only payment structure of Schwab's HELOC product slightly decreased from 2022 to 2023. In 2022, approximately 28% of adjustable-rate mortgages had interest-only terms, while in 2023, this percentage dropped to 27%. Additionally, the portion of interest-only loans not scheduled to reset for three or more years decreased from 89% in 2022 to 86% in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 28% to 27% for the percentage of adjustable-rate mortgages with interest-only terms, and 89% to 86% for the portion not scheduled to reset for three or more years—both correctly reported with the right years. (2) The answer is complete, addressing both components of the question: the change in interest-only loan percentage and the change in the portion not resetting for three or more years. (3) Entity accuracy is correct—referring to Schwab's HELOC product context, adjustable-rate mortgages, and interest-only terms appropriately. (4) The reasoning is sound and reflects the minor decrease in both metrics, implying a slight evolution in the product structure, which aligns with the original conclusion. The LLM conveys the same semantic meaning as the ground truth, with clear, concise, and factually precise language. No errors in multi-hop synthesis—correctly linking percentages across years and metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 296,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "Qualcomm's involvement in the XR (Extended Reality) market evolved from 2022 to 2023 through strategic investments and product development. In 2022, XR was mentioned as part of QSI's investment focus, particularly in early-stage companies across industries like 5G, AI, and XR. By 2023, XR was explicitly included in QCT's revenue streams under the \"Consumer\" category within the IoT segment, indicating product sales for XR devices. This suggests Qualcomm expanded its XR footprint by both investing in the ecosystem and integrating XR-capable technologies into its semiconductor offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Qualcomm's 2022 focus on strategic investments in XR via early-stage company funding, particularly under QSI (Qualcomm Strategic Investments), and the 2023 shift to direct product revenue through QCT (Qualcomm CDMA Technologies) under the IoT 'Consumer' segment. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable beyond correct use of years (2022, 2023), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 vs 2023), business units (QSI vs QCT), and strategic focus (investment vs revenue-generating product sales), correctly inferring a shift from ecosystem support to commercialization. (4) The only minor shortcoming is that the LLM does not explicitly state the *implication* of this shift—'a transition from supporting external innovation to deriving tangible revenue'—as clearly as the original answer. However, the core facts, entities, timeline, and strategic evolution are all correct and well-articulated. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 374,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained unchanged at $1,100 million between 2022 and 2024, as noted in the long-term debt sections of both the 2022 and 2024 10-K filings. This stability indicates that RTX has not refinanced or repaid this specific long-term debt issue during this period, reflecting a consistent component of its long-term debt structure with a distant maturity date, contributing to the company's extended debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the aggregate principal balance of the 3.030% Notes Due 2052 remained unchanged at $1,100 million between 2022 and 2024, which matches the ground truth exactly. All numeric values (interest rate: 3.030%, amount: $1,100 million, years: 2022 and 2024) are accurate and properly formatted. (2) Quantitative accuracy is perfect—no calculation errors or misstatements; the dollar amount and time frame align precisely with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from both the 2022 and 2024 10-K filings to infer stability in the debt balance. It logically concludes that the lack of change indicates no repayment or refinancing, which is consistent with the ground truth’s interpretation of strategic consistency. The only minor gap is that the LLM answer does not explicitly mention 'no additional issuances'—the original answer notes both no repayments and no new issuances, while the LLM focuses only on lack of repayment/refinancing. This omission slightly weakens completeness but does not invalidate the core reasoning. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: the evolution of the debt balance and its implication for RTX's long-term debt structure. The mention of the 'distant maturity date' and 'extended debt profile' adds relevant context. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a minor omission in qualitative detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 430,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "AXP's focus on Corporate Card solutions evolved between 2023 and 2024 by emphasizing innovation and differentiation in its commercial payments offerings. In 2023, the company aimed to build on its strong position in commercial payments by evolving card value propositions and differentiating corporate card and accounts payable expense management solutions. By 2024, this strategy expanded to include designing innovative products and features, such as financing, banking, and payment solutions for business customers. This shift suggests a broader commercial payments strategy focused on enhancing value for business clients through tailored, integrated financial tools and services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: AXP's 2023 focus on evolving card value propositions and differentiating corporate card and accounts payable solutions is accurately reported, as is the 2024 shift toward innovative, integrated solutions including financing, banking, and payments. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable beyond correct use of years (2023 and 2024), which are accurate. (3) The multi-hop reasoning is sound—information from two time points is correctly synthesized to infer a strategic evolution in AXP’s commercial payments approach. The LLM captures the shift from product differentiation to a broader, integrated suite of services, which reflects correct qualitative interpretation. (4) The only minor shortcoming is a slight softening of the conclusion: the original answer explicitly states this evolution suggests AXP is 'expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services,' which more clearly articulates the strategic implication. The LLM response says 'enhancing value... through tailored, integrated financial tools,' which is semantically similar but slightly less precise in framing the strategic embedding of the card product. This small nuance prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 425,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "Between 2023 and 2024, PCA SKIN's strategic positioning within Colgate-Palmolive's Oral, Personal, and Home Care segment remained consistent, as it continued to be marketed as a skin health brand under the broader portfolio of personal care products. However, there is no explicit mention of changes in its distribution channels during this period. The company's products, including PCA SKIN, are primarily sold to traditional and e-commerce retailers, wholesalers, distributors, and in some cases, directly to consumers. No specific evolution in PCA SKIN's distribution strategy was highlighted in the provided documents.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is incorrect in its core claim that there was no explicit mention of changes in distribution channels for PCA SKIN between 2023 and 2024. The ground truth clearly states that in 2024, the distribution channels were expanded to include sales to skin health professionals in some geographies, which represents a strategic refinement in positioning. This key evolution is entirely missed by the LLM, which asserts no change was highlighted—this contradicts the documented update in the filing. While the LLM correctly identifies the general distribution channels (traditional and e-commerce retailers, wholesalers, etc.) and PCA SKIN’s status as part of the personal care portfolio, it fails to capture the nuanced but important multi-hop detail: the addition of skin health professionals as a distribution channel in 2024. There are no numerical values in this question, so quantitative accuracy is not applicable but assumed correct by default. The reasoning is flawed due to failure in synthesizing the updated channel strategy across years. Contextually, the answer is relevant and on-topic, but lacks the critical update that defines the evolution asked in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 333,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "Between 2022 and 2023, Opdivo's strategic focus and commercial positioning evolved by expanding into earlier lines of therapy and new tumor indications, such as adjuvant treatment for melanoma and neoadjuvant treatment for resectable non-small cell lung cancer (NSCLC). Additionally, Opdivo's combination with Yervoy and other anti-cancer agents was emphasized to broaden its therapeutic utility. These developments, along with the approval of new indications in multiple regions, supported Opdivo's role as a key growth driver in Bristol Myers Squibb's portfolio, partially offsetting revenue declines from other products like Revlimid and contributing to overall portfolio resilience.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Opdivo's strategic focus between 2022 and 2023, noting expansion into earlier lines of therapy (e.g., adjuvant melanoma, neoadjuvant NSCLC) and broader use in combination therapies, particularly with Yervoy. These points align with the ground truth's emphasis on earlier lines of therapy and combination regimens. However, the LLM omits specific mention of the tumor types listed in the original answer (bladder, blood, CRC, HCC, MPM, stomach cancers, etc.) beyond melanoma and NSCLC, which reduces completeness. It also does not mention the subcutaneous formulation, a key strategic development highlighted in the ground truth for enhancing patient benefits and long-term adoption. (2) There are no numeric values, dates, or financial figures in either answer that require direct quantitative verification; thus, quantitative accuracy is fully preserved as no incorrect numbers are presented. (3) The multi-hop reasoning is sound: the model synthesizes information about indication expansion, combination therapies, and commercial implications across time (2022 to 2023), correctly inferring Opdivo’s role in offsetting Revlimid declines and supporting portfolio resilience—consistent with the strategic intent described in the ground truth. (4) The answer is contextually excellent and semantically close, conveying the core strategic shift and commercial implications accurately. The correctness score is 8 due to minor but notable omissions (specific tumor types, subcutaneous formulation), which affect completeness but not the overall factual correctness of the main developments and implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 456,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "American Express's investment in foreign government bonds and obligations remained relatively stable between 2023 and 2024 in terms of fair value, with a slight decrease from $770 million in 2023 to $765 million in 2024. In terms of maturity distribution, all of these investments were due within one year in both periods, indicating a short-term focus.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, American Express held $549 million in foreign government bonds in 2023, not $770 million as stated by the LLM. The 2024 value of $765 million is correct, but the characterization of a 'slight decrease' is incorrect since the actual trend is a substantial increase from $549M to $765M. Additionally, the maturity distribution is completely misrepresented: in 2023, all $549 million matured in 12 months or more (i.e., long-term), whereas the LLM claims all investments matured within one year in both years. In 2024, $764 million matured within one year and $1 million after one year but within five years, which the LLM partially captures but fails to note the dramatic shift from long-term to short-term maturities. (2) Quantitative accuracy is low: the 2023 fair value is off by $221 million, and the maturity breakdown is entirely wrong for 2023. The LLM also invents a 'stable' trend when the actual change is a 39.3% increase. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution across years in both fair value and maturity distribution. It misses the key insight that American Express significantly increased its exposure and shifted to short-term maturities. (4) Contextual relevance is moderate because the answer addresses the right topic and metric (fair value and maturity), but the incorrect data and reasoning severely undermine the response. The conclusion about a 'short-term focus in both periods' is false given the 2023 long-term positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 440,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "Between 2022 and 2024, Walmart's use of intercompany financing arrangements remained consistent in purpose but saw a reduction in the amount of cash not freely transferable to the U.S. As of January 31, 2022, $4.3 billion of cash was not freely transferable, with $2.2 billion subject to approval by Flipkart minority shareholders. By January 31, 2024, this amount had decreased to $3.5 billion, still subject to local laws or noncontrolling interest approvals. The company continues to use these arrangements to efficiently allocate cash across jurisdictions while minimizing costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it states that the amount of cash not freely transferable in 2024 was $3.5 billion, whereas the ground truth reports $3.3 billion. All other numbers are accurate—$4.3 billion in 2022 and $2.2 billion subject to Flipkart minority shareholder approval are correctly cited. (2) The fiscal dates (January 31, 2022 and January 31, 2024) align with Walmart’s reporting periods and are consistent with the knowledge graph, so date usage is appropriate. The calculation of change (from $4.3B to $3.5B vs. actual $3.3B) is slightly off, but the direction (decrease) is correct. (3) The multi-hop reasoning is sound: the model correctly identifies the evolution over time, notes the shift from Flipkart-specific restrictions to broader noncontrolling interest approvals, and contextualizes the purpose of intercompany financing. However, the original answer emphasizes a 'broader framing' of transfer conditions beyond Flipkart, which the LLM mentions only implicitly by referencing 'noncontrolling interest approvals' generally. (4) Despite the small numerical discrepancy, the LLM captures the core trend—slight reduction in restricted cash and evolving conditions for transfer—and remains factually and contextually aligned with the question. Wording differences do not affect meaning significantly, and the answer addresses both parts of the question: amount changes and transfer conditions. Thus, high scores are justified, with a slight deduction in quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 429,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "Between 2023 and 2024, the composition of Texas Instruments' U.S. Retiree Health Care Plan assets showed a shift in allocation. Fixed income securities and cash equivalents increased from $210 million (80% of total assets) in 2023 to $248 million (80% of total assets) in 2024. Meanwhile, equity securities slightly decreased from $54 million (20% of total assets) in 2023 to $50 million (20% of total assets) in 2024, maintaining the target allocation range of 75%-85% for fixed income and 15%-25% for equity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that there was a shift in asset allocation between 2023 and 2024. The ground truth confirms that the composition remained completely unchanged in both years: fixed income and cash equivalents were $210 million, equity securities were $54 million, totaling $264 million. The LLM incorrectly reports fixed income increasing to $248 million and equity decreasing to $50 million in 2024, which contradicts the source data. (2) Quantitative inaccuracies include the false increase in fixed income from $210M to $248M and equity drop from $54M to $50M. Additionally, the percentages cited (80% and 20%) are approximations but not precisely aligned with the actual figures—79.5% and 20.5%—though this minor rounding difference would be acceptable if the underlying numbers were correct. However, the incorrect totals and allocations result in significant quantitative errors. (3) The reasoning is flawed as it assumes a reallocation occurred when the data shows no change. The model fails the multi-hop requirement to compare identical figures across two filings and conclude no evolution. Instead, it fabricates changes and even references a 'target allocation range' not mentioned in the original answer, introducing unsupported details. (4) Despite the factual errors, the answer is contextually relevant—it addresses the right plan, company, and asset classes, and attempts to discuss allocation trends—hence a moderate relevance score. However, correctness and quantitative accuracy are severely compromised due to incorrect numbers and erroneous conclusion about asset evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 449,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "Between 2022 and 2024, Honeywell's 2006 Stock Plan for Non-Employee Directors evolved by introducing updated forms of award agreements, including the \"Form of Stock Option Award Agreement\" and \"Form of Restricted Stock Unit Agreement\" under the 2016 Stock Plan for Non-Employee Directors. These changes suggest a shift in the company's non-employee director compensation structure toward more modern and flexible equity award mechanisms, aligning with broader corporate governance trends and potentially enhancing director retention and alignment with shareholder interests.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual and entity errors. (1) It incorrectly states that the changes occurred under the '2016 Stock Plan for Non-Employee Directors', while the original answer and ground truth refer exclusively to the '2006 Stock Plan'. This is a critical entity error. (2) The LLM claims new forms were 'introduced', but the ground truth indicates that the 'Form of Restricted Unit Agreement' was dropped between 2022 and 2024, not replaced or updated under a new plan. The 'Form of Option Agreement' remained, but the LLM misrepresents this continuity as an introduction under a different plan. (3) There is no mention in the ground truth of a 2016 plan being involved in these changes, making the core premise of the LLM's response factually wrong. (4) The reasoning about 'modern and flexible equity award mechanisms' and 'enhancing director retention' is speculative and not supported by the evidence provided in the original answer, which only infers a shift toward stock options over restricted units based on exhibit removal. (5) While the question asks about evolution between 2022 and 2024, the LLM misattributes the context to a different stock plan and time frame, failing the multi-hop synthesis requirement. Quantitative accuracy is low due to incorrect dates and misidentification of plans. Qualitative accuracy suffers from flawed reasoning and incorrect entity mapping. Contextual relevance is moderate because the answer addresses director compensation evolution, but with wrong details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 423,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "Between 2022 and 2024, Walmart's strategic position regarding its ownership stake in Flipkart evolved as it received $3.2 billion in fiscal 2022 from a new equity funding round, reducing its ownership from approximately 83% to 75%. Financially, this dilution reduced Walmart's direct equity exposure but provided capital infusion. Regulatory risks emerged in 2024, as Flipkart faced investigations in India related to foreign direct investment compliance and antitrust allegations. These matters could result in penalties or operational restrictions, exposing Walmart to potential financial and reputational risks tied to Flipkart's regulatory challenges.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.2 billion equity funding in fiscal 2022 and the reduction in Walmart's ownership stake from 83% to 75%, which matches the ground truth. These quantitative elements are accurate, including the dollar amount and percentage change. (2) The timeline is slightly simplified—the regulatory scrutiny actually originated earlier (show cause notice in July 2021), but the LLM correctly notes that these risks became more apparent or were disclosed in 2024, aligning with the reporting context. However, the LLM omits that the regulatory issues pertain to Flipkart's pre-2018 operations (2009–2015), before Walmart's acquisition, which is a key nuance affecting Walmart’s exposure and indemnification considerations. (3) The multi-hop reasoning is mostly sound: it connects the financial dilution with reduced exposure and links ongoing regulatory issues to potential risks. But it misses the deeper synthesis that Walmart, despite reduced ownership, remains exposed to legacy liabilities and cannot estimate potential losses or recoveries from prior shareholders—this weakens the qualitative completeness. (4) The answer is contextually relevant and well-structured, addressing both financial implications and regulatory risks as asked. The omission of pre-acquisition timing and indemnification uncertainty prevents a top score, but core facts and numbers are correct, warranting a high but not perfect correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 407,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "Between 2022 and 2024, HON's U.S. cash balances decreased from $11.5 billion in 2022 to $8.0 billion in 2024, while total cash holdings (including non-U.S. balances) increased from $15.2 billion in 2022 to $11.0 billion in 2024. The geographic distribution of funds shifted, with a notable increase in non-U.S. cash balances, which rose from $3.7 billion in 2022 to $8.0 billion in 2024. This shift reflects a strategic emphasis on leveraging non-U.S. liquidity, likely to optimize global operations and fund international acquisitions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, HON had $11.5 billion in total cash and equivalents as of December 31, 2021 (reported in 2022), not $11.5 billion in 2022 as U.S. cash. By 2024, total cash was $11.0 billion, with $8.0 billion held in non-U.S. subsidiaries—meaning only $3.0 billion was in the U.S., not $8.0 billion as the LLM incorrectly states. The LLM falsely claims U.S. cash decreased from $11.5B to $8.0B, but the original answer never states that $11.5B was U.S.-only; it was total cash. Additionally, the LLM invents a 2022 total cash figure of $15.2 billion and non-U.S. cash of $3.7 billion, which are not present in the ground truth and contradict it. (2) The quantitative inaccuracies are severe: the LLM fabricates numbers, misrepresents totals as U.S.-only balances, and incorrectly calculates trends. The only correct number is the $8.0 billion in non-U.S. subsidiaries in 2024. The $11.0 billion total cash in 2024 is correctly cited, but the rest of the numerical framework is wrong. (3) The multi-hop reasoning fails: the model incorrectly infers geographic distribution in 2022 by inventing data rather than acknowledging lack of explicit breakdown. It also misinterprets the timeline, treating 2021 data (reported in 2022) as 2022 year-end data. The strategic emphasis is partially correct—there is a shift in geographic distribution—but the reasoning is based on false premises. (4) Correctness and quantitative accuracy are low due to fabricated figures and misattribution of total vs. U.S. cash. Qualitative accuracy is low because of flawed entity and time period mapping. Contextual relevance is moderate because the answer addresses the right topic (geographic shift, strategic emphasis) but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 491,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "From 2023 to 2024, the financial treatment and liability estimation methodology for the Membership Rewards program remained largely consistent in terms of key assumptions and modeling approaches. The liability is still estimated using the Ultimate Redemption Rate (URR) and the Weighted Average Cost (WAC) per point. The URR is derived from statistical and actuarial models based on redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes. The WAC per point is based on 12 months of redemptions and adjusted for changes in redemption costs and patterns. However, in 2024, additional sensitivity disclosures were provided, indicating that a 25 basis point increase in URR would raise the liability by approximately $197 million, and a 1 basis point increase in WAC per point would increase it by approximately $220 million. These updates reflect a more detailed quantification of the impact of assumption changes on the liability.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is quantitatively accurate, correctly reporting the $197 million and $220 million sensitivity figures for a 25 basis point increase in URR and a 1 basis point increase in WAC per point, respectively. These numbers match the ground truth exactly, and the key modeling components—URR and WAC—are correctly identified. Contextually, the answer is relevant and addresses the evolution in disclosure detail, particularly around sensitivity analysis. However, the qualitative reasoning contains a significant error: it claims the methodology 'remained largely consistent' between 2023 and 2024, which contradicts the ground truth. The original answer emphasizes a clear evolution—from a simpler recognition of deferred fees in 2023 to a more sophisticated, model-driven liability estimation approach in 2024 with detailed disclosures. The LLM incorrectly frames this as continuity rather than evolution, missing the core shift in methodology depth and transparency. This misrepresents the multi-hop synthesis required: the progression from basic deferral accounting to an advanced actuarial model with sensitivity quantification. While the individual facts are correct, the overall interpretation and reasoning are flawed, leading to a misleading conclusion about the nature of the change. Hence, the correctness score is reduced to 6 for partial accuracy with a major conceptual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 385,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "Adobe's strategic positioning and integration of Frame.io between 2022 and 2024 has evolved to more deeply align with Adobe's broader product ecosystem, particularly within the Digital Media segment. Initially acquired in 2021, Frame.io has been integrated as a cloud-native creative collaboration platform, streamlining the production of creative assets and enabling seamless collaboration across Adobe's Creative Cloud applications such as Premiere Pro, After Effects, Photoshop, and Lightroom. By 2024, Frame.io is positioned as a key component of Adobe's content production at scale, directly integrated with Adobe Express and Adobe Firefly Services within Adobe GenStudio, enhancing end-to-end creative workflows and reinforcing Adobe's leadership in digital media creation and collaboration.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Frame.io's integration from 2022 to 2024, noting its role in Adobe's Digital Media segment and progression into deeper ecosystem alignment. It accurately reflects that Frame.io is a cloud-based collaboration platform integrated with key Creative Cloud apps. However, it incorrectly states the acquisition year as 2021, while the ground truth implies the integration discussion began in 2022 (acquisition was announced December 2021, closed in 2022—so contextually 2022 is the relevant year for integration reporting). This is a minor factual misstatement but does not undermine the overall correctness. (2) Quantitatively, no specific numbers (e.g., $1.18B) are mentioned in the LLM answer, but none are misstated either. The absence of the acquisition price is a minor omission but not an error. Dates (2022–2024) are used appropriately in context. (3) The multi-hop reasoning is sound: the model correctly synthesizes Frame.io’s integration trajectory, its inclusion in Adobe GenStudio, and alignment with services like Firefly and Express. It correctly identifies the strategic shift from standalone platform to core ecosystem component. However, it omits mention of Workfront as an integrated product (mentions Lightroom and Firefly instead), and the original answer specifically highlights Workfront. Also, the original notes Frame.io’s inclusion in GenStudio as a 2024 development, which the LLM captures, though it slightly overreaches by specifying 'Adobe Firefly Services' without direct confirmation in the ground truth. (4) Despite minor omissions and one date reference imprecision, the LLM answer conveys the essential evolution and strategic alignment accurately and is highly relevant to the question. Hence, high scores across the board with a slight deduction in qualitative accuracy for incomplete entity mapping and one factual nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 519,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "Between 2022 and 2023, the fair value measurements of equity-like funds (a category of private alternative investments) using significant unobservable inputs (Level 3) slightly decreased. In 2022, equity-like funds under defined benefit pension plans had a Level 3 fair value of $25.4 million, while in 2023, this amount decreased to $25.1 million. For retiree health benefit plans, the Level 3 fair value of equity-like funds remained relatively stable, decreasing slightly from $2.4 million in 2022 to $2.4 million in 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, the Level 3 fair value of equity-like funds in private alternative investments increased from $5.5 million in 2022 to $25.4 million in 2023. However, the LLM claims it decreased from $25.4 million to $25.1 million, which is the opposite trend and misstates both the magnitude and direction of change. Additionally, the LLM introduces 'defined benefit pension plans' and 'retiree health benefit plans' not mentioned in the original question or answer, indicating a complete mismatch in context. (2) Quantitatively, all key numbers are wrong: the 2022 value is stated as $25.4M (should be $5.5M), the 2023 value as $25.1M (should be $25.4M), and an irrelevant $2.4M figure is introduced. The calculation of a 'slight decrease' is therefore based on fabricated data. (3) The reasoning is fundamentally flawed—instead of identifying a fivefold increase in Level 3 valuation for equity-like funds, the model incorrectly infers a minor decline, failing to capture the significant shift toward more opaque valuation methods. It also fails to synthesize the correct multi-hop information, likely pulling data from unrelated contexts or misattributing figures across different investment categories or plans. (4) The contextual relevance is low because the answer discusses pension and health benefit plans not referenced in the question, which specifically asked about private alternative investments broadly, not segmented by benefit plans. While the terminology (e.g., Level 3, equity-like funds) is used correctly, the factual core is entirely inaccurate, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 466,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "Between 2022 and 2024, Adobe has further integrated Frame.io into its Digital Media offerings, positioning it as a key component of its creative collaboration ecosystem. Frame.io, acquired in 2021, has been deeply integrated with Adobe's Creative Cloud applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront, enabling seamless real-time collaboration, frame-accurate feedback, and streamlined workflows for video and creative asset production. Additionally, Frame.io is now part of Adobe GenStudio, which allows for large-scale content production and is supported by Adobe Firefly's generative AI capabilities, enhancing automation and creative efficiency. This integration reflects Adobe's strategy to provide end-to-end solutions for content creation, collaboration, and delivery within the Digital Media segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Frame.io was acquired in 2021, integration into Adobe's Digital Media segment began in 2022, and by 2024 it was deeply embedded in Creative Cloud apps including Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront. The inclusion in Adobe GenStudio is correctly noted. (2) There are no numeric values requiring verification (e.g., dates like 2021, 2022, 2024 are used appropriately and correctly), so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—information is synthesized across time (2022 to 2024) and systems (integration across multiple Adobe products and GenStudio). The only minor omission is that the original answer specifies the acquisition occurred in October 2021, which the LLM mentions only as '2021'—a small loss of precision. Also, the original explicitly notes Lightroom as an integrated product, which the LLM omits. (4) Despite these minor gaps, the LLM captures the strategic evolution from initial integration to core ecosystem component, including generative AI via Firefly, which adds contextual depth. The answer is fully relevant and conveys semantic equivalence. Thus, correctness is 9/10 due to near-perfect factual alignment with only minor omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 366,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "Between 2022 and 2024, CVS has significantly evolved its approach to Medication Management by expanding its clinical programs and enhancing digital tools to improve medication adherence and cost efficiency. In 2022, the company emphasized programs like Pharmacy Advisor and Drug Savings Review, which focused on identifying gaps in care and promoting adherence through counseling and outreach. By 2024, CVS expanded its offerings with the introduction of the CVS Weight Management program, which optimizes GLP-1 medication use and includes lifestyle coaching. Additionally, the company enhanced its digital connectivity and analytics to provide real-time benefits information and expanded visibility to lower-cost alternatives. These advancements reflect a stronger integration of digital tools and a broader focus on chronic disease management and cost optimization.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of CVS's Medication Management approach between 2022 and 2024 with accurate emphasis on clinical programs and digital tools aimed at adherence and cost efficiency. It correctly identifies the 2024 launch of the CVS Weight Management program with GLP-1 optimization and lifestyle coaching, which aligns with the ground truth. The mention of enhanced digital tools, real-time benefits information, and lower-cost alternatives is consistent with the introduction of NovoLogix and advanced analytics in 2024. However, the LLM incorrectly names specific 2022 programs as 'Pharmacy Advisor' and 'Drug Savings Review,' which are not mentioned in the ground truth; instead, the original answer highlights formulary management via the National Pharmacy and Therapeutics Committee, generic drug promotion, mail/specialty pharmacy operations, and opioid prescription limits. These omissions and substitution with unverified program names represent a factual inaccuracy in entity identification. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is unaffected and scores a 10. (3) The multi-hop reasoning is partially sound: the model correctly infers a shift from cost-containment to integrated, proactive care, and connects digital expansion with clinical programs. However, it fails to reference key 2022 initiatives like the seven-day opioid supply limit or the role of the National P&T Committee, and omits the expansion through Oak Street Health with 239 centers in 27 states—a significant multi-hop element in the ground truth. (4) The contextual relevance is high because the answer addresses the core question about evolution in clinical programs and digital tools. The qualitative accuracy is reduced due to incorrect program naming and missing key factual components, but the overall trajectory and 2024 developments are accurately portrayed. Thus, the correctness score is 7—core facts and direction are correct, but with notable omissions and some factual inaccuracies in entity details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 564,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved significantly from 2022 to 2024 by deepening its integration into key Creative Cloud applications such as Premiere Pro and After Effects, enhancing review and approval workflows, and expanding its role in enabling seamless collaboration across stakeholders. Specific enhancements to collaboration features included improved real-time upload, frame-accurate commenting, and annotations, as well as Camera to Cloud functionality for automatic footage uploads from recording devices directly into Frame.io for immediate review.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core evolution of Frame.io's integration into Adobe's Creative Cloud from 2022 to 2024. It correctly identifies the initial integration focus on Premiere Pro and After Effects, the enhancement of collaboration features like real-time upload, frame-accurate commenting, and annotations, and the introduction of Camera to Cloud functionality—key points from the ground truth. The dates (2022–2024) are correctly used, and no numeric inaccuracies are present (no specific numbers like dollar amounts or percentages were involved, so quantitative accuracy is 10). However, the LLM answer omits some important expansions mentioned in the original answer: the extension of Frame.io’s capabilities to still images, design files, and PDFs; its integration with Photoshop, Lightroom, and Workfront; and the strategic repositioning of Frame.io as a broader creative collaboration platform beyond video. These omissions reduce completeness and slightly weaken the qualitative accuracy, though the reasoning and entity identification (Adobe, Frame.io, Creative Cloud, correct years) remain sound. The answer is highly contextually relevant, directly addressing the question’s focus on integration evolution and collaboration enhancements. While the core facts and multi-hop synthesis (acquisition → integration → feature expansion) are correct, the lack of full scope on cross-application expansion and platform repositioning prevents a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 408,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "The use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024 by becoming a more prominent input in fair value determination, particularly for Level 3 assets where observable market data is limited. In 2023, the valuation of loans and lending commitments relied on recently executed transactions, market price quotations, and comparable pricing, but the range of inputs was broader. By 2024, the Firm emphasized the use of recently executed transactions more explicitly, especially for corporate loans and other debt, where pricing data was less observable. This shift reflects a greater reliance on transactional data to enhance the accuracy of fair value estimates in less liquid markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in qualitative reasoning and entity synthesis compared to the ground truth. (1) What was correct: The answer correctly identifies that recently executed transactions were used in both 2023 and 2024 for valuing loans and lending commitments, and that they are particularly relevant in less observable markets (e.g., Level 3 assets), which aligns with the general context. The dates (2023 to 2024) are accurate, and there are no numeric values to dispute, so quantitative accuracy is high. (2) However, the key evolution described in the LLM answer—that transaction data became 'more prominent' or 'greater reliance' in 2024—is not supported by the original answer. Instead, the ground truth states that the role remained 'significant' but became more *targeted*, specifically tied to held-for-sale loans and extended to other investments like other investments using DCF and comparable multiples. The LLM incorrectly frames the evolution as an increase in prominence, whereas the actual change was a refinement in application. (3) Multi-hop reasoning is flawed: the LLM fails to mention the shift toward held-for-sale categories and the extension to other asset types (e.g., other investments), missing critical synthesis points. It also omits the use of discounted cash flow models and comparable company multiples in 2024, which are key differentiators in the original answer. (4) Contextual relevance is strong because the response stays on topic and discusses fair value determination and market observability, but the reasoning misrepresents the nature of the evolution. Thus, while the answer is plausible-sounding, it does not accurately reflect the specific evolution documented in the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 482,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "Adobe's approach to Substance 3D Stager evolved between 2022 and 2024 by positioning it more cohesively within the broader Substance 3D ecosystem. In 2022, Substance 3D Stager was mentioned as part of the Substance 3D Collection, a suite of desktop applications for 3D creation and asset management. By 2024, the product was more explicitly integrated into Adobe's 3D strategy, emphasizing its role in building and assembling 3D scenes alongside other Substance 3D tools like Painter, Designer, and Modeler. This shift highlights Adobe's focus on enhancing cross-tool collaboration and expanding Substance 3D Stager's utility within creative workflows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution of Adobe's approach to Substance 3D Stager from 2022 to 2024 is accurately described, with correct positioning within the broader Substance 3D ecosystem. (2) There are no numeric values requiring verification (e.g., financials, percentages), so quantitative accuracy is not applicable beyond correct use of years (2022 and 2024), which are accurate. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across time points and product positioning: from being part of the Substance 3D Collection in 2022 to a more explicitly integrated tool in 2024 focused on scene assembly. The mention of Painter, Designer, and Modeler is consistent with the ecosystem described in the original answer. (4) The only minor shortcoming is that the LLM answer does not explicitly reference the 2022 trademark listing as evidence of early-stage positioning, which slightly weakens the contrast in strategic evolution compared to the original answer. However, stating it was part of the 'Substance 3D Collection' in 2022 is factually consistent and conveys similar meaning. Overall, the answer is semantically equivalent, well-reasoned, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 361,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "From 2022 to 2023, GE's strategic positioning regarding grid-scale batteries evolved as part of its broader energy transition strategy. In 2022, GE acknowledged that emerging technologies like grid-scale batteries were critical for deep decarbonization in the power sector, but the company emphasized the need for significant investments in infrastructure, R&D, and new products. By 2023, with the planned separation of its energy businesses into GE Vernova, grid-scale batteries were positioned as a key enabler for modernizing power grids to support higher penetration of renewables. GE Vernova was expected to focus on advancing such technologies, reflecting a more defined strategic reliance on grid-scale batteries as a core component of its energy transition efforts.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the general evolution of GE's strategic positioning on grid-scale batteries from 2022 to 2023, and correctly identifies the increasing strategic importance of the technology within GE's energy transition efforts. The dates (2022 and 2023) are accurate, and there are no numerical inaccuracies (quantitative accuracy is perfect, hence score of 10). The contextual relevance is high, as the response directly addresses the question about strategic evolution and reliance, and appropriately references GE Vernova’s role post-separation, which aligns with 2023 developments. However, the LLM introduces information not present in the original answer: specifically, the claim that in 2022 GE emphasized 'significant investments in infrastructure, R&D, and new products' is not supported in the ground truth, which only states that grid-scale batteries were seen as potentially more important over time. Additionally, the original answer highlights a key semantic shift—from 'may become more important' to 'depend in part'—indicating a stronger strategic reliance, which the LLM answer does not explicitly capture. Instead, it infers increased reliance through the context of GE Vernova’s focus, which is plausible but less precise. This omission of the specific linguistic and strategic nuance in the shift reduces qualitative accuracy (score 7). While the LLM captures the directional change correctly, it misses the exact framing from the source documents, which is critical in assessing strategic evolution. Thus, the overall correctness score is 7: core facts are right, but key details that reflect the depth of strategic shift are not fully or accurately represented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 471,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "CVS's disclosure regarding the use of broker-quoted debt securities in its fair value measurements remained consistent between 2022 and 2024, with no broker-quoted debt securities reported in either period. In both years, Level 3 debt securities were valued using internal analyses or private placement pricing, and no broker quotes were utilized. This indicates that broker-quoted debt securities had no material presence or impact on CVS's financial reporting during this timeframe.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its core facts: it accurately states that CVS did not report any broker-quoted debt securities in either 2022 or 2024, and correctly notes that Level 3 debt securities were valued using internal analyses or private placement pricing. The quantitative accuracy is perfect—no incorrect dates, years, or financial figures are presented, and the absence of broker quotes is correctly reported for both periods. However, the LLM answer misses a key qualitative nuance highlighted in the ground truth: the evolution in disclosure tone and content. Specifically, while the 2022 filing included discussion of a review process and potential impact (even if zero in practice), the 2024 filing no longer mentions such processes or impacts, indicating a reduced emphasis over time. The LLM fails to capture this shift in disclosure emphasis, instead framing the consistency as purely factual (no securities present), without acknowledging the change in narrative or disclosure depth. This omission affects the completeness of the multi-hop reasoning—while the presence/absence is correctly synthesized, the evolution in reporting relevance is not. Contextual relevance is strong, as the answer directly addresses the question’s focus on presence and impact on financial reporting. Overall, the answer is factually sound but lacks the full depth of comparative disclosure analysis required for a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 394,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "Between 2023 and 2024, the composition of BlackRock's Equity Securities at FVTNI changed as follows: \n\n- **Equity securities/mutual funds** increased from $1,585 million in 2023 to $1,950 million in 2024, representing a $365 million increase.\n- **Equity method investments** increased from $2,756 million in 2023 to $2,783 million in 2024, reflecting a $27 million increase, primarily driven by growth in private equity and real assets funds. \n\nOverall, the total Equity Securities at FVTNI rose from $4,214 million in 2023 to $4,733 million in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for both equity securities/mutual funds and equity method investments. According to the ground truth, in 2023, equity securities/mutual funds were $1,211 million, but the LLM incorrectly states $1,585 million. Similarly, equity method investments in 2023 were $1,895 million (ground truth), but the LLM reports $2,756 million. The 2024 values for both categories are correct in the LLM answer ($1,950 million and $2,783 million respectively), but the 2023 figures are wrong, leading to incorrect change calculations. (2) The LLM calculates a $365 million increase in equity securities/mutual funds, but with correct 2023 data this should be $739 million ($1,950M - $1,211M). The increase in equity method investments is reported as $27 million, but should be $888 million ($2,783M - $1,895M). The total FVTNI figures provided by the LLM ($4,214M in 2023 and $4,733M in 2024) are inconsistent with ground truth totals (sum of $1,211M + $1,895M = $3,106M in 2023; $1,950M + $2,783M = $4,733M in 2024), indicating the LLM used incorrect inputs. (3) While the LLM attempts multi-hop reasoning by comparing two years and calculating changes, it fails because it relies on incorrect base data. The mention of 'private equity and real assets funds' as drivers is not present in the original answer and introduces unsupported detail. (4) Scores reflect major quantitative errors (correctness and quantitative accuracy scored low), though the structure and intent to address the question are sound (moderate qualitative accuracy and high contextual relevance).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 450,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "From 2022 to 2024, UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities remained consistent, with no material allowance for credit losses reported in either period. In both years, the Company assessed impairments by evaluating expected cash flows, issuer credit quality, and its intent to hold securities, concluding that unrealized losses were primarily due to interest rate changes rather than credit deterioration. As of December 31, 2021 (2022 10-K) and December 31, 2024, the allowance for credit losses on available-for-sale debt securities was not material.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that unrealized losses were due to interest rate changes and not credit deterioration in 2022, and that the allowance for credit losses was not material as of December 31, 2021 (reported in the 2022 10-K). It also correctly notes the consistency in evaluation methodology across years, including the assessment of expected cash flows and issuer credit. However, it fails to capture a key evolution described in the ground truth: by 2024, UnitedHealth Group had moved to a more formalized framework where credit-related impairments are now recorded through a separate allowance account, with impacts on investment and other income. The LLM incorrectly implies no change occurred, stating the treatment 'remained consistent' and that the allowance was 'not material' in both periods, but the ground truth emphasizes a structural shift in accounting presentation and recognition, even if the allowance remains small. (2) Quantitatively, all dates and references (e.g., December 31, 2021, December 31, 2024) are accurate or appropriately framed, and there are no numerical errors. (3) The multi-hop reasoning is partially sound—it connects disclosures across years and correctly identifies the qualitative assessment of impairments, but it misses the conceptual evolution in accounting treatment from a 'qualitative, low-risk assessment' to a 'more formalized impairment accounting framework,' which is central to the question about how the evaluation and treatment evolved. (4) The answer is contextually relevant and well-structured, but the lack of recognition of the methodological evolution significantly undermines the qualitative accuracy and overall correctness, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 474,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "Between 2022 and 2023, AMD's financial relationship with the ATMP JV showed an increase in both investment value and equity income. The carrying value of AMD's investment in the ATMP JV rose from approximately $83 million as of December 31, 2022, to $99 million as of December 30, 2023. Additionally, equity income from the ATMP JV increased from $14 million in 2022 to $16 million in 2023, reflecting improved performance of the joint venture during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying value increased from $83 million in 2022 to $99 million in 2023, and equity income rose from $14 million to $16 million. The dates (December 31, 2022, and December 30, 2023) are consistent with typical fiscal year-end reporting in SEC filings and do not contradict the ground truth, which does not specify exact dates but refers to annual figures. (2) The answer is complete, addressing both parts of the question—investment value (carrying value) and equity income—across both years. (3) Entities are correctly identified: AMD, ATMP JV, and the relevant financial metrics (carrying value, equity income) are used accurately. (4) The reasoning is sound: the LLM correctly infers that increases in both carrying value and equity income indicate a strengthening financial relationship and improved JV performance, which is a valid qualitative interpretation supported by the data. There are no factual errors, omissions, or misinterpretations. The answer achieves semantic equivalence with the original, using slightly different phrasing but conveying the same meaning and multi-hop synthesis (comparing two financial metrics across two years). All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 372,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "UnitedHealth Group's exposure to tort claims between 2022 and 2024 has remained significant, with the nature of claims including medical malpractice by affiliated physicians, clinical quality failures, and general professional liabilities. The potential financial impact has increased due to the rising frequency of legal actions and the complexity of claims, which involve large defense costs and potential monetary damages. Additionally, the 2024 filing highlights a specific cyberattack on Change Healthcare, which, while not a tort claim, underscores the broader vulnerability to incidents that could lead to tort-related liabilities. The company remains largely self-insured, and the potential for actual losses to exceed recorded liabilities persists, posing a material risk to its financial position and operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that UnitedHealth Group faces ongoing exposure to tort claims involving medical malpractice, clinical quality, and professional liabilities, and notes the self-insured status and risk of losses exceeding recorded liabilities—key points from the original answer. However, it introduces a specific cyberattack on Change Healthcare in 2024, which, while contextually relevant to broader risk, is not mentioned in the ground truth as part of the tort claim evolution and distracts from the core shift in tort claim focus. The original answer emphasizes a shift from narrowly defined medical malpractice claims in 2022 to broader health care delivery risks (e.g., clinical quality, patient safety, reputational harm) in 2024, which the LLM captures partially but does not clearly articulate the evolution in risk framing. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the model connects self-insurance, malpractice, and professional liability across years, but fails to clearly synthesize the nuanced shift in risk profile from 2022 to 2024 as described in the original. The addition of the cyberattack, while factually plausible, is extraneous and not supported by the ground truth in this context. (4) The answer is contextually relevant and mostly accurate in substance, but misses the precise qualitative evolution in how UnitedHealth characterizes its tort exposure—hence a 7 on qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 441,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "Between 2023 and 2024, Boeing's three-year revolving credit agreement, with $3.0 billion in total commitments expiring in August 2025, remained unchanged in structure and capacity. However, the company terminated its $0.8 billion 364-day credit facility and a $3.2 billion five-year credit agreement expiring in October 2024, replacing them with a new $4.0 billion five-year revolving credit agreement expiring in May 2029. This indicates a shift toward longer-term liquidity support, reflecting Boeing's strategy to maintain robust backup liquidity while optimizing its credit facilities to align with long-term financial obligations and market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Boeing's three-year $3.0 billion revolving credit agreement expiring in August 2025 remained unchanged between 2023 and 2024. It accurately states the new $4.0 billion five-year facility expiring in May 2029 and correctly notes the termination of two other facilities. The only minor discrepancy is in the characterization of the terminated facilities: the ground truth does not specify the amounts ($0.8 billion 364-day and $3.2 billion five-year) as being terminated—this level of detail is plausible but not confirmed in the original answer. However, the net effect (termination of two facilities and replacement with a $4.0 billion facility) aligns with the ground truth. (2) All numeric values—$3.0 billion, $4.0 billion, August 2025, May 2029—are factually correct and match the original. No calculations are required, but the synthesis of facility changes is quantitatively sound. (3) The multi-hop reasoning is strong: the model correctly infers that maintaining the existing three-year facility while adding a larger, longer-term facility indicates a strategic shift toward enhanced liquidity and extended maturities. The conclusion about Boeing's liquidity strategy—emphasizing financial flexibility and long-term alignment—is semantically equivalent to the original. (4) The answer is highly relevant, directly addressing both the structural evolution and strategic implications. The slight over-specification of the terminated facilities' amounts does not introduce factual error but adds detail beyond the ground truth; this does not detract significantly from accuracy. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 484,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "The financial impact of the 2017 Performance-based Options evolved between 2023 and 2024 as follows: the total fair value of options vested decreased from $56 million in 2023 to $52 million in 2024, while the aggregate intrinsic value of options exercised increased significantly from $44 million in 2023 to $373 million in 2024. This indicates a substantial rise in the value of exercised options in 2024, likely due to a higher stock price or increased number of exercised options.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information from the ground truth. The fair value of options vested decreased from $56 million in 2023 to $52 million in 2024, and the intrinsic value of options exercised increased from $44 million to $373 million—both figures match the original answer exactly. (2) All numeric values are accurate and properly attributed to the correct years and metrics. There are no calculation errors, and the format variations (e.g., 'aggregate' vs. 'total') do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two years and two financial metrics (fair value vested and intrinsic value exercised) related to the 2017 Performance-based Options. The conclusion about the increased financial benefit from exercised options is logically supported. (4) The LLM answer is semantically equivalent to the original, with slightly enhanced interpretation (e.g., suggesting possible reasons like higher stock price), which adds context without introducing inaccuracies. All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 322,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "Between 2022 and 2023, AMD's approach to estimating adjustments for product return rights remained largely consistent, with no specific changes in methodology highlighted in the provided documents. In both years, AMD estimated adjustments based on historical product return rates, actual historical returns, and known events or economic conditions. The methodology involved utilizing trended historical data and adjusting for known factors, ensuring estimates were consistent with actual results. No material changes to the approach were mentioned in the 2023 filing compared to 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that AMD made no changes to its methodology between 2022 and 2023. The ground truth states that while AMD continued using historical data, it adopted a more structured approach in 2023 by explicitly aligning with ASC 606-10-32-8 through 14 and using the 'most likely amount' method for variable consideration, including returns, rebates, and price protection. This represents a significant qualitative shift in methodology that the LLM failed to identify. There are no numeric values to verify, so quantitative accuracy is not applicable (scored 10 by default for absence of errors). However, the qualitative accuracy is very low because the model missed the key evolution in accounting treatment and mischaracterized the consistency of the approach. Contextual relevance is moderate because the answer addresses the general topic of return estimation but fails to capture the specific changes requested in the question. The reasoning is flawed as it incorrectly asserts no changes occurred, contradicting the ground truth synthesis from multi-hop data across the two years' filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 321,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 in 2023 to 625,825 in 2024. This decline is primarily due to a large number of exercises (905,219 shares) in 2024, as the three tranches of the 2017 Performance-based Options vested in equal installments at the end of 2022, 2023, and 2024. The minimal forfeitures (18,036 shares) indicate strong employee retention for these awards during the vesting period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numbers from the ground truth: the starting number of shares (1,549,080 in 2023), ending number (625,825 in 2024), exercises (905,219 shares), and forfeitures (18,036 shares). These match exactly with the original answer. (2) The calculation of the decrease (1,549,080 - 625,825 = 923,255 total reduction) is consistent with the sum of exercises and forfeitures (905,219 + 18,036 = 923,255), confirming quantitative accuracy. (3) The reasoning is sound and adds contextual value by explaining that the three tranches vested equally at the end of 2022, 2023, and 2024, which explains the high exercise volume in 2024 as the final vesting tranche. This aligns with the ground truth's implication of lifecycle completion. The conclusion about strong employee retention due to minimal forfeitures is a reasonable qualitative inference. (4) The answer fully addresses both parts of the question: the evolution of shares (quantitative change) and what it indicates (exercise and forfeiture trends). All entities (2017 Performance-based Options, correct years) are accurate. Semantic equivalence is strong, with no factual deviations. Minor wording differences (e.g., 'decline is primarily due to' vs 'this indicates that') do not affect meaning. All scores are maximized due to full factual correctness, accurate multi-hop synthesis, and relevant, logical interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 395,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "Between 2022 and 2024, Optum Rx has expanded its role and strategic positioning within UnitedHealth Group's ecosystem by enhancing its pharmacy care services and integrating more deeply with medical and behavioral health care. In 2022, Optum Rx managed $112 billion in pharmaceutical spending, including $45 billion in specialty spending, and focused on clinical programs to manage costs and improve outcomes. By 2024, Optum Rx's managed pharmaceutical spending increased to $178 billion, with $74 billion in specialty spending, reflecting growth in its service offerings. Additionally, Optum Rx expanded its services to include rare disease and gene therapy support and direct-to-consumer solutions, emphasizing a more holistic approach by embedding pharmacists into patient care teams to address the whole patient.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. While the 2022 figures ($112 billion total pharmaceutical spending, $45 billion in specialty) match the ground truth, the 2024 figures ($178 billion total, $74 billion specialty) are fabricated—no spending data was provided in the original answer for 2024. This invalidates the core of the quantitative comparison. (2) The LLM introduces specific new services like 'rare disease and gene therapy support' and 'direct-to-consumer solutions' that are not mentioned in the ground truth. While some strategic expansion is implied, these specific offerings lack support. Additionally, the claim about embedding pharmacists into patient care teams is not present in the original. (3) The reasoning is partially sound in recognizing a broader integration of Optum Rx within UnitedHealth Group’s ecosystem and a shift toward holistic, connected care. The emphasis on data, analytics, and population health aligns with the 2024 strategic positioning. However, the model invents metrics and services rather than acknowledging the absence of updated financials and focusing on qualitative evolution. (4) The contextual relevance is fair—the answer addresses service offerings and strategic positioning within the broader ecosystem, which matches the question. But due to major quantitative errors and unsupported qualitative additions, the correctness score is low. The qualitative accuracy is modest because the general direction of integration and strategic elevation is correct, but specifics are not grounded in evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 444,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "The composition and valuation of BlackRock's Equity Securities at FVTNI increased from $1,585 million in 2023 to $1,950 million in 2024. Specifically, investments related to deferred cash compensation plans were newly included in 2023 at $241 million and remained part of the equity method investments in 2024. This indicates that BlackRock continued to hold and value these investments as part of its equity securities at FVTNI in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, in 2023, BlackRock reported $9 million in Equity Securities at FVTNI related to deferred cash compensation plans, not $241 million as stated by the LLM, and the total for Equity Securities at FVTNI was not $1,585 million or $1,950 million—these totals are unsupported by the ground truth. The LLM falsely claims that these investments were 'newly included in 2023 at $241 million' and 'remained part of the equity method investments in 2024', which contradicts the ground truth: the $173 million in 2024 was reclassified under the Equity Method section, meaning it was no longer part of FVTNI. (2) The numbers provided by the LLM ($1,585M, $1,950M, $241M) are factually incorrect and not present in the original answer; there is no support for any aggregate totals of Equity Securities at FVTNI in the ground truth. The only correct numeric elements are the years 2023 and 2024. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the reclassification indicated in the original answer—moving from FVTNI to Equity Method investments—and instead asserts continuity in categorization, which is the opposite of what occurred. This reflects a failure to synthesize the change in financial statement presentation. (4) The contextual relevance is moderate because the LLM addresses the general topic (deferred compensation investments and FVTNI), but the factual inaccuracies and incorrect interpretation of reclassification severely undermine correctness. Thus, the scores are low: 2/10 for correctness and quantitative accuracy due to wrong numbers and calculations, 2/10 for qualitative accuracy due to flawed reasoning and misrepresentation of entity relationships, and 5/10 for contextual relevance as the topic is addressed but with major errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 510,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $6,129,296 as of August 31, 2022, to $2,694,281 as of August 31, 2024. This reduction indicates that the company has utilized a significant portion of its repurchase authorization during this period, reflecting an active capital allocation strategy focused on returning value to shareholders through share buybacks. However, the Board has continued to replenish the authorization, as evidenced by the $4,000,000 added in September 2024, signaling ongoing commitment to capital return while balancing other financial priorities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. The starting authorization amount is incorrect: it states $6,129,296 as of August 31, 2022, while the ground truth reports $3,129,296 — a $3 million overstatement. This error fundamentally undermines the answer’s reliability. The 2024 figure ($2,694,281) is correct. (2) The calculation of change is therefore wrong: the LLM implies a reduction from $6.13M to $2.69M (~$3.43M used), whereas the actual reduction is from $3.13M to $2.69M (~$435K used). Additionally, the LLM introduces a $4,000,000 replenishment in September 2024, which is not present in the original answer or implied by the ground truth data; this is extraneous and unsupported information. (3) The multi-hop reasoning is partially sound — the model correctly interprets a decrease in authorization as indicative of share buyback activity and attempts to infer capital allocation strategy. However, the conclusion that this reflects an 'active' buyback strategy contradicts the ground truth interpretation of a more conservative or reduced capital allocation to repurchases. The introduction of future replenishment (post-2024) distorts the analysis of the 2022–2024 period. (4) Scores reflect that while the direction of change (decrease) and one data point (2024 authorization) are correct, major numerical errors and unsupported additions severely impact correctness and quantitative accuracy. Qualitative reasoning is plausible but based on false premises. Contextual relevance is high as the answer addresses the right topic and strategy implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 444,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "Between 2022 and 2024, the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved in terms of repurchase activity and shareholder rights. In 2022, the company highlighted its intention to use cash for share repurchases, including those of exchangeable shares, with activity primarily under open-market and other share purchase programs. By 2024, the company expanded its repurchase authority significantly, with $4,000,000 in additional share repurchase authority approved, and disclosed specific repurchase activity for both Accenture plc Class A ordinary shares and exchangeable shares, including 47,752 exchangeable shares repurchased for $15,254 in fiscal 2024. Shareholder rights remained consistent, as exchangeable shares continue to entitle holders to exchange them for Class A ordinary shares on a one-for-one basis and receive equivalent distributions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. While it correctly identifies the general evolution in disclosure around share repurchases and shareholder rights for Accenture Canada Holdings Inc. exchangeable shares, it fabricates or misstates key figures. The claim of $4,000,000 in additional repurchase authority is not supported by the ground truth, which states a remaining authorization of $2,694,281 as of August 31, 2024—not an increase of $4 million. Additionally, the LLM states that 47,752 exchangeable shares were repurchased for $15,254 in fiscal 2024, but this specific transaction data is absent from the original answer and cannot be verified; the ground truth does not include any such itemized repurchase volume or cost. (2) The original answer emphasizes a shift from general intent in 2022 to more structured, quantified disclosures in 2024, particularly around alignment of Class X shares with exchangeable shares and the precise remaining authorization. The LLM introduces numerical specifics not present in the ground truth, which undermines quantitative accuracy. (3) The qualitative reasoning partially captures the multi-hop evolution—comparing disclosures across years and noting consistency in shareholder rights (one-for-one exchangeability)—but fails to mention the key 2024 disclosure about aligning Class X ordinary shares with outstanding exchangeable shares, a critical detail in the original. (4) Contextually, the answer is relevant and addresses both repurchase activity and shareholder rights over time, but the inclusion of fabricated metrics significantly reduces factual correctness. The core narrative of increasing disclosure detail is plausible but unsupported by accurate data synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 486,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "The global revenue from Electrophysiology Devices increased by 12.3% in 2024 compared to 2023. Excluding the impact of foreign exchange fluctuations, the percentage change in this revenue was 14.4%.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the percentage change in revenue (12.3%) and the foreign exchange-excluded change (14.4%), which match the ground truth. However, it omits the actual revenue figures for 2023 ($2,195 million) and 2024 ($2,467 million), which were explicitly requested in the question as part of understanding how the revenue 'evolved'—implying both absolute values and the change. (2) The percentages are accurate and correctly formatted; there are no calculation errors. The 12.3% overall growth is consistent with (2,467 - 2,195) / 2,195 ≈ 12.39%, and the FX-neutral growth of 14.4% is also correct per the source. (3) The reasoning is sound in terms of interpreting the two growth rates, but the answer fails to fully synthesize the multi-hop requirement of reporting both the revenue evolution (i.e., the actual dollar amounts across years) and the derived percentage changes. (4) Scores reflect high accuracy in numbers and relevance, but partial completeness loss due to missing base-year revenue figures essential for full context. While the percentages are correct, the omission of dollar amounts reduces quantitative and qualitative accuracy slightly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 336,
        "total_tokens": 1459
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "Accenture's investment in Duck Creek Technologies, accounted for under the equity method, showed a significant increase in fair value between fiscal 2022 and fiscal 2024. As of August 31, 2022, the carrying amount of the investment was $138,902, with an estimated fair value of $223,166 for Accenture's approximately 16% ownership stake. By fiscal 2024, this investment generated a $253 million gain, which positively impacted Accenture's adjusted effective tax rate and adjusted diluted earnings per share. This gain reflects the appreciation in Duck Creek Technologies' valuation during this period, contributing favorably to Accenture's financial performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a discrepancy in the fiscal 2022 carrying amount. The ground truth states the investment was valued at $223,166 (fair value), which aligns with the LLM's mention of that figure as the estimated fair value. However, the LLM introduces a new number—$138,902—as the 'carrying amount' as of August 31, 2022, which is not present in the original answer and cannot be verified against the provided ground truth. This reduces quantitative accuracy. All other numbers—16% ownership, $253 million gain in fiscal 2024—are correct and match the original. (2) The $253 million gain is accurately reported and correctly tied to fiscal 2024. The format variation ($253 million vs $253,000,000) is acceptable. However, the introduction of the carrying amount without corroboration from the ground truth introduces unverified data, which is a factual risk. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of the investment over time, connects the increase in value to financial performance impact (gain affecting tax rate and EPS), and maintains correct entity and time period alignment (Accenture, Duck Creek Technologies, fiscal 2022 to 2024). The qualitative shift in impact—from equity method accounting to a realized gain—is logically inferred and well-articulated. (4) The answer is highly contextually relevant, addressing both investment valuation and financial performance impact. The qualitative accuracy is high due to correct entity identification and logical synthesis. The correctness score is 8 because core facts are accurate and the main conclusion is valid, but the inclusion of an unverified carrying amount prevents a 9–10 score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 471,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "Between 2022 and 2023, Union Pacific shifted its executive compensation strategy by reducing the scale of retention share and unit awards, reflecting a focus on performance-based incentives. In 2023, the company introduced performance stock unit grants tied to metrics like return on invested capital (ROIC) and operating income growth (OIG), emphasizing alignment with long-term financial performance. This indicates a strategic move to link executive compensation more closely to measurable outcomes and shareholder value creation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and content. The original answer states that Union Pacific significantly increased retention instruments from 389,207 retention shares in 2022 to 954,405 retention shares and 366,046 retention units in 2023, indicating an expansion in retention-based compensation. In contrast, the LLM claims there was a reduction in retention awards, which is the opposite of the truth. (2) No numeric values from the ground truth are mentioned in the LLM response—there is no reference to 389,207, 954,405, or 366,046—so quantitative accuracy is extremely low. Furthermore, the LLM introduces performance stock units tied to ROIC and OIG, which are not mentioned in the original answer and thus unsupported. (3) The multi-hop reasoning is flawed: instead of recognizing the increase in retention instruments and the introduction of retention units as a strategic shift toward enhanced retention incentives, the LLM incorrectly infers a move toward performance-based incentives due to a supposed reduction. This misrepresents the data and fails to synthesize the correct trend. (4) While the general topic of executive compensation strategy is addressed, the LLM’s conclusion is based on fabricated or misinterpreted data, leading to a low correctness score. Contextual relevance is moderate because it discusses executive compensation, but the substance is inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 395,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "Between 2023 and 2024, MetLife's application of GAAP guidance for adjusted earnings remained consistent in terms of exclusions related to market volatility and asymmetrical accounting adjustments. Adjusted earnings continued to exclude the impact of market volatility, such as net investment gains/losses, net derivative gains/losses, and MRB remeasurement gains/losses, to provide a clearer view of underlying business performance. Additionally, asymmetrical and non-economic accounting adjustments, including those related to in-force reinsurance and non-economic losses at contract inception, were still excluded in 2024 as they were in 2023. The 2024 disclosures reflect no material changes in the methodology or rationale for these exclusions.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that MetLife's application of GAAP guidance remained consistent between 2023 and 2024. The ground truth states that there were meaningful refinements and expansions in exclusions in 2024, particularly around policyholder liability remeasurement gains (losses) related to asymmetrical accounting from in-force reinsurance and the inclusion of joint venture adjustments under the equity method in net investment income. The LLM incorrectly claims 'no material changes,' which contradicts the documented evolution. (2) There are no specific numerical values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not heavily applicable; however, the years 2023 and 2024 are correctly referenced, and terms like MRBs and in-force reinsurance are accurately mentioned, supporting a moderate score in quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks how the application evolved, requiring comparison across years and synthesis of changes in exclusions. The LLM fails this by asserting continuity rather than change, missing the key developments in 2024. It does not reflect the expanded scope of exclusions or the structural refinement noted in the ground truth. (4) While the LLM answer is relevant to the topic and uses appropriate terminology, it fundamentally misrepresents the core fact of evolution in methodology. Hence, correctness and qualitative accuracy are low despite some contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 425,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "From 2022 to 2024, Accenture's approach to achieving compressed transformations has evolved by integrating generative AI and expanding the scope of its transformation services. In 2022, the focus was on leveraging technologies like cloud, data, AI, and IoT to help clients build digital cores, optimize operations, and accelerate revenue growth. By 2024, Accenture emphasized AI as \"the new digital,\" incorporating generative AI, advanced robotics, and artificial reality into its offerings. Additionally, the scope of services expanded to include designing and manufacturing automation equipment and deeper integration of AI and digital twins in capital projects and operations, enabling clients to achieve faster, more intelligent transformations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Accenture's approach from 2022 to 2024, noting the integration of generative AI, advanced robotics, and artificial reality/virtual reality (referred to as 'artificial reality' in the answer, which is semantically close). The core technologies mentioned in 2022—cloud, data, AI, IoT—overlap significantly with the ground truth (digital twins, AI, IoT, cloud/Edge, 5G, etc.), though the LLM omits specific mentions of 5G, metaverse, and Edge computing. In 2024, the LLM correctly highlights generative AI and advanced robotics, and captures the expansion into designing automation equipment, which aligns with the ground truth. However, it does not explicitly mention 'virtual reality' or 'metaverse' as evolved tools, instead using the less precise term 'artificial reality'. The scope expansion into capital projects (plant construction, infrastructure, etc.) is accurately reflected through the mention of 'capital projects and operations', though the specific examples (power grids, data centers, public infrastructure) are not listed. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored 10 by default as no inaccuracies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes Accenture’s technological evolution across two time points and infers broadening service scope. It connects AI’s evolving role ('AI as the new digital') and applies it to transformation services, showing logical progression. The omission of some technologies and specific capital project types reduces completeness slightly but does not break the reasoning chain. (4) The answer is contextually highly relevant, directly addressing how Accenture's approach evolved in terms of technology and scope. The phrasing 'designing and manufacturing automation equipment' matches the ground truth's 'enhancing its own development of automation equipment and commercial hardware'. Overall, the answer captures the essence and key developments with minor omissions in technological specificity, warranting a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 581,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "Between 2023 and 2024, Abbott reduced its use of interest rate hedge contracts, with the notional value decreasing from $2.9 billion in 2023 to $2.2 billion in 2024. This reduction was primarily due to the maturity of $700 million of interest rate hedge contracts in 2023, which coincided with the repayment of long-term debt that also matured in 2023. The remaining hedges continued to serve the purpose of managing exposure to changes in the fair value of fixed-rate debt by converting fixed interest obligations to variable rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Abbott maintained a consistent notional value of interest rate hedge contracts at $2.2 billion in both 2023 and 2024. However, the LLM incorrectly states that the notional amount decreased from $2.9 billion in 2023 to $2.2 billion in 2024, which contradicts the original data. Additionally, the claim that $700 million of hedges matured in 2023 due to debt repayment is unsupported by the ground truth, which does not mention any such maturity or reduction. (2) Quantitative accuracy is severely compromised: the $2.9 billion figure for 2023 is false (correct value is $2.2 billion), and the implied $700 million decrease is therefore also incorrect. The only correct number is the $2.2 billion notional value in 2024. (3) The reasoning is flawed—while the LLM correctly identifies the purpose of the hedges (converting fixed to variable rates), it constructs a narrative of strategic reduction that is not supported by the data. The ground truth emphasizes continuity in hedging strategy, whereas the LLM infers a change based on incorrect numbers. (4) Contextual relevance is moderate because the answer addresses the right topic (use of interest rate hedges to manage fair value exposure) and correctly explains the economic function of the hedges, but the core evolution claim is factually wrong. The answer fails the primary requirement of accurately describing how the use of hedges evolved—there was no reduction, yet the LLM asserts one.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 426,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "Between 2023 and 2024, MetLife's treatment and definition of Adjusted Earnings remained largely consistent in its core purpose and methodology, as it continues to be the primary measure used by the Company's chief operating decision maker (CODM) for evaluating segment performance and allocating resources. However, the adoption of the Lifetime Discounting of Insurance Liabilities (LDTI) in 2024 simplified the measurement model for Deferred Acquisition Costs (DAC) and Value of Business Acquired (VOBA), and reclassified most embedded derivatives as Market Risk Benefits (MRBs). As a result, MetLife updated its Adjusted Earnings calculation to remove certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and adjusted for changes in the measurement of certain guarantees. Additionally, Adjusted Earnings now excludes changes in fair value associated with MRBs, changes in discount rates on certain annuitization guarantees, and asymmetrical accounting associated with in-force reinsurance. These changes align with GAAP guidance for segment reporting and enhance the consistency and comparability of Adjusted Earnings across periods and with industry practices.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its description of MetLife's evolution of Adjusted Earnings between 2023 and 2024, particularly regarding the impact of LDTI adoption and the removal of DAC/VOBA amortization adjustments. It accurately notes the shift to adjusting for changes in the measurement of guarantees, exclusion of MRB fair value changes, discount rate impacts on annuitization guarantees, and asymmetrical accounting from in-force reinsurance—key elements from the 2023 update. However, the LLM incorrectly states that LDTI was adopted in 2024, when the original answer and factual record confirm the changes were implemented in 2023. This misplacement of the timeline affects the reasoning flow and undermines the accuracy of the multi-hop synthesis. Additionally, the 2024 refinements—such as more structured exclusions including inflation-indexed benefit adjustments, non-economic losses from single premium annuity contracts, and clearer delineation of market volatility and divested business impacts—are not mentioned, leading to a partial omission of how the exclusions were expanded and formalized in 2024. While the core conceptual evolution is captured, the answer lacks completeness in reflecting the full scope of 2024 developments. Quantitative accuracy is high as no specific numerical values are misstated (the years are the primary quantitative issue). Contextual relevance is strong, as the response directly addresses the question’s focus on GAAP alignment and segment performance. The qualitative accuracy is reduced due to the incorrect timing of LDTI adoption and missing 2024-specific refinements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 443,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "From 2022 to 2024, Accenture's funding and utilization of its share purchase program evolved as follows: \n\nAs of August 31, 2022, the available authorization for share repurchases was $3,129,296, which increased to $2,694,281 by August 31, 2024, following additional repurchase authorizations of $3,000,000 in 2022 and $4,000,000 in 2024, bringing the total authorization to $6,694,281. In terms of share acquisition methods, open-market purchases remained the primary method, with 11,753,807 shares repurchased in 2024 compared to 9,635,751 in 2022. Additionally, Accenture continued to acquire shares through other programs, such as share withholding for payroll tax obligations, though these did not impact the available authorization.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Accenture had an aggregate available authorization of $3,129,296, but the LLM incorrectly claims this increased to $2,694,281 by 2024 after adding $3M and $4M in new authorizations, resulting in a total of $6,694,281. This is contradicted by the original answer, which does not mention any increase in total authorization or specific new authorizations in 2022 and 2024. There is no support for the claim that available authorization was reduced to $2,694,281 or that total authorizations reached over $6.6 billion. These numbers are entirely fabricated or misinterpreted. (2) The LLM introduces specific share repurchase volumes (11,753,807 in 2024 and 9,635,751 in 2022), which are not present in the ground truth and cannot be verified. The original answer does not provide any quantitative data on the number of shares repurchased via open-market purchases. (3) The qualitative reasoning is flawed: the original answer emphasizes a shift in acquisition methods—specifically, increased use of share withholding for payroll taxes in 2024 that did not impact the public program’s authorization. The LLM incorrectly states that open-market purchases remained the 'primary method' and cites fabricated numbers to support this, contradicting the ground truth’s implication of a methodological shift away from public market purchases. (4) Contextual relevance is moderate—the response addresses funding levels and acquisition methods as asked, but the information is largely incorrect. While it mentions share withholding and distinguishes it from public program impacts (aligned with ground truth), this correct point is overshadowed by pervasive quantitative and qualitative errors. Overall, the answer fails on correctness due to invented figures and incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 509,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "From 2023 to 2024, MetLife's treatment and valuation methodology for Unit-linked Securities remained consistent in terms of cost basis, as these securities are primarily valued at original cost adjusted for repayments and amortization of premiums or accretion of discounts. However, there was an increase in the fair value of Unit-linked Securities, rising from $10,331 million in 2023 to $11,90 million in 2024. The sensitivity of these fair values to changes in significant unobservable inputs, such as equity volatilities and mortality rates, was also highlighted, indicating that increases in equity volatility and changes in mortality assumptions could significantly impact the estimated fair value of these instruments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that MetLife's treatment and valuation methodology for Unit-linked Securities 'remained consistent' from 2023 to 2024, which directly contradicts the ground truth: in 2023, cost basis was based on original or amortized cost, but in 2024, Unit-linked securities were moved into Level 3 fair value measurements using significant unobservable inputs, indicating a major shift in methodology. The LLM incorrectly implies continuity when there was a clear evolution toward a more dynamic, assumption-driven approach. (2) Quantitative errors are severe: the reported 2024 value of '$11,90 million' is both numerically incorrect and improperly formatted—it should be $11,900 million or $11.9 billion, but more importantly, this figure is not supported by the ground truth, which does not provide specific dollar values for Unit-linked Securities in either year. The $10,331 million figure for 2023 also does not appear in the original answer and is therefore fabricated. (3) Multi-hop reasoning is flawed: the question asks about changes in methodology (cost basis and fair value sensitivity), but the LLM fails to recognize the shift from cost-based valuation to Level 3 fair value with unobservable inputs. Instead, it incorrectly asserts consistency in cost basis while mentioning sensitivity disclosures, which does not reflect the fundamental methodological change. (4) Contextual relevance is moderate because the answer discusses fair value sensitivity and mentions relevant inputs like equity volatility and mortality rates, but these points are undermined by the incorrect framing of unchanged cost basis and false quantitative claims. Overall, the answer misrepresents the core evolution in MetLife's valuation approach and introduces unsupported numbers, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 508,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "Between fiscal years 2022 and 2023, the structure and vesting timeline of market-based RSUs evolved as follows: In fiscal year 2022, market-based RSUs generally vested over four years, contingent on total stockholder return (TSR) performance. In fiscal year 2023, the company introduced market-based RSUs with a five-year vesting period, subject to stock price performance milestones. This change reflects a shift toward longer-term performance metrics for certain equity awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in market-based RSUs between fiscal years 2022 and 2023. (1) It correctly states that in 2022, RSUs generally vested over four years based on TSR performance, which matches the ground truth. In 2023, it accurately notes the introduction of five-year vesting tied to stock price performance milestones. (2) There are no numeric values requiring calculation, but the timeframes (four-year and five-year vesting) are correctly reported. (3) The multi-hop reasoning is sound—comparing the structure across two fiscal years and identifying a shift toward longer-term incentives. (4) The only minor omission is that the ground truth mentions grantees could receive 0% to 300% of the original grant in 2022 based on TSR, which adds detail about payout mechanics that the LLM answer leaves out. While not critical to the structural evolution, this detail enriches the understanding of the 2022 plan. Otherwise, the answer is semantically equivalent, well-reasoned, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 301,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "Between 2023 and 2024, the phase-in treatment of the CECL standard's ongoing impact on regulatory capital progressed as follows: In 2023, 50% of the cumulative 'day 2' ongoing impact of CECL was phased in, with the remaining 50% to be phased in over 2024 and 2025. By 2024, 75% of this impact had been phased in, with the final 25% to be fully phased in by 2025. The regulatory capital treatment during the phase-in period allowed the Company to add back an amount equal to the after-tax 'day 1' CECL adoption impact and a portion (25% annually) of the cumulative 'day 2' impact to its regulatory capital.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the CECL phase-in began on January 1, 2022, and was to be phased in at 25% per year through December 31, 2024—meaning 25% in 2022, 50% by end of 2023, and 75% by end of 2024. However, the LLM incorrectly states that in 2023, 50% was phased in (implying no prior phase-in), and that the remaining 50% would be phased in over 2024 and 2025—extending the period to 2025, which contradicts the 2024 end date in the original answer. The phase-in period ends in 2024, not 2025. (2) Quantitatively, the 25% annual phase-in rate is correctly mentioned, but the cumulative application is wrong. By 2023, it should be 50% cumulative (after two years), and by 2024, 75%—but the LLM misattributes the timing and duration. The mention of 'after-tax day 1 impact' is not in the original and introduces unverified information. (3) The multi-hop reasoning is flawed: the model fails to correctly track the multi-year timeline from 2022–2024 and incorrectly extends it to 2025, showing a failure in synthesizing the regulatory timeline. It also conflates 'day 1' and 'day 2' impacts without support from the ground truth. (4) Despite these errors, the answer is contextually relevant—it addresses the CECL phase-in, regulatory capital, and annual percentages—so it receives moderate relevance and partial qualitative credit for using correct terminology and structure, but major factual and quantitative errors severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 421,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "Between 2022 and 2023, Broadcom continued its relationship with Wilmington Trust, National Association as the trustee for its senior notes indentures, with multiple new indentures and supplemental agreements executed in 2023. In 2022, the company issued senior notes such as the 4.00% Senior Notes due 2029 and 4.15% Senior Notes due 2032 under indentures dated April 14 and 18, 2022, respectively. In 2023, Broadcom expanded its senior notes portfolio by issuing additional notes, including the 5.050% Senior Notes due 2027, 2029, and 2031 under an indenture dated July 12, 2024, and the 4.150%, 4.350%, 4.550%, and 4.800% Senior Notes due 2028, 2030, 2032, and 2034 under a supplemental indenture dated October 2, 2024. This indicates an expansion in the types and terms of senior notes issued under their indentures during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Broadcom issued senior notes under indentures from January 2021 (not April 2022), with interest rates ranging from 1.950% (due 2028) to 3.750% (due 2051). The LLM incorrectly claims that in 2022, Broadcom issued 4.00% and 4.15% notes under indentures dated April 14 and 18, 2022—these dates and rates do not match the original answer. Furthermore, the LLM references a July 12, 2024 indenture and an October 2, 2024 supplemental indenture, but the original answer only mentions April 18, 2022 and July 12, 2024 as new indenture dates, with October 2024 issuance under those. The LLM also invents a '5.050% Senior Notes due 2027, 2029, and 2031' which is not present in the ground truth. (2) Quantitative accuracy is very low: multiple incorrect interest rates (e.g., 4.00%, 5.050%), incorrect issue dates (April 2022 vs. January 2021), and future-dated indentures (July 2024, October 2024) presented as if executed in 2023. The ground truth does mention a 4.926% note due 2037 and later issuances in October 2024 ranging from 4.150% to 4.800%, but the LLM misattributes these to different dates and structures. (3) Multi-hop reasoning is flawed: the LLM fails to correctly trace the evolution from lower-rate, long-term 2021 notes to higher-rate 2022/2024 issuances. Instead, it fabricates a timeline and set of instruments, missing the core trend of increasing yields and longer maturities over time. It also misidentifies the nature of the indentures—original answer emphasizes continuity from 2021 and new ones in 2022 and 2024, not 2023 activity. (4) Contextual relevance is moderate because the answer addresses the trustee relationship and types of notes, but the factual foundation is so compromised that the conclusion about 'expansion' is misleading. The correct narrative is a shift toward higher-yielding, longer-term debt, not just portfolio expansion. Due to major factual and temporal errors, the correctness score is low at 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 551,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "Capital One's regulatory capital add-back under the CECL Transition Rule was fully phased in by January 1, 2024, with 75% of the cumulative impact added back to regulatory capital as of that date, leaving $600 million to be phased in on January 1, 2025. As a result, the Company's CET1 capital ratio was 13.5% as of December 31, 2024, compared to 13.3% on a fully phased-in basis.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual inaccuracies. It correctly states that 75% of the CECL add-back was phased in by January 1, 2024, which matches the ground truth. However, it incorrectly claims that $600 million remains to be phased in on January 1, 2025 — this figure is not supported by the original answer and introduces a number not present in the ground truth. The original answer states that the phase-in progressed from 50% in 2023 to 75% in 2024 as part of a five-year 25%-per-year schedule, but the LLM does not mention the 2023 baseline of $2.4 billion at 50%, which is a key part of the evolution. (2) The calculation of the remaining add-back is flawed: if 75% is phased in by 2024, and assuming the total CECL add-back is $2.4B / 50% = $4.8B (implied total), then 25% ($1.2B) would remain — not $600M. The LLM’s $600M figure suggests either a miscalculation or incorrect total. Additionally, the CET1 ratio of 13.5% vs 13.3% is new information not found in the ground truth and cannot be verified, making it extraneous and potentially misleading. (3) The multi-hop reasoning is weak: the model fails to connect the 2023 starting point (50%, $2.4B) with the 2024 progression (75%), instead jumping to a future date and introducing unverified figures. It misses the core narrative of a 25 percentage point increase during the 2023–2024 period. (4) Scores reflect partial credit for correct 75% phase-in by 2024 and contextual relevance to the CECL rule, but major deductions for incorrect numbers, missing baseline data, flawed calculations, and introduction of unsupported metrics like CET1 ratios and $600M.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 457,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "Following the Broadcom acquisition, the treatment of VMware stock options for non-employee directors evolved as follows: in 2022, all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors were accelerated and converted into the right to receive cash and shares of Broadcom common stock in equal parts. By 2023, after the completion of the VMware Merger, the same treatment was confirmed for these awards, ensuring that non-employee directors received a combination of cash and Broadcom stock for their in-the-money VMware equity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly states that in 2022, outstanding in-the-money VMware stock options and RSUs for non-employee directors were accelerated and converted into equal parts cash and Broadcom shares upon acquisition. By 2023, this was confirmed as completed. (2) There are no numeric values requiring calculation, but all dates (2022, 2023) and structural details (equal parts cash and Broadcom stock) are correct. (3) The multi-hop reasoning is sound—synthesizing the change in treatment from a planned event in 2022 to an actualized outcome in 2023. (4) The only minor shortcoming is that the LLM slightly conflates timing: the 2022 filing described a future plan upon completion, whereas the LLM states the acceleration 'were accelerated' in 2022, which could imply the event occurred during that year rather than being contingent on the acquisition's completion. The original answer more precisely distinguishes the plan (2022) from the realization (2023). This nuance is important but does not undermine the overall correctness. Hence, a score of 9 is appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 326,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "Based on AbbVie's disclosures, the therapeutic positioning of Vraylar evolved from 2022 to 2024 by expanding its use as an adjunctive treatment for major depressive disorder (MDD), with top-line results from two Phase 3 clinical trials in 2021 showing statistically significant improvement in one trial and numerical improvement in the other. By 2024, Vraylar was positioned as a treatment for acute and maintenance treatment of schizophrenia in adults, acute treatment of manic or mixed episodes associated with bipolar disorder in adults, acute treatment of depressive episodes associated with bipolar I disorder in adults, and as an adjunctive treatment in MDD, indicating a broader and more established therapeutic role in psychiatric care.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that in 2022, Vraylar was evaluated in two Phase 3 trials for adjunctive treatment of MDD, with one showing statistically significant improvement and the other numerical (but not statistically significant) improvement—this aligns with the original answer, though it references '2021' for trial results, which is a minor temporal imprecision but not incorrect since top-line results could have been released then. (2) The quantitative and descriptive details about trial outcomes are accurate and consistent with the ground truth. (3) The 2024 therapeutic indications are fully and correctly listed: schizophrenia, bipolar manic/mixed episodes, bipolar depressive episodes, and adjunctive MDD—demonstrating proper multi-hop synthesis across time and disclosures. (4) The evolution from investigational use in MDD to broader approved indications is clearly and logically conveyed, showing sound reasoning. The only minor issue is the reference to '2021' trial results when the question focuses on 2022 disclosures, but this does not undermine the overall correctness. Wording differs slightly but maintains semantic equivalence. All entities (Vraylar, AbbVie, correct indications) are accurate. Thus, the answer is excellent with only a slight deduction for the date reference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 384,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "From 2022 to 2024, GE's accounting policy for long-term services agreements has remained consistent in using the percentage of completion method for revenue recognition, based on costs incurred relative to total expected costs. However, there is a notable evolution in the specificity of estimating future billings and contract profitability. In 2024, GE provides more detailed insights into how it incorporates forward-looking information such as market conditions and asset retirements into utilization estimates, which directly impact expected revenue and cost projections. Additionally, the 2024 disclosure highlights the sensitivity of long-term service agreements to changes in estimates, noting that a one percentage point change in profitability would affect the contract balance by $0.4 billion, reflecting a more granular discussion of risk and financial impact compared to 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in stating that GE used the percentage of completion method in both 2022 and 2024. According to the ground truth, GE used the straight-line method in 2022 and only shifted to the percentage of completion method in 2024, primarily in the CES segment. This misrepresentation of the core revenue recognition change severely undermines the factual accuracy. Additionally, the LLM introduces a sensitivity analysis stating that a one percentage point change in profitability would affect the contract balance by $0.4 billion — this figure is not present in the original answer and appears fabricated. (2) Quantitatively, the LLM fails to report any of the key numbers from the ground truth: the $6.6 billion net liability, the $162 billion total estimated life of contract billings, or the 4.1% ratio. Instead, it invents a $0.4 billion sensitivity figure with no basis in the provided truth. These omissions and inaccuracies result in very low quantitative accuracy. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the evolution in accounting policy — a central requirement of the question. It incorrectly assumes consistency in method rather than recognizing the shift from straight-line to percentage-of-completion. While it correctly notes increased disclosure detail in 2024 regarding forward-looking estimates, this does not compensate for the core error in policy description. (4) Contextual relevance is moderate because the answer addresses revenue recognition and contract billing estimates, and discusses forward-looking elements mentioned in the truth. However, due to major factual and quantitative errors, especially regarding the revenue recognition method timeline and invented financial figures, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 498,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "In the 2022 10-K filing, IBM's 1.250% Notes due 2027 were referenced under the list of instruments defining the rights of security holders in Part IV, Item 15, but no specific details about the issuance or terms were provided. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed in the table of securities registered under Section 12(b) of the Exchange Act with the trading symbol \"IBM 27B,\" indicating it was issued and actively traded on the New York Stock Exchange. This reflects an evolution in disclosure, with the 2023 filing providing more direct visibility into the note's market listing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in the 2022 10-K, the 1.250% Notes due 2027 were referenced as part of the instruments defining rights of holders, specifically citing Exhibit 4.3 to the Form 8-K filed January 30, 2019 (though the LLM does not mention the Exhibit reference, this is a minor omission). In the 2023 10-K, the notes are listed under Section 12(b) securities with trading symbol 'IBM 27B' on the NYSE, which matches the ground truth. (2) Quantitative accuracy is perfect: the interest rate (1.250%), maturity year (2027), and trading symbol (IBM 27B) are all correct. No calculations were required. (3) The multi-hop reasoning is sound—comparing disclosure treatment across two years and interpreting the evolution from a legal instrument reference to a registered security listing. The conclusion about increased visibility in the 2023 filing is a reasonable qualitative interpretation. (4) The only minor shortcoming is the omission of the specific Exhibit 4.3 reference from the 2022 filing, which slightly reduces completeness but does not affect the core factual accuracy. Overall, the answer is semantically equivalent and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 346,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "Between 2022 and 2024, AbbVie's performance-vested RSUs have maintained a structure where vesting occurs in one-third increments over a three-year performance period. The performance criteria for these RSUs are based on AbbVie's return on invested capital (ROIC) performance relative to a defined peer group of pharmaceutical, biotech, and life sciences companies. No significant changes to the vesting increments or the primary performance metric (ROIC) were noted in the provided documents for this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that AbbVie's performance-vested RSUs vest in one-third increments over a three-year period and that the primary performance metric is ROIC relative to a peer group of pharmaceutical, biotech, and life sciences companies. All entities (AbbVie, RSUs, ROIC, peer group) and timeframes (2022–2024) are correctly referenced. There are no numeric inaccuracies—no specific percentages or dollar amounts are involved, and the description of vesting increments is quantitatively sound. The reasoning is logically sound and synthesizes the key continuity in structure and metric. However, the LLM answer omits a subtle but relevant detail mentioned in the original answer: the 2022 description tied performance metrics to awards granted in 2021 and 2020 with specific tranches, while by 2024 the criteria were streamlined and no longer referenced those specific years or tranches. This reflects a minor omission in qualitative depth regarding the evolution (i.e., simplification) of the criteria. While the LLM correctly states there were 'no significant changes,' it misses the nuance of standardization or streamlining noted in the ground truth. This prevents a perfect 10 but does not undermine the overall correctness. The answer remains semantically equivalent in core content and highly contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 388,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "Based on the information provided in the 2024 10-K filing, GE's financial relationship with AerCap evolved from 2022 to 2024 as follows: In 2022, GE reported a realized and unrealized loss of $865 million related to its investment in AerCap. This loss significantly improved in 2023, with a gain of $129 million, and further improved in 2024, with a gain of $38 million. This indicates a gradual improvement in the value of GE's investment in AerCap over the three-year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, GE reported an *unrealized loss* of $865 million, but the LLM incorrectly describes it as a 'realized and unrealized loss,' conflating the nature of the loss. More critically, the LLM introduces a figure for 2023—'a gain of $129 million'—which is not present in the original answer or implied by the ground truth. This number is unsupported and appears fabricated. The 2024 figure of $38 million gain is correct in amount and characterization as a 'realized and unrealized gain,' matching the ground truth. (2) Quantitative accuracy is low because of the incorrect 2023 data and mischaracterization of the 2022 loss. While $865M and $38M are correct in magnitude, the nature of the 2022 loss (unrealized only) is misrepresented, which affects financial interpretation. The addition of a 2023 gain breaks fidelity with the source. (3) The multi-hop reasoning is partially sound in identifying a trend from loss to gain, but the inclusion of an unsupported intermediate year undermines the validity of the synthesis. The original answer draws a direct comparison between 2022 and 2024 without 2023 data, making the LLM's extrapolation incorrect. (4) Contextual relevance is high because the answer addresses the evolution of GE's financial relationship with AerCap through gains/losses, which is directly responsive to the question. However, due to key factual and quantitative errors, especially the introduction of unverified data, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 433,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "In the 2023 SEC filing, IBM's 0.300% Notes due 2026 are explicitly listed under \"Securities registered pursuant to Section 12(b) of the Act\" with the trading symbol \"IBM 26B\" and are noted as being traded on the New York Stock Exchange. In contrast, the 2022 filing does not specifically mention these notes, indicating an increased disclosure and visibility of the 0.300% Notes due 2026 in the 2023 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that in 2023, the 0.300% Notes due 2026 were explicitly listed under Section 12(b) with the trading symbol 'IBM 26B' on the New York Stock Exchange, reflecting increased visibility. It also correctly contrasts this with the 2022 filing, where these notes were not specifically mentioned in the same context. The quantitative details—interest rate (0.300%), maturity year (2026), symbol (IBM 26B)—are all correct. The only minor shortcoming is that the original answer adds context about the 2016 Form 8-K exhibit reference (Exhibit 4 to Form 8-K filed November 1, 2016), which the LLM omits. While this is a relevant detail about the earlier disclosure status, its absence does not undermine the core correctness of the evolution in disclosure and visibility between 2022 and 2023. The reasoning is sound, the entities and years are accurate, and the multi-hop synthesis (comparing disclosure treatment across two years) is appropriately handled. The answer is semantically equivalent to the ground truth, with slightly less background detail but no factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 327,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "Between 2022 and 2024, GE's approach to the RISE Program has evolved to emphasize sustainable aviation technologies more strategically. In 2022, the RISE Program was introduced as a technology development initiative targeting a 20% reduction in fuel consumption and CO2 emissions. By 2024, the RISE Program had progressed to include a suite of pioneering technologies such as Open Fan, compact core, and hybrid electric systems, with over 250 tests conducted on a full-scale Open Fan engine. This shift reflects a stronger investment focus on developing scalable, sustainable solutions compatible with alternative fuels, aligning with broader industry decarbonization goals.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of GE's RISE Program from a conceptual initiative in 2022 to a more advanced, technology-driven R&D effort by 2024. The 20% reduction in fuel consumption and CO2 emissions is accurately reported, matching the ground truth. However, the ground truth emphasizes the collaborative nature of the program with Safran in 2022, which the LLM omits, representing a minor but relevant omission in entity accuracy. Additionally, while the LLM mentions 'over 250 tests on a full-scale Open Fan engine' and specific technologies (Open Fan, compact core, hybrid electric), these details are not present in the ground truth and may represent over-specificity or external knowledge not confirmed in the source. (2) Quantitatively, the 20% figure is correct and properly attributed. There are no calculations in this response, so accuracy on numbers is high. The years (2022, 2024) are correctly used. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift from announcement to active development. It synthesizes the timeline and evolving focus appropriately, though it adds technical details (e.g., number of tests) not in the original, which slightly undermines qualitative accuracy. (4) The answer is highly contextually relevant, directly addressing both strategic emphasis and investment focus. The core message—that GE moved from announcement to active investment in sustainable aviation tech—aligns with the ground truth. The score of 8 reflects minor omissions (Safran collaboration) and unverified additions (test counts, specific tech suite), but the overall factual and conceptual accuracy remains strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 461,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "From 2022 to 2023, the role and emphasis on asset securitizations within American Express's funding strategy remained a key component, with a continued focus on leveraging cost-effective funding through the securitization of Card Member loans and receivables. In both years, American Express highlighted the importance of asset securitizations as part of a diverse funding mix that includes deposits, unsecured debt, and secured borrowings. In 2023, the company reiterated its strategy of using securitization programs to fund its U.S. card business, transferring assets to trusts that issue asset-backed securities to third-party investors. The emphasis on maintaining a balanced and diversified funding approach, including securitizations, remained consistent, though the 2023 filing provided more detailed descriptions of specific securitization activities and debt issuances, reflecting ongoing execution of the strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly portrays the evolution of asset securitizations in American Express's funding strategy. According to the ground truth, in 2022, securitizations were only defined in a glossary and not emphasized as a strategic component, whereas in 2023 they were explicitly elevated to a core funding source alongside deposits and unsecured debt. The LLM answer falsely claims that securitizations were already a 'key component' and part of a 'diverse funding mix' in 2022, which is not supported by the 2022 filing. This misrepresents the evolution as one of consistency rather than a strategic shift. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors in this regard, hence a score of 10. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the change in disclosure tone and strategic emphasis between the two years. Instead of identifying a shift from definitional to strategic treatment, it assumes continuity, missing a key qualitative distinction. (4) Contextual relevance is moderate—the response discusses securitizations and funding strategy appropriately and mentions correct mechanisms (e.g., trusts, asset-backed securities), but it inaccurately characterizes the historical role in 2022, undermining the correctness of the comparative analysis. The 2023 description aligns better with the truth, but the lack of contrast weakens the overall response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 414,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "Emerson's financial and strategic relationship with AspenTech evolved significantly from 2022 to 2023. In 2022, Emerson completed the acquisition of Heritage AspenTech, creating \"New AspenTech,\" in which Emerson owned 55% of the outstanding shares. The AspenTech segment was added as a separate business segment, reflecting the combined results of Heritage AspenTech and Emerson's Industrial Software Business. By 2023, Emerson increased its ownership to approximately 57%, and the AspenTech segment showed improved financial performance, with sales rising from $656 million in 2022 to $1.3 billion in 2023, and earnings turning from a $12 million loss in 2022 to $12 million profit in 2023. Operationally, AspenTech's integration into Emerson's portfolio contributed to Emerson's strategic focus on industrial software and optimization solutions, enhancing Emerson's digital ecosystem offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Emerson had a minority investment in AspenTech, not a 55% ownership from an acquisition of Heritage AspenTech completed that year. The acquisition that gave Emerson a 55% stake occurred in 2023, not 2022. The LLM incorrectly states that the acquisition was completed in 2022 and that ownership increased to 57% in 2023, which is not supported by the original answer. (2) Quantitatively, the LLM misrepresents key figures: it claims sales rose from $656 million to $1.3 billion and that earnings turned from a $12 million loss to a $12 million profit. However, the ground truth states AspenTech contributed $656 in sales (not million) and a $12 earnings gain (profit) in 2022 — there was no loss. The units are critically wrong (e.g., $656 vs $656 million), and the 2023 financials are entirely fabricated with no support in the original answer. (3) The multi-hop reasoning is flawed: the LLM fails to correctly sequence the evolution of the relationship — it reverses the timeline, portraying the controlling interest as starting in 2022 rather than marking 2023 as the shift from passive to active control. The operational integration is described plausibly (e.g., forming a new segment, strategic focus on software), but this is speculative and not detailed in the ground truth. (4) Despite the incorrect facts and timeline, the answer is contextually relevant — it addresses investment returns and operational integration as asked, and attempts to show progression. However, due to major factual and quantitative errors, especially in financial data and ownership timeline, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 468,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved significantly. In 2022, Emerson acquired Heritage AspenTech, creating \"New AspenTech,\" and held a 55% controlling interest, with the remaining 45% as a noncontrolling interest valued at $5.9 billion. By 2023, Emerson further solidified its control by acquiring the remaining noncontrolling interest in Copeland, which was part of the broader portfolio transformation. The 2023 acquisition of Heritage AspenTech contributed to increased sales and expenses, particularly through higher amortization of intangible assets and foreign currency hedge impacts. Additionally, the 2023 financials reflect the impact of the Heritage AspenTech acquisition on equity and expenses, including a $146 increase in intangibles amortization and a $112 unfavorable foreign currency transaction impact.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It incorrectly states that Emerson acquired Heritage AspenTech in 2023, when in fact the creation of New AspenTech and Emerson's 55% ownership occurred in 2022. The noncontrolling interest of $5.9 billion is correctly mentioned, but the LLM omits the $550 million decrease to additional paid-in capital, a key accounting impact from 2022. The LLM introduces a $146 increase in intangibles amortization and $112 foreign currency impact, which are not present in the ground truth and appear fabricated. The $572 million increase in SG&A expenses from the ground truth is entirely missing. Instead, the LLM incorrectly attributes increased expenses to amortization and foreign exchange, not the stock compensation and transaction costs cited in the original. (2) Quantitative accuracy is low: only the $5.9 billion noncontrolling interest is correct. The $146 and $112 figures are unsupported. The 0.6 percentage point gross margin improvement and $572 million SG&A increase—both critical numbers—are absent. (3) Multi-hop reasoning is flawed: the LLM confuses the timeline, suggesting a 2023 acquisition of Heritage AspenTech when it was already formed in 2022. It also conflates the AspenTech transaction with the Copeland acquisition, which is unrelated to the noncontrolling interest discussion. The shift from accounting impacts in 2022 to operational impacts in 2023 is not accurately reflected. (4) Contextual relevance is moderate—the answer addresses financial impacts and noncontrolling interest, but misattributes events and metrics. While it attempts to discuss equity and expense impacts, the incorrect entities and numbers undermine the response. The core evolution—initial accounting in 2022 vs. integration effects in 2023—is not accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 496,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "IBM's treatment and disclosure of the 6.22% Debentures due 2027 remained consistent between the 2022 and 2023 SEC filings. In both years, the debentures were disclosed in the exhibits section of the 10-K filings, with the 2022 filing referencing Exhibit 3 to Form 8-K filed on August 1, 1997, and the 2023 filing including the same reference. Additionally, in both filings, the debentures were listed among IBM's registered securities under the appropriate sections, indicating no material changes in their terms or disclosure requirements.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that IBM's treatment and disclosure of the 6.22% Debentures due 2027 remained consistent between 2022 and 2023. The ground truth shows a clear evolution: in 2022, IBM only referenced the debentures via Exhibit 3 to Form 8-K filed on August 1, 1997, while in 2023, it introduced a more structured disclosure by listing the debentures with their trading symbol (IBM 27) and identifying them among other NYSE-registered securities. The LLM incorrectly claims no change, which contradicts the ground truth. (2) Quantitatively, the LLM correctly identifies the 6.22% interest rate, the 2027 maturity, and the August 1, 1997 Form 8-K filing date, so numeric accuracy is preserved. (3) The multi-hop reasoning is flawed: the question asks for a comparison of disclosure evolution across two years, requiring synthesis of differences in presentation and transparency. The LLM fails to detect or report the shift from a historical reference to a current, market-oriented disclosure, missing the core insight. (4) Contextual relevance is moderate because the answer discusses the right instrument and filings, but it draws an incorrect conclusion about consistency, undermining the overall correctness. The answer would have scored higher if it had acknowledged the enhanced transparency in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 376,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "From 2023 to 2024, UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers has increased, as these arrangements constitute nearly 80% of its total consolidated revenues. The evolution of these arrangements involves a heightened reliance on accurate cost estimation and effective management of medical costs, as any inaccuracies or failures in these areas could significantly impact profitability and financial performance. This exposure also entails greater service delivery responsibilities, particularly for Optum Health's value-based care models, where the company must ensure high-quality outcomes and efficient care delivery to meet financial and operational targets.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies an increase in UnitedHealth Group's financial risk exposure from 2023 to 2024 through risk-based arrangements and links this to greater cost estimation and service delivery responsibilities, which aligns with the ground truth. However, it introduces a specific quantitative claim—'nearly 80% of its total consolidated revenues'—that is not present in the original answer and cannot be verified from the provided ground truth, making this a significant factual overreach. There is no mention of such a percentage in the ground truth, so this number is unsupported and likely incorrect in context. (2) The quantitative accuracy is low because the 80% figure is unverified and potentially misleading. No other numbers (e.g., premium amounts, claim liabilities) are mentioned in either answer, so the error lies solely in the introduction of this unsupported statistic. (3) The qualitative reasoning is mostly sound: the model correctly infers increased financial and operational risk, ties it to cost estimation challenges, and connects it to service delivery, especially within Optum Health’s value-based models. It captures the essence of expanded responsibility, though it misses the specific 2024 disclosure about UnitedHealth being liable for unpaid claims if providers fail financially—a key multi-hop detail in the ground truth. (4) Contextual relevance is high because the answer stays focused on the evolution of risk-based arrangements and their implications. Despite missing some nuanced operational risks (e.g., provider solvency, data availability for cost estimation), it generally reflects the trend described. The correctness score is 6 due to the mix of accurate directional reasoning and the critical flaw of introducing an unverified quantitative claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 493,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved significantly in terms of investment magnitude and strategic involvement. In 2022, Emerson completed a transaction to create \"New AspenTech\" by contributing two of its industrial software businesses and $6.0 billion in cash to Heritage AspenTech, resulting in Emerson owning 55% of the newly formed AspenTech on a fully diluted basis. By 2023, Emerson had further increased its ownership stake in AspenTech, acquiring additional shares to reach approximately 57% ownership by 2024. This strategic move reflects Emerson's deepening investment in and integration with AspenTech, positioning it as a controlling stakeholder and aligning with its focus on expanding its digital and automation solutions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Emerson had a financial investment of $362 million in AspenTech, and the major transaction creating 'New AspenTech' occurred in 2023, not 2022 as the LLM claims. The LLM incorrectly states that the $6.0 billion cash contribution and business transfer happened in 2022, when it actually occurred in 2023. Additionally, the LLM mentions Emerson increasing ownership to 57% by 2024, which is not supported by the original answer—no such increase is mentioned, and the ownership stake is stated as 55% following the 2023 transaction. (2) Quantitative accuracy is low: while the $6.0 billion cash amount and 55% ownership are correct figures, they are assigned to the wrong year. The $362 million investment in 2022 is completely omitted. The claim of 57% ownership by 2024 introduces data not present in the ground truth. (3) The multi-hop reasoning is partially sound in that the model recognizes a shift from financial to strategic involvement and identifies key transaction components, but the incorrect timeline undermines the logical progression. The synthesis fails because it reverses the chronological evolution: the strategic move happened in 2023, not 2022, and there is no evidence of a further stake increase. (4) Contextual relevance is high—the answer addresses investment magnitude and strategic involvement as asked, and uses appropriate financial and strategic terminology. However, due to major factual and temporal errors, the correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 439,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, Adobe Target's role within Adobe's customer journey solutions has evolved to become a more integral part of Adobe's AI-driven personalization strategy. In fiscal 2022, Adobe Target is described as an AI- and machine learning-driven personalization engine that enables customers to test, target, and optimize content across channels. By fiscal 2023, Adobe Target is highlighted as a key component of Adobe's broader AI and generative AI initiatives, particularly through Adobe Sensei and Firefly, indicating a strategic shift toward embedding AI-driven personalization more deeply into customer journey management. This evolution reflects Adobe's focus on leveraging AI to deliver more accurate, scalable, and real-time personalized experiences across all touchpoints.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy regarding Adobe Target's description in fiscal 2022. The original answer states that in 2022, Adobe Target was part of a broader set of customer journey tools and described as enabling testing, targeting, and personalization—but it was not yet labeled an 'AI- and machine learning-driven personalization engine' at that time. The LLM incorrectly attributes this AI-focused characterization to 2022, when in fact this elevated description emerged in 2023. This misrepresentation undermines the accuracy of the evolution narrative. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors in this regard, scoring 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift toward AI-driven personalization. However, it fails to accurately represent the baseline state in 2022, leading to flawed synthesis. Additionally, the mention of Adobe Sensei and Firefly, while contextually relevant to Adobe’s AI strategy, is not supported in the original answer as direct components linking to Adobe Target’s evolution, introducing unsupported extrapolation. (4) Despite the incorrect timeline of AI positioning, the LLM captures the broader strategic direction correctly—emphasizing AI-driven, scalable personalization—as indicated in the original answer. The response is well-structured and contextually relevant, but the core factual error in attributing the AI-driven label to 2022 reduces its correctness significantly. Hence, a score of 6 reflects partially correct information with key factual inaccuracies affecting the qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 473,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly from 2022 to 2023, as Emerson completed the acquisition of Heritage AspenTech in the third quarter of 2022. This acquisition led to a substantial increase in Emerson's financial stake in AspenTech, with goodwill for AspenTech rising from $1,044 million in 2021 to $8,326 million in 2022. Post-acquisition integration activities included aligning AspenTech's stock-based compensation plans with Emerson's structure, converting Heritage AspenTech awards into AspenTech awards, and integrating financial reporting and operational processes. Additionally, Emerson assumed responsibility for AspenTech's financial obligations, including a $240 million revolving term loan credit facility as of September 30, 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. The $8,326 million balance in 2022 is correctly stated and matches the ground truth, but the claim that goodwill rose from $1,044 million in 2021 to $8,326 million in 2022 is not supported by the original answer and introduces a figure ($1,044M) not mentioned in the ground truth. This is a significant quantitative inaccuracy. Additionally, the LLM incorrectly states that AspenTech was acquired by Emerson as 'Heritage AspenTech'—the original answer refers to 'Heritage AspenTech' only in passing and does not support the framing of the acquisition as being of 'Heritage AspenTech' specifically. (2) The $240 million revolving term loan credit facility is not mentioned in the ground truth and appears to be fabricated or misattributed, further reducing quantitative accuracy. (3) The reasoning partially captures the post-acquisition integration, such as alignment of stock-based compensation plans, but misrepresents the direction: the original answer states that AspenTech's plans were maintained under its own equity structure, not aligned with Emerson's structure. The LLM incorrectly implies integration into Emerson's system, whereas the ground truth emphasizes AspenTech operating as a separate publicly traded company with continued independent equity plans. This misrepresents the nature of the integration. (4) Contextual relevance is high because the answer addresses both financial stake and integration activities. However, due to key factual errors in numbers, entities, and direction of integration, the correctness score is reduced to 6—partially correct but with significant inaccuracies affecting the overall reliability of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 474,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "From 2022 to 2023, Adobe Experience Platform has evolved to play a more central role in Adobe's customer journey solutions by enhancing its integration with AI-powered tools and improving cross-channel campaign orchestration. In 2022, the platform was described as a foundational infrastructure for customer experience management, enabling data collection, connection, and activation for real-time insights and unified customer profiles. By 2023, Adobe Experience Platform was further integrated with AI and machine learning capabilities, particularly through Adobe Sensei, to deliver AI-driven insights and automation across Adobe Experience Cloud apps. Additionally, cross-channel campaign orchestration was strengthened through tools like Adobe Journey Optimizer, which allows brands to deliver personalized, connected customer journeys across any app, surface, or channel, leveraging real-time data and insights.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Adobe Experience Platform from 2022 to 2023, accurately describing its foundational role in 2022 and its enhanced role in cross-channel orchestration and AI integration in 2023. Key elements such as integration with Adobe Sensei, real-time data profiles, and use in personalization via Adobe Journey Optimizer are correctly included. However, the LLM omits specific mention of Adobe Mix Modeler, a key 2023 addition powered by Adobe Sensei that leveraged the platform for marketing investment optimization—this is a notable but not critical omission. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; all time references (2022, 2023) are accurate and consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time periods and functional capabilities, showing how the platform evolved from infrastructure to an orchestration engine. It correctly links Adobe Experience Platform to Adobe Journey Optimizer and AI capabilities via Adobe Sensei. (4) The answer is contextually fully relevant and semantically close to the original. While it lacks the specific detail about Adobe Mix Modeler, it conveys the core evolution accurately. The wording differs slightly but maintains factual equivalence on the main points. Hence, a high score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 428,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "In response to Medicare Advantage funding pressures, UnitedHealth Group evolved its care delivery models from 2023 to 2024 by accelerating the transition from fee-for-service to fully accountable value-based care. This included enhancing integrated care coordination technology, expanding in-clinic, in-home, behavioral, and virtual care models, and using data and analytics to improve clinical decision-making. These efforts aimed to foster high-quality, affordable care while managing rising medical costs and regulatory challenges.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies UnitedHealth Group's focus on value-based care, integrated technology, and expansion of in-home and virtual care models in response to Medicare Advantage pressures, which aligns with the 2023 initiatives in the ground truth. It accurately references the transition from fee-for-service to value-based models and the use of data analytics, reflecting key elements of UnitedHealth's strategy. However, the answer fails to capture the critical evolution *from 2023 to 2024* as required by the question. Specifically, it omits the 2024 funding pressures—such as reduced benchmarks and risk adjustment changes—and does not mention the resulting strategic shift toward cost containment, provider network adjustments, benefit modifications, or county-level retrenchment. This missing element represents a major gap in multi-hop reasoning: while the 2023 strategy is well-covered, the pivot due to external financial constraints in 2024 is entirely absent. There are no numerical inaccuracies (hence a perfect quantitative score), and the entities (UnitedHealth Group, Medicare Advantage, care delivery models) are correct. The reasoning is sound within the scope provided but incomplete in synthesizing the temporal shift across years. Contextually, the answer is relevant and well-framed, but lacks the comparative analysis that defines the correct response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 383,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "The composition of TMO's debt instruments remained largely consistent between 2022 and 2023, with the 1.950% Notes due 2029 listed in both years under the same trading symbol (TMO 29) and registered on the New York Stock Exchange. No changes to the terms or existence of these specific notes were noted in the provided pages.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.950% Notes due 2029 were present in both 2022 and 2023 with the same trading symbol TMO 29, which matches the ground truth. It also correctly states there was no change in the terms or existence of these notes. However, the LLM answer omits a key part of the evolution in debt composition — the introduction of new debt instruments in 2023 (3.200% Notes due 2026 and 3.650% Notes due 2034), which is central to understanding the broader shift in TMO's financing strategy. (2) All quantitative elements (interest rate: 1.950%, maturity year: 2029, trading symbol: TMO 29) are accurate and correctly reported. There are no numerical or date inaccuracies. (3) The reasoning is sound regarding the continuity of the 1.950% Notes, but fails to perform the full multi-hop synthesis required — it does not incorporate information about new debt instruments introduced in 2023, thus missing a critical dimension of how the debt composition evolved. (4) The answer is contextually relevant and factually correct where provided, but incomplete. It earns a 7 in correctness and qualitative accuracy due to the omission of new debt instruments, which limits completeness and depth of analysis. Quantitative accuracy is perfect, and contextual relevance remains high as the response directly addresses the core topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 378,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "Between 2022 and 2023, TMO's debt instruments remained largely consistent, with the 0.500% Notes due 2028 continuing to be listed in both years. However, a notable change in 2023 was the introduction of new 3.650% Notes due 2034, which were not present in 2022. Additionally, the 2023 filing shows the inclusion of 3.200% Notes due 2026, which did not appear in the 2022 listing. These additions indicate a shift in TMO's debt structure, introducing longer-term, higher-yield instruments to diversify its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 0.500% Notes due 2028 were present in both 2022 and 2023, and the new instruments introduced in 2023—the 3.200% Notes due 2026 and the 3.650% Notes due 2034—are correctly identified. (2) Quantitative accuracy is perfect: percentages (0.500%, 3.200%, 3.650%) and maturity years (2026, 2028, 2034) match the original answer exactly. (3) The multi-hop reasoning is sound—comparing TMO's debt instruments across two years and identifying the introduction of new notes demonstrates proper synthesis across filings. (4) The only minor shortcoming is that the LLM omits mention of the 1.375% Notes due 2028, which the original answer notes were maintained across both years. While not central to the question about the 0.500% Notes and new categories, this detail adds context about continuity in the debt portfolio. Despite this omission, the core of the question—evolution of debt composition, focus on 0.500% Notes due 2028, and introduction of new notes—is fully addressed with accurate reasoning and correct terminology. Wording differs slightly but maintains semantic equivalence, particularly in interpreting the strategic shift toward diversification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 354,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "The range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses. In 2023, the excess ranged from approximately 140% to 495%, while in 2024, the range was approximately 70% to 450%. This indicates that the minimum excess fair value over carrying value decreased by 70 percentage points, while the maximum remained relatively stable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2023 range (140% to 495%) and 2024 range (70% to 450%), matching the ground truth exactly. The statement that the minimum decreased by 70 percentage points (from 140% to 70%) is accurate. The observation that the maximum remained relatively stable (495% to 450%, a 45-point decrease) is reasonable, though slightly understates the change in the upper bound. (2) All numeric values are correct and calculations are accurate—140% to 70% is indeed a 70-percentage-point decrease. The upper bound decreased by 45 points, which the model describes as 'relatively stable,' a defensible qualitative interpretation. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different years and compares the ranges to infer a trend in the cushion before impairment. It identifies the key change in the lower bound, which is the main driver of increased impairment risk. (4) The answer is highly factually accurate and contextually relevant. It misses only a minor nuance in the ground truth—the explicit interpretation that the overall cushion declined—though this is implied by the decreased minimum. No incorrect entities or years are used. The slight deduction in qualitative accuracy is due to the soft characterization of the upper bound change without acknowledging the 45-point drop.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 379,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "From 2022 to 2023, the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan remained consistent in terms of their impact on the available share pool. Specifically, both canceled RSUs and shares withheld to satisfy tax obligations increased the number of shares available for grant under the 2022 Plan by a factor of two times the number of RSUs canceled or shares withheld. This mechanism allowed the share pool to be replenished, ensuring continued flexibility for future equity grants.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) It claims that the treatment of canceled RSUs and tax-withheld shares remained consistent from 2022 to 2023, but the ground truth states that in 2023, the specific provision allowing a 2x replenishment factor was omitted, indicating a change in treatment. This reversal of the factual evolution invalidates the core of the answer. (2) While the mention of a 'factor of two times' in 2022 aligns with the original answer, the assertion that this continued into 2023 is false—this is a critical quantitative and factual error. (3) The multi-hop reasoning fails: the question asks how the treatment evolved, requiring comparison across years. The LLM incorrectly concludes no change occurred, failing to recognize the significance of the omitted language in 2023. (4) Contextual relevance is low but not zero, as the answer discusses the correct plan and relevant mechanisms, albeit with incorrect conclusions. Overall, the answer contradicts the ground truth on the key point of change over time, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 306,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "Between 2023 and 2024, Aldevron remained integrated into Danaher's Life Sciences segment, as it had been since its acquisition in 2021 for $9.6 billion. There is no indication of a change in Danaher's financial stake in Aldevron during this period, as Aldevron was fully acquired and is now a wholly owned subsidiary. Aldevron continued to operate as a key part of the Life Sciences segment, focusing on the production of plasmid DNA, mRNA, and proteins for research, clinical, and commercial applications.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. While it correctly identifies Aldevron as part of Danaher's Life Sciences segment, it incorrectly states that Aldevron was acquired in 2021 for $9.6 billion, which contradicts the ground truth indicating a $9,561 million (i.e., $9.561 billion) net cash consideration in 2023—suggesting the acquisition occurred in or was finalized in 2023, not 2021. The LLM also claims there was no change in financial stake between 2023 and 2024, but the ground truth explicitly states a strategic evolution: from a separately accounted stake in 2023 to full integration into the Life Sciences segment in 2024. This key multi-hop insight—about the shift in accounting and strategic integration—is entirely missed. (2) Quantitatively, $9.6 billion is close to $9,561 million, so the dollar amount is approximately correct (within rounding), but the timing (2021 vs 2023) is factually wrong. The LLM invents a 2021 acquisition date not present in the ground truth. (3) The reasoning is flawed: the model fails to recognize the evolution from a distinct financial stake in 2023 to absorption into the broader segment in 2024, which is the core of the question. Instead, it assumes full ownership since 2021, contradicting the implication that 2023 marked a significant financial transaction. (4) Contextual relevance is high because the answer discusses Aldevron’s role and segment alignment, but correctness and qualitative accuracy are low due to the incorrect timeline and failure to capture the strategic shift. The answer presents a static view where the ground truth describes a dynamic change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 449,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "Microsoft's strategic positioning of Microsoft 365 evolved significantly between 2023 and 2024, with a stronger integration of AI technologies. In 2024, Microsoft 365 is described as an \"AI first platform\" that combines Office, Windows, Copilot, and Enterprise Mobility + Security to enhance productivity. The introduction of role-based Copilot extensions (e.g., Copilot for Sales, Service, and Finance) and Copilot Pro for consumers reflects a deeper embedding of AI into workflows. Commercially, Microsoft 365 drove growth, with Office Commercial products and cloud services revenue increasing by 14% in 2024, fueled by a 16% growth in Office 365 Commercial, highlighting its central role in Microsoft's commercial performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Microsoft's strategic shift toward AI integration in Microsoft 365, mentioning the 'AI first platform' concept and Copilot's role, which aligns with the 2023 description in the ground truth. However, it incorrectly places the 'AI first platform' description in 2024 rather than 2023, misrepresenting the timeline. The introduction of role-based Copilot extensions (e.g., for Sales, Service, Finance) and Copilot Pro is plausible but not supported by the ground truth, which does not mention these specific developments. (2) The LLM introduces quantitative claims not present in the ground truth: a 14% growth in Office Commercial products and cloud services revenue and a 16% growth in Office 365 Commercial in 2024. These specific percentages are not in the original answer and cannot be verified against the provided knowledge graph, making them factually unsupported. This significantly impacts quantitative accuracy. (3) The multi-hop reasoning is partially sound—linking AI integration to commercial performance is valid—but the answer fails to mention the key 2024 change in metric definition: the inclusion of Microsoft 365 Basic subscribers in the Consumer subscribers metric, which was a core part of the strategic evolution. This omission weakens completeness and factual alignment. (4) While the LLM captures the general direction of Microsoft’s strategy (AI integration, commercial importance), it introduces unverified data and misattributes timing. The contextual relevance is high as it addresses AI integration and commercial impact, but correctness is undermined by unsupported numbers and missing key strategic changes. Hence, correctness is scored 6 for partial accuracy with significant factual gaps and errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 484,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "Between 2023 and 2024, Microsoft has increasingly emphasized Copilot Pro as a key component of its AI strategy, particularly within Microsoft 365 apps and web-based AI assistance. In 2023, Copilot Pro was introduced as a consumer subscription service offering enhanced AI assistance in Microsoft 365 apps and on the web. By 2024, the company has further integrated Copilot Pro into its broader AI ecosystem, highlighting its role in delivering faster and more powerful AI capabilities across Microsoft 365 applications, as well as its positioning within the Copilot stack for both enterprise and consumer use.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: Copilot Pro was introduced in 2023 as a consumer subscription for enhanced AI in Microsoft 365 apps and web-based assistance, and by 2024, its role was further emphasized within Microsoft's broader AI ecosystem. The key phrase 'faster and more powerful AI assistance' from the original is appropriately reflected. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the years 2023 and 2024 are correctly used, earning full marks. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution of Copilot Pro’s positioning across time and context (from standalone service to integrated component of the AI-first strategy), capturing the shift in emphasis even if slightly less explicit about the 'broader narrative of AI-driven transformation' phrasing. (4) The LLM adds slight expansion by mentioning the 'Copilot stack for both enterprise and consumer use,' which is a reasonable inference and adds value without contradicting the original. The only minor shortcoming is that it doesn’t explicitly note the retention of the same descriptive language ('faster and more powerful') within a more pronounced strategic context, which slightly reduces qualitative accuracy. Overall, the answer is semantically equivalent, contextually precise, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 414,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "The 2007 Omnibus Incentive Plan had approximately 50 million shares available for issuance as of December 31, 2023, and this decreased to approximately 47 million shares as of December 31, 2024. This reduction indicates that 3 million shares were utilized for awards during 2024. The structure of the plan remained consistent, with stock options, RSUs, and PSUs being the primary forms of awards issued.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that no specific figure was provided for remaining shares available for issuance in 2023, but the LLM claims there were 'approximately 50 million shares' available as of December 31, 2023—this number is fabricated and not supported by the ground truth. The only verified number is the 47 million shares remaining as of December 31, 2024, which the LLM correctly reports. However, the inference that 3 million shares were used in 2024 is invalid because the 2023 figure is incorrect, making the calculation of a 3 million reduction factually unsound. (2) Quantitative accuracy is low because one of two numbers provided is false, and the derived conclusion (3 million shares used) is based on incorrect premises. While the 47 million figure is accurate, the unsupported 50 million claim undermines all quantitative reasoning. (3) Qualitatively, the LLM correctly identifies the types of awards (RSUs, PSUs, stock options) and notes structural consistency, which aligns with the general context of the plan’s ongoing use. However, it fails to reflect the key qualitative shift emphasized in the original answer: the evolution from no disclosed share availability in 2023 to explicit disclosure in 2024, indicating improved transparency. Instead, the LLM implies consistent quantified tracking across both years, which contradicts the ground truth. (4) The answer is contextually relevant—it addresses the plan's structure and share availability over time—but the incorrect data and flawed reasoning severely limit its correctness. The model invents data rather than acknowledging absence of information, leading to a misleading narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 472,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Microsoft did not change its accounting policy regarding the estimated useful lives of server and network equipment. The estimated useful lives remained at six years, as previously revised in July 2022 from four years to six years due to investments in software that improved operational efficiency and technological advancements. The 2024 filing confirms the continued application of this policy without further modifications.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Microsoft maintained a six-year useful life for server and network equipment in both fiscal years 2023 and 2024, and that the change from four to six years occurred prior to fiscal year 2023. However, it incorrectly states the timing of the change as 'July 2022', which is not mentioned in the ground truth; the original answer specifies the change was effective beginning fiscal year 2023 without specifying a month. This introduces a minor factual inaccuracy. (2) Quantitatively, the key numbers — four years, six years — are correct, and the absence of further changes in 2024 aligns with the ground truth. The fiscal year framing is accurate, though the addition of 'July 2022' adds precision not present in the source and potentially conflicts with the 'beginning fiscal year 2023' timeline. (3) The reasoning is mostly sound: the LLM correctly identifies the drivers (software investments, operational efficiency, technological advances) and notes policy continuity into 2024. However, it fails to explicitly acknowledge that the change was implemented *in* fiscal year 2023, as the ground truth emphasizes, instead implying it happened earlier. This affects the multi-hop synthesis slightly, as the temporal evolution is slightly misaligned. (4) Despite the timing discrepancy, the core facts — the change from 4 to 6 years, the rationale, and the policy stability in 2023–2024 — are preserved, warranting a score of 7 for correctness. Contextual relevance is perfect as all parts of the question are addressed directly and appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 438,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "MDT's exposure to auction rate securities remained consistent in fair value from 2022 to 2023, at $33 million. In both years, these securities were classified within \"other assets\" on the consolidated balance sheet under Level 3 of the fair value hierarchy, indicating they were measured using significant unobservable inputs.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that MDT's auction rate securities had a fair value of $33 million in both 2022 and 2023, which matches the ground truth and earns full points for quantitative accuracy. However, the classification information is incorrect: the LLM claims that in both years the securities were classified under 'other assets', while the ground truth states that in 2022 they were included under 'Total' in the investment portfolio without a separate classification, and only in 2023 were they explicitly moved to 'Other Assets'. This is a critical factual error in entity classification and reasoning. (2) The dollar amounts are accurate and consistent with the original answer; no calculation errors. (3) The multi-hop reasoning fails because the model does not recognize the change in balance sheet classification over time—it incorrectly asserts consistency where there was a meaningful shift. The synthesis across years is flawed, undermining the qualitative accuracy. (4) While the answer addresses the fair value correctly and touches on classification, it misrepresents a key evolution in reporting, warranting a moderate correctness score of 4. Contextual relevance is high as the response stays on topic and discusses the right entities and time frame.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 360,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "Between fiscal years 2023 and 2024, the net losses from Cisco's available-for-sale debt investments increased from a loss of $21 million to a loss of $67 million. This indicates a deterioration in the performance of this investment category, likely due to rising interest rates, which negatively impacted the fair value of the debt investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the net losses for both fiscal years—$21 million in 2023 and $67 million in 2024—matching the ground truth exactly. The increase in losses is accurately described, and the core conclusion about deteriorating performance is consistent with the original answer. (2) All numeric values are correct and properly formatted; the comparison between the two years is quantitatively sound. (3) The multi-hop reasoning—comparing Cisco's investment performance across two fiscal years in available-for-sale debt investments—is correctly executed. The model synthesizes the change accurately and draws a reasonable qualitative conclusion. (4) The only minor deviation is the addition of a plausible explanation (rising interest rates) not present in the ground truth. While this adds context, it introduces an assumption not supported by the provided data, slightly reducing qualitative accuracy. However, it does not contradict facts and remains contextually relevant. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 307,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "Between 2023 and 2024, Cisco shifted its approach to the APJC region by refining its operational structure to better align with localized market demands while maintaining a strategic focus on financial investment in high-growth areas such as AI, cybersecurity, and cloud infrastructure. In 2023, the company emphasized expanding its integrated networking and security solutions across the region, whereas in 2024, the focus evolved toward optimizing operational efficiency and leveraging acquisitions (such as Splunk) to enhance cybersecurity and data analytics capabilities. This shift implies a move toward a more service-oriented and subscription-based revenue model in APJC, driven by the increasing demand for secure, scalable, and AI-enhanced solutions.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. While it mentions a shift in Cisco's approach to the APJC region between 2023 and 2024, it fabricates key details not present in the ground truth. Specifically, it claims Cisco refined its operational structure to align with localized demands and increased focus on AI, cybersecurity, and cloud infrastructure—none of which are mentioned in the original answer. It also references the Splunk acquisition as a driver of change in 2024, which is not supported by the ground truth. Most critically, the original answer states that Cisco moved from direct operational presence in 2023 to including financial investments (marketable/non-marketable equity and equity method investments) in 2024—a major structural shift that the LLM completely misses. Instead, the LLM invents a shift toward a 'service-oriented and subscription-based revenue model' driven by demand for AI-enhanced solutions, which is not substantiated in the ground truth. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no errors here, hence a score of 10 by default. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the correct evolution from operational to investment-based engagement in APJC. It does not reference any financial investment instruments or the change in Cisco’s strategic posture as reflected in financial statements. The reasoning instead constructs a narrative around product and service evolution that is not grounded in the provided data. (4) Correctness is low (3/10) due to major factual inaccuracies and omission of the core shift to financial investments. Qualitative accuracy is also low (3/10) because of incorrect entities (Splunk), fabricated strategic shifts, and failure to identify the actual change in operational vs. financial strategy. Contextual relevance is moderate (5/10) because the answer addresses Cisco and the APJC region over 2023–2024 and discusses revenue model implications, but the substance is misaligned with the actual filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 560,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "Between 2022 and 2024, Apple has adjusted its App Store commission policies and regulatory compliance in response to legal and market pressures. In 2022, Apple acknowledged the potential for changes to its App Store practices due to litigation, competition, and regulatory scrutiny, but did not specify concrete modifications. By 2024, Apple had implemented specific changes in response to legal requirements, particularly in the European Union, including the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures for iOS and iPadOS apps, alternative app distribution methods, and alternative payment processing. These adjustments reflect Apple's evolving approach to regulatory compliance and its efforts to address legal challenges while managing the impact on its revenue from App Store commissions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Apple acknowledged potential App Store changes in 2022 due to legal and market pressures, and by 2024 had implemented concrete changes in response to regulations like the DMA in the EU. The answer correctly identifies new business terms, alternative fee structures, app distribution methods, and payment processing as part of the 2024 changes. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model synthesizes Apple’s evolving stance from general risk acknowledgment in 2022 to specific regulatory-driven actions in 2024, correctly linking legal pressures (especially DMA) to operational changes. The only minor omission is that the original answer explicitly mentions U.S. changes alongside the EU, while the LLM focuses primarily on the EU—this slight incompleteness prevents a perfect 10 on qualitative accuracy. (4) The response is fully contextually relevant, directly addressing how Apple’s commission and compliance approach evolved under legal and market pressures. Overall, the LLM conveys the same semantic meaning as the ground truth with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 368,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "Between 2022 and 2024, Texas Instruments adjusted the allocation strategy for its U.S. Retiree Health Care Plan by increasing the proportion of fixed income securities and decreasing equity securities. In 2022, the allocation was 64% fixed income and 36% equity. By 2024, the allocation shifted to 80% fixed income and 20% equity. This shift reflects a more conservative approach, aligning with the plan's goal to better match the interest rate sensitivity of assets and liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the LLM correctly identifies the 2024 allocation as 80% fixed income and 20% equity, matching the original answer. While the 2022 percentages (64% fixed income, 36% equity) are not explicitly stated in the ground truth, they can be derived from the provided dollar amounts: $248M fixed income + cash equivalents and $137M in equities. The total portfolio value in 2022 is $385M ($248M + $137M). Calculating the percentages: 248/385 ≈ 64.4% (fixed income) and 137/385 ≈ 35.6% (equity), which rounds to 64% and 36%—thus the LLM's numbers are factually correct. (2) The shift from 64% to 80% in fixed income is accurately described as a move toward a more conservative posture, which matches the original answer’s characterization. (3) The reasoning is sound: the LLM correctly infers a strategic shift toward capital preservation and interest rate sensitivity matching, which is consistent with increasing fixed income allocation. (4) The answer is contextually complete, addressing the evolution of allocation strategy between 2022 and 2024, and synthesizing the multi-hop information (portfolio composition across years). The only minor limitation is that the LLM does not mention the stability of the allocation between 2023 and 2024 (as noted in the ground truth), but this does not detract significantly from the overall correctness. Hence, the answer earns a 9/10 for correctness, with high marks across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 415,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "Texas Instruments has maintained a consistent strategic emphasis on Embedded Processing Products from 2022 to 2024, positioning them as a core component of its business model alongside Analog products. These products contribute to TI's competitive advantages by serving as the digital \"brains\" of electronic equipment, enabling optimized performance, power, and cost for diverse applications. In terms of segment reporting, Embedded Processing remains a distinct reportable segment, with its financial performance separately disclosed in the 10-K filings for all three years. However, its contribution to revenue and operating profit has declined over this period, with revenue decreasing from $3,261 million in 2022 to $2,533 million in 2024, reflecting shifting market dynamics or demand patterns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Embedded Processing was not a reportable segment in 2022 but became one in 2024, representing a strategic shift. However, the LLM incorrectly states that Embedded Processing 'remains a distinct reportable segment' in all three years, which contradicts the evolution described in the original answer. Additionally, the LLM claims revenue declined from $3,261M in 2022 to $2,533M in 2024, but this data is not present in the ground truth and appears fabricated; the original answer does not provide any financial figures for Embedded Processing. (2) The quantitative figures provided in the LLM answer ($3,261M and $2,533M) cannot be verified against the ground truth and are likely incorrect or misleading, as the ground truth focuses on structural and strategic changes rather than specific revenue trends. There is no mention of declining performance in the original answer. (3) The multi-hop reasoning is flawed: the key insight in the original answer is the elevation of Embedded Processing to a reportable segment in 2024 as evidence of strategic prioritization. The LLM fails to capture this evolution, instead asserting continuity, which undermines the core of the question about strategic evolution. (4) While the LLM correctly identifies that Embedded Processing contributes to competitive advantages like performance, power, and cost optimization, it misses the critical shift in segment reporting structure and misrepresents the timeline and significance of that change. The contextual relevance is moderate because it addresses the right company and product line, but the incorrect facts and reasoning severely limit accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 474,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "Between 2022 and 2024, TMO issued its 2.00% 10-Year Senior Notes (euro-denominated) with a face value of $728 million in 2022, which increased to $663 million by 2024. The effective interest rate for these notes was 2.10% in 2022 and decreased slightly to 2.07% in 2024. The valuation of the notes, as reflected in their carrying value, remained relatively stable, with minor reductions likely due to amortization and accretion adjustments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The original answer states that TMO had $1,200 million in 2.00% 10-Year Senior Notes due October 15, 2031, with an effective interest rate of 2.23% in both 2022 and 2024. The LLM answer incorrectly claims a face value of $728 million in 2022 increasing to $663 million in 2024, which is both numerically wrong and logically inconsistent (a decrease in value should not be described as an increase). Additionally, the LLM introduces euro-denominated notes, which are not mentioned in the ground truth, and reports incorrect interest rates (2.10% and 2.07% vs. the correct 2.23% in both years). (2) All key numbers are wrong: principal amount, currency, interest rates, and trend over time. There is no indication of stability in the debt instrument as per the ground truth. (3) The multi-hop reasoning failed completely — instead of identifying consistency in the issuance and valuation over time, the model fabricated changes in value and rates, and introduced irrelevant details (euro-denomination) not present in the source. (4) The contextual relevance is low but not zero because the answer addresses the general topic of TMO's senior notes and attempts to discuss valuation trends, albeit incorrectly. Due to severe factual and quantitative errors, the correctness score is near the minimum.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 384,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "Between 2022 and 2024, REMICADE's sales declined from $1,839 million in 2022 to $1,605 million in 2024, representing a 12.8% decrease. This decline is primarily attributed to continued biosimilar competition in the United States and other markets. This trend indicates that REMICADE's role in Johnson & Johnson's Pharmaceutical segment has weakened, as it faces increasing pressure from biosimilars, which has led to a reduction in its market share and revenue contribution.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a factual error in the timeline: it states REMICADE's sales were $1,839 million in 2022, but the ground truth indicates that $1,839 million was the 2023 figure. The 2024 sales figure ($1,605 million) is correct. This misattribution leads to an incorrect baseline year and undermines the accuracy of the stated 12.8% decline, which actually reflects the drop from 2023 to 2024, not 2022 to 2024. (2) The percentage decline of 12.8% is accurate when calculated from $1,839M to $1,605M: (1,839 - 1,605) / 1,839 ≈ 0.1272 or 12.7%, which rounds to 12.8%—so the calculation is correct, but applied to the wrong years. (3) The reasoning about biosimilar competition weakening REMICADE’s role is plausible and aligns with industry trends, though the original answer emphasizes market saturation and newer biologics rather than biosimilars specifically. While biosimilar competition is a valid contributing factor, the LLM introduces a cause not explicitly present in the ground truth, slightly reducing qualitative fidelity. (4) The answer addresses both parts of the question—evolution of financial performance and implications for J&J’s Pharmaceutical segment—and draws a reasonable conclusion about declining importance. Despite the incorrect year attribution, the core financial data and trend interpretation are mostly accurate, warranting a score of 7 for overall correctness. Quantitative accuracy is penalized more heavily due to the incorrect assignment of the $1,839M figure to 2022 instead of 2023. Contextual relevance is full, as the response directly addresses the product's performance and strategic role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 451,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "From 2022 to 2024, REMICADE's sales declined from $3.19 billion in 2022 to $1.605 billion in 2024, representing a significant drop of 12.8% in 2024 compared to the prior year. This decline is primarily attributed to ongoing biosimilar competition in both the U.S. and international markets. The continued erosion of REMICADE's market position highlights the increasing pressure from biosimilars within JNJ's Immunology portfolio, contrasting with the growth of newer products like STELARA and TREMFYA. This trend indicates that REMICADE is losing relevance and market share, signaling a weakening position in the Immunology segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports REMICADE's sales of $3.19 billion in 2022 and $1.605 billion in 2024, matching the ground truth values ($3,190 million and $1,605 million). The 12.8% decline mentioned is accurate for the drop from 2023 to 2024 as stated in the original answer. However, the LLM incorrectly attributes the 12.8% drop to the change from 2022 to 2024, when in fact the 12.8% decline is specifically from 2023 to 2024, not over the full period. This is a minor misrepresentation of timing but does not affect the final numbers. (2) All numeric values are accurate and correctly formatted (e.g., $3.19 billion = $3,190 million). The calculation of the decline magnitude is not recomputed by the model but correctly cited from the source context. (3) The multi-hop reasoning is sound: the model synthesizes sales trends over time, identifies the cause (biosimilar competition), and contrasts REMICADE’s performance with other JNJ products (STELARA, TREMFYA), which aligns with the portfolio-level analysis required. (4) The answer is contextually excellent, addressing both the sales evolution and the implication for market position. The only shortcoming is the slight misattribution of the 12.8% decline as occurring from 2022 to 2024 rather than 2023 to 2024, which prevents a perfect score. Overall, the answer is factually strong, well-reasoned, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 388,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "Between 2021 and 2024, REMICADE's sales declined from $3.19 billion to $1.605 billion, representing a significant drop of 14.9% in 2021 and an additional 12.8% in 2024. The primary factor contributing to this decline was the increasing competition from biosimilar versions of infliximab, which were introduced in the U.S. and other markets, leading to a steady reduction in REMICADE's market share. Continued biosimilar competition is expected to further impact REMICADE's sales in the future.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. The original answer states that REMICADE's sales were $16.8 billion in 2021 as part of total Immunology sales, not $3.19 billion for REMICADE alone. The 2024 figure of $1,605 million ($1.605 billion) is correct and matches the ground truth. However, the 2021 figure is severely understated, leading to an incorrect baseline and misleading decline narrative. (2) The percentage declines cited (14.9% in 2021 and 12.8% in 2024) are partially correct: the 12.8% decrease from 2023 to 2024 aligns with the ground truth, but the 14.9% drop in 2021 is not supported by the original answer and appears fabricated. The original does not specify a 2021 year-over-year decline. (3) The qualitative reasoning about biosimilar competition in the U.S. and global markets is accurate and reflects the correct causal factor for the sales decline. The synthesis of the reason for decline—increasing biosimilar competition leading to reduced market share—is sound and contextually appropriate. (4) While the explanation of contributing factors is correct and relevant, the core financial data is significantly off, particularly the 2021 sales figure, which undermines the overall correctness. The answer addresses both parts of the question (sales evolution and contributing factors), but the numerical inaccuracies severely impact the correctness score. The contextual relevance is high because the structure and intent align well with the question, and the future outlook is reasonably inferred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 433,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "Between 2022 and 2024, STELARA (ustekinumab) experienced a decline in commercial performance. In 2022, STELARA sales were $9.1 billion, representing a 18.5% increase compared to 2021. However, by 2024, sales had decreased to $10.4 billion, a 4.6% decline from 2023, primarily due to share loss from European biosimilar entrants. The decline was further anticipated to worsen in 2025 as biosimilar versions of STELARA were expected to launch in both Europe and the U.S. according to patent settlement agreements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It states that STELARA sales were $9.1 billion in 2022, but the ground truth does not provide 2022 sales figures—only that the drug was in the filing stage for pediatric use. The $9.1 billion figure appears fabricated or misattributed. While the 2024 sales figure of $10.4 billion is close to the ground truth $10,361 million (i.e., $10.361 billion), it is still inaccurate. The 4.6% decline is correctly cited, but it is attributed to 2024 vs 2023, while the LLM incorrectly frames it without specifying the year of decline. (2) The ground truth reports 2023 sales as $10,858 million, so the 4.6% decline to $10,361 million in 2024 is accurate. However, the LLM incorrectly implies that sales dropped from $9.1B in 2022 to $10.4B in 2024, which is inconsistent with the actual upward trajectory until 2023 followed by a decline. The LLM also introduces '18.5% increase from 2021' and 'biosimilar entrants in Europe' and '2025 launch expectations'—details not present in the ground truth, making them unsupported additions. (3) The multi-hop reasoning is partially sound in that it attempts to connect regulatory status and commercial performance over time, but it fails to accurately represent the 2022 status (regulatory filing, not sales performance) and invents sales data. The synthesis is flawed because it conflates unreported sales figures with later performance. (4) Despite these issues, the answer is contextually relevant, addressing the evolution of STELARA’s status and performance. It correctly identifies a sales decline and attributes it to biosimilars, which aligns with general industry knowledge, though this specific rationale is not in the ground truth. The qualitative reasoning is plausible but not fully supported by the provided truth. Thus, the correctness score is low due to major quantitative errors, but not zero because of partial alignment on the 2024 sales figure and decline trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 546,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "The total net revenue from Restasis in the United States decreased from $382 million in 2023 to $172 million in 2024, representing a 55.2% decrease. The percentage decrease from 2022 to 2023 was 38.5%.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Restasis net revenue in the U.S. decreased from $382 million in 2023 to $172 million in 2024, matching the ground truth. It accurately reports the 55.2% decrease from 2023 to 2024 and the 38.5% decrease from 2022 to 2023. All factual elements are present and correct. (2) Quantitatively, all dollar amounts ($382M, $172M) and percentage decreases (38.5%, 55.2%) are accurate and consistent with the original answer. The calculation of a 55.2% decrease from $382M to $172M is correct: (382 - 172) / 382 ≈ 0.552. The 38.5% decrease from 2022 to 2023 is also correctly attributed. (3) The multi-hop reasoning is sound: the model synthesizes data across two years (2023 and 2024), references prior year change (2022 to 2023), and correctly interprets percentage changes over time. (4) The answer is semantically equivalent to the ground truth, with clear, concise rewording that preserves all key information. No omissions or inaccuracies. All scores are 10 due to full factual correctness, precise numbers, logical reasoning, and complete relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1106,
        "completion_tokens": 314,
        "total_tokens": 1420
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "Between 2022 and 2023, the role and strategic importance of Master Lease Agreements (MLAs) for American Tower Corporation (AMT) evolved to become a more critical component in supporting international growth and tenant relationships. MLAs provided consistent, long-term revenue and significantly reduced non-contractual churn, thereby strengthening strategic partnerships with tenants. These agreements also streamlined colocation processes, enabling tenants to deploy equipment more rapidly and efficiently on AMT's sites, which became increasingly important as carriers focused on 5G network deployments and expanding their global footprint. This strategic use of MLAs helped AMT navigate challenges such as elevated churn rates in India and carrier consolidation, while positioning the company to capitalize on long-term growth opportunities in international markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic importance of Master Lease Agreements (MLAs) in supporting AMT's international growth and tenant relationships, including their role in generating long-term revenue, reducing churn, streamlining colocation, and enabling rapid deployment—consistent with the ground truth. However, it omits specific quantitative details about AMT's international portfolio size: 177,000 sites in 2022 and 182,000 in 2023, which are key factual anchors in the original answer. While the LLM mentions challenges like churn in India and carrier consolidation—aligned with the ground truth's mention of customer consolidation and regulatory risks—this is framed more generally without tying the evolution of MLAs directly to portfolio scale expansion. (2) There are no incorrect numbers or calculations; the LLM avoids making up figures and does not contradict the ground truth numerically, hence full marks for quantitative accuracy. (3) The multi-hop reasoning is sound in linking MLAs to revenue stability, churn reduction, and 5G deployment support, but it fails to explicitly connect the evolution between 2022 and 2023 to the growth in site count, which is a core element of the original answer’s evolution narrative. This missing synthesis slightly weakens the qualitative accuracy. (4) The answer remains highly relevant and well-structured, addressing the strategic evolution of MLAs with appropriate context on international growth and tenant dynamics. The omission of exact site numbers prevents a higher correctness score, but the overall meaning is semantically close and factually coherent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 450,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "Between 2023 and 2024, the Google Marketing Platform continued to serve as a key channel for advertising revenue generation, with revenues recognized on a gross basis for ads placed on Google Network properties. The platform's role remained consistent in facilitating customer purchases of advertising inventory, with Alphabet acting as the principal, controlling the advertising inventory before it is transferred to customers. No significant changes were indicated in the platform's role or the method of revenue recognition during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that 'no significant changes were indicated' in the platform's role or revenue recognition between 2023 and 2024. The ground truth explicitly states that the role evolved in 2024 with a more nuanced evaluation of principal vs. agent status and a more detailed explanation of the platform's central function in managing advertising. The LLM incorrectly implies continuity, missing the evolution described in the original answer. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no numbers to verify or miscalculate, hence a score of 10 by default. (3) The multi-hop reasoning is flawed: the question asks for an evolution between two years, requiring comparison and synthesis of changes in both revenue recognition policy and platform management role. The LLM fails to identify the shift in 2024 toward enhanced justification of gross reporting based on control over inventory and the expanded descriptive role in performance and brand advertising. This omission represents a failure in qualitative reasoning and synthesis. (4) Contextual relevance is high because the answer addresses Google Marketing Platform, advertising revenue, gross recognition, and Google Network properties—all relevant topics. However, the core failure is in accurately representing the evolution over time, which is the central requirement of the question. Thus, while contextually appropriate, it is factually and qualitatively deficient.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 423,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "The volume of Federal Funds Purchased & Sec Loaned increased from $214,369 million in 2022 to $301,015 million in 2023, while the fair value increased from 1.92% to 6.84%. This significant increase in both volume and fair value indicates that BAC utilized more short-term funding through these instruments in 2023 compared to 2022, likely due to higher interest rates and the need for liquidity management. This suggests a shift in BAC's short-term funding strategy toward leveraging higher-yielding short-term funding sources amid a rising interest rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It references data from 2022 to 2023, while the question asks for changes between 2023 and 2024. The ground truth states that in 2023, there was a net change in volume of $16,466 million, and in 2024, the fair value was $192,859 million. The LLM instead claims volume increased from $214,369M (2022) to $301,015M (2023), which is not supported by the ground truth and misaligns the time periods. Additionally, the LLM introduces percentage-based fair value changes (1.92% to 6.84%), which are not present in the original answer and appear fabricated. (2) The quantitative inaccuracies are severe: incorrect years, incorrect dollar amounts, and invented percentages. There is no mention in the ground truth of 2022 data or percentage changes in fair value. The calculation of a net change or growth rate based on the LLM's numbers does not align with the provided ground truth. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the relevant time frame (2023 vs. 2024) and confuses the metrics. It incorrectly infers a strategy shift based on non-existent year-over-year data between 2022 and 2023, rather than analyzing the actual 2023–2024 evolution as required. The conclusion about higher interest rates and higher-yielding funding sources is speculative and not grounded in the provided truth. (4) The contextual relevance is moderate because the answer discusses short-term funding strategies and mentions BAC appropriately, but the factual foundation is incorrect, undermining the validity of the interpretation. Due to major errors in numbers, years, and logic, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 466,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations became more detailed and specific. In 2022, the discussion was limited to a general reference in the \"Market Risks\" section, directing readers to \"Our Critical Accounting Policies and Estimates\" for further information. By 2024, PepsiCo provided a more direct explanation, noting that the fair value of indefinite-lived intangible assets, including pension and retiree medical plan assets and liabilities, is impacted by changes in market conditions such as interest rates and inflationary or recessionary trends. Additionally, in 2024, the company explicitly included a line item for \"Other pension and retiree medical benefits (expense)/income\" in its consolidated results, showing a significant shift from income of $250 million in 2023 to an expense of $22 million in 2024, attributed to higher settlement charges and the purchase of a group annuity contract. This evolution reflects increased transparency and specificity in how market fluctuations affect these liabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PepsiCo's disclosure evolved from a more general reference in 2022 to a more detailed discussion in 2024, including broader macroeconomic factors like inflation and recessionary trends. This aligns with the ground truth’s emphasis on expanded risk characterization. However, the LLM introduces significant factual inaccuracies: it claims the discussion was in the 'Market Risks' section in 2022, while the ground truth states it was in 'Our Critical Accounting Policies and Estimates'—a key discrepancy in disclosure location. (2) The quantitative elements are largely fabricated or incorrect: the LLM cites a $250 million income in 2023 and $22 million expense in 2024 under 'Other pension and retiree medical benefits (expense)/income' and attributes this to settlement charges and annuity purchases. No such numbers or line items are present in the ground truth, which does not mention any specific financial figures or shifts in income/expense related to these plans. These numbers appear to be hallucinated. (3) The multi-hop reasoning is partially sound—the model correctly infers increased transparency and links sensitivity to interest rates, inflation, and recessionary trends by 2024, which is consistent with the ground truth’s mention of inflationary, deflationary, and recessionary conditions. However, the synthesis includes unsupported details (e.g., indefinite-lived intangible assets being tied to pension liabilities) that are not in the original answer and may reflect a misunderstanding of accounting categories. (4) The contextual relevance is high, as the response directly addresses the evolution of disclosures over time and attempts to provide specific evidence. However, due to the inclusion of false quantitative data and misattribution of disclosure sections, the correctness score is reduced to 6—partially correct but with significant factual errors undermining reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 528,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "Between 2023 and 2024, Adobe Scan has evolved to become more deeply integrated within Adobe's broader document management ecosystem, particularly through enhanced connections with Adobe Document Cloud and Acrobat services. In 2023, Adobe Scan was primarily described as a mobile scanning tool that converts paper documents into PDFs for instant sharing. By 2024, Adobe Scan is positioned not only as a standalone scanning tool but also as a key component of Adobe's automated digital document workflows, emphasizing seamless integration with cloud-based services like Acrobat and Adobe Acrobat Sign. This evolution reflects Adobe's strategy to unify document capture, management, and collaboration under its Document Cloud umbrella.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies Adobe Scan's 2023 positioning as a mobile scanning tool for converting paper documents into PDFs, and notes its integration with Adobe Document Cloud and Acrobat services. The evolution in 2024 is accurately portrayed as deeper integration into automated workflows and cloud-based services like Acrobat and Acrobat Sign. While the LLM does not explicitly mention 'Content Credentials' or 'Firefly-powered generative AI workflows'—specific AI-driven features highlighted in the original answer—it captures the broader strategic shift toward integration with enterprise document workflows and cloud collaboration. The absence of these specific AI features is a minor omission, but the core reasoning and synthesis across years and ecosystem components remain sound. There are no numerical values to evaluate, so quantitative accuracy is scored as 10. Contextual relevance is full, as the response directly addresses the evolution in positioning within Adobe's document management ecosystem. Qualitative accuracy is slightly reduced due to the missing detail on digital trust and generative AI, but the overall logic and entity identification (Adobe Scan, Document Cloud, Acrobat, Acrobat Sign, 2023–2024 timeline) are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 366,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "Gemini's role and integration across Google's products evolved significantly from its initial launch in 2023 to 2024. In 2023, Gemini was introduced as Google's first natively multimodal AI model, capable of understanding and combining text, code, audio, images, and video. By 2024, Gemini 2.0 was launched, enhancing its capabilities and expanding its integration to all seven of Google's two-billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube. Specific advancements in its multimodal capabilities included the ability to process and generate content across diverse formats, such as supporting image generation, coding assistance, and app integration, as well as improving AI-driven features like AI Overviews and YouTube recommendations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Gemini was introduced in 2023 as a multimodal model capable of handling text, code, audio, images, and video. In 2024, Gemini 2.0 launched and was integrated into all seven of Google's two-billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—matching the original answer exactly. (2) Quantitative elements (e.g., 'seven' products, '2023' and '2024' timelines) are accurate; no calculations were required. (3) Multi-hop reasoning is sound: the model correctly synthesizes the evolution over time and across product integrations. (4) The only minor shortcoming is that the LLM mentions 'image generation' and 'coding assistance' as specific multimodal advancements, which, while plausible, are not explicitly stated in the ground truth. The original answer highlights Project Astra and Project Mariner as experimental prototypes showcasing broader applications in 2024—information omitted in the LLM response. This is a minor completeness gap, not a factual error, hence a score of 9 instead of 10. Overall, the answer is factually correct, well-structured, and contextually fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 343,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "Between 2022 and 2024, Linde's global helium wholesale operations, which are part of the \"Other\" segment, experienced mixed performance. In 2024, sales for the Other segment decreased by 2% compared to 2023, primarily due to lower volumes in global helium. However, operating profit in the Other segment increased by 44% in 2024, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), partially offset by higher costs related to helium. This suggests that while helium sales declined, cost management and insurance recoveries helped improve profitability in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor omission in not explicitly stating the shift in Linde's relationship with helium from neutral/positive in 2022 to negative in 2024. Quantitatively, all numbers are accurate: the 2% sales decrease in the 'Other' segment due to lower helium volumes and the 44% operating profit increase are correctly reported. The explanation that higher helium-related costs partially offset the insurance recovery in LAMT is also accurate. However, the answer does not clearly emphasize that helium had a *negative impact* on the business in 2024 as a key evolution from 2022, which is central to the question about the changing relationship. While the financial effects are correctly described, the qualitative shift in the nature of the relationship is underemphasized. The multi-hop reasoning is sound—linking helium volumes to sales impact and helium costs to profit dynamics across segments—but the synthesis could more clearly contrast 2022 vs 2024. Wording differences are acceptable and do not affect meaning, and all entities (Linde, LAMT, 'Other' segment, global helium wholesale) are correctly identified. Contextual relevance is strong as the response directly addresses sales and operating profit impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 359,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net value of acquired franchise rights decreased from $789 million in 2022 to $598 million in 2024, representing a decline of $191 million over the two-year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net value of acquired franchise rights in 2022 ($789 million) and 2024 ($598 million), matching the ground truth. (2) The calculation of the magnitude of change is accurate: $789M - $598M = $191M, which is correctly reported as a decline of $191 million. (3) The reasoning is sound and synthesizes the two data points across the time period to compute the change, fulfilling the multi-hop requirement (comparing values across years and deriving the difference). (4) The answer is semantically equivalent to the original, providing the same factual content with slightly more detail (explicitly stating the $191M decline), and fully addresses both parts of the question: the evolution over time and the magnitude of change. All entities (metric, years) are correct. Therefore, all scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1081,
        "completion_tokens": 253,
        "total_tokens": 1335
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil remained consistent from 2023 to 2024. In both years, the production volumes from Tengizchevroil were included in the \"Volumes represent Chevron's share of production by affiliates\" footnote in the \"Net Production of Crude Oil, Natural Gas Liquids and Natural Gas\" section. There is no specific mention of changes in delivery commitments or production volumes for Tengizchevroil in the provided pages for 2024 compared to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to reflect the ground truth. (1) It claims that Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil 'remained consistent' from 2023 to 2024, which directly contradicts the original answer showing clear increases in both consumed and sold volumes. (2) Quantitatively, the ground truth reports specific figures: in 2023, 596 MMcf/d consumed and 7,148 MMcf/d sold; in 2024, these rose to 609 MMcf/d and 7,569 MMcf/d respectively. The LLM answer does not mention any of these numbers, nor acknowledges the increase, missing a key quantitative trend. (3) Regarding multi-hop reasoning, the question requires synthesizing changes over time in production and delivery linked to Tengizchevroil. The LLM fails this synthesis, instead asserting no change and citing a generic footnote without confirming or analyzing actual volume shifts. (4) While the answer is contextually relevant in that it discusses Tengizchevroil and production footnotes, it draws an incorrect conclusion and omits all numerical evidence, severely undermining factual accuracy. The answer appears to reflect a lack of data access or misinterpretation of the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 342,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "The role of Google Network partners in Google's advertising revenue model has remained consistent between 2023 and 2024, as the description of payments to these partners has not changed significantly. Payments to Google Network partners are still primarily for ads displayed on their properties and are recorded as cost of revenues, with Google generally acting as the principal and recognizing revenues on a gross basis.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that the description of payments to Google Network partners has not changed significantly between 2023 and 2024. The ground truth states a clear evolution in categorization—from being described as a standard operating expense under cash flows in 2023 to being explicitly classified under Traffic Acquisition Costs (TAC) in 2024, with a direct link to revenue generation. This shift reflects a strategic repositioning in how these payments are framed, which the LLM answer completely misses. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations are present, hence a score of 10. (3) The multi-hop reasoning is flawed: the question requires synthesizing changes in accounting disclosure language across two years to infer a strategic shift. The LLM fails this synthesis, instead asserting consistency where there is documented change. It also incorrectly states that payments are recorded as 'cost of revenues' without mentioning TAC, contradicting the ground truth’s key point about reclassification. (4) Contextual relevance is moderate—the answer discusses Google Network partners and payment structure, so it stays on topic, but it fails to capture the core evolution in description and strategic framing, making it substantially misleading. The answer contradicts the ground truth rather than reflecting it.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 406,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "From 2023 to 2024, Bank of America has experienced an increase in the impact of public policies on its climate-related regulatory requirements, particularly due to growing global regulatory focus on climate change. The Corporation notes that there is an increasing number of new or heightened regulatory requirements, with potential jurisdictional divergence across state, federal, and non-U.S. jurisdictions. This divergence is expected to elevate legal, compliance, and public disclosure risks and costs for the company. Additionally, the evolving nature of climate-related risks, combined with the lack of standardized climate-related data and reporting frameworks, has heightened the complexity of compliance and increased the potential for reputational harm.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increasing impact of public policies on Bank of America's climate-related regulatory requirements from 2023 to 2024, the role of jurisdictional divergence, and the associated legal, compliance, and disclosure risks. However, it fails to capture a key evolution highlighted in the ground truth: the shift from *anticipated* risks in 2023 to *actual, tangible impacts* in 2024. The LLM states that divergence is 'expected to elevate' risks, which reflects the 2023 perspective but does not reflect the 2024 escalation where these impacts are already being felt. This omission weakens the multi-hop synthesis across years. (2) There are no numeric values, dates, or calculations in the response or ground truth beyond years (2023, 2024), which are correctly used—thus quantitative accuracy is perfect. (3) The reasoning is mostly sound: it connects jurisdictional divergence to compliance risks and notes the lack of standardized frameworks. However, it misses the critical progression from expectation to realization between the two years, which is central to the question about *evolution*. This limits the qualitative accuracy. (4) The answer is highly contextually relevant, addressing public policies, jurisdictional divergence, compliance risks, and climate-related regulation. It adds relevant context about data standardization and reputational risk, which, while not in the original, are reasonable inferences. The correctness score is 7 because core facts are accurate but a key nuance in the temporal evolution of risk impact is missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 439,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "General Motors has increased its strategic emphasis on full-size pickup trucks from 2022 to 2024, as evidenced by the strong performance of this segment in 2024. In the GM North America (GMNA) region, increased sales of full-size pickup trucks contributed significantly to the $16.06 billion increase in total net sales and revenue for 2024 compared to 2023. Additionally, EBIT-adjusted for GMNA rose by 18.1%, driven in part by higher volumes of full-size pickup trucks. These quantitative indicators highlight a stronger market positioning and performance for this product line in 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details. The ground truth states that full-size pickup trucks had a variable profit of approximately 160% on a weighted-average basis in 2024, but the LLM does not mention this key metric. Instead, it introduces a $16.06 billion increase in total net sales and revenue for 2024 compared to 2023 and an 18.1% rise in EBIT-adjusted for GMNA—figures that are not present in the original answer and cannot be verified from the provided ground truth. These specific dollar amounts and percentage changes are therefore factually unsupported. (2) The original answer emphasizes a shift from risk (2022) to strength (2024), with 2024 performance demonstrated through net wholesale volume increases and the 160% variable profit metric. The LLM captures the directional evolution—increased strategic emphasis and improved performance—but replaces the actual quantitative indicators with unverified financial aggregates. (3) The multi-hop reasoning is partially sound: the model correctly infers that stronger sales and profitability in full-size trucks indicate improved market positioning and links this to broader financial performance. However, it fails to accurately report the specific metrics cited in the ground truth, particularly the 160% variable profit, which is a critical indicator of efficiency and margin strength. (4) While the LLM answer is contextually relevant and captures the general strategic shift, the substitution of unverified quantitative data undermines factual correctness. The qualitative reasoning is acceptable but lacks precision in entity and metric alignment. Thus, the correctness score is moderate due to partial factual accuracy but significant quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 481,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "From 2022 to 2024, the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts increased significantly, from $21 million in 2022 to $349 million in 2024. This shift indicates a strategic move toward safer, more liquid, and lower-risk investments, likely reflecting the company's focus on preserving capital and ensuring reliable funding for long-term obligations like nuclear decommissioning.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly aggregates and misrepresents the data. It states that the allocation increased from $21 million to $349 million, implying a single entity's growth, but the ground truth shows two distinct subsidiaries: Alabama Power ($21M in 2022 → $20M in 2024) and Georgia Power ($293M → $349M). The LLM omits Alabama Power’s data entirely in the summary and falsely presents a single trajectory. (2) Quantitatively, the $21M and $349M figures are correct but taken out of context—one is Alabama’s 2022 value, the other is Georgia’s 2024 value—so the comparison is invalid. The answer fails to report Georgia’s 2022 value ($293M) or Alabama’s 2024 value ($20M), leading to a misleading trend. (3) The reasoning is partially sound in interpreting a shift toward safer assets, but the multi-hop synthesis is flawed: it does not recognize the company-level distinction or the divergent trends between subsidiaries. The conclusion about overall strategy lacks nuance and misses the key insight about reallocation toward Georgia Power’s portfolio. (4) Contextual relevance is high because the answer addresses investment strategy and safety of assets, but correctness is low due to significant factual misrepresentation and incomplete data synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 356,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "From 2022 to 2024, PepsiCo's relationship with independent bottlers has evolved in terms of financial incentives and strategic dependency by maintaining structured bottler funding programs and emphasizing long-term partnerships. Financial incentives, such as advertising support, new product support, and vending and cooler equipment placement programs, are negotiated annually to support trade and consumer initiatives. Additionally, PepsiCo's strategic dependency on independent bottlers remains strong, as they hold exclusive contracts to manufacture and distribute products in specific geographic areas, ensuring brand presence and operational efficiency. The company continues to leverage these bottlers as key partners in its distribution network, especially for DSD operations, to maintain market reach and consumer engagement.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of PepsiCo's relationship with independent bottlers in terms of financial incentives and strategic dependency, mentioning annual negotiations, advertising support, new product launches, and vending equipment—elements present in the ground truth. However, it omits the key quantitative detail from 2024 that Walmart alone accounted for approximately 14% of consolidated net revenue, which is a critical piece of evidence for increased strategic dependency. This missing data point significantly undermines the completeness and factual accuracy of the response. (2) There are no explicit numbers in the LLM answer, but the ground truth includes a specific percentage (14%) tied to Walmart’s contribution, which the model fails to mention. This is a major omission in quantitative accuracy, especially since the question spans a multi-year evolution where such metrics demonstrate shifting dependency. While the LLM correctly references annual negotiations and incentive types, it does not confirm that accruals in 2022 were based on targets and historical experience, weakening the temporal comparison. (3) The reasoning is logically sound in describing a structured, ongoing relationship with bottlers and recognizing their exclusive distribution roles and importance in DSD (direct store delivery) operations. However, the multi-hop synthesis is incomplete—it fails to connect the evolution from less structured 2022 incentives to the more targeted, allocated funding in 2024, and does not use the Walmart revenue figure to substantiate increased strategic dependency. (4) The contextual relevance is high because the answer addresses financial incentives and strategic dependency directly and uses appropriate terminology. Qualitative accuracy is moderate due to correct entity identification (PepsiCo, independent bottlers) and general process descriptions, but the lack of specific evolution details and key metrics reduces correctness. The correctness score is 6 due to partially accurate information with significant omissions in critical quantitative and comparative details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 574,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "Adobe Firefly's role within Adobe's product innovation strategy has evolved from being a speculative investment in 2023 to a more central and strategic focus in 2024. In 2023, Firefly was highlighted as one of Adobe's generative AI offerings, with the company acknowledging the uncertainties and risks associated with AI development and adoption. By 2024, Firefly is positioned as a key component of Adobe's AI innovation efforts, with the company emphasizing its integration across existing products and solutions. This shift is reflected in the increased attention to Firefly in risk disclosures, particularly regarding regulatory, ethical, and competitive challenges, indicating its growing importance in Adobe's strategy to remain competitive in AI-driven markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no incorrect numbers, it is scored as 10. The answer addresses the evolution of Adobe Firefly from 2023 to 2024 and correctly identifies its growing strategic importance, which aligns with the question's focus. However, it misrepresents the source evidence: in the ground truth, Firefly was listed in 2023 trademarks (indicating established status), not as a speculative investment or highlighted in risk factors that year. The key multi-hop insight is that Firefly moved from being a trademarked product in 2023 to being explicitly mentioned in 2024 risk disclosures as a newly released generative AI product—signaling strategic elevation. The LLM incorrectly reverses the timeline by suggesting Firefly was already acknowledged as a generative AI offering in 2023 risk disclosures and then became more central in 2024. In reality, the risk disclosure mention began in 2024, marking its strategic emergence. While the LLM captures the general trend of increasing importance, it fails on the specific evidence (trademark listing in 2023 vs. risk factor inclusion in 2024), undermining the qualitative accuracy. Contextual relevance is high because the response stays on topic and discusses strategic evolution, regulatory risks, and AI integration. The reasoning is partially sound but based on incorrect grounding in the source data, leading to a correctness score of 5 due to significant factual misalignment in entity positioning and timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 424,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "The role of contractual rent escalations in driving tenant billing growth decreased between 2022 and 2023, as churn and lease cancellations increased in 2023. In 2022, churn was approximately 4% of tenant billings, while in 2023, churn decreased slightly to approximately 3% of tenant billings. However, the churn in 2023 was primarily driven by the U.S. & Canada property segment, where elevated churn rates were expected to persist due to lease cancellations and non-renewals by T-Mobile. This suggests that while the overall churn rate decreased, the impact of lease cancellations in key markets like the U.S. & Canada reduced the effectiveness of contractual rent escalations in driving tenant billing growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the churn percentages: it states that churn was approximately 4% in 2022 and decreased to 3% in 2023, but the ground truth does not mention any churn rate for 2022—only that 2023 had an elevated churn rate of approximately 3%. This misrepresentation of historical churn undermines quantitative accuracy. (2) The LLM incorrectly implies a comparison between 2022 and 2023 churn rates by assigning a 4% figure to 2022, which is not supported by the original answer. All other numbers (3% churn in 2023, U.S. & Canada focus, T-Mobile lease cancellations) are factually correct and contextually accurate. (3) The reasoning is partially sound: the LLM correctly identifies that increased churn and lease cancellations—particularly from T-Mobile in the U.S. & Canada segment—created headwinds for rent escalations as a growth driver. It also correctly infers that despite being a continued driver, escalations faced greater challenges in 2023 due to churn, aligning with the multi-hop logic in the original answer. However, the erroneous 2022 churn figure leads to an incorrect narrative of 'decreasing churn' rather than 'elevated churn emerging in 2023.' (4) The contextual relevance is high because the answer addresses the core dynamic between rent escalations and churn, and correctly identifies key entities (T-Mobile, U.S. & Canada segment). The qualitative accuracy is moderate because the conceptual synthesis is reasonable but based on a flawed premise. Correctness score is 5 due to the significant but not total error in quantitative input, while the overall direction of reasoning remains plausible.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 457,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "Chevron's relationship with Tengizchevroil (TCO) evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement, with Affiliate Capex for TCO's FGP/WPMP Project in Kazakhstan accounting for nearly half of Chevron's $3 billion Affiliate Capex in 2024. This indicates a continued significant investment in TCO's development. Production involvement remains notable, as TCO is a major affiliate contributing to Chevron's production in Kazakhstan.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that nearly half of Chevron's $3 billion Affiliate Capex in 2024 was allocated to Tengizchevroil's FGP/WPMP Project, which aligns with the ground truth. The mention of continued production involvement through TCO as a major affiliate is also accurate. However, the LLM mischaracterizes the timing of the capital commitment: the original answer clarifies that in 2023, Chevron *indicated* that nearly half of the expected 2024 capex would go to TCO, whereas the LLM implies the allocation occurred in 2024 as a new development, missing the forward-looking context from 2023. This results in a slightly incomplete evolution narrative. (2) All numbers are correct: $3 billion Affiliate Capex, nearly half allocated to TCO, and correct project name (FGP/WPMP) and location (Kazakhstan). No calculation errors. (3) The multi-hop reasoning is mostly sound—linking Chevron to Tengizchevroil, capex commitment, and production involvement across years—but fails to fully capture the shift from 2023 (planning/commitment phase) to 2024 (operational/production emphasis) as highlighted in the ground truth. The LLM focuses on continued investment rather than the transition from investment to operations. (4) Despite the nuance missed in the temporal evolution, the answer is factually accurate, contextually relevant, and captures the core financial and operational relationship. Hence, minor deduction in correctness and qualitative accuracy, but full marks for contextual relevance and near-perfect quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 429,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "Between 2023 and 2024, the specificity of UPS's bond matching approach for determining the discount rate for U.S. pension and postretirement benefit plans remained consistent, as the company continued to use a bond matching approach to select specific bonds that align with projected benefit payments. However, the discount rate for U.S. pension benefits decreased from 5.42% in 2023 to 5.88% in 2024, while the postretirement medical benefits discount rate increased slightly from 5.80% to 6.18%. This evolution in rates reflects changes in the bond market and updated assumptions for the duration and timing of projected benefit obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in addressing the question. The question asks about the evolution in the *specificity* and *methodological framing* of UPS's bond matching approach in determining the discount rate, not changes in the discount rates themselves. The original answer focuses on a shift in language from describing the method as directly selecting bonds to stating it 'guides' the selection, indicating a subtle operational reframing. The LLM instead discusses changes in discount rate percentages, which were not part of the ground truth and are factually unsupported in the context provided. (2) The numeric values (5.42%, 5.88%, 5.80%, 6.18%) are entirely fabricated and not present in the original answer, resulting in severe quantitative inaccuracy. There is no mention of actual discount rate figures in the ground truth, so including them constitutes a major factual error. (3) The multi-hop reasoning fails because the LLM misinterprets the core of the question—evolution in methodological description—instead focusing on unrelated numerical changes in discount rates. It does not synthesize the qualitative shift in disclosure language between years, which is the key insight. (4) Correctness is low (3/10) due to complete misalignment with the actual evolution described; quantitative accuracy is very low (2/10) due to invented numbers; qualitative accuracy is poor (3/10) as the reasoning and entity synthesis are off-track; contextual relevance is moderate (5/10) because it discusses UPS, pension plans, and bond matching, but misses the actual point of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 441,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "Linde's relationship with helium from 2022 to 2024 is characterized by a decline in volumes and increased costs, as noted in the 2024 10-K. Sales for the \"Other\" segment, which includes global helium wholesale, decreased by 2% in 2024 compared to 2023 due to lower helium volumes. Despite this, operating profit in the \"Other\" segment increased by 44%, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), partially offsetting higher helium-related costs. Thus, while helium volumes negatively impacted sales, the segment's operating profit improved due to insurance recoveries.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decline in helium volumes and increased costs from 2022 to 2024, noting a 2% decrease in sales for the 'Other' segment in 2024 due to lower helium volumes. It accurately states the $32 million sales impact (implied by 2% decrease) and links it to global helium and LAMT. The operating profit improvement of 44% in the 'Other' segment is correctly attributed to an insurance recovery that offset higher helium-related costs. However, the original answer specifies that helium had a negative impact on *both* sales and operating profit, with the insurance recovery only *partially* offsetting the pressure—this nuance is slightly understated in the LLM answer, which emphasizes the 44% profit increase without clearly stating that helium still had a net negative effect before the recovery. (2) Quantitatively, all numbers are accurate: 2% sales decrease, 44% operating profit increase, and the $32 million figure (implied from context) align with the ground truth. The LLM does not explicitly state the $32M figure but correctly infers the 2% impact. (3) The multi-hop reasoning is sound—linking helium volume declines to sales impact, then connecting cost pressures and insurance recovery to operating profit. The synthesis across time (2022 to 2024) and segments (Other segment, LAMT) is appropriate. (4) The answer is contextually relevant and addresses both parts of the question: evolution of relationship and financial impact. The slight deduction in correctness and qualitative accuracy is due to downplaying the negative operational impact of helium by highlighting the profit increase without sufficient emphasis on the underlying cost pressure. Overall, the answer is factually strong but slightly less precise in conveying the net negative impact of helium.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 494,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Between 2023 and 2024, Bank of America's unfunded capital contributions for renewable energy investments decreased from $6.2 billion to $4.6 billion. Correspondingly, the recognized tax credits related to these investments decreased from $4.0 billion in 2023 to $3.9 billion in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: unfunded capital contributions decreased from $6.2 billion in 2023 to $4.6 billion in 2024, and recognized tax credits declined from $4.0 billion to $3.9 billion. These values exactly match the original answer. (2) The answer is complete, addressing both parts of the question: the evolution of unfunded capital contributions and the corresponding change in tax credits. (3) Entity accuracy is correct—Bank of America, the years 2023 and 2024, and the financial metrics (unfunded capital contributions and recognized tax credits) are all properly identified. (4) The reasoning is sound and reflects appropriate multi-hop synthesis across time points and related financial impacts. While the LLM answer is more concise than the original and omits the interpretive sentence about reduced near-term commitments and stable tax benefits, it still conveys the essential factual evolution accurately and without distortion. The omission does not affect factual correctness, so full credit is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 316,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "General Motors' approach to fleet sales involving commercial fleet customers from 2022 to 2024 has shown a strategic shift toward optimizing profitability and expanding direct engagement. In 2022, fleet sales accounted for 11.3% of total vehicle sales, with a noted emphasis on dealer networks for fleet transactions. By 2024, GM had refined its strategy, leveraging both dealer networks and direct sales channels to commercial fleet customers, particularly in the context of its electric vehicle (EV) initiatives like BrightDrop. This evolution reflects a focus on higher-margin opportunities, such as electric commercial vehicles and partnerships with large fleets, while managing the traditionally lower profitability associated with fleet sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes a specific percentage (11.3% of total vehicle sales in 2022) that is not present in the original ground truth and cannot be verified from the provided context, making it factually unsupported. No such quantitative data appears in the ground truth, so this number is likely fabricated or misattributed. This significantly undermines quantitative accuracy. (2) The ground truth does not mention BrightDrop, EV initiatives, or specific partnerships with large fleets, which are introduced in the LLM answer without corroboration. These additions, while plausible, go beyond the information provided and introduce unverified details. (3) Qualitatively, the LLM correctly identifies a strategic evolution in GM’s fleet sales approach—shifting from primarily dealer-based (with some direct) in 2022 to a dual-channel model (dealer and direct) by 2024—with an emphasis on profitability. This aligns with the ground truth’s description of a more structured and optimized approach. The reasoning around balancing lower fleet profitability with strategic channel use is sound and reflects accurate synthesis. (4) Contextual relevance is high, as the answer directly addresses the evolution in sales channels and profitability considerations for commercial fleet customers from 2022 to 2024. However, the inclusion of unsupported specifics (like 11.3%) and unmentioned programs (BrightDrop) reduces factual correctness. While the overall direction of the answer is reasonable, the lack of quantitative support and introduction of external elements lowers the correctness score despite accurate qualitative trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 449,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's relationship with Sabra evolved from holding a 50% equity ownership to fully divesting its stake. In the first quarter of 2022, PepsiCo sold its 50% ownership in Sabra, recognizing a pre-tax gain of $122 million ($92 million after-tax or $0.07 per share) from the remeasurement of its previously held equity interest at fair value. This transaction marked the end of PepsiCo's ownership in Sabra and had a positive financial impact on its results.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, PepsiCo transitioned from full ownership of Sabra in 2022 to holding a 50% equity stake in 2024, not the reverse. The LLM incorrectly states that PepsiCo sold its 50% stake in Q1 2022, implying it previously held only 50%, when in fact it divested part of a fully owned asset, retaining 50%. This reverses the direction of the ownership change. (2) The pre-tax gain of $122 million is correctly reported, as is the after-tax amount of $92 million and $0.07 per share, which aligns with the financial implications. However, the timing and context of this gain are misrepresented—the gain resulted from remeasuring the retained 50% stake at fair value upon partial divestiture, not from selling the entire stake. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution of ownership (full → 50% retained) and instead reports the opposite (50% → 0%), indicating a failure in logical and factual synthesis across time points. (4) While the financial figures are accurate and relevant, the core narrative is inverted, leading to a low correctness score. Contextual relevance is moderate because the answer discusses the right companies, time frame, and financial impact, but with incorrect ownership trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 375,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "Adobe Scan has transitioned from being a standalone mobile scanning tool to being more deeply integrated within Adobe's broader Document Cloud ecosystem. In 2023, Adobe Scan was primarily described as a free mobile app for converting paper documents into PDFs. By 2024, it is positioned as a complementary component of Adobe Document Cloud, emphasizing seamless integration with Adobe Acrobat and other Document Cloud services for enhanced workflow and collaboration capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no issues here. (2) The LLM correctly identifies the evolution of Adobe Scan between 2023 and 2024: from a standalone mobile app (implied established product, consistent with trademark status in 2023) to a more integrated component of Adobe Document Cloud in 2024. While the original answer emphasizes trademark listing in 2023 and explicit positioning within Document Cloud in 2024, the LLM captures the semantic equivalent by describing functional integration and strategic emphasis. (3) The multi-hop reasoning is sound—synthesizing information across years and product strategy shifts. The LLM correctly infers increased integration without misrepresenting the nature or timing of the change. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention the 'trademark' status in 2023, which is a factual detail from the ground truth, but it compensates by accurately describing its functional role. Overall, the answer conveys the same core evolution in positioning with high fidelity, making it contextually relevant and semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 350,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "General Motors' financial exposure and nature of obligations to Stellantis from 2022 to 2024 have remained largely consistent, with continued indemnification obligations related to the 2017 sale of the Opel/Vauxhall Business. In both 2022 and 2024, GM agreed to indemnify Stellantis for certain losses arising from inaccuracies in representations and warranties, as well as for emissions and product liabilities related to vehicles sold prior to the sale. In 2024, GM noted that it indemnified Stellantis for an immaterial amount related to certain recalls, including Takata inflator recalls in legacy Opel vehicles, but believes further indemnification for such matters is remote. The nature of these obligations remains subject to time limitations, thresholds, and/or caps, with no material accruals recorded in either year.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in terms of factual content and captures the core indemnification obligations of GM to Stellantis stemming from the 2017 Opel/Vauxhall sale. It correctly identifies that GM continued to have indemnity obligations in both 2022 and 2024 for emissions, product liabilities, and Takata-related recalls, and notes the immaterial accrual in 2024—consistent with the ground truth. The quantitative accuracy is high: no specific dollar amounts are misstated, and 'immaterial' aligns with the original answer’s 'immaterial amount accrued as of December 31, 2024.' However, the LLM answer misses a key evolution highlighted in the ground truth: the shift from operational supply-related transactions in 2022 to a purely financial/guarantee-based relationship in 2024. This transformation is central to the question about how the 'nature of obligations' evolved, but the LLM implies continuity rather than change, stating obligations 'remained largely consistent.' This misrepresents the qualitative shift in the relationship. Additionally, the LLM omits mention of European regulatory investigations into end-of-life vehicle practices, a specific liability cited in the original. While the core indemnity framework is accurately described, the failure to capture the evolution in nature—from active supply ties to passive indemnifications—reduces the qualitative accuracy. The reasoning is sound within the scope of information provided but lacks full multi-hop synthesis across time and obligation type. Contextual relevance is strong as the answer directly addresses the financial exposure and indemnifications, but the omission of the operational-to-financial shift limits completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 464,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's relationship with co-packers has remained consistent in terms of operational dependency, as the company continues to utilize a highly distributed network of plants, warehouses, and distribution centers owned or leased by co-packers, strategic alliances, or joint ventures. There is no indication of a significant shift in strategic involvement during this period; however, the company emphasizes the importance of these partnerships in supporting its global operations, particularly in regions where direct ownership is less prevalent.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that PepsiCo's relationship with co-packers evolved from an operationally dependent model in 2022 to a more strategic, ownership-based involvement by 2024, specifically through 'strategic alliances or joint ventures in which we have an equity interest.' In contrast, the LLM claims there was 'no significant shift in strategic involvement,' which directly contradicts the documented evolution. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or formats, hence a score of 10. (3) The multi-hop reasoning is flawed: the model fails to synthesize the change in language and strategic posture between 2022 and 2024. Instead of identifying the shift from third-party operational dependency to equity-based strategic alliances, it incorrectly asserts continuity. This represents a failure in qualitative reasoning and entity-year-metric linkage. (4) Contextual relevance is moderate—the response addresses PepsiCo, co-packers, and the correct time frame, and discusses operational networks, so it stays on topic. However, the incorrect conclusion about no strategic shift severely undermines the answer's validity. The correctness score is low due to the central factual inaccuracy despite correct context and entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 387,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "Between 2023 and 2024, SPG's financial relationship with ABG evolved significantly. In 2023, SPG recognized a pre-tax gain of $157.1 million from the sale of a portion of its interest in ABG and a non-cash pre-tax gain of $59.1 million from ABG's capital transactions that diluted SPG's ownership. By 2024, SPG fully exited its remaining interest in ABG, selling it for cash proceeds of $1.2 billion and recognizing a substantial pre-tax gain of $414.8 million. This marked a strategic divestment, indicating a shift away from ABG as a key investment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the $157.1 million gain from the sale of a portion of SPG's ABG interest and the $59.1 million non-cash gain from ABG's capital transactions in 2023, it fabricates a $414.8 million pre-tax gain in 2024 from a supposed full exit of SPG's ABG interest for $1.2 billion in cash — this is not supported by the ground truth. Instead, the original answer states that in 2024, SPG disclosed an $18.8 million gain from the sale of a portion of its ABG interest that occurred in December 2021 (not 2024), and highlighted a strategic partnership with ABG around Reebok. The LLM incorrectly frames 2024 as a year of full divestment and major financial gain, when in fact the emphasis was on operational collaboration. (2) Quantitative accuracy is poor: the $414.8 million gain and $1.2 billion cash proceeds are entirely incorrect and contradict the ground truth. The only correct numbers are the 2023 gains of $157.1M and $59.1M. The $145.8M gain from SPARC Group dilution in 2023 is omitted. The 2024 $18.8M gain is not mentioned at all. (3) Multi-hop reasoning fails: the model misinterprets the evolution of the relationship, missing the shift from financial gains to strategic operational partnership (Reebok licensing) in 2024. Instead, it invents a narrative of complete divestment, which is the opposite of the actual deepening operational collaboration. (4) Contextual relevance is moderate because it addresses SPG-ABG financial evolution and mentions gains, but the core narrative is factually wrong. Correctness is severely compromised by fabricated data and mischaracterization of strategic direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 465,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "Lockheed Martin's involvement in Sikorsky helicopter programs, as part of its Rotary and Mission Systems (RMS) segment, saw increased production volume from 2022 to 2024. In 2022, RMS reported higher product sales due to increased production on various Sikorsky helicopter programs. By 2024, Sikorsky helicopter programs remained a major focus for RMS, with the Black Hawk, Seahawk, and CH-53K King Stallion heavy lift helicopters continuing to serve U.S. and foreign governments. The program scope also expanded to include the Combat Rescue Helicopter (CRH) for the U.S. Air Force and the VH-92A helicopter for the U.S. Marine One transport mission, with final deliveries completed in 2024. This indicates both sustained and expanded involvement in Sikorsky programs during this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies increased production volume in Sikorsky helicopter programs within Lockheed Martin's RMS segment from 2022 to 2024, aligning with the ground truth. It accurately notes the 2022 increase in production as a driver of higher product costs/sales and correctly lists key programs (Black Hawk, Seahawk, CH-53K) as central to RMS in 2024. However, the ground truth does not mention the Combat Rescue Helicopter (CRH) or VH-92A programs or their 2024 final deliveries; these specific expansions are not supported in the original answer and represent an overreach in program scope details. (2) Quantitatively, the LLM avoids citing specific dollar amounts like the $560 million cost increase from 2022, which was present in the ground truth. While this omission doesn't introduce inaccuracy, it reduces completeness on the quantitative side. No incorrect numbers are stated, so quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the model connects Sikorsky programs to RMS, tracks their evolution across years, and infers sustained and expanded focus. However, the addition of unverified programs (CRH, VH-92A) introduces minor factual overstatement, slightly weakening qualitative accuracy. (4) The answer is highly contextually relevant, directly addressing production volume and program scope evolution. The core facts are correct, and the reasoning is logical, warranting high scores in all categories, though not perfect due to unsupported program expansions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 421,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "In fiscal 2023, Walmart acquired Alert Innovation for $0.4 billion, increasing its ownership to 100%. No further changes to Walmart's ownership stake in Alert Innovation are mentioned for fiscal 2024, indicating that the company maintained full ownership during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Walmart acquired Alert Innovation for $0.4 billion in fiscal 2023 and increased its ownership to 100%, which matches the ground truth. However, it incorrectly concludes that Walmart maintained full ownership in fiscal 2024, while the ground truth explicitly states there was no mention of continued ownership, indicating a full exit. This is a critical factual and interpretive error. (2) Quantitative accuracy is perfect: the $0.4 billion figure is correct and properly formatted. (3) The multi-hop reasoning fails in the second hop: the model should have inferred from the absence of ownership mentions in fiscal 2024—after full ownership in 2023—that Walmart likely divested, but instead assumed continuity. This misinterprets the evidentiary silence as confirmation of status quo, which contradicts the ground truth inference. (4) While contextually relevant and numerically accurate, the answer is factually incorrect on the key point of ownership evolution in fiscal 2024, warranting a moderate correctness score of 4 due to partial accuracy on the first year but major error on the second.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 324,
        "total_tokens": 1464
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "Between 2023 and 2024, SPG's utilization of the Supplemental Facility evolved with a focus on repayment and strategic refinancing. In 2023, the Operating Partnership used the Supplemental Facility to borrow €750.0 million, which was later repaid in full on November 17, 2023, using proceeds from the issuance of senior unsecured bonds. By 2024, the Supplemental Facility was not heavily utilized, with only $8.6 million in letters of credit outstanding and no significant borrowings reported. The repayment strategy in 2023 involved issuing fixed-rate debt to replace variable-rate borrowings, thereby managing interest rate risk and optimizing the cost of capital. In 2024, the focus shifted to maintaining liquidity through the broader Credit Facilities, which had an aggregate available borrowing capacity of $8.2 billion.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the €750.0 million borrowing in 2023 and its repayment on November 17, 2023, using proceeds from senior unsecured bonds, which aligns with the ground truth. However, it introduces a new figure—$8.6 million in letters of credit outstanding in 2024—that is not present in the original answer and contradicts the ground truth statement that there was 'no outstanding balance' under the Supplemental Facility in 2024. This is a significant quantitative inaccuracy. Additionally, the LLM mentions a $1.0 billion unsecured note issuance in September 2024 in the original answer, which the LLM omits, instead referring more generally to fixed-rate debt issuance without specifying this key refinancing event. (2) The date of repayment (November 17, 2023) and the amount borrowed (€750.0 million) are accurate. The $8.6 million figure for letters of credit lacks corroboration and appears to be either fabricated or misattributed, reducing quantitative accuracy. The $8.2 billion available capacity in broader Credit Facilities is contextually relevant but not directly tied to the Supplemental Facility’s utilization, potentially conflating facilities. (3) The reasoning around refinancing from variable-rate to fixed-rate debt is plausible and consistent with strategic logic, and the shift toward long-term unsecured notes is partially captured, though the specific $1.0 billion September 2024 issuance—a key multi-hop data point—is missing. This weakens the synthesis across years and instruments. (4) Despite the omission of the 2024 bond issuance and the introduction of an unsupported outstanding amount, the core narrative of reduced reliance on the Supplemental Facility and repayment via bond issuance is preserved, warranting a score of 7 for overall correctness. Qualitative accuracy is higher due to sound logic and entity identification (SPG, Supplemental Facility, senior unsecured bonds), while contextual relevance remains strong as the response directly addresses borrowing activity and repayment strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 555,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "Linde has maintained helium as a key process gas within its industrial gases business in both 2023 and 2024, with no significant repositioning as a primary product. Helium is consistently listed among process gases (alongside hydrogen, carbon dioxide, etc.) and is sold through the same distribution methods—onsite, merchant, and packaged gases—as other gases. In 2024, there is no indication of a strategic shift in supply strategies specific to helium, and it continues to be managed within the broader context of Linde's industrial gas offerings.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Linde maintained helium as a distinct, consistently listed primary product in both 2023 and 2024. According to the ground truth, helium was explicitly named as a primary product in 2023 alongside oxygen, nitrogen, and hydrogen, but in 2024 it was no longer specifically mentioned and instead subsumed under general gas descriptions—indicating a strategic repositioning. The LLM incorrectly asserts there was 'no significant repositioning' and that helium remained listed among process gases, which contradicts the documented shift in disclosure. While the answer correctly references Linde's distribution methods (onsite, merchant, packaged) and general context of industrial gas offerings, these are generic details that do not reflect the specific evolution in helium's status. There are no numeric values to evaluate, so quantitative accuracy is scored as 10 by default. However, the qualitative accuracy is very low due to failure in multi-hop reasoning: the model did not detect the change in product classification across years, misrepresenting a key strategic shift as continuity. Contextual relevance is moderate because the answer addresses the right topic and company but misses the central analytical point about helium's changing prominence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 364,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "Between 2022 and 2023, the allocation of assets in the U.S. Retiree Health Care Plan shifted significantly, with fixed income securities and cash equivalents increasing from 65% to 80%, while equity securities decreased from 35% to 20%. This change reflects a more conservative allocation strategy for the plan during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both dollar amounts and percentages. According to the ground truth, in 2022, fixed income and cash equivalents were $248 and equity securities were $137 (total $385), which corresponds to approximately 64.4% and 35.6%, respectively. In 2023, fixed income was $210 and equity was $54 (total $264), corresponding to approximately 79.5% and 20.5%. While the LLM's reported percentages are close to these correct values, it presents them as exact (65% to 80%, 35% to 20%) without acknowledging the actual dollar figures, which are critical to the question. More critically, the LLM implies an increase in fixed income allocations, but in absolute terms, fixed income decreased from $248 to $210. The answer misrepresents the nature of the change by focusing only on percentages, thus missing the overall reduction in total plan assets from $385 to $264. (2) The dollar amounts are entirely omitted in the LLM answer, which fails the quantitative accuracy check. The percentages, while roughly aligned with correct proportions, are presented as precise shifts without source data and distract from the actual decline in both asset categories. (3) The reasoning is flawed because it interprets a proportional increase in fixed income as an intentional conservative shift, without recognizing that both asset classes declined in value, with equities declining more sharply. This requires multi-hop synthesis of absolute values and their implications, which the model fails to perform. (4) The answer is contextually relevant—it addresses asset allocation changes and identifies the correct plan and time frame—but the lack of factual grounding in dollar amounts and the misleading emphasis on percentages over absolute values severely undermine correctness. Hence, low scores for correctness and quantitative accuracy; slightly higher for qualitative and contextual relevance due to partial structural alignment with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 533,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's financial performance showed significant growth, with product sales increasing by 56% to $1.1 billion in 2023 compared to $680 million in 2022, driven by higher demand in new and existing geographies. Strategically, Trodelvy received FDA approval for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting, expanding its market reach and therapeutic utility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, Trodelvy generated $380 million in product sales in 2022, not $680 million as claimed. The LLM states a 56% increase to $1.1 billion in 2023, but the original answer explicitly notes that specific revenue figures for 2023 are not provided. These financial figures are entirely fabricated and significantly overstate performance. (2) The calculation of a 56% increase from $680M to $1.1B is mathematically plausible (a ~61.8% increase), but since both input numbers are incorrect, the conclusion is invalid. No actual revenue data for 2023 exists in the ground truth to support any numerical claim. (3) On qualitative aspects, the LLM correctly identifies a key regulatory milestone — FDA approval for HR+/HER2- metastatic breast cancer — which aligns with the strategic positioning improvement noted in the original answer. However, it omits the EC approval in Europe, which is a key part of the multi-hop synthesis across geographies and regulatory bodies. (4) While the answer addresses both financial performance and strategic positioning as required by the question, the complete inaccuracy of the revenue data severely undermines correctness. The reasoning about expanded market reach due to FDA approval is sound and contextually relevant, but the false quantification dominates the assessment. Hence, the correctness and quantitative accuracy scores are very low, while contextual relevance is moderate due to correct framing and partial entity alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 428,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "Chevron's downstream-related earnings from GS Caltex increased from $874 million in 2022 to $58 million in 2023, indicating a significant decline. However, in 2024, the earnings rebounded slightly to $58 million, showing some stabilization. The joint venture remains strategically important as it continues to be a key player in the downstream segment in South Korea, with Chevron maintaining a 50% stake and ongoing investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth does not specify Chevron's downstream earnings from GS Caltex as $874 million in 2022 or $58 million in 2023/2024; these numbers are entirely fabricated. The only accurate quantitative data in the original answer is that Chevron maintained a 50% ownership stake in GS Caltex in 2024 and that sales with affiliated companies (including GS Caltex) were $13,850 million in 2024 vs $16,286 million in 2022 — none of which are mentioned in the LLM response. (2) The LLM invents specific earnings figures and trends (e.g., decline from $874M to $58M) with no support in the ground truth, which only states that downstream earnings from GS Caltex contributed to improved income in 2022 and does not provide exact figures for any year. This constitutes a severe quantitative error. (3) The reasoning is flawed: the LLM incorrectly infers a sharp decline and stabilization based on non-existent data, failing to correctly synthesize the actual trend — a slight decrease in total affiliated revenues from $16,286M to $13,850M — and misattributing it to GS Caltex-specific earnings. The strategic importance is acknowledged correctly in that the joint venture remains key and Chevron retains 50% ownership, which aligns with the original answer. (4) The contextual relevance is moderate because the answer addresses the right entities (Chevron, GS Caltex, downstream earnings, joint venture importance) and time frame (2022–2024), but the core financial claims are false. Due to the invention of specific numbers and incorrect trend analysis, the correctness and quantitative accuracy scores are very low despite partial entity and contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 470,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "From 2022 to 2024, the CH-53K program, part of the Sikorsky helicopter programs under the RMS segment, experienced notable production growth and risk retirements. In 2022, the RMS segment reported higher production volume for the CH-53K, contributing to increased net sales and operating profit. By 2024, the CH-53K program continued to show production ramp-up, with higher production volume driving a $140 million increase in net sales for Sikorsky helicopter programs. Additionally, the program benefited from risk retirements, which improved profit booking rates and contributed to higher operating profit. Overall, the CH-53K program demonstrated steady progress in production and risk mitigation during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the $140 million increase was in 'net sales' in 2024, while the ground truth specifies that the $140 million increase in operating profit occurred in 2022 due to risk retirements and production volume—not net sales, and not in 2024. The LLM misattributes the timing and nature of the financial impact. Additionally, the LLM fails to mention the 73% decline in RMS operating profit by 2024, which is a key part of the evolution and contradicts the implication of continued profit growth. Instead, it suggests ongoing profit improvement in 2024, which is inconsistent with the ground truth. (2) Quantitatively, the $140 million figure is real but misapplied: it refers to increased operating profit in 2022, not net sales in 2024. No dollar figures for 2024 CH-53K performance are provided in the ground truth, so asserting a $140M sales increase in 2024 is factually wrong. The LLM also omits the 73% profit decline in RMS, a critical quantitative benchmark. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies CH-53K as part of Sikorsky/RMS and links production volume and risk retirements to financial performance, it fails to synthesize the contrast between 2022 gains and 2024 declines. It does not acknowledge the maturation of the program leading to diminished risk retirement benefits, which is central to the correct interpretation. (4) Contextual relevance is high—the answer addresses production volume, risk retirements, and financial performance over time—but correctness is undermined by key factual and temporal errors. The overall score reflects partial credit for correct entity identification and general trends, but major deductions for misstated figures, timing, and direction of financial performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 499,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "Between 2022 and 2023, PayPal's approach to seller protection programs evolved by emphasizing risk management and enhancing protections for both merchants and consumers. In 2022, the focus was on managing transaction and credit losses, with provisions for expected credit losses and adjustments for macroeconomic factors impacting merchant insolvency and fraud. By 2023, PayPal reorganized its operations to align more closely with customer segments, including small businesses and enterprises, and expanded its seller protection programs to reduce merchant losses through proprietary solutions. Additionally, PayPal emphasized its ability to leverage data from its two-sided network to improve fraud detection and enhance the security of transactions, reflecting a strategic shift toward a more integrated and proactive approach to risk exposure and customer trust.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PayPal and the relevant years (2022–2023), and accurately describes a shift in strategic emphasis toward seller protection programs. However, it omits the specific quantitative risk exposure metric from the ground truth—historical transaction loss rates between 0.09% and 0.15% of TPV—which is a key factual detail in the original answer. While the LLM mentions managing transaction and credit losses, it does not quantify them, representing a partial omission. (2) No incorrect numbers are presented; the LLM avoids making up figures and does not contradict the ground truth numerically. Thus, quantitative accuracy is high, earning a 10. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic evolution from risk management to enhanced protection and integration with merchant services. However, it reframes the 2023 shift around operational reorganization and customer segmentation, which, while plausible, diverges from the ground truth’s emphasis on seller protection as a competitive differentiator tied to merchant trust and platform growth. The core idea of strategic elevation is present but not precisely aligned in framing. (4) Contextually, the response is highly relevant, addressing both risk exposure and strategic emphasis as asked. The synthesis across years is logical and focused, though missing the precise linkage to merchant trust and platform growth as a value proposition. Overall, the answer captures the directional shift accurately but lacks specific supporting data and nuanced strategic framing from the original, justifying a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 454,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "Between 2023 and 2024, Starbucks' approach to its ready-to-drink beverages remained consistent in terms of revenue recognition, with sales of these products generally recognized upon shipment to customers outside of company-operated and licensed stores. There is no indication of a significant change in the accounting treatment for these beverages during this period. Regarding supplier dependency, Starbucks continues to source ready-to-drink beverages from several specialty suppliers, typically under long-term supply contracts, and the company believes the risk of non-delivery from these suppliers is remote based on historical performance and established relationships.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of revenue recognition and supplier sourcing practices, and there are no numeric inaccuracies (quantitative accuracy is high, scoring 10). The description of revenue recognition upon shipment and sourcing from specialty suppliers under long-term contracts aligns with the original answer. However, the LLM fails to capture the key evolution highlighted in the ground truth: the strategic shift from a revenue-centric reporting approach in 2023 to a supply-chain risk management focus in 2024. Instead, the LLM states there was 'no significant change in accounting treatment' and 'remained consistent,' which contradicts the original answer's emphasis on an evolving strategic focus, even if the core accounting policy did not change. This omission represents a failure in qualitative accuracy and multi-hop reasoning, as the model does not synthesize the shift in emphasis across years—from disclosure practices to risk mitigation strategy. While the entities (Starbucks, ready-to-drink beverages, suppliers, years) are correct and contextually relevant, the answer misses the analytical evolution the question asks for, resulting in a correctness score of 5 due to partial but not full alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 358,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's geographic reach and regulatory approvals expanded significantly. In 2022, Trodelvy was approved in the U.S. and Europe for metastatic triple-negative breast cancer (TNBC) and received accelerated approval for urothelial cancer. By 2023, Trodelvy gained additional approvals, including EC authorization for HR+/HER2- breast cancer and expanded use in new geographies, contributing to a 56% increase in product sales. These developments reflect both broader regulatory acceptance and expanded global market access.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of Trodelvy's regulatory approvals and geographic reach between 2022 and 2023, and correctly notes EC approval in 2023 for HR+/HER2- breast cancer. However, it introduces inaccuracies: it claims Trodelvy had approvals in 2022 for metastatic triple-negative breast cancer (TNBC) and urothelial cancer, which is not mentioned in the ground truth and cannot be verified from the provided data. The ground truth only reports sales figures ($370M U.S., $10M Europe) in 2022, not indications or approvals. (2) The 56% increase in product sales is a significant quantitative claim not supported by the original answer, which does not mention any sales growth percentage. This number appears fabricated or inferred beyond available data. The original answer only provides 2022 sales by region but no 2023 sales figures or growth rates. (3) The multi-hop reasoning is partially sound—linking regulatory approvals to expanded market access is logical—but the model assumes prior approvals (TNBC, urothelial) without evidence in the ground truth, and incorrectly uses sales growth to support geographic expansion without data. (4) The contextual relevance is high because the answer addresses both geographic reach and regulatory approvals over time. Qualitative accuracy is moderate due to plausible reasoning but unsupported claims. Quantitative accuracy is low due to the unsupported 56% sales increase. Correctness score is 6 because core elements (EC approval expansion) are correct, but key details are invented or incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 435,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's ownership stake in ABG decreased significantly. In 2023, ABG completed multiple capital transactions that led to dilution of Simon's ownership from approximately 12.3% to 9.6%, resulting in non-cash gains from deemed disposals. In 2024, Simon sold all of its remaining interest in ABG for cash proceeds of $1.2 billion, resulting in a pre-tax gain of $414.8 million. This marked the complete divestment of Simon's stake in ABG.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Simon Property Group (SPG) experienced a series of dilutions in 2023, reducing its stake from 12.3% to 11.8%, then 11.7%, and finally to 9.6%, with corresponding non-cash pre-tax gains of $36.4M, $12.4M, and $10.3M. The LLM correctly notes a reduction from 12.3% to 9.6% but omits the intermediate steps and misrepresents the nature and magnitude of financial gains. Crucially, the LLM claims that in 2024, SPG sold all of its remaining interest for $1.2 billion and recognized a $414.8 million pre-tax gain—this is entirely incorrect. The ground truth states that SPG did not report any new transactions in 2024 and instead referenced a prior 2021 transaction involving an $18.8M gain and a $100M acquisition. There is no mention of a $1.2B sale or a $414.8M gain in the original answer. (2) Quantitative accuracy is very low: the three correct gains in 2023 total $59.1M, not $414.8M, and no 2024 sale occurred. The $1.2B figure is unsupported. (3) The multi-hop reasoning fails: the model incorrectly infers a complete divestment in 2024 when the actual data shows no active stake changes and only a reference to past activity. It fails to capture the shift from active dilution in 2023 to passive disclosure in 2024. (4) Contextual relevance is moderate because the answer addresses ownership evolution and financial gains, but the core facts are wrong. The qualitative reasoning is flawed due to incorrect entity-event mapping and lack of synthesis with the correct timeline. The answer fabricates a major transaction not present in the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 452,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "The 2012 Equity Incentive Plan was amended in the 2024 filing with the addition of a Fourth Amendment, disclosed in Exhibit 10.2(C)+ filed on August 1, 2024. Additionally, new forms of award agreements were disclosed in the 2024 filing, specifically under Exhibit 10.2(K)+, filed on April 25, 2024. No new amendments or forms of award agreements were disclosed in the 2023 filing beyond those previously disclosed in earlier years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct but contains a minor inaccuracy regarding the 2023 filing. According to the ground truth, the 2023 filing did disclose the 2012 Equity Incentive Plan as amended, including the Third Amendment, and referenced 2012 and 2017 forms of award agreements. The LLM incorrectly states that 'no new amendments or forms of award agreements were disclosed in the 2023 filing beyond those previously disclosed in earlier years,' which downplays the explicit mention of the Third Amendment and specific forms in 2023. This is a factual omission affecting completeness and qualitative accuracy. However, the 2024 details are accurate: the Fourth Amendment is correctly dated August 1, 2024 (Exhibit 10.2(C)+), and the new April 2024 award agreement forms are correctly cited under Exhibit 10.2(K)+ (April 25, 2024 aligns with April 2024 in the ground truth). Dates and exhibit numbers match or are semantically equivalent. The reasoning correctly synthesizes multi-hop information across years and document types, and the response directly addresses the evolution of amendments and award forms. Quantitative accuracy is high—dates and exhibit references are precise. Contextual relevance is perfect. The core facts about 2024 are correct, and the error in 2023 is moderate but not fundamental, warranting a score of 8 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 374,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "Between 2022 and 2023, the treatment and valuation of capitalized software licenses showed an increase in both the balance and amortization. The capitalized software licenses rose from $152 million in 2022 to $223 million in 2023, while the amortization expense increased from $54 million to $63 million. This indicates a significant investment in software licensing by the company during 2023, reflecting a growing reliance on or expansion of software assets within its operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in capitalized software licenses from $152 million in 2022 to $223 million in 2023, which matches the ground truth and is a key factual point. However, it introduces an unsupported claim about amortization expense increasing from $54 million to $63 million, which is not mentioned in the original answer or implied by the ground truth. This is a significant quantitative inaccuracy. (2) The dollar amounts for the carrying value of software licenses are accurate and correctly formatted. However, the amortization figures are extraneous and incorrect—no such numbers appear in the ground truth, and the original answer only notes that the amortization policy (straight-line) remained unchanged. There is no mention of actual amortization expense in either year. (3) The reasoning correctly infers increased investment in software licensing based on the rise in carrying value, which aligns with the ground truth’s interpretation. The multi-hop synthesis between years and valuation is sound, but the addition of false amortization data undermines the reasoning accuracy. (4) The contextual relevance is high—the answer addresses the evolution of treatment and valuation and draws a reasonable conclusion about investment trends. Due to the inclusion of fabricated financial data, the quantitative accuracy is penalized significantly, but the core insight about growing investment remains valid, warranting a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 414,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "Between 2022 and 2023, PayPal increased its utilization of European customer balances for credit activities, with the approved amount rising from $2.7 billion (27% of European customer balances) in 2022 to $3.0 billion (39% of European customer balances) in 2023. This indicates a strategic shift toward leveraging internal liquidity sources to fund credit products, reflecting PayPal's effort to expand its credit offerings while managing liquidity needs more efficiently.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that PayPal approved $2.7 billion (27%) of European customer balances in 2022, while the ground truth is $3.8 billion (37%). The 2023 figure of $3.0 billion (39%) is correct. This misrepresentation distorts the trend: the LLM claims an increase in approved amounts, whereas the actual data shows a decrease from $3.8B to $3.0B. (2) The calculation of percentages is wrong in the LLM answer—27% and $2.7B do not align with the source data. Additionally, the LLM omits the critical strategic development in 2023: the new €40 billion agreement to sell consumer installment receivables, of which $5.5 billion was sold. This omission removes a key part of PayPal’s shift toward external funding mechanisms. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers a strategic shift toward internal liquidity sources, while the ground truth indicates a move toward external funding via receivables sales. The correct interpretation should note that despite a smaller total approved base, PayPal used a higher percentage of available balances (39% vs 37%), suggesting efficiency gains, but supplemented this with external funding. (4) The contextual relevance is moderate because the answer addresses the general topic and timeframe, but due to major quantitative errors and missing key strategic developments, the overall correctness is low. The reasoning and conclusions are based on incorrect data, leading to an inaccurate strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 426,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Starbucks' investment in Valor Siren Ventures I L.P. had a carrying value of $211.9 million as of September 29, 2024, indicating no significant change from the prior fiscal year. The financial impact of this investment on Starbucks' consolidated statements was not material during fiscal 2024, as the related financial statement activities were described as non-material.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the $211.9 million carrying value as of September 29, 2024, which matches the ground truth. However, it incorrectly implies that this value was also present in fiscal 2023 by stating 'indicating no significant change from the prior fiscal year,' which contradicts the original answer stating that the carrying value was not specifically disclosed for 2023. This is a significant factual error. (2) The date 'September 29, 2024' and dollar amount '$211.9 million' are accurate and properly formatted. However, the inference of 'no significant change' is unsupported by the source data and introduces a false quantitative comparison. (3) The reasoning fails on a key multi-hop aspect: the evolution of the investment relationship. The original answer notes a shift from a non-disclosed, general equity stake in 2023 to a more defined and quantified investment in 2024. The LLM answer misses this evolution entirely and incorrectly assumes continuity. It also omits the fact that the 2024 value includes both Valor Siren Ventures I and II L.P., not just I L.P. alone. (4) While the financial impact being non-material is correctly noted, the answer lacks completeness regarding the reporting line ('interest income and other, net') and fails to reflect the qualitative evolution of the relationship. The contextual relevance is high because it addresses the core question about carrying value and financial impact, but the factual inaccuracies and missing synthesis reduce correctness significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 424,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "Between 2022 and 2023, the strategic positioning of Analog Products at Texas Instruments (TI) experienced a notable shift in both competitive advantages and financial contribution. Financially, Analog revenue decreased by 15% in 2023 compared to 2022, and operating profit dropped by 30%, primarily due to lower revenue and higher manufacturing costs linked to planned capacity expansion and reduced factory loadings. Despite this, TI maintained its focus on strengthening its competitive advantages, particularly in manufacturing and technology, as well as market channel reach. However, the financial performance of the Analog segment weakened in 2023, reflecting broader market challenges and operational costs, even as TI continued to invest in long-term strategic goals.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The claim that Analog revenue decreased by 15% and operating profit dropped by 30% in 2023 is not supported by the ground truth, which does not mention any such decline. Instead, the original answer emphasizes continued strategic importance and strong gross margin (67.5% in 2022) without indicating a drop in financial performance. (2) Quantitative accuracy is severely lacking—there are no numbers in the ground truth about revenue or profit declines, nor any mention of higher manufacturing costs or reduced factory loadings. These figures appear fabricated or misattributed. The ground truth highlights gross margin and free cash flow as key metrics, not year-over-year percentage changes in revenue or operating profit. (3) The reasoning is flawed in terms of multi-hop synthesis. While the LLM attempts to discuss competitive advantages (manufacturing, technology, market reach), it incorrectly frames them against deteriorating financials, contradicting the ground truth that positions Analog Products as increasingly aligned with TI’s sustainable advantages and long-term cash generation. The shift in strategic framing—from standalone strength to integration within TI’s four competitive advantages—is completely missed. (4) Contextual relevance is moderate because the answer addresses Analog Products, TI, and strategic positioning, but the focus on declining financials distracts from the actual evolution in strategic narrative. The core of the ground truth—reinforced strategic role, supply chain control, cost leadership, and emphasis on free cash flow per share—is absent or contradicted. Thus, despite relevant topic coverage, factual and reasoning errors severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 483,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, as reflected in the increase in depreciation, depletion, and amortization (DD&A) from $4,854 million in 2022 to $5,729 million in 2023, indicating higher capital investment and asset utilization. However, impairments remained relatively stable, at $0 million in both years, suggesting that asset values in the Lower 48 were not significantly impacted by write-downs during this period. This evolution reflects a focus on maintaining and developing existing assets rather than significant divestitures or impairments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in depreciation, depletion, and amortization (DD&A) from $4,854 million in 2022 to $5,729 million in 2023, matching the ground truth exactly. It also accurately notes that impairments were $0 in both years, which aligns with the data in the knowledge graph. These figures are critical quantitative inputs and are reported without error. (2) All numeric values are correct and properly contextualized. The dollar amounts for DD&A in both years are accurate, and the observation about stable impairments is factually sound. There are no calculation errors. (3) The reasoning is strong: the LLM correctly infers that rising DD&A reflects increased capital investment and asset utilization in the Lower 48, which is a valid interpretation of the data. It appropriately distinguishes between capital development (reflected in higher DD&A) and lack of impairments (indicating no major write-downs). However, the original answer adds a comparative dimension—contrasting Lower 48 growth with stable or declining trends in other regions like Europe, Middle East and North Africa—which the LLM omits. This is a minor but relevant contextual gap in the multi-hop synthesis. (4) Despite this omission, the LLM captures the core evolution in capital allocation strategy with accurate data and sound logic. The answer is semantically very close to the ground truth, with only slight reduction in completeness due to missing the cross-segment comparison. Hence, a correctness score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 426,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "Between 2023 and 2024, Verizon has positioned FWA broadband as a more integral part of its product portfolio, leveraging its 5G and 4G LTE networks to serve both residential and business customers. In 2023, FWA was highlighted as an alternative to traditional landline internet access, primarily within the Consumer segment. By 2024, FWA broadband is explicitly integrated into both the Consumer and Business segments, with a focus on expanding its availability and enhancing its role in delivering high-speed internet access. The target customer segments have also broadened, with FWA being marketed not only to residential users but also as a scalable solution for businesses, particularly in areas where traditional wired infrastructure is limited.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Verizon's FWA broadband strategy between 2023 and 2024, accurately stating that FWA was offered over 5G and LTE networks and served both Consumer and Business segments. It correctly identifies the positioning shift toward integration within both segments and the role as an alternative to landline internet. However, the original answer includes a specific data point—3.1 million FWA connections in 2023—which is missing in the LLM response, representing a minor omission. Additionally, the LLM does not mention the semantic shift from 'provides' to 'produces' as an indicator of strategic emphasis, which is a key qualitative insight in the ground truth. (2) There are no numerical inaccuracies; the LLM avoids making up numbers and does not contradict the 3.1 million figure, though it fails to include it. Since no incorrect calculations or figures are presented, quantitative accuracy is full. (3) The multi-hop reasoning is sound: the model synthesizes information about product positioning and customer segments across time and business units, correctly inferring broader integration in 2024. However, it misses the nuanced linguistic evidence (‘provides’ vs ‘produces’) that supports the strategic shift, slightly weakening the qualitative depth. (4) Scores reflect high accuracy in facts and context, with a slight deduction in correctness and qualitative accuracy due to missing the connection count and strategic wording shift, which are important for full completeness and insight depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 430,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly from 2022 to 2024, transitioning from a 55% ownership stake in a newly formed \"New AspenTech\" in May 2022 to proposing a full acquisition of the remaining shares in November 2024. In 2022, Emerson contributed its industrial software businesses to Heritage AspenTech in exchange for 55% ownership. By 2024, Emerson proposed to acquire the remaining 43% of AspenTech for $240 per share, signaling full ownership. This evolution impacted Emerson's financials: the 2024 gross margin increased to 50.8% (up from 49.0% in 2023), partly due to the Test & Measurement acquisition, while the equity structure was affected by the $279 pre-tax loss on the Copeland note receivable and the $539 pre-tax gain on the sale of the Copeland equity interest.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Emerson did not hold a 55% stake in AspenTech in May 2022; rather, the strategic transaction forming 'New AspenTech' with 55% ownership occurred by 2024, not 2022. The claim that Emerson proposed acquiring the remaining 43% in November 2024 is incorrect—AspenTech was already majority-owned by Emerson as part of the 2024 transaction, and no such 'remaining 43%' acquisition was reported. Additionally, the LLM incorrectly attributes gross margin improvement to the Test & Measurement acquisition, while the ground truth states the 0.6 percentage point benefit in 2023 came from the AspenTech relationship. The reported 2024 gross margin of 50.8% (vs 49.0% in 2023) and specific pre-tax figures ($279M loss, $539M gain) related to Copeland are irrelevant to the AspenTech impact and contradict the original answer. (2) Quantitative accuracy is very low: none of the numbers provided (50.8%, 49.0%, $240/share, $279M, $539M) are supported by the ground truth in the context of AspenTech’s financial impact. The only correct numeric element is the 55% ownership, but it is misdated (2022 instead of 2024). (3) Multi-hop reasoning is flawed: the model fails to correctly sequence the evolution of the relationship (from partnership in 2022 to majority ownership in 2024) and incorrectly links financial impacts to unrelated transactions (Copeland, Test & Measurement). It also fabricates a full acquisition proposal not present in the ground truth. (4) Contextual relevance is moderate—the answer addresses the general theme of Emerson-AspenTech evolution and financial impact—but the incorrect entities, timing, and financial figures severely undermine factual correctness. The answer introduces unrelated financial events, reducing its reliability. Thus, the correctness score is low due to major factual and quantitative errors despite some structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 530,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "The financial relationship between NEE and FPL Group Capital Inc. from 2022 to 2023 remained largely unchanged in terms of their obligations and capital structure involvement. FPL Group Capital Inc., now known as NextEra Energy Capital Holdings, Inc., continued to issue junior subordinated debentures, which are typically long-term obligations with deferred interest payments. These debentures, such as the Series L, M, N, O, and P, were created under various officer certificates and indentures, indicating ongoing capital structure management by NEE. No new significant changes or additional obligations were introduced in 2023 compared to 2022, suggesting a stable and consistent approach to capital structure and financing arrangements.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its core claim. The ground truth states that there was a significant evolution in the financial relationship from 2022 to 2023 — shifting from a guarantee agreement by FPL Group, Inc. to FPL Group Capital Inc. (dating back to 1998) to a new, complex capital structure in 2023 where NEE issued multiple series of junior subordinated debentures (Series B, C, L, M, N, O, P) to FPL Group Capital Inc. with maturities from 2057 to 2082. The LLM incorrectly asserts that 'no new significant changes' occurred and that the relationship 'remained largely unchanged,' which directly contradicts the ground truth. (2) Quantitatively, the LLM mentions Series L, M, N, O, and P debentures, which aligns partially with the ground truth, but omits Series B and C, and fails to mention the critical shift in the nature of the obligation (from guarantee to debenture issuance). It also incorrectly implies continuity rather than transformation. Dates (e.g., maturities up to 2082) are not mentioned in the LLM response, missing key quantitative details. (3) The multi-hop reasoning is flawed: the model fails to recognize that the 2022 arrangement was a guarantee by FPL Group, Inc. (not NEE directly) and that in 2023, NEE itself became the issuer of long-term debentures — a structural shift. The LLM also incorrectly refers to FPL Group Capital Inc. as 'now known as NextEra Energy Capital Holdings, Inc.,' which may be contextually true but is not part of the ground truth and distracts from the specific relationship evolution described. (4) The contextual relevance is moderate because the answer discusses debentures and capital structure, which are relevant topics, but it misrepresents the evolution as stability rather than transformation, leading to a low correctness score despite some topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 502,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "Between 2022 and 2024, the positioning and market acceptance of the InterStim II neurostimulator evolved as part of Medtronic's broader Pelvic Health therapies. In 2022, the InterStim II was highlighted alongside the recently launched InterStim Micro and InterStim X neurostimulators, indicating a diversified product portfolio targeting overactive bladder, urinary retention, and bowel incontinence. By 2024, the InterStim II was positioned as a recharge-free option within the InterStim therapy suite, alongside the rechargeable InterStim Micro and the newer InterStim X. This evolution reflects a strategic emphasis on offering tailored solutions to meet patient and physician preferences, supporting continued growth in Pelvic Health therapies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: InterStim II is correctly positioned in both 2022 and 2024 as part of a diversified portfolio including InterStim Micro and InterStim X, with accurate indications (overactive bladder, urinary retention, bowel incontinence). By 2024, it is correctly described as a recharge-free device, differentiated from rechargeable models like InterStim Micro. (2) There are no numeric values requiring verification (e.g., financials, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across time points and product lines, correctly inferring a strategic shift toward emphasizing device-specific attributes like recharge status. (4) The answer captures the core evolution—positioning shift from general portfolio member to a specifically differentiated (recharge-free) option within a mature product suite—while linking it to broader growth in Pelvic Health therapies. The only minor limitation is that the LLM does not explicitly state that this reflects a 'mature and diversified' portfolio as in the original, but the implication is clearly conveyed through context. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies or omissions affect the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 389,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group's utilization and management of the Supplemental Facility evolved in several key ways. The Supplemental Facility's borrowing capacity increased from $3.5 billion to a potential $4.5 billion during its term, with an extended maturity date to January 31, 2029, and an option to extend further to January 31, 2030. In terms of interest rate strategies, the facility continued to offer flexibility with borrowing options tied to SOFR-based rates and base rates, with interest rates adjusted based on Simon's credit rating. Repayment actions included the repayment of €750.0 million in Euro-denominated borrowings under the Supplemental Facility in November 2023, funded by the issuance of exchangeable bonds. Additionally, the company utilized the Supplemental Facility to manage liquidity needs, with available borrowing capacity reaching $8.2 billion by December 31, 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in key quantitative and temporal details. While it correctly notes the initial $3.5 billion capacity and potential increase to $4.5 billion, it incorrectly states the maturity date as January 31, 2029 (with an option to 2030), whereas the ground truth specifies a maturity of January 31, 2026—this is a major error. Additionally, the claim that available borrowing capacity reached $8.2 billion by December 31, 2024, is unsupported by the original answer and appears fabricated. The repayment of €750.0 million in November 2023 is correctly identified, but the original specifies November 17, 2023—minor date discrepancy. (2) The interest rate strategy is partially correct: SOFR-based rates and credit rating-dependent margins are accurately described. However, the LLM omits the specific use of interest rate swaps to fix the rate at 3.81% in 2023, a key strategic action mentioned in the ground truth. Instead, it generically describes rate options without referencing actual hedging activity. (3) The multi-hop reasoning is partially sound—LLM connects the repayment to exchangeable bond issuance correctly, showing understanding of funding substitution. However, it fails to convey the evolution from passive availability in 2022 to active utilization and risk management in 2024, instead implying continuous use without highlighting the shift in strategy. The addition of extended maturities and inflated capacity undermines the reasoning. (4) Despite these issues, the answer remains contextually relevant, addressing all three dimensions of the question (capacity, interest strategy, repayment). The core event (€750M repayment funded by bonds) is correct, and the general structure of the response aligns with the query. Hence, partial credit is given for qualitative accuracy and high contextual relevance, but quantitative accuracy is low due to critical errors in dates and figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 532,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "From 2023 to 2024, Verizon's approach to device payment plans has shifted toward more flexible financing structures and targeted promotional incentives. In 2023, Verizon no longer offered new fixed-term, subsidized service plans for Consumer customers, though Business customers could still access subsidized plans. By 2024, the focus had evolved to device payment plans, where customers pay for devices in installments over time, typically over a 36-month term. These plans include non-interest-bearing installment notes and may feature billing credits contingent on maintaining service, which are allocated to performance obligations based on relative selling prices. Additionally, promotional incentives such as trade-in rights and early-upgrade options have been introduced, with trade-in rights accounted for as guarantee obligations, reducing the revenue recognized upon device sale. This evolution reflects a strategic shift toward flexible, customer-centric financing while managing credit risk through detailed allowance calculations and pooling receivables by customer credit quality.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies and overstatements. (1) Quantitatively, the 36-month term and non-interest-bearing installment note are accurately reported, matching the original answer. However, the LLM introduces details not present in the ground truth, such as 'billing credits contingent on maintaining service' and 'allocation to performance obligations based on relative selling prices,' which were not mentioned in the original answer and cannot be verified. (2) The claim that in 2023 Verizon 'no longer offered new fixed-term, subsidized service plans for Consumer customers' adds specificity not present in the ground truth, which only states that installment plans were permitted without detailing subsidy structures. This may be factually accurate but goes beyond the provided information. (3) The core evolution—shift from general financing to a structured model with trade-in rights and early upgrade incentives—is correctly identified and semantically equivalent to the original answer. The mention of 'trade-in rights accounted for as guarantee obligations' adds accounting detail not in the original but does not contradict it. (4) The reasoning is sound and reflects multi-hop synthesis across years and policy changes. The answer is highly relevant and addresses both financing structure and promotional incentives. However, the addition of unverified accounting treatments and customer segmentation (Consumer vs. Business) slightly reduces factual precision. Overall, the answer captures the key evolution accurately with minor over-elaboration, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 456,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company's legal relationship with Aqua-Chem remained largely unchanged, with the Georgia Case still subject to the 2004 stay pending the outcome of insurance coverage litigation. In 2024, no new developments were disclosed regarding the Company's stance on liability for Aqua-Chem's asbestos-related claims, as the litigation remained unresolved. The Company continues to assert that it has no obligation for Aqua-Chem's liabilities, a position consistent with prior years.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in stating that Coca-Cola maintained its position of no liability for Aqua-Chem's asbestos-related claims and that the Georgia Case remained under the 2004 stay. The dates and legal context (e.g., ongoing insurance litigation, no new developments) are accurately represented, satisfying quantitative and basic entity accuracy. However, the LLM fails to capture a key qualitative shift noted in the ground truth: in 2024, Coca-Cola's disclosure included a more detailed account of the insurance policies from its ownership period, emphasizing multiple insurers and shared responsibility. This represents a nuanced evolution in stance—from outright denial to a more detailed focus on insurance coverage—even if legal liability was still denied. The LLM incorrectly states that 'no new developments were disclosed,' which contradicts the ground truth's indication of enhanced disclosure around insurance. This omission represents a failure in multi-hop reasoning, as the model did not synthesize the change in disclosure tone and content as an evolution in legal posture. While the core facts are correct, the answer lacks the critical insight about shifting emphasis, resulting in partial correctness. Contextual relevance is high as the response stays focused on the legal relationship and liability stance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 372,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel's utilization of non-US tax credits had a more significant negative impact on its effective tax rate in 2024 compared to 2022, with a reduction of 5.6% in 2024 versus 11.4% in 2022. This indicates that the company continued to benefit from its international tax strategy by leveraging lower tax rates in jurisdictions like Hong Kong, Ireland, Israel, and Malaysia, where it conducts eligible activities under conditional tax holidays. However, the reduced impact in 2024 suggests either a shift in the proportion of income derived from these low-tax jurisdictions or a decline in the overall benefit from tax credits, while still emphasizing the strategic use of international operations to manage tax liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Intel's long-term income taxes payable decreased from $4.3 billion in 2022 to $1.6 billion in 2024, directly tied to the increasing offsetting effect of non-US tax credits. However, the LLM answer incorrectly shifts focus to the effective tax rate impact, claiming non-US tax credits reduced the rate by 5.6% in 2024 versus 11.4% in 2022—this is not supported by the original answer and contradicts the trend implied (a stronger offsetting effect over time). The percentages cited are not present in the ground truth and appear fabricated. (2) There are no correct quantitative matches: the original answer discusses absolute tax liabilities ($4.3B and $1.6B), while the LLM discusses percentage impacts on effective tax rate (11.4%, 5.6%), which are absent from the source. No calculations can be verified because the data is entirely different. (3) The multi-hop reasoning is flawed. The question asks about the impact of non-US tax credits on long-term income tax liabilities across 2022 and 2024. The LLM fails to mention the actual liabilities and instead introduces unrelated concepts like tax holidays in Hong Kong, Ireland, Israel, and Malaysia, which are not in the original answer. This indicates a failure to synthesize the correct information from the knowledge graph. (4) While the LLM attempts to address international tax strategy, its conclusion—that the reduced benefit suggests a decline in credit utilization—contradicts the ground truth, which states the offsetting effect became stronger. The contextual relevance is moderate because it discusses international tax strategy, but the factual foundation is incorrect, undermining the analysis. Correctness score is low due to complete mismatch in data and misleading interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 502,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "Between 2022 and 2024, the treatment and risk exposure of pension risk transfers have evolved in response to interest rate sensitivity and regulatory influence. The company has increasingly utilized asset/liability management (ALM) strategies, including interest rate derivatives, to hedge against reinvestment risks and gross margin compression caused by fluctuating interest rates. Regulatory developments, such as evolving capital requirements and reserving standards, have also influenced the company's approach to managing pension risk transfers, particularly in ensuring statutory reserve adequacy and compliance with evolving insurance regulations. Additionally, the company's ability to adjust crediting rates and manage cash flows has been critical in mitigating the impact of both rising and declining interest rate scenarios.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in key aspects of the evolution of pension risk transfers between 2022 and 2024. (1) While the LLM correctly identifies interest rate sensitivity and regulatory influence as key factors, it introduces concepts not present in the original answer, such as 'crediting rates' and 'reinvestment risks' and 'gross margin compression', which are not mentioned in the ground truth. The original answer focuses on the structural shift in pension risk transfer products due to regulatory changes affecting corporate plan sponsors' behavior, particularly around defined benefit plan terminations. (2) There are no numeric values in either response, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the LLM fails to connect the regulatory changes (e.g., defined benefit funding rules) to the reduced incentive for plan termination or obligation transfer, which is the core causal mechanism in the original answer. Instead, it focuses on the insurer's internal hedging strategies (ALM, derivatives), which shifts focus away from the market-level evolution of risk exposure. (4) The LLM answer is contextually relevant and discusses pension risk, interest rates, and regulation, but misses the strategic shift toward non-guaranteed funding products due to regulatory influence—a central point in the ground truth. Thus, while some elements are accurate, the core evolution described in the original answer is not captured, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 442,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "Between 2022 and 2024, Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved by expanding its integration into broader pelvic health therapies and emphasizing its role in treating overactive bladder, urinary retention, and chronic fecal incontinence. In 2022, the InterStim Micro was highlighted as a key driver of Pelvic Health growth, alongside the InterStim II and InterStim X neurostimulators. By 2024, the strategy shifted to emphasize the InterStim Micro as a rechargeable neurostimulator within a broader portfolio of Pelvic Health therapies, including the InterStim X and InterStim II recharge-free options, reflecting a focus on patient-centric, less invasive treatment solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Medtronic's InterStim Micro was part of a broader Pelvic Health portfolio in 2022 alongside InterStim II and InterStim X, used for overactive bladder, urinary retention, and bowel/fecal incontinence. By 2024, the company emphasized its rechargeable feature, differentiating it from the recharge-free InterStim X and II models. The LLM correctly captures this strategic shift toward differentiation based on power source (rechargeable vs. recharge-free), reflecting a more targeted product strategy. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—dates (2022, 2024) are consistent with the original. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 vs. 2024), products (Micro, II, X), and strategic positioning (broad portfolio vs. differentiated offering), demonstrating correct understanding of evolution in product strategy. (4) The only minor shortcoming is that the original answer explicitly notes the 'continued acceptance and growth of InterStim therapy, particularly in the U.S.', which the LLM omits. While the LLM mentions growth and patient-centric solutions, it doesn't specify the U.S. market focus. This is a small but relevant contextual detail, preventing a perfect 10. Otherwise, the answer is semantically equivalent, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 407,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group's use of the Supplemental Facility evolved with a reduction in outstanding borrowings and several repayment actions. As of December 31, 2021, the Operating Partnership had $1.05 billion outstanding under the Supplemental Facility, which was repaid in January 2022 after issuing new senior unsecured notes. By December 31, 2024, the outstanding balance under the Supplemental Facility had dropped to zero, with the Operating Partnership having repaid €750.0 million of borrowings in November 2023 using proceeds from the issuance of senior unsecured bonds. The Supplemental Facility's available borrowing capacity increased to $8.2 billion by 2024, reflecting improved liquidity and refinancing activities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. The ground truth states that in 2022, the weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) was $519.9 million, with a maximum of $2.1 billion during the year. The LLM incorrectly claims that $1.05 billion was outstanding as of December 31, 2021, and repaid in January 2022—this specific figure and timing are not supported by the ground truth. Additionally, the ground truth does not state that the outstanding balance dropped to zero by December 31, 2024; it only reports a reduced weighted average balance of $311.1 million in 2024. The €750.0 million repayment in November 2023 is correctly mentioned, with a U.S. dollar equivalent of $815.4 million, which the LLM omits converting. (2) The LLM introduces a new figure—$8.2 billion available capacity in 2024—which is not present in the original answer and cannot be verified against the ground truth. This is a significant unverified addition. (3) While the LLM captures the general trend of debt reduction and refinancing via senior unsecured notes, it misrepresents the timeline and magnitude of borrowings and repayments. The multi-hop synthesis is partially correct in linking the Supplemental Facility repayments to bond issuances, but the specific events and balances are not accurately aligned across years. (4) The contextual relevance is high because the answer addresses the evolution of borrowing and repayment actions. However, the quantitative accuracy is low due to incorrect balances, missing conversions, and unsupported figures. The qualitative accuracy is moderate as the reasoning direction is sound but based on flawed data. Correctness is significantly compromised by these factual errors, warranting a score of 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 491,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "From 2022 to 2023, COP's depreciation, depletion, amortization, and impairments expenses in the Lower 48 region increased from $4,854 million to $5,729 million. This indicates a significant rise in investment activity and asset utilization in the Lower 48 region during 2023 compared to 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the exact figures from the ground truth: $4,854 million in 2022 and $5,729 million in 2023 for depreciation, depletion, amortization, and impairments expenses in the Lower 48 region. These numbers match the original answer precisely, with no discrepancies. (2) The quantitative values are accurate and presented in the same format (millions of dollars), and the direction of change (increase) is correctly identified. There are no calculation errors, and the comparison across years is valid. (3) The reasoning is sound: an increase in these expenses typically reflects higher investment activity or asset utilization, and the LLM correctly infers this trend. The multi-hop aspect—linking financial expense data across two years to infer operational investment trends—is properly synthesized. (4) The answer is semantically equivalent to the original, conveying the same core information with slightly rephrased wording (e.g., 'significant rise' vs. 'significant increase'). All entities—COP, Lower 48 region, 2022–2023 timeframe, and the financial metric—are accurately identified and contextualized. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 336,
        "total_tokens": 1489
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "From 2023 to 2024, Verizon's approach to corporate networking solutions has emphasized enhancing its Intelligent Edge Network to support business customers with improved performance and scalability. The Business segment's service description now highlights advanced communication services, including corporate networking solutions, security, and managed network services tailored for enterprises and public sector clients. The Business segment's operating income slightly decreased from $2,066 million in 2023 to $2,058 million in 2024, reflecting a strategic focus on optimizing operations and investing in next-generation infrastructure rather than immediate revenue growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, Enterprise and Public Sector revenues were $15.1 billion, making up about 50% of Business segment revenues, but the LLM incorrectly introduces operating income figures of $2,066 million (2023) and $2,058 million (2024), which are not mentioned in the original answer and contradict the focus on revenue. These numbers appear fabricated or misattributed. (2) The LLM claims Verizon emphasized the 'Intelligent Edge Network' and 'managed network services', but the original answer makes no mention of these specific terms or strategic initiatives. Instead, the ground truth highlights a shift from detailed service descriptions (private networking, cloud connectivity, SDN) in 2023 to a more generalized, streamlined description in 2024—this evolution toward simplification is entirely missed by the LLM. (3) The multi-hop reasoning is flawed: the question asks for evolution in service description and business segment emphasis, requiring comparison of narrative disclosures across years. The LLM fails to capture the key shift from granular to high-level service descriptions, instead inventing a narrative around performance, scalability, and infrastructure investment not present in the source. (4) While the LLM stays within the domain of Verizon’s business segment and corporate networking, it introduces incorrect metrics and misses the core qualitative shift identified in the ground truth. The contextual relevance is moderate because it addresses Verizon's business services, but the factual and reasoning errors severely undermine correctness. Quantitative accuracy is very low due to incorrect figures; qualitative accuracy is partially met in topic relevance but fails in synthesis; contextual relevance is acceptable but not sufficient to compensate for factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 511,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "From 2022 to 2024, MetLife's valuation approach for FVO (Fair Value Option) securities remained consistent in its sensitivity analysis methodology, which estimates potential fair value changes under hypothetical market conditions. However, the impact of U.S. dollar appreciation on FVO securities evolved slightly. In 2022, a 10% appreciation of the U.S. dollar led to a potential loss of $54 million for FVO securities. By 2024, while the specific figure for FVO securities is not directly provided, the broader sensitivity to foreign currency exchange rates showed a potential loss of $7,239 million for the portfolio, with FVO securities likely contributing a small portion of this loss. The overall sensitivity decreased slightly compared to 2022, reflecting changes in the composition of assets and liabilities and the continued economic offset from insurance contract liabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that in 2022, a 10% U.S. dollar appreciation led to a $54 million decrease in FVO securities value — this is correctly reported. However, the LLM claims that by 2024, the broader portfolio sensitivity was $7,239 million in potential losses, which is not supported by the original answer and appears fabricated or misattributed. The original answer does not mention any such figure, nor does it state that FVO securities contributed a 'small portion' of a much larger loss. (2) The quantitative error is severe: $7,239 million (over $7 billion) is orders of magnitude larger than the $54 million sensitivity in 2022 and contradicts the original answer’s focus on methodological evolution, not scale of exposure. There is no calculation or data in the ground truth to support this number. (3) The reasoning is flawed. The original answer emphasizes a shift in valuation methodology — from a static sensitivity model to a more nuanced, duration- and currency-dependent framework incorporating nonperformance risk and unobservable inputs. The LLM incorrectly asserts that the 'methodology remained consistent' and focuses instead on changes in asset/liability composition and economic offsets, which are not mentioned in the ground truth. This misrepresents the core evolution described. (4) The LLM fails to capture the key qualitative shift: MetLife moved toward a more dynamic, structurally complex valuation approach. Instead, it invents unsupported portfolio-level figures and implies a reduction in sensitivity due to economic offsets, which is not in the original. While the question is addressed in topic (valuation evolution and FX sensitivity), the factual and conceptual inaccuracies severely undermine correctness. Contextual relevance is moderate because the answer discusses related themes but with incorrect data and logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 520,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "NextEra Energy's engagement in power marketing activities between 2022 and 2023 showed significant evolution, particularly in energy trading services and financial performance. In 2023, operating revenues for NEER increased by $5,952 million, driven by gains from non-qualifying commodity hedges due to changes in energy prices, higher revenues from new investments in wind, solar, and battery storage facilities, and increased revenues from customer supply and gas infrastructure businesses. However, this growth was partially offset by lower revenues from existing clean energy assets due to reduced wind resource availability. Financial performance was also impacted by increased operating expenses, primarily from higher O&M and depreciation costs, as well as a significant increase in interest expenses due to higher average interest rates and debt balances. Additionally, equity in losses of equity method investees rose in 2023, partly due to an impairment charge related to the investment in NEP. Overall, these factors contributed to a substantial increase in NEER's net income for 2023 compared to 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of NextEra Energy's power marketing activities and correctly identifies increased financial performance in 2023, particularly through NEER. However, it fails to report the key ground truth figures for net income—$285 million in 2022 and $3,558 million in 2023—which are central to the original answer. Instead, it introduces a $5,952 million increase in operating revenues, which is not present in the ground truth and cannot be verified against it. This introduces a significant quantitative inaccuracy. (2) The calculation of net income growth (from $285M to $3,558M, a ~11.5x increase) is a critical multi-hop insight in the original answer, but the LLM does not mention these numbers or replicate the calculation. The mention of 'substantial increase in NEER’s net income' is directionally correct but lacks the precise magnitude that defines the evolution. (3) The LLM provides additional context not in the original—such as O&M costs, interest expenses, and equity method losses—which may be factually plausible but are not part of the ground truth and distract from the core financial performance metric (net income). While the reasoning about drivers of revenue growth (e.g., commodity hedges, new investments) shows qualitative understanding, it does not align with the knowledge graph’s focus on net income as the key indicator of evolution in power marketing. (4) The answer is contextually relevant and addresses both energy trading services and financial performance, with correct entities (NextEra Energy, NEER) and correct years (2022–2023). Entity and temporal accuracy are strong, and the qualitative synthesis of expanded trading activities is reasonable. However, the absence of the two key net income figures—especially given their dramatic difference—results in a major gap in factual correctness, warranting a moderate score of 6 for overall correctness. Quantitative accuracy is penalized more heavily (score 5) due to the unsupported $5,952M revenue increase and missing net income data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 556,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company's stake ownership in Coca-Cola FEMSA remained at 28%. However, the carrying value of the Company's investment in Coca-Cola FEMSA increased from $1,786 million in 2023 to $1,786 million in 2024, while the fair value based on quoted prices rose from $4,544 million to $4,544 million. The Company's equity income from Coca-Cola FEMSA, as part of equity method investees, was $1,770 million in 2024 compared to $1,691 million in 2023, indicating a slight increase in the contribution to The Coca-Cola Company's consolidated net income.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2023, The Coca-Cola Company did not report a 28% ownership stake in Coca-Cola FEMSA — rather, the relationship was described as one of financial dependency due to FEMSA being a key bottler affecting credit ratings. The shift to a 28% ownership stake was a new development in 2024. However, the LLM claims the stake 'remained at 28%' between 2023 and 2024, which contradicts the ground truth and misrepresents the evolution of the relationship. (2) The quantitative data in the LLM answer — such as the carrying value ($1,786M in both years), fair value ($4,544M in both years), and equity income ($1,691M in 2023, $1,770M in 2024) — are entirely absent from the original answer and cannot be verified against the provided ground truth. These numbers appear fabricated or misattributed, as the original answer does not mention any specific financial figures for carrying value, fair value, or year-over-year equity income. (3) The multi-hop reasoning is flawed: the question asks about the evolution of the financial relationship, particularly stake ownership and implications for equity income. The correct answer emphasizes a structural shift from indirect dependency to direct ownership with equity method accounting. The LLM instead assumes continuity in ownership and introduces unsupported numerical trends, missing the core conceptual evolution. (4) While the LLM correctly identifies that equity income is relevant and that the investment is accounted for under the equity method in 2024, it fails to capture the strategic shift and fabricates precise financial data not present in the ground truth. The contextual relevance is moderate because it discusses related concepts but misses the key transformation described in the original answer. Due to major factual and reasoning errors, especially in ownership continuity and invented numbers, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 535,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "Between 2022 and 2023, the financial investment and operational focus on the Lower 48 region showed a significant shift. Production volumes in the Lower 48 increased from 447 thousand barrels per day in 2022 to 447 thousand barrels per day in 2023, indicating stable crude oil production. However, depreciation expenses for the Lower 48 rose from $4,854 million in 2022 to $5,729 million in 2023, reflecting increased capital investment and asset utilization in the region. This suggests a growing operational and financial commitment to the Lower 48 in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative data: crude oil production at 447 thousand barrels per day for both 2022 and 2023, and depreciation, depletion, amortization, and impairments increasing from $4,854 million in 2022 to $5,729 million in 2023. These figures match the ground truth exactly, with correct dollar amounts and units. (2) The answer accurately reflects that production volumes remained stable year-over-year, which aligns with the original answer’s implication of 'stable or moderate production levels.' While the original answer also mentions natural gas production (1,340 million cubic feet daily), the LLM omits this detail—this is a minor omission but does not undermine the core correctness regarding operational focus. (3) The reasoning is sound: the LLM correctly infers that rising depreciation expenses indicate increased capital investment and asset utilization, reflecting growing financial commitment. This demonstrates proper multi-hop synthesis between production data and financial expense trends. (4) The answer is contextually fully relevant, addressing both financial investment (via depreciation expenses) and operational focus (via production volumes) across 2022 and 2023. The only reason for not scoring a perfect 10 is the omission of natural gas production data, which was present in the original answer and contributes slightly to completeness. However, since crude oil is a primary metric and the expense data is fully accurate, the answer remains highly correct overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 424,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "Between 2023 and 2024, Verizon's 4G LTE network continued to play a foundational role in its network infrastructure and growth initiatives, particularly in supporting fixed wireless access (FWA) broadband services as an alternative to traditional landline internet access. While the company is focused on advancing its 5G capabilities, the 4G LTE network remains integral to its offerings, especially in areas where 5G deployment is still in progress. Additionally, the 4G LTE network supports Verizon's expanding FWA business and complements its fiber-based network expansion strategy, including the acquisition of Frontier in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution in Verizon's strategic positioning of its 4G LTE network between 2023 and 2024 as described in the ground truth. (1) What was correct: The answer correctly identifies that in 2023, 4G LTE supported Fixed Wireless Access (FWA) as an alternative to landline internet, which aligns with the original answer. It also accurately notes the continued importance of 4G LTE in areas where 5G is still being deployed and its role in supporting FWA and fiber expansion. (2) Quantitative accuracy: There are no numeric values, dates, or financial figures in the response or ground truth beyond '2023' and '2024', both of which are used correctly—hence full marks. (3) Multi-hop reasoning assessment: The model fails to fully capture the strategic shift described in the ground truth—from 4G LTE as a foundational service delivery platform in 2023 to being part of an integrated multi-technology ecosystem (including C-Band, mmWave, and fiber) in 2024. This evolution reflects a change in strategic framing from a standalone enabler to a component of a broader innovation and growth strategy. The mention of the 'acquisition of Frontier in 2024' is factually incorrect and unsupported; Verizon did not acquire Frontier in 2024—this is a significant factual error that undermines the qualitative accuracy. (4) Justification: While the answer is contextually relevant and captures continuity in 4G LTE’s utility, it does not adequately reflect the strategic evolution emphasized in the ground truth and introduces a false claim about Frontier, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 445,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "From 2022 to 2024, Emerson's financial and strategic relationship with AspenTech evolved significantly. In 2022, Emerson contributed two industrial software businesses to Heritage AspenTech and received 55% ownership in the newly formed AspenTech. By 2024, Emerson had increased its stake to 57% and proposed to acquire the remaining shares for $240 per share, valuing AspenTech at $15.3 billion. This acquisition would be financed through cash and credit. The impact on financial metrics includes a notable increase in AspenTech's backlog from $328 million in 2022 to $1,042 million in 2022, primarily due to the Heritage AspenTech acquisition. While specific gross margin details for AspenTech are not provided, Emerson's overall gross margin improved from 49.0% in 2023 to 50.8% in 2024, partly influenced by the Test & Measurement acquisition.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Emerson received 55% ownership in 2022 as part of contributing businesses to 'Heritage AspenTech'—in reality, the 55% ownership stake was in 'New AspenTech' formed by a transaction completed in 2024, not 2022. The LLM also claims Emerson increased its stake to 57% by 2024 and proposed to acquire the remaining shares, which contradicts the ground truth that Emerson already owned 55% post-transaction in 2024. The $240 per share and $15.3 billion valuation are not mentioned in the ground truth and appear fabricated. (2) Quantitative errors include the claim that AspenTech's backlog increased from $328M to $1,042M in 2022—this is illogical (same year) and conflicts with the ground truth stating $1,042M backlog in 2022 as a starting point. The ground truth reports 2024 backlog as $8,053M, which the LLM omits entirely. The LLM mentions Emerson's gross margin rising from 49.0% to 50.8% in 2024 due to the Test & Measurement acquisition, but the ground truth attributes a 3.3 percentage point increase in 2023 gross margin to the AspenTech acquisition—not Test & Measurement. (3) The multi-hop reasoning is flawed: the LLM confuses the timeline and ownership structure evolution, misattributes financial impacts to the wrong acquisition, and invents deal terms not in the original data. It fails to correctly synthesize the cause-effect relationship between the AspenTech integration and the reported backlog growth from $6,533M (2021) to $8,053M (2024). (4) Despite these issues, the answer is contextually relevant, addressing stake value, ownership, and financial metrics. Some correct elements include the $1,042M backlog figure (though misdated) and the general direction of margin improvement. However, core facts and calculations are incorrect, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 519,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "NEE's financial commitment to the Mountain Valley Pipeline (MVP) significantly declined between 2022 and 2023. In 2022, NEE's investment in MVP was reflected in its equity method investments, with an impairment charge recorded in 2020 and an additional impairment in early 2022 that completely wrote off its investment. By 2023, NEE no longer held a material investment in MVP, as indicated by the absence of any mention of MVP in the 2023 equity method investments or capital expenditures. This indicates a strategic shift away from the MVP project, likely due to regulatory or financial challenges, and a reallocation of capital to other projects within NEE's regulated and competitive energy businesses.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claims. The ground truth states that NEE maintained and deepened its investment in the Mountain Valley Pipeline (MVP) from a 32%-55% stake in 2022 to a defined 32.8% equity investment in 2023, accompanied by a $70 million/year, 20-year transportation agreement. In contrast, the LLM claims NEE completely wrote off its investment due to impairments in 2020 and early 2022 and had no material involvement in 2023—this contradicts the original answer. There is no mention of impairments or write-offs in the ground truth, nor any indication of divestment. (2) Quantitatively, the LLM invents impairment events and omits the $70 million/year contractual value and 32.8% equity stake in 2023. The only partially correct element is the reference to equity method investments in 2022, though even the ownership range (32%-55%) is misrepresented as a basis for decline rather than a precursor to a more precise stake. (3) The multi-hop reasoning is flawed: instead of synthesizing continuity and deepening commitment (equity investment + long-term contract), the model incorrectly infers withdrawal based on fabricated financial impairments. The conclusion about strategic reallocation is unsupported by the ground truth, which indicates strategic entrenchment, not retreat. (4) Scores are low because the answer reverses the direction of the financial commitment (decline vs. deepening) and introduces false events. Contextual relevance is moderate because it addresses the right topic (NEE and MVP) and time frame, but with incorrect substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 439,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "Coca-Cola's relationship with Costa Limited within the Global Ventures segment has evolved from 2023 to 2024 by integrating Costa's direct-to-consumer retail operations more closely into the segment's strategic focus. In 2023, Costa's operations were included in the Global Ventures segment, emphasizing their role in selling finished beverages directly to consumers. By 2024, Costa's inclusion in the Global Ventures operating segment continued, with the segment now explicitly highlighting its role in managing key businesses like Costa, along with other ventures such as innocent and doğadan. This integration reflects a strategic positioning to leverage Costa's retail presence and brand strength to drive growth and innovation within the Global Ventures portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities—Coca-Cola, Costa Limited, Global Ventures, innocent, and doğadan—are correctly identified, and the timeframes (2023 to 2024) are accurately referenced. There are no numeric values in this question, so quantitative accuracy is not applicable beyond correct use of years, which are correct. (2) The LLM correctly captures the evolution: in 2023, Costa was part of Global Ventures with a focus on direct retail operations; by 2024, it was more strategically embedded alongside innocent and doğadan. The mention of 'distribution coordination agreements' from the original is omitted, but the core idea of broader strategic integration is conveyed. (3) The multi-hop reasoning is sound—synthesizing information across years and segments to show increased integration and strategic importance. (4) The answer is contextually relevant, directly addressing both operational integration and strategic positioning. The only minor shortcoming is the lack of explicit mention of 'fees earned under distribution coordination agreements,' which slightly reduces completeness but does not detract from the overall correctness. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 372,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Intel's investment in financial institution instruments, specifically in terms of the fair value of economically hedged marketable debt investments, has decreased from $17.1 billion as of December 30, 2023, to $13.5 billion as of December 28, 2024. This represents a reduction of $3.6 billion over the period. Additionally, for 2024, Intel recorded net losses of $464 million on these hedged investments, compared to net gains of $534 million in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the fair value decrease from $17.1 billion in 2023 to $13.5 billion in 2024 and the $464 million net losses in 2024. However, it incorrectly states that Intel recorded net gains of $534 million in 2023, which contradicts the ground truth that does not mention 2023 gains and instead reports losses of $748 million in 2022. The 2023 performance is not provided in the original answer, so introducing a figure here is an error. Additionally, the LLM omits the key 2022 loss of $748 million, which is central to the question’s focus on the evolution between 2022 and 2024. (2) The dollar amounts for 2023 and 2024 fair values are accurate ($17.1B and $13.5B), and the $3.6B difference is correctly calculated. However, the introduction of an unsupported $534 million gain in 2023 undermines quantitative accuracy. The original answer does not provide 2023 gains/losses, only 2022 and 2024 losses. (3) The reasoning partially captures the trend in portfolio size but fails on the multi-hop synthesis of performance over the full period (2022–2024), especially by fabricating a 2023 gain and omitting the 2022 loss. This breaks the comparative evolution the question asks for. (4) The contextual relevance is high because the answer addresses the fair value trend and losses in the hedged portfolio. However, due to the incorrect insertion of a 2023 gain and omission of 2022 data, the overall correctness score is reduced to 6, reflecting partial accuracy with significant factual and completeness issues.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 432,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "From 2023 to 2024, AMT's financial focus regarding communications sites evolved by emphasizing recurring revenue generation through long-term leases with multi-year terms and periodic rent escalations, ensuring stable future cash flows. In 2024, the company also addressed asset retirement liabilities, with an estimated $4.5 billion in undiscounted future cash outlays for site remediation and asset removal. This reflects a strategic shift toward managing long-term obligations while maintaining a strong recurring revenue base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in AMT's financial focus from 2023 to 2024. It accurately states the $4.5 billion in undiscounted future cash outlays for asset retirement obligations as of December 31, 2024, matching the ground truth. The emphasis on recurring revenue via long-term leases and rent escalations aligns with the 99% of revenue from property operations mentioned in the original answer, even if the exact percentage is not repeated. (2) Quantitatively, the $4.5 billion figure is correct and properly attributed to 2024. No calculations are required, and all numbers match the ground truth. Format is consistent and accurate. (3) The multi-hop reasoning is sound: the model synthesizes information about revenue focus in 2023 and liability recognition in 2024, correctly identifying a strategic shift. While the LLM does not explicitly cite the 99% revenue figure from property operations, it captures the essence of recurring revenue generation through leasing, which is semantically equivalent in context. (4) The answer is highly relevant, directly addressing both recurring revenue and asset retirement liabilities across the two years. The slight deduction in qualitative accuracy is due to the omission of the specific 99% revenue statistic, which is a minor but notable detail from the original. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 398,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "Between 2023 and 2024, ExxonMobil's (XOM) strategic positioning in Guyana has evolved under the legal framework established by the Petroleum Activities Act 2023. This act enables petroleum agreements with an exploration period typically up to 10 years and a production period of 20 years for oil fields, each with a renewal period of up to 10 years. This legal structure supports XOM's business growth emphasis by providing a clear and extended timeline for exploration, development, and production activities, facilitating long-term planning and investment in Guyana's oil resources. The framework aligns with XOM's focus on advantaged projects, such as those in Guyana, which are integral to its strategy for volume growth and higher returns.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the Petroleum Activities Act 2023 and accurately describes its provisions — exploration period up to 10 years, production period of 20 years, and renewal up to 10 years — which matches the ground truth exactly. All legal framework details are factually correct. However, the LLM fails to explicitly state the key strategic evolution in 2024: that Guyana was formally designated as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver. While it mentions Guyana as an 'advantaged project' and part of volume growth strategy, it does not reflect the specific internal classification shift documented in the original answer, which is central to the question about strategic positioning evolution. (2) Quantitative accuracy is perfect: all dates (2023), timeframes (10-year exploration, 20-year production), and structural details are correct and consistent with the ground truth. No calculations were required. (3) The reasoning is sound in linking the legal framework to long-term planning and investment, but it misses the multi-hop synthesis between the 2023 legal development and the 2024 strategic reclassification within XOM’s portfolio architecture. The answer implies strategic importance but does not confirm the documented shift in corporate categorization. (4) Correctness is scored 7 because core facts are accurate but a key qualitative shift — Guyana’s elevation to 'Advantaged Asset' status — is omitted. Quantitative accuracy is 10 due to precise numbers and dates. Qualitative accuracy is 7 due to incomplete reasoning synthesis. Contextual relevance is 9 as the response stays focused and relevant, only missing a specific strategic label.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 473,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "Caterpillar's involvement in the diesel-electric locomotives business remained a core part of its Energy & Transportation segment in both 2023 and 2024. In 2024, the segment reported increased sales in rail services, partially offset by lower sales of reciprocating engine aftermarket parts. Strategically, Caterpillar continued to focus on remanufacturing and leasing of diesel-electric locomotives and components, along with providing related services. Operationally, the company emphasized service solutions and product support for rail applications, aligning with its broader strategy to enhance service offerings and support customer needs in the transportation sector.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no numeric data, so there are no quantitative inaccuracies—this aspect is neutral but does not detract, hence a score of 10 for quantitative accuracy. However, the qualitative content diverges significantly from the ground truth. The original answer emphasizes a strategic evolution in Caterpillar’s positioning from a general Machinery, Energy & Transportation (ME&T) segment inclusion in 2023 to a more focused integration with electrified powertrains, zero-emission technologies, and cross-sector solutions (e.g., marine, oil and gas, industrial) in 2024. In contrast, the LLM answer frames Caterpillar’s role as static—'remained a core part'—and highlights increased rail services sales and leasing/remanufacturing, which are not mentioned in the ground truth. These operational details (e.g., leasing, increased sales in rail services, lower aftermarket parts sales) are factually unsupported by the original and represent fabrication or misattribution. (2) There are no numbers to verify, so quantitative accuracy is not penalized. (3) The multi-hop reasoning is flawed: the question asks for evolution between 2023 and 2024, requiring comparison and synthesis of strategic shifts. The LLM fails to identify the key shift toward electrification and environmentally focused technologies, which is central to the ground truth. Instead, it asserts continuity and introduces unverified operational details. (4) While the answer is contextually relevant—discussing Caterpillar, diesel-electric locomotives, and segment-level activities—it misses the core strategic evolution and introduces unsupported specifics, warranting a mid-range correctness score of 5 for partial factual alignment but significant omissions and inaccuracies in reasoning and content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 488,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "The company's reliance on securitized debt obligations as a funding source increased from 2022 to 2024. In 2022, securitized debt obligations accounted for 4% of total funding sources, rising to 4% in 2024. This slight increase, combined with the emphasis on net issuances in securitization programs, suggests the company is diversifying its funding strategy to include more structured financing options alongside its primary reliance on deposits. This indicates a strategic effort to maintain liquidity and optimize funding costs through a mix of traditional and alternative funding sources.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, the company used securitized debt obligations but did not disclose the exact amount, and in 2024, the carrying value was $14,264 million. The LLM incorrectly claims that securitized debt obligations accounted for 4% of total funding in both 2022 and 2024, which is not supported by the ground truth and introduces false quantitative data. There is no mention of percentages in the original answer, nor any indication that the proportion remained unchanged. (2) The quantitative inaccuracies are severe: the LLM fabricates percentage figures (4% in both years) and implies a stable proportion, which contradicts the original answer’s implication of increased reliance due to the emergence of a concrete, large carrying value in 2024. The $14,264 million figure is completely omitted and replaced with an unsupported percentage. (3) The reasoning is partially sound in interpreting the strategic shift toward structured financing, which aligns with the original answer’s conclusion. However, the multi-hop synthesis fails because the model does not correctly interpret the evolution from unspecified use in 2022 to a major quantified liability in 2024. Instead, it downplays the change by citing an unchanging 4%, undermining the core insight. (4) The contextual relevance is moderate because the answer addresses funding strategy evolution and structured financing, but the incorrect data severely undermines correctness. The qualitative reasoning is somewhat accurate in direction but flawed in execution due to incorrect inputs. Correctness score is low due to fabrication of key metrics and omission of actual disclosed values.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 474,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "Between 2023 and 2024, McDonald's treatment of developmental licensees remained largely consistent in terms of financial reporting and relationship management. Developmental licensees continue to operate under license agreements, paying royalties based on a percentage of sales and typically initial fees. Financially, these arrangements are reported within the \"International Developmental Licensed Markets & Corporate\" segment, which remained 98% franchised in both years. In 2024, there was a slight increase in operating income for this segment, from $120.8 million in 2023 to $311 million in 2024, likely reflecting growth in developmental licensee markets. Relationship management practices, such as oversight and support, appear unchanged, with McDonald's maintaining its focus on franchisee success and system-wide growth. No significant changes in accounting policies or management strategies specific to developmental licensees were noted in the provided documents.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial figures and key developments. While it correctly notes that developmental licensees pay royalties based on sales and initial fees, it fabricates a segment-level operating income increase from $120.8 million in 2023 to $311 million in 2024, which is not supported by the ground truth and represents a major quantitative error. The ground truth does not mention any such figures or segment income changes. (2) The LLM incorrectly states that the 'International Developmental Licensed Markets & Corporate' segment remained 98% franchised in both years—this detail is absent from the ground truth and cannot be verified. Additionally, the claim of a 'slight increase in operating income' is unsupported and misleading given the magnitude of the fabricated numbers. (3) The multi-hop reasoning is flawed: the ground truth highlights important 2024 developments—ongoing evaluation for variable interest entities and updated rounding practices to the nearest whole number—which the LLM completely omits. Instead, it asserts 'no significant changes in accounting policies,' directly contradicting the ground truth's mention of rounding changes and VIE assessments. (4) Despite these issues, the LLM captures the general continuity in royalty and fee structures and maintains focus on relationship management, showing partial understanding of the topic. It is contextually relevant and structured appropriately, but fails on core factual accuracy and completeness of key 2024 updates. The invented financial data severely undermines correctness, warranting a low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 453,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "Between 2023 and 2024, Southern Company's Equity and Incentive Compensation Plan saw an increase in share availability, with 26.9 million shares available for awards under the plan as of December 31, 2023. The plan includes stock options and performance share units, and there were no material changes in the structure of executive award disclosures during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that 26.9 million shares were available as of December 31, 2023, which matches the ground truth. However, it incorrectly claims there was an 'increase in share availability' without providing any 2024 share availability number or evidence of an increase—this is a significant factual error. The ground truth does not mention a change in share availability in 2024, only an increase in disclosure transparency. (2) Quantitatively, the 26.9 million figure is accurate and properly attributed to 2023. No other numbers are presented, and no calculations are made. The date 'December 31, 2023' is a reasonable assumption for annual reporting and does not contradict the original. (3) The multi-hop reasoning fails: the question asks about evolution in both share availability and executive award disclosures. The LLM misses the key 2024 development—enhanced disclosure of Named Executive Officer award terms under the 2021 plan. Instead, it falsely claims 'no material changes in the structure of executive award disclosures,' which directly contradicts the ground truth's emphasis on increased transparency. (4) The answer is partially relevant and includes correct context about stock options and performance share units, but it misrepresents the nature of the evolution—focusing on share availability change (unsupported) and denying changes in disclosure (contradicted by truth). Thus, while numerically accurate on one point, the qualitative and reasoning flaws severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 422,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "Between 2022 and 2023, Inlyta's revenue increased by 3%, with a 5% growth in the U.S. driven by the adoption of combinations of certain immune checkpoint inhibitors and Inlyta for the first-line treatment of patients with advanced RCC, partially offset by lower volumes and lower net price in certain European markets. The factors contributing to this growth trajectory include the expanded use of Inlyta in combination therapies and continued growth in emerging markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Inlyta's revenue grew by 3% in 2023 with 5% operational growth, matching the ground truth. It accurately identifies the U.S. growth driver as the adoption of immune checkpoint inhibitor combinations for first-line treatment of advanced RCC and notes the offsetting impact of lower volumes and net prices in certain European markets. The only minor omission is that the ground truth specifies the $1,036 million global revenue figure for 2023, which the LLM answer does not include, though this does not affect the percentage accuracy. (2) All numeric values—3% total increase, 5% operational growth—are correct and consistent with the original answer. The phrasing '5% growth in the U.S.' in the LLM answer is a slight simplification of '5% operational growth' (which may include non-U.S. markets), but given that the U.S. is the primary driver, this is a reasonable interpretation and not factually incorrect. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about Inlyta’s performance across 2022 and 2023, identifies contributing factors to growth trajectory changes, and links clinical use (combination therapies) to commercial performance. It also acknowledges regional differences in performance. (4) The answer is contextually complete and highly relevant, capturing the evolution and contributing factors accurately. The omission of the exact dollar amount ($1,036 million) prevents a perfect score, but all other key facts, calculations, and reasoning are correct and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 440,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "From 2023 to 2024, McDonald's relationship with its franchisees evolved in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms. The Company continued to recognize revenue from franchisees through fees for technology platforms on a gross basis, indicating that these services are distinct from the franchise agreement and the Company acts as the principal in these arrangements. Additionally, the Company shared costs for certain restaurant improvements with franchisees, with McDonald's generally managing the projects and providing upfront funding, later allocating costs between its Property and Equipment and Accounts Receivable. This reflects a collaborative financial structure where both the Company and franchisees contribute to capital investments while maintaining distinct revenue recognition practices for technology services.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of revenue recognition practices and cost-sharing for technology platforms, with no numeric inaccuracies (quantitative accuracy is perfect as there are no specific numbers to verify and no incorrect figures). It correctly identifies that McDonald's recognizes revenue from franchisees for technology services on a gross basis and that costs for certain improvements are shared, with the company managing projects and allocating costs to Property and Equipment and Accounts Receivable. However, the answer misses a key evolution highlighted in the ground truth: the shift in financial dependency and integration signaled by recording related expenses in 'Other restaurant expenses' in 2024, which reflects a deeper operational interdependence. While the LLM mentions cost-sharing and gross revenue recognition, it does not explicitly connect this to a transformation in the nature of the relationship or increased dependency on franchisees through shared technology infrastructure. The reasoning is sound but incomplete in synthesizing the full strategic shift from 2023 to 2024. The answer remains contextually relevant and captures important elements of the financial structure, but lacks the full qualitative depth of the original answer regarding the evolving partnership dynamic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 371,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "From 2022 to 2023, the fair value of energy-related derivatives held by Southern Company's subsidiaries increased from $199 million (assets) and $210 million (liabilities) to $55 million (assets) and $358 million (liabilities). This indicates a significant rise in the company's exposure to energy market fluctuations, particularly in liabilities, reflecting greater financial risk due to changes in natural gas and power prices during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. It states that in 2022, Southern Company's subsidiaries had $199 million in assets and $210 million in liabilities, but the ground truth shows total assets of $95 million (59+8+28) and total liabilities of $109 million (32+12+65), resulting in a net liability of $14 million, not a net liability of $11 million as implied. The LLM incorrectly aggregates or fabricates numbers not present in the original data. For 2023, the LLM reports $55 million in assets and $358 million in liabilities, but the ground truth only provides data for Alabama Power ($15 assets, $110 liabilities) and Georgia Power ($13 assets, $124 liabilities), totaling $28 million in assets and $234 million in liabilities. The LLM overstates both liabilities and assets, with liabilities particularly inflated by $124 million. (2) Calculations are incorrect: the net liability in 2022 was $14 million (not $11 million as implied by 210-199), and in 2023 it was $206 million (234-28), not $303 million as implied by the LLM. The actual increase in net liability is from $14M to $206M, not from $11M to $303M. The LLM also fails to mention Mississippi Power, Southern Power, and Southern Company Gas in 2022, and omits that Alabama and Georgia Power were the only ones reporting in 2023. (3) The multi-hop reasoning is partially sound in that it recognizes a shift toward greater liability and increased exposure, which aligns with the conclusion in the ground truth. However, due to incorrect base numbers and misattribution of data across subsidiaries, the synthesis is flawed. (4) The contextual relevance is fair because the answer addresses the evolution of fair value and interprets increased exposure correctly in direction, though not in magnitude. Due to severe quantitative errors and incomplete entity coverage, the correctness score is low at 3, quantitative accuracy is 2, qualitative accuracy is 4 (some correct logic but wrong data), and contextual relevance is 7 (topic and intent are addressed appropriately).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 562,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "The treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024 in terms of remaining shares available for future issuance. In 2022, the plan had 119 million shares available, while by 2024, this number decreased to 77 million shares. This reduction indicates increased utilization of the plan for granting securities during this period, reflecting its ongoing role in the company's executive and employee compensation strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative data—119 million shares available in 2022 and 77 million in 2024—that are not present in the original ground truth answer. The ground truth does not mention any share numbers or utilization metrics, focusing instead on the qualitative evolution of the plan's disclosure context (from introduction to integration into broader equity compensation disclosures). Therefore, while the numbers may be factually accurate in a broader data context, they are not supported by the provided ground truth and represent a divergence in focus. (2) There is no way to verify the accuracy of the 119M and 77M figures against the ground truth, as the truth statement contains no quantitative data. If those numbers were correct in reality, the model would still be penalized here because the evaluation is based on alignment with the provided ground truth, not external facts. (3) The multi-hop reasoning is partially sound—the model infers increased utilization from decreasing available shares, which is logical—but it misses the core qualitative evolution emphasized in the original answer: the shift in disclosure context from formal establishment to standard integration. This reflects a failure to fully capture the 'significance' and 'treatment' aspects as framed in the question and truth. (4) The answer is contextually relevant and addresses the evolution of the plan, but it substitutes quantitative details (shares available) for the qualitative disclosure narrative provided in the ground truth, leading to a partially correct but misaligned response. Hence, correctness is scored low due to factual misalignment with the truth, despite plausible reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 467,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "From 2023 to 2024, Southern Company's approach to managing the risk of large losses in its pension plan assets remained focused on diversification and formal rebalancing programs, but there was a slight shift in emphasis toward increasing allocations in private equity and private credit. In 2023, private equity represented 9% of the portfolio, rising to 12% in 2024, while private credit moved from 3% to 1% (though still within the target range). Additionally, the company continued to use derivative instruments for hedging and maintained a strong emphasis on diversification across major asset classes, with no significant concentrations of risk. The 2024 disclosures also highlighted a more detailed discussion of risk management practices, indicating a heightened focus on monitoring and managing risk beyond diversification.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer states that Southern Company shifted its risk management emphasis from external manager oversight in 2023 to market-driven risks like volatility and interest rates in 2024. However, the LLM answer fabricates specific portfolio allocation percentages (e.g., private equity rising from 9% to 12%, private credit from 3% to 1%) that are not present in the ground truth and misrepresents the nature of the change. There is no mention in the original answer of increased allocations to private equity or private credit, nor any discussion of derivative use or concentration risk. (2) The quantitative inaccuracies are severe: the percentages cited (9%, 12%, 3%, 1%) have no basis in the provided ground truth, which contains no numerical data about asset allocations. This indicates hallucination rather than accurate extraction or inference. (3) The multi-hop reasoning is flawed. The question asks for evolution in risk management approach, but the LLM fails to identify the actual shift—from active oversight to market-exposure focus—and instead invents a narrative around asset allocation changes. It misses the core conceptual shift involving external manager oversight and market risk linkage. (4) While the answer remains within the general topic of pension risk management and mentions rebalancing and diversification (which aligns with the original), the invented details and incorrect emphasis severely undermine accuracy. The contextual relevance is moderate because it addresses pension risk and time-based changes, but the substance is factually wrong. Correctness is low due to major factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 471,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "Between 2022 and 2023, NVIDIA's role in the development and supply of the CUDA platform evolved from being a foundational element of its accelerated computing strategy to becoming a central pillar of its broader AI and computing ecosystem. In 2022, CUDA was highlighted as the core programming model enabling GPU-based parallel computing for AI, data analytics, and scientific workloads. By 2023, CUDA's role expanded significantly, with NVIDIA emphasizing its integration into full-stack solutions like NVIDIA AI Enterprise and DGX Cloud, as well as its support for generative AI, large language models (LLMs), and enterprise applications. This shift indicates a strategic focus on solidifying CUDA as the backbone of NVIDIA's AI and high-performance computing (HPC) platforms, enabling broader industry adoption and reinforcing its leadership in AI-driven innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable—no errors in dates or numbers (2022 and 2023 are correctly used). (2) The answer addresses all parts of the question: it describes NVIDIA's evolving role in CUDA from 2022 (as a foundational supplier) to 2023 (as a strategic developer integrated into full-stack solutions), and correctly infers the strategic focus on AI and full-stack computing. (3) The multi-hop reasoning is sound: it synthesizes the shift in NVIDIA’s role with broader ecosystem integration (e.g., CUDA-X, APIs, AI Enterprise, DGX Cloud), which reflects the intended inference from the knowledge graph. The mention of generative AI and LLMs adds timely context not in the original answer but is consistent with the strategic direction and does not introduce inaccuracies. (4) Semantic equivalence is strong: while the LLM uses different phrasing (e.g., 'central pillar' vs 'developer role'), it captures the essence of CUDA's expanded strategic role. The only minor gap is that the original emphasizes 'developer vs supplier' more explicitly, while the LLM frames it as a shift in strategic centrality—this is a nuance, not an error. Hence, correctness is excellent with only slight room for more precise role labeling.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 382,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "Between 2022 and 2023, Pfizer's financial relationship with Viatris, formed through the 2020 spin-off and combination with Mylan, remained largely stable in terms of supply agreements and outstanding balances. The manufacturing and supply agreements under Master Services Agreements (MSAs) continued to operate, with Pfizer and Viatris manufacturing products for each other. As of December 31, 2023, the net amounts due to Viatris under these agreements were $33 million, compared to $94 million as of December 31, 2022. These amounts were not material to Pfizer's overall operations during either year.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the quantitative figures for the net amounts due to Viatris—$94 million as of December 31, 2022, and $33 million as of December 31, 2023—which matches the ground truth exactly. These numbers are accurate and properly contextualized in terms of timing and direction of change (decrease). However, the LLM omits the key 2022 revenue growth figure of $780 million from PC1 related to manufacturing legacy Upjohn products for Viatris, which is a significant part of the financial relationship evolution. This omission reduces completeness and affects qualitative accuracy. (2) All provided numbers are factually correct and no calculation errors are present. The format ($33 million vs. $94 million) is consistent and acceptable. (3) The reasoning is partially sound: the LLM correctly infers a continued but declining financial relationship based on decreasing balances and notes the non-materiality to Pfizer, which may be valid but is not in the ground truth. However, it fails to capture the multi-hop nuance that the supply agreement revenue was a major component in 2022 and that most transitional services (TSAs) were completed by end of 2023—this evolution toward reduced interdependence is underemphasized. Instead, the LLM describes the relationship as 'largely stable,' which contradicts the ground truth indicating a clear reduction in ties. (4) Contextual relevance is high as the answer addresses supply agreements and balances directly. The inclusion of MSAs and mutual manufacturing adds context not in the ground truth but is not incorrect. The main shortcoming is the failure to reflect the evolving (declining) nature of the relationship, instead characterizing it as stable. Thus, while quantitatively accurate, the qualitative and completeness aspects limit the score to 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 498,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "Between 2023 and 2024, the treatment and disclosure of communications sites in relation to debt obligations evolved in terms of increased specificity and updated financial metrics. In 2023, the disclosures focused on securitization structures, repayment activities, and the cash flow mechanisms tied to communications sites securing debt, such as the 3,343 sites backing the Series 2015-2 Notes. By 2024, the disclosures provided more granular details on debt obligations, including updated debt service coverage ratios (DSCR) and reserve account balances, as well as the number of sites securing debt (e.g., 3,338 for the 2015 Securitization and 5,029 for the Trust Securitizations). Additionally, 2024 emphasized the conditions under which excess cash flow could be distributed or restricted, reflecting a more dynamic and risk-focused approach to managing site-related debt obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The original answer states that in 2024, there was *no explicit mention* of specific communications sites securing debt, indicating a shift toward broader financial disclosures. However, the LLM claims that in 2024, there were *more granular details*, including specific numbers of sites (3,338 and 5,029) securing debt and updated DSCRs and reserve balances—information not present in the ground truth. These specific figures (e.g., 3,338 sites, 5,029 for Trust Securitizations) are fabricated or hallucinated, as the ground truth does not provide any such data for 2024. (2) Quantitatively, the only accurate number is the 3,343 sites from 2023, which the LLM correctly references. However, all 2024 numbers are incorrect or unsupported. The ground truth mentions a $4.5 billion asset retirement obligation in 2024, which the LLM omits entirely. (3) The reasoning is flawed: the LLM suggests increased specificity and enhanced disclosures in 2024, while the ground truth describes a move *away* from site-specific disclosures to more general obligations. This is a direct reversal of the correct interpretation. (4) Contextually, the answer addresses the general topic of debt and communications sites, so relevance is moderate, but factual and qualitative inaccuracies severely undermine correctness. The synthesis fails the multi-hop requirement by misrepresenting the evolution of disclosure practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 406,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "Comcast's approach to retransmission consent agreements between 2022 and 2023 remained largely consistent in terms of revenue recognition, with fees from NBC and Telemundo retransmission consent agreements being recognized as programming is provided on a monthly basis under multiyear contracts. However, in 2023, there was a notable emphasis on expanding distribution models, particularly through the integration of streaming services like Peacock, where revenue from monthly subscription fees is recognized alongside traditional multichannel video provider agreements. This shift reflects a broader strategy to adapt to evolving viewer consumption habits by combining linear and digital distribution channels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that in 2022, Comcast recognized retransmission consent revenue monthly as programming was provided, consistent with the original answer. It also accurately notes that by 2023, there was a strategic shift toward integrating streaming services like Peacock into the distribution model, reflecting the hybrid linear and digital approach. (2) There are no numeric values (e.g., dollar amounts, percentages, subscriber counts) in either the original or LLM answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years (2022 vs 2023), identifies the continuity in revenue recognition, and highlights the evolution in distribution models, particularly the inclusion of virtual MVPDs and Peacock. The mention of NBC and Telemundo adds specificity not in the original but is factually consistent with Comcast’s operations. (4) The only minor shortcoming is that the LLM does not explicitly mention that retransmission fees in 2023 now cover both traditional and virtual multichannel providers—a detail present in the ground truth. However, the reference to 'digital distribution channels' and Peacock subscription fees implies this expansion. Overall, the answer is semantically equivalent, contextually relevant, and factually correct with only slight omission of explicit terminology around virtual MVPDs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 413,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives remained consistent from 2023 to 2024, as both years highlight the company's continued focus on manufacturing and supporting diesel-electric locomotives and rail-related products and services. In 2023, the Energy & Transportation segment explicitly included diesel-electric locomotives and components, along with remanufacturing and leasing services. In 2024, the segment description reiterated this focus, emphasizing the production of diesel-electric locomotives and related rail services, with no notable changes in strategy or scope.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that Caterpillar's involvement remained consistent from 2023 to 2024. The ground truth shows a clear evolution: in 2023, diesel-electric locomotives were part of the ME&T segment with a focus on remanufacturing and support, while in 2024, the company explicitly stated it 'produces' diesel-electric locomotives under the Energy & Transportation segment, indicating a more direct strategic role. The LLM incorrectly claims no notable changes, which contradicts the ground truth. Additionally, the LLM misattributes the 2023 segment description to Energy & Transportation, when in fact in 2023 it was under ME&T. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is flawed: the model failed to synthesize the shift in segment classification, the change in language from operational support to 'production', and the new mention of competitive pressures from Wabtec and Siemens in 2024. These are key indicators of strategic evolution that the LLM overlooked. (4) While the answer is contextually relevant—discussing Caterpillar and diesel-electric locomotives—it misses the core of the question, which is about *evolution* or *change*. Instead, it asserts continuity, which is incorrect. Hence, low correctness and qualitative accuracy scores despite proper context and no numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 409,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "Between 2023 and 2024, McDonald's relationship with its franchisees in terms of revenue recognition and cost-sharing arrangements remained largely consistent, with a few notable developments. Revenue recognition continued to follow the same principles, with royalty revenues based on a percentage of franchisee sales recognized at the time of the underlying sales, and initial fees recognized over the franchise term. Cost-sharing arrangements for restaurant improvements persisted, with McDonald's managing projects and estimating cost allocations between the Company and franchisees. However, in 2024, the Company acquired additional restaurants from franchisees (including 228 in Israel), which involved cost-sharing for improvements and resulted in goodwill additions, though these acquisitions did not significantly impact revenue or net income. Overall, the framework for revenue and cost-sharing remained stable, with operational adjustments supporting franchising initiatives.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that McDonald's revenue recognition model remained largely consistent between 2023 and 2024, with royalties based on franchisee sales and initial fees recognized over time. However, it misses the key 2024 enhancement in disclosure regarding technology platform fees being presented on a gross basis in the Consolidated Statement of Income—a significant qualitative change in revenue recognition transparency. Additionally, while the LLM mentions cost-sharing for restaurant improvements, it fails to accurately reflect the new 2024 disclosure about interim cost allocation between Property and Equipment and Accounts Receivable during projects, with finalization upon completion. Instead, it introduces the acquisition of 228 restaurants in Israel, which is factually plausible but not present in the ground truth and distracts from the core evolution in accounting practices. (2) The number '228' (restaurants in Israel) is presented without confirmation in the ground truth and appears to be extraneous or incorrectly sourced; no other numeric data (percentages, dollar amounts, dates) are provided or challenged, so quantitative accuracy is partially acceptable but based on unsupported facts. (3) The multi-hop reasoning is partially sound—linking revenue recognition and cost-sharing across years—but fails to synthesize the correct evolution in financial reporting detail. The focus shifts to asset acquisitions rather than the improved transparency in franchisee financial arrangements, indicating a misalignment in reasoning. (4) The contextual relevance is high because the answer addresses the general theme of franchisee financial relationships, but correctness and qualitative accuracy are reduced due to missing key disclosures from 2024 and introducing unverified information. The core evolution in reporting granularity—especially around technology fees and cost allocation timing—is omitted, which is central to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 537,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "Between 2023 and 2024, Southern Company updated its executive equity compensation approach by amending the terms of its equity awards under the Southern Company 2021 Equity and Incentive Compensation Plan. Specifically, the company revised plan documentation to include the \"Form of Terms for Named Executive Officer Equity Awards,\" which was updated and designated in filings in 2024. Additionally, Southern Company amended its change-in-control protections and severance plans for executives, with the Amended and Restated Southern Company Change in Control Benefits Protection Plan and related severance plans being updated and effective as of August 15, 2022, reflecting continued alignment with corporate governance standards. These changes emphasize enhanced clarity and alignment of award terms with executive compensation strategies.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of increased formalization in Southern Company's executive equity compensation approach between 2023 and 2024, particularly around plan documentation, which aligns with the ground truth. It correctly identifies the use of the Equity and Incentive Compensation Plan and notes the introduction of specific award terms for Named Executive Officers in 2024, referencing updated forms and exhibits. However, there are significant factual inaccuracies: (1) The LLM claims the plan is the '2021 Equity and Incentive Compensation Plan,' but the original answer does not specify the year of the plan, so this detail is unsupported; (2) It references amendments to the Change in Control Benefits Protection Plan effective August 15, 2022, which predates both 2023 and 2024 and is not mentioned in the original answer—this introduces irrelevant information and misaligns the timeline; (3) While the original answer emphasizes a shift in documentation practices (e.g., specific exhibit designation) as a 2024 development, the LLM overemphasizes 'amendments' and 'revisions' without confirming whether the 2024 changes were substantive or merely presentational. The answer is partially correct in identifying enhanced clarity and structure but introduces unsupported specifics. Quantitative accuracy is moderate—no numerical errors per se, but incorrect dates (2022) are introduced. Qualitative accuracy is limited by incorrect entity attribution and timeline confusion. Contextual relevance is high as it addresses executive equity compensation evolution, but includes extraneous details. Overall, the core idea of increased structure is correct, but key details are inaccurate or fabricated, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 475,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "Procter & Gamble's strategic reliance on membership club stores has increased from 2022 to 2024, reflecting a broader shift toward optimizing retail execution and channel diversification. In 2022, membership club stores were listed among key customers, but by 2024, the company emphasized a more intentional focus on these channels as part of its strategy to enhance retail execution and consumer value. This evolution indicates P&G's broader retail channel strategy to strengthen relationships with high-volume, high-efficiency retailers and adapt to changing consumer shopping behaviors, particularly in the face of growing e-commerce and omnichannel demands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years 2022 and 2024 are correctly referenced, and the evolution in strategic language is accurately portrayed. (2) The answer addresses both parts of the question: the change in P&G's reliance on membership club stores from 2022 to 2024 and the implications for its broader retail strategy. (3) The multi-hop reasoning is sound—correctly identifying the shift from listing membership clubs as one of many channels in 2022 to emphasizing deeper strategic focus by 2024. The conclusion about adapting to consumer behavior and omnichannel trends is a reasonable inference consistent with the ground truth’s indication of growing centrality. (4) While the LLM uses slightly different phrasing (e.g., 'high-volume, high-efficiency retailers' and 'omnichannel demands'), it captures the semantic meaning of increased strategic reliance and evolving retail dynamics. The only minor gap is that the original answer explicitly notes the shift from 'key retail channels' to 'dependency,' which the LLM paraphrases as 'more intentional focus'—accurate but slightly less precise in capturing the depth of 'dependency.' This justifies a 9 instead of 10 on qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 374,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "AMT's involvement with Nigeria Letters of Credit indicates that there were no outstanding amounts as of December 31, 2024, compared to $3.4 million in 2023. This suggests that the financial obligations related to these instruments were fully settled or drawn upon during the period, with any drawn amounts due 270 days from the date of drawing and bearing interest based on SOFR plus a spread. The absence of a carrying value in 2024 implies that AMT no longer holds any active obligations under these letters of credit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $3.4 million obligation in 2023 and $0 in 2024 are accurately reported, matching the original answer. There are no calculation errors. (2) The answer correctly identifies the key entities: AMT, Nigeria Letters of Credit, and the relevant years (2023–2024). (3) The multi-hop reasoning is sound—comparing the obligation across years and concluding that the obligation was fully settled or exited is logically supported by the data. (4) The LLM adds minor additional detail about the 270-day term and SOFR-based interest, which is not contradicted by the ground truth and may reflect accurate context from the filings, though not explicitly confirmed in the original answer. This does not detract from correctness but introduces slight unverified detail. Otherwise, the core conclusion—that AMT no longer has active obligations—is fully supported. The answer is semantically equivalent to the ground truth and addresses both parts of the question: evolution over time and implications for financial obligations. Only a minor deduction in qualitative accuracy due to the slight overreach in unconfirmed terms; otherwise, all aspects are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 355,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "Between 2022 and 2024, the valuation methodology and composition of GD's Retirement Annuity Contracts shifted from being classified under Level 3 (significant unobservable inputs) to being excluded from the fair value hierarchy. In 2022, these contracts were valued using significant unobservable inputs with a fair value of $38 million, whereas by 2024, they were reclassified as investments measured using NAV as a practical expedient, with a fair value of $22 million. This change indicates a shift in the company's approach to reporting these assets, likely reflecting a move toward more liquid or standardized valuation methods, reducing reliance on internal assumptions and enhancing transparency.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. According to the ground truth, the fair value was $35 million as of December 31, 2021, and $38 million as of December 31, 2020 — not $38 million in 2022 as stated by the LLM. More critically, the LLM claims a 2024 fair value of $22 million, which is not supported by the original answer; the ground truth does not provide a 2024 dollar amount at all. This is a major quantitative error. (2) The description of the methodology shift is partially correct: the move from Level 3 to NAV as a practical expedient, thus being excluded from the fair value hierarchy, aligns with the original answer. However, the LLM incorrectly implies the NAV-based valuation began in 2024 without specifying that this change reflects a broader reporting trend already underway. (3) The multi-hop reasoning is sound in structure — the model correctly identifies a shift in classification and infers implications about transparency and reduced reliance on unobservable inputs — but it synthesizes incorrect numerical data, undermining the conclusion. (4) The contextual relevance is high because the answer addresses both parts of the question: changes in valuation methodology and what they indicate. The qualitative reasoning about reporting approach is plausible and aligns with the direction of the ground truth, even if not fully accurate. Overall, the answer gets the general direction of change right but fails on key facts, especially numbers and timing, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 433,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "Based on the information provided in the document pages, the fair value hierarchy classification for restricted cash for securitization investors remained unchanged between 2022 and 2024. In both 2024 and 2022, restricted cash for securitization investors was classified entirely within Level 1 of the fair value hierarchy, with no amounts classified in Level 2 or Level 3. This indicates that the composition and valuation method for this asset remained consistent during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) Quantitatively, the LLM claims that restricted cash for securitization investors was classified entirely in Level 1 in both 2022 and 2024, but the ground truth states that in 2022, the fair value hierarchy was not explicitly detailed for this category, meaning there is no evidence of Level 1 classification in 2022. The only confirmed value is $441 million in 2024 under Level 1. The LLM incorrectly asserts continuity where the ground truth indicates a shift and lack of prior detail. (2) The answer fabricates information by asserting 2022 classification with no support from the original answer, which explicitly says the hierarchy was not detailed in 2022. (3) The multi-hop reasoning fails: the question asks about changes in composition and value between 2022 and 2024, particularly regarding fair value hierarchy. The correct answer requires recognizing that 2022 lacked explicit hierarchy detail while 2024 introduced full Level 1 classification—indicating a move toward transparency. The LLM incorrectly concludes no change occurred. (4) Contextual relevance is moderate because the answer addresses the right topic (restricted cash, securitization investors, fair value levels) and time frame, but the core factual claim is false. Minor score given for topical alignment, but major deductions for factual inaccuracy and flawed synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 392,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "Between 2023 and 2024, McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management as reflected in the increased number of franchised restaurants and the acquisition of additional restaurants from franchisees to support key franchising initiatives. The total franchised restaurants increased from 39,680 in 2023 to 41,432 in 2024, with notable growth in both conventional franchised and developmental licensed categories. Additionally, the Company acquired restaurants from franchisees, particularly in Israel, resulting in the recording of $240 million in goodwill. These acquisitions were part of strategic efforts to enhance franchisee support and optimize asset management.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses the core evolution described in the ground truth. It correctly notes that McDonald's acquired restaurants from franchisees, which aligns with 2023 activity, and mentions goodwill ($240M), which is plausible though not in the original answer. However, the key shift in 2024—toward a service-based model with technology platform services, gross revenue recognition, and expense classification under 'Other restaurant expenses'—is entirely missing. Instead, the LLM focuses on growth in the number of franchised restaurants (39,680 to 41,432), which is not mentioned in the ground truth and appears fabricated or misattributed. (2) Quantitative accuracy is partially correct: the $240M goodwill figure may be factually accurate in external sources, but it is not present in the provided ground truth, so its inclusion cannot be verified as correct in this context. The restaurant count increase is unsupported by the original answer and introduces data not present in the knowledge graph, reducing factual fidelity. (3) Multi-hop reasoning is weak: the model fails to synthesize the shift from asset acquisition (2023) to service-based financial interactions (2024). It stays focused on asset management via acquisitions but ignores the critical evolution in revenue recognition and service provision, which is the central theme of the original answer. (4) Scores reflect partial factual alignment on acquisition activity and goodwill, but major omissions and potential hallucinations (franchised restaurant counts) severely limit correctness. The answer is contextually relevant to McDonald's and franchisee relationships but misrepresents the nature of the evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 478,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "Between 2022 and 2024, the 2019 Stock and Incentive Compensation Plan remained the sole active equity compensation plan for future grants at Procter & Gamble. In 2022, the plan had 119 million shares available for future issuance, while by 2024, this number had decreased to 77 million shares, reflecting ongoing use of the plan for equity awards. The plan continued to serve as the primary vehicle for granting stock options, stock appreciation rights, and full-value awards like RSUs and PSUs, with older plans such as the 2001 and 2014 plans no longer permitting new grants. This evolution highlights the 2019 Plan's central role in the company's equity compensation strategy during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative inaccuracy: The claim that the 2019 Plan had 119 million shares available in 2022 and 77 million in 2024 is not supported by the ground truth, which does not provide specific share numbers for those years. These figures are fabricated or incorrectly sourced, failing the quantitative accuracy test. (2) Entity and completeness issues: The ground truth emphasizes a shift in disclosure focus—from governance and adoption details in 2022 to strategic ownership and total shares context in 2024—while the LLM answer incorrectly frames the evolution as a quantitative drawdown in shares and asserts the 2019 Plan was the 'sole active' plan, which is not confirmed in the original answer. The original does not state exclusivity or share depletion as the core evolution. (3) Reasoning: The LLM introduces a narrative of share reduction and ongoing use as evidence of centrality, but this misrepresents the actual evolution described in the ground truth, which is about disclosure framing, not usage rates or share counts. (4) Contextual relevance: The answer stays on topic—discussing the plan’s role over time—and correctly identifies older plans (2014, 2001) as inactive, which aligns with typical plan sunsetting. However, it misses the key qualitative shift from procedural to strategic disclosure, which is the central point of the original answer. Thus, while contextually relevant and partially accurate in structure, the LLM substitutes unsupported numbers and a different analytical framework, leading to a partially correct but fundamentally misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 454,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "Salvatore Ferragamo's presence in Simon Property Group's international outlet locations between 2022 and 2023 remained consistent, as the brand was listed as a tenant in multiple international Premium Outlets across Japan, South Korea, Canada, and Thailand in both years. For example, Ferragamo was present in the Gotemba Premium Outlets (Japan), Yeoju Premium Outlets (South Korea), Toronto Premium Outlets (Canada), and other locations in 2022, and its presence was similarly noted in 2023 in these and other international outlets. There is no indication of a significant expansion or contraction of Ferragamo's footprint during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. According to the ground truth, Salvatore Ferragamo was present in three Japanese outlets in 2022 and only in one U.S. location (Las Vegas Outlets North) in 2023, indicating a significant reduction. The LLM claims consistent presence across Japan, South Korea, Canada, and Thailand in both years, which contradicts the ground truth. (2) Quantitative accuracy is severely lacking: the LLM states 'multiple international locations' in both years, but the truth is a drop from three to one location, with a geographic shift from Japan to the U.S. The specific outlets mentioned by the LLM (Yeoju, Toronto, etc.) are not supported by the ground truth. (3) Multi-hop reasoning failed: the question requires comparing Ferragamo's presence across SPG's international outlets between two years. The LLM incorrectly infers stability, while the truth shows a contraction and geographic shift. It also introduces non-existent locations and fails to note the U.S. shift in 2023. (4) Contextual relevance is low because the answer discusses international presence but misrepresents the locations and trends. The core conclusion—'no significant change'—is directly contradicted by the ground truth. Only minimal relevance is retained as it addresses the general topic of Ferragamo's outlet presence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 378,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "COP's natural gas position in the Asia Pacific/Middle East region saw an increase in total proved natural gas reserves from 312 billion cubic feet (BCF) at the end of 2023 to 296 BCF at the end of 2024, indicating a slight decline. However, this region remained a focus for exploration and development, with extensions and discoveries in the Middle East and Australia in 2024. The decline in reserves was primarily due to downward revisions from lower prices and changes in development plans, partially offset by technical revisions and acquisitions. This suggests that while COP is maintaining a strategic interest in the region, operational focus may be shifting toward optimizing existing assets rather than significant new development.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of change: it states that reserves increased from 312 BCF in 2023 to 296 BCF in 2024, which is incorrect because 296 is less than 312—this indicates a decrease, not an increase. This misstatement undermines the core quantitative claim. (2) The numbers themselves (312 BCF in 2023 and 296 BCF in 2024) are factually correct and match the ground truth, but the interpretation is reversed. The calculation of a decline of 16 BCF is accurate, but the LLM incorrectly frames it as an 'increase' followed by a 'slight decline', which is logically inconsistent. (3) The qualitative reasoning about operational focus—mentioning continued strategic interest, exploration in the Middle East and Australia, and a shift toward optimization—is plausible and aligns with the ground truth's suggestion of stabilization rather than aggressive growth. However, this reasoning is built on a flawed premise, weakening the multi-hop synthesis. (4) Contextually, the answer addresses both parts of the question (evolution of position and operational focus), so relevance is high. Quantitative accuracy is low due to the inversion of the trend, which is a major error despite correct raw numbers. Qualitative accuracy is moderate because the explanation for the decline (price revisions, development changes, technical adjustments) is reasonable and consistent with typical SEC filing disclosures, even if not explicitly confirmed in the ground truth. Correctness score is low because the central fact—the direction of change—is wrong, which fundamentally misleads the reader.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 447,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "Comcast's approach to wireless gateways from 2022 to 2024 has evolved with a stronger strategic emphasis on enhancing customer connectivity and expanding network capabilities. In 2022, wireless gateways were highlighted as part of the broadband services, combining an internet modem with a Wi-Fi router to improve in-and-out-of-home coverage. By 2024, the company increased its investment in scalable infrastructure and line extensions to support multigigabit symmetrical speeds and the continued deployment of wireless gateways, reflecting a commitment to upgrading its network and meeting growing customer demand for high-speed connectivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: in 2022, Comcast offered wireless gateways as part of broadband services, combining modem and Wi-Fi router functions to improve coverage. By 2024, the strategic emphasis shifted toward deeper integration into network infrastructure, with investment in scalable infrastructure and line extensions to support multigigabit symmetrical speeds. These details match the original answer's core claims. (2) There are no numeric values (e.g., dollar amounts, percentages, speeds) in the question or answers that require verification—only qualitative descriptions of strategy and investment, which are correctly represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 vs 2024), identifies the evolution in strategic emphasis (from customer-facing service component to infrastructure investment), and captures the broader context of network upgrades. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the xFi whole-home application or advanced security features highlighted in 2022 per the original answer, which slightly reduces completeness in qualitative detail. However, this omission does not undermine the central thesis of strategic evolution and increased investment. Overall, the answer is semantically equivalent, factually correct, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 401,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "Between 2022 and 2024, the G600's market presence and production evolution has shown notable growth. By the end of 2022, cumulative deliveries of the G500 and G600 totaled almost 150, while by the end of 2024, this figure had more than doubled to over 300. The G600 has solidified its role within Gulfstream's product lineup as a key ultra-long-range, ultra-large-cabin aircraft, replacing older models and contributing to Gulfstream's leadership in innovation and performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports that cumulative deliveries of the G500 and G600 totaled almost 150 by the end of 2021 (referenced in the 2022 context) and more than doubled to over 300 by the end of 2024, which aligns with the ground truth. The numbers, timeframes, and comparisons are factually accurate. (2) Quantitative accuracy is perfect: 'almost 150' and 'over 300' match the original answer, and the statement that deliveries 'more than doubled' is mathematically sound (300 is exactly double 150, and 'over 300' supports 'more than double'). (3) The reasoning is sound and captures the multi-hop synthesis: the model correctly infers increased market presence from delivery growth and identifies the G600's role in replacing older models. However, it omits a specific detail from the ground truth: by 2024, the G600 was no longer framed as a new product, and Gulfstream's focus had shifted to newer models like the G800 and G400. This nuance about evolving product focus is missing, slightly reducing qualitative completeness. (4) Despite this minor omission, the answer is highly relevant, factually correct, and conveys the core evolution in production and market presence. The scores reflect near-perfect accuracy with a slight deduction in qualitative accuracy for missing the shift in narrative focus in Gulfstream's product communication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 381,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge underwent significant changes. As of December 31, 2023, AIG held a 52.2% ownership stake in Corebridge. However, by June 9, 2024, AIG deconsolidated Corebridge after reducing its ownership to 48.4% and waiving its majority board representation. This deconsolidation resulted in a $4.8 billion pre-tax loss, primarily driven by an accumulated comprehensive loss. Post-deconsolidation, AIG accounted for its remaining stake using the equity method, recognizing equity method income of $601 million for the period June 10, 2024, to December 31, 2024. By December 31, 2024, AIG's ownership had further decreased to 22.7% after additional share sales, including a $3.8 billion transaction with Nippon Life in December 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides a more detailed and precise account than the original ground truth, particularly in terms of specific dates, ownership percentages, financial figures, and the sequence of events. (1) All key facts align with the ground truth: AIG began 2023 with majority control (52.2%) and transitioned to a passive equity method accounting approach by 2024. The LLM correctly identifies the deconsolidation date (June 9, 2024), the drop to 48.4%, and the further reduction to 22.7% by year-end 2024. (2) Quantitatively, the $4.8 billion pre-tax loss and $601 million equity method income are factually correct and consistent with disclosed financials. The $3.8 billion transaction with Nippon Life is also accurate. These numbers are not in the original answer but represent correct additional detail. (3) The reasoning is sound and reflects proper multi-hop synthesis: the shift from consolidation to equity method accounting after losing control, the impact on income recognition, and the continued divestment are all logically connected. (4) The only reason for not scoring a 10 is that the original ground truth does not include the $601M income or Nippon Life transaction, so while the LLM adds verified correct information, slight caution is applied in case those details were not in the source documents used for ground truth. However, given their accuracy and consistency with public filings, the answer exceeds the original in completeness and precision. Contextual relevance is perfect—directly addresses equity ownership evolution and income recognition as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 438,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "Between 2022 and 2024, Tesla's production strategy for the Solar Roof has evolved with a greater emphasis on localized manufacturing and addressing operational challenges. In 2022, Tesla highlighted its reliance on Gigafactory New York for Solar Roof production and noted the need to manage supply chain dependencies and localized procurement. By 2024, the company had expanded its manufacturing capabilities and workforce development programs, such as apprenticeships and technical training, to support skilled labor needs. Additionally, Tesla continued to focus on integrating automation and optimizing production processes to enhance efficiency and reduce costs, while also navigating supply chain constraints and ensuring compliance with regulatory requirements in various markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses key factual developments and introduces unsupported claims. It correctly identifies Gigafactory New York as the production site in 2022, which aligns with the ground truth. However, it inaccurately states that Tesla 'expanded its manufacturing capabilities' and implemented 'apprenticeships and technical training' by 2024—details not present in the original answer or supported by the knowledge graph. The ground truth emphasizes increasing challenges and risks in 2024, not expansion or workforce programs. The LLM also omits the critical shift in tone from active production in 2022 to explicit concerns about delays and production ramp difficulties in 2024. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no errors in this regard. (3) The multi-hop reasoning is flawed: while the LLM synthesizes manufacturing and supply chain themes, it fails to correctly trace the evolution from a dedicated, strategically promoted production setup in 2022 to a risk-laden, delayed ramp-up phase in 2024. Instead, it implies progress and scaling, which contradicts the ground truth. (4) The contextual relevance is moderate—the answer addresses manufacturing dependencies and operational challenges but misrepresents the direction of strategic evolution. Correctness and qualitative accuracy are reduced due to factual inaccuracies and omission of key risk disclosures in the 2024 timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 413,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "From 2023 to 2024, Qualcomm has increasingly emphasized on-device artificial intelligence (AI) as a core component of its strategic focus, leveraging its foundational technologies in high-performance and low-power computing. In 2023, Qualcomm highlighted its advancements in AI as part of its broader innovation efforts across mobile and emerging industries. By 2024, the company explicitly positioned on-device AI as a key differentiator, integrating it into its wireless connectivity and computing solutions to scale across industries like automotive and IoT. This evolution reflects a more targeted investment approach, with Qualcomm aiming to drive growth through AI-enabled products and expanding its leadership in next-generation technologies beyond traditional mobile handsets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's focus on on-device AI in both 2023 and 2024 and accurately references its application in automotive and IoT, as well as its integration with wireless and low-power computing. However, it misrepresents the strategic evolution: the original answer states that Qualcomm shifted from a product-focused approach in 2023 to a more investment-centric, ecosystem-driven strategy in 2024, emphasizing R&D, acquisitions, and third-party integration. In contrast, the LLM answer suggests Qualcomm intensified its product-centric strategy by positioning AI as a 'key differentiator' and focusing on 'AI-enabled products,' which contradicts the ground truth. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound—the model connects Qualcomm’s AI efforts across years and industries but fails to correctly synthesize the shift in business model from product-driven to investment- and ecosystem-driven, a key nuance in the original answer. (4) Contextual relevance is high because the response addresses the timeframe, company, and technology in question and discusses strategic focus and investment, though the characterization of the investment approach is inaccurate. Thus, correctness and qualitative accuracy are moderate due to a significant misrepresentation of strategic direction despite accurate contextual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 415,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "Between 2022 and 2023, Dolce & Gabbana expanded its presence in SPG-operated properties, notably appearing in multiple U.S. Premium Outlets such as Las Vegas Outlets, Houston Premium Outlets, and others. This growth indicates that SPG is strategically enhancing its premium outlet locations by attracting high-end luxury brands like Dolce & Gabbana, reinforcing its focus on curating a luxury retail experience to drive foot traffic and higher sales in these destinations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims Dolce & Gabbana expanded its presence in SPG-operated properties between 2022 and 2023, but the original answer shows a contraction—from multiple locations in Japan in 2022 (Gotemba, Kobe-Sanda, Rinku) to only one location in the U.S. (Las Vegas Outlets North Premium NV) in 2023. (2) The quantitative and entity accuracy is poor: the LLM invents new locations (e.g., Houston Premium Outlets) not mentioned in the ground truth and misrepresents the direction of change (expansion vs. contraction). No correct numerical data or location-year mappings are provided. (3) The reasoning is flawed: instead of identifying a strategic shift from broad Japanese market presence to a more exclusive U.S. flagship positioning, the LLM suggests a general expansion and luxury curation strategy, which misreads the evidence. (4) While the answer is contextually relevant in discussing SPG's brand positioning and luxury retail strategy, the factual foundation is incorrect, leading to an invalid conclusion. The core multi-hop synthesis—comparing Dolce & Gabbana's presence across years and geographies—is entirely inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 335,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "COP's investment in exploration activities in the Asia Pacific/Middle East region decreased between 2023 and 2024, as evidenced by the drop in exploratory wells from 3 in 2023 to zero in 2024, while development activities remained stable. This shift indicates a strategic pivot toward development and optimization of existing assets rather than new exploration in the region. The company appears to be focusing on maximizing returns from established reserves and partnerships rather than pursuing high-risk, high-cost exploration initiatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies a decrease in exploration activity, it introduces unverified metrics—specifically, the number of exploratory wells (3 in 2023, 0 in 2024)—which are not present in the ground truth and cannot be confirmed. The original answer states that exploration expenditures dropped from $49 million in 2023 to $0 in 2024, but the LLM fails to mention any dollar amounts, omitting key quantitative data. (2) The absence of financial figures ($49M and $0) severely undermines quantitative accuracy. These numbers are central to the original answer and necessary for a correct response. The LLM instead substitutes with operational metrics (well counts) that are not supported by the ground truth, making the quantitative accuracy low. (3) The reasoning is partially sound—reducing exploration to zero could indicate a strategic shift—but the LLM mischaracterizes the nature of the shift. It suggests a pivot toward development and optimization of existing assets *in the region*, whereas the original answer implies a broader strategic withdrawal *from the region*. This misrepresents the company’s geographic focus and fails to acknowledge the complete halt in spending as a sign of regional deprioritization. (4) Contextual relevance is moderate because the answer addresses the evolution and strategic implications, but the incorrect data and misdirected conclusion reduce its validity. The answer synthesizes a plausible narrative but not the correct one based on the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 433,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "Comcast's financial stake in Universal Beijing Resort remains at a 30% interest from 2022 to 2024. As of December 31, 2024, Universal Beijing Resort had $3.4 billion of debt outstanding, including a $3.0 billion term loan, compared to $3.5 billion of debt outstanding, including a $3.1 billion term loan, as of December 31, 2023. Comcast consolidates Universal Beijing Resort as a variable interest entity (VIE), and its maximum risk of financial loss is limited to its 30% equity stake.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. It incorrectly states that Comcast's 30% ownership stake was known in 2022, while the original answer clarifies that no specific financial stake or debt figures were disclosed in 2022—Comcast only mentioned the resort's opening and its impact on depreciation and amortization. The 30% stake was first explicitly stated in 2024, not retroactively confirmed for 2022. (2) The debt figures are partially correct: $3.4 billion outstanding as of December 31, 2024, and $3.5 billion in 2023 match the ground truth. However, the LLM adds unverified details about a $3.0 billion term loan in 2024 and $3.1 billion in 2023, which are not present in the original answer and cannot be verified. These specific loan breakdowns introduce unsupported precision. (3) The LLM fails to mention key financial data from the original answer: the assets and liabilities of Universal Beijing Resort were $7.3B and $7.0B in 2024 (vs $7.8B and $7.2B in 2023), which is a significant omission in tracking the evolution of Comcast’s debt involvement. This missing balance sheet context weakens the multi-hop synthesis across years. (4) While the LLM correctly identifies Comcast’s consolidation of the resort as a VIE and notes the risk is limited to its equity stake—consistent with qualitative disclosures—the reasoning about stake stability from 2022–2024 is flawed due to lack of 2022 disclosure. The answer assumes continuity not supported by the source. Overall, core debt numbers are accurate, but incorrect stake timeline, added unverified loan details, and missing asset/liability data reduce correctness. Quantitative accuracy is penalized for unsupported loan breakdowns; qualitative accuracy suffers from flawed multi-hop reasoning; contextual relevance remains high as the response directly addresses the question’s scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 517,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "From 2022 to 2023, Duke Energy's net derivatives balance decreased from $4,985 million to $5,460 million, primarily due to a reduction in derivative assets and liabilities. The settlement activity showed a net outflow, with derivative liabilities increasing and derivative assets decreasing. This indicates a shift in the company's exposure to derivative instruments, suggesting a potential reduction in hedging activities or changes in market conditions affecting the fair value of these instruments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The net derivatives balance values are grossly inaccurate: it claims $4,985 million in 2022 and $5,460 million in 2023, whereas the ground truth states $29 million in 2022 and $13 million in 2023. These figures are off by over two orders of magnitude. Additionally, the LLM claims the balance increased from 2022 to 2023, while in reality it decreased. The settlement activity is completely omitted in the LLM answer—no mention of the $32 million in 2022 or $68 million in 2023. (2) The numbers provided by the LLM do not match the ground truth in any way—neither the balances nor the settlements are correct. There is no indication of accurate data retrieval or calculation. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the correct evolution of both the net balance and settlement activity across years. Instead, it fabricates a narrative around increasing net balances and net outflows without supporting data. The conclusion about reduced hedging or changing market conditions is speculative and not grounded in the actual data showing a declining net balance amid rising settlements. (4) The contextual relevance is low because the answer discusses derivative management, which is relevant to the question, but uses entirely incorrect data and misses key metrics. The qualitative reasoning is weak due to incorrect entity values and lack of proper synthesis. The answer fails on all core dimensions: correctness, quantitative accuracy, and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 431,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "From 2022 to 2023, SPG's treatment and disclosure of LTIP Units evolved in terms of their dilutive effect and valuation modeling as follows: \n\nIn 2022, SPG disclosed that LTIP units were subject to performance and market conditions, with vesting dates set for January 1, 2025, and the valuation of market-based awards was estimated using a Monte Carlo model. By 2023, the 2023 LTI Program extended the vesting period to January 1, 2027, and continued to use a similar valuation approach for performance-based awards, with a maximum potential fair value at grant date of $42.5 million. Additionally, the 2023 disclosures emphasized the inclusion of a TSR modifier for FFO performance conditions, indicating a more nuanced valuation model. The dilutive effect remained minimal in both years, with no material impact on earnings per share or unit calculations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces details not present in the ground truth. While the ground truth states that in 2022, SPG disclosed LTIP units as potentially dilutive with no material effect for 2019–2021, the LLM incorrectly claims specific vesting dates (January 1, 2025) and Monte Carlo modeling usage in 2022 without confirming the lack of material dilutive effect. The 2023 disclosures in the ground truth emphasize Monte Carlo modeling for market-based LTIP units and their treatment as participating securities under the two-class method, but the LLM shifts focus to a 'TSR modifier for FFO performance conditions' and a '$42.5 million' maximum fair value—details absent in the original answer and unverifiable against the ground truth. (2) Quantitative accuracy is low: the dollar amount ($42.5M), vesting dates (2025, 2027), and specific program names ('2023 LTI Program') are not mentioned in the ground truth and appear to be hallucinated. There is no mention of FFO or TSR modifiers in the original, nor is there a comparison of vesting periods. (3) The multi-hop reasoning is partially sound in that it attempts to compare 2022 and 2023 disclosures around valuation and dilution, but it fails to capture the core evolution: from a high-level dilution statement to a more granular disclosure involving Monte Carlo modeling and classification as participating securities. Instead, it invents new metrics and timelines. (4) Contextual relevance is high because the answer addresses the general theme of evolving disclosure and valuation, and attempts to discuss dilutive effects and modeling changes. However, the qualitative accuracy is compromised by incorrect entity details and unsupported specifics, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 490,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "Between 2022 and 2024, Comcast's financial commitment to Atairos Group, Inc. evolved as follows: \n\n- **Capital Funding**: In 2022, Comcast contributed $52 million, increasing to $145 million in 2023 and $73 million in 2024. As of December 31, 2024, the total investment in Atairos, including advances, was $5.1 billion, down from $5.5 billion in 2023. \n- **Management Fee Commitments**: Comcast committed to funding $40 million annually for a management fee in 2024, down from $45 million in 2022. \n\nComcast's unfunded capital commitment also decreased to $1.4 billion in 2024 from $1.5 billion in 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the ground truth. (1) QUANTITATIVE INACCURACY: The ground truth states that Comcast had a commitment to fund *up to* $5 billion in 2022, reduced to *up to* $4.5 billion by 2024, not actual contributions of $52M, $145M, and $73M as claimed. The LLM incorrectly reports these as annual contributions, which are not supported by the original answer. The total investment figures of $5.1 billion (2024) and $5.5 billion (2023) are fabricated and contradict the stated commitment reductions. The management fee is misrepresented: the original answer states a *new* $40 million annual commitment in 2024, while the LLM claims it decreased from $45 million in 2022 — this reduction is not in the ground truth. (2) COMPLETENESS: The answer attempts to address capital funding and management fees but introduces false granularity (yearly contributions) not present or inferable from the original. (3) ENTITY & REASONING: While the entities (Comcast, Atairos) and time frame are correct, the multi-hop synthesis is flawed — the LLM invents specific annual funding amounts and trends (e.g., $45M to $40M fee decrease) that are not in the source. The conclusion about recalibration in the original is interpretive and absent in the LLM response, which instead presents misleading numerical trends. (4) SEMANTIC EQUIVALENCE: The LLM answer is not semantically equivalent — it shifts from a high-level commitment narrative to precise, incorrect financials. The only correct element is the $40 million management fee in 2024. The unfunded commitment figures ($1.4B/$1.5B) are also not in the original and appear invented. Overall, the answer fabricates data and misrepresents the evolution of Comcast's involvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 483,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region decreased from 312 billion cubic feet (BCF) at the end of 2023 to 296 BCF at the end of 2024. This decline, despite some upward revisions in technical estimates, was primarily driven by lower prices impacting reserves and development plan changes. The reduction suggests a decreased operational focus or strategic shift in the region, as COP appears to be reallocating resources or facing economic constraints in maintaining or expanding its natural gas reserves in Asia Pacific/Middle East.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region as 312 billion cubic feet (BCF) in 2023 and 296 BCF in 2024, matching the ground truth exactly. These numbers are accurate and properly attributed to the correct company (COP) and time periods. (2) The quantitative values are correct, and the implied decrease of 16 BCF is accurate. No calculations are required beyond this comparison, and the model presents the data correctly. (3) The reasoning is sound and goes beyond the ground truth by adding context about lower prices and development plan changes as drivers for the decline—information that is plausible and consistent with SEC filing patterns, though not explicitly confirmed in the ground truth. While this additional causality is not present in the original answer, it does not contradict it and enhances the explanation without introducing errors. The conclusion about a potential strategic shift or decreased operational focus aligns semantically with the original answer’s suggestion of a 'potential shift in operational focus or resource allocation.' (4) The answer fully addresses both parts of the question: the evolution of reserves (quantitative change) and the implication for operational focus (qualitative interpretation). The only reason for not scoring a 10 is that the original answer does not mention 'lower prices' or 'development plan changes' as causes, so including them as definitive drivers slightly exceeds the supported evidence, though it remains reasonable. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 451,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "In 2022, Comcast's wireless gateway procurement strategy focused on offering wireless gateways to customers to enhance in-and-out-of-home Wi-Fi coverage and provide features like personalized network management and advanced security through the xFi platform. By 2024, the company shifted its focus toward network deployment investments, emphasizing scalable infrastructure and line extensions to expand capacity and deliver multigigabit symmetrical speeds. This shift reflects a broader strategy to upgrade the network for future demand while continuing to support customer-facing technologies like wireless gateways.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Comcast's strategy from 2022 to 2024. In 2022, it accurately describes Comcast's focus on providing wireless gateways to customers with features via the xFi platform, which aligns with the ground truth's emphasis on procurement of customer premise equipment. In 2024, the shift toward network deployment investments, scalable infrastructure, and multigigabit symmetrical speeds is correctly identified. However, the LLM answer omits the explicit mention of wireless gateways being a 'key component' of capital expenditures and does not directly contrast 'passive procurement' versus 'active integration into infrastructure strategy,' which is a nuanced but important part of the original answer. (2) There are no numeric values, dates, or financial figures in either answer that conflict; all time periods (2022, 2024) are correct, and no calculations are required. (3) The multi-hop reasoning is sound: the model synthesizes information across time periods and strategic focus areas, correctly identifying a shift in approach. It links wireless gateway use in 2022 to customer-facing services and in 2024 to broader network upgrades. The only gap is the lack of emphasis on gateways as a capital investment item in 2024, which weakens the completeness of the synthesis. (4) The contextual relevance is high as the answer directly addresses the comparison asked. The qualitative accuracy is slightly reduced due to missing strategic framing around capital deployment, but core facts and direction of change are correct. Quantitative accuracy is perfect as no numbers are misstated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 451,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Solar Roof product has evolved in terms of strategic importance and production challenges. In 2022, Solar Roof was highlighted as part of the energy generation and storage segment, with deployments increasing due to product introductions like Megapack and Powerwall, though it operated at a lower gross margin due to manufacturing underutilization during the product ramp. By 2024, Solar Roof remained a key part of Tesla's energy strategy, but the company faced ongoing production challenges, including the need to scale manufacturing and manage costs effectively. The strategic importance of Solar Roof was underscored by its inclusion in Tesla's broader energy product offerings, though it continued to face hurdles in achieving profitability and production efficiency.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of dates (2022 and 2024), entities (Tesla, Solar Roof, Megapack, Powerwall), and overall context—namely, the evolution of Tesla's approach to the Solar Roof. It correctly identifies that in 2022, Solar Roof was part of Tesla's energy growth narrative and faced production inefficiencies, and that by 2024, it remained strategically important but continued to face production and cost challenges. However, the LLM answer misses a key nuance in the shift in tone and strategic framing: the original answer emphasizes a clear pivot from highlighting deployment success in 2022 to explicitly cautioning about production ramp delays in 2024, likening them to past vehicle and energy product launch issues. The LLM response softens this evolution by stating the product 'continued to face hurdles,' which is accurate but does not fully capture the change in corporate messaging from optimism to caution. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), and all entities and years are correct. The reasoning is sound but lacks the precise multi-hop synthesis of shifting strategic communication. Contextual relevance is high as the answer directly addresses both strategic importance and production challenges across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 368,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "Duke Energy's investment in \"Net pending transactions and other investments\" increased from $14 million as of December 31, 2022, to $54 million as of December 31, 2023. This increase suggests a strategic shift or expansion in Duke Energy's approach to managing its retirement trust investments, potentially indicating a greater focus on short-term or transitional investment opportunities within its broader asset allocation strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The original answer states that Duke Energy's investment decreased from $53 million in 2022 to $14 million in 2023, whereas the LLM claims an increase from $14 million to $54 million — reversing both the starting and ending values. This fundamental error undermines the entire response. (2) Number verification: The correct figures are $53M (2022) and $14M (2023), per the ground truth. The LLM reports $14M in 2022 and $54M in 2023 — all values are incorrect. The dollar amounts and years are swapped and misstated, indicating a severe data retrieval or synthesis failure. (3) Multi-hop reasoning assessment: The question requires comparing two annual figures across filings and interpreting the trend. The LLM failed this core task — it not only retrieved incorrect numbers but also reversed the trend (increase vs actual decrease), leading to an invalid strategic interpretation. The reasoning about 'expansion' or 'greater focus' contradicts the actual reduction, which suggests de-prioritization or completion of initiatives. (4) Justification for scores: Correctness is 1 due to complete factual inaccuracy in numbers and trend. Quantitative accuracy is 1 — all numbers and timepoints are wrong. Qualitative accuracy is 2 — while the LLM attempts strategic interpretation (hence not zero), the reasoning is based on false premises. Contextual relevance is 6 — the answer addresses the right category and attempts strategic analysis, so it's on-topic but factually flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 432,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "Between 2023 and 2024, the company's defined contribution plan expenses increased from $109 million in 2023 to $112 million in 2024. Regarding the liability-driven investment framework, the pension plan asset composition shifted slightly from 18% equity securities in 2023 to 21% in 2024, while corporate bonds increased from 57% to 63%. The postretirement plan asset composition remained relatively stable, with equity securities at 57% in both years, though corporate bonds decreased slightly from 31% to 30%.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states the defined contribution plan expenses of $109 million in 2023 and $112 million in 2024, it fabricates detailed asset composition data (e.g., 18% equity in 2023, 21% in 2024, corporate bond percentages) that are not present in the ground truth. The original answer states that the target allocation remained constant at 20%/80% equity/fixed income in both years, with no mention of actual asset shifts or postretirement plan details. (2) The quantitative accuracy is low because the model invents specific percentages for asset classes (e.g., 18%, 21%, 57%, 63%) that do not appear in the ground truth and are inconsistent with it. The only correct numbers are the $109M and $112M expense figures. (3) The qualitative accuracy is poor: the model fails to capture the core evolution — increased transparency in disclosure about the actual composition of plan assets in 2024 — and instead invents a narrative about asset allocation changes and postretirement plans not mentioned in the original. It also confuses actual asset composition with target allocation. (4) Contextual relevance is moderate because the answer addresses defined contribution expenses and asset composition, which are relevant topics, but misrepresents the nature of the evolution in the liability-driven investment framework. The key point about enhanced disclosure in 2024 is entirely missed, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 413,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "Between fiscal 2023 and 2024, Qualcomm's strategic focus on On-Device AI evolved as the company emphasized the integration of high-performance, low-power computing and on-device artificial intelligence into its broader technology roadmap. In fiscal 2024, Qualcomm highlighted its continued investment in foundational technologies, including on-device AI, to extend its reach into industries and applications beyond mobile handsets, such as automotive and IoT. The company also underscored the importance of 5G combined with on-device AI in driving innovation across these sectors. Specific investments included research and development efforts to advance AI capabilities and the pursuit of strategic transactions to support its growth and diversification strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Qualcomm's strategic focus on On-Device AI in fiscal 2023 centered on combining it with 5G and low-power computing to expand into automotive and IoT, and by fiscal 2024, this evolved into active investment and expansion via R&D and strategic transactions. The LLM correctly identifies the continuity in focus areas (automotive, IoT) and the shift toward investment-driven strategy. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes Qualcomm’s evolving strategy across two fiscal years and correctly infers a shift from vision to execution. The only minor shortcoming is that the LLM does not explicitly mention 'acquisitions' as a form of strategic transaction, instead using the broader 'strategic transactions,' which slightly reduces precision in conveying the full specificity of the 2024 shift. (4) The answer is contextually excellent—directly addresses both parts of the question (evolution of focus and specific investments) and maintains semantic equivalence with the original answer. Wording differs but meaning is preserved. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 365,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "The classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members remained consistent between the 2022 and 2023 10-K filings, as both years reference the same agreement (Exhibit 9.1) titled \"Second Amended and Restated Voting Trust Agreement, Voting Agreement and Proxy dated as of March 1, 2004.\" This consistency indicates a stable governance structure, with no material changes to the agreement or its presentation in the filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that both the 2022 and 2023 10-K filings refer to the Voting Trust Agreement as 'Second Amended and Restated.' According to the ground truth, while the 2022 filing includes this modifier, the 2023 filing omits it, referring only to the agreement dated March 1, 2004. This misrepresentation undermines the core of the answer. (2) The date 'March 1, 2004' is correctly cited in both cases, so quantitative accuracy for dates is acceptable. However, the key change in classification — the removal of 'Second Amended and Restated' — is missed entirely, which is a critical factual error despite not being a numerical value. (3) The multi-hop reasoning fails because the model does not recognize the evolution (or lack thereof) in presentation between the two years. Instead of identifying the subtle but meaningful shift in terminology that indicates stability due to no amendments, the model incorrectly asserts consistency in labeling, leading to flawed reasoning. The conclusion about governance stability may align with the ground truth, but it is based on incorrect premises. (4) Contextual relevance is moderate because the answer addresses the right entities and general topic, but the failure to detect the change in presentation severely limits its accuracy. Correctness and qualitative accuracy are low due to the central factual error in entity presentation across filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 399,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 312 billion cubic feet (BCF) at the end of 2023 to 296 BCF at the end of 2024, reflecting a modest decline. This slight reduction, despite ongoing exploration and development activities in the Middle East, indicates that the region's strategic importance to COP's global reserves portfolio has remained relatively stable but not significantly expanded in recent years. The region continues to play a role in COP's reserves, particularly through equity affiliates, but the growth in other regions, such as the Lower 48 and Canada, has outpaced developments in Asia Pacific/Middle East.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that natural gas reserves increased from 312 BCF in 2023 to 296 BCF in 2024, when in fact this is a decrease. This fundamental error undermines the entire response. The correct evolution is a decline from 312 to 296 BCF, a reduction of 16 BCF or approximately 5.1%, which the LLM fails to accurately report. (2) The quantitative inaccuracies are severe: while the two reserve figures (312 and 296 BCF) are correctly cited, their directional interpretation is reversed. The LLM says 'increased' when it should be 'decreased'. The percentage decline (~5.1%) is not mentioned, and no calculation is provided. However, the mention of equity affiliates holding additional reserves is contextually relevant, though the exact 5,870 BCF figure from the ground truth is omitted. (3) The multi-hop reasoning is partially sound—linking reserve changes to strategic importance and comparing regional focus—but it is based on a false premise (growth vs. decline). The conclusion that strategic importance has remained stable may be plausible, but it conflicts with the ground truth implication of a potential reevaluation due to the decline. The use of equity affiliates to contextualize ongoing relevance shows appropriate synthesis, but the absence of the large 5,870 BCF number weakens precision. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of reserves and strategic implications) and attempts to situate the region within COP's global portfolio. However, the reversal of the key numerical trend severely damages factual correctness, warranting a low overall score despite some structural and contextual adequacy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 463,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge underwent significant changes, particularly with the deconsolidation of Corebridge in June 2024. In 2023, Corebridge's debt, which was guaranteed by AIG under specific collateral agreements, totaled $9,368 million. By 2024, following the deconsolidation, AIG no longer guaranteed Corebridge's debt, and its retained interest in Corebridge was classified as an equity method investment. In the period from June 10, 2024, to December 31, 2024, AIG recognized $601 million in equity method income from Corebridge, primarily driven by changes in Corebridge's stock price and dividends received. Additionally, AIG sold a significant portion of its Corebridge shares, including a 21.6% stake to Nippon Life for $3.8 billion, resulting in a $282 million gain.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly around debt guarantees and specific financial figures. The original answer states that AIG did *not* guarantee Corebridge's debt in 2023—specifically noting $6,452 million in senior unsecured notes and $989 million in junior subordinated debt were *not* guaranteed by AIG. However, the LLM incorrectly claims that Corebridge's debt was 'guaranteed by AIG under specific collateral agreements,' which contradicts the ground truth. This is a major factual error affecting the debt structure narrative. (2) The LLM introduces a figure of $601 million in equity method income and a $282 million gain from share sales, which are not present in the original answer and cannot be verified against the ground truth. While the mention of Nippon Life and a 21.6% stake sale for $3.8 billion may be factually correct in external context, this information is not part of the provided ground truth and distracts from the core question about debt structure and equity method income evolution. (3) The multi-hop reasoning is partially sound—the model correctly identifies the shift from consolidation to equity method accounting in mid-2024 and links it to discontinued operations and income recognition based on stock price changes and dividends. The timeline (deconsolidation in June 2024, income from June 10 onward) aligns with the original answer. (4) Despite incorrect details on guarantees and unsupported financial figures, the LLM captures the high-level transformation in AIG's relationship with Corebridge—shifting from consolidated subsidiary with debt on balance sheet to equity method investment with income reporting. This core conceptual accuracy supports a moderate score, but significant factual deviations, especially on debt guarantees and unverified numbers, prevent a higher rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 506,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "From 2022 to 2024, NextEra Energy's investment strategy in Special Use Funds has shown a shift in allocation between fixed income and equity securities. In 2022, the total fair value of Special Use Funds for NEE was $2,505 million in fixed income securities and $5,511 million in equity securities. By 2024, this increased to $1,342 million in fixed income and $9,799 million in equity securities. This suggests a significant increase in equity exposure relative to fixed income, indicating a higher risk appetite and potentially a longer-term investment horizon. The shift may also reflect a strategic decision to capitalize on equity market opportunities while maintaining a portion of fixed income for liquidity and stability.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, in 2022, NextEra Energy's Special Use Funds were entirely composed of fixed income securities at $2,505 million and there was no equity allocation. However, the LLM incorrectly states that in 2022, NEE had $5,511 million in equity securities, which is completely false. In 2024, the LLM reports $1,342 million in fixed income and $9,799 million in equity, but the ground truth shows fixed income totaling $722M (U.S. Government/municipal) + $685M (corporate debt) + $873M (asset-backed) = $2,280 million in fixed income and $6,164 million in equity. The LLM overstates both total size and misallocates the split. (2) The numbers are significantly off: 2022 equity should be $0, not $5.5B; 2024 equity is overstated by $3.6B; fixed income in 2024 is misreported as $1.3B vs actual $2.28B. Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning is flawed because the model fails to correctly extract and compare the composition across years. It invents data for 2022 that does not exist in the source. While the general direction of increased equity exposure is conceptually aligned, the magnitude and starting point are wrong, undermining the conclusion. (4) Despite incorrect numbers, the answer attempts to address the question’s intent—evolution of allocation and implications for risk appetite—so contextual relevance is moderate. However, due to severe quantitative errors and incorrect entity values, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 433,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "The adoption of 5G technology has increased the risk associated with site infrastructure sharing, as carriers utilize shared equipment and radio access network (RAN) sharing, reducing the need to lease new sites or maintain equipment on existing sites. Between 2022 and 2024, this trend has intensified, with 5G deployment leading to network redundancy and slower new lease activity. As a result, American Tower faces heightened risks of reduced leasing demand and potential decommissioning of existing equipment, which could negatively impact its growth and revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of site infrastructure sharing risk between 2022 and 2024 in the context of 5G adoption and its impact on new lease activity. It accurately captures that 5G deployment has led to increased infrastructure sharing (including RAN sharing), resulting in reduced demand for new leases and potential decommissioning of existing equipment, which aligns with the ground truth. The financial and operational implications for American Tower (AMT) are correctly framed. However, the LLM answer does not explicitly mention the key evolution highlighted in the original answer: the shift in risk characterization from general infrastructure sharing in 2022 to more specific concerns around RAN sharing, roaming, or resale arrangements in 2024—and crucially, the lack of compensation to AMT despite carrier use of shared infrastructure. This nuance reflects a maturation in the risk profile that the LLM answer omits, slightly weakening the qualitative accuracy. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response remains highly relevant to the question. Semantic equivalence is largely preserved, but the absence of the compensation issue and the more precise framing in 2024 prevents a top score in qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 360,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Between 2022 and 2023, Chevron's investment in Angola LNG Limited, which holds a 36.4% interest in the company, decreased from $1,963 million to $1,762 million. Additionally, Chevron's equity in earnings from Angola LNG Limited dropped significantly from $1,857 million in 2022 to $513 million in 2023, indicating a substantial decline in the financial performance of this joint venture during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) The key facts in the LLM response—such as Chevron's investment decreasing from $1,963 million to $1,762 million and equity earnings dropping from $1,857 million to $513 million—are not supported by the original answer and are factually inaccurate based on the provided ground truth. These specific dollar amounts and financial metrics (investment value, earnings) are entirely absent from the ground truth, indicating fabrication or hallucination. (2) Quantitative accuracy is very low: none of the numbers mentioned in the LLM answer appear in the original answer, and there is no indication of financial performance changes or monetary values in the ground truth. The only correct quantitative detail is the 36.4% ownership interest, which both answers agree on. (3) Qualitatively, the LLM fails to capture the core evolution described in the ground truth—the shift from a 'Depends_On' to an 'Invests_In' relationship type—reflecting a change in investment structure and accounting classification. Instead, it fabricates a narrative around declining financials, which is not mentioned or implied in the original. The multi-hop reasoning is flawed because it does not synthesize the change in relationship type, which is central to the question. (4) Contextual relevance is moderate because the answer discusses Chevron and Angola LNG Limited over 2022–2023 and mentions equity method accounting indirectly via 'equity in earnings,' but it misses the actual focus on investment structure and accounting relationship evolution. The answer substitutes financial performance for structural and classification changes, which misaligns with the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 471,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "From 2022 to 2023, the G600 aircraft's role in Gulfstream's product lineup remained prominent as a high-performance, large-cabin business jet. By the end of 2023, cumulative deliveries of the G600 had increased to over 250 from 150 in 2021, reflecting strong market acceptance. Performance-wise, the G600 continued to hold over 90 city-pair speed records, showcasing its speed and efficiency. The aircraft's production status remained stable, with no indication of changes to its ongoing production or its position within Gulfstream's lineup during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but misses key aspects of the evolution in the G600's role from 2022 to 2023 as described in the ground truth. While it correctly notes strong market acceptance and over 250 cumulative deliveries by end of 2023, it incorrectly implies that the 150 deliveries were from 2021 without confirming 2022 delivery numbers, which undermines the year-over-year evolution. The ground truth emphasizes a shift in characterization—from 'recent addition' in 2022 to 'mature product' in 2023—which the LLM fails to capture. Additionally, the LLM mentions performance metrics like city-pair speed records, which are not referenced in the original answer and thus introduce unverified details. (2) The quantitative claim of 'over 250' deliveries by end of 2023 aligns with the ground truth and is accurate. However, the reference to '150 in 2021' is not present in the original answer and cannot be verified against the provided knowledge; this introduces a potential factual inconsistency or unsupported inference. There are no explicit calculation errors, but the use of 2021 data to contrast 2023 is not responsive to the 2022–2023 focus of the question. (3) The multi-hop reasoning is weak: the question asks about evolution in role, including performance metrics and production status, but the LLM does not address how the G600’s technological features (e.g., Symmetry Flight Deck) became foundational for newer models (G700, G800, G400), which is a central point in the ground truth. This omission represents a failure to synthesize the strategic shift from standalone product to platform enabler. (4) The contextual relevance is high because the answer discusses delivery numbers, production stability, and performance—topics relevant to the question—but the qualitative accuracy is moderate due to missing key conceptual evolution and inclusion of unsupported data points. The correctness score reflects partial factual alignment but significant gaps in capturing the nuanced role transition described in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 560,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees has evolved to emphasize greater strategic collaboration and financial co-investment. The company has increasingly partnered with franchisees to fund restaurant improvements and modernization initiatives, aiming to enhance performance and brand value. Additionally, the business model continues to prioritize franchising, with over 95% of restaurants being franchised in 2024, reflecting a strong and structured partnership that supports consistency, innovation, and profitability across the system.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in McDonald's relationship with franchisees between 2022 and 2024. It accurately identifies the shift toward greater financial co-investment and strategic collaboration, particularly in funding restaurant improvements and modernization, which aligns with the ground truth. The mention of over 95% of restaurants being franchised in 2024 is consistent with McDonald's long-standing franchising model and adds relevant context, though this specific percentage is not present in the original answer and cannot be independently verified from the provided ground truth. However, the LLM omits a key detail from the original answer: the contrast between McDonald's previously passive role in capital investment (not investing under developmental licenses in 2022) and the new active co-investment model introduced by 2024. This weakens the multi-hop synthesis slightly, as the transformation from a passive to an active financial partner is underemphasized. There are no numerical inaccuracies—dates (2022, 2024) and the implied percentage are reasonable and contextually appropriate. The reasoning is sound and relevant, and the answer remains focused on the question. While not all nuances are captured, the essential factual and strategic shift is conveyed with high accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 371,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a slight decline in net revenues, which decreased from $22,476 million to $21,756 million. However, operating income remained relatively stable, decreasing only slightly from $10,688 million in 2022 to $10,670 million in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information: net revenues decreased from $22,476 million in 2022 to $21,756 million in 2023, and operating income declined from $10,688 million to $10,670 million. These values match the ground truth exactly. (2) All numeric values are accurate and properly formatted; no calculation errors are present. The slight decrease in both metrics is correctly characterized. (3) The reasoning is sound and reflects appropriate multi-hop synthesis across the two years for both net revenues and operating income. The conclusion that revenue declined slightly while operating income remained relatively stable is logically consistent with the data. (4) The only minor shortcoming is that the LLM answer does not explicitly label the change in operating income as a 'decline'—instead saying it 'remained relatively stable'—which slightly understates the marginal drop. However, this phrasing is still reasonable given the small magnitude of change. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 317,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within BMY's product development and commercialization strategy has evolved through expanded therapeutic approvals and continued emphasis on collaboration. In 2024, Opdivo received multiple approvals, including FDA approval for Opdivo Qvantig (a subcutaneous formulation) across several indications, approval for unresectable urothelial carcinoma in Japan, and EC approval for combination therapy in colorectal cancer. These approvals reflect BMY's strategy to strengthen Opdivo's position in oncology. Collaboratively, Opdivo remains central to joint efforts with Ono in Asia and partnerships like the Nektar collaboration for combination therapies, highlighting BMY's focus on leveraging alliances to drive innovation and expand Opdivo's therapeutic applications.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Opdivo's role in BMY's strategy with relevant context on approvals and collaborations, but contains significant factual inaccuracies and omits key details from the ground truth. (1) Correct elements: The mention of continued collaboration with Ono and the 2024 urothelial carcinoma approval (though not specified as FDA or March 2024) aligns with the original answer. The focus on expanding therapeutic applications and leveraging partnerships is thematically accurate. (2) Quantitative/Specific inaccuracies: The LLM incorrectly states that Opdivo received FDA approval for Opdivo Qvantig (subcutaneous formulation) across several indications in 2024—this is not in the ground truth and cannot be assumed. It also mentions EC approval for colorectal cancer combination therapy and approval in Japan for urothelial carcinoma, which are not supported by the original answer. The critical March 2024 FDA approval for combination with cisplatin and gemcitabine in first-line unresectable/metastatic urothelial carcinoma is mentioned only vaguely without the specific regimen or regulatory authority. (3) Multi-hop reasoning: The LLM correctly infers that approvals indicate strategic expansion, but fails to capture the key shift from a joint development model (with Ono cost/profit sharing) to a more independent commercialization strategy led by BMY, which is central to the ground truth. The collaborative framework is mentioned but not contrasted between 2022 and 2024. (4) The answer is contextually relevant and well-structured, but factual deviations—especially regarding unverified approvals and lack of precise regulatory details—reduce correctness. The absence of the 80-20 cost split and equal sharing for combinations in 2022 further limits completeness and accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 492,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024 by transitioning from referencing LIBOR and EURIBOR to referencing SOFR. In 2022, debt instruments primarily referenced LIBOR or EURIBOR with applicable margins, as seen in the 2021 Credit Facility and related term loans. By 2024, the Nigeria Letters of Credit explicitly referenced SOFR as the benchmark rate for interest calculations. Additionally, covenants remained focused on maintaining debt service coverage ratios (DSCR) and compliance with financial reporting requirements, but the shift to SOFR reflects a broader industry move away from LIBOR-based instruments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in AMT's interest rate benchmark disclosures from LIBOR/EURIBOR in 2022 to SOFR in 2024, particularly citing the Nigeria Letters of Credit as a specific example. The shift away from LIBOR is accurately framed as part of a broader industry trend, which aligns with the ground truth. However, the LLM omits specific details from the 2022 disclosures about covenants tied to debt ratings and commitment fees ranging from 0.080% to 0.300%, which were present in the original answer. Additionally, while the LLM mentions covenants around DSCR and reporting, it does not reflect the ground truth observation that 2024 disclosures focused more on consequences of non-compliance rather than specifying renewal terms or interest rate structures—indicating a change in disclosure presentation. These omissions affect completeness but do not undermine the core factual accuracy. All referenced rates (LIBOR, EURIBOR, SOFR) and years (2022, 2024) are correct, and the multi-hop synthesis between years and instruments is sound. No numerical inaccuracies are present, hence high quantitative accuracy. The answer remains contextually relevant and well-reasoned, earning strong scores overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 347,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with franchisees evolved to emphasize co-investment in real estate and modernization initiatives to enhance restaurant performance and brand value. The Company continues to generally own or secure long-term leases on restaurant land and buildings under conventional franchise agreements, while franchisees invest in equipment, signage, and décor. Additionally, McDonald's collaborates with franchisees through co-investment opportunities to fund restaurant improvements and operating system upgrades, aiming to meet consumer preferences and drive higher revenue. This strategy reflects a continued focus on leveraging franchisee partnerships to maintain high operational standards and modernize the McDonald's restaurant experience globally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All key facts are correct: McDonald's typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor—this co-investment model is accurately described for the 2024 timeframe. The evolution from 2022 to 2024 is correctly framed as a shift toward a more structured co-investment strategy, even if the LLM does not explicitly state that real estate roles were 'not detailed' in 2022. (2) There are no numeric values, dates, or calculations in the response that conflict with the ground truth; all time references (2022–2024) are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across years and correctly infers a strategic evolution in franchisee relationships centered on real estate and co-investment, aligning with the documented shift from general ESG collaboration in 2022 to a clearly defined operational model in 2024. (4) The LLM emphasizes modernization and brand value, which are contextually valid extensions of 'high restaurant performance' mentioned in the original answer. The only minor shortcoming is that it does not explicitly contrast the lack of real estate detail in 2022 with the clarity in 2024, but the evolution is still logically conveyed. Thus, the answer is highly accurate, complete, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 400,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective October 26, 2022, as noted in the 2023 filing. This update likely reflects adjustments to align director compensation with evolving governance standards or regulatory requirements. The evolution of the plan indicates Altria's ongoing commitment to structured, shareholder-approved governance practices, ensuring transparency and alignment with corporate objectives in compensating its board.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key event—the amendment and restatement of the 2015 Stock Compensation Plan for Non-Employee Directors effective October 26, 2022, as reflected in the 2023 filing. This aligns with the ground truth. However, the LLM omits the specific quantitative detail from 2022 that 703,256 shares were available for issuance under the plan, which was part of the original answer and directly responsive to the 'status and documentation' aspect of the question. This omission reduces completeness. (2) The date 'October 26, 2022' is accurately reported, and no incorrect numbers are stated—thus, quantitative accuracy is high. The missing share number (703,256) is a factual omission but not an error in calculation or misstatement. (3) The reasoning is sound: the LLM correctly infers that the amendment likely reflects alignment with evolving governance standards or regulatory requirements and interprets this as evidence of Altria’s structured governance approach. It synthesizes the implication correctly, though it does not explicitly reference the incorporation by reference from the September 30, 2022, Form 10-Q, which is a minor gap in entity/source linkage. (4) The answer is contextually highly relevant, directly addressing both the change in the plan and its implications for governance. The conclusion about Altria's commitment to shareholder-approved, transparent governance practices is semantically consistent with the ground truth’s interpretation. The score is reduced from 9 to 8 due to the omission of the share availability figure, which is a material detail in assessing the plan’s status in 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 454,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "The impact of roaming and resale arrangements among wireless service providers on American Tower's (AMT) leasing activity has intensified from 2022 to 2024, as these arrangements increasingly allow carriers to share infrastructure rather than lease new sites. In 2022, the filing noted that such arrangements could slow new lease activity or lead to decommissioning of existing equipment. By 2024, the impact was more pronounced, with the mention of RAN sharing, roaming, and resale arrangements linked to 5G technology explicitly reducing the need for new tower-based infrastructure. This evolution indicates growing competitive pressures, as carriers prioritize cost efficiency and network optimization over expanding their leased infrastructure footprint, thereby constraining AMT's new lease growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: the evolution from 2022 to 2024 is properly captured, with roaming and resale arrangements initially posing a risk to new lease activity and later expanding to include RAN sharing, which threatens both new leases and existing equipment. The mention of 5G technology as a driver is consistent in both answers. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2024) are correct and used appropriately. (3) The multi-hop reasoning is sound—information is synthesized across time periods and technological developments (e.g., infrastructure sharing trends intensifying over time). The LLM correctly infers that increased sharing reduces the need for new leasing, indicating competitive pressure. (4) The only minor shortcoming is that the LLM slightly conflates the 2022 risk by stating it 'could slow new lease activity or lead to decommissioning of existing equipment,' whereas the original answer specifies that decommissioning became a more explicit concern by 2024, not 2022. This is a subtle but important distinction in the evolution of risk. Otherwise, the answer is semantically equivalent, contextually relevant, and accurately reflects the growing competitive pressure from infrastructure sharing. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 416,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees has evolved to emphasize strategic investment and operational alignment to drive growth and modernization. The Company has increasingly collaborated with franchisees on capital-intensive initiatives, including co-investing in restaurant improvements to meet consumer preferences and enhance brand value. Operational expectations have also shifted to prioritize technology integration, digital engagement, and adherence to McDonald's Global Brand Standards, ensuring consistency and quality across all locations. This approach reflects a stronger partnership model, where franchisees are expected to actively participate in innovation and reinvestment efforts to support long-term profitability and brand strength.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in McDonald's relationship with its franchisees between 2022 and 2024. It accurately reflects the shift from operational challenges to a more strategic, investment-focused partnership. While the original answer specifically references the 'Accelerating the Arches' strategy and the impact of the pandemic in 2022—including labor and supply chain issues—the LLM answer generalizes these points but still correctly identifies increased collaboration, co-investment, and modernization as central themes by 2024. The mention of technology integration, digital engagement, and Global Brand Standards aligns with McDonald's operational expectations, though these specifics are not explicitly in the ground truth; however, they are reasonable inferences consistent with the direction of the brand's strategy. There are no numerical values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. The qualitative accuracy is slightly reduced because the LLM omits the explicit pandemic context in 2022 and does not name the 'Accelerating the Arches' strategy, which are key anchors in the original answer. Nevertheless, the reasoning is sound, and the synthesis across time periods is logically presented. Contextual relevance is strong, as the response directly addresses both strategic investment and operational expectations as asked. Minor omissions prevent a perfect score, but the overall meaning and trajectory are correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 421,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "NextEra Energy's investment strategy in equity securities within its Special Use Funds evolved from 2022 to 2024 by increasing the fair value of equity securities held. In 2022, the fair value of equity securities in the Special Use Funds was $2,349 million for NEE and $863 million for FPL. By 2024, this amount had grown to $2,614 million for NEE and $1,028 million for FPL. Additionally, the unrealized gains on equity securities improved significantly, shifting from a loss of $1,028 million in 2022 to a gain of $917 million in 2024, indicating a more favorable market performance and a strategic shift toward higher-value equity investments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. The ground truth states that in 2022, NextEra Energy reported $8,922 million in total Special Use Funds with no breakdown of equity securities. The LLM incorrectly claims that in 2022, equity securities were $2,349 million for NEE and $863 million for FPL—this breakdown does not appear in the 2022 filing and contradicts the ground truth. Similarly, for 2024, the ground truth states that $6,164 million was allocated to equity securities in total, but the LLM reports $2,614 million for NEE and $1,028 million for FPL (summing to $3,642 million), which is significantly lower and inconsistent. Additionally, the LLM introduces unrealized gains shifting from a $1,028 million loss in 2022 to a $917 million gain in 2024—this data is not present in the ground truth and appears fabricated. (2) All numeric values are incorrect and do not match the ground truth. The total Special Use Funds decreased from $8,922 million in 2022 to an unspecified total in 2024 (with $6,164 million in equities), but the LLM invents granular figures for NEE and FPL that are not supported. Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning is flawed. The question asks about the evolution of investment strategy in equity securities within Special Use Funds, and the ground truth emphasizes increased transparency and explicit disclosure in 2024 versus no breakdown in 2022. The LLM fails to capture this key point and instead fabricates detailed figures and trends that do not exist, indicating a failure to synthesize actual filing data. (4) The answer is contextually relevant in topic (discussing equity investments in Special Use Funds) but factually and quantitatively incorrect throughout, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 495,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a decline in net revenues, which decreased from $22,476 million in 2022 to $21,756 million in 2023. Operating income remained relatively stable, with a slight decrease from $10,688 million in 2022 to $10,670 million in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures: net revenues of $22,476 million in 2022 and $21,756 million in 2023, and operating income of $10,688 million in 2022 and $10,670 million in 2023. These match the ground truth exactly, with acceptable formatting (e.g., 'million' vs 'M'). (2) Quantitative accuracy is perfect—no calculation or number errors. The year-over-year decreases are correctly implied by the values provided. (3) The reasoning is sound and synthesizes the correct metrics across two years for the smokeable products segment. The conclusion that net revenues declined and operating income remained relatively stable with a slight decrease is logically supported by the data. However, the original answer explicitly characterizes the trend as a 'marginal decrease in both revenue and profitability,' while the LLM slightly downplays the operating income decline by calling it 'relatively stable.' While not incorrect, this softens the conclusion slightly, warranting a minor deduction in qualitative accuracy. (4) The answer is fully contextually relevant, addressing both net revenues and operating income across 2022 and 2023 as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 339,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "Between 2022 and 2023, Accenture plc increased its share repurchase activity, with the 2023 authorization for open-market share purchases rising to $6,129,296 from $3,129,296 in 2022. In 2022, the company repurchased 12,180,917 Class A ordinary shares for $4,111,266, while in 2023, the additional $3,000,000 in repurchase authority suggests a strategic focus on returning value to shareholders. These repurchased shares are held as treasury shares and may be used for employee benefits, such as equity awards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies, particularly in quantitative claims. The original answer states that in 2022, Accenture had an aggregate available authorization of $3,129,296 for share purchase programs. The LLM incorrectly claims that the 2023 authorization rose to $6,129,296, implying a $3 million increase, which is not supported by the ground truth. The original answer does not state any increase in authorization in 2023, nor does it specify the total authorization amount for 2023. Additionally, the LLM invents a figure of 12,180,917 shares repurchased for $4,111,266 in 2022, which is entirely absent from the ground truth. (2) There are no verifiable calculations in the LLM response that align with the original data; the $3,000,000 increase is fabricated. The only correct number mentioned is the 2022 authorization of $3,129,296. (3) The qualitative reasoning partially captures the intended usage of shares—correctly noting that repurchased shares are held as treasury shares and used for employee benefits like equity awards. It also correctly identifies the relevance of share purchase programs. However, it misses the key 2023 clarification about usage and fails to mention the separate mechanism in fiscal 2024 involving share withholding for payroll taxes, which is important context. (4) The contextual relevance is moderate because the answer addresses share purchase programs and intended usage, but the severe quantitative errors and invented data undermine correctness. The model introduces false precision and misleading trends (e.g., increased authorization), which distort the actual evolution. Thus, while the general direction (use for employee benefits) is correct, the factual foundation is flawed, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 489,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "Between 2022 and 2024, AMT's operating covenants remained largely consistent in structure, focusing on financial metrics like debt service coverage ratios (DSCR) and restrictions on additional debt, asset sales, and liens. In 2022, the covenants primarily applied to USD and EUR denominated debt instruments under term loans and credit facilities, with interest rates benchmarked to LIBOR or EURIBOR plus a fixed margin of 1.125%. By 2024, the covenants continued to apply to similar debt instruments, including securitizations and subsidiary debt, with interest rates still tied to LIBOR or EURIBOR, though specific rates and spreads were not detailed for newer instruments. The core covenant framework remained focused on maintaining sufficient liquidity and financial stability to service debt obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several inaccuracies and misses the key evolution highlighted in the ground truth. (1) It incorrectly states that AMT's covenants in 2024 still used LIBOR or EURIBOR as benchmarks, while the ground truth confirms a shift to SOFR, specifically for letters of credit in Nigeria. This is a major factual error, as the transition from LIBOR/EURIBOR to SOFR is central to the question. (2) The LLM introduces specific details not present in the ground truth, such as a 'fixed margin of 1.125%,' which is unsupported and potentially misleading. (3) The answer emphasizes consistency in covenant structure (e.g., DSCR, restrictions), which is not addressed in the original answer and distracts from the core focus on interest rate benchmark evolution. (4) While the LLM correctly identifies the types of debt instruments (credit facilities, term loans) in 2022, it fails to acknowledge the structural shift in 2024 toward SOFR-based pricing, missing the regulatory and strategic implication noted in the ground truth. (5) The multi-hop reasoning is flawed: the question requires tracing a change in benchmark rates across time and instruments, but the LLM asserts continuity where there is documented change. (6) Contextually, the answer is relevant to AMT and debt covenants but misdirects on the nature of the evolution. Quantitative accuracy is low due to the fabricated spread and incorrect benchmark persistence. Qualitative accuracy suffers from incorrect synthesis and omission of the SOFR transition. Correctness is severely impacted by these core factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 436,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "Between the 2023 and 2024 SEC filings, Disney+ Hotstar's subscriber base remained relatively stable, with approximately 36 million paid subscribers as of September 28, 2024, compared to the prior year. The consolidation of Star+ into Disney+ in Latin America during June 2024 streamlined Disney's international streaming strategy by simplifying its product offerings and enhancing content integration, allowing for a more cohesive and competitive presence in the region. This move reflects Disney's broader strategy to unify its streaming services and optimize user experience across markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Disney+ Hotstar had approximately 36 million paid subscribers as of September 28, 2024, which matches the ground truth. However, the phrasing 'compared to the prior year' implies a year-over-year comparison, but the original answer does not provide the 2023 subscriber number—only the 2024 figure—so the claim of stability is an inference not directly supported by the source. This is a minor overreach but does not introduce false data. (2) The date 'September 28, 2024' is correctly cited, and the June 2024 consolidation of Star+ into Disney+ in Latin America is accurately placed. The only nuance missing is that the 2023 filing reported the state *prior* to the merger, while the 2024 filing reflects the post-consolidation strategy. (3) The multi-hop reasoning is sound: the LLM correctly links the Star+ consolidation to a broader international strategy of streamlining services, drawing a parallel to the Disney+ Hotstar model. It synthesizes subscriber data and strategic changes across filings appropriately. (4) The answer is contextually excellent, addressing both subscriber evolution and strategic impact. The minor deduction in quantitative accuracy is due to the unsubstantiated implication of stability without explicit prior-year data in the ground truth. Overall, the answer is factually aligned, well-reasoned, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 388,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "The number of employees covered under collective labor agreements decreased from approximately 3,000 in 2022 to around 2,100 in 2023. This reduction suggests that the company may be either renegotiating agreements with fewer employees or adjusting its workforce structure, while still maintaining a strategic focus on managing labor agreements with minimal disruption to operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in employees covered under collective labor agreements from approximately 3,000 in 2022 to 2,100 in 2023, matching the ground truth. All quantitative figures are accurate and properly contextualized. (2) The numbers are correct and consistent with the original answer—3,000 and 2,100 employees for the respective years—with no calculation errors. Format variations (e.g., 'approximately' vs 'around') are acceptable and semantically equivalent. (3) The reasoning is sound: the LLM correctly infers a reduction in employees involved in negotiations and links it to potential strategic adjustments in labor agreement management. While the original answer emphasizes fewer expiring agreements or proactive resolution, the LLM suggests possible workforce restructuring or reduced renegotiation scope—this is a reasonable interpretation and aligns with the trend. The multi-hop synthesis across years and implications is logically valid. (4) The answer is fully relevant, addresses both parts of the question (change in number and strategic implication), and conveys the same core information. The only minor difference is in the specificity of the strategic reason (e.g., 'fewer expiring agreements' not explicitly mentioned), but the LLM's interpretation remains plausible and consistent with the data. Thus, the answer is highly accurate with only slight room for added nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 397,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "NextEra Energy's investment in U.S. Government and municipal bonds increased from 2022 to 2024. In 2022, the total value was $137 million, in 2023 it rose to $722 million, and by 2024, it reached $1,383 million (sum of $663 million for NEE and $522 million for FPL). This represents a significant increase of $1,246 million over the two-year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that NextEra Energy's investment in U.S. Government and municipal bonds was $137 million in 2022 and increased to $161 million in 2024, a change of $24 million. However, the LLM claims the investment rose to $722 million in 2023 and $1,383 million in 2024, which is over 8 times higher than the correct value. The LLM also introduces FPL ($522 million) and NEE ($663 million) as components, but the ground truth only references NEE's 'Other investments' and does not mention FPL in this context. (2) The quantitative inaccuracies are severe: the 2024 value is wrong by over $1.2 billion, and the claimed increase of $1,246 million is completely unsupported by the ground truth. The calculation of growth is based on fabricated data. (3) The multi-hop reasoning is flawed—the model fails to correctly extract and synthesize the actual investment values across years and incorrectly combines entities (FPL and NEE) that were not indicated in the original answer. There is no evidence in the ground truth for a $722 million figure in 2023 or a split between NEE and FPL in 2024. (4) The contextual relevance is low but not zero because the answer addresses the general topic (evolution of bond investments) and attempts a year-over-year comparison. However, due to massive factual and numerical errors, the answer is misleading and substantially incorrect. Correctness, quantitative, and qualitative scores are very low as a result.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 424,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "Between 2022 and 2024, Opdivo's role in Bristol-Myers Squibb's portfolio has expanded significantly in terms of therapeutic approvals and manufacturing strategy. In 2022, Opdivo benefited from FDA's expedited review processes, such as the Assessment Aid pilot program, which accelerated its approval for non-small cell lung cancer (NSCLC). By 2024, Opdivo received multiple new approvals, including for urothelial carcinoma in Japan and the U.S., unresectable urothelial carcinoma in Japan, and new indications in colorectal cancer through the EC. Additionally, Opdivo Qvantig, a subcutaneous formulation, was approved in late 2024, enhancing delivery options. Manufacturing-wise, BMS maintained internal production capabilities while also utilizing third-party manufacturers to meet growing demand, reflecting a strategic shift toward flexible and scalable supply chain solutions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that in 2022 Opdivo benefited from the FDA's Assessment Aid pilot program for approval in non-small cell lung cancer (NSCLC); this specific event is not supported by the ground truth and misrepresents the 2022 context, which focused on manufacturing strategy, not new approvals. The ground truth highlights that in 2022, Opdivo relied on both internal and third-party manufacturing, which the LLM correctly notes. However, the LLM fabricates or misattributes approvals in 2022 that are not in the original answer. (2) Regarding 2024, the ground truth specifies a single, clear FDA approval in March 2024 for first-line treatment of unresectable or metastatic urothelial carcinoma in combination with cisplatin and gemcitabine. The LLM overstates this by claiming 'multiple new approvals' including in Japan and for colorectal cancer via the EC, which are not mentioned in the ground truth. The subcutaneous formulation Opdivo Qvantig is mentioned as approved in late 2024, but this detail is absent from the ground truth and cannot be verified as correct. (3) The multi-hop reasoning is partially sound—linking manufacturing strategy and therapeutic expansion over time—but the synthesis is flawed due to inclusion of unverified approvals and misattribution of events to incorrect years. The core idea of expanded role is directionally correct, but execution lacks factual fidelity. (4) The contextual relevance is high because the answer addresses both manufacturing and therapeutic evolution as asked. However, correctness and quantitative accuracy are significantly reduced due to incorrect dates, unverified approvals, and fabricated program details. Minor formatting issues aside, the key issue is introduction of unsupported facts rather than omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 502,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "Between 2023 and 2024, National Geographic magazine remained under the Entertainment segment, where it is reported with Content Sales/Licensing. There is no indication of a structural change in its ownership or reporting within Disney’s portfolio during this period. However, its strategic positioning appears to have been reinforced through continued integration with Disney’s broader content and streaming platforms, such as Disney+, where National Geographic is a top-level tile. This suggests a focus on leveraging National Geographic's brand and content to enhance Disney’s direct-to-consumer offerings and global content library.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in stating that National Geographic magazine remained under the Entertainment segment and Content Sales/Licensing, which aligns with the ground truth. However, it fails to accurately capture the key evolution in Disney's relationship with National Geographic between 2023 and 2024. The ground truth highlights a notable shift: in 2023, Disney explicitly reported a 73% ownership stake, but in 2024, the language changed to emphasize 'publishing' rather than ownership, indicating a more operational and less equity-focused relationship. The LLM answer incorrectly states there is 'no indication of a structural change,' which contradicts the documented shift in reporting and strategic framing. While the mention of integration with Disney+ is contextually relevant and plausible for strategic positioning, it is not supported in the ground truth and distracts from the actual structural change in ownership representation. Quantitatively, no numbers are misstated (the 73% figure is not mentioned in the LLM response, but it doesn't invent any incorrect figures), so quantitative accuracy is high. However, the failure to identify and explain the ownership-to-operation shift—a core multi-hop insight across years and reporting language—results in low qualitative accuracy. The answer is contextually relevant but misses the factual evolution, leading to a correctness score of 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 390,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "PayPal's description of its transaction management databases' capabilities in 2024 shows an expanded emphasis on supporting global payment processing in different currencies compared to 2023. In 2023, the document noted that PayPal's platform enabled transactions in approximately 150 currencies and allowed customers to hold balances in 24 currencies. By 2024, the description highlights that PayPal's platform supports sending payments in approximately 140 currencies, withdrawing funds to bank accounts in 57 currencies, and holding balances in 24 currencies, indicating a slight reduction in the number of supported payment currencies but an increase in withdrawal currency options. This evolution reflects PayPal's ongoing efforts to enhance its global payment infrastructure and adapt to regulatory and market demands.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, the ground truth states that in 2023 PayPal allowed withdrawal of funds in 56 currencies and updated this to 57 in 2024. However, the LLM claims that in 2023 the platform supported transactions in approximately 150 currencies and holding balances in 24, and in 2024 supports 140 payment currencies and 57 withdrawal currencies—none of which are mentioned in the original answer. These numbers (150, 140, 24) are entirely fabricated or misattributed and not supported by the ground truth. (2) The original answer focuses solely on the number of withdrawal currencies increasing from 56 to 57 and a shift in language emphasis from merchants to consumers. The LLM introduces unrelated metrics like 'sending payments in X currencies' and 'holding balances in 24 currencies,' which are not present in the ground truth, indicating a failure in multi-hop reasoning and entity alignment. (3) While the LLM correctly identifies a change in currency support between years and attempts to interpret strategic implications, it does so using incorrect data, leading to a misleading conclusion about a 'reduction' in payment currencies. (4) Contextually, the answer addresses the evolution of PayPal's capabilities in global payment processing, so it remains relevant in topic, but the incorrect data renders the response substantially inaccurate. The qualitative reasoning would be sound if based on correct facts, but due to fundamental errors in entity and numerical accuracy, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 439,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "The interest rate terms associated with the Series K Debentures increased from an initial issuance in February 2020 to a reset rate of 6.051% per year in March 2023. This indicates that NEE's financing strategy involves leveraging remarketing opportunities to secure more favorable interest rates, reflecting a proactive approach to managing debt costs in a changing interest rate environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 6.051% interest rate reset in March 2023, which matches the ground truth. However, it incorrectly references an 'initial issuance in February 2020' that is not mentioned in the original answer, introducing extraneous information. The 2024 update is omitted—the original answer notes that terms were reaffirmed via a letter dated March 1, 2023, effective the same date, indicating continuity into 2024, which the LLM fails to mention. (2) Quantitatively, the 6.051% rate and March 2023 timing are accurate. No calculations are required, and the numbers presented are correct. (3) The reasoning is partially flawed: while the LLM correctly infers that NEE uses remarketing to manage debt, it characterizes the 6.051% reset as 'more favorable,' whereas the ground truth suggests a higher rate was locked in, likely due to rising market rates—thus, 'favorable' is contextually questionable and misrepresents the strategic implication. The multi-hop synthesis is incomplete, as it does not connect the 2023 reset to the 2024 continuation of terms. (4) The answer is contextually relevant and addresses the evolution of interest rate terms and financing strategy, but misses key nuances in the strategic indication—adjusting to market conditions by accepting a higher rate, not necessarily securing a 'favorable' one. Hence, correctness is reduced due to incomplete and slightly misleading interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 400,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "ExxonMobil's application of the Unit-of-Production Depreciation method between 2022 and 2023 remained consistent in its core approach, with adjustments primarily driven by changes in proved reserves and commodity prices. In 2022, higher realized oil prices ($87.25 per barrel) compared to 2021 ($61.89) likely influenced reserve estimates and, consequently, depreciation rates. In 2023, despite a slight decline in oil prices to $69.85 per barrel, the method continued to rely on proved reserves as the basis for depreciation, with revisions reflecting updated reserve estimates and production data. Notably, the Corporation maintained its disciplined process for reserve estimation and asset depreciation, ensuring equitable cost allocation over the economic life of upstream assets, even as it adapted to evolving market conditions and regulatory environments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces unsupported quantitative data not present in the ground truth. Specifically, it cites oil prices of $87.25 per barrel in 2022 and $69.85 in 2023, which are not mentioned or verifiable from the original answer and appear to be fabricated or incorrectly sourced. These numbers undermine the quantitative accuracy. Additionally, the original answer does not reference year-over-year price changes as a driver of depreciation method evolution, so this emphasis is misleading. (2) The original answer highlights a methodological refinement in 2023: increased reliance on the most recent SEC price for depreciation when reserves are significantly de-booked. The LLM answer fails to mention this key shift and instead generalizes about 'updated reserve estimates' and 'market conditions' without capturing the specific policy refinement related to SEC pricing. (3) While the LLM correctly identifies that the core Unit-of-Production method remained consistent and that proved reserves are central, it misses the multi-hop nuance: the conditional shift to straight-line depreciation when asset life doesn't correlate with reserves, and the specific trigger (substantial de-booking) for using SEC price-based reserves. These are critical components of the evolution described in the ground truth. (4) The answer is contextually relevant and structured well, addressing the general theme of depreciation method stability with adjustments due to reserves and prices. However, the lack of precise methodological details and introduction of incorrect numerical data significantly reduce factual correctness. The qualitative reasoning is partially sound but lacks the specific synthesis required by the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 485,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "Between 2023 and 2024, Netflix has increasingly scaled its internal studio operations to produce original programming, as highlighted by its acquisitions such as Scanline and Animal Logic. This shift reflects a strategic move to reduce reliance on third-party production partners and enhance control over content creation. The company is focusing on expanding its in-house capabilities in creative, marketing, and production disciplines to support its growing original content portfolio, which includes TV series, films, games, and live programming.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies Netflix's strategic shift toward internal studio scaling through acquisitions like Scanline and Animal Logic, and notes the reduced reliance on third-party production partners, which aligns with the ground truth. It accurately reflects the 2023 emphasis on internal scaling and the direction of reduced dependency on external partners. However, it omits a key qualitative detail present in the original answer: the explicit mention in 2023 of risks associated with third-party partners (legal violations, insolvency, fraud) and the notable shift in 2024 language—where such risks were no longer mentioned, and the focus turned to internal systems, culture, and operational practices. This omission reduces completeness in capturing the evolution of strategic emphasis as reflected in Netflix's own disclosures. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Netflix, Scanline, Animal Logic, years 2023–2024) are correct. The reasoning is sound but lacks full synthesis of the change in risk disclosure tone between years, which is central to the multi-hop comparison. Contextual relevance is strong as the answer directly addresses the question's focus on strategic evolution in production reliance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 356,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "Between 2022 and 2023, Mastercard's Cyber and Intelligence Solutions evolved to become a more integral part of its value-added services, emphasizing security and trust in digital transactions. The strategic positioning highlighted the importance of these solutions in preventing, detecting, and responding to fraud, ensuring secure transactions, and leveraging data analytics for insights. This evolution reflects Mastercard's broader focus on enhancing the safety and efficiency of the global payments ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's Cyber and Intelligence Solutions from a fraud-focused offering to a more strategic, value-added service enhancing security and trust in digital transactions. It accurately reflects the increased strategic importance of the solutions in supporting secure transactions and leveraging data analytics. However, it omits the specific structural change noted in the ground truth — that in 2022, these solutions were categorized under 'Other revenues' — which is a key detail about their initial positioning. The 2023 elevation to a broader role enabling secure, easy, and confident transactions across the payments ecosystem is partially conveyed but not explicitly tied to new network investments or integration with core operations as stated in the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable; the years 2022 and 2023 are correctly referenced, earning full marks. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points and infers a strategic shift. However, it misses the explicit reclassification and expanded scope mentioned in the ground truth, slightly weakening the qualitative accuracy. (4) The answer is highly contextually relevant, directly addressing the evolution in strategic positioning. The correctness score is 8 because the core facts are accurate and the overall direction of evolution is correctly described, but a key detail about the 2022 categorization under 'Other revenues' and the explicit link to network investments in 2023 are missing, preventing a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 464,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "From 2023 to 2024, Tesla's approach to energy storage products has evolved by emphasizing modular design and software optimization to enhance scalability and performance. In 2023, the company highlighted the integration of vehicle technologies into energy storage systems and the development of remote control and dispatch software. By 2024, Tesla expanded on these efforts, focusing on improving manufacturing efficiency and leveraging its expertise in power electronics to optimize grid interconnectivity. However, production challenges such as supply chain constraints and the need for localized procurement at new manufacturing facilities remain significant hurdles. Additionally, Tesla continues to rely on strategic supplier partnerships for key components, exposing it to risks related to component availability and cost volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and evolution of Tesla's energy storage strategy from 2023 to 2024. It accurately captures the emphasis on modular design, software optimization, and in-house expertise in power electronics in 2023, and the shift in 2024 toward addressing production scalability, supply chain constraints, and manufacturing efficiency. The mention of supplier partnerships and associated risks (availability, cost volatility) matches the ground truth's focus on supplier reliability and strategic dependencies. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is slightly reduced because the LLM introduces details not present in the ground truth—such as 'integration of vehicle technologies' and 'localized procurement at new manufacturing facilities'—which, while plausible, are not mentioned in the original answer. Additionally, the ground truth specifically emphasizes 'production ramps' and 'meeting planned output rates and quality standards,' which the LLM touches on indirectly but does not explicitly highlight. Despite these minor deviations, the core multi-hop reasoning—synthesizing Tesla’s strategic shift across years and identifying evolving challenges—is sound and semantically equivalent. Contextual relevance is perfect, as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 400,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "NextEra Energy Capital Holdings (NEECH) significantly expanded its issuance of floating rate debentures from 2023 to 2024. In 2023, NEECH issued $600 million of floating rate debentures due in 2026. By January 31, 2024, this strategy evolved with the issuance of an additional $600 million of floating rate debentures due in 2026, maintaining the same maturity structure but increasing the principal amount by $600 million compared to 2023. This reflects a more aggressive approach to leveraging floating rate instruments in early 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that NextEra Energy Capital Holdings issued an additional $600 million in floating rate debentures in 2024, implying a total of $1.2 billion. However, the ground truth confirms only the original $600 million issuance was disclosed in 2023, and in 2024, the company formalized the same series (due January 29, 2026) via an Officer's Certificate without updating or increasing the principal amount. Thus, the claim of an 'additional' $600 million is factually incorrect. (2) The date January 31, 2024, is correctly cited, and the 2026 maturity is accurate, but the core financial claim—doubling the principal—is unsupported by the source. This is a major quantitative error. (3) The reasoning fails on multi-hop synthesis: while the model identifies both years and the instrument, it incorrectly infers expansion from formalization. The ground truth emphasizes continuity and consistency, not growth or strategic shift. The LLM misinterprets the 2024 Officer's Certificate as a new issuance rather than a specification of terms for the previously disclosed debt. (4) Scores reflect severe factual inaccuracy in numbers and interpretation (correctness 3/10), poor quantitative accuracy due to false doubling of principal (3/10), flawed reasoning and entity-event linkage (3/10), but acceptable contextual relevance as the answer addresses the right company, instrument, and timeframe (7/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 398,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "From 2023 to 2024, Intel expanded its collaboration focus and supplier engagement scope in supply chain responsibility initiatives. In 2023, the company emphasized verifying compliance and building supplier capacity to address risks like forced labor and human rights issues, primarily through audits and capability-building programs for critical direct suppliers. By 2024, Intel significantly broadened its engagement to include more suppliers and introduced new initiatives, such as expanding the number of suppliers covered by its programs and increasing efforts to reduce greenhouse gas emissions across the supply chain. Additionally, Intel set new sustainability targets, including linking executive and employee bonuses to water conservation and emissions reduction goals, and furthering collaboration on responsible minerals sourcing and industry-wide standards.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. While it correctly identifies Intel's focus on supplier engagement and sustainability, it incorrectly states that Intel 'significantly broadened its engagement to include more suppliers' and 'expanded the number of suppliers covered' in 2024. The original answer explicitly states that by 2024, there was no 'explicit mention of expanding the number of suppliers engaged,' indicating a shift from expansion to deepening existing partnerships. This is a major factual contradiction. Additionally, the LLM claims Intel linked executive and employee bonuses to water conservation and emissions reduction goals in 2024, which is not mentioned in the ground truth and lacks supporting evidence. (2) There are no specific numbers (e.g., percentages, dollar amounts, supplier counts) in either answer, so quantitative accuracy is neutral—no incorrect figures were cited, but the LLM introduced unsupported claims that could imply numerical growth without basis. (3) The multi-hop reasoning is partially sound in that the model recognizes the evolution of Intel’s initiatives and attempts to contrast 2023 and 2024 focuses. However, it fails to accurately synthesize the shift from expansion (2023) to consolidation and collaboration depth (2024), instead portraying continued expansion, which contradicts the ground truth. The emphasis on responsible minerals and transparency in 2024 is correctly noted, but the broader narrative is misaligned. (4) Correctness is scored at 4 due to significant factual errors in the evolution narrative and introduction of unsupported initiatives. Qualitative accuracy is 4 because entity identification (Intel, RISE strategy themes) is correct, but reasoning and synthesis are flawed. Quantitative accuracy is 5 since no incorrect numbers are present, but implied growth metrics are unsubstantiated. Contextual relevance is 8 because the answer stays on topic and addresses collaboration focus and supplier scope as asked, even if inaccurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 554,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "Between 2022 and 2023, XOM's framing of the standardized measure of discounted future cash flows continued to emphasize its limitations, particularly due to the use of first-day-of-the-month average prices. In both years, the company reiterated that this pricing methodology creates significant year-to-year variability and does not reliably reflect expected future cash flows or the value of its reserves. However, in 2023, the discussion became more concise, with no new qualitative changes in the characterization of the assumptions, while maintaining the critique of the standardized measure's reliability.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core characterization of the evolution between XOM's 2022 and 2023 disclosures. While it correctly identifies that both years reference first-day-of-the-month average prices and acknowledge variability, it incorrectly claims there was 'no new qualitative changes' and that the 2023 discussion was merely 'more concise.' This directly contradicts the ground truth, which states that 2023 introduced a significant shift in tone—changing from describing the measure as 'prepared on the basis of certain prescribed assumptions' (2022) to stating it 'depends on' these assumptions (2023), thereby emphasizing greater dependency and sensitivity. The LLM answer fails to capture this key qualitative evolution, which is the central point of the question. There are no numerical values in the question or answer, so quantitative accuracy is not applicable—however, the absence of numbers does not excuse the factual inaccuracy. The reasoning is flawed because it misrepresents the nature of the change in disclosure tone, suggesting continuity where there is a documented shift in framing. Contextually, the answer is relevant to the topic and addresses the right company and metric, but it misses the critical nuance of increased emphasis on dependency in 2023. Thus, while the context and entities are correct, the qualitative inaccuracy severely undermines the correctness of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 393,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "Between 2022 and 2023, Mastercard's digital identity solutions evolved significantly by enhancing integration with open banking capabilities and expanding their reach across financial institutions. In 2023, Mastercard launched a new Consumer Fraud Risk solution leveraging AI and real-time payment data to help banks prevent payment scams. Additionally, their open banking platform achieved connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks in Europe, directly and through partners. These advancements strengthened secure digital transactions and improved customer experiences by enabling seamless data sharing and fraud prevention across a broader network of financial institutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution of MA's digital identity solutions in 2023, including the significant expansion of open banking connectivity to over 95% of U.S. deposit accounts and approximately 3,000 banks in Europe, which matches the ground truth. These quantitative figures are accurate and properly attributed to 2023. However, the LLM introduces a detail not present in the original answer—'launched a new Consumer Fraud Risk solution leveraging AI and real-time payment data'—which, while plausible, is not mentioned in the ground truth and thus adds unverified information. Additionally, the original answer highlights a specific partnership to launch an ACH payment solution using open banking infrastructure in 2023, which the LLM omits. This is a meaningful detail related to the integration of digital identity with financial services and represents a gap in completeness. (2) All numbers and percentages are correct and consistent with the ground truth: 'over 95%' and 'approximately 3,000 banks' are directly aligned. (3) The multi-hop reasoning is mostly sound—the LLM correctly synthesizes the expansion of open banking reach and its impact on digital identity and fraud prevention. However, it substitutes one application (fraud risk solution) for another (ACH payment solution), which reflects a deviation in entity and initiative accuracy. (4) The contextual relevance is high as the response directly addresses the evolution of digital identity solutions with respect to open banking integration and reach. The qualitative accuracy is slightly reduced due to the omission of the ACH partnership and the introduction of an unverified product. Overall, the answer captures the core factual developments but misses a key strategic initiative and adds unsupported detail, warranting a score of 8 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 505,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "Between 2023 and 2024, Tesla's approach to the Solar Roof product has evolved to emphasize improved installation capabilities and collaboration with real estate developers and builders on new homes, as noted in the 2024 filing. In 2023, the product was described as being in the process of enhancing installation efficiency, while by 2024, the focus had shifted toward expanding integration into new residential construction. Strategic dependencies remain on supply chain management for components and collaboration with partners to scale production and installation, with production challenges potentially tied to supplier constraints and the need for localized procurement.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low because the LLM misrepresents Tesla's actual disclosures in the 2023 and 2024 filings. The original answer states that in 2023, Tesla emphasized the design maturity and integration of Solar Roof with Powerwall, positioning it as a customized energy solution. In 2024, Tesla acknowledged production ramp delays similar to past products and highlighted that its success 'depends in large part' on scaling mass-market vehicle production—implying a strategic prioritization shift away from Solar Roof. The LLM answer incorrectly claims that in 2024, Tesla emphasized collaboration with real estate developers and builders and expanding into new residential construction, which is not supported by the ground truth. It also cites 'supplier constraints' and 'localized procurement' as production challenges, but the original answer only notes general production ramp delays without specifying supplier issues. The LLM introduces new details not present in the ground truth, failing the multi-hop reasoning requirement to accurately synthesize the actual evolution in strategy and challenges. While the response is framed around the right topic (Solar Roof evolution), it fabricates key strategic shifts and dependencies, leading to a low correctness score. Contextual relevance is moderate because it addresses the Solar Roof’s development timeline and strategic factors, but with incorrect specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 431,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "NextEra Energy, Inc. introduced a Pledge Agreement on September 1, 2022, involving Deutsche Bank Trust Company Americas as Collateral Agent, Custodial Agent, and Securities Intermediary, and The Bank of New York Mellon as Purchase Contract Agent. This was followed by another Pledge Agreement on June 1, 2024, with the same counterparties. These agreements indicate an expansion or continuation of NextEra's structured financial arrangements in 2024 compared to 2023, where no Pledge Agreements were explicitly mentioned.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the September 1, 2022 Pledge Agreement and the June 1, 2024 agreement with the same counterparties (Deutsche Bank Trust Company Americas and The Bank of New York Mellon), which aligns with the ground truth. However, it fails to mention the October 1, 2024 Pledge Agreement, resulting in a significant omission. Additionally, the claim that 'no Pledge Agreements were explicitly mentioned' in 2023 is misleading — the 2023 filing disclosed the 2022 agreement, which is a key part of the evolution. (2) Dates mentioned (September 1, 2022 and June 1, 2024) are accurate, but the missing October 1, 2024 date reduces quantitative accuracy. The roles of the counterparties (e.g., Collateral Agent, Purchase Contract Agent) add detail not in the ground truth but are plausible and not factually incorrect. (3) The reasoning correctly infers an expansion or continuation of financial arrangements, showing sound qualitative logic. However, the failure to recognize that the 2023 disclosure of the 2022 agreement constitutes a reference to a Pledge Agreement weakens the multi-hop synthesis. The evolution should compare 2023's disclosure of a prior agreement to 2024's introduction of two new ones, which the LLM only partially captures. (4) Despite the omission, the answer remains contextually relevant and conveys a largely accurate narrative of increasing use of Pledge Agreements, hence high scores in qualitative accuracy and relevance. The correctness score is reduced due to the missing agreement date and mischaracterization of 2023 disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 436,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "From 2023 to 2024, Intel strengthened its strategic positioning in Edge AI by enhancing its software platform offerings and expanding ecosystem partnerships. In 2023, Intel focused on launching AI-enabled hardware like the 4th Gen Intel Xeon processors and the OpenVINO toolkit version 2023.1, while continuing to collaborate with partners such as Ericsson, Nokia, and Microsoft to drive software-defined edge infrastructure. By 2024, Intel further advanced its edge AI capabilities by introducing the Intel Xeon 6 processors and Intel Gaudi 3 AI accelerators, emphasizing performance and efficiency for edge and cloud workloads. Intel also deepened its ecosystem engagement, working with over 500 network builders and expanding its software platform to support modular, edge-native solutions for diverse industries like healthcare, retail, and smart cities.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of Intel's evolution in Edge AI from 2023 to 2024 and correctly identifies the importance of software platforms and ecosystem partnerships. However, it diverges significantly from the ground truth in key strategic details. In 2023, the original answer emphasizes Intel's edge-native software platform with modular building blocks and a horizontal approach to scaling infrastructure, avoiding vendor lock-in—this is not mentioned. Instead, the LLM focuses on specific hardware (4th Gen Xeon, OpenVINO 2023.1), which, while relevant, shifts focus away from the platform-centric strategy described in the ground truth. The 2024 evolution under the NEX initiative, which transforms fixed-function hardware into cloud-native, programmable systems, is entirely missing. The LLM mentions Xeon 6 and Gaudi 3, which are factual product releases, but these are not tied to the strategic shift toward cloud-native, general-purpose edge compute as emphasized in the original. Ecosystem partnerships are mentioned, but the LLM names Ericsson, Nokia, and Microsoft without confirming their relevance to the specific platform strategy, while the ground truth highlights broader engagement without naming specific partners. The claim of working with 'over 500 network builders' is a specific number not present in the original and cannot be verified—this introduces unverified quantitative information. While the industries (healthcare, retail, smart cities) are plausible, they are not specified in the ground truth. The reasoning is partially sound but fails the multi-hop synthesis: it does not connect Intel’s software platform evolution to the NEX initiative or explain the shift to cloud-native programmability. The answer is contextually relevant and addresses the question's scope, but lacks the core strategic narrative and introduces unverified specifics, reducing factual accuracy. Quantitative accuracy is moderate—no incorrect calculations, but introduces unsupported numbers (e.g., '500 network builders'). Qualitative accuracy suffers due to misalignment with the actual strategic framing in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 574,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "The composition and value of CVS's long-term debt related to the 1.75% senior notes due August 2030 remained unchanged between 2023 and 2024, with both years reporting $1.25 billion in aggregate principal amount for these notes. This indicates that the 1.75% senior notes due August 2030 were neither issued, redeemed, nor materially modified during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.75% senior notes due August 2030 had a value of $1.25 billion (i.e., $1,250 million) in both 2023 and 2024, matching the ground truth exactly. The formatting variation ($1.25 billion vs. $1,250 million) is acceptable and semantically equivalent. (2) All numeric values—amount, interest rate, maturity date—are accurate. There are no calculation errors. (3) The reasoning is sound: the LLM correctly infers that since the value remained unchanged, there was no issuance, redemption, or modification, which is a logical conclusion from the data. However, the original answer also mentions other senior notes due in 2030 (e.g., 3.75% due April 2030), which remained stable at $1,500 million—this contextual detail about the broader composition of 2030 debt is omitted in the LLM answer. While the question focuses on the 1.75% notes, it asks about the 'composition and value' of long-term debt related to senior notes due in 2030, implying a broader scope that includes other tranches. (4) The LLM answer is highly accurate and relevant, with perfect quantitative fidelity and strong qualitative reasoning. The minor omission of other 2030-dated notes prevents a full 10 on correctness and qualitative accuracy, but the core of the question—regarding the 1.75% notes—is fully and correctly addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 377,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "Between 2023 and 2024, Netflix's ad-supported subscription plan became a more integral part of its pricing strategy and membership growth objectives. In 2023, the plan was introduced as a lower-priced option to attract price-sensitive consumers and expand market reach. By 2024, the company emphasized this plan further as part of its broader strategy to offer a range of pricing options, aiming to meet diverse consumer needs while driving membership growth. The ad-supported tier was positioned to help Netflix retain and attract members, particularly in competitive markets and during periods of economic uncertainty, thereby supporting its global expansion and operating margin goals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Netflix introduced the ad-supported plan in 2023 as a lower-priced option to expand membership and address competition, and by 2024 it became a core part of the pricing strategy. The LLM correctly captures the evolution from an experimental offering to a strategic, integrated tier. (2) There are no numeric values (e.g., prices, subscriber counts) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2023 and 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes the plan’s introduction, its strategic intent, and its enhanced role in 2024, correctly inferring its importance for membership growth, market competitiveness, and global expansion. (4) The LLM adds slight elaboration (e.g., 'economic uncertainty', 'operating margin goals') not in the original, but these are reasonable inferences consistent with Netflix’s public strategy and do not contradict the ground truth. Only a minor deduction in qualitative accuracy due to slight expansion beyond the original scope. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 344,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "Between 2023 and 2024, Tesla's approach to the Tesla Semi evolved from early production and deliveries in 2023 to entering pilot production in 2024, as outlined in the respective 10-K filings. In 2023, the Semi was mentioned as part of Tesla's planned electric vehicles with early production underway. By 2024, the Semi was specifically listed under pilot production in the Nevada region, indicating progress in manufacturing readiness and strategic positioning to ramp production. This shift reflects Tesla's focus on expanding its commercial vehicle offerings and leveraging its manufacturing capabilities to scale production for broader market deployment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2023, Tesla began early production and deliveries of the Tesla Semi, and by 2024, the production status advanced to 'pilot production' at the Nevada facility—this matches the original answer exactly in substance. (2) There are no numeric values requiring calculation, but the years (2023 and 2024) and production phases ('early production' and 'pilot production') are correctly cited. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and two 10-K filings to show progression in production status and strategic intent. It correctly infers that moving from early to pilot production reflects a maturation in manufacturing readiness and a strategic push toward scaling. (4) The only minor shortcoming is that the LLM slightly generalizes the strategic positioning without explicitly stating that full-scale commercial production had not yet been reached—though this is implied. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 327,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024, as evidenced by the addition of new agreements for executives like Nicole J. Daggs and Brian Bolster, suggests a deliberate effort to ensure leadership continuity and reinforce the company's commitment to retaining key executive talent. This strategic emphasis on retention likely reflects the company's recognition of the value of experienced leadership in navigating its long-term goals, including growth initiatives and operational stability.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in asserting that NextEra Energy expanded its Executive Retention Employment Agreements from 2023 to 2024, reflecting a strategic emphasis on leadership continuity and talent retention. However, it introduces a factual error by naming Nicole J. Daggs as a new executive with a retention agreement in 2024, which is not supported by the ground truth. The ground truth confirms only Brian Bolster as a new addition in 2024 (May 6, 2024), while Nicole J. Daggs is not mentioned at all. This incorrect entity inclusion undermines factual accuracy. (2) Regarding quantitative accuracy, the LLM does not provide specific dates for the 2023 agreements or the new 2024 agreement beyond naming executives, and while it correctly identifies Brian Bolster’s addition in 2024, the unsupported claim about Nicole J. Daggs reduces confidence in the data sourcing. No numerical values (e.g., dollar amounts or counts) are provided in either answer, so the error lies in entity/date attribution rather than arithmetic. (3) The multi-hop reasoning is sound in structure—comparing 2023 to 2024 agreements to infer strategic intent—but flawed due to reliance on incorrect data. The logic that expansion implies increased focus on retention is valid and aligns with the ground truth, but the conclusion is based on inaccurate inputs. (4) Contextual relevance is high because the answer directly addresses the question about leadership continuity and talent retention strategy. Qualitative accuracy is moderate because the reasoning framework is correct, but entity accuracy fails. Correctness score is 6 due to a mix of valid interpretation and significant factual error in named executives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 469,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "From 2023 to 2024, Intel's approach to xPU products has evolved with a stronger strategic focus on product competitiveness and ecosystem expansion. In 2024, the company emphasized the x86 ecosystem and announced the creation of an advisory group to enhance compatibility across platforms and simplify software development. Intel is also prioritizing the development of a broad xPU portfolio, including GPUs, IPUs, FPGAs, and accelerators, to meet diverse computing needs. Additionally, the company is leveraging third-party foundry manufacturing where advantageous, providing flexibility and enabling the delivery of high-performance products.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel's xPU strategy from 2023 to 2024, highlighting the increased strategic focus on product competitiveness and ecosystem expansion through the advisory group and x86 ecosystem development. It accurately identifies the xPU product categories (GPUs, IPUs, FPGAs, accelerators) and their role in addressing diverse computing needs. However, it omits the specific context of Intel's 2023 R&D spending ($16.0 billion) and the challenges with delays and cost overruns in product development and manufacturing, which were key elements in the ground truth and important for fully addressing the 'evolution' aspect of the question. (2) There are no numeric values in the LLM answer, but it does not introduce any incorrect figures, and since the ground truth includes a dollar amount ($16.0 billion) that is missing in the response, this is a minor gap in quantitative completeness. The absence of incorrect numbers keeps the quantitative accuracy high. (3) The multi-hop reasoning is mostly sound: the model correctly infers a strategic shift toward product competitiveness and ecosystem development in 2024. However, it fails to contrast this with the 2023 context of broad R&D focus and operational challenges, weakening the comparative analysis. (4) The answer is highly relevant and conveys much of the core qualitative information, but the omission of key 2023 context reduces completeness. Hence, correctness and qualitative accuracy are slightly docked, while contextual relevance and quantitative accuracy remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 436,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "Between 2023 and 2024, Netflix's approach to advertising technology has evolved with a focus on developing the necessary infrastructure and expanding its advertising sales organization. In 2023, the company highlighted the nascent stage of its advertising offering and the risks associated with it, such as the need to build technology and infrastructure to support advertising and the development of an advertising sales team. By 2024, Netflix emphasized its efforts to drive value to advertisers through improved technology and infrastructure, indicating progress in scaling its advertising capabilities and enhancing the tools to measure and demonstrate the effectiveness of ads.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Netflix's advertising technology approach between 2023 and 2024. (1) It correctly identifies that in 2023, Netflix acknowledged the nascent stage of its advertising efforts, including risks related to building technology infrastructure and forming an advertising sales team—consistent with the ground truth emphasis on limited experience and reliance on third parties. In 2024, the LLM correctly notes Netflix's shift toward internal development of technology and infrastructure to support advertising and drive value to advertisers, aligning with the ground truth's description of building an 'advertising sales and advertising technology organization team.' (2) There are no numeric values, dates, or financial figures in the question or answers that require calculation; all temporal references (2023, 2024) are accurate. (3) The multi-hop reasoning—comparing Netflix’s strategic posture across two years using qualitative shifts in tone and focus from reliance to internal development—is sound and well-synthesized. The only minor omission is the explicit mention of 'third-party service providers' in 2023, which is part of the original nuance but not critical to the overall correctness. (4) The LLM answer conveys semantic equivalence: while it doesn't quote the exact phrasing about 'develop and expand an advertising sales... team,' it effectively communicates the same strategic progression. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only a slight lack of specificity on third-party dependency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 447,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "Between 2023 and 2024, Tesla's free Supercharging programs remained structured as performance obligations under ASC 606, with revenue recognized over time based on the expected ownership life of the vehicle. In 2024, Tesla continued recognizing revenue for unlimited free Supercharging on a straight-line basis, while limited incentives were based on actual usage or expiration. Notably, Tesla expanded its paid Supercharging revenue, which increased as part of the broader \"Services and Other\" segment, reflecting a potential shift toward monetizing Supercharging for some customers while maintaining free access as a bundled feature for others.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but misses key aspects of the evolution in Tesla's revenue recognition and program structure between 2023 and 2024. (1) Correctly identifies that revenue is recognized over time under ASC 606 and mentions straight-line recognition for unlimited Supercharging in 2024, which aligns with the ground truth's emphasis on amortization over time. However, it fails to note the critical shift from bundling free Supercharging revenue into Automotive Sales Revenue in 2023 to deferring it as a liability in 2024. This structural change—where Tesla began treating features like free Supercharging, FSD, and connectivity as separate performance obligations with deferred revenue—is central to the question and entirely omitted. (2) There are no explicit numerical values in either answer, so quantitative accuracy is not compromised; the use of terms like 'straight-line basis' and 'actual usage' is consistent with acceptable financial reporting language. (3) The multi-hop reasoning is partially sound—linking Supercharging to revenue recognition and segment reporting—but fails to synthesize the key evolution: the move from immediate bundling to deferral and amortization. The mention of growth in paid Supercharging under 'Services and Other' is contextually relevant but distracts from the core issue of how *free* Supercharging is accounted for. (4) While the answer is relevant and uses correct terminology, it misrepresents the nature of the program's evolution by focusing on continuity rather than change. The ground truth emphasizes a formal shift in accounting treatment; the LLM answer implies consistency in approach, which is inaccurate. Hence, correctness and qualitative accuracy are significantly penalized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 476,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, with the 2024 issuance featuring a fixed coupon rate of 4.85% and a maturity date of August 15, 2055, compared to the 2023 issuance with a floating rate structure. This shift toward fixed-rate, long-term debt suggests a strategy to lock in favorable interest rates amid potential market volatility and to stabilize long-term financing costs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the 2023 Series O issuance had no explicit coupon rate disclosed and a maturity date of May 1, 2079, while the 2024 issuance had a 5.55% coupon and matured on November 1, 2029. The LLM incorrectly states the 2024 coupon as 4.85% and the maturity as August 15, 2055, which is both numerically and temporally incorrect. It also falsely claims the 2023 issuance had a floating rate structure, which is not supported by the original answer. (2) Quantitative accuracy is severely compromised: the coupon rate is off by 0.7 percentage points, and the maturity date is misstated by over 25 years. The original answer highlights a shift to shorter maturities (from 2079 to 2029), but the LLM suggests a long-term maturity (2055), contradicting the trend. (3) The multi-hop reasoning is flawed. The LLM fails to recognize the strategic shift from very long-dated, potentially deferred-interest debentures to shorter-term, fixed-coupon instruments. Instead, it infers a move toward long-term fixed-rate debt, which is the opposite of the actual trend. This undermines the qualitative accuracy of the interpretation. (4) Contextual relevance is moderate—the response addresses the general question about evolution in debenture terms and attempts to interpret strategy—but due to factual errors, the conclusion is misleading. The model appears to fabricate specific terms rather than accurately reflecting the disclosed data, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 427,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "From 2022 to 2023, ExxonMobil's consideration of OPEC investment activities in its impairment assessment framework remained focused on their influence on long-term oil supply dynamics. In both years, the Corporation emphasized that OPEC's investment and production policies impact global oil supply, which, along with declining production from mature fields, is offset by new investments and technological advancements. In 2023, the Corporation explicitly included estimated costs related to its 2030 greenhouse gas emission-reduction goals in its cash flow assessments, reflecting a more detailed integration of regulatory and environmental factors into impairment evaluations. However, the core framework continued to rely on long-term supply-demand fundamentals and OPEC's role in shaping oil market conditions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures that ExxonMobil continued to acknowledge OPEC's influence on global oil supply in both 2022 and 2023, which is factually correct. It also correctly notes the increased integration of environmental factors—specifically greenhouse gas emission costs related to 2030 goals—in 2023, matching the original answer's point about forward-looking variables like emission costs and net-zero targets. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the model synthesizes information across years and correctly identifies the evolution from a more direct focus on OPEC to a broader framework. However, the LLM slightly underemphasizes the shift in framing—while it says the 'core framework continued to rely' on supply-demand and OPEC, the original answer suggests a more pronounced evolution toward embedding OPEC considerations within a wider macroeconomic and environmental context. The LLM answer makes it seem like OPEC remains a central, explicit pillar, whereas the ground truth implies it became one component of a more complex, integrated assessment. This nuance is partially missed, justifying a qualitative accuracy of 8. (4) The answer is highly relevant and responsive to the question about evolution in the impairment framework, with only minor interpretive differences from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 401,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "Netflix's approach to its ad-supported subscription plan shows a notable shift in strategic emphasis from 2023 to 2024. In the 2023 filing, the ad-supported plan is mentioned in the context of pricing strategies and potential consumer adoption challenges, but with limited detail on its role in the broader business strategy. By 2024, the plan is explicitly highlighted as part of Netflix's core strategy to \"offer a range of pricing plans, including our ad-supported subscription plan, to meet a variety of consumer needs,\" indicating a more deliberate and prominent integration into the company's growth and operational goals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2023 mention of the ad-supported plan in the context of uncertainty and consumer adoption challenges, and the 2024 framing as a core part of Netflix's pricing strategy to meet diverse consumer needs. The strategic evolution from risk-focused to strategically integrated is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages, user counts) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifying a shift in tone and strategic emphasis. The only minor shortcoming is that the LLM does not explicitly mention the 'risk' or 'uncertainty' language tied to forecasts in 2023 as strongly as the original answer, slightly downplaying the risk-disclosure context. However, it does reference 'consumer adoption challenges,' which captures part of that idea. (4) The answer is fully contextually relevant, directly addressing the evolution in level of detail and strategic emphasis. Overall, the response conveys the same semantic meaning as the ground truth with high fidelity, warranting a correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 369,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "Amazon's approach to shipping offers evolved between 2022 and 2024 by maintaining a strategic focus on price competitiveness and fulfillment efficiency. In 2022, shipping costs were driven by increased investments in the fulfillment network, labor, and carrier rates, partially offset by inefficiencies from supply chain constraints. By 2024, Amazon achieved fulfillment network efficiencies, including lower transportation costs, which helped reduce the growth rate of shipping costs. The company continued to leverage fast shipping offers as a key driver of customer demand while emphasizing operational improvements to mitigate expenses and enhance scalability.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution in Amazon's shipping strategy from 2022 to 2024, correctly identifying increased fulfillment network investments and cost drivers in 2022, and a shift toward efficiency gains by 2024. However, it omits the specific $76.7 billion shipping cost figure from 2021 mentioned in the original answer, which provides important quantitative context for the cost trajectory. While the LLM notes 'lower transportation costs' and 'reduced growth rate' in 2024, it does not explicitly state that fulfillment costs still increased due to sales and network expansion—only that efficiency gains partially offset them, which slightly weakens completeness. (2) There are no incorrect numbers or dates; the LLM avoids making up figures and does not contradict the ground truth. It refrains from citing the $76.7B number but doesn't fabricate any dollar amounts, so quantitative accuracy is high by omission rather than inclusion. (3) The multi-hop reasoning is generally sound: the model connects 2022 cost drivers (network expansion, labor, carrier rates) with 2024 efficiency improvements, showing an understanding of the strategic shift. However, it downplays the 2022 emphasis on customer-driven cost increases (faster delivery adoption) and overemphasizes price competitiveness, which was not a highlighted focus in the original. The synthesis is logical but slightly misaligned in emphasis. (4) The answer remains contextually relevant and conveys a semantically similar narrative of evolving cost pressures and operational responses. The correctness score is 7 due to accurate core facts and reasoning, minor omissions of key data points, and slight misplacement of emphasis in strategic drivers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 474,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "Between 2023 and 2024, Duke Energy's utilization and reporting of the Master Retirement Trust showed notable changes in asset allocation and disclosure practices. In terms of asset allocation, the target allocation for the RCBP assets remained at 35% liability hedging and 65% return-seeking assets, while the DELPP assets shifted to 80% liability hedging and 20% return-seeking assets in 2024. Additionally, the actual allocations for the RCBP and DELPP assets showed minor adjustments, with the RCBP assets slightly deviating from the target in global equity and real estate and cash categories. The fair value measurements for the Master Retirement Trust also indicated a decrease in total assets from $7,241 million in 2023 to $6,969 million in 2024, reflecting changes in the valuation of equity and debt securities. Disclosure practices remained consistent, with detailed breakdowns of asset allocations and fair value measurements provided for both years.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key areas. (1) Quantitative Accuracy: The dollar amounts ($7,241 million in 2023 and $6,969 million in 2024) are plausible but not mentioned in the original answer, so their accuracy cannot be verified against the ground truth. The allocation percentages for RCBP and DELPP (e.g., 35%/65%, 80%/20%) are specific but absent from the original, suggesting potential hallucination or misattribution. The original does not mention RCBP or DELPP at all. (2) Completeness: The question asks about evolution in utilization and reporting, particularly asset allocation and disclosure practices. The LLM focuses on asset allocation shifts and asset value changes but completely misses the core evolution in disclosure practices highlighted in the original—specifically, the 2024 introduction of subsidiary-level allocations (e.g., Duke Energy Progress at 15%, Duke Energy Florida at 18%) and the new reconciliation of beginning/ending balances with Level 3 fair value disclosures. These are central to the original answer and entirely omitted. (3) Entity Accuracy: The LLM introduces RCBP and DELPP, which are not referenced in the ground truth, raising concerns about incorrect entity mapping. The subsidiaries mentioned in the original (Duke Energy Progress, Duke Energy Florida) are not mentioned in the LLM response. (4) Reasoning: The multi-hop synthesis is flawed—the LLM appears to pull data from Duke Energy’s retirement trust disclosures but fails to connect the correct evolution in reporting granularity and transparency between years. Instead, it invents a narrative around specific plan-level allocations not present in the ground truth. (5) Semantic Equivalence: While the general theme of 'increased detail' is loosely touched upon via asset value and allocation changes, the specific, fact-based evolution in disclosure practices is missing. The LLM invents metrics not in the original, reducing factual fidelity. Overall, partially correct on high-level trends but incorrect on key details and missing critical multi-hop elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 569,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "Based on the information provided, Google's financial relationship with Google Network Partners between 2022 and 2024 has shown an increase in revenues, with Google Network revenues rising from $23,090 million in 2022 to $31,701 million in 2023 and further to $31,701 million in 2024. The cost structure related to these partners, primarily through Traffic Acquisition Costs (TAC), has remained a significant portion of the cost of revenues for ads placed on Google Network properties, indicating that payment obligations to these partners have continued to be substantial relative to the revenues generated from these properties.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures for Google Network partners—$23,090 million in 2022 and $31,701 million in 2023 and 2024—that are not present in the original ground truth answer and cannot be verified from the provided context. These numbers are factually unsupported in the source material, making them incorrect. The ground truth does not mention any revenue amounts or growth trends, so their inclusion is a significant factual error. (2) The LLM correctly identifies Traffic Acquisition Costs (TAC) as a key component of cost of revenues related to Google Network partners, which aligns with the 2022 portion of the ground truth. However, it fails entirely to capture the critical evolution described in the original answer: the shift from TAC being a cost-of-revenue item in 2022 to becoming a primary operating cash outflow in 2024. This transformation in financial relationship—from cost structure to cash flow obligation—is the central point of the original answer and is completely missing in the LLM response. (3) The multi-hop reasoning is flawed. The original answer synthesizes information across years and financial statements (income statement in 2022 vs. cash flow statement in 2024) to infer a structural shift in Google’s financial relationship with partners. The LLM instead focuses on fabricated revenue growth and a static view of TAC, failing to recognize or report this evolution. (4) While the LLM mentions correct entities (Google, Google Network Partners, TAC), the introduction of false quantitative data and omission of the key conceptual shift severely undermine accuracy. The answer is contextually relevant to Google’s payments to partners but misrepresents both the data and the analytical insight, warranting low scores in correctness and quantitative accuracy, a moderate score in qualitative accuracy due to partial term usage, and a mid-range score for relevance since it addresses the general topic but not the actual evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 538,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "Between 2022 and 2023, the financial impact of offsetting swap positions, particularly in terms of fair value changes and settlements, showed a significant shift. In 2022, the company reported a loss of $69 million related to foreign currency exchange contracts not designated as hedges, recognized in investment income and other. In contrast, 2023 saw a much smaller loss of $7 million in the same category. This indicates a substantial reduction in the negative impact of non-hedge derivative settlements and fair value changes in 2023 compared to 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that UPS reported net gains of $163M in 2021 and $124M in 2020 for derivatives not designated as hedges, but does not provide a specific loss figure for 2022 or 2023. The LLM incorrectly claims a $69M loss in 2022 and a $7M loss in 2023 for foreign currency exchange contracts, which is not supported by the original answer. These specific numbers are fabricated or misattributed, making the quantitative claims false. (2) There are no verifiable calculations in the original answer to support the LLM's comparison of $69M vs $7M; thus, the core numerical assertions fail the accuracy test. The original answer explicitly notes that the financial impact in 2023 was *not quantified*, directly contradicting the LLM’s precise $7M figure. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the topic (non-hedge derivative treatment), it fails to accurately represent the evolution of disclosure practices. The original emphasizes a shift in transparency and reporting focus (from older to more recent years), not a quantifiable reduction in losses. The LLM invents a narrative of improving financial performance without evidence. (4) Despite the incorrect facts, the LLM stays contextually relevant by addressing fair value changes, settlements, and non-hedge derivatives. However, the qualitative reasoning is weak due to unsupported claims, and the quantitative accuracy is very low due to invented figures. Hence, the correctness score is low at 2, reflecting major factual errors that undermine the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 448,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures compared to 2023 indicates a shift in the company's director compensation strategy toward emphasizing deferred compensation mechanisms. This suggests a potential focus on aligning director incentives with long-term shareholder value and enhancing retention through deferral options tied to company stock performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures as indicative of a strategic shift in director compensation, emphasizing deferred compensation mechanisms. This aligns with the ground truth, which notes the move from minimal mention in 2023 (via exhibit references) to a substantive description in 2024. However, the LLM omits specific details from the original answer, such as the ability of outside directors to defer annual compensation, the phantom investment options, and how balances are adjusted—key elements that demonstrate the plan’s structural and strategic integration. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; the score of 10 reflects no errors in this dimension. (3) The multi-hop reasoning is partially sound: the LLM infers a strategic shift and links it to long-term alignment and retention, which is a reasonable interpretation. However, it does not fully synthesize the evidence from the 2023 vs. 2024 disclosures as presented in the ground truth (e.g., exhibit referencing vs. descriptive detail), weakening the qualitative accuracy. (4) The answer is contextually relevant and captures the high-level implication, but lacks the specific evidentiary support and descriptive precision of the original, justifying a correctness score of 7 rather than higher.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 400,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "Between 2022 and 2024, American Express has evolved its approach to developing value propositions by increasingly focusing on differentiation through premium services, digital innovation, and enhanced customer experiences to counter competitive pressures and shifting consumer behaviors. In 2022, the company emphasized adapting to post-pandemic spending patterns and addressing challenges from alternative payment methods, while in 2024, it highlighted strategic investments in digital capabilities, expanding its premium dining and travel offerings, and deepening partnerships to deliver personalized and compelling value to Card Members. These efforts reflect a shift toward leveraging data-driven insights and expanding its ecosystem to meet the evolving needs of both consumers and businesses.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in American Express's value proposition strategy between 2022 and 2024. It correctly identifies the shift from responding to competitive pressures (e.g., alternative payment methods) in 2022 to a more proactive strategy centered on digital innovation, premium offerings, and partnerships by 2024. The answer accurately reflects the company's focus on evolving customer behaviors, particularly around digital and personalized experiences. Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. The qualitative accuracy is high: the LLM correctly synthesizes the strategic shift, though it omits some specific details present in the ground truth, such as the explicit targeting of Millennial and Gen-Z consumers, the role of AI and automation, and specific platforms like Tock and Rooam. These omissions are notable but do not undermine the overall correctness of the strategic narrative. The reasoning is sound and reflects multi-hop understanding across years and strategic themes. Contextual relevance is excellent—the response directly addresses the question about evolution in value propositions in response to competition and customer behavior. The answer is semantically equivalent to the original in intent and key message, though slightly less detailed in execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 404,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "Between 2022 and 2024, Exxon Mobil's long-term debt financing composition remained relatively stable, with a focus on maintaining low-interest, long-dated notes. In both years, the Corporation listed similar long-term notes, including the 0.524% Notes due 2028, 0.835% Notes due 2032, and 1.408% Notes due 2039, all traded on the New York Stock Exchange. However, in 2024, the 0.142% Notes due 2024 listed in 2022 were no longer included, suggesting their maturity or retirement. The overall approach reflects a strategy of managing long-term debt with low-yield, extended maturity instruments to support financial flexibility and reduce refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates and maturity years (0.142% due 2024, 0.524% due 2028, 0.835% due 2032, 1.408% due 2039)—are correctly reported, matching the original answer exactly. The observation that the 0.142% Notes due 2024 are absent in 2024 filings is accurate and correctly interpreted as maturity or retirement. (2) Quantitative accuracy is perfect: all percentages and years are correct, and no calculations are required beyond correct identification and comparison across years. (3) The multi-hop reasoning—comparing debt composition across 2022 and 2024 to infer strategic evolution—is sound. The LLM correctly infers that retiring short-term notes while retaining long-dated instruments reflects a strategy favoring extended-term financing. It slightly softens the conclusion by saying the composition 'remained relatively stable' rather than emphasizing a strategic shift, but still acknowledges the retirement of near-term debt and continued use of long-term instruments. (4) Contextual relevance is excellent: the answer directly addresses the evolution in debt composition and correctly synthesizes information across years and instruments. The mention of NYSE listing, while not in the ground truth, is not incorrect but adds minor extraneous detail. Overall, the answer is factually complete and semantically equivalent to the original, warranting a high correctness score with only minor room for stronger emphasis on strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 421,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "Between 2022 and 2024, American Express has increasingly emphasized differentiating its corporate card and accounts payable expense management solutions by evolving its value propositions and introducing innovative features such as financing and payment solutions tailored for business customers. The strategic focus has shifted toward strengthening its global, integrated network to expand merchant acceptance and enhance services for partners, while also leveraging data analytics and fraud prevention tools to provide unique value to merchants and business clients.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in American Express's strategy between 2022 and 2024. It accurately reflects the 2022 focus on evolving value propositions and differentiating corporate card and accounts payable solutions. It also correctly identifies the 2024 shift toward a more integrated global network, expanded merchant acceptance, and enhanced fraud protection and data analytics. While the original answer explicitly mentions 'marketing insights' and 'externally integrated ecosystem strategy,' the LLM conveys similar meaning through 'leveraging data analytics,' 'fraud prevention tools,' and 'enhance services for partners,' which are semantically aligned. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; all time references (2022–2024) are correct and consistent with the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two time points and correctly infers a strategic shift from internal product development to external ecosystem integration, even if the exact phrasing differs. (4) The correctness score is 9 because the LLM captures all key factual elements and strategic shifts but slightly omits the explicit contrast between internal (2022) vs. external/integrated (2024) focus present in the original. Quantitative accuracy is 10 as no numbers are involved. Qualitative accuracy is 9 due to high but not perfect semantic mirroring of the strategic evolution. Contextual relevance is 10 as the response directly and fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 439,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "Between 2022 and 2024, Amazon's financial relationship with AWS Services has shown significant evolution, particularly in cash flow generation and strategic emphasis. AWS demonstrated strong growth, with net sales increasing from $90,757 million in 2023 to $107,556 million in 2024, representing a 19% year-over-year growth in 2024. This growth contributed to AWS becoming a more prominent segment, accounting for 17% of Amazon's consolidated net sales in 2024. Additionally, AWS played a central role in Amazon's capital expenditures, with a significant portion of the $77.7 billion in 2024 cash capital expenditures supporting AWS infrastructure, underscoring its strategic importance.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies in numbers and metrics not present in the ground truth. The ground truth states that AWS contributed to Amazon's overall operating cash flow of $115.9 billion in 2024 (up from $84.9 billion in 2023), but the LLM incorrectly cites AWS net sales as $90,757 million in 2023 and $107,556 million in 2024, which are not mentioned in the original answer and conflict with known public data. These figures may be confused with AWS revenue, but even then, they do not align with Amazon's reported AWS segment revenues (~$80B in 2023, ~$100B in 2024). The 19% YoY growth and 17% of consolidated sales are plausible but not verifiable from the ground truth and appear to be fabricated or misattributed. (2) The $77.7 billion in 2024 cash capital expenditures is not mentioned in the original answer and introduces new, unsupported data. The ground truth emphasizes AWS's shift from a risk-focused to a cash-generating segment, but the LLM focuses on sales and capex without mentioning the key evolution in strategic framing or the actual operating cash flow figures. (3) The multi-hop reasoning is partially sound—AWS growing in strategic importance is consistent with the ground truth—but the LLM fails to capture the core narrative shift: from 'competitive risk' in 2022 to 'core financial engine' by 2024 driven by cash flow. Instead, it substitutes this with sales growth and capex, missing the qualitative transformation emphasized in the original. (4) The contextual relevance is high because the answer addresses cash flow implications and strategic emphasis, but quantitative accuracy is low due to incorrect or unverified numbers. Qualitative accuracy is moderate because the direction of reasoning (increased strategic role) is correct, but key evidence is misrepresented or invented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 501,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "Between 2023 and 2024, the scope and focus of trend analyses used to evaluate the historical consistency of regulatory asset balances expanded to include a more detailed assessment of regulatory recoverability for specific costs, such as coal ash-related asset retirement obligations and estimated storm costs. In 2023, trend analyses were used to evaluate historical consistency, while in 2024, they were combined with comparisons to independently developed expectations and analyses of commission-approved amortization and regulatory orders.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution in trend analyses between 2023 and 2024, noting a broader expansion in scope and the inclusion of more detailed assessments. It accurately states that in 2023, trend analyses focused on historical consistency, which aligns with the ground truth. The mention of 2024 enhancements—such as comparisons to independently developed expectations and analyses of commission-approved amortization and regulatory orders—is contextually plausible and adds relevant detail about audit procedure evolution. However, the LLM introduces 'estimated storm costs' as a specific cost included in the expanded analysis, which is not mentioned in the ground truth. The ground truth specifies that the 2024 expansion focused on 'asset retirement obligations related to coal ash'—a precise regulatory compliance area—not storm costs. While the general direction of increased specialization is correct, the substitution of 'storm costs' for 'coal ash-related AROs' represents a factual inaccuracy in entity and focus. This error affects the qualitative accuracy, as the multi-hop synthesis includes an unsupported claim. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. Contextual relevance is high because the response addresses the temporal evolution of audit procedures and remains focused on regulatory asset balances. The core of the answer is partially correct but contains a significant factual deviation in the specifics of the expanded focus area.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 422,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "Between 2022 and 2023, Costco's strategy regarding the penetration of private-label items evolved in response to cost and pricing pressures by increasing their use as part of broader merchandising and pricing adjustments. In 2022, Costco mentioned increasing the penetration of private-label items to adapt to competition and cost increases. By 2023, this strategy continued as part of efforts to maintain competitive pricing and manage gross margins, particularly in the face of inflation and supply chain challenges. The focus remained on leveraging private-label items to provide value to members while mitigating the impact of rising merchandise costs.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Costco increased penetration of private-label items in response to cost and pricing pressures in both 2022 and 2023, and notes the continuation of the strategy into 2023. However, it inaccurately states that in 2022 Costco 'mentioned increasing the penetration of private-label items' as a primary strategy, whereas the ground truth specifies that in 2022, the main strategies were absorbing costs, bulk purchasing, and selective price passing—private-label emphasis became more strategic in 2023. This misrepresents the evolution by implying equal emphasis in both years. (2) There are no numerical values, dates, or calculations in the response that conflict with the ground truth; all time periods (2022, 2023) are correctly referenced, so quantitative accuracy is perfect. (3) The multi-hop reasoning is partially sound—Costco’s use of private-label as a response to inflation and margin pressure is correctly synthesized across years—but the shift from reactive (2022) to strategic (2023) emphasis on private-label is underdeveloped, weakening the qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution of private-label strategy in response to cost pressures, but misses the nuance of strategic escalation in 2023 versus more immediate margin-preserving tactics in 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 384,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "The financial outlook for Paxlovid has significantly declined between 2023 and 2024. In 2023, Paxlovid contributed $1,279 million in revenues, a sharp drop from $18,933 million in 2022. By 2024, Paxlovid revenues further declined to $5,716 million. Additionally, remaining performance obligations for Paxlovid were $1 billion as of December 31, 2024, down from $5.1 billion in 2023, reflecting reduced future commitments and a transition to commercial market sales.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. The original answer states that Pfizer did not disclose specific remaining performance obligations (RPOs) for Paxlovid in 2023, but the LLM claims RPOs were $5.1 billion in 2023—this figure is entirely fabricated and contradicts the ground truth. Additionally, the LLM invents revenue figures: $1,279 million in 2023 and $5,716 million in 2024, none of which are mentioned or implied in the original answer. The only correct number is the $1 billion RPO as of December 31, 2024, which matches the ground truth. (2) The quantitative inaccuracies are severe: the LLM incorrectly asserts a decline in RPOs from $5.1B to $1B, while the original answer states no RPO was disclosed in 2023. The revenue numbers are also unsupported and contradict the forward-looking positive evolution described in the original. (3) The multi-hop reasoning is fundamentally flawed. Instead of interpreting the emergence of disclosed RPOs in 2024 as a sign of increased contractual certainty (as per the original), the LLM incorrectly frames it as a decline, misrepresenting the trend and financial outlook. The model fails to recognize that the absence of a 2023 RPO disclosure does not imply a prior high value. (4) The correctness score is 1 due to massive factual errors, with only one correct number in isolation. Quantitative accuracy is 1 because all but one number are false. Qualitative accuracy is 1 due to incorrect entities, logic, and synthesis. Contextual relevance is 3 because the answer discusses Paxlovid and RPOs but misrepresents the core financial evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 446,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "Between 2022 and 2024, American Express has maintained a consistent approach to estimating credit loss reserves by incorporating historical loss experience and current and future economic conditions over a Reasonable and Supportable (R&S) Period. However, the 2024 disclosures indicate a more nuanced and data-driven evolution in the company's assumptions, particularly in how it models the probability of default, exposure at default, and incorporates economic forecasts. The increased emphasis on qualitative reserves to address model limitations and external factors suggests a more cautious and comprehensive approach to financial risk management, reflecting a proactive stance in navigating economic uncertainties and ensuring robust credit loss provisions.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but diverges significantly from the ground truth in its characterization of the evolution of American Express's use of the R&S Period. While the LLM correctly identifies that American Express uses the R&S Period in credit loss estimation and incorporates economic conditions, it introduces details not present in the original answer—such as 'increased emphasis on qualitative reserves,' 'probability of default,' and 'exposure at default' modeling—without grounding in the provided truth. These specific modeling enhancements are not mentioned in the ground truth and represent an overinterpretation or fabrication of details. (2) Quantitatively, the LLM answer does not contradict any numbers: it avoids citing specific reserve amounts or years incorrectly. It does not mention the $3.3 billion reserve figure from 2021 or explicitly reference the shift in disclosure tone between 2022 and 2024, but it also does not misstate any figures, so quantitative accuracy is preserved. (3) The multi-hop reasoning is flawed: the ground truth emphasizes a shift in disclosure maturity—R&S moving from a newly explained concept in 2022 to an embedded, standard component in 2024—whereas the LLM interprets this as a technical evolution in modeling sophistication. This misrepresents the nature of the change, which was in presentation and integration into disclosures, not necessarily in modeling complexity. (4) The contextual relevance is high because the answer addresses the core topic—evolution of R&S Period use in credit loss estimation—and discusses risk management implications. However, the qualitative inaccuracy in depicting the nature of the evolution reduces correctness. The answer invents specifics not supported by the source, leading to a moderate score of 5 for correctness and qualitative accuracy, while quantitative accuracy remains high due to absence of numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 523,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "Amazon issued the 0.800% Note due 2025 as part of its debt financing strategy in 2020, as indicated in the 2022 10-K under Exhibit 4.6. By 2024, Amazon had not issued any new notes with similar low coupon rates, as reflected in the 2024 10-K's exhibits. Instead, Amazon's debt offerings in 2024 featured higher coupon rates, such as the 4.600% Note due 2025 (Exhibit 4.8), suggesting a shift in financing strategy likely due to rising interest rates during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.800% Note due 2025 was issued in 2020 and referenced in the 2022 10-K (Exhibit 4.6), and by 2024, Amazon introduced higher-rate debt like the 4.600% Note due 2025 (Exhibit 4.8). These details match the original answer’s timeline and instruments. (2) Quantitative accuracy is perfect: percentages (0.800%, 4.600%), maturity year (2025), and exhibit numbers are correct. No calculation errors. (3) The multi-hop reasoning is sound—correctly synthesizing data from 2022 and 2024 filings to infer a strategic shift in debt financing due to rising interest rates. The conclusion about shifting to higher coupon rates is logically supported. (4) The only minor gap is that the LLM does not explicitly state that the 0.800% Note was still *referenced* in 2024 filings as part of the ongoing debt structure, though this is implied by discussing it in context. The original answer emphasizes continuity, while the LLM focuses more on the contrast in new issuances. This is a nuance, not a factual error. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 334,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "The Twenty-third Supplemental Indenture, dated May 15, 2020, is consistently referenced in both the 2022 and 2024 SEC filings, indicating its ongoing relevance as part of the company's series of indentures. The lack of any new or updated references to it in the 2024 filing suggests that it has not been amended or superseded and remains in effect as a material contractual obligation. This continuity highlights its continued importance in the company's debt structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The Twenty-third Supplemental Indenture was dated June 1, 1978, not May 15, 2020, as incorrectly stated. Furthermore, the LLM claims it is 'consistently referenced in both the 2022 and 2024 SEC filings,' but the ground truth confirms it is explicitly mentioned only in the 2022 filing and entirely absent in the 2024 filing. This misrepresents the core evolution of disclosure. (2) The date error (May 15, 2020 vs. June 1, 1978) is a major quantitative inaccuracy. There are no correct financial figures or calculations in dispute, but the incorrect date fundamentally undermines the answer. (3) The multi-hop reasoning is flawed: the model fails to recognize the absence of the indenture in the 2024 filing, which is central to the question. Instead of identifying a decline in relevance due to omission, it asserts ongoing relevance based on false continuity. The synthesis across years is incorrect. (4) While the answer addresses the question's structure and attempts to interpret the significance of disclosure patterns, its factual foundation is unsound. The conclusion about 'continued importance' contradicts the ground truth, which infers diminished significance due to non-reaffirmation. Contextual relevance is moderate because the response engages with the right type of analysis but on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 386,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "From 2022 to 2024, the repurchase activity for Class C Capital Stock evolved as follows:\n\n- In 2022, 450 million shares of Class C stock were repurchased for a total value of $52,868 million.\n- In 2023, 306 million shares of Class C stock were repurchased for a total value of $50,192 million.\n- In 2024, 306 million shares of Class C stock were repurchased for a total value of $50,192 million.\n\nThe total value of shares repurchased in each year was $52,868 million in 2022, $50,192 million in 2023, and $50,192 million in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the dollar amounts and share counts for repurchases. The ground truth states that Alphabet repurchased $59.3 billion in 2022, $62.2 billion in 2023, and $62.0 billion in 2024 across Class A and Class C shares. However, the LLM claims $52,868 million ($52.868 billion) in 2022, $50.192 billion in 2023, and the same in 2024 — all of which are incorrect, with deviations of billions of dollars. Additionally, the LLM specifies exact share counts (e.g., 450 million, 306 million), which are not present in the original answer and cannot be verified from the provided ground truth. (2) The calculations are internally consistent within the LLM’s own numbers but do not match the ground truth. For example, the LLM reports decreasing repurchase values from 2022 to 2023–2024, while the ground truth shows an increase from 2022 to 2023 and a slight decrease in 2024 — a different trend. (3) The multi-hop reasoning is partially sound in structure — the model attempts to track repurchase activity over time and report annual totals — but fails in execution due to incorrect data sourcing. It incorrectly isolates Class C stock repurchases when the original answer combines Class A and C, and introduces granular share count data not present in the source. (4) Contextual relevance is high because the answer addresses the evolution of repurchase activity and provides yearly totals as requested. However, the quantitative inaccuracies severely undermine correctness, leading to a low overall score. The model appears to fabricate precise figures (share counts and values) that do not align with the verified data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 459,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "The American Express Company Salary/Bonus Deferral Plan was amended in the 2024 SEC filing with the addition of a new exhibit, \"10.16,\" titled \"Amendments of (i) the American Express Salary/Bonus Deferral Plan and (ii) the American Express Key Executive Life Insurance Plan,\" incorporated by reference from the 1997 filing. This suggests that while the plan itself was originally documented in 1988, a significant amendment affecting both the Salary/Bonus Deferral Plan and the Key Executive Life Insurance Plan occurred in 1997, and this amendment was newly referenced in the 2024 filing, indicating updated disclosure or emphasis on these changes. No specific new amendments to the plan were listed in the 2024 filing beyond this reference.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that the 2024 filing added Exhibit 10.16, which incorporates the 1997 amendments to the American Express Salary/Bonus Deferral Plan, matching the original answer's key point about expanded disclosure. The dates (1988 plan, 1994 amendment, 1997 amendment) and exhibit numbers (10.16 in 2024) are factually correct. (2) Quantitative accuracy is perfect: all years and exhibit numbers are accurate, and no calculations are required. (3) The reasoning is sound—LLM correctly infers that the plan was not newly amended in 2024 but that a historical amendment from 1997 was newly referenced, indicating updated disclosure. It also correctly notes the dual impact on the Key Executive Life Insurance Plan, which is consistent with the exhibit title. (4) The only minor omission is that the LLM does not explicitly mention the re-introduction of the plan via Exhibits 10.13 and 10.14 in 2024 (referencing the 1988 and 1994 documents), which were also part of the structural changes in documentation. However, the core multi-hop insight—that the 2024 filing expanded historical documentation by adding the 1997 amendment—is fully captured. Wording differs slightly but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses the evolution in treatment and documentation between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 391,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "Starbucks' exposure to interest rate swaps decreased significantly between 2022 and 2024. In 2022, the balance sheet liability for interest rate swaps was $34.0 million, classified under other long-term liabilities, while in 2024, this liability was reduced to $19.2 million, still under other long-term liabilities. Additionally, the magnitude of outstanding interest rate swaps dropped from $1,100 million in 2022 to $350 million in 2024, indicating a reduction in both the liability and the overall exposure to these instruments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the magnitude of outstanding interest rate swaps. The ground truth states that in 2022, the liability was $34.0 million under 'Other long-term liabilities', and in 2024, it was $19.2 million under the same category. The LLM correctly reports these liability amounts. However, it introduces a new metric—'magnitude of outstanding interest rate swaps'—claiming it dropped from $1,100 million in 2022 to $350 million in 2024—which is not present in the original answer and unsupported by the provided ground truth. This figure appears fabricated or misattributed, severely undermining quantitative accuracy. (2) The original answer mentions a $41.4 million liability from interest rate swaps reported for 2023, indicating a prior-year liability that contributes to understanding the trend. This information is entirely omitted in the LLM response, resulting in incomplete multi-year synthesis. (3) While the LLM correctly identifies the decrease in the balance sheet liability and its classification, it fails to reflect the full evolution across three years (2022–2024) and misses the nuance of carryover liabilities from 2023 to 2024. The reasoning is partially sound in noting a reduction in exposure but draws conclusions based on incorrect data. (4) The contextual relevance is high because the answer addresses balance sheet classification and magnitude changes, aligning with the question’s focus. However, due to the inclusion of false quantitative data and omission of key multi-hop details (especially the 2023 liability), the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because core concepts like liability classification and directional change are correct, but the overall synthesis is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 498,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "The Directors' Savings Plan has remained a deferral mechanism for director compensation, allowing outside directors to defer all or a portion of their annual compensation, typically in the form of retainers. Between 2022 and 2024, there is no indication of significant structural changes to the plan, as it continued to function as an unfunded account where deferred amounts were adjusted based on phantom investment options, including the Duke Energy Common Stock Fund. This consistency suggests that Duke Energy maintains a stable and transparent governance approach, emphasizing flexibility and alignment with long-term shareholder interests through deferral and investment choices.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of entity identification, time frame (2022–2024), and plan mechanics. It correctly identifies the Directors' Savings Plan as a deferral mechanism with phantom investment options, including the Duke Energy Common Stock Fund, and notes its unfunded nature—key points from the original answer. There are no numeric inaccuracies (quantitative accuracy is perfect), as no specific numbers are involved and all descriptive details are consistent. The reasoning is sound and contextually relevant, addressing both the evolution of the plan and implications for governance. However, the LLM slightly underrepresents the evolution aspect by stating there is 'no indication of significant structural changes,' whereas the ground truth emphasizes a shift from formal introduction and policy establishment in 2022 to greater operational transparency in 2024, particularly in how deferrals are invested. This nuance—highlighting a progression from documentation to functional clarity—is missing, resulting in a minor gap in qualitative accuracy. Nonetheless, the conclusion about alignment with shareholder interests is consistent. Thus, the answer is largely correct but lacks full depth on the plan’s developmental trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 361,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "Between 2022 and 2023, Costco's Kirkland Signature brand has continued to evolve as a key differentiator in its product offerings, emphasizing high-quality private-label merchandise at competitive prices. The brand remains central to Costco's strategy to offer value to members while achieving higher profit margins. There is no explicit mention of a significant shift in the risk profile of Kirkland Signature during this period, but the brand's reliance on maintaining quality standards and member demand remains a critical factor. Risks associated with supply chain disruptions, quality control, and competition persist, as Costco continues to expand the sales penetration of Kirkland Signature products.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Kirkland Signature remains a strategic asset for Costco with emphasis on quality, value, and margin, which aligns with the 2022 positioning in the ground truth. However, it fails to accurately reflect the evolution in risk profile between 2022 and 2023. The original answer notes a clear shift in tone and content in the 2023 filing—where broader risks (supply chain, FX fluctuations, catastrophic events) were explicitly tied to the Kirkland Signature brand, indicating increased operational and financial vulnerability due to its growth. The LLM answer downplays this shift by stating 'no explicit mention of a significant shift in the risk profile,' which contradicts the ground truth. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—score reflects no errors in numbers or dates. (3) The multi-hop reasoning is partially sound: the model connects Kirkland Signature to strategy and margin, but fails to synthesize the change in risk disclosure between the two years, which is the core of the question. It mentions persistent risks but misses the escalation in emphasis and scope in 2023. (4) Correctness is scored at 5 due to partial factual accuracy—core elements about the brand’s strategic role are correct, but the critical evolution in risk framing is omitted or mischaracterized. Qualitative accuracy is low for the same reason. Contextual relevance is high as the answer stays on topic and addresses brand positioning and associated risks, albeit incompletely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 431,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 326 BCF at the end of 2022 to 296 BCF at the end of 2024. Key changes included upward revisions in 2024 due to technical improvements and development plans, partially offset by downward adjustments from lower prices and operating costs. Additionally, extensions and discoveries in equity affiliates, primarily in the Middle East, contributed to reserve additions during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that COP's natural gas reserves increased from 326 BCF in 2022 to 296 BCF in 2024, when in fact the reserves decreased from 326 to 296 BCF — a reduction of 30 BCF. The direction of change is therefore wrong, which is a critical error. (2) Quantitatively, while the starting and ending values (326 and 296 BCF) are numerically accurate, the interpretation is reversed — the LLM claims an increase when it should be a decrease. This undermines all subsequent reasoning. Additionally, the LLM mentions 'upward revisions in 2024 due to technical improvements' and 'extensions and discoveries in equity affiliates', but the ground truth states there were 'no sales or significant reserve additions' and only 'minimal extensions and discoveries'. These additions are factually incorrect and contradict the original answer. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution of reserves over time and misrepresents the drivers of change. It introduces technical improvements and development plans as positive factors in 2024, which are not supported by the ground truth, and ignores the stated reduction in focus or activity in the region. (4) Contextual relevance is moderate — the answer addresses the right company (COP), region (Asia Pacific/Middle East), and time frame (2022–2024), and discusses relevant categories like revisions and discoveries. However, the core facts about volume change and sources of additions are incorrect, leading to a low correctness score despite some structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 446,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "Between 2022 and 2024, FedEx's strategic relationship with the Boeing 767F has shifted toward modernization and fleet optimization. As of 2022, FedEx Express owned 114 Boeing 767F aircraft with no leased units. However, by 2024, FedEx had significantly reduced its commitment to the 767F, with only 14 units scheduled for delivery in 2025 and no deliveries planned beyond 2026. This reflects a strategic focus on newer, more fuel-efficient aircraft like the Boeing 777F, which aligns with FedEx's modernization efforts to enhance operational efficiency and reduce long-term costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that FedEx owned 114 Boeing 767F aircraft in 2022 (matching the ground truth), it incorrectly claims that by 2024, FedEx had 'significantly reduced its commitment' with only 14 units scheduled for delivery in 2025 and none beyond 2026. The original answer states no updated ownership figures were disclosed for 2024 and emphasizes continued strategic importance of the B767F for modernization. There is no mention in the ground truth about delivery schedules ending in 2026 or a shift to 777F as the primary modernization vehicle. (2) The quantitative inaccuracies are severe: the 14-unit delivery figure and 2025/2026 delivery timelines are not supported by the original answer and contradict the emphasis on ongoing necessity of 767F purchases for long-term savings. (3) The multi-hop reasoning is flawed. The LLM infers a strategic reduction in 767F use and pivot to 777F, which is not present in the ground truth. Instead, the original answer highlights continued reliance on and investment in the 767F for fuel efficiency and fleet modernization, with limited flexibility to delay purchases. The LLM misrepresents the strategic direction. (4) Contextual relevance is moderate because the answer addresses fleet ownership and modernization, but the conclusions drawn are factually incorrect. The mention of fuel efficiency aligns with the original, but the overall narrative of reduced commitment is unsupported. Thus, correctness is low due to major factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 434,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "From 2022 to 2024, Starbucks' involvement with roasted coffee showed an increase in inventory value, with roasted coffee inventory valued at $310.3 million in 2022 and growing to $430.9 million in 2024. In terms of production infrastructure, Starbucks maintained and expanded its roasting facilities, including significant roasting, warehousing, and distribution centers in locations such as York, PA; Minden, NV; Kunshan, China; and Kent, WA, indicating continued investment in its production capabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2024 roasted coffee inventory value, stating it grew to $430.9 million, which is not supported by the ground truth. The original answer only provides the 2022 inventory value ($310.3 million) and does not mention any 2024 inventory figure, so asserting a specific higher number is incorrect. This undermines the quantitative accuracy. (2) The production infrastructure details are accurate—facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA—are correctly listed, aligning with the original answer’s claim of expanded roasting infrastructure. (3) The reasoning partially captures the evolution: it correctly infers increased involvement through infrastructure expansion, but incorrectly implies inventory growth from 2022 to 2024 due to the fabricated $430.9 million figure. This breaks the multi-hop synthesis, as there is no evidence in the ground truth for inventory value in 2024. (4) Contextually, the answer is well-structured and relevant, addressing both inventory and infrastructure. However, the incorrect numerical claim reduces correctness significantly. While the qualitative understanding of infrastructure expansion and strategic shift is sound, the unsupported inventory number leads to a moderate score of 5/10 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 377,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "Based on the provided document pages, PepsiCo's utilization of the 2.750% Senior Notes due 2025 remained consistent between 2023 and 2024. In both years, the notes were referenced as part of the broader list of authorized debt instruments, with no specific changes or new issuances noted for the 2.750% Senior Notes due 2025 in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its conclusion. While it correctly identifies that the 2.750% Senior Notes due 2025 were referenced in both years, it fails to capture the key evolution noted in the ground truth: the strategic extension of the same interest rate to a new 2.750% Senior Notes due 2030 in 2024, indicating a shift in debt strategy. The LLM incorrectly states there was 'no specific changes or new issuances noted' when in fact a new note at the same rate was introduced, which is a significant strategic development. (2) Quantitatively, the dates (2025, 2023, 2024) and interest rate (2.750%) are accurate, hence the higher score for quantitative accuracy. There are no numerical calculations required, so no errors in arithmetic. (3) The multi-hop reasoning is flawed: the model fails to synthesize the connection between the continued authorization of the 2025 notes and the introduction of the 2030 notes at the same rate, which is central to the evolution of PepsiCo's financing strategy. This represents a failure in qualitative reasoning and contextual interpretation. (4) The contextual relevance is moderate because the answer discusses the correct instruments and time frame, but misses the core strategic evolution, making it partially relevant but ultimately misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 368,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "FedEx's planned utilization of the B777F aircraft decreased from 2022 to 2024, with deliveries dropping from 8 aircraft planned through 2026 in 2022 to only 2 aircraft planned by 2026 in 2024. This reduction indicates a diminished strategic role for the B777F in FedEx's fleet modernization plans, with a shift toward other aircraft types like the B767F and regional freighters such as the Cessna SkyCourier 408 and ATR 72-600F for long-term efficiency and operational needs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timeline. According to the ground truth, in 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the plan was revised to 2 aircraft in 2025 with no further plans beyond. The LLM incorrectly states that 8 aircraft were planned through 2026 in 2022 and only 2 by 2026 in 2024—this timeline and count are not supported by the ground truth. There is no mention of 2026 in the original answer, nor were 8 aircraft ever referenced. (2) The quantitative inaccuracies are severe: the number of aircraft (8 vs. 4), the years referenced (2026 not mentioned in ground truth), and the absence of correct year-specific deployment plans (e.g., 4 in 2024) undermine the factual basis. (3) The reasoning about reduced strategic emphasis is partially sound and aligns with the ground truth’s conclusion of a phase-out, but the multi-hop synthesis is flawed because it draws conclusions from incorrect data. The mention of B767F, Cessna SkyCourier 408, and ATR 72-600F is extraneous and not supported in the original answer, introducing unverified strategic shifts. (4) Correctness is scored low (4) due to major factual errors in numbers and timeline. Quantitative accuracy is poor (3) due to incorrect aircraft counts and fabricated timeframes. Qualitative accuracy is moderate (5) because the general direction of reasoning (reduced role) is correct, but synthesis is based on false premises. Contextual relevance is high (8) as the answer addresses the question’s intent and strategic implications, albeit with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 445,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "From 2022 to 2024, Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolved as follows: in 2022, the net gains included in AOCI were $55.3 million, expected to reclassify $32.5 million within 12 months; by 2024, the net gains included in AOCI were $11.5 million, with $9.5 million expected to reclassify within 12 months. This decline suggests reduced exposure to foreign currency fluctuations over the period, indicating either a decrease in hedged positions or more stable currency conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million (not net gains in AOCI of $55.3 million as claimed by the LLM). The only correct number is the 2024 net gains in AOCI of $11.5 million. The $32.5 million and $9.5 million reclassification expectations are not present in the ground truth and appear fabricated. (2) Quantitative accuracy is very low: the key 2022 figure is completely wrong ($55.3M vs actual $0.3M liability), and additional unsupported numbers are introduced. The correct 2024 gain of $11.5M is the only accurate data point. (3) The reasoning is flawed due to incorrect inputs: the conclusion of 'reduced exposure' is based on a false premise of declining gains from $55.3M to $11.5M, whereas the actual data shows a shift from a minimal liability in 2022 to a significant unrealized gain in 2024, suggesting increased—not decreased—exposure or hedging activity. The model fails to recognize the shift from liability to gain, misinterpreting the nature of the financial position. (4) Contextual relevance is moderate because the answer addresses the right topic (foreign currency derivatives and AOCI) and time frame, and attempts to interpret implications for currency exposure, but the incorrect data leads to an invalid conclusion. The multi-hop synthesis is compromised by incorrect entity-metric alignment (confusing liabilities with gains in AOCI).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 417,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "PepsiCo's engagement with the 2.625% Senior Notes due 2026 is reflected in broader debt instrument disclosures that show increased activity between 2023 and 2024. In 2023, PepsiCo disclosed the 4.550% Senior Notes due 2026 and the 5.125% Senior Notes due 2026, both issued in February and November 2023, respectively. By 2024, the disclosures expanded to include additional senior notes due in 2026, such as the 4.500% Senior Notes due 2026 and the 2.850% Senior Notes due 2026, indicating a more diversified set of instruments and ongoing management of its debt portfolio for this maturity year.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The original answer states that PepsiCo's 2.625% Senior Notes due 2026 were part of a board resolution in 2023 and remained in disclosures in 2024, alongside newly added notes like the 3.000% due 2027 and 2.625% due 2029. However, the LLM incorrectly claims that in 2023, PepsiCo disclosed '4.550% Senior Notes due 2026' and '5.125% Senior Notes due 2026', which are entirely fabricated and not present in the ground truth. Similarly, the 2024 disclosures are misrepresented with '4.500% Senior Notes due 2026' and '2.850% Senior Notes due 2026', which are also not mentioned in the original answer. The correct note referenced in both years is the 2.625% due 2026, not the various higher-rate notes cited by the LLM. (2) Quantitative accuracy is extremely low: all percentages and implied issuance dates (February and November 2023) are incorrect. There is no mention in the ground truth of notes with 4.550%, 5.125%, 4.500%, or 2.850% interest rates, nor of multiple 2026-dated notes being issued in those months. The only correct quantitative element is the focus on 2026 as a maturity year, but even that is distorted by incorrect instrument details. (3) The multi-hop reasoning is flawed. The LLM fails to recognize that the evolution lies in the expansion of the overall senior notes portfolio (including new maturities like 2027 and 2029), not in the proliferation of multiple 2026-dated notes with varying rates. The conclusion about 'ongoing management of its debt portfolio for this maturity year' is plausible but based on false premises. (4) Contextual relevance is moderate because the answer addresses debt disclosures and attempts to compare 2023 and 2024, but the factual foundation is incorrect, undermining the analysis. The correct answer emphasizes strategic diversification across maturities, while the LLM invents a narrative around rate variation within a single maturity year. Thus, correctness and quantitative accuracy are severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 551,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "Cisco's exposure to and reliance on overcoming technical hurdles from 2022 to 2024 has increased, particularly as the company has intensified strategic investments in key priority areas such as AI, cloud, cybersecurity, and observability. In 2022, the focus was on adapting to market transitions like network programmability and SDN, while by 2024, the emphasis had expanded to include the integration of acquired technologies (e.g., Splunk) and the development of more complex, software-driven solutions. This evolution reflects a growing reliance on timely product development and innovation to maintain competitiveness, with heightened risks from technical challenges and the need to align with rapidly changing customer needs and industry standards.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Cisco's exposure to technical hurdles from 2022 to 2024. It accurately captures the shift from internal execution risks (e.g., product planning, timing) in 2022 to a more strategic and complex dependency on overcoming technical challenges in 2024, particularly in AI, cloud, cybersecurity, and observability. The mention of strategic investments and integration of acquired technologies like Splunk is contextually appropriate and reflects Cisco's actual 2024 focus, even if not explicitly stated in the original answer. The answer correctly identifies the increased reliance on timely innovation and the heightened consequences of failure, such as loss of competitiveness and misalignment with customer needs. However, the LLM omits specific risks highlighted in the 2024 disclosures—namely reputational damage, legal liability, and reduced customer retention—which are key differentiators in the escalation of risk exposure. While the overall reasoning is sound and the entities (Cisco, AI, cloud, security, observability) and years (2022, 2024) are accurate, the absence of these specific consequences prevents a perfect score. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The answer is fully contextually relevant and synthesizes the multi-hop evolution of risk and strategy effectively.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 401,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "Based on the provided information, Google Ad Manager's role in driving Google Network revenues remained a key contributor between 2022 and 2023. In 2022, Google Network revenues increased due to strength in AdMob, Google Ad Manager, and AdSense. In 2023, while specific figures for Google Network are not provided, Google Ad Manager continued to be highlighted as a core advertising platform used by customers to purchase advertising inventory, indicating its sustained importance in the revenue-driving ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Google Ad Manager was a key contributor to Google Network revenues in 2022 alongside AdMob and AdSense, which aligns with the ground truth. It also correctly states that in 2023, Google Ad Manager remained a core platform. However, it fails to capture a critical qualitative shift noted in the original answer: in 2022, Google Ad Manager was explicitly cited as a driver of the $8.6 billion year-over-year increase, while in 2023 it was grouped among other platforms (Google Ads, Display & Video 360, Marketing Platform) without specific attribution to revenue growth. This represents a downgrading in emphasis and a shift from a standout contributor to part of a broader suite, which the LLM answer omits. (2) Quantitatively, the LLM does not mention the $8.6 billion figure, which is a key data point in the ground truth. While it doesn't introduce incorrect numbers, the omission of this specific amount reduces quantitative completeness. The absence of 2023 revenue figures is justified as they are not provided in the ground truth, so no penalty there. (3) The multi-hop reasoning is partially sound—information from both years is referenced—but the synthesis is incomplete. The model fails to contrast the explicit growth attribution in 2022 with the generic positioning in 2023, which is central to answering how the role changed. Instead, it concludes that the role 'remained a key contributor,' which understates the shift in narrative and strategic emphasis. (4) The contextual relevance is high because the answer stays focused on the question and uses appropriate entities and timeframes. However, the qualitative accuracy is lower due to the failure to identify the nuanced but important change in how Google Ad Manager was positioned in the financial narrative across years, which is the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 508,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "Starbucks' derivative liabilities related to foreign currency - other decreased from $0.3 million as of October 2, 2022, to $4.7 million as of September 29, 2024. The magnitude of the change was an increase of $4.4 million over the two-year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the starting and ending values ($0.3 million in 2022 and $4.7 million in 2024) and calculated the change accurately as $4.4 million. However, it incorrectly stated that the liabilities 'decreased' when in fact they increased, which is a critical qualitative error in directionality. (2) Quantitatively, all numbers are correct: $0.3M and $4.7M match the ground truth, and the difference ($4.7M - $0.3M = $4.4M) is accurate. Fiscal dates (October 2, 2022, and September 29, 2024) align with Starbucks' reported fiscal year-ends and are acceptable variations. (3) The multi-hop reasoning is sound—LLM synthesized data across two years and computed the change correctly. The only flaw is the mischaracterization of the change direction, which affects interpretation. (4) Scores reflect high factual accuracy and proper context, with a moderate deduction in correctness and qualitative accuracy due to the incorrect 'decreased' wording despite correct numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 289,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "In 2023, PepsiCo's 4.600% Senior Notes due 2045 were authorized as part of broader debt offerings, as noted in resolutions referenced in the 2023 filing. By 2024, the 4.600% Senior Notes due 2045 were explicitly issued, as detailed in the 2024 filing. This evolution indicates PepsiCo's strategy to extend its debt maturity profile and access long-term capital at favorable rates, aligning with its objective of maintaining a balanced and flexible capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.600% Senior Notes due 2045 and the years 2023 and 2024, which are factually accurate per the ground truth. The percentages, note types, and years are all correct, satisfying quantitative accuracy. (2) However, the LLM incorrectly states that the notes were 'explicitly issued' in 2024, while the ground truth indicates they were only authorized in 2023 and remained part of the debt structure in 2024 alongside new notes—but does not confirm actual issuance in 2024. This is a significant qualitative error in reasoning and factual claim. (3) The multi-hop synthesis is partially sound: the model connects the 2023 authorization to 2024 status, but fails to accurately reflect that the 2024 filing shows continuation and diversification (e.g., addition of 4.000% notes due 2047 and floating rate notes), not the first-time issuance of the 4.600% notes. The strategic interpretation about extending maturities is plausible but less precise than the ground truth’s emphasis on diversification. (4) Correctness is scored 6 due to the core factual error about issuance; quantitative accuracy is 10 as all numbers/dates are correct; qualitative accuracy is 6 due to flawed reasoning on the evolution; contextual relevance is 9 as the response stays focused and relevant to the question’s intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 375,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "COP's natural gas position in the Asia Pacific/Middle East region has shown a decline in proved reserves, from 764 BCF at the end of 2021 to 296 BCF at the end of 2024, with significant downward revisions in 2023 due to infrastructure constraints, lower prices, and technical adjustments. This trend suggests a reduced strategic focus on natural gas development in the region, as COP has shifted capital and exploration efforts toward its core U.S. assets, particularly in the Permian Basin. The company's emphasis on unconventional plays in the Lower 48 and its acquisition of Marathon Oil further indicate a realignment of priorities away from the Asia Pacific/Middle East natural gas segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that COP's natural gas reserves in the Asia Pacific/Middle East region were 326 BCF in 2022 and 296 BCF in 2024, showing a slight decrease. However, the LLM claims reserves were 764 BCF at the end of 2021 and dropped to 296 BCF in 2024, which contradicts the provided data. The 764 BCF figure does not appear in the ground truth and introduces a false baseline, leading to an exaggerated perception of decline. Additionally, the LLM references 'downward revisions in 2023 due to infrastructure constraints, lower prices, and technical adjustments,' which is not supported by the original answer and adds unverified detail. (2) The only correct number is 296 BCF in 2024, which matches the ground truth. However, the 2022 figure of 326 BCF is omitted and replaced with an incorrect 2021 figure of 764 BCF. The calculation of change is therefore fundamentally flawed. (3) The multi-hop reasoning is partially sound in that it attempts to infer strategic focus from reserve trends, but it builds this analysis on incorrect data. The conclusion about shifting capital to U.S. assets and the Permian Basin, while potentially contextually plausible, goes beyond the scope of the original answer and introduces external assumptions not present in the ground truth. (4) The contextual relevance is moderate because the answer addresses the evolution of COP's natural gas position and strategic implications, but the factual foundation is weak. The qualitative reasoning would score higher if based on accurate data. Due to major quantitative errors and unsupported claims, the overall correctness score is low at 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 464,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "From 2022 to 2023, Google Play's role in Google's non-advertising revenue strategy has remained consistent as a key contributor, generating revenue primarily from the sales of apps and in-app purchases. However, in 2023, it is explicitly categorized under \"platforms\" as part of Google Services' non-advertising revenue streams, alongside consumer subscriptions (e.g., YouTube Premium) and device sales. This reflects a broader emphasis on diversifying non-advertising revenue sources, with Google Play continuing to play a central role in monetizing digital content and app ecosystems.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Google Play's revenue sources in both years and notes its categorization under 'platforms' in 2023, which aligns with the ground truth. However, it misses the key nuance that the description of Google Play’s revenue became more narrowly focused in 2023—specifically shifting from including 'digital content sold in the Google Play store' in 2022 to emphasizing only 'apps and in-app purchases' in 2023. This evolution in language and strategic emphasis is underreported. Instead, the LLM suggests continuity ('remained consistent') and broader diversification, which downplays the narrowing of focus indicated in the original answer. (2) There are no numbers, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes Google Play's role across two years and identifies its re-categorization under 'platforms.' However, it fails to fully capture the shift in narrative emphasis from broader digital content sales to core app-based monetization, which is central to the ground truth. (4) Contextual relevance is high—the response stays on topic and provides relevant context about non-advertising revenue streams. Correctness and qualitative accuracy are reduced due to the omission of the narrowing in revenue focus, which is a critical part of the strategic evolution described in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 410,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "From 2022 to 2024, the projected utilization of the Cessna SkyCourier 408 by FedEx shifted from planned deliveries in 2023 and 2024 to being fully scheduled for 2025 and beyond. In 2022, 11 deliveries were planned for 2023 and 12 for 2024, but by 2024, all 31 planned deliveries were deferred to 2025 and later. This delay indicates a reduced immediate strategic reliance on the Cessna SkyCourier 408, suggesting FedEx may have shifted focus to other aircraft or adjusted its fleet modernization priorities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, FedEx projected 49 total aircraft to be in operation from 2023 onward, not 11 in 2023 and 12 in 2024 as claimed by the LLM. Similarly, the 2024 projection was revised to 31 aircraft from 2025 to 2029, not a deferral of 31 deliveries from earlier years. The LLM incorrectly frames the change as a delay of previously scheduled deliveries, while the original answer indicates a reduction in total projected fleet size (from 49 to 31) and a shift in strategic relationship from 'Increases' to 'Depends_On'. (2) Quantitative accuracy is low: the numbers 11 and 12 are not supported by the ground truth, and the total projected aircraft decreased from 49 to 31, not a re-scheduling of 31 units. There is no mention in the original answer of annual delivery breakdowns for 2023 and 2024. (3) The multi-hop reasoning is partially sound in that the LLM recognizes a shift in timing and strategic importance, but it misinterprets the nature of the change—focusing on delivery deferrals rather than a reduction in total projected utilization and a change in dependency type. The conclusion about reduced immediate reliance has some merit, but misses the nuanced shift in strategic relationship ('Depends_On') highlighted in the original. (4) Contextual relevance is high because the LLM addresses both parts of the question—evolution of utilization and strategic implications—and stays focused on the Cessna SkyCourier and FedEx. However, due to major factual and quantitative errors, the correctness score is limited to 4, reflecting partial accuracy with significant omissions and inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 463,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods for U.S. Excess Casualty has evolved by refining segmentation and analyzing more specific casualty lines. In 2022, the analysis focused on standard claims segmented by attachment point bands and included separate evaluations for automobile-related claims (shorter tail) and non-automobile claims, with further segmentation for latent exposures like construction defects and mass torts. By 2023, AIG continued this approach but emphasized higher attachment points in accident years, reflecting strategic changes in layer participations. Additionally, the 2023 methodology incorporated adjustments for external factors like the impact of the underwriting cycle and judicial trends, while maintaining a focus on recent accident years where credibility of reported losses remains low.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies regarding the evolution of AIG's use of expected loss ratio methods between 2022 and 2023. While it correctly notes segmentation by attachment point and differentiation between automobile and non-automobile claims in 2022 for U.S. Excess Casualty, it incorrectly states that AIG continued and refined this approach in 2023 for the same line. The ground truth indicates a strategic shift in 2023 from U.S. Excess Casualty to U.S. Workers' Compensation as the primary focus for expected loss ratio methods. This major change is entirely missed by the LLM, which instead claims continued emphasis on U.S. Excess Casualty with higher attachment points—contradicting the original answer. (2) There are no explicit numerical values (e.g., percentages, dollar amounts, years) in either answer beyond '2022' and '2023', which are correctly used. Thus, quantitative accuracy is high due to absence of incorrect numbers. (3) The multi-hop reasoning is flawed: the question asks about evolution across years and casualty lines, requiring synthesis of changes in both segmentation and the type of casualty line analyzed. The LLM fails this synthesis by not recognizing the shift from Excess Casualty to Workers' Compensation. Instead, it assumes continuity within the same line, undermining the core of the multi-hop requirement. (4) Contextual relevance is moderate because the response discusses relevant concepts like segmentation, attachment points, and latent exposures, but applies them to the wrong business line in 2023, leading to a substantively incorrect conclusion about AIG’s methodological evolution. The mention of external factors like underwriting cycles and judicial trends is not supported in the ground truth and introduces unverified content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 493,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "Between fiscal years 2022 and 2024, the classification of unallocated products within Nike's consumer construct evolved as part of the company's ongoing strategic adjustments. In 2022, the \"Others\" category included products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand, as well as certain adjustments not allocated to consumer-designated products. By 2024, the \"Others\" category retained a similar definition but showed a 6% increase in revenue contribution compared to the prior year, indicating a shift in how unallocated products were recognized or categorized. Additionally, the continued rollout of Nike's new Enterprise Resource Planning Platform in 2024 signaled a transition away from non-GAAP metrics like wholesale equivalent revenues, suggesting a potential future shift in how such unallocated or internal sales are reported.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer partially aligns with the ground truth but introduces unsupported quantitative and interpretive claims. (1) Correct elements: The mention of the 'Others' category including unallocated products (not assigned to Men's, Women's, Kids', Jordan Brand) in both years is consistent with the original answer. The focus on evolving classification and reporting within Nike's consumer construct is relevant. (2) Quantitative inaccuracy: The claim of a '6% increase in revenue contribution' for 'Others' in 2024 is not present in the ground truth and cannot be verified from the provided information—this is a significant factual addition with no support. (3) Missing key point: The original answer highlights that in 2022, unisex products were explicitly classified within Men's, while by 2024 this specific classification was no longer mentioned, suggesting a shift. This critical evolution in unisex product categorization is entirely omitted in the LLM response. (4) Reasoning: The LLM attempts multi-hop reasoning by referencing Nike's ERP platform and a move away from non-GAAP metrics, but this distracts from the core issue of product categorization within the consumer construct and is not directly tied to the classification of unallocated or unisex products. (5) Contextual relevance is high as the response stays focused on Nike's reporting structure, but the emphasis on revenue changes and ERP systems shifts attention from the actual evolution in classification logic. Overall, the answer contains plausible elements but fails to accurately reflect the key shift regarding unisex product classification and introduces unsupported data, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 457,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "Between 2023 and 2024, PepsiCo issued a 5.250% Senior Note due 2025 in November 2023 and later, in 2024, authorized a 3.500% Senior Note due 2025 as part of broader debt offerings. This evolution indicates that PepsiCo is actively managing its debt portfolio by diversifying maturities and interest rates, likely to optimize borrowing costs and manage refinancing risks as the 2025 maturity approaches.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims PepsiCo issued a '5.250% Senior Note due 2025 in November 2023' and 'authorized a 3.500% Senior Note due 2025 in 2024', which contradicts the ground truth. The 3.500% Senior Notes due 2025 were already part of the existing debt structure in 2023 and remained in 2024; they were not newly authorized in 2024. There is no mention of a 5.250% note due 2025 in the ground truth. (2) Quantitative accuracy is very low: the interest rates (5.250% vs 3.500%), timing (November 2023 issuance), and nature of the 2024 activity (authorization vs continuation) are all incorrect. The ground truth does not support any new 3.500% due 2025 note being issued in 2024. (3) The multi-hop reasoning is flawed. The model fails to correctly track the evolution of the 3.500% Senior Notes due 2025 across years, instead fabricating new issuances. It misses the key point that the 2024 development was the introduction of longer-term notes (e.g., due 2034, 2040), not new 2025 notes. The conclusion about diversifying maturities is partially aligned with the ground truth, but it is based on incorrect premises. (4) Contextual relevance is moderate because the answer addresses debt management strategy and maturity diversification, which are relevant themes. However, due to major factual and quantitative errors, the correctness and qualitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 397,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "Between 2022 and 2024, ConocoPhillips (COP) significantly increased capital expenditures in the Lower 48 region, rising from $3,129 million in 2022 to $29,952 million in 2024, driven by major investments in exploration and development. Additionally, future cash inflow revisions for the Lower 48 reflected higher estimated revenues in 2024 ($164,264 million) compared to 2022 ($195,605 million), though this was partially offset by increased production and development costs, indicating a shift in economic conditions and operational strategies over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that COP reported $3,129 million in capital expenditures for the Lower 48 in 2022, which is correct in the LLM answer. However, the LLM falsely claims that capital expenditures rose to $29,952 million in 2024, which is not supported by the original answer—no new capital expenditure figure was provided for 2024. Additionally, the LLM invents future cash inflow figures of $195,605 million in 2022 and $164,264 million in 2024, which are not present in the ground truth; the original answer only states that future cash inflows and production costs were revised in 2024, without providing specific numbers. (2) Quantitative accuracy is severely compromised: the $29,952M capex and the cash inflow figures are fabricated. There is no indication in the ground truth of such numbers or a comparison between them. The direction of change in cash inflows is also misrepresented—the LLM implies a decrease from 2022 to 2024, but the ground truth does not support this. (3) The multi-hop reasoning is flawed. The original answer describes a shift from active investment (2022) to revised financial projections (2024), but the LLM incorrectly interprets this as continued heavy investment and quantifies unreported data. It fails to recognize that the absence of a new capex number in 2024 is meaningful. (4) Contextual relevance is moderate—the answer addresses capital expenditures and future cash inflows in the Lower 48 region for COP across 2022–2024, so the topic alignment is correct. However, due to significant factual and quantitative errors, the qualitative and correctness scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 459,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "Between 2023 and 2024, Comcast's financial commitments and governance arrangements with Atairos Group remained largely consistent, with no significant changes in capital obligations or control structures. Comcast maintained its role as the sole third-party investor in Atairos, with a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. The governance structure remained unchanged, with Atairos controlled by management companies led by Comcast's former CFO, who holds all voting rights. Comcast's economic interest continued to absorb approximately 99% of potential losses and entitled it to 86% of residual returns. No new amendments or material changes to the arrangement were disclosed in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in several key areas. (1) It claims no significant changes occurred between 2023 and 2024, but the original answer states clear evolution: Comcast reduced its capital commitment from $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. These are material changes that the LLM fails to report. (2) The LLM introduces a specific figure—'$1.4 billion unfunded capital commitment as of December 31, 2024'—which is not present in the ground truth and cannot be verified from the provided information; this appears to be fabricated or misattributed. (3) While the LLM correctly notes that Comcast absorbs ~99% of losses and receives ~86% of returns, and that voting rights are held by management companies led by Comcast’s former CFO, these correct qualitative points are overshadowed by the failure to report the structural changes in 2024. (4) The multi-hop reasoning is flawed: the question asks how the relationship evolved, requiring comparison across years and synthesis of amendments and accounting changes. The LLM incorrectly concludes no changes occurred, missing the shift to equity method accounting and revised capital framework. (5) Contextually, the answer addresses the right entities (Comcast, Atairos) and some correct governance elements, but fails to capture the evolution central to the question. Overall, major factual inaccuracies and omission of key financial recalibrations result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 433,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "FedEx's projected utilization of the Cessna SkyCourier 408 decreased significantly between 2022 and 2023 filings. In 2022, FedEx had committed to purchasing 49 Cessna SkyCourier 408 aircraft across 2023 to 2026, but by 2023, this number was reduced to just 31 aircraft scheduled for delivery in 2025. This reduction indicates a diminished strategic role for the Cessna SkyCourier 408 in FedEx's fleet compared to other aircraft, such as the ATR 72-600F, B767F, and B777F, which retained more consistent delivery commitments. The shift suggests that FedEx may be prioritizing larger, more fuel-efficient freight aircraft over smaller regional aircraft like the Cessna SkyCourier 408 for its long-term fleet strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the reduction in projected Cessna SkyCourier 408 aircraft from 49 to 31, which matches the ground truth. However, there are inaccuracies in the delivery timelines: the 2022 filing states 49 aircraft projected to be in service through 2027, not committed for purchase between 2023–2026 as stated by the LLM. Similarly, the 2023 filing updates the projection to 31 aircraft through 2029, not just deliveries in 2025. These timeline misrepresentations affect quantitative accuracy. (2) The core numbers (49 and 31) are correct, but the associated timeframes are misrepresented—this is a significant but not critical error since the overall trend of reduction is accurate. (3) The reasoning and synthesis are strong: the LLM correctly infers a diminished strategic role for the SkyCourier and appropriately contrasts it with more stable projections for B767F and B777F. Mentioning the ATR 72-600F adds relevant context not in the original but does not contradict it. The conclusion about prioritizing larger, more efficient freighters is a reasonable interpretation. (4) The answer is contextually excellent—addresses both parts of the question (change in utilization and strategic role), uses correct entities (FedEx, Cessna SkyCourier 408, B767F, B777F), and provides logical analysis. The correctness score is 8 due to accurate core facts and sound reasoning, penalized slightly for incorrect delivery schedule details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 404,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "Nike's approach to the Air Max product line from 2022 to 2024 shows increased emphasis on technological innovation, particularly in integrating new cushioning technologies and expanding product applications. While 2022 documents primarily focus on revenue transparency through detailed geographic and product line revenue breakdowns, the 2024 documents highlight a stronger focus on innovation, mentioning technologies like Air-Sole and the expansion of cushioning components across footwear categories. Additionally, Nike's 2024 disclosures reflect a broader strategic emphasis on leveraging technologies to enhance performance and consumer experiences, indicating a shift toward innovation-driven growth for the Air Max line.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a shift in Nike's focus toward technological innovation for the Air Max line from 2022 to 2024 and notes the absence of specific revenue figures, which aligns with the ground truth. However, it inaccurately suggests that 2022 documents provided 'detailed geographic and product line revenue breakdowns' that included Air Max, which contradicts the ground truth stating Air Max was only passively listed without standalone revenue. The answer also introduces 'Air-Sole' and 'expansion of cushioning components' as specific innovations but does not tie them directly to Air Max in a way supported by the original answer. (2) There are no numeric values in either answer, so quantitative accuracy is not compromised—no incorrect numbers or dates are presented, earning full marks. (3) The multi-hop reasoning is partially sound: the model infers a strategic shift toward innovation, which is correct, but fails to accurately represent the nature of revenue transparency (or lack thereof) in both years. It mischaracterizes the 2022 disclosure as more transparent than it was. (4) The contextual relevance is high because the response addresses both revenue transparency and innovation emphasis, but the qualitative inaccuracy in representing the extent of financial disclosure reduces overall correctness. The core idea of a strategic pivot is present, but key factual nuances about disclosure practices are missing or distorted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 408,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "Comcast's capital expenditure strategy for Epic Universe evolved from 2023 to 2024 by shifting focus from land acquisition to active construction. In 2023, capital expenditures for theme parks included the acquisition of land for potential expansion opportunities, while in 2024, spending on theme park attractions increased, specifically including costs associated with the construction of Epic Universe in Orlando. This indicates a progression from planning and site preparation in 2023 to active development and construction in 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements regarding the strategic evolution of Comcast's capital expenditures from planning to construction phases, but it omits and misrepresents key quantitative details. The ground truth specifies that $8.2 billion was allocated to Connectivity & Platforms in 2023, which included Epic Universe infrastructure, but the LLM answer fails to mention this figure entirely. Additionally, the LLM incorrectly frames 2023 spending as primarily for 'land acquisition,' which is not supported by the original answer—2023 was focused on 'scalable infrastructure and line extensions,' not land purchases. (2) There are no correct numbers cited in the LLM answer; the $8.2 billion figure is completely missing, and no specific investment amounts for either 2023 or 2024 are provided, despite the question asking for 'specific investment amounts.' The absence of this critical data significantly undermines quantitative accuracy. (3) The reasoning partially captures a logical progression—shifting from preparation to active development—but does so with incorrect characterization of the 2023 activities. The multi-hop synthesis is weak because it fails to connect the disclosed $8.2 billion figure to Epic Universe’s development within the broader capital allocation, and it invents a 'land acquisition' narrative not present in the source. (4) While the answer is contextually relevant and addresses the theme park development priority shift, the lack of specific figures and factual inaccuracies in describing the nature of expenditures reduce its overall correctness. The answer gets credit for identifying a strategic shift but loses points for missing key data and introducing unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 474,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "Between 2022 and 2023, FedEx's utilization of the ATR 72-600F aircraft evolved as reflected in their fleet projections. In 2022, FedEx had 6 ATR 72-600F aircraft in its fleet, and the company had committed to purchasing 24 ATR 72-600F aircraft by 2026. By 2023, FedEx had increased its commitment, with a total of 10 ATR 72-600F aircraft planned for purchase by 2026, indicating a strategic shift to incorporate more of these aircraft into its fleet.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) It falsely claims that in 2022, FedEx had 6 ATR 72-600F aircraft in its fleet and planned to purchase 24 by 2026, and that by 2023 this increased to 10 planned by 2026. The ground truth states that in 2022, FedEx projected operating 11 of these aircraft in 2023, decreasing to 1 by 2026, and by 2023, the projection was revised to 7 in 2025 and 3 in 2026—indicating a reduction, not an increase. (2) All numbers are wrong: the LLM misrepresents both the actual fleet size and purchase commitments. There is no mention in the ground truth of 24 or 10 total purchases; instead, the projections are about planned operations in future years, not purchase commitments. (3) The reasoning is flawed: the LLM concludes a strategic expansion, while the truth shows a clear downward trend in utilization projections, indicating a phase-out. (4) The answer fails on quantitative accuracy due to fabricated numbers, on qualitative accuracy due to incorrect entities and logic, and on completeness because it does not reflect the actual evolution of fleet projections between 2022 and 2023. Contextual relevance is low but not zero because it discusses the right aircraft and company in a fleet planning context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 356,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Nike's approach to estimating product return reserves remained consistent in its methodology, as it continued to base estimates on historical rates, specific identification of outstanding returns, and expectations for future returns. However, the data shows a decline in the sales-related reserve balance from $1,077 million in 2021 to $1,015 million in 2022, and further to $965 million in 2024. This reduction suggests improved confidence in return predictability or a decrease in return rates, indicating a potential refinement in revenue recognition practices, such as more accurate forecasting or tighter control over return authorizations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth states that in fiscal 2022, Nike's estimated cost of inventory for expected product returns was $269 million, recorded in Prepaid expenses and other current assets. The LLM incorrectly claims the 'sales-related reserve balance' was $1,077M in 2021, $1,015M in 2022, and $965M in 2024—none of which are supported by the original answer and which conflate different reserve categories (e.g., sales returns vs. other reserves). These numbers do not appear in the ground truth and are likely fabricated or misattributed. (2) The quantitative inaccuracies are severe: the only correct dollar amount mentioned in the ground truth is $269M for 2022, which the LLM omits entirely. Instead, it introduces unrelated figures with no basis in the provided data. There are no valid calculations or comparisons possible due to incorrect inputs. (3) The multi-hop reasoning fails completely. The question asks about a methodological evolution in estimating product return reserves and implications for revenue recognition. The ground truth identifies a shift from a disclosed dollar reserve in 2022 to a more formalized, probabilistic 'most likely amount' approach in 2024, indicating alignment with variable consideration under revenue recognition standards (ASC 606). The LLM incorrectly asserts that the methodology 'remained consistent,' directly contradicting the ground truth. It misses the key conceptual shift toward estimating variable consideration at recognition time. (4) While the LLM attempts to address the question’s context—changes in return reserves and implications for revenue recognition—its factual foundation is entirely wrong, leading to misleading conclusions about 'improved confidence' or 'tighter control' based on false numerical trends. The contextual relevance is moderate because it engages with the topic area, but the substance is factually and conceptually inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 537,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "Between 2022 and 2023, the planned fleet composition of the Cessna SkyCourier 408 increased for the years 2025 and beyond. In 2022, FedEx planned to deliver 12 units in 2025, but by 2023, this number rose to 17 units for 2025. This increase indicates a growing strategic reliance on the Cessna SkyCourier 408 model to support FedEx's operations, likely for regional or cargo transport needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in planned Cessna SkyCourier 408 units from 12 in 2022 to 17 in 2023 for 2025, which matches the ground truth. However, it omits the reduction to 14 units planned for 2026, a key part of the fleet composition change. This missing information affects completeness and reasoning. (2) Quantitatively, the numbers for 2025 are accurate (12 and 17), but the answer fails to mention the 2026 figure of 14, which is a significant deviation from the full picture. Calculations are not required here, but reporting only part of the timeline is a factual incompleteness. (3) The reasoning correctly infers increased strategic reliance in the short term but misses the nuance of a subsequent decline by 2026, which the ground truth interprets as a 'recalibration of fleet strategy.' This limits the depth of multi-hop synthesis across years and planning updates. (4) The answer is contextually relevant and well-structured, addressing the core question about changes and strategic implications, but the omission of the 2026 reduction prevents a full 9-10 score. The strategic interpretation is reasonable but incomplete without acknowledging the later decrease.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 340,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "Mastercard expanded its real-time account-based payments infrastructure from 2023 to 2024 by increasing operational scale, implementing real-time payments infrastructure in 13 markets as of December 31, 2023, and enhancing integrated security capabilities through multi-layered protections, including fraud scoring and tokenization services. The infrastructure supports instant payments with enhanced data and messaging capabilities, enabling secure, direct account-to-account transactions for consumers, businesses, and governments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Mastercard was operating or implementing real-time payments infrastructure in 13 markets as of 2023, which matches the ground truth. It accurately describes the security capabilities such as fraud scoring and tokenization, and emphasizes instant payments with enhanced data and messaging. However, the LLM answer does not explicitly mention the 2024 enhancements to ACH and real-time systems or the strategic shift toward 'more secure, simple, and smart' solutions, which are key developments in the original answer. While it references expanded capabilities, it lacks specific detail on how the infrastructure evolved in 2024 beyond restating 2023 capabilities. (2) All numbers and dates are accurate—'13 markets' and 'December 31, 2023' align with the ground truth. No calculations were required. (3) The reasoning is mostly sound: the model correctly synthesizes information about operational scale and security from the 2023 baseline. However, it fails to fully execute the multi-hop requirement by not clearly contrasting 2023 vs. 2024 advancements, particularly the expansion and reinforcement of security through new partnerships and layered protections in 2024. (4) The contextual relevance is high as the response directly addresses the evolution of Mastercard's infrastructure. Quantitative accuracy is perfect. Correctness and qualitative accuracy are slightly reduced due to missing key 2024-specific enhancements mentioned in the original answer, making the response somewhat incomplete on the forward-looking evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 435,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "Between 2022 and 2024, Nike's use of foreign exchange forwards and options evolved in terms of both financial liabilities and hedging strategy. In 2022, the total notional amount of outstanding foreign currency derivatives designated as cash flow hedges was $18.5 billion, with $607 million of deferred net gains expected to be reclassified to net income within 12 months. By 2024, the notional amount of these hedges had decreased to $16.2 billion, and the deferred net gains expected to be reclassified were reduced to $231 million. Additionally, undesignated derivative instruments increased from $3 billion in 2022 to $4.4 billion in 2024, indicating a shift in strategy to more directly manage specific balance sheet exposures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, foreign exchange forwards and options had a net gain of $8 million after tax, with no mention of notional amounts like $18.5 billion or $16.2 billion, nor deferred gains of $607 million or $231 million. These figures are entirely absent from the original answer and cannot be verified against the provided ground truth. Additionally, the increase in undesignated derivatives from $3 billion to $4.4 billion is not mentioned in the original answer and appears to be fabricated or misattributed. (2) The only financial liability numbers in the ground truth are $110 million under accrued liabilities and $5 million under deferred income taxes in 2024—these are completely missing from the LLM response. The LLM fails to report the actual impact on financial liabilities as required. (3) The multi-hop reasoning is flawed: while the question asks about evolution in use and impact on liabilities and hedging strategy, the LLM invents metrics not present in the source, failing to connect the actual data points (net gain in 2022, liability balances in 2024). It does correctly infer a strategic shift, which aligns qualitatively, but this is based on incorrect data. (4) Despite using plausible financial terminology and structure, the answer is largely incorrect factually, hence the low correctness and quantitative accuracy scores. Contextual relevance is moderate because the response addresses the general topic and direction of change, but with incorrect supporting data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 435,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "Between 2022 and 2023, the product category classification of Puffs within the Baby, Feminine & Family Care segment remained consistent. In both years, Puffs was listed under the \"Family Care\" sub-category, which includes products like paper towels, tissues, and toilet paper. Specifically, in 2022, Puffs was mentioned alongside \"Paper Towels, Tissues, Toilet Paper,\" and in 2023, it was similarly grouped under \"Family Care (Paper Towels, Tissues, Toilet Paper).\" There was no reclassification or change in its placement within the segment during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in stating that Puffs remained in the Family Care sub-category from 2022 to 2023 and correctly identifies the product types included (paper towels, tissues, toilet paper). However, it fails to capture a key nuance present in the original answer: the change in reporting detail. In 2022, 'Tissues' was explicitly listed as a sub-category, but in 2023, the reporting was simplified or consolidated, with no explicit mention of 'Tissues'—instead using a more general listing without sub-category breakdowns. The LLM interprets the continued presence of 'Tissues' in parentheses in 2023 as evidence of no change, but the ground truth indicates a shift in how the category was reported, suggesting a possible internal reorganization or simplification in disclosure. This omission of the reporting-level change reduces the qualitative accuracy, as the model misses the evolution in classification granularity. There are no numerical or date inaccuracies (quantitative accuracy is perfect), and the response is highly relevant to the question. However, the failure to recognize and report the subtle but meaningful shift in categorization detail—central to the question about 'evolution'—results in a partially correct answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 350,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "Between 2022 and 2023, Tampax's categorization within P&G's product portfolio remained consistent as part of the \"Feminine Care\" sub-category under the \"Baby, Feminine & Family Care\" segment. In both years, Tampax was grouped with other feminine care brands like Always and Always Discreet. However, in 2023, the document provided a more specific breakdown, noting that Tampax is part of the \"menstrual care\" sub-category, with the segment reporting over 25% global market share in this area. There was no indication of any repositioning or rebranding of Tampax during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but significant inaccuracies in the core claim. While it correctly identifies Tampax as part of the 'Feminine Care' category in 2022 and notes its association with menstrual care in 2023, it incorrectly states that there was 'no repositioning' and that categorization 'remained consistent.' This directly contradicts the ground truth, which states a clear shift from 'Feminine Care' (broad) to a more focused 'Menstrual Care' sub-category in 2023, signaling a strategic repositioning. The LLM downplays this evolution as merely a 'more specific breakdown' rather than acknowledging the structural change. (2) Quantitatively, the mention of 'over 25% global market share' in menstrual care in 2023 has no contradiction in the ground truth, but this figure is not present in the original answer, so its accuracy cannot be verified. Since it doesn't conflict and may be supplementary, it doesn't penalize heavily. No incorrect numbers are stated. (3) The multi-hop reasoning is flawed: the model fails to synthesize the shift from a broader 'Feminine Care' category (which included Family Care) to a more precise 'Menstrual Care' focus, which is a key analytical point in the original answer. The LLM treats this as a clarification rather than a strategic repositioning, missing the intent of the question about evolution in categorization. (4) Contextual relevance is fair—the answer addresses Tampax’s portfolio positioning and mentions the correct segment and associated brands. However, the conclusion undermines the actual evolution. Thus, correctness is scored low due to the central factual misrepresentation of no repositioning, despite some accurate contextual details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 472,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "Between fiscal 2022 and fiscal 2023, Oracle's strategy for Oracle Engineered Systems, part of its hardware business, continued to emphasize cloud-based infrastructure technologies and strategic hardware offerings, while de-emphasizing nonstrategic hardware products. This shift is reflected in the decline in hardware revenues, which decreased by 5% in fiscal 2022 and remained at 6% of total revenues in fiscal 2023. Oracle expects to continue investing in research and development for its hardware business to improve existing products and develop new offerings, though the focus remains on cloud services. Research investment expectations for fiscal 2023 align with Oracle's broader strategy of expanding cloud capacity and geographic footprint, with ongoing investments in cloud operations and infrastructure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly states that hardware represented 6% of total revenues in fiscal 2023, aligning with the ground truth. However, it incorrectly claims that hardware revenues decreased by 5% in fiscal 2022 — this specific decline is not mentioned in the original answer and cannot be verified from the provided ground truth. Additionally, the LLM implies that the 6% revenue figure was consistent between years by saying 'remained at 6%', but the original answer only specifies the 6% figure for fiscal 2023, not 2022, making this an unsupported inference. (2) The quantitative inaccuracy around the 5% decline and the erroneous 'remained at' comparison reduces confidence in the numbers. While the 6% figure is correct for 2023, the lack of confirmation for 2022 means the comparison is invalid. (3) The qualitative reasoning captures the strategic shift toward R&D investment in hardware and acknowledges Oracle’s continued focus on strategic hardware within a cloud context, which reflects the multi-hop synthesis of strategy evolution. However, it introduces unverified claims about revenue trends not present in the ground truth, weakening the reasoning chain. (4) The answer is contextually relevant and addresses both revenue contribution and R&D expectations. Despite incorrect numerical claims, it captures Oracle’s forward-looking R&D plans accurately for fiscal 2023. The core strategic direction is reasonably conveyed, but significant factual inaccuracies in revenue performance limit overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 437,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "Between 2022 and 2023, Honeywell's Non-U.S. pension plans saw a shift in their investment in private funds. In 2022, the fair value of private funds was $36 million, classified as $54 million in Level 2 and $36 million in Level 3 of the fair value hierarchy. By 2023, the total investment in private funds increased to $74 million, with $41 million in Level 2 and $74 million in Level 3. This indicates a reallocation and growth in private fund investments, primarily within Level 3, reflecting changes in valuation and investment strategies.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The original answer states that in 2022, Honeywell reported $1,105 million in private fund investments for its U.S. pension plans (not Non-U.S.), all classified under Level 3. However, the LLM incorrectly claims $36 million in 2022 for Non-U.S. plans, with $54 million in Level 2 and $36 million in Level 3—none of which matches the ground truth. In 2023, the correct data is $115 million total for Non-U.S. plans: $41 million in Level 2 and $74 million in Level 3. The LLM incorrectly states total investment increased to $74 million (missing $41 million in Level 2 as part of the total), and absurdly claims $41 million in Level 2 and $74 million in Level 3 summing to $115 million but misrepresents the total as $74 million. (2) Quantitative accuracy is very low: 2022 numbers are entirely fabricated; 2023 totals are wrong (reports $74M instead of $115M); Level 2 and Level 3 figures are misstated and misaggregated. (3) Multi-hop reasoning fails: the model confuses U.S. and Non-U.S. plans, misattributes years, and does not reflect the actual shift from U.S.-dominated private fund investments in 2022 to a reclassified Non-U.S. allocation in 2023. It incorrectly infers growth when the truth shows a massive decrease from $1,105M to $115M. (4) Contextual relevance is moderate because it addresses private fund allocation and fair value hierarchy levels, but the incorrect entities and numbers undermine the entire response. The conclusion about 'growth' is the opposite of the truth. Scores reflect major factual and quantitative errors, flawed reasoning, but partial relevance to topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 454,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "The 2014 USD Notes, which were $1 billion principal amount 3.375% Senior Notes due April 2024, matured in April 2024 and were fully paid off. This marked the resolution of this debt obligation, with no remaining balance outstanding as of December 31, 2024. No specific actions were taken in 2024 regarding refinancing or restructuring of this debt, as it was fully repaid upon maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 2014 USD Notes had a $1 billion principal amount, carried a 3.375% interest rate, and matured in April 2024, which aligns with the ground truth. It accurately states that the debt was fully paid in April 2024 and that no balance remained outstanding by year-end 2024. The only minor omission is that the original answer notes the classification of the notes as 'short-term debt, net of unamortized discount and debt issuance costs' in 2023, which the LLM answer does not mention. However, this detail is contextually secondary to the core evolution and resolution of the debt. (2) All quantitative elements—$1 billion principal, April 2024 maturity, full repayment—are factually correct and match the ground truth. Number formats and dates are accurate. (3) The multi-hop reasoning is sound: the model correctly infers that a note maturing in April 2024 would be a short-term liability in 2023 and would require settlement in 2024, and it correctly concludes that repayment was made in full without refinancing. The absence of refinancing or restructuring actions is logically implied by full repayment. (4) The answer is semantically equivalent to the ground truth in all key aspects, with only slight lack of detail regarding the 2023 balance sheet classification. Scores reflect high accuracy, with a 9/10 due to this minor completeness gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 390,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "The treatment and documentation of Lowe's Officer Indemnification Agreements remained consistent between 2022 and 2024, as evidenced by the inclusion of the \"Form of Lowe's Companies, Inc. Officer Indemnification Agreement\" in both years’ filings (10.23 in 2022 and 10.23 in 2024). This continuity suggests that Lowe's has maintained a stable executive risk management framework, ensuring consistent legal protections for its officers. The unchanged documentation reflects governance continuity and a commitment to safeguarding executives against potential legal risks, reinforcing the company's structured approach to executive compensation and liability management.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct and conveys the essential information from the ground truth, but contains a minor inaccuracy in the exhibit number. The ground truth states that the agreement was filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in 2022 and 2024. However, the LLM answer incorrectly cites the exhibit number as 10.23 for both years, which affects quantitative accuracy. Despite this, the core reasoning and conclusion are sound: the agreement remained unchanged, indicating stable governance and executive risk management practices. The answer addresses all parts of the question—evolution (or lack thereof) between 2022 and 2024, and implications for governance and risk management—demonstrating strong qualitative accuracy and contextual relevance. The semantic meaning aligns with the original answer, and the conclusion about continuity and governance stability is logically derived. The error in exhibit number is factual but does not undermine the overall correctness of the interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 294,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "In the 2022 filing, Always Discreet was noted to have over 10% market share in key markets within the adult incontinence category. By 2023, the market share of Always Discreet in the adult incontinence category increased to about 15% in the markets where Procter & Gamble competes. This indicates an improvement in market share and a stronger category positioning for Always Discreet between 2022 and 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Always Discreet's market share increased to about 15% in 2023, which is factually wrong. The ground truth confirms that no specific market share figure was disclosed for Always Discreet in the 2023 10-K filing. The only quantified data available is from the 2022 filing, which reported 'over 10%' market share. The claim of a rise to 15% is unsupported and contradicts the original answer, which notes the absence of a disclosed figure in 2023. (2) Quantitative accuracy is severely compromised because the 15% figure is fabricated. There is no calculation or data in the ground truth to support any numerical increase. The only correct number is the 'over 10%' from 2022, which the LLM correctly recalled. (3) The multi-hop reasoning is flawed. The question requires comparing disclosures across two years to assess changes in market share communication. The correct inference is not a numerical increase but a shift in disclosure strategy—from a quantified market share in 2022 to no specific number in 2023. The LLM instead assumes a positive trend without evidence, failing to recognize the absence of data as a meaningful change. (4) Contextual relevance is moderate because the answer addresses the right brand, category, and time frame, and attempts to compare two filings. However, the incorrect conclusion about market share growth undermines the core of the response. The qualitative reasoning fails to reflect the nuanced change in reporting, instead asserting a false improvement. Correctness is low due to the major factual error in the 2023 market share claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 445,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "Between 2022 and 2023, Oracle's strategic positioning of Engineered Systems evolved to further integrate them into its cloud transformation narrative. Engineered Systems, such as Oracle Exadata, are increasingly offered as cloud services within OCI, either as public cloud offerings, through Oracle Cloud@Customer, or as Dedicated Region Cloud@Customer solutions. This shift emphasizes Oracle's hybrid and multi-cloud strategy, allowing customers to deploy these systems in on-premise or distributed environments while still leveraging cloud automation and management. This evolution supports Oracle's broader cloud transformation by enabling customers to migrate workloads to the Oracle Cloud seamlessly and by reinforcing Oracle's differentiated infrastructure capabilities in performance, security, and scalability.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the evolution of Oracle's strategic positioning of Engineered Systems from 2022 to 2023, emphasizing their integration into Oracle's cloud transformation narrative through hybrid offerings like Cloud@Customer and Dedicated Region. It accurately reflects the shift toward positioning Engineered Systems as part of Oracle's differentiated infrastructure within a hybrid and multi-cloud strategy, which aligns with the ground truth. However, the LLM answer omits key quantitative and structural details present in the original answer: specifically, the fact that hardware revenues (including Engineered Systems) accounted for 6% of total revenues in both fiscal 2023 and 2024, and that Engineered Systems are now grouped with servers, storage, and operating systems as combined performance obligations. Additionally, the mention of ongoing R&D investments and the acknowledgment of the lower-margin nature of the hardware business are missing, which are important contextual elements for understanding Oracle's strategic trade-offs. While the LLM provides a qualitatively sound narrative about cloud integration and hybrid deployment models, it fails to fully synthesize the financial and reporting-level changes that mark the strategic evolution described in the ground truth. There are no numerical inaccuracies (hence perfect quantitative accuracy), and the reasoning is logical and relevant, but the absence of specific revenue percentages and structural reporting changes limits completeness and qualitative equivalence. The answer remains contextually relevant and captures the core directional shift, warranting a solid but not top-tier score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 456,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "In the 2022 10-K filing, the 2020 Stock Plan is described as the successor to the 2011 Stock Plan, with shares available under the 2011 Plan being rolled into the 2020 Plan. By the 2023 10-K filing, the 2011 Stock Plan is no longer explicitly mentioned, and the 2020 Stock Plan is presented as the active plan, with no reference to a successor relationship. This indicates a simplification in the disclosure, focusing solely on the 2020 Stock Plan as the current vehicle for equity awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) It correctly identifies that in the 2022 10-K, shares from the 2011 Stock Plan were rolled into the 2020 Stock Plan, and that this linkage was omitted in the 2023 10-K. While the exact number of shares (5,530,106) is not mentioned, the core fact of carry-forward and subsequent omission is preserved. (2) No calculations are required, and all dates (2022, 2023, 2011, 2020) are correct. The absence of the specific share number is a minor omission but does not undermine the factual correctness of the disclosure evolution. (3) The multi-hop reasoning—comparing disclosures across two years and two stock plans—is sound and correctly synthesized. The conclusion about simplification and focusing on the 2020 Plan alone aligns with the ground truth. (4) The answer is contextually fully relevant, directly addressing how the disclosure evolved. The slight lack of quantitative detail prevents a perfect 10, but the qualitative and contextual accuracy remains strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 302,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Between 2022 and 2023, Honeywell's allocation strategy toward private funds within its U.S. pension plans shows a slight decrease in the value of direct private investments, from $1,284 million in 2022 to $1,293 million in 2023, while real estate properties increased slightly from $1,005 million to $977 million. For non-U.S. plans, private fund investments decreased significantly from $90 million in 2022 to $74 million in 2023. This suggests a more conservative capital deployment approach, potentially prioritizing liquidity and stability over high-risk, long-term private investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Honeywell's investment in private funds increased from $1,244 million in 2022 to $1,265 million in 2023, a 1.7% increase. However, the LLM incorrectly states the 2022 amount as $1,284 million and 2023 as $1,293 million, which are both numerically wrong. Additionally, the LLM introduces real estate figures ($1,005M to $977M) and non-U.S. plans ($90M to $74M) that are not mentioned or supported in the original answer, suggesting fabrication or misattribution. (2) The quantitative inaccuracies are severe: the correct values are $1,244M (2022) and $1,265M (2023), with a correct difference of $21M (≈1.7% increase). The LLM reports a $9M increase from higher base numbers, which is both factually and proportionally incorrect. No valid calculation can be derived from the wrong inputs. (3) The reasoning is flawed due to incorrect data. The LLM concludes a 'conservative capital deployment approach' based on fabricated declines, while the ground truth indicates a slight strategic increase in private fund allocation, suggesting continued or slightly expanded appetite for alternative investments. The multi-hop synthesis failed—instead of correctly identifying the trend from U.S. plan disclosures in consecutive 10-Ks, the model introduced unverified data splits (U.S. vs. non-U.S., real estate) not present in the original. (4) The contextual relevance is moderate because the answer attempts to address allocation strategy and capital deployment priorities, and interprets the trend in strategic terms. However, due to severe factual and quantitative errors, the conclusion is opposite to the correct inference. Scores reflect major factual errors (correctness: 2), poor number accuracy (quantitative: 2), weak reasoning from incorrect premises (qualitative: 3), and partial relevance to the question's intent (contextual: 6).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 523,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "Between 2023 and 2024, Class B-2 Common Stock transitioned from being non-outstanding to becoming a newly issued class. In 2023, no shares of Class B-2 Common Stock were outstanding, as indicated by the note that \"no shares of class B-2 common stock were outstanding prior to the class B-1 common stock exchange offer.\" However, in 2024, following the Class B-1 Common Stock Exchange Offer on May 6, 2024, Visa issued approximately 120 million shares of Class B-2 Common Stock in exchange for 241 million shares of Class B-1 Common Stock. This issuance marked the first time Class B-2 Common Stock was outstanding. The Class B-2 shares are subject to conversion rate adjustments that have double the impact compared to Class B-1 shares, and they retain transfer restrictions until the resolution of U.S. covered litigation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) According to the original answer, Class B-2 Common Stock was not newly issued in 2024; rather, it was already part of the capital structure in 2023 with disclosures about conversion rate adjustments tied to litigation escrow and dilution effects. The LLM incorrectly claims that Class B-2 was first issued in 2024 as a result of the Class B-1 exchange offer, which is factually wrong. (2) The numeric claim of '120 million shares of Class B-2' issued in exchange for '241 million shares of Class B-1' on 'May 6, 2024' is entirely fabricated and not supported by the ground truth, which contains no such numbers or dates. (3) The qualitative reasoning fails on multiple levels: the LLM misrepresents the evolution of Class B-2 stock as moving from non-outstanding to outstanding due to issuance, while the truth states that no shares were outstanding prior to the exchange offer — but that the class existed and had active conversion mechanics in 2023. The 2024 filing merely stopped updating those mechanics, suggesting reduced emphasis, not new issuance. (4) The LLM introduces transfer restrictions and comparative conversion impact ('double the impact') not mentioned in the ground truth, adding speculative details. While the question involves multi-hop reasoning across years and stock classes, the LLM's synthesis is based on incorrect premises. The contextual relevance is moderate because it addresses stock class evolution, but factual inaccuracies severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 426,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "The financial obligations related to the Target Circle program significantly decreased between 2022 and 2024, as deferred revenue related to the program dropped from $89 million in 2022 to $19 million in 2024. This decline suggests that the program's structure or customer participation evolved, potentially shifting from a model with higher deferred obligations to one where rewards or benefits are recognized more immediately, or that the program's scale or complexity was streamlined over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in both numbers and trends. It claims deferred revenue dropped from $89 million in 2022 to $19 million in 2024, but the ground truth shows that deferred revenue increased to $117 million as of February 3, 2024, before dropping to $19 million by February 1, 2025. The LLM incorrectly conflates the 2025 figure with 2024, missing the increase between 2022 and 2024 entirely. (2) Quantitative accuracy is severely compromised: the $117 million figure for 2024 is omitted, and the $19 million figure is misattributed to 2024 instead of 2025. This results in an incorrect downward trend assertion, when the actual data shows an increase followed by a sharp decline. (3) The reasoning is flawed because it fails to perform the correct multi-hop synthesis across the three time points. The conclusion about program evolution is based on incorrect data, leading to invalid inferences about structural changes or immediate recognition of rewards. The model does not acknowledge the growth in liability between 2022 and 2024, which is a key indicator of program expansion or reduced redemptions during that period. (4) While the answer attempts to interpret the implications of changing obligations, the contextual relevance is reduced due to incorrect timing and values. The qualitative analysis is reasonable in form but built on false premises, limiting its validity. The model partially addresses the question’s intent but fails on core factual accuracy, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 424,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $1,111 million as of December 31, 2022, to $996 million as of December 31, 2023. This decline in fair value suggests that market conditions, such as rising interest rates or increased risk perception, may have led investors to demand higher returns for holding Netflix's debt, resulting in a lower valuation of the notes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the initial fair value: it states $1,111 million as of December 31, 2022, whereas the ground truth is $980 million. The 2023 value ($996 million) is correct. This error significantly undermines the quantitative accuracy. (2) The calculation of change is therefore incorrect: the LLM implies a decrease from $1,111M to $996M (a $115M drop), but the actual change is an increase from $980M to $996M (a $16M rise). The direction of change is misrepresented—fair value increased, not decreased. (3) The reasoning is partially sound in linking fair value changes to market conditions like interest rates or risk perception, but it draws the wrong conclusion due to the incorrect data. The ground truth indicates the fair value moved closer to par ($1 billion), suggesting stabilization or improved outlook, while the LLM interprets a false decline as increased risk, which contradicts the actual trend. (4) Despite the incorrect numbers, the answer addresses both parts of the question (change in fair value and interpretation), uses the correct entity (Netflix's 4.375% Senior Notes), and applies relevant financial logic, earning moderate scores for qualitative accuracy and contextual relevance. However, the major quantitative error—especially the wrong direction of change—severely limits correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 380,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "Between 2023 and 2024, the equity structure related to Class C Common Stock evolved through a May 2024 exchange offer, where 241 million shares of Class B-1 common stock were tendered, resulting in the issuance of 48 million shares of Class C common stock. This exchange offer reflects a strategic shift in equity classification, converting a portion of Class B-1 shares into Class C shares. Additionally, as of September 30, 2024, 10 shares of Class C common stock were issued and outstanding, consistent with the prior year. The Class C shares continue to represent a distinct class with different voting and conversion rights compared to Class A and B shares.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the timing of the exchange offer. The ground truth states the exchange occurred in 2023, but the LLM incorrectly places it in May 2024, which fundamentally misrepresents the timeline of equity restructuring. The numbers 241 million Class B-1 shares tendered and 48 million Class C shares issued are correct and match the ground truth. The 2024 balance of 10 shares of Class C common stock issued and outstanding is accurately reported, including the consistency with the prior year. (2) Quantitative accuracy is partially correct: the share numbers are accurate, but the date of the exchange (May 2024 vs. 2023) is wrong, which affects the interpretation of the evolution between 2023 and 2024. The statement that the 10 shares are 'consistent with the prior year' is misleading because the prior year (2023) involved a major issuance of 48 million shares, which implies a significant change, not stability—only by 2024 did the balance stabilize at 10 shares. (3) The multi-hop reasoning is partially sound: the model correctly links the exchange of Class B-1 for Class C shares and recognizes the distinct classification of Class C stock. However, it fails to explain the apparent contradiction between issuing 48 million shares and ending with only 10 outstanding, which the ground truth implies was a temporary issuance followed by cancellation or reclassification—this key aspect of the equity evolution is missing. (4) Contextual relevance is high as the answer addresses share issuance, equity classification, and structural changes. However, due to the incorrect date and incomplete explanation of the 48 million to 10 share reduction, the correctness and qualitative accuracy are significantly reduced. A score of 5 reflects partial correctness with major factual and reasoning gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 503,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "Lowe's engagement with Rough Plumbing from 2022 to 2024 has remained consistent in terms of business classification, as it is categorized under the \"Building Products\" division, which includes product categories like Building Materials, Electrical, Lighting, Lumber, Millwork, and Rough Plumbing. In terms of service offerings, Rough Plumbing is included in Lowe's installed sales model, where installation services are provided through independent contractors, and it is also covered under Lowe's Protection Plans, which offer extended protection and repair services for products, including Rough Plumbing. There is no indication of significant changes in classification or service offerings during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the evolution of Lowe's engagement with Rough Plumbing. The ground truth states there was a strategic shift from 2022 to 2024—from a pure product offering under 'Building Products' to a service-oriented model including installation and protection plans. However, the LLM claims there was 'no indication of significant changes,' which directly contradicts the original answer. This is a major factual error in reasoning and synthesis. (2) Quantitatively, the LLM does not mention the 'approximately 5% of total sales attributed to installed sales in 2024'—a key metric from the ground truth. While it correctly identifies Rough Plumbing as part of Building Products and mentions installation services and protection plans, it fails to tie these to a temporal evolution or quantify the impact, missing a critical data point. (3) The multi-hop reasoning is flawed: the question asks about evolution *from 2022 to 2024*, requiring comparison across time. The LLM fails to recognize the shift in business classification and service integration over time, instead presenting a static view. It does not synthesize the change in strategy despite having access to relevant concepts (installation, protection plans). (4) Contextual relevance is moderate—the answer discusses the right entities (Rough Plumbing, installation services, protection plans, Building Products) and is on-topic, but misrepresents the core dynamic of change over time, which is central to the question. Thus, while some elements are accurate, the overall correctness is low due to the failure to capture the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 452,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "Between 2023 and 2024, the introduction and evolution of Class B-2 common stock reflect a structural shift in Visa's capital structure. In January 2024, Visa implemented an exchange offer that redenominated existing Class B common stock as Class B-1 and authorized new Class B-2 common stock, which would be issued in future exchange offers. By May 2024, Visa executed the first such exchange, issuing 120 million shares of Class B-2 common stock in exchange for 241 million shares of Class B-1 common stock. This indicates that Class B-2 stock is part of a tiered structure designed to manage transfer restrictions and conversion rates, particularly in relation to litigation settlements. Its creation and issuance suggest a strategic approach to gradually release restricted shares into the market while maintaining control over conversion dynamics and capital flexibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2023, Class B-2 common stock was introduced with 77 million shares outstanding, but the LLM claims that in May 2024, 120 million Class B-2 shares were issued — a figure not supported by the ground truth. Additionally, the ground truth indicates that by 2024, no Class B-2 shares were outstanding prior to the exchange offer, directly contradicting the LLM's claim of issuing 120 million shares. The LLM also incorrectly names Visa as the company, which is not mentioned in the original answer or implied in the context. (2) Quantitative inaccuracies include the fabricated numbers: 120 million Class B-2 shares issued and 241 million Class B-1 shares exchanged — neither appears in the ground truth. The only correct number in the original is 77 million shares in 2023, which the LLM omits entirely. Dates like 'January 2024' and 'May 2024' are specific but unsupported. (3) The multi-hop reasoning is flawed. The LLM invents a narrative about redenomination, exchange offers, and tiered structures related to litigation settlements — none of which are present in the original answer. The actual inference should focus on the introduction followed by the absence of Class B-2 shares, suggesting possible replacement or restructuring, not active issuance. (4) The contextual relevance is moderate because the answer discusses capital structure evolution and stock classes, which aligns with the question’s intent, but the fabricated details and wrong company undermine correctness. Due to major factual and quantitative errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 456,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The financial liability associated with the Target Circle program decreased significantly from $117 million in 2024 to $19 million in 2022. This reduction in deferred revenue suggests that Target has been effectively recognizing and fulfilling its obligations related to the program, potentially indicating growth and increased engagement with members, as well as efficient management of program-related commitments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly reverses the direction and magnitude of the change in financial liability. The ground truth states that no specific liability was disclosed in 2022, but by 2024 it had grown to $117 million. The LLM claims liability decreased from $117 million in 2024 to $19 million in 2022, which is factually wrong—$19 million does not appear in the original answer, and the 2022 figure was not disclosed. (2) Quantitative accuracy is severely compromised: the $19 million figure is fabricated, and the temporal comparison is inverted (2024 to 2022 instead of 2022 to 2024). The correct interpretation is an increase from no disclosed liability to $117 million, not a decrease. (3) The reasoning is flawed: the LLM concludes that a decrease suggests growth and efficient obligation management, but the actual increase to $117 million indicates program growth due to higher participant activity or enrollment. The model fails to correctly synthesize the multi-hop information—specifically, the absence of a 2022 liability figure and the emergence of a $117 million deferred revenue in 2024. (4) Scores reflect major factual and quantitative errors (correctness: 2), very poor number accuracy (quantitative: 2), weak reasoning and entity synthesis (qualitative: 3), but partial relevance to the topic of program evolution (contextual: 6).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 379,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "NVDA's exposure to and concern about pollution limits and their regulatory impact on operations and customer data center expansion evolved between 2023 and 2024, as outlined in the provided documents. In 2023, NVDA acknowledged that new or proposed regulations related to pollution limits could result in increased direct costs, such as changes to manufacturing processes, capital expenditures for facility improvements, and higher compliance and energy costs to reduce emissions. These regulations could also indirectly affect NVDA by increasing costs from suppliers or customers passing along compliance expenses. \n\nBy 2024, the concern had expanded to include the potential for stricter pollution limits to impact the availability of energy and water, which are critical for data center operations. Specifically, power or water shortages or regulatory constraints on their availability could impair customers' ability to expand their data center capacity and consume NVDA's products and services. This highlights a growing awareness of how pollution-related regulations and resource availability could directly affect both NVDA's operations and its customers' expansion plans in the data center market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of NVDA's evolving concerns about pollution limits from 2023 to 2024. It correctly identifies the 2023 risks: increased direct costs (compliance, energy, capital expenditures) and indirect costs via supply chain and customer pass-throughs. The 2024 expansion of concern is also accurately captured, particularly the impact on resource availability (energy and water) and how that could constrain customer data center expansion. However, the original answer specifically mentions 'land and permitting constraints' as a new 2024 concern, which the LLM answer omits, instead focusing on energy and water shortages. While energy and water constraints are related, the absence of 'land and permitting'—a key regulatory bottleneck explicitly noted in the ground truth—represents a minor but notable omission in the synthesis. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), and the reasoning is sound and contextually relevant. The answer captures the core evolution in NVDA's risk disclosure, but misses one specific dimension of regulatory impact mentioned in the original, justifying a slight deduction in qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 351,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "Between 2023 and 2024, Costco's Guaranteed Senior Notes, issued by its Japanese subsidiary, evolved as follows: In November 2023, four Guaranteed Senior Notes totaling $500 were issued, with fixed interest rates ranging from 1.400% to 2.120% and maturities from 2033 to 2043. These notes were valued using Level 3 inputs. In July 2024, $77 of these Guaranteed Senior Notes were repaid, reducing the outstanding balance. No further issuance or repayment of these specific Guaranteed Senior Notes is noted for the remainder of the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of four Guaranteed Senior Notes totaling $500 in 2023 at fixed interest rates from 1.400% to 2.120%, valued using Level 3 inputs, and the repayment of $77 in 2024. These figures match the ground truth exactly. The addition of maturities (2033–2043) is extra detail not in the original answer but does not contradict it. (2) All numeric values—$500 issuance, $77 repayment—are accurate. The fair value figures ($5,738 in 2023 and $5,412 in 2024) are not mentioned in the LLM answer, which is a minor omission, but the core quantitative facts about the notes themselves are correct. (3) The reasoning is sound: the LLM correctly attributes the issuance and repayment to the Japanese subsidiary and tracks the evolution of the notes across years. It synthesizes information correctly across time and entity, though it does not incorporate the broader context of total long-term debt fair value change, which was part of the original answer’s conclusion. (4) The answer is highly relevant and factually aligned with the ground truth. The only shortfall is the lack of mention of the overall fair value of long-term debt at the end of 2023 and 2024, which provides important context about the valuation trend. However, the core multi-hop elements (issuance, repayment, valuation inputs) are accurately addressed. Hence, a score of 9 is justified—excellent accuracy with a minor completeness gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 402,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "From 2022 to 2024, Netflix increased its investment in streaming service improvements, as evidenced by higher personnel-related costs in technology and development, as well as cybersecurity measures. In 2022, the company noted a $384 million rise in technology and development expenses due to headcount growth to support streaming service improvements. By 2024, the cybersecurity risk exposure was managed through an enterprise-wide information security program, including dedicated leadership (e.g., the Vice President of Security and Privacy Engineering), regular risk assessments, and third-party security programs. These measures reflect a strategic evolution in both personnel investment and proactive cybersecurity risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $384 million increase in personnel-related costs in 2022, accurately reflecting the quantitative data from the ground truth. The shift to cybersecurity focus in 2024 is also correctly described, including enterprise-wide security programs, third-party risk management, and leadership roles like the Vice President of Security and Privacy Engineering, which aligns with the disclosed risk evolution. (2) All numbers and dates are accurate: the $384 million figure for 2022 is correctly cited, and no incorrect calculations are made. Format is consistent and matches ground truth in meaning. (3) The multi-hop reasoning is sound—linking 2022 investment in headcount for streaming improvements to 2024's expanded focus on cybersecurity shows a logical evolution in Netflix’s strategic posture. The synthesis across years and domains (personnel growth → cybersecurity infrastructure) is valid and well-supported. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the risk of digital content theft or unauthorized data releases impacting financial results, which is a key element in the original answer’s characterization of risk exposure. While cybersecurity programs are noted, the adverse business impact is slightly underemphasized. Otherwise, the answer is factually correct, contextually appropriate, and semantically equivalent to the ground truth with strong qualitative and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 411,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "Between 2023 and 2024, The Bank of New York Mellon Corporation updated its Restricted Stock Unit (RSU) agreements, as evidenced by the filing of the 2024 Form of Restricted Stock Unit Agreement (Exhibit 10.29 in the 2024 filing). This suggests a continued evolution in the lifecycle management of these equity instruments, potentially reflecting adjustments to align with executive compensation strategy, regulatory requirements, or shareholder expectations. While specific terms of the 2024 RSU agreement are not detailed in the provided pages, the filing indicates a structured approach to managing equity compensation, reinforcing the company's focus on long-term incentives and executive retention.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the introduction of the '2024 Form of Restricted Stock Unit Agreement' in the 2024 filing and references it as Exhibit 10.29, which aligns with the ground truth. It also accurately implies an evolution in the company's RSU framework, noting updates between years and suggesting alignment with executive compensation strategy. However, the LLM answer fails to capture the full multi-hop reasoning present in the original answer. Specifically, it does not mention that the 2024 Form was 'Filed herewith' in the 2023 filing, nor does it note that in the 2024 filing, the 2024 Form became 'Previously filed' while the '2025 Form' was newly introduced as 'Filed herewith.' This omission is significant because it misses the annual iterative pattern of updating RSU agreements and the lifecycle transition from new to established documents, which is central to the question about lifecycle management and strategic implications. While the LLM provides a plausible and contextually relevant summary, it lacks the detailed progression of document status changes over time, resulting in incomplete qualitative accuracy. Quantitatively, there are no numbers to verify, but the dates and document references are correctly used. Contextual relevance is strong as the response stays focused on RSU evolution and executive compensation strategy, but the absence of the forward-looking introduction of the 2025 form weakens the strategic insight. Thus, the answer is partially correct but misses key evidence of systematic, annual updates that define the company's mature compensation governance process.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 442,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "The 4.90% Senior Notes were issued in November 2023 with a maturity date of April 15, 2029. As of January 28, 2024, the carrying amount of these notes was $743 million. By February 2, 2025, the carrying amount had increased to $744 million, reflecting the amortization of the initial discount. The maturity timeline remains unchanged, with the notes maturing in fiscal 2029.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance in November 2023, the maturity date of April 15, 2029, and the carrying amount of $743 million as of January 28, 2024, which aligns with the ground truth. However, it introduces a forward-looking carrying amount of $744 million as of February 2, 2025, which is not present in the original answer or supported by the provided data. This figure is speculative and factually unsupported, as the ground truth only reports up to January 28, 2024. (2) The principal amount of $750 million and the initial discount of $3.4 million are omitted, which are key structural details from the original answer. While the $743 million carrying amount is accurate (reflecting $750M - $3.4M discount and partial amortization), the LLM fails to explain this relationship, weakening quantitative completeness. The claim of an increase to $744 million implies amortization progress but lacks context or source. (3) The reasoning is partially sound—correctly tracking the maturity timeline and recognizing amortization effects—but fails in multi-hop synthesis by introducing unverified future data instead of focusing on the 2023–2024 evolution. The original answer emphasizes the notes' status as newly issued in 2023 and their continued outstanding status in 2024; the LLM captures this but adds unsupported extrapolation. (4) Correctness is scored 6 due to accurate core facts but significant omission of initial terms and introduction of incorrect future data. Quantitative accuracy is 5 due to one incorrect number and missing calculations. Qualitative accuracy is 7 for generally sound logic but flawed synthesis. Contextual relevance is 9—response stays on topic and addresses the evolution question appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 479,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "Between 2023 and 2024, Costco's Japanese subsidiary issued Guaranteed Senior Notes totaling approximately $500 in November 2023, with fixed interest rates ranging from 1.400% to 2.120% and maturity dates from 2033 to 2043. In July 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes, indicating a partial repayment of the issued debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of $500 in Guaranteed Senior Notes in 2023 and the repayment of $77 in 2024, matching the ground truth. It adds specific months (November 2023 and July 2024) and maturity dates (2033 to 2043), which are not contradicted by the original answer and provide additional precision without introducing errors. (2) All numeric values—$500 total issuance, $77 repayment, interest rates from 1.400% to 2.120%—are accurate and match the ground truth. Format variations are acceptable and consistent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about issuance in 2023 and repayment in 2024 by the Japanese subsidiary, linking two time points and financial actions. The addition of maturity dates and months improves detail but does not affect correctness. (4) The only minor gap is that the LLM omits the mention of 'four' notes issued, which is present in the original answer, and does not explicitly reference the 2024 filing's characterization of the proceeds as a source of financing activity. However, the core facts, numbers, and evolution are accurately conveyed. Thus, the answer is highly accurate with only slight incompleteness in contextual detail, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 366,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "From 2022 to 2023, the risk associated with competitors developing after-market parts for DHR's products remained a concern but was not explicitly highlighted as a material change in the 10-K filings. In both years, the risk was mentioned in the context of competitive pressures and potential impacts on sales, with no significant evolution in terms of its direct impact on DHR's business or financial statements. The 2023 filing did emphasize broader competitive challenges, including pricing pressures and the introduction of low-cost alternatives, but no specific escalation in after-market parts risk was noted.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is partially correct in noting that the risk of competitors developing after-market parts remained a concern in both 2022 and 2023 and was discussed in the context of competitive pressures. However, it incorrectly states that there was 'no significant evolution' in the risk, which directly contradicts the ground truth. The original answer highlights a clear shift in framing: in 2022, the risk was described as a direct threat that could 'detract from our sales,' while in 2023, it was repositioned as being 'Impacted By' such competition, embedded within broader industry-wide cost containment and pricing pressures. This indicates a strategic recalibration and relative de-emphasis of the risk, which the LLM answer fails to capture. The LLM also misses the nuanced evolution in how the risk was contextualized—moving from a primary competitive threat to one of several external pressures—thus failing the multi-hop reasoning required to compare the qualitative shift across years. While there are no numerical inaccuracies (hence a perfect quantitative score), the qualitative inaccuracy in representing the evolution of risk framing significantly undermines the answer's correctness. The response is relevant to the question but lacks the depth and precision needed to reflect the actual change in risk characterization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 371,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "From 2022 to 2024, Netflix's membership plans evolved by introducing a lower-priced ad-supported subscription plan and increasing enforcement of terms of use to limit multi-household usage and shared viewing outside of a household. These changes were intended to address business challenges such as retaining members, managing costs, and improving revenue per membership. Additionally, the company aimed to sustain growth by expanding its content offerings, including games and live programming, to provide added value and differentiate its service in a competitive market.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Netflix's key strategic changes from 2022 to 2024—introducing an ad-supported plan and enforcing terms to limit password sharing. It also accurately links these changes to business challenges like retention and competition. However, it omits specific quantitative data from the original answer, such as the 19% revenue increase, 11% membership growth, 7% rise in revenue per membership, and the 50% drop in paid net additions in 2022. These omissions affect completeness and quantitative accuracy. (2) No incorrect numbers are stated, but the absence of key metrics from the ground truth—especially those showing the scale of Netflix’s revenue growth and membership trends—means the quantitative accuracy is reduced. The answer does not include any calculations, but it also fails to report the factual figures that were present in the original. (3) The multi-hop reasoning is sound: the model correctly infers that pricing and access changes were responses to member acquisition and retention challenges. It appropriately connects the introduction of the ad-supported tier and enforcement of usage policies to broader competitive and economic pressures, even if it doesn’t explicitly cite 'macroeconomic conditions' or 'consumer sensitivity to pricing' as directly as the original. (4) The answer is contextually relevant and well-structured, addressing pricing strategy, service features, and business challenges. While it adds information about games and live programming not in the original, this is a reasonable inference about differentiation strategies and doesn’t contradict the ground truth. The main shortcoming is the lack of supporting data from 2022, which weakens the factual foundation of the response. Hence, correctness is scored 7 for being substantially accurate but missing key evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 503,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "Between 2022 and 2023, Boeing's approach to in-orbit incentive payments has shown increased risk exposure and financial recognition due to the long-term performance obligations tied to satellite contracts. In 2023, the company explicitly highlighted that in-orbit incentive payments are recognized as revenue during the construction period based on the net present value of expected fees, but these payments remain at risk if satellites fail to meet performance criteria for up to 15 years post-acceptance. This reflects a more conservative financial recognition approach compared to 2022, where such specifics were not as clearly outlined, and emphasizes heightened exposure to potential refunds and charges if performance issues arise.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in Boeing's approach to in-orbit incentive payments between 2022 and 2023. (1) Quantitatively, the LLM does not include the $1,585 million loss figure explicitly mentioned in the ground truth for 2023, which is a notable omission. However, no incorrect numbers are presented, and there are no errors in calculation or misstatements of dates or financial terms. (2) The answer correctly identifies the shift in financial recognition: revenue is recognized during construction based on net present value of expected fees, while payments remain at risk for up to 15 years post-acceptance due to performance criteria. This aligns with the ground truth. (3) The multi-hop reasoning is sound—comparing 2022’s general risk acknowledgment with 2023’s more detailed disclosure on revenue recognition and long-term exposure. The LLM correctly infers a more conservative and transparent financial approach in 2023, even if it doesn’t name the specific programs (Commercial Crew, KC-46A, VC-25B), which are contextually relevant but not essential to the core question about risk and recognition. (4) The answer is contextually excellent—directly addressing risk exposure and financial recognition as asked. The omission of the $1.585B loss figure prevents a top score, as this quantification is central to the 2023 update in the original answer. Still, the qualitative explanation of increased risk exposure and conservative recognition is accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 416,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "Between 2023 and 2024, the Directors' Code of Conduct remained accessible on BNY Mellon's website at the same URL, indicating no change in its availability. However, the 2024 filing explicitly states the company's intention to disclose any amendments or waivers to the Directors' Code of Conduct on its website, emphasizing a commitment to transparency and updated disclosure practices.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in stating that the Directors' Code of Conduct remained accessible on the website, and it correctly identifies the company's stated intention to disclose amendments or waivers — a detail present in the 2023 filing. However, it misrepresents the evolution between 2023 and 2024. According to the ground truth, in 2023 the filing included a direct, explicit URL to the Code and stated the disclosure policy, while in 2024 the reference became more general, embedded within a broader list of governance documents without repeating the URL. The LLM incorrectly implies that the 2024 filing introduced or emphasized the disclosure policy, when in fact this was already stated in 2023. Furthermore, the LLM fails to note the key shift in disclosure approach: from specific and direct in 2023 to consolidated and implicit in 2024. This omission mischaracterizes the nature of the evolution. While all entities (BNY Mellon, Directors' Code of Conduct, website accessibility) and years are correct, and there are no numerical inaccuracies (no numbers involved), the reasoning is flawed in terms of multi-hop synthesis — the model did not correctly compare the two years’ disclosure styles. The answer is contextually relevant and addresses the question’s focus on accessibility and disclosure, but misses the core qualitative change, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 391,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "Between 2022 and 2023, the role and deployment strategy of Mobileye Drive™ evolved from being primarily a self-driving system for commercial and fleet use to a more scalable and production-focused solution. In 2022, Mobileye positioned Mobileye Drive™ as a core component for Robotaxi and cargo delivery services, with partnerships such as Udelv and Transdev. By 2023, Mobileye expanded its deployment strategy to include production design wins for consumer-level autonomous driving, such as with Polestar and FAW, and emphasized scaling Mobileye SuperVision to serve as a foundation for its Chauffeur consumer AV product. Additionally, Mobileye Drive™ was integrated with Moovit’s mobility platform to support MaaS (Mobility as a Service) networks, reflecting a broader push into both fleet and consumer autonomous markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Mobileye Drive™ from 2022 to 2023 and mentions key partnerships (Udelv, Transdev) and the integration with Moovit, which aligns with the ground truth. However, it introduces inaccuracies in entity details: it claims design wins in 2023 with Polestar and FAW, but the ground truth specifies Geely as the consumer L4 design win in 2022, not 2023, and does not mention Polestar or FAW in this context. Additionally, the LLM shifts focus to Mobileye SuperVision and Chauffeur, which are related but not central to Mobileye Drive™, potentially conflating different product lines. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default due to absence of errors. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift toward MaaS and fleet deployment, and the Moovit integration is accurately noted. However, it misattributes the timing and nature of consumer design wins and incorrectly expands the 2023 strategy to include consumer AV products, while the ground truth emphasizes fleet and transit operators, not consumer expansion in 2023. The original answer indicates a refinement of focus, not a broadening into consumer markets. (4) The correctness score is 6 due to significant entity and strategic misrepresentation, despite correct overall direction and context. Qualitative accuracy is 6 due to flawed entity linkage and reasoning gaps. Contextual relevance is high as the answer addresses the evolution question directly and includes relevant strategic themes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 455,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "The structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024 as follows: In 2022, the Tower Preferred Interests included two series—Class A-1 with a 5.0% initial distribution rate and Class A-2 with a 4.75% initial distribution rate, both resetting every five years. In 2024, these were restructured into Fixed Rate Class A Limited Membership Interests (paying 5.90%) and Floating Rate Class A Limited Membership Interests (paying SOFR + 250 basis points). The Floating Rate Interests will gradually transition from the Fixed Rate over five years, with the first $525 potentially converting by 2028.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 structure with two series—Class A-1 at 5.0% and Class A-2 at 4.75%, both resetting every five years—and accurately describes the 2024 restructuring into Fixed Rate (5.90%) and Floating Rate (SOFR + 250 bps) interests. However, it introduces a detail not present in the ground truth: 'the first $525 potentially converting by 2028.' This dollar amount and timeline are absent from the original answer and cannot be verified, representing a factual overreach. Additionally, the ground truth specifies that the 2024 amendment in August 2024 reclassified *all 2019* Tower preferred interests, which the LLM omits, instead generalizing the restructuring without specifying the origin of the reclassified interests. (2) Quantitative accuracy is mostly correct: percentages (5.0%, 4.75%, 5.90%, SOFR + 250 bps) are accurate, but the unsupported $525 figure and the projection to 2028 reduce confidence in numerical fidelity. The original answer does not mention annual transition amounts or specific dollar conversions. (3) The multi-hop reasoning is sound—linking 2022 structure to 2024 changes, recognizing both structural and rate evolution—but slightly overextends by adding unverified transition mechanics. The synthesis across time and structure is logically coherent and aligns with the intent of the question. (4) Scores reflect high correctness and relevance, with minor deduction in quantitative accuracy due to unsupported numbers, and a slight reduction in overall correctness for missing the '2019 interests' origin and introducing speculative details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 443,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "The Balanced Index Fund, which comprises approximately 60% equities and 40% debt securities, is valued using a market approach based on quoted market prices (Level 1), and its unrealized gains or losses are not specifically detailed for Level 3 assets. From 2022 to 2023, the Level 3 assets related to the fund showed a decrease in total value from $268 to $226. In 2022, the unrealized losses were significant, with a total net loss of $90, while in 2023, there was a net unrealized gain of $14, indicating an improvement in the performance of Level 3 assets during that period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Level 3 assets had unrealized losses of ($16) million for corporate fixed income and ($11) million for mortgage-backed/asset-backed securities, totaling $27 million in losses, not $90 million as claimed. In 2023, the gains were $2 million and $6 million respectively (total $8 million), not $14 million. The LLM also introduces a total value decrease from $268 to $226, which is not mentioned in the original answer and lacks support. (2) Calculations are incorrect: the LLM reports a 'net loss of $90' in 2022 and 'net gain of $14' in 2023, which do not align with the ground truth figures. There is no evidence in the original answer for these totals. (3) The multi-hop reasoning is flawed. While the LLM correctly notes the Balanced Index Fund's 60/40 allocation remained stable, it incorrectly claims the fund is valued using Level 1 inputs, whereas the original answer states that the *valuation methodology in 2023 explicitly referenced* a market approach (Level 1), implying a shift in transparency, not that the entire fund is Level 1. The LLM fails to mention the shift from losses to gains in specific asset categories, a key point in the original. (4) The contextual relevance is moderate—it addresses the evolution of Level 3 assets and performance trends—but major quantitative errors and missing granular details (specific asset classes and their gains/losses) severely undermine correctness. The qualitative reasoning is partially sound but based on incorrect data, leading to a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 444,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "Between 2023 and 2024, BNY Mellon's emphasis on accounting developments in its forward-looking statements has become more explicit and integrated into its strategic priorities. In 2023, accounting developments were mentioned as one of several external factors that could impact the company's financial reporting and operations. By 2024, the mention of accounting developments is more prominent and explicitly linked to strategic areas such as capital planning, risk management, and financial performance expectations. This evolution suggests a growing recognition of the material influence of evolving accounting standards on BNY Mellon's strategic decision-making and financial reporting framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the evolution from a general mention of accounting developments in 2023 to a more explicit and integrated treatment in 2024 is accurately described. The LLM correctly identifies that in 2023, accounting developments were listed among other factors without elaboration, and in 2024, they are more prominently linked to strategic outcomes. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—dates (2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure language across years and infers a shift in strategic emphasis, correctly concluding that accounting standards now play a more material role in strategic decision-making. (4) The LLM captures the core insight—that accounting developments are increasingly tied to capital planning and financial performance—even if it uses slightly different phrasing (e.g., 'capital planning, risk management' vs. the original's mention of 'dividends and repurchases' and 'efficiency savings'). The only minor shortcoming is that it does not quote or specifically name those exact strategic levers ('dividends and repurchases', 'efficiency savings'), which slightly reduces qualitative precision. However, the semantic meaning and strategic implication are preserved. Thus, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 417,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "The evolution of risks related to store safety and cybersecurity in 2023, as outlined in the 10-K filing, had a notable impact on the associate experience compared to the engagement-focused initiatives of 2022. In 2022, the company emphasized engagement through communication, recognition programs, and initiatives to support associate well-being and inclusivity. However, in 2023, the focus shifted toward addressing operational risks, such as increased shrink due to organized retail crime and cybersecurity threats, which required associates to adapt to heightened safety protocols and operational changes. These risks introduced potential stressors for associates, such as increased vigilance against theft and the need to navigate evolving technology systems, which could detract from the positive engagement initiatives of the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 2022 engagement initiatives (communication, recognition, well-being, inclusivity) are accurately described, and the 2023 shift to store safety and cybersecurity risks—specifically organized retail crime and cybersecurity threats—is correctly identified. (2) There are no numeric values in the question or answers that require verification (e.g., percentages or dollar amounts), so quantitative accuracy is not compromised; all dates (2022 vs 2023) are correct. (3) The multi-hop reasoning is sound: the model correctly contrasts the internal, positive associate experience initiatives in 2022 with the external, risk-based challenges in 2023 and infers the potential negative impact on associate morale due to increased stress and operational changes. The LLM captures the core causal logic—that emerging risks could undermine prior engagement gains—even if it doesn't explicitly mention 'erosion of trust' or 'retention' as directly as the original answer. (4) The answer is contextually relevant and fully addresses the comparative, multi-year evolution of associate experience drivers. The only minor shortcoming is the omission of the specific data point that 'four out of five associates were emotionally committed' in 2022, which slightly reduces completeness but does not affect the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 427,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "Between 2022 and 2023, the role of the 'learning curve' in influencing cost and production estimates became more critical due to ongoing production challenges and uncertainties in program profitability and risk management. In 2022, the learning curve was a factor in estimating production costs and gross margins, particularly for complex programs like the 777X and 787, where production delays and rework impacted profitability. By 2023, the learning curve's influence was heightened by increased supply chain constraints, regulatory requirements, and production quality issues, which added complexity to cost estimation and risk management. The evolving learning curve assumptions were essential in adjusting production rates and managing program risks, especially as Boeing faced continued challenges in achieving anticipated cost reductions and maintaining program profitability.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses the key evolution described in the ground truth. (1) What was correct: The answer correctly identifies that the learning curve influenced cost and production estimates in both 2022 and 2023, particularly for programs like the 787 (and mentions 777X, which is contextually plausible). It acknowledges ongoing production challenges, rework, and delays affecting profitability—consistent with 2022 risk framing. It also notes that learning curve assumptions were used in adjusting production rates and managing risks in 2023, which aligns with the idea of integration into planning. (2) Quantitative accuracy: There are no specific numbers, percentages, or dollar amounts in either the ground truth or the LLM answer, so no numerical inaccuracies exist—this aspect is neutral but does not detract. (3) Multi-hop reasoning assessment: The critical failure is in the qualitative shift. The ground truth emphasizes a conceptual evolution—from viewing the learning curve as a *risk factor* in 2022 to treating it as a *predictable, integrated component* of cost estimation in 2023. The LLM answer instead suggests the learning curve became *more challenging* in 2023 due to external pressures (supply chain, regulatory issues), framing it as an escalating risk rather than a managed variable. This misrepresents the core transformation. The LLM implies increased complexity and difficulty, whereas the truth is about improved modeling and integration. (4) Justification for scores: Correctness is 6 due to partial factual alignment but significant omission of the key conceptual shift. Quantitative accuracy is 10 because no numbers are incorrect. Qualitative accuracy is 6—entities and context are mostly right, but reasoning about the evolution is flawed. Contextual relevance is 9 because the response stays on topic and addresses cost, production, profitability, and risk across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 518,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "The treatment and disclosure of the Dividend Reinvestment Plan in the 2024 SEC filing remain consistent with the 2023 filing, both referencing officer and director participation in the plan as part of broader equity and benefit arrangements. In both years, the filings disclose that certain officers or directors have elected to participate in the Dividend Reinvestment Plan, along with other plans such as the employee stock purchase plan and 401(k) plan. Additionally, they may have shares withheld to cover withholding taxes or pay the exercise price of stock awards, which may be structured under Rule 10b5-1 or as non-Rule 10b5-1 trading arrangements. There is no indication of substantive changes in the nature of officer or director participation or the associated trading arrangements between the 2023 and 2024 filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. The original answer states that the 2024 filing omitted the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements that was present in the 2023 filing, indicating a reduction in disclosure specificity. However, the LLM answer claims there is 'no indication of substantive changes' and that disclosures remain 'consistent,' which directly contradicts the ground truth. This is a major qualitative error in reasoning and factual accuracy. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no numbers to verify or miscalculate, hence a score of 10 by default. (3) The multi-hop reasoning is flawed: the question asks for a comparison of evolution between 2023 and 2024 filings, particularly regarding disclosure of trading arrangements. The LLM failed to identify the key difference—the omission of Rule 10b5-1 details in 2024—thus failing the required synthesis. Instead, it incorrectly asserts consistency. (4) Contextual relevance is moderate because the answer addresses the right topic (Dividend Reinvestment Plan, officer/director participation, trading arrangements) and references correct associated plans (ESPP, 401(k)), but it draws the wrong conclusion about disclosure evolution, undermining the overall correctness. The answer appears plausible but misrepresents the factual change in disclosure depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 405,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "The Home Depot's investment in creating an interconnected shopping experience evolved significantly from fiscal 2021 to fiscal 2023. In fiscal 2021, the company invested $2.6 billion in capital expenditures to support this initiative, focusing on blending digital and physical shopping experiences to meet customer expectations shaped by the pandemic. By fiscal 2023, this investment had increased to $3.2 billion, with a continued emphasis on enhancing digital capabilities, store experiences, and supply chain efficiency. Specific changes in tailoring the experience included improved mobile app functionality for personalized shopping, expanded fulfillment options (e.g., BOPIS, BORIS), and investments in store technology such as electronic shelf labels and self-checkout systems, all aimed at creating a seamless, frictionless journey for customers across channels.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. While it correctly states that The Home Depot invested $2.6 billion in capital expenditures in fiscal 2021 (aligned with ground truth), it falsely claims that the investment increased to $3.2 billion in fiscal 2023, which is not supported by the original answer or knowledge graph. No specific total investment figure for 2023 is provided in the ground truth—instead, the focus shifts to how the investment was used. Additionally, the original answer does not mention BOPIS, BORIS, electronic shelf labels, self-checkout systems, or mobile app functionality, making these details fabricated or unsupported. (2) The only verified number is the $2.6 billion in fiscal 2021; all other financial claims are incorrect or unverified. There are no calculations in the question, but the erroneous assertion of a higher capital expenditure in 2023 undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound in that the model attempts to trace an evolution from 2021 to 2023 and identify changes in strategy. However, it fails to capture the actual shift described in the ground truth—from general investment in interconnectedness to a data-driven, intent- and location-based personalization using merchandising IT tools. Instead, it invents a narrative around fulfillment and store tech not present in the source. (4) The contextual relevance is high because the answer addresses the evolution of the shopping experience and attempts to describe tailoring mechanisms. However, correctness and qualitative accuracy are low due to invented figures and misrepresentation of strategic focus. The core evolution—toward intent- and location-based personalization via enhanced IT tools—is entirely missed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 494,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "Between 2022 and 2023, DHR's financial relationship with Aldevron primarily reflects the integration of Aldevron, which was acquired in August 2021 for $9.6 billion. In 2022, DHR continued to invest in capital expenditures related to Aldevron, with $87 million in purchases of property, plant, and equipment partially offset by government grants. By 2023, the focus shifted toward the acquisition of Abcam for $5.6 billion, which became the major capital investment, while Aldevron remained part of the Life Sciences segment contributing to expanded product offerings and sales opportunities. No further major acquisition-related expenditures for Aldevron were reported in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that Aldevron was acquired in August 2021 for $9.6 billion, while the ground truth indicates that the net cash consideration of $9,561 million ($9.561 billion) was paid in 2023, not 2021. This misrepresents the timeline and nature of the acquisition. Additionally, the claim that $87 million in capital expenditures in 2022 were related to Aldevron is not supported by the original answer, which states that DHR anticipated approximately $1.5 billion in total capital expenditures in 2022, with only a portion linked to Aldevron—no specific dollar amount is provided. The mention of Abcam’s $5.6 billion acquisition as a 2023 event distracts from the focus on Aldevron and is irrelevant to the question. (2) Quantitative accuracy is severely compromised: the $9.6 billion figure is close but not exact (vs $9,561 million), and the $87 million figure appears fabricated. The original answer does not specify any exact capital expenditure amount tied solely to Aldevron. (3) The multi-hop reasoning is flawed—the LLM fails to correctly trace the evolution from capital investment anticipation in 2022 to full acquisition integration in 2023. Instead, it assumes the acquisition was completed in 2021 and downplays 2023 acquisition-related expenditures, contradicting the ground truth that 2023 marked the major cash outflow. (4) Contextual relevance is moderate because the answer discusses DHR and Aldevron in the correct timeframe and touches on capital investment themes, but it introduces irrelevant information (Abcam) and mischaracterizes the financial relationship's evolution. The core shift—from capital investment in 2022 to full acquisition integration in 2023—is misrepresented, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 494,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "From 2022 to 2024, the total value of Telco LLC's preferred interests increased from $2,000 (Telco Class A-1) to $7,250, following additional issuances of $5,250 in April 2023 (Telco Class A-2 and A-3). In 2024, Telco LLC also agreed to issue an additional $2,250 of preferred interests (Telco Class A-4) in Q1 2025. The distribution rates varied by class: Telco Class A-1 had a 4.25% rate with a seven-year reset, while Telco Class A-2 and A-3 had a higher 6.85% rate with a reset on November 1, 2027. The Telco Class A-4, set to be issued in 2025, carries a 5.94% distribution rate with a reset on November 1, 2028.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the initial $2,000 in preferred interests (Class A-1) in 2022 and the $5,250 issuance in April 2023 (Class A-2 and A-3), resulting in a total of $7,250 by 2024, which matches the ground truth. However, it introduces new information not present in the original answer: the planned issuance of $2,250 in Telco Class A-4 in Q1 2025 with a 5.94% rate and reset on November 1, 2028. This detail is absent from the ground truth and cannot be verified from the provided data, making it factually unsupported. (2) The distribution rates for Class A-1 (4.25%) and Class A-2/A-3 (6.85%) are correct, as is the reset date of November 1, 2027, for the latter. However, the addition of a future Class A-4 with specific terms introduces incorrect quantitative elements—specifically $2,250, 5.94%, and November 1, 2028—that are not in the original answer. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the increase in total value and differentiates distribution rates and reset schedules across classes. However, it extrapolates beyond the provided data by including a future issuance not mentioned in the ground truth, indicating a failure in information containment. (4) The contextual relevance is high as the answer addresses the evolution of structure, total value, distribution rates, and reset schedules. However, the inclusion of unsupported future issuances significantly undermines factual correctness, leading to a moderate score. Quantitative accuracy is penalized due to the introduction of false numbers and dates. Qualitative accuracy is reduced due to incorrect entity expansion (new class not in source).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 461,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "AIG's use of Expected Loss Ratio Methods between 2022 and 2024 has evolved to be more refined and tailored to specific insurance lines. In 2022, the Expected Loss Ratio method was primarily applied to short-tail classes like U.S. Property, where it was used in combination with other methods such as frequency/severity and loss development. The rationale was to account for low-frequency, high-severity losses and to adjust for inflation, rate changes, and market conditions.\n\nBy 2024, AIG expanded the application of Expected Loss Ratio methods to newer accident years and more complex lines, such as U.S. Excess Casualty and U.S. Workers' Compensation. The rationale for this expansion included addressing inconsistent loss development patterns, incorporating updated rate changes and inflation trends, and responding to evolving underwriting strategies (e.g., higher attachment points in Excess Casualty). Additionally, the Expected Loss Ratio method was weighted more heavily for recent accident years, reflecting a focus on current market conditions and emerging claim trends.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces inaccuracies in key details. The ground truth states that in 2022, AIG used Expected Loss Ratio (ELR) methods primarily for the latest accident year and in aviation exposures (high-severity), whereas the LLM claims it was used for U.S. Property, which is not supported by the original answer. This is a significant entity and line-of-business error. In 2024, the ground truth confirms expansion to U.S. Workers' Compensation (a long-tail line), which the LLM correctly identifies. However, the LLM adds 'U.S. Excess Casualty' as a new line in 2024, which is not mentioned in the original answer, introducing an unsupported claim. (2) There are no explicit numbers (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is not compromised—dates (2022, 2024) are correct, hence a score of 8. (3) The multi-hop reasoning is partially sound: the LLM captures the evolution over time and attempts to explain rationale (e.g., inconsistent loss patterns, inflation, underwriting changes), which aligns with the type of reasoning expected. However, the synthesis is flawed due to incorrect insurance lines, undermining the qualitative accuracy. The rationale for expansion (e.g., current market conditions, emerging trends) is plausible but not explicitly confirmed in the ground truth. (4) Contextual relevance is high because the answer addresses the evolution of ELR methods, timelines, insurance lines, and rationale, even if some specifics are incorrect. Overall, the answer is partially correct but contains significant factual deviations in the types of insurance lines used in both years, warranting a correctness score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 472,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "Target's approach to its owned brands from 2023 to 2024 has shown a stronger strategic emphasis on expanding and strengthening its owned and exclusive brands portfolio as a key differentiator. In 2023, the focus was on leveraging owned brands to deliver value and style, while in 2024, the strategy has evolved to include a broader and more curated portfolio of owned and exclusive brands, such as Project 62™, Threshold™, and Hearth & Hand™ with Magnolia, alongside exclusive adult beverage brands like SunPop™ and Wine Cube™. This evolution reflects a more intentional effort to enhance product differentiation, guest experience, and brand loyalty through a diverse and high-quality product portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Target's strategy: from a 2023 focus on leveraging owned brands for value and style (synonymous with 'drive relevancy and market share growth') to a 2024 emphasis on broadening and curating a diverse portfolio of owned and exclusive brands. (2) There are no numeric values in the original or LLM answer requiring calculation, but the mention of specific brands (e.g., Project 62™, Threshold™, SunPop™, etc.) adds concrete detail not in the original but consistent with Target’s known brand portfolio—this enhances rather than distorts accuracy. (3) The multi-hop reasoning is sound: it synthesizes a strategic shift across two years and correctly identifies the deepening of product portfolio development as a strategic move. (4) While the original answer notes 'over 40 distinct brands' as evidence of execution, the LLM answer doesn't repeat this exact figure but conveys the same qualitative progression—strategic expansion into a broader, more curated set of brands. This omission is minor and does not detract from the overall correctness. The LLM adds brand examples for illustration, which improves clarity without introducing error. Thus, the answer is semantically equivalent and contextually rich, meriting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 373,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggests that the company is employing a diversified long-term debt financing strategy. By issuing new higher-yield notes while retaining lower-yield existing debt, IBM may be taking advantage of favorable market conditions to refinance or supplement its capital structure at attractive rates. This approach could indicate confidence in stable borrowing costs and the ability to manage debt maturity profiles effectively, while also potentially locking in lower interest expenses over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the two notes (0.875% and 2.900% Notes due 2030) and their continued listing in 2024, which aligns with the ground truth. The entities (IBM, note types, maturity year 2030) and percentages are accurate, satisfying quantitative accuracy. However, the reasoning misinterprets the implications of the rate increase. The ground truth emphasizes that the jump from 0.875% to 2.900% suggests less favorable borrowing conditions in 2024, likely due to rising market interest rates, whereas the LLM incorrectly frames this as 'favorable market conditions' and 'attractive rates,' which contradicts the evidence. (2) There are no calculation errors, and all numbers (0.875%, 2.900%, 2030 maturity) are correctly cited. Format is consistent and semantically equivalent. (3) The multi-hop reasoning is partially sound—linking the two debt instruments and inferring a strategic intent—but fails in the critical synthesis: recognizing that higher coupon rates for the same maturity indicate deteriorating borrowing conditions, not favorable ones. This undermines the qualitative accuracy. (4) Contextually, the answer addresses debt financing strategy and long-term borrowing, so relevance is high. However, the incorrect interpretation of market conditions significantly reduces correctness. A score of 5 reflects partial accuracy: right facts, flawed logic and conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 391,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "Between 2022 and 2024, the composition of AT&T's long-term debt instruments remained largely consistent, with the 4.000% Global Notes due June 1, 2049 (T 49A) listed in both the 2022 and 2024 10-K filings. No new long-term notes were explicitly added during this period based on the provided pages; the list of debt instruments in 2024 includes the same 4.000% Global Notes due in 2049 and aligns closely with the 2022 list, with no indication of new issuances beyond the existing instruments.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims no new long-term notes were added between 2022 and 2024, but the original answer confirms the addition of the 4.300% Global Notes due November 18, 2034 (T 34C) by 2024, which were not present in 2022. This is a major factual error. (2) Quantitatively, the LLM correctly identifies the 4.000% Global Notes due June 1, 2049 (T 49A) as present in both years, which matches the ground truth. However, it fails to report the new 4.300% notes due 2034, including their interest rate, maturity date, and ticker symbol (T 34C), all of which are critical details. (3) The reasoning is flawed: the LLM asserts consistency in debt composition and denies new issuances, failing the multi-hop synthesis required to compare AT&T’s debt instruments across years. The correct analysis requires identifying both the continuity of existing debt (2049 notes) and the introduction of new debt (2034 notes), which the model misses entirely. (4) Contextual relevance is moderate because the answer discusses the right topic (AT&T’s long-term debt evolution) and references the correct instrument in 2022 and 2024, but omits the key development—new debt issuance—rendering the conclusion inaccurate. Overall, the answer fails on correctness due to missing critical factual additions in the debt portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 377,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "The financial impact of the Heritage AspenTech acquisition evolved between 2023 and 2024, with intangibles amortization increasing from $258 million in 2023 to $560 million in 2024, primarily due to the full year impact of the NI acquisition in 2024. Restructuring costs related to the Heritage AspenTech acquisition were $97 million in 2022, $258 million in 2023, and $560 million in 2024, reflecting ongoing integration and operational adjustments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains almost entirely incorrect information. According to the ground truth, intangibles amortization decreased from $258 in 2023 to $97 in 2024, but the LLM claims it increased to $560 million in 2024—this is factually wrong. Similarly, restructuring costs were $72 in 2023 and $228 in 2024, but the LLM reports $258 million in 2023 and $560 million in 2024, which is incorrect. The LLM also references a 'NI acquisition' not mentioned in the question or ground truth, introducing an irrelevant and unverified event. (2) All numeric values are wrong: amortization figures are inverted and inflated, restructuring costs are misstated across years, and an extra year (2022) is introduced without basis. (3) The multi-hop reasoning is fundamentally flawed—the model fails to correctly track the evolution of two financial metrics over two years and introduces unrelated acquisitions and figures. (4) The answer is contextually relevant in structure (discussing amortization and restructuring costs over time) but fails on factual accuracy, making it highly misleading. Due to complete failure on quantitative and qualitative accuracy, the correctness score is near-zero.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 338,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG's use of expected loss ratio methods for workers' compensation between 2022 and 2024 has evolved to place greater emphasis on segmentation by business types and the impact of large deductible accounts. In 2022, the expected loss ratio methods were given significant weight in the most recent five accident years, with adjustments made for rate changes, loss trends, and market conditions. By 2024, the proportion of large deductible business had increased, slowing the reporting pattern of claims and influencing the use of expected loss ratio methods. Additionally, AIG further segmented guaranteed cost and excess of deductible business by state and industry subset, reflecting meaningful differences in development patterns. These changes highlight a more refined and nuanced approach to reserving, driven by the evolving mix of business and risk-sharing structures.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its high-level description of AIG's evolving use of expected loss ratio methods between 2022 and 2024, with accurate dates and correct identification of key trends: increased proportion of large deductible accounts slowing claim reporting, and greater segmentation in 2024. However, there are notable discrepancies in the details. The LLM incorrectly states that in 2022, expected loss ratio methods were given significant weight in the most recent five accident years for all workers' compensation business, when the ground truth specifies this applied specifically to excess of deductible business, while guaranteed cost business used only the most recent accident year. This misattribution reduces qualitative accuracy. The LLM correctly notes segmentation by business type and the impact of large deductible accounts in 2024 but adds unverified detail about segmentation by state and industry subset, which is not present in the original answer. Additionally, the LLM omits key 2024-specific disclosures about limitations in claim count data due to aggregation and reinsurance exclusions—a point explicitly highlighted in the ground truth. Quantitative accuracy is high as no actual numbers (e.g., percentages, dollar amounts) are misstated—dates (2022, 2024) and directional trends (increasing large deductible business, slower reporting) are correct. Contextual relevance is strong as the response directly addresses the evolution of methodology, segmentation, and impact of large deductible accounts. The reasoning is logically structured but contains minor inaccuracies in entity-specific application (e.g., which business lines used which methods in 2022), affecting multi-hop synthesis fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 471,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "From 2023 to 2024, Target's Cyber Fusion Center operations have remained a central component of its cybersecurity threat investigation and response strategy. In both years, the company emphasizes using a combination of industry-leading tools and in-house technologies to detect and respond to threats. In 2024, there is a slight expansion in the description of the Cyber Fusion Center's role, highlighting its proactive threat intelligence program and its integration with broader enterprise risk management. Additionally, Target continues to collaborate with external organizations across different industries to share threat intelligence, best practices, and regulatory insights, reinforcing its commitment to enhancing cybersecurity capabilities through external partnerships.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Target maintained its Cyber Fusion Center from 2023 to 2024 and continued collaborating with external organizations, which aligns with the ground truth. However, it misses key specific advancements in 2024 mentioned in the original answer, such as the introduction of a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors. It also omits the expansion of external engagement through regular training and compliance activities for team members and the use of third-party vendors to assess and test the cybersecurity program. Instead, the LLM response vaguely references a 'proactive threat intelligence program' and 'integration with broader enterprise risk management,' which are not mentioned in the ground truth. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes continuity in Cyber Fusion Center operations and external collaboration across years, but fails to accurately identify the new elements of Target’s 2024 strategy that represent evolution, thus missing the core of the 'how it evolved' aspect of the question. (4) The contextual relevance is high because the answer stays on topic and discusses the correct entities and general themes, but the qualitative accuracy is reduced due to the inclusion of unverified details (e.g., enterprise risk integration) and the omission of critical factual developments from the ground truth. Hence, correctness is scored at 6—partially correct but with significant omissions and slight misdirection in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 481,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "Eli Lilly's financial relationship with Baqsimi evolved significantly between 2023 and 2024, particularly in terms of revenue recognition. In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million recognized in the U.S. and $31.9 million outside the U.S. This marked a notable increase from 2022, where Baqsimi generated only $139.3 million. By 2024, the revenue from Baqsimi was no longer reported as a standalone product, as the rights for Baqsimi were sold in 2023, resulting in a one-time gain included in collaboration and other revenue. This shift reflects a transition from ongoing product sales to a one-time contractual arrangement through the sale of rights.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that Eli Lilly recognized $579.0 million in revenue from the sale of Baqsimi rights in 2023, but the LLM claims $677.6 million in total revenue for Baqsimi, with $645.7 million in the U.S. and $31.9 million internationally—these figures are entirely incorrect and not supported by the original data. Additionally, the LLM references a 2022 revenue of $139.3 million, which is irrelevant and unsupported in the context of the question and ground truth. (2) The calculation and reporting of revenue are fundamentally wrong: the ground truth specifies that the $579.0 million was from the sale of rights (a one-time event), not ongoing product sales, whereas the LLM treats Baqsimi revenue as recurring product revenue before being folded into collaboration revenue. The shift described in the LLM answer—from product sales to collaboration revenue—is partially aligned with the ground truth, but the reasoning is based on false premises. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies that Baqsimi was no longer reported as a standalone product in 2024 and was included in broader collaboration revenue, it fails to correctly attribute this to the 2023 sale of rights and misrepresents the nature and amount of that transaction. (4) The contextual relevance is moderate because the answer addresses revenue recognition and contractual evolution, but the qualitative accuracy is low due to incorrect entities (revenue amounts, implied timeline), and the correctness score is low because the core financial facts are wrong, undermining the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 468,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "From 2023 to 2024, AT&T's approach to managing its capital structure through preferred interests evolved as follows: In 2023, the company repurchased all remaining Mobility Preferred Interests, valued at $5,414, primarily funded by the issuance of Telco LLC preferred interests. In 2024, AT&T expanded its Tower Holdings preferred interests by restructuring and resetting the rates of the 2019 Tower preferred interests, introducing a mix of fixed and floating rate distributions. Additionally, AT&T issued new Telco LLC preferred interests, including an additional $2,250 of Telco Class A-4 interests in October 2024, to further diversify its capital structure and fund preferred equity redemptions.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution in AT&T's capital structure strategy from 2023 to 2024, correctly identifying the repurchase of Mobility Preferred Interests in 2023 and the expansion of Tower Holdings and Telco LLC preferred interests in 2024. However, there are minor quantitative inaccuracies. The repurchase amount of $5,414 is correct, but the funding source is only partially accurate — the original answer specifies $5,250 in new Telco LLC preferred interests issued in 2023, while the LLM omits this exact figure and instead references a $2,250 issuance in October 2024, which is not mentioned in the ground truth. Additionally, the ground truth states total Telco LLC preferred interests reached $7,250 (including original $2,000 and 2023 additions), but the LLM implies a new $2,250 issuance in 2024 without confirming the cumulative total. (2) The restructuring of the 2019 Tower preferred interests into fixed (5.90%) and floating (SOFR + 250 bps) rate classes is correctly noted, though the LLM does not specify the $6,000 value involved. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift from repurchasing legacy interests to issuing new structured preferred instruments, reflecting strategic capital management. (4) Despite missing specific dollar amounts and slightly misrepresenting the timing and size of Telco LLC issuances, the overall narrative aligns with the ground truth. Wording differences are acceptable under semantic equivalence, but the omission of key figures like $6,000 for Tower Holdings and $5,250 for 2023 Telco issuance reduces quantitative precision. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 460,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly from 2023 to 2024, as Emerson announced a proposal to acquire the remaining shares of AspenTech not already owned, which would make Emerson the full owner. In 2023, Emerson already owned 55% of AspenTech, and by 2024, this ownership had increased to approximately 57%. Financially, this transformation had mixed impacts: AspenTech's performance in 2024 showed a decline in earnings, with a loss of $73 million compared to a $107 million loss in 2023. Additionally, Emerson's gross margin for the overall company was negatively affected by acquisition-related inventory step-up amortization of $231 million in 2024, which reduced gross margin by approximately 1.3 percentage points.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Emerson acquired a 55% stake in 'New AspenTech' in 2024 as part of a strategic transaction involving $6.0 billion in cash, transforming from a partner to a majority owner. However, the LLM incorrectly states that Emerson already owned 55% in 2023 and increased it to 57% in 2024, which contradicts the original timeline and ownership evolution. Furthermore, the LLM claims Emerson proposed to acquire the remaining shares to become full owner—this is not supported by the ground truth, which only confirms a 55% acquisition in 2024. (2) Quantitative inaccuracies include: the $73 million loss in 2024 and $107 million loss in 2023 for AspenTech are not mentioned in the ground truth; the $231 million inventory step-up amortization reducing gross margin by 1.3 percentage points is also absent from the original answer. Instead, the ground truth reports that the AspenTech acquisition contributed a 3.3 percentage point increase in gross margin in 2023 and a 1.8 percentage point increase in 2024—directly contradicting the LLM’s claim of negative impact. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the transformation from partnership to majority ownership as a 2024 event and misattributes financial impacts. It introduces financial data (losses, amortization) not present in the source and contradicts the direction of gross margin impact (positive vs. negative). (4) The contextual relevance is moderate because the answer addresses the relationship evolution and financial impacts as asked, but the factual foundation is incorrect. Due to major errors in numbers, timing, ownership progression, and financial impact direction, the correctness score is low at 2. Quantitative accuracy is severely compromised (score 2), qualitative reasoning is weak due to incorrect entity-state transitions (score 3), and relevance is partial (score 5) as the structure follows the question but with wrong content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 548,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "Between 2022 and 2024, AIG's Japan pension plans contributed 50% (2022), 54% (2023), and 50% (2024) to the total projected benefit obligations for non-U.S. pension plans. The weighted average discount rate for these Japan plans increased from 1.48% in 2023 to 1.81% in 2024, reflecting an improvement in the economic environment and adjustments based on the Mercer Yield Curve for Japan.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly for 2022. The original answer states that in 2022, Japan pension plans accounted for 61% of non-U.S. pension *assets* (not projected benefit obligations), while the LLM incorrectly claims a 50% contribution to *projected benefit obligations* in 2022. This misrepresents both the metric (assets vs. obligations) and the percentage. The 2023 (54%) and 2024 (50%) figures for projected benefit obligations are consistent with the ground truth, but the 2022 figure is not supported by the original data. (2) The discount rate numbers are correct: 1.48% in 2023 and 1.81% in 2024, with an increase accurately noted. However, the original answer does not provide a 2022 discount rate, so the absence of that data in the LLM response is acceptable. (3) The multi-hop reasoning is partially sound—correctly identifying trends in PBO share and discount rate changes between 2023 and 2024—but fails on the first hop by mischaracterizing the 2022 data point and conflating assets with obligations. (4) The contextual relevance is high as the answer addresses both parts of the question—evolution of contribution and change in discount rate—and provides appropriate interpretation. However, due to the incorrect 2022 percentage and mislabeled metric, the quantitative accuracy is low, pulling down the overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 395,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "Between 2022 and 2023, Amazon's disclosure about the impact of competitive stores on its business became more explicit in framing external market conditions as a growing and intensifying challenge. In 2022, the company noted that competition would intensify as international e-commerce and retail services grew, with local companies having a competitive advantage due to their understanding of local customers and established brands. In 2023, the framing expanded to include the adoption of evolving business models as a contributing factor to increased competition, emphasizing the broader and more dynamic nature of the competitive landscape. This evolution reflects a heightened awareness of the complexity and speed of market changes globally.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no numbers to verify or miscalculate, it is scored as 10 by default. The qualitative accuracy is low because the LLM misrepresents the actual content and evolution of Amazon's disclosures in the 2022 and 2023 10-K filings. According to the ground truth, the core language about competitive stores remained largely unchanged between the two years, with the key difference being the broader framing of external economic and geopolitical conditions in 2023. However, the LLM incorrectly claims that in 2022 Amazon discussed local companies having a competitive advantage due to local customer understanding and brand strength, and that in 2023 it added evolving business models as a factor—neither of which appears in the provided ground truth. These details are fabricated or misattributed. The actual shift was in contextual framing: the 2023 filing embedded competitive stores within a wider set of global external risks (economic, business, geopolitical), whereas in 2022 they were listed among various internal and external factors. The LLM captures the general idea of increasing emphasis on external conditions but does so with factually incorrect supporting details and misses the actual textual evolution described in the original answer. Thus, while the high-level theme of 'increased focus on external challenges' is directionally relevant (supporting a moderate contextual relevance score), the failure to accurately represent the specific disclosures, their wording, and the nature of the change results in a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 455,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "Based on the information provided in the 2023 and 2024 10-K filings, Target's exposure to port security risks has remained a concern due to its reliance on global supply chains, particularly with a significant portion of merchandise sourced from outside the U.S., including China. In both years, the company highlighted that disruptions at ports—such as closures, labor disputes, and congestion—could increase costs and impact inventory availability. However, in 2024, there is a more explicit emphasis on the broader implications of geopolitical conflicts and the increasing volatility of global trade dynamics, suggesting a heightened awareness and potential expansion of geographic and operational risks. Target continues to make alternative arrangements to mitigate these disruptions, but the evolving nature of port security risks indicates a growing operational impact as global trade conditions become more unpredictable.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that port security risks remained a concern for Target in both 2023 and 2024, with reliance on global supply chains and potential impacts on costs and inventory. It accurately reflects the ongoing nature of these risks and mentions mitigation through alternative arrangements, which aligns with the 2023 disclosure. However, it misses the specific evolution in geographic focus: the shift from explicitly naming California ports in 2023 to referring more broadly to 'major U.S. ports' in 2024. This is a key detail in how the company's risk exposure characterization evolved. Additionally, the LLM correctly notes increased emphasis on geopolitical conflicts and global trade volatility in 2024, which matches the ground truth’s mention of 'ongoing global conflicts and labor disputes.' But it fails to highlight the shift in temporal focus—from past disruptions (2023) to potential future impacts (2024)—which is a critical operational evolution. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable; no errors present. (3) The multi-hop reasoning is partially sound: the model synthesizes information across years and recognizes broadening concerns, but it does not fully capture the precise change in geographic specificity or the shift from retrospective to forward-looking risk framing. (4) The answer is contextually relevant and well-articulated, but lacks two key differentiators between 2023 and 2024 disclosures, warranting a score of 7 for correctness and qualitative accuracy. Quantitative accuracy is 10 by default due to absence of numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 458,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "Between 2023 and 2024, Emerson's financial relationship with Heritage AspenTech evolved primarily through acquisition-related amortization and restructuring costs. In 2023, amortization of intangibles related to the Heritage AspenTech acquisition was $258 million, while restructuring costs were $72 million. By 2024, amortization increased to $560 million, largely driven by the NI acquisition, and restructuring costs rose significantly to $228 million, reflecting broader operational adjustments and integration efforts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key quantitative values. While it correctly states the 2023 intangibles amortization ($258 million) and 2023 restructuring costs ($72 million), it incorrectly claims that amortization increased to $560 million in 2024 'largely driven by the NI acquisition'. The ground truth states that AspenTech-related amortization was no longer reported in 2024, indicating a decline or cessation—not an increase—and makes no mention of an 'NI acquisition'. This $560M figure is entirely fabricated or misattributed. The 2024 restructuring cost of $228 million is correct. (2) Quantitative accuracy is low because one of the two major financial figures for 2024 is wrong, and the error involves a large dollar amount ($560M vs the implied reduction to zero). The increase in restructuring costs is accurate. (3) The multi-hop reasoning is partially sound—linking amortization and restructuring costs to acquisition integration efforts is reasonable—but the conclusion is undermined by incorrect data. The model fails to note the absence of AspenTech amortization in 2024, a key evolution in the financial relationship. Instead, it invents a new acquisition (NI) not mentioned in the original, breaking entity accuracy. (4) Contextual relevance is high because the answer addresses the right financial metrics and time frame, and attempts to interpret the evolution meaningfully. However, due to major factual and quantitative errors, the correctness score is low despite relevant structure and partial accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 430,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "AIG's use of Expected Loss Ratio methods between 2022 and 2024 has evolved to place greater emphasis on recent accident years, particularly in lines of business with low frequency and high severity losses, such as U.S. Financial Lines (D&O, E&O, EPLI) and U.S. Excess Casualty. In 2022, Expected Loss Ratio methods were given significant weight for the most recent five accident years, especially for business written above a deductible. By 2024, this approach was reinforced, with Expected Loss Ratio methods being used more prominently for recent accident years and loss development methods for more mature years. The weight given to Expected Loss Ratio methods was also influenced by changing market conditions, rate changes, and loss trends, with adjustments made for emerging claim experience and inflation.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AIG's use of Expected Loss Ratio (ELR) methods in low frequency/high severity lines such as D&O, E&O, EPLI, and references recent accident years, which aligns with the 2022 ground truth. It also accurately notes the method's application in recent years and its combination with other methods for mature years. However, a key factual omission is the 2024 expansion into U.S. Workers' Compensation—a long-tail line—which is a critical evolution highlighted in the original answer. This missing element significantly undermines completeness and qualitative accuracy. (2) There are no explicit numerical values (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is not compromised; the LLM does reference 'most recent five accident years,' which is plausible but not confirmed in the ground truth, so no penalty is applied. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that ELR methods are used where data is sparse and updated with emerging experience, but it fails to synthesize the key development—expansion into Workers' Compensation by 2024—which represents a meaningful shift in methodology application across risk profiles. This limits the qualitative score. (4) Contextual relevance is high because the answer stays focused on the evolution of ELR methods, accident years, and business lines, even if it misses a major update. The overall correctness score is 6 due to significant but not total omission of a core factual development in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 427,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "Between 2022 and 2023, Amazon's monetization strategy for its film groups showed a modest increase in capitalized video and music content costs, rising from $16.7 billion to $17.4 billion. This suggests a continued investment in content, particularly for Amazon Prime memberships, though the growth in capitalized costs was relatively flat compared to the prior year. Additionally, total video and music expenses increased from $16.6 billion in 2022 to $18.9 billion in 2023, indicating higher spending on licensing and production of content. The strategy appears to focus on maintaining and expanding the value of film groups as a unit in major geographies, with a continued emphasis on monetizing content through Prime memberships and digital subscriptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values from the ground truth: capitalized video and music content costs increased from $16.7 billion in 2022 to $17.4 billion in 2023, and total video and music expenses rose from $16.6 billion to $18.9 billion. These figures are accurately cited with correct years and metric names, satisfying quantitative accuracy. (2) The calculations implied (comparisons of year-over-year increases) are logically sound and consistent with the data. The increase in both capitalized costs and total expenses is correctly interpreted as evidence of heightened investment and monetization efforts. (3) The multi-hop reasoning—linking changes in capitalized costs and expenses to Amazon's evolving monetization strategy—is well-executed. The LLM correctly infers that higher spending reflects a strategic focus on content value for Prime memberships and digital subscriptions, which aligns with the ground truth's conclusion of 'more aggressive investment' and 'rise in monetization efforts.' (4) The only minor shortcoming is that the LLM describes the growth in capitalized costs as 'relatively flat' or 'modest,' which slightly downplays the $700 million increase. While not incorrect, this characterization is less assertive than the ground truth’s interpretation of an 'evolved' and 'more aggressive' strategy. However, this is a nuance in tone rather than a factual error. All entities (Amazon, film groups, video/music content costs, years 2022–2023) are correct, and the answer fully addresses the question’s focus on strategy evolution based on financial changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 445,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International's financial relationship with Rothmans, Benson & Hedges (RBH) evolved significantly, primarily due to litigation and a proposed settlement. As of 2024, the court-appointed mediator in the Canadian tobacco claims proceedings proposed a settlement requiring RBH to pay CAD 32.5 billion (approximately $22.3 billion), though the allocation among RBH and other parties remained unresolved. This led PMI to assess its investment in RBH for impairment, concluding that the investment's fair value was lower than its carrying value. As a result, PMI recorded a non-cash impairment charge of $2,316 million (or $1.49 per diluted share) in 2024. This marked a significant financial impact on PMI's stake in RBH, reflecting increased risk and uncertainty in the relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the $2,316 million impairment charge in 2024 is accurately reported, as is the $32.5 billion CAD (noted as ~$22.3B USD) Canadian litigation settlement. The unresolved allocation among RBH, ITL, and JTIM is implied through the mention of 'allocation among RBH and other parties,' which preserves factual integrity. (2) Quantitative accuracy is perfect: the $2,316 million impairment and the $32.5 billion CAD settlement amount are correctly cited; the approximate USD conversion is reasonable and commonly accepted (~0.68 exchange rate), though not explicitly required. (3) The multi-hop reasoning is sound: the answer correctly links the litigation development to PMI's impairment assessment, showing cause and effect across events and entities. It captures the evolution from a prior relationship (implied by context) to a current equity investment with financial consequences. (4) The only minor shortcoming is that the LLM does not explicitly mention PMI's earlier trademark and brand licensing relationship with RBH in 2022 (e.g., reporting HEETS volumes), which was part of the original answer and shows the nature of the evolution. However, the focus on the 2024 equity stake and impairment fully addresses the core of the question. Wording differs but semantic meaning and financial implications are preserved. Thus, the answer is factually excellent with only slight omission of contextual detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 413,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "Between 2023 and 2024, the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities remained relatively stable. As of December 31, 2023, a 5% change in these liabilities would have resulted in a $615 million change in revenue, while as of December 31, 2024, the impact slightly decreased to approximately $600 million for a similar percentage change. This suggests that the overall exposure of net product revenue to fluctuations in these liabilities did not significantly increase, despite higher rebate volumes driven by incretin products in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that a $600 million sensitivity figure was disclosed for 2024. The ground truth explicitly states that LLY did not provide an updated sensitivity figure in 2024, making the $600 million number fabricated. The only correct number is the 2023 sensitivity: a 5% change leading to a $615 million change in revenue, which the LLM correctly reports. (2) Quantitative accuracy is severely compromised because the 2024 figure is not supported by the filings. There is no indication in the ground truth that the sensitivity decreased to $600 million; in fact, the absence of disclosure means no quantitative comparison can be made. Any calculation or implication about 2024 sensitivity is speculative and incorrect. (3) The reasoning is flawed because it assumes continuity and comparability between 2023 and 2024 disclosures when the 2024 filing lacks the necessary data. The LLM fails to recognize the significance of the omitted disclosure, which is central to the question. Instead of noting the absence of updated quantitative sensitivity, it invents a figure and draws a conclusion about stability, which cannot be supported. This represents a failure in multi-hop reasoning—correctly identifying the 2023 disclosure but incorrectly inferring the 2024 state. (4) Contextual relevance is moderate because the answer addresses the right topic (sensitivity of revenue to rebates/discounts) and mentions relevant factors like incretin products, but the core response misrepresents the actual disclosures. The conclusion about 'relative stability' is unsupported due to missing 2024 data. Correctness and quantitative accuracy are low due to the invented number; qualitative accuracy is slightly higher only because the 2023 fact is correct and the general context is understood.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 498,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "Based on Union Pacific's disclosures, the role and revenue contribution of Bulk shipments evolved from 2022 to 2024 as follows: In 2022, Bulk shipments generated $6.656 billion in freight revenues, representing a 12% increase from 2020 and driven by volume growth, core pricing gains, and higher fuel surcharge revenue. By 2024, Bulk shipments accounted for 32% of the company's total freight revenues, which amounted to $22.8 billion, indicating a continued significant contribution to the company's revenue mix.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. The ground truth states that in 2022, Union Pacific referenced an average revenue per car of $3,305 for Bulk shipments in 2021 (not 2022), with a 6% increase from 2020. The LLM incorrectly claims that Bulk shipments generated $6.656 billion in freight revenues in 2022, driven by a 12% increase from 2020—this figure and comparison are not supported by the ground truth and introduce unsupported financial data. Additionally, the LLM states that total freight revenues in 2024 were $22.8 billion, which is not mentioned in the original answer and cannot be verified from the provided information. While the 32% contribution of Bulk shipments to total freight revenues in 2024 matches the ground truth, the supporting context about strategic expansion into grain, fertilizer, coal, Mexico, and Canadian interline routes is omitted. (2) Quantitative accuracy is low because the dollar amounts and percentage changes introduced ($6.656B, 12% increase, $22.8B total revenue) are either fabricated or not present in the original answer. The only correct number is the 32% revenue contribution in 2024. (3) The reasoning partially follows a logical structure—tracking evolution from 2022 to 2024—but fails in multi-hop synthesis: it invents financial figures instead of relying on disclosed metrics like revenue per car and omits the strategic qualitative developments. (4) Contextual relevance is high because the answer addresses the evolution of Bulk shipments’ role and revenue contribution over time and focuses on the correct company and segment. However, due to significant quantitative errors and missing strategic context, the overall correctness score is moderate at 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 474,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "Between 2023 and 2024, the interest rate for IBM's 0.300% Notes due 2028 remained unchanged at 0.300%. This consistency in the interest rate suggests that IBM maintained a stable and long-term debt strategy, likely leveraging low-interest-rate environments to issue or retain fixed-rate debt, which can help manage interest costs and provide financial predictability.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that IBM has '0.300% Notes due 2028'. The ground truth confirms that IBM's Notes due 2028 carry a 1.750% interest rate (IBM 28A), not 0.300%. This fundamental error invalidates the core of the response. (2) Quantitative accuracy is severely compromised: the interest rate is wrong (0.300% vs correct 1.750%), and no mention is made of the fact that the rate remained unchanged at 1.750% across 2023 and 2024. Additionally, the LLM fails to mention IBM's new debt issuances in 2024 (2.900% Notes due 2030 and 3.150% Notes due 2033), which are critical to understanding IBM's broader debt strategy. (3) The reasoning is flawed: while the LLM attempts multi-hop synthesis by linking stable rates to a long-term debt strategy, it does so based on incorrect data. The correct reasoning should note that while existing note rates were stable, the introduction of higher-rate, longer-term notes in 2024 suggests a strategic shift toward locking in longer maturities despite higher costs, possibly in anticipation of rising rates. (4) Contextual relevance is moderate because the answer addresses the general question of rate evolution and strategy, but the factual foundation is incorrect, leading to a misleading conclusion. The structure and intent align with the question, but accuracy failures dominate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 379,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "From 2023 to 2024, AT&T's capital structure strategy regarding preferred interests evolved by repurchasing all outstanding Mobility Preferred Interests in April 2023, which eliminated this instrument from its capital structure. In 2024, AT&T introduced new preferred instruments, including the Telco Class A-4 preferred interests in its Telco LLC, which were set to be issued in early 2025 with an initial distribution rate of 5.94% and reset provisions. Additionally, AT&T issued Mobility II Redeemable Noncontrolling Interests in June 2023, offering a 6.8% annual distribution. These actions reflect a shift from the Mobility Preferred Interests to a more diversified approach involving new preferred instruments with varying terms and reset mechanisms.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly states that AT&T repurchased all Mobility Preferred Interests in 2023, it incorrectly claims that Mobility II Redeemable Noncontrolling Interests were issued in June 2023 with a 6.8% annual distribution—this is not supported by the ground truth and contradicts the strategy of eliminating mobility-linked preferred interests. Additionally, the LLM introduces 'Telco Class A-4 preferred interests' with a 5.94% rate set for early 2025 issuance, which is not mentioned in the original answer; instead, the ground truth states that Telco LLC preferred interests were expanded to $7,250 million in 2024, without specifying classes or rates. The original answer also highlights the restructuring of Tower Holdings preferred interests to include fixed and floating rate components, which the LLM omits entirely. (2) Quantitative accuracy is low: the LLM fails to report the $5,340 million redemption value and $373 million annual distributions of the Mobility Preferred Interests, both key figures in the original answer. The $7,250 million total for Telco LLC is not mentioned, and the introduction of unverified numbers (5.94%, 6.8%) further reduces quantitative reliability. (3) Multi-hop reasoning is partially sound—the model recognizes a strategic shift from Mobility to other preferred instruments—but it introduces unsupported instruments and misses the actual structural changes to Tower Holdings and the overall diversification toward infrastructure assets. (4) Contextual relevance is high because the answer addresses the evolution of preferred interests and attempts to describe strategic shifts. However, due to significant factual and numerical errors, the correctness score is low despite the relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 490,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "Between 2022 and 2023, Amazon's characterization of the competitive threat from websites shifted from a general acknowledgment of intensifying competition to a more specific emphasis on evolving business models and the growing influence of local companies. In 2022, the language focused on the intensification of competition as international e-commerce and omnichannel retail grow, with local companies having a competitive advantage due to their understanding of local customers and established brand presence. In 2023, the language expanded to highlight the adoption of evolving business models by competitors and reiterated the challenge posed by local companies, particularly in terms of their focus on local customers and brand strength. This shift suggests a recognition of more dynamic and adaptive competition, especially from regionally dominant players.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually misaligned with the ground truth. While it correctly identifies a shift in Amazon's competitive language between 2022 and 2023, the specific content of that shift is incorrect. The ground truth states that in 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, and in 2023, it specifically highlighted 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. In contrast, the LLM claims the shift was toward emphasizing 'evolving business models' and 'local companies' with local customer understanding and brand presence—details not present in the ground truth. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the years 2022 and 2023 are correctly referenced, earning full marks here. (3) The multi-hop reasoning is partially sound in that the model identifies a linguistic evolution over time, but it synthesizes incorrect content from those years. The LLM appears to conflate Amazon's actual disclosures with generic competitive trends, failing to accurately represent the specific language changes from the filings. (4) The correctness score is low due to major factual inaccuracies in the characterization of Amazon's disclosures. While the answer addresses the question's structure and timeframe appropriately, the core information is not semantically equivalent to the ground truth, resulting in a partially correct but ultimately misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 430,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "PMI's relationship with KT&G has evolved from a strategic collaboration in 2020 to a more integrated partnership by 2024, with KT&G's heat-not-burn products playing a significant role in PMI's smoke-free portfolio. The 2020 agreement allowed PMI to exclusively commercialize KT&G's heat-not-burn products globally, and by 2024, these products, including licensed brands like Fiit and Miix, were included in PMI's heated tobacco units (HTUs) and contributed to HTU shipment volume growth of 11.6%. This reflects PMI's increasing strategic reliance on KT&G's innovations to expand its smoke-free offerings and strengthen its market position in the transition away from combustible products.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it incorrectly states the agreement began in 2020, while the ground truth specifies 2022, which is a significant factual error. Second, it mentions licensed brands 'Fiit' and 'Miix', which are not mentioned in the original answer (the correct products are LIL Mini and LIL Plus), indicating entity inaccuracies. Third, it introduces a specific shipment growth figure of 11.6% for HTUs, which is not present in the ground truth and cannot be verified from the provided information—this is an unsupported quantitative addition. (2) The quantitative accuracy is low because the 11.6% figure is unverified and the start date of the agreement is wrong. While HTU shipment growth may be contextually relevant, its inclusion without grounding in the source data reduces factual reliability. (3) The multi-hop reasoning is partially sound: the model correctly infers a deepening strategic relationship and integration of KT&G's products into PMI's portfolio by 2024. It captures the evolution from distribution to integration, which aligns with the ground truth’s conclusion about a shift toward a more embedded partnership. However, the use of incorrect product names and dates weakens the synthesis. (4) Despite these errors, the answer addresses the core of the question—how the relationship evolved and KT&G's growing role in PMI’s smoke-free strategy—making it contextually relevant and qualitatively reasonable, though not fully accurate. Hence, correctness is scored as 6 due to key factual flaws undermining full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 436,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "Between 2022 and 2024, IBM's use of the PWCC Plan remained consistent in its administration and scope. The PWCC Plan continued to be administered by the Executive Compensation and Management Resources Committee of the Board of Directors and was solely used to fund awards for employees of PricewaterhouseCoopers Consulting (PwCC) who became IBM employees due to the 2002 acquisition. The terms and conditions of the PWCC Plan remained substantively identical to those of the 2001 Plan, and it did not fund awards for senior executives. No significant changes in administration or scope were noted during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly states that the PWCC Plan was used solely to fund awards for former PwCC employees who joined IBM after the 2002 acquisition, and that the plan's administration and terms remained substantively identical to the 2001 Plan. The administration by the Executive Compensation Committee is correctly noted, as is the exclusion of senior executives from funding under this plan. All entities (PwCC, IBM, 2001 Plan, 2002 acquisition) and timeframes (2022–2024) are accurate. There are no numeric inaccuracies—dates and references are correct. The answer captures the consistency in scope and administration, which is the core of the original answer. However, it omits the nuanced evolution in language from 2022 to 2024—the shift from 'will continue to be used' to 'has been and will continue to be used solely,' which signals a stronger reaffirmation of intent in 2024. This subtle but important qualitative shift in tone and commitment is missing, which prevents a perfect score. Nonetheless, the omission does not introduce inaccuracy but slightly reduces depth in reasoning about the evolution of IBM's stated intent. The answer remains contextually relevant and semantically equivalent in substance, with only minor loss in nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 365,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "Between 2023 and 2024, AT&T repurchased all outstanding Mobility Preferred Interests, which were initially issued in 2018. These interests, which carried a 7% annual distribution rate, were fully redeemed by April 2023, removing them from AT&T’s capital structure. In 2024, AT&T shifted focus to managing other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which were restructured or reset to align with market conditions and long-term strategic goals. This evolution reflects AT&T’s broader strategy to optimize its capital structure by reducing high-cost obligations and reconfiguring preferred equity to enhance flexibility and financial stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core facts: AT&T repurchased all Mobility Preferred Interests in 2023, eliminating the obligation, and shifted focus to other preferred interests like Tower Holdings and Telco LLC in 2024. The strategic interpretation about optimizing capital structure by reducing high-cost obligations aligns with the ground truth. However, the LLM adds specific details not present in the ground truth—namely that the interests were issued in 2018 and carried a 7% annual distribution rate. While these details may be accurate, they are not confirmed in the provided ground truth, making them unverifiable and a minor overreach. (2) Quantitatively, the LLM omits the exact repurchase amount of $5,414 million stated in the ground truth. This is a notable omission, though the fact of full repurchase is correct. The date 'April 2023' is more specific than the ground truth, which only references 2023; without confirmation, this precision could be misleading. (3) The multi-hop reasoning is sound: the model correctly synthesizes the elimination of Mobility Preferred Interests in 2023 and contrasts it with the continued presence and restructuring of other preferred interests in 2024, supporting a conclusion about selective capital structure management. (4) Scores reflect high accuracy in facts, reasoning, and relevance, with minor deductions for unverified specifics and missing dollar amount. Contextual relevance is perfect as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 418,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "Between 2022 and 2024, IBM's regulatory exposure for its debt securities remained consistent in terms of being subject to governmental and stock exchange regulations, as outlined in the \"Risks Related to Ownership of IBM Securities\" section in both years. However, the 2024 filing added more detailed context about the company's cybersecurity governance and risk management framework, which indirectly influences regulatory compliance and investor confidence. No significant evolution in direct regulatory exposure for debt securities was noted, but enhanced cybersecurity measures and oversight could affect broader compliance with evolving financial regulations.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of IBM's regulatory exposure. The ground truth states that IBM's language evolved from describing stock exchange regulations as an influencing factor in 2022 to stating it is 'subject to' them in 2024, indicating a stronger, more direct regulatory stance. However, the LLM claims there was 'no significant evolution in direct regulatory exposure,' which directly contradicts the ground truth. While the LLM correctly identifies the section ('Risks Related to Ownership of IBM Securities') and mentions cybersecurity enhancements in 2024, this is irrelevant to the specific evolution in regulatory exposure regarding debt securities. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. The qualitative accuracy is low because the model fails to capture the key shift in IBM's language and regulatory acknowledgment. Contextual relevance is moderate because the answer discusses related topics (regulations, securities, filings) but misses the central point of the evolution in regulatory posture. The multi-hop reasoning is flawed: the model should have compared the specific language used in 2022 versus 2024 filings regarding regulatory exposure but instead introduced tangential information about cybersecurity, failing the synthesis requirement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 385,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "Disney's equity income contribution from A&E declined significantly from fiscal 2023 to 2024, decreasing by $207 million, with equity income from A+E being a primary factor in this decline. In fiscal 2024, equity in the income of investees totaled $575 million compared to $782 million in the prior year, largely driven by lower income from A+E. This suggests a deterioration in A+E's financial performance during the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $207 million decrease in equity income from A+E as a key factor in Disney's decline in equity income, which aligns with the ground truth. It accurately reports the total equity income figures for fiscal 2024 ($575 million) and 2023 ($782 million), and correctly calculates the difference (782 - 575 = 207), confirming quantitative accuracy. However, the original question asks about the evolution from 2022 to 2024, while the LLM focuses on 2023 to 2024, omitting any mention of Disney's relationship with A&E in 2022, which is explicitly covered in the ground truth (noting A&E's significance in 2022 alongside CTV Specialty Television). This omission reduces completeness and affects multi-hop synthesis across the full time range. (2) All numbers are correct and properly contextualized: $575M (2024), $782M (2023), and the $207M year-over-year decline match the ground truth. The use of 'A+E' instead of 'A&E' is a minor naming variation but refers to the same entity. (3) The reasoning is sound within the timeframe used (2023–2024), correctly attributing the decline in equity income to A+E. However, the failure to address the 2022 baseline weakens the full evolution narrative required by the question. (4) Despite the temporal gap, the answer remains highly relevant and factually accurate for the period it covers, earning high marks for contextual relevance and qualitative reasoning. The core financial insight is preserved, but the incomplete time coverage prevents a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 425,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The carrying value of securitized debt obligations increased from $16.973 billion in 2022 to $18.043 billion in 2023, indicating a $1.07 billion growth. This increase suggests that the company is actively utilizing securitization as a long-term funding strategy to diversify its funding sources and manage liquidity needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The original answer states that the carrying value of securitized debt obligations decreased to $18.043 billion by December 31, 2023, but does not provide the 2022 value directly. However, it references long-term funding of $42.3 billion as of December 31, 2021, with a significant portion from securitized debt. The LLM incorrectly claims the value increased from $16.973 billion in 2022 to $18.043 billion in 2023, which contradicts the downward trend implied in the original answer. There is no mention in the ground truth of a $16.973 billion figure for 2022, nor any indication of an increase. (2) The quantitative values are inconsistent with the source: the $1.07 billion increase is fabricated, and the 2022 figure appears to be invented. While $18.043 billion in 2023 matches the ground truth, the comparison is invalid due to the incorrect prior-year number. (3) The multi-hop reasoning fails: the original answer implies a reduction in reliance on securitized debt as part of long-term funding strategy, while the LLM concludes the opposite — increased utilization — based on incorrect data. This reverses the correct strategic interpretation. (4) Despite addressing the question's structure (change over time and strategic implication), the answer is fundamentally flawed in facts and logic, warranting a low correctness score. Contextual relevance is moderate because it attempts the right analysis framework but with wrong inputs and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 427,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "Between 2022 and 2024, Disney has shifted its focus toward DTC platforms, which has impacted its international general entertainment channels. The company has moved away from traditional linear channel monetization in favor of streaming services like Disney+ and Disney+ Hotstar, which now serve as primary distribution channels for scripted and general entertainment content. This strategic shift is evident in the consolidation of services, such as merging Star+ into Disney+ in Latin America by June 2024, and the expansion of Disney+’s Star-branded tile to include general entertainment programming internationally. As a result, international general entertainment channels under the Fox, National Geographic, and Star brands have seen a reduced emphasis compared to the DTC-driven content strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic shift from linear international general entertainment channels to DTC platforms. It accurately identifies the reduced emphasis on traditional channels under the Fox, National Geographic, and Star brands and highlights key developments such as the integration of Star+ into Disney+ in Latin America by June 2024 and the expansion of the Star-branded tile on Disney+. These points reflect a sound understanding of Disney’s evolving distribution strategy. However, the LLM omits specific quantitative context from 2022—namely, that Disney operated approximately 220 international general entertainment channels—which is a notable detail for assessing the scale of the shift. Additionally, while the LLM correctly emphasizes the DTC pivot, it misses the forward-looking strategic elements highlighted in the original answer, such as the Venu Sports joint venture with Fox Corporation and Warner Bros. Discovery and the planned fall 2025 DTC launch featuring live ESPN streams. These omissions do not undermine the core accuracy but represent missing multi-hop elements that would strengthen completeness. All dates and company names are correct, and there are no factual or numerical inaccuracies. The reasoning is logical and contextually appropriate, earning high marks for qualitative and contextual accuracy despite the partial omission of forward-looking strategic initiatives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 405,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "Tesla faced financial and operational challenges related to energy storage products from 2022 to 2023, particularly in terms of accounts receivable and production scaling. In 2022, accounts receivable were impacted by fluctuations in customer payments, government rebate collection timelines, and sales of regulatory credits, which can take up to a year to collect. By 2023, these challenges persisted, with continued reliance on efficient supply chains and production scaling to meet growing demand. Additionally, production scaling for energy storage products remained dependent on supplier capabilities and internal manufacturing ramp-ups, which could lead to delays if not managed effectively.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Tesla's challenges from financial (accounts receivable) to operational (production scaling), which aligns with the ground truth and shows contextual understanding. However, it misses the specific quantitative figure of $627 million in long-term government rebates receivable as of December 31, 2021, disclosed in the 2022 filing—this is a critical omission in quantitative accuracy. The LLM vaguely references 'government rebate collection timelines' and 'fluctuations in customer payments' but does not tie the extended collection period (up to a year or more) to a concrete balance or reporting date. (2) No numeric values are provided in the LLM answer despite the ground truth including a precise dollar amount ($627M) and a specific date (December 31, 2021), which were essential for full factual accuracy. The absence of this data significantly undermines quantitative accuracy. (3) The qualitative reasoning is partially sound: the LLM correctly identifies a shift toward production scaling dependencies in 2023, mentioning supplier constraints and manufacturing ramp-ups, which matches the ground truth. However, it fails to specify the named facilities (Nevada, Texas) and the explicit risks (bottlenecks, facility ramp delays) highlighted in the 2023 filing, weakening the multi-hop synthesis. (4) Contextually, the answer remains relevant and addresses both financial and operational dimensions across the two years, but lacks precision in entities, metrics, and supporting data. The correctness score is 6 due to partially correct facts with significant omissions in key financial figures and specific operational details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 463,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "Between 2022 and 2023, the role of syrups in Coca-Cola's business model remained central to its operations, particularly in relation to bottling partners and fountain retailers. Syrups, including fountain syrups, are produced by Coca-Cola and sold to bottling partners, who either use them to produce finished beverages or sell them directly to fountain retailers for on-the-spot consumption. In 2023, syrups continued to be a key component of concentrate operations, which accounted for 58% of total net operating revenues, reflecting their importance in generating revenue through sales to bottlers and fountain retailers. Additionally, fountain syrup sales were included in the North America operating segment, emphasizing their role in supporting immediate consumption channels. The business model emphasizes collaboration with bottling partners and fountain retailers to ensure widespread availability of Coca-Cola products across various consumption settings.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but misses the core evolution in the role of syrups between 2022 and 2023 as described in the ground truth. (1) Correctly identifies that syrups are produced by Coca-Cola and sold to bottling partners and fountain retailers, and notes their inclusion in the North America segment—this aligns with the 2023 operational description. The 58% revenue figure from concentrate operations is factually accurate and relevant. (2) Quantitative accuracy is high: the 58% net operating revenue figure is correctly stated and contextually appropriate, with no calculation errors. (3) However, the answer fails to capture the key multi-hop shift in accounting and strategic emphasis: in 2022, revenue recognition differed based on bottler consolidation status (deferred for consolidated, immediate for unconsolidated), and in 2023, the framing shifted to syrups as an operationally embedded component in the finished beverage system, especially for fountain channels. This evolution—from a volume- and revenue-recognition-driven model to a more integrated, strategically emphasized component—is entirely missing. The LLM implies continuity rather than change. (4) Contextual relevance is strong as it addresses bottling partners, fountain retailers, and the importance of syrups. However, due to the omission of the critical shift in business model logic and revenue recognition policy, the qualitative accuracy is significantly reduced. The answer provides supporting facts but does not synthesize the transformation in the role of syrups over time as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 438,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) increased from fiscal year 2022 to fiscal year 2024, with the fair value rising from $84 million in 2022 to $166 million in 2024. However, the proportion of these investments relative to the overall fair value hierarchy decreased, dropping from 1% in 2022 to 1% in 2024, indicating a relatively stable but smaller share within the broader investment portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts and misrepresents the proportional trend. According to the ground truth, Disney's investment in Other MBS & ABS was $96 million in fiscal year 2022 and increased to $120 million in 2024, maintaining a stable 1% share of the total plan asset mix. The LLM incorrectly states the 2022 value as $84 million and 2024 value as $166 million, both of which are factually wrong. Additionally, while the LLM correctly notes the proportion remained at 1%, it misleadingly interprets this as a 'decrease' and 'smaller share', which contradicts the stable proportion described in the original answer. (2) The quantitative inaccuracies are severe: the correct values are $96M (2022) and $120M (2024), not $84M and $166M. The percentage (1%) is correctly cited but misinterpreted in context. No valid calculation can justify the LLM's figures. (3) The multi-hop reasoning is partially sound in that the model attempts to compare absolute value changes and relative proportions over time, but due to incorrect data inputs, the synthesis fails. The model also fails to recognize that a constant percentage implies stable relative weight, not a decline. (4) The correctness score is low (3) due to major factual errors in core financial figures and flawed interpretation of trends. Quantitative accuracy is very poor (2) because both dollar values are incorrect. Qualitative accuracy is moderate (4) as the structure and intent of the response follow the required logic, but reasoning is flawed. Contextual relevance is acceptable (7) because the answer addresses the right topic, time frame, and metric type, even if with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 469,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "Between 2022 and 2023, Skunk Works' advanced development programs expanded their focus areas to include air dominance and hypersonics in addition to their existing emphasis on unmanned and manned aerial systems, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. This evolution reflects a strategic shift toward next-generation military aircraft capabilities aligned with emerging threats and mission requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the focus areas mentioned in the ground truth, including hypersonics, ISR, situational awareness, and air mobility, and correctly notes the continued emphasis on unmanned and manned aerial systems from 2022. However, it inaccurately frames the evolution as an 'expansion' to 'include' air dominance and hypersonics, when in fact hypersonics was already a focus in 2022. The ground truth states that the shift was a refinement with increased emphasis on air dominance, not the addition of entirely new focus areas. Air dominance was not present in the 2022 list but became emphasized in 2023, so highlighting it as a change is correct, but implying hypersonics was newly added is factually wrong. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly contrasts 2022 and 2023 priorities but fails to accurately represent the continuity of hypersonics as a focus area, leading to a mischaracterization of the evolution as an expansion rather than a prioritization shift. (4) The contextual relevance is high because the answer addresses the evolution of focus areas in relation to next-generation military aircraft. However, due to the significant factual error regarding the introduction of hypersonics, the qualitative and overall correctness scores are reduced. The core message of strategic refinement is partially captured but misrepresented as expansion rather than reprioritization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 439,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "From 2022 to 2023, Tesla's approach to the Powerwall product has evolved by emphasizing integration with residential solar energy products and enhancing cross-selling opportunities. In 2022, the focus was on increasing production to meet demand and addressing global component constraints. By 2023, Tesla highlighted improved availability of Powerwall and growing customer interest driven by grid stability concerns, alongside efforts to streamline the customer experience through localized procurement and simplified online ordering. This shift reflects a stronger emphasis on integration strategy and leveraging synergies within Tesla's broader energy ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in spirit and captures the general evolution of Tesla's Powerwall strategy from 2022 to 2023, with accurate emphasis on integration, customer experience, and ecosystem synergy. There are no numeric inaccuracies (quantitative accuracy is 10), as the answer avoids specific figures that could introduce errors and instead uses qualitative descriptions consistent with the timeframes. However, the LLM misrepresents some key aspects of the original answer: in 2022, the ground truth emphasizes cross-selling due to better availability and grid concerns, not increasing production or addressing component constraints (which is not mentioned in the original). Additionally, the 2023 shift in the original answer is toward a more engineered, technical integration of Solar Roof and solar systems with Powerwall, whereas the LLM focuses on procurement and ordering improvements, which are not in the original. These omissions and substitutions affect qualitative accuracy, as the multi-hop reasoning—while logical—is not fully aligned with the source. The answer remains contextually relevant and addresses both integration strategy and production emphasis, albeit with some inaccuracies in the details of Tesla’s actual focus. Thus, correctness is reduced to 7 due to significant but not fundamental errors in the characterization of Tesla’s strategic priorities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 383,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "Between 2022 and 2024, Gilead has maintained Biktarvy as a cornerstone of its HIV portfolio, emphasizing its role as a leading single-tablet regimen for the treatment of HIV-1 infection. Biktarvy's position has remained strong due to its efficacy, convenience, and favorable resistance profile. However, the company faces commercial risks, including market share pressures from competitive products and the potential for generic alternatives. Additionally, evolving treatment paradigms and regulatory developments, such as FDA's class labeling changes for CAR T-cell therapies, highlight the need for Gilead to continue innovating and adapting its HIV portfolio to maintain its competitive edge and sustain revenue growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Biktarvy as a cornerstone of Gilead's HIV portfolio in both 2022 and 2024, and acknowledges its strong positioning due to efficacy and convenience—this aligns with the ground truth. However, it misses the key strategic shift highlighted in the original answer: the increasing commercial risk due to overreliance on TAF-based therapies. While it mentions generic competition and market share pressures, it does not capture the core vulnerability related to dependence on nucleoside-based regimens or the risk from a paradigm shift away from TAF, which is central to the 2024 risk assessment. Additionally, the mention of 'FDA's class labeling changes for CAR T-cell therapies' is factually irrelevant—CAR T-cell therapies are unrelated to HIV or Biktarvy, indicating a significant error in contextual reasoning. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, all mentioned years (2022, 2024) are correct, earning full marks here. (3) The multi-hop reasoning is partially sound—linking Biktarvy’s role over time and identifying commercial risks—but fails in synthesizing the specific risk of therapeutic class overconcentration (TAF dependence), which is a critical multi-hop insight from the knowledge graph. (4) The correctness score is 6 due to accurate framing of Biktarvy’s importance but significant omission of the key strategic vulnerability and inclusion of an irrelevant regulatory risk. Qualitative accuracy is reduced due to flawed reasoning around CAR T and missing the TAF-specific risk. Contextual relevance is high as the answer stays focused on Biktarvy and Gilead’s HIV strategy, despite inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 470,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "Between 2022 and 2023, the U.S. Retrospective Responsibility Plan saw changes in the U.S. litigation escrow account balance, with deposits increasing significantly. In 2022, the escrow account balance increased from $894 million to $1,449 million, with $850 million deposited and $295 million paid out. In 2023, the balance rose further to $3,089 million, with $1,500 million deposited and $685 million paid out. Additionally, the plan now includes makewhole agreements as a new mechanism, which were not explicitly referenced in the 2022 disclosures. These agreements reimburse Visa for future deposits into the escrow account that would have otherwise reduced the conversion rate of class B-1 common stock for participating stockholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to accurately reflect the ground truth. (1) The original answer states that the composition of the U.S. Retrospective Responsibility Plan evolved by adding 'makewhole agreements relating to the Class B-1 common stock exchange offer' as a new mechanism in 2023, while retaining the U.S. Litigation Escrow Agreement and other prior mechanisms. The LLM answer incorrectly shifts focus to quantitative changes in the escrow account balance (e.g., $894M to $1,449M in 2022, $3,089M in 2023), which are not mentioned in the ground truth and appear to be fabricated or misattributed. (2) There are no numerical figures in the original answer, so all dollar amounts in the LLM response ($850M deposited, $295M paid out, etc.) are unsupported and factually inaccurate. These numbers do not appear in the ground truth and represent a significant hallucination. (3) While the LLM correctly identifies the addition of 'makewhole agreements' as a new element in 2023, it mischaracterizes their purpose — stating they reimburse Visa for future escrow deposits affecting conversion rates — whereas the original answer only states they are a new component of the plan without specifying mechanics. This shows partial qualitative understanding but flawed reasoning. (4) The question asks about changes in the composition of the plan, particularly regarding mechanisms tied to the U.S. Litigation Escrow Agreement. The LLM incorrectly interprets this as asking about financial flows in the escrow account rather than structural mechanisms. It fails the multi-hop reasoning test by conflating financial activity with governance structure. (5) Contextual relevance is moderate because it discusses related entities (Class B-1 stock, escrow, makewhole agreements) but answers a different question. Final scores reflect major factual inaccuracies, especially in quantitative claims, poor qualitative reasoning, and only partial relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 526,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, the strategic importance of Biktarvy for Gilead has remained significant due to its strong patent protection, with compound patent expiration estimated for 2033 in both the U.S. and the European Union. This extended exclusivity supports its role as a key revenue driver in Gilead’s HIV portfolio. However, the company continues to highlight the risk of HIV product dependency, noting that a substantial portion of its revenue comes from HIV treatments, including Biktarvy. The risk of competition, including from generics, and the potential for changes in treatment paradigms remain ongoing concerns, underscoring the need for continued innovation and diversification in Gilead’s product pipeline.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Biktarvy's U.S. patent expiration in 2033, aligning with the ground truth. However, it incorrectly states that the European Union also has a 2033 expiration 'estimated' for both regions, while the original answer notes that no expiration was listed in the E.U. in 2022, indicating uncertainty or absence of public expiration data—this is a factual overstatement. (2) There are no calculations in the response, but the dates are mostly accurate except for the unwarranted extension of the 2033 date to the E.U. without evidence. (3) The multi-hop reasoning is partially sound: the model connects patent protection to strategic importance and acknowledges Gilead’s risk disclosures around HIV dependency and market competition. However, it misses the key evolution highlighted in the ground truth: that by 2024, despite continued patent protection, the strategic vulnerability increased due to heightened risk disclosures around competition and treatment shifts—even if patents remain intact. The LLM treats the risk as 'ongoing' rather than escalating, which downplays the shift in tone from 2022 to 2024. (4) The contextual relevance is high, as the answer addresses patent timelines, revenue importance, and risk factors. The qualitative accuracy is reduced due to the incorrect inference about E.U. patents and the weaker synthesis of the evolving risk narrative. Quantitative accuracy is high because the U.S. date is correct and no other numbers are misstated, though the E.U. claim introduces inaccuracy by implication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 432,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "Based on the provided document pages, there is no indication of modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023 in terms of guarantee structure or referenced documentation. The guarantees for Illinois Bell Telephone Company are listed under historical exhibits (Exhibit 4-c) and do not show any updates or changes in the 2022 or 2023 filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly concludes that there were no modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023 in terms of structure or documentation, which aligns with the ground truth. The key factual point—that the guarantee remained unchanged—is accurately conveyed, and there are no errors in dates, numbers, or referenced forms. However, there is a minor discrepancy in the exhibit number: the LLM states 'Exhibit 4-c' while the ground truth specifies 'Exhibit 4-d'. This is a factual inaccuracy in entity detail, though it does not affect the overall conclusion about the lack of changes. The reasoning is sound in that it infers stability from the absence of updates in filings, and the answer addresses all parts of the question. The semantic meaning is largely equivalent to the original answer, with only the exhibit number being incorrect. Hence, the quantitative accuracy is perfect (no numerical or date errors), qualitative accuracy is slightly reduced due to the exhibit number mismatch, and contextual relevance is full as the response directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 322,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggests that there has been no significant dilution or adjustment to the voting power of Class A common stockholders during this period. Since Class C shares carry fewer voting rights compared to Class A shares, maintaining a stable conversion rate implies that the relative influence of Class A stockholders in significant corporate transactions has remained largely unchanged, assuming no material changes in the number of outstanding shares of each class.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the stable conversion rate and its implication on voting power stability for Class A stockholders. It correctly identifies that the unchanged conversion rate (4.0000, though not explicitly stated) implies no structural change in voting influence, which aligns with the original answer. Quantitatively, while the LLM does not mention the specific as-converted Class A stock values of 38 million in 2022 and 39 million in 2023, it does not contradict them and correctly infers stability despite a potential increase in value. The absence of these specific numbers reduces completeness slightly, but since the core reasoning about stable voting power remains valid, the impact is minor. The LLM correctly performs the multi-hop reasoning by linking conversion mechanics to voting rights and corporate control, though it does not explicitly reference the slight increase in as-converted value, which slightly weakens the depth of synthesis. Wording differs but semantic meaning is equivalent. Contextual relevance is strong as it directly addresses the question about voting power impact in significant corporate transactions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 335,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "From 2022 to 2023, Tesla's relationship with the Solar Roof evolved in terms of production focus and strategic dependencies by shifting toward greater integration with its broader energy generation and storage initiatives. In 2022, the Solar Roof was highlighted as part of Tesla's energy product offerings, emphasizing customization and installation through direct and channel partner sales. By 2023, the Solar Roof was increasingly positioned as part of a holistic clean energy ecosystem, with a focus on leveraging Tesla's manufacturing capabilities and strategic partnerships to streamline production and deployment. Additionally, the Solar Roof's development and production remained tied to Gigafactory New York, reflecting a continued strategic dependency on localized manufacturing and government incentives to support its growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements, such as the continued association of Solar Roof with Gigafactory New York and its role in Tesla's energy offerings. However, it misrepresents the nature of Tesla's evolving relationship from 2022 to 2023. The original answer highlights a shift from active production focus in 2022 to increased emphasis on strategic risks and production challenges in 2023, including delays, supply chain constraints, and ramping difficulties. In contrast, the LLM answer portrays a more positive evolution—greater integration, streamlined production, and strategic partnerships—without acknowledging the cautionary tone or increased risk disclosures that define Tesla's 2023 stance. This misalignment in qualitative interpretation significantly affects correctness. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; no errors in dates or formats. (3) The multi-hop reasoning is partially sound: the model correctly identifies the Solar Roof’s production site and general strategic context, but fails to synthesize the key shift from operational execution (2022) to risk disclosure (2023), which is central to the question. It also introduces unverified claims about 'strategic partnerships' and 'holistic ecosystem' focus not present in the ground truth. (4) Correctness and qualitative accuracy are penalized due to the mischaracterization of Tesla's strategic posture, despite correct entity and location references. Contextual relevance remains high because the answer addresses the right topic and timeframe with relevant themes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 444,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "Between 2022 and 2023, the role of syrups in Coca-Cola's business model remained integral to both concentrate and finished beverage operations, with a continued emphasis on their use in fountain channels. Syrups are produced by combining concentrates with water and sweeteners and are sold to bottling partners or fountain retailers for on-site mixing. In 2023, concentrate operations accounted for 58% of total net operating revenues, with syrups playing a central role in this segment. The relationship between syrups and finished beverage production remained unchanged, as bottlers and fountain retailers continue to rely on syrups to produce finished beverages for retail and immediate consumption. Distribution channels also remained consistent, with bottling partners and authorized wholesalers handling syrup distribution to maintain alignment with Coca-Cola's global beverage supply chain.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and omits key aspects of the evolution in Coca-Cola's syrup business model between 2022 and 2023. While it correctly identifies syrups as intermediate products used in fountain beverage production and notes their role in concentrate operations, it incorrectly states that 'concentrate operations accounted for 58% of total net operating revenues' in 2023 — this figure is not present in the ground truth and cannot be verified from the provided context. No revenue percentage related to concentrate or syrup operations was mentioned in the original answer, making this a major quantitative error. (2) The LLM claims that 'the relationship between syrups and finished beverage production remained unchanged,' which directly contradicts the original answer’s emphasis on a strategic shift in 2023, including direct management of fountain syrup sales in the U.S. by Coca-Cola and the inclusion of fountain syrup operations in the North America operating segment. This omission misrepresents the evolution of the business model. (3) The multi-hop reasoning is flawed: the question asks for changes between 2022 and 2023, but the LLM fails to identify the shift toward tighter control and regional segmentation in 2023. Instead, it asserts continuity in both production relationships and distribution channels, missing the key point that Coca-Cola took a more direct role in U.S. syrup sales and restructured reporting under the North America segment. (4) Despite these issues, the answer is contextually relevant — it addresses the role of syrups, their use in fountain systems, and distribution via bottling partners — but incorrectly concludes no change occurred. The qualitative reasoning is partially sound but based on incorrect premises. The contextual relevance is moderate because it discusses the right domain but fails to capture the strategic evolution. Overall, the answer is partially correct in general background but fails on the core requirement: identifying how the role of syrups evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 557,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "Between 2022 and 2024, Colgate-Palmolive's Africa/Eurasia segment showed modest growth in financial contribution. In 2022, the segment reported net sales of $1,082 million and operating profit of $228 million, while in 2024, net sales increased to $1,095 million and operating profit rose to $253 million. The geographic reporting structure remained consistent, with Africa/Eurasia classified as one of the five reportable operating segments under the Oral, Personal and Home Care product segment. Notably, the 2024 results reflect a slight improvement in profitability despite relatively stable sales, indicating a focus on operational efficiency in the region.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Africa/Eurasia was part of the Oral, Personal and Home Care segment with an operating profit of $203 million, not $228 million as stated. The LLM also fabricates net sales figures ($1,082M in 2022 and $1,095M in 2024) that are not present in the original answer and cannot be verified from the provided truth. Furthermore, the claim that Africa/Eurasia remained a reportable segment 'under the Oral, Personal and Home Care product segment' contradicts the ground truth, which states it became a distinct reportable segment within that geographic structure in 2024—indicating a structural change, not consistency. (2) The quantitative inaccuracies are severe: the operating profit is misstated by over $25 million in 2022, and entirely new sales figures are invented. There is no mention of net sales in the ground truth, so introducing them undermines factual integrity. Calculations about growth or profitability improvements are therefore baseless. (3) The multi-hop reasoning fails: the LLM misses the key structural evolution—realignment of the skin health business from Europe to North America in 2024—as a signal of strategic refinement in geographic reporting. Instead, it incorrectly asserts the reporting structure remained consistent, when the truth indicates a meaningful shift toward more nuanced regional evaluation. (4) While the answer addresses the general topic of Africa/Eurasia's operational focus and attempts to discuss financials and structure, the core facts are wrong or fabricated, leading to a low correctness score. Contextual relevance is moderate because the response stays on topic but draws incorrect conclusions from inaccurate data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 483,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson's strategic presentation of its Orthopaedics business within the MedTech segment has emphasized steady global sales performance and a focus on enabling technologies. In 2023, Orthopaedics reported worldwide sales of $8,942 million, reflecting a 4.1% increase compared to 2022, with growth in both U.S. and international markets. By 2024, the company continued to highlight the Orthopaedics portfolio's role in supporting hips, knees, trauma, spine, sports, and other areas, with an emphasis on enabling technologies to enhance patient outcomes. This strategic emphasis aligns with the broader MedTech segment's focus on innovation and advanced healthcare solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the 2023 global sales figure of $8,942 million and the 4.1% year-over-year increase, with accurate context on U.S. and international growth. These numbers match the ground truth exactly, and formatting is consistent. (2) All numeric values—$8,942 million, 4.1% increase, and implied prior-year comparison—are factually correct. No calculations were required beyond what was stated, and the LLM accurately reflects the reported growth. (3) The multi-hop reasoning is mostly sound: it correctly identifies the shift from 2023's financial emphasis to 2024's focus on enabling technologies. However, the LLM does not explicitly note that 2024 omitted revenue figures entirely, which is a key strategic shift highlighted in the ground truth. Instead, it implies continuity in reporting ('continued to highlight'), which slightly misrepresents the pivot as incremental rather than a qualitative reframing. (4) Despite this nuance, the answer captures the core evolution—shifting emphasis from sales performance to innovation and enabling technologies—and correctly identifies the business areas (hips, knees, trauma, spine, sports medicine). The answer is contextually relevant and conveys most of the key information, but misses the full strategic implication of dropping quantitative metrics in 2024, which slightly reduces qualitative accuracy. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 395,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "Between 2022 and 2023, Visa's approach to managing litigation liabilities through loss sharing agreements has shown notable evolution, particularly in the scope of U.S. covered litigation and liability allocation. In 2022, the U.S. litigation escrow account balance increased from $894 million to $1,449 million, primarily due to deposits of $850 million. By 2023, the balance further increased to $3,089 million, with an additional $1,500 million in deposits. This reflects a broader allocation of funds to address potential liabilities from U.S. covered litigation, including cases brought by merchants that opted out of the MDL 1720 settlement class. Additionally, the amendments to the loss sharing agreement in 2015 expanded the scope to include such opt-out cases, ensuring a more comprehensive liability management framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of Visa's litigation liability management between 2022 and 2023. (1) Quantitative Accuracy: The financial figures cited—such as the U.S. litigation escrow account increasing from $894M to $1,449M in 2022 and then to $3,089M in 2023 with $1.5B in deposits—are not present in the original answer and contradict the ground truth. The original answer does not mention any escrow account balances or deposit amounts, so these numbers are fabricated or misattributed. There is no support for these specific dollar amounts in the provided truth. (2) Completeness: The LLM misses key aspects of the evolution: it omits the 66.6667%/33.3333% liability split between Visa and Mastercard under the omnibus agreement, fails to mention the October 2015 amendment explicitly, and does not reference the U.S. Retrospective Responsibility Plan introduced in 2023. The shift from a bilateral loss sharing framework to a consolidated, retrospective plan is entirely absent. (3) Entity Accuracy: While Visa and MDL 1720 are correctly referenced, Mastercard is not mentioned despite being a critical party in the liability allocation. The term 'U.S. Retrospective Responsibility Plan'—a central element in 2023—is missing. (4) Reasoning: The multi-hop synthesis is flawed. The LLM incorrectly infers that increased escrow deposits reflect an evolution in strategy, whereas the ground truth describes a structural and contractual evolution (from amendment-based coverage to a broader retrospective framework). The reasoning is based on incorrect data and misses the conceptual shift. (5) Semantic Equivalence: The overall message diverges significantly. Instead of describing a strategic pivot toward resolution and consolidation of legacy liabilities through structural changes, the LLM focuses on unverified funding increases. Despite addressing U.S. covered litigation and opt-out cases, the core factual and conceptual content is incorrect. Minor relevance is retained due to correct mention of MDL 1720 and opt-out litigation, but correctness is severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 574,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "Between 2022 and 2024, Colgate-Palmolive's investment in Guaranteed Investment Contracts (GICs) decreased significantly. In 2022, GICs were valued at $51 million for international plans, and by 2024, this amount dropped to $30 million. This reduction suggests a strategic shift in the company's pension plan asset allocation, likely aiming to diversify investments or reallocate funds to other asset classes such as fixed income or equity funds, which saw increases in their allocations. This shift may indicate a move toward more liquid or market-sensitive investments to better manage risk and returns in the pension portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, CL held $1 million in GICs for U.S. Pension Plans and $55 million for International Pension Plans (total $56 million), not $51 million as stated for international only. By 2024, the U.S. allocation was fully phased out (correctly implied in the trend but not mentioned), and international dropped to $34 million, not $30 million. The LLM reports $30 million instead of $34 million and omits the U.S. $1 million entirely, leading to incorrect totals and misrepresentation of the data. (2) Calculations and comparisons are flawed: the drop from $51M to $30M suggests a $21M decrease, but the actual international drop was from $55M to $34M ($21M decrease — coincidentally correct magnitude but based on wrong base). The U.S. elimination is not mentioned at all, missing a key part of the multi-hop synthesis. (3) The reasoning about strategic reallocation is plausible and aligns with the ground truth's interpretation of a strategic shift, so the qualitative logic is sound in direction but lacks completeness. The LLM correctly infers a strategic move toward diversification or more liquid assets, which is consistent with the ground truth's indication of asset reallocation. However, it fails to acknowledge the complete exit from U.S. GICs, a critical component of the strategy. (4) Contextual relevance is high — the answer addresses the evolution and strategic implication as asked, and the interpretation is reasonable. However, due to major numerical errors and omission of U.S. data, the correctness score is limited to 5 — partially correct but with significant factual gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 464,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "Between 2022 and 2024, the Mastercard Developer Platform evolved to become a more integral enabler of integration for digital assets and new technologies. In 2022, the platform was described as simplifying access to and integration of Mastercard's digital assets, offering a single access point with tools and capabilities to find APIs across a broad range of services. By 2024, the platform had expanded its role to support blockchain-based business models, including programmable payments through the Mastercard Multi-Token Network™, and enabling consumers to buy and spend cryptocurrencies. Additionally, the platform supported innovation by providing access to new technologies and early-stage fintech players through Mastercard Foundry, further enhancing its functionality in integrating digital assets and emerging technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: in 2022, the Mastercard Developer Platform served as a single access point for digital assets and APIs, which is accurately described. By 2024, it evolved to support blockchain-based solutions and the Mastercard Multi-Token Network™, including programmable payments and cryptocurrency integration—this is correctly reflected. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all temporal references (2022, 2024) are correct, satisfying the date accuracy requirement. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 vs 2024) and technology evolution (from general API access to blockchain and digital asset integration). It appropriately references the Mastercard Multi-Token Network™ and programmable payments, which are key developments in 2024. The mention of Mastercard Foundry enhancing access for fintechs adds contextual depth, though this specific point is not in the ground truth; however, it does not contradict it and is plausibly aligned with Mastercard's innovation strategy. (4) The semantic meaning matches the original answer: the evolution from a general integration platform to one focused on next-gen financial tech is clearly conveyed. The only minor gap is that the original emphasizes 'secure, scalable, and interoperable blockchain-based transactions' and 'strategic positioning' more explicitly, which the LLM answer implies but doesn't fully mirror in phrasing. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only slight room for enhanced precision in reflecting the strategic emphasis noted in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 510,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "The company's investment in U.S. common stocks within its pension plans remained minimal between 2022 and 2024, with only $1 million allocated in 2024 and none in 2023, 2022, or earlier. This indicates that the company's strategic asset allocation continues to prioritize fixed income securities and other investments over direct equity holdings in its U.S. pension plans, aligning with its target allocation of 26% in equities for U.S. plans in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, there was no investment in U.S. common stocks in the U.S. pension plan in 2022 or 2024, but the international pension plan had a $2 million investment in both years. The LLM incorrectly states only $1 million was allocated in 2024 and none in 2022 or earlier, which contradicts the ground truth. It also fabricates a $1 million figure not present in the original data. Additionally, the LLM introduces a 'target allocation of 26% in equities for U.S. plans in 2024' which is not mentioned or supported by the ground truth. (2) Quantitative accuracy is low: the correct figures are $0 in U.S. common stocks for the U.S. pension plan in both years and $2 million in the international plan in both years. The LLM reports $1 million in 2024 and zero otherwise, which is factually wrong. No correct calculations are made. (3) The multi-hop reasoning is flawed. The model fails to distinguish between U.S. and international pension plans, conflating them into a single narrative. It incorrectly infers strategic prioritization of fixed income based on incomplete and inaccurate data, and introduces unsupported targets. The synthesis across entities (U.S. vs. international plans) is missing. (4) Contextual relevance is moderate because the answer addresses the general topic of strategic asset allocation and pension investments, but the incorrect data and reasoning undermine the validity. The conclusion about avoiding direct equity exposure is partially aligned, but the evidence cited is wrong. Overall, major factual and reasoning errors lead to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 457,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "Between 2022 and 2023, Disney's strategic focus on cruise ships evolved with a renewed emphasis on capital investment and operational risk management. In 2023, the company announced plans for additional expansion of its cruise ship fleet, reflecting a commitment to growing its Disney Cruise Line segment. This aligns with broader investments in the Parks & Experiences segment, which includes cruise ships, resorts, and theme parks. Operationally, Disney acknowledged risks such as disruptions from uncontrollable events (e.g., natural disasters, global health concerns) and the need for robust insurance and contingency planning to mitigate potential impacts on cruise operations. Additionally, the company highlighted the importance of aligning its offerings with evolving consumer preferences and managing costs associated with new ship launches and ongoing fleet maintenance.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Disney's strategic evolution between 2022 and 2023. While the original answer states that Disney shifted from a growth-oriented investment strategy in cruise ships in 2022 to a focus on operational risk mitigation in 2023, the LLM incorrectly claims that in 2023 Disney 'announced plans for additional expansion of its cruise ship fleet,' which contradicts the ground truth. This misrepresents the core strategic shift from asset expansion to risk management. (2) There are no specific numeric values (e.g., dollar amounts, percentages) in either the question or original answer, so quantitative accuracy is not heavily applicable; however, the LLM does not fabricate numbers, so this aspect is neutral. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the shift in strategic emphasis over time. Instead of identifying the pivot from capital investment to operational risk, it portrays continuity in expansion plans, missing the recalibration entirely. The mention of operational risks (e.g., natural disasters) is partially correct but framed as a coexisting priority with growth, rather than a replacement focus. (4) Contextual relevance is moderate—the answer discusses cruise ships, capital investment, and operational risks, which are relevant topics—but the failure to capture the directional change in strategy severely undermines factual correctness. The LLM answer suggests ongoing growth intentions in 2023, while the ground truth indicates a retreat from that stance due to external disruptions like Hurricane Milton. This fundamental contradiction justifies a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 471,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Mastercard's use of short duration foreign exchange derivative contracts has increased between 2022 and 2024, as evidenced by the rise in notional amounts from $2,741 million in 2024 compared to earlier periods. These contracts are primarily used to manage foreign exchange risk arising from daily settlement activities, where exposure is typically limited to a few days. The Company employs these derivatives to offset potential gains and losses from currency fluctuations between transaction dates and settlement, ensuring stability in its financial results.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding quantitative data. It claims that notional amounts rose to $2,741 million in 2024, but this figure is not present in the ground truth and cannot be verified from the provided context. No specific notional amounts or trends in volume are mentioned in the original answer, so asserting an increase based on such a figure is incorrect. (2) There is no support in the ground truth for any numerical comparison across years or mention of $2,741 million; thus, the quantitative claim fails verification. The original answer emphasizes continuity in the use of short duration contracts, not an increase in volume or notional value. (3) The reasoning partially captures the purpose of the derivatives—managing FX risk in daily settlement—but misses the key multi-hop insight: while short-duration contract usage remained consistent, Mastercard's broader FX strategy evolved due to active re-designation of euro-denominated debt hedges in 2023 and 2024. This dynamic adjustment is a critical contextual shift absent in the LLM response. (4) While the LLM correctly identifies the role of short-duration derivatives in managing settlement risk, it fabricates quantitative evidence of growth and omits the nuanced evolution in hedging strategy, leading to a partially correct but misleading narrative. Hence, correctness is scored low due to unsupported numbers and incomplete reasoning, though the core concept of using derivatives for daily settlement risk is contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 431,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "From 2023 to 2024, Salesforce's strategic relationship with enterprise cloud companies has evolved with a stronger focus on ecosystem integration and expanding its solution ecosystem. In 2023, the company emphasized managing a portfolio of strategic investments in enterprise cloud companies and technology startups, aiming to digitally transform industries and support corporate initiatives such as AI. By 2024, Salesforce further deepened this focus by introducing Agentforce, an agentic layer of the Salesforce Platform for deploying autonomous AI agents across business functions, which enhances integration with third-party applications and data sources. Additionally, the company continued to invest in and expand its partner ecosystem, including independent software vendors and system integrators, to accelerate market reach and innovation. These efforts reflect a strategic shift toward not only investing in but also more tightly integrating with enterprise cloud companies to drive growth and customer value.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Salesforce's strategic relationships from 2023 to 2024. It accurately captures the shift from a focus on strategic investments in enterprise cloud companies and startups in 2023 to deeper ecosystem integration in 2024. The mention of expanding the partner ecosystem, including ISVs and system integrators, and accelerating market reach matches the original answer. However, the LLM introduces 'Agentforce' and describes it as an 'agentic layer of the Salesforce Platform for deploying autonomous AI agents'—a specific product detail not present in the ground truth and not verifiable from the provided knowledge graph. This addition, while plausible, represents a factual overreach or hallucination that slightly undermines qualitative accuracy. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default (no errors). Contextual relevance is strong—the response directly addresses investment focus and ecosystem integration across both years. The core reasoning and multi-hop synthesis (comparing 2023 investment strategy to 2024 integration focus) are sound and semantically equivalent to the original, just enhanced with unverified specifics. Hence, correctness is high but not perfect due to the unsupported detail about Agentforce.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 383,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the company maintained a consistent methodology for recognizing vendor funds but refined its accrual rates based on updated purchase volume projections and vendor agreement provisions. In fiscal 2024, the company continued to adjust accrual rates throughout the year by analyzing historical purchase trends and confirming actual amounts with select vendors. The sensitivity to projected purchase volumes remained significant, particularly for programs with graduated funding tiers tied to volume thresholds. Any deviations between actual and projected volumes could still impact the amounts accrued, though the company emphasized that adjustments historically had not been material.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant qualitative inaccuracy in its interpretation of the evolution of the company's approach to accrual rates. While it correctly notes that the methodology for recognizing vendor funds remained consistent and that historical purchase trends and vendor confirmations were used in fiscal 2024, it incorrectly asserts that sensitivity to projected purchase volumes 'remained significant' and that programs had 'graduated funding tiers tied to volume thresholds.' This contradicts the ground truth, which states that the explicit reference to 'graduated purchase volumes'—a key indicator of such sensitivity—was present in fiscal 2023 but omitted in fiscal 2024, suggesting a potential simplification or stabilization. The LLM answer thus misrepresents the directional change (i.e., reduced emphasis on volume sensitivity) implied by the removal of this language. There are no quantitative inaccuracies, as no specific numbers are involved and the time periods (fiscal 2023 and 2024) are correctly referenced. The answer is contextually relevant and addresses the core question about accrual rate evolution, but fails in accurately synthesizing the nuanced shift in disclosure that indicates a change in emphasis. Therefore, while the reasoning is logical, it is based on an incomplete or incorrect reading of the change in disclosure tone between years, leading to a flawed conclusion about the continued significance of volume sensitivity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 410,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "From 2022 to 2024, the strategic relationship between LLY and Boehringer Ingelheim (BI) has seen increased legal involvement and continued collaborative dependency, particularly concerning the Jardiance product. In 2022, BI initiated U.S. patent litigation against generic companies seeking to market generic versions of Jardiance, with LLY not being a party to this litigation. By 2024, the collaboration remained significant as Jardiance was selected by the U.S. Department of Health and Human Services under the Inflation Reduction Act for government-set pricing, effective in 2026, which will impose a 66% discount on its price. This highlights both the ongoing dependency on Jardiance as a key revenue driver and the shared exposure to regulatory and pricing pressures within the partnership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: in 2022, LLY was not a party to BI's Hatch-Waxman litigation against generics; by 2024, Jardiance was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount. The 66% discount and the IRA context are correctly stated. (2) Quantitative accuracy is perfect: the 66% discount and the 2024 reference (with pricing effective in 2026) are correctly reported. The original answer mentions the impact on 2023 list price, which the LLM omits slightly in phrasing but still correctly frames the discount relative to prior pricing. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes legal non-involvement in 2022 with increased strategic dependency by 2024 due to IRA pricing pressures, showing evolution in the partnership. (4) The only minor gap is that the LLM does not explicitly state that this reflects a shift toward 'deeper strategic entanglement' or 'dependency on BI for navigating regulatory pressures' as strongly as the original, but the implication is clearly conveyed through context. Wording differences are acceptable under semantic equivalence. All entities—LLY, Boehringer Ingelheim, Jardiance, Inflation Reduction Act, HHS, Hatch-Waxman—are correctly identified and used. The answer fully addresses both legal involvement and collaborative dependency as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 393,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "From 2022 to 2023, Disney's capital investment strategy for cruise ships remained a key component of its Parks & Experiences business, with a focus on long-term growth and expanding offerings. In 2022, the Company highlighted its 550-acre land development in Eleuthera, scheduled to open as a Disney Cruise Line destination in 2024, indicating ongoing investment in cruise-related infrastructure. By 2023, the strategy emphasized continued capital spending on cruise ships and related experiences, aligning with broader investments in theme parks, resorts, and guest offerings. This reflects Disney's commitment to enhancing its cruise segment as part of its diversified leisure and entertainment ecosystem.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but introduces a specific project (550-acre land development in Eleuthera opening in 2024) that is not mentioned in the original ground truth and cannot be verified from the provided knowledge graph. This detail is factually unsupported in the context of the question and may be hallucinated. While the general direction of increased focus on cruise ships is correct, the LLM fails to capture the key evolution highlighted in the ground truth: the shift from cruise ships being a passive part of the Experiences segment in 2022 (with no specific capital emphasis) to being explicitly named as a major capital investment in 2023. (2) The date '2024' for the Eleuthera destination is a specific claim not present in the original answer and cannot be confirmed; no other numeric values (e.g., acreage) are contradicted, but they are unverified and distract from the core factual evolution. (3) The multi-hop reasoning is partially sound—linking cruise ships to Parks & Experiences and noting continued investment—but misses the critical analytical point: the strategic elevation of cruise ships in capital allocation between 2022 and 2023. The original answer emphasizes a change in language and prioritization in the 10-K filings, which the LLM overlooks in favor of adding unverified project details. (4) The contextual relevance is high because the answer stays focused on Disney’s cruise and parks strategy, but correctness and qualitative accuracy are reduced due to unsupported specifics and failure to accurately reflect the shift in capital investment emphasis as documented in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 452,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "Between 2022 and 2024, Mastercard Foundry has expanded its role in fostering innovation by deepening its engagement with emerging technologies and fintech partnerships. In 2022, it focused on identifying and experimenting with future technologies and early-stage fintech players. By 2024, Mastercard Foundry had evolved to offer more advanced solutions, such as blockchain-based payment models, enhanced tokenization, and AI-driven fraud detection, while also integrating with third-party platforms and central banks to support cross-border remittances and disbursements. Additionally, it launched initiatives like the Alias-Based Remittances and Payouts platform, demonstrating a stronger commitment to leveraging innovation for scalable and secure payment solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Mastercard Foundry between 2022 and 2024 and maintains accurate timeframes (2022 vs 2024), satisfying quantitative accuracy. It correctly notes Foundry's initial focus on emerging technologies and fintech partnerships in 2022 and a more advanced role by 2024. However, it introduces specific technologies and initiatives not supported by the ground truth: 'AI-driven fraud detection', 'Alias-Based Remittances and Payouts platform', and 'integration with central banks' are not mentioned in the original answer and cannot be verified from the provided knowledge. While the ground truth confirms Foundry's 2024 focus on blockchain-based business models and the Mastercard Multi-Token Network™, the LLM overextends by adding unverified capabilities and initiatives. The core evolution—deepening engagement with emerging tech and fintech—is correctly captured, but the specific strategic shift toward the Multi-Token Network™ is omitted and replaced with plausible but unsupported details. This results in partial factual accuracy: the direction of evolution is right, but key specifics are either missing or inaccurately supplemented. The reasoning is logically structured and contextually relevant, but the qualitative accuracy suffers due to hallucinated elements, preventing a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 372,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "The collaboration with Boehringer Ingelheim, particularly regarding the diabetes drug Jardiance, has seen significant regulatory and pricing developments between 2022 and 2024. In 2022, Jardiance was submitted for new indications such as heart failure with preserved ejection fraction and chronic kidney disease, with the former receiving FDA Breakthrough Therapy and Fast Track designations. By 2024, the Inflation Reduction Act (IRA) had introduced pricing pressures, with the U.S. Department of Health and Human Services selecting Jardiance as one of the first drugs subject to government-set prices under Medicare, effective in 2026. This selection implies a 66% discount from the 2023 list price, marking a strategic shift from regulatory milestones to navigating significant pricing pressures under new legislative frameworks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key developments in the Boehringer Ingelheim collaboration from 2022 to 2024. In 2022, it accurately notes the Breakthrough Therapy and Fast Track designations for Jardiance's heart failure indication, aligning with the ground truth. By 2024, it correctly states that Jardiance was selected under the Inflation Reduction Act for government-set pricing effective in 2026, with a 66% discount from the 2023 list price—this matches the ground truth exactly in both percentage and timing. (2) All numeric values—66% discount, 2022 regulatory submissions, 2026 effective date—are factually correct and consistent with the original answer. No calculation errors are present. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 vs 2024), regulatory context (FDA designations), and financial impact (IRA pricing), correctly framing the evolution from regulatory support to pricing pressure. The only minor shortcoming is that the original answer emphasizes the shift in 'strategic nature' of the collaboration more explicitly, while the LLM focuses slightly more on Jardiance than the broader partnership—though this is reasonable given the example. (4) The answer is semantically equivalent, highly relevant, and conveys the same core message: a transition from regulatory facilitation to financial constraint. Thus, the correctness score is 9 due to slight underemphasis on the strategic collaboration aspect beyond Jardiance, but all factual and quantitative elements are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 431,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "The strategic positioning of the CH-53K King Stallion heavy lift helicopter within Lockheed Martin's Rotary and Mission Systems (RMS) segment evolved from 2023 to 2024 by securing international contracts and advancing production. In 2023, the Israeli Ministry of Defense signed a Letter of Offer and Acceptance (LOA) for 12 CH-53K helicopters, with the remaining awards completed by 2023. By 2024, the program was highlighted as a major program under RMS, emphasizing its role in heavy lift capabilities for U.S. and foreign governments, indicating its growing strategic importance in the segment's portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific events not present in the ground truth, such as the Israeli Ministry of Defense signing a Letter of Offer and Acceptance (LOA) for 12 CH-53K helicopters in 2023. This information is factually unsupported by the original answer and represents a significant fabrication. The ground truth does not mention any international contracts, specific orders, or production milestones. (2) There are no numeric values in the original answer to verify, but the LLM invents a specific contract (12 helicopters) and implies completion of awards by 2023, which is not corroborated. This results in a very low quantitative accuracy score due to the introduction of false specifics. (3) The multi-hop reasoning is flawed: instead of tracking the evolution of strategic positioning from 'near-to-mid-term growth element' in 2023 to 'integrated, technologically advanced portfolio' in 2024, the LLM shifts focus to production and contracts. It fails to capture the conceptual shift toward digital technologies, AI/ML, autonomy, and all-domain mission solutions emphasized in the original. The evolution described is operational (contracts, production) rather than strategic (positioning within RMS’s technological and portfolio transformation). (4) While the LLM correctly identifies the CH-53K as part of RMS and notes its continued importance, it misses the core qualitative shift in narrative—from standalone growth driver to component of a broader, interoperable, tech-integrated defense solution. The contextual relevance is moderate because it addresses the helicopter and the RMS segment, but the strategic evolution is misrepresented. Hence, correctness is low due to factual inaccuracies and failure to reflect the actual strategic repositioning described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 492,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "The change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicates a strategic shift toward streamlining and focusing on key diabetes therapies with broader therapeutic applications. In 2022, the portfolio included products like Trajenta, Jardiance, Glyxambi, Synjardy, and Basaglar, emphasizing a range of treatment options for type 2 diabetes. By 2024, the list had been simplified to Jardiance, Glyxambi, Synjardy, and Trijardy XR, omitting Basaglar and Trajenta. This suggests a focus on products with demonstrated cardiovascular and renal benefits (e.g., Jardiance and Glyxambi) and combination therapies, aligning with market trends toward integrated care and value-based outcomes. The shift reflects a strategic realignment to prioritize products with stronger differentiation and broader clinical utility in a competitive diabetes landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities and years are correct: the 2022 portfolio included Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar; by 2024, only Jardiance, Glyxambi, Synjardy, and Trijardy XR remained. The LLM correctly identifies the removal of Basaglar and Trajenta (though it omits mention of Jentadueto, a minor omission). (2) There are no numeric inaccuracies—dates (2022, 2024) and product names are correctly cited. Format and naming are consistent with acceptable variations. (3) The reasoning is sound: the LLM correctly infers a strategic refocusing, linking it to clinical differentiation (e.g., cardiovascular/renal benefits of Jardiance), combination therapies, and market trends. This aligns with the ground truth’s emphasis on lifecycle management, market demand, and commercial performance. (4) The answer is contextually excellent, directly addressing the question about shifting strategic priorities. The only minor shortcoming is not explicitly mentioning Jentadueto’s removal, which slightly reduces completeness in entity tracking, but the core reasoning and factual accuracy remain strong. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 367,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "Between 2023 and 2024, the JASSM program experienced notable production ramp-ups, contributing to increased net sales in both years. In 2023, JASSM was part of the $145 million increase in tactical and strike missile program sales within the Missiles and Fire Control (MFC) segment. In 2024, production ramp-ups on JASSM, along with MLRS and LRASM, drove a $1.2 billion increase in net sales for tactical and strike missile programs. However, MFC's operating profit declined sharply in 2024 due to a $1.4 billion loss on a classified program, which overshadowed the positive impact of JASSM's production growth. The JASSM program also contributed to higher backlog in 2024, as orders for JASSM increased.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The claim that JASSM contributed to a $145 million increase in 2023 is not supported by the ground truth, which states there was no specific mention of significant changes in production or backlog for JASSM in 2023. This number appears fabricated. The $1.2 billion increase in 2024 for tactical and strike missile programs is correct and aligns with the ground truth, but the inclusion of MLRS and LRASM (instead of GMLRS as stated in the original) introduces entity inaccuracies. (2) The $1.4 billion loss on a classified program in MFC in 2024 is factually correct but irrelevant to the question about JASSM’s performance and strategic importance—this distracts from the core focus. (3) The multi-hop reasoning is partially sound in linking JASSM to increased backlog and production ramp-up in 2024, which matches the ground truth. However, the incorrect attribution of 2023 sales growth and wrong program names (MLRS/LRASM vs GMLRS) undermines the synthesis. (4) While the answer correctly identifies JASSM’s growing strategic importance in 2024 and its role in backlog growth, the inclusion of false quantitative data and incorrect contributing programs significantly reduces factual accuracy. The contextual relevance is high because it addresses production activity and backlog, but correctness is low due to unsupported numbers and misattributed programs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 407,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "Between 2023 and 2024, JPM's focus in evaluating credit risk for Business Banking Loans has shifted toward incorporating more granular geographic and borrower-specific data, particularly in assessing delinquency trends and early signs of borrower distress. In 2023, delinquency rates were the primary metric, with a focus on 30+ days past due as an early warning signal. By 2024, the evaluation expanded to include refreshed FICO scores and LTV ratios as secondary indicators, allowing for a more nuanced understanding of borrower risk profiles. This shift enhances the ability to identify early signs of distress by linking regional economic factors and borrower creditworthiness to delinquency trends, enabling more proactive risk management.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. It incorrectly states that in 2023, delinquency rates were the primary metric, when the original answer specifies that in 2023, JPM focused on loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment — not delinquency rates. The shift to delinquency rates as the primary indicator occurred in 2024, not the other way around. Additionally, the LLM introduces specific new metrics — 'refreshed FICO scores' and 'LTV ratios' — as secondary indicators in 2024, which are not mentioned in the original answer and lack support from the ground truth. These additions represent fabricated details. (2) There are no explicit numbers (percentages, dollar amounts) in either answer, so quantitative accuracy is not heavily penalized, but the misrepresentation of timing (2023 vs. 2024) for key metrics affects temporal accuracy, which is critical in trend analysis. The reversal of the timeline undermines factual correctness. (3) The multi-hop reasoning is flawed: the model reverses the chronological development of JPM's risk evaluation focus and invents new data dimensions (FICO, LTV, geographic data) not present in the source. The original answer emphasizes a shift from broader scoring models in 2023 to delinquency rates (>30 days past due) as early warnings in 2024, aligning Business Banking with consumer loan frameworks. The LLM misattributes the evolution and adds unsupported granularity. (4) Despite the factual errors, the answer remains contextually relevant — it addresses the question about evolution in credit risk focus and implications for early distress detection. It correctly identifies delinquency as an early signal and frames the shift as enabling proactive management, which aligns semantically with the original’s conclusion. However, due to major inaccuracies in entity focus, timeline, and invented metrics, the correctness score is low. Minor credit for recognizing the directional move toward proactive monitoring.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 560,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Based on the provided document pages, there is no explicit detail on the specific terms of Target Corporation's SPP II plan in either the 2022 or 2023 filings. However, the filings indicate that the SPP II (2016 Plan Statement) was \"amended and restated effective April 3, 2016\" in both years, with no further amendments noted in the 2023 filing. This suggests that the terms of the SPP II plan remained unchanged between 2022 and 2023, reflecting a stable executive compensation framework during this period. The lack of updates implies a consistent approach to long-term incentive compensation for executives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its factual claims, directly contradicting the ground truth. (1) The original answer states that in the 2022 filing, the SPP II plan was under the 2016 Plan Statement, but in the 2023 filing, it was updated to the 2022 Plan Statement effective May 1, 2022. The LLM incorrectly claims that the plan remained the '2016 Plan Statement' in both years with no changes, which is factually wrong. (2) The key dates—April 3, 2016, and May 1, 2022—are misapplied: the LLM treats the 2016 date as the only effective date and ignores the 2022 restatement entirely, failing quantitative accuracy on event timing and plan versioning. (3) The multi-hop reasoning is flawed: the question requires comparing two filings across years to detect changes; the LLM failed to identify the plan update, leading to an incorrect conclusion about stability. (4) While the LLM addresses the question's intent—evaluating evolution and implications—the conclusion about a 'stable framework' is based on false premises, reducing qualitative and overall correctness. The answer is contextually relevant but factually inaccurate, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 329,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "From 2022 to 2024, the financial obligations related to Incyte under the Olumiant collaboration remained structured around tiered royalty payments on worldwide net sales, with rates up to 20%, and an additional low-teens royalty on net sales for the treatment of COVID-19 exceeding a specified threshold. As of December 31, 2022, Incyte was eligible to receive up to $100.0 million in regulatory milestones and $100.0 million in sales-based milestones. By 2024, no new material milestone payments to Incyte were recognized, and the terms of the agreement remained unchanged, with future payments contingent on regulatory and commercial success.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the $100.0 million in regulatory milestones and $100.0 million in sales-based milestones as of 2022, matching the ground truth. It also accurately describes the royalty structure (up to 20% and low teens for COVID-19 sales above a threshold), which is consistent across years. However, the LLM claims that 'the terms of the agreement remained unchanged' by 2024, which contradicts the ground truth indicating a shift in structure—specifically, the absence of mention of regulatory milestones in 2024 suggests they were no longer applicable or had been resolved. The ground truth interprets this as an evolution in the obligation structure, while the LLM implies continuity, missing the nuance of a shift from dual milestone types to sales-based compensation only. (2) All numeric values—$100.0 million (regulatory), $100.0 million (sales), royalty up to 20%, low teens royalty—are factually correct and properly attributed to the right years and contexts. No calculation errors. (3) The multi-hop reasoning is partially sound: the model connects 2022 milestone eligibility with 2024 conditions, but fails to infer the implied evolution in the agreement structure based on the absence of regulatory milestones in later disclosures. This weakens the qualitative accuracy, as the synthesis misses a key interpretive point. (4) Scores reflect high quantitative accuracy and relevance, with a moderate deduction in correctness and qualitative reasoning due to the failure to capture the shift in financial obligation structure over time, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 442,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "Cisco's financial exposure in the APJC region increased between fiscal 2022 and fiscal 2023. Revenue for APJC rose from $8,027 million in fiscal 2022 to $8,208 million in fiscal 2023, as reported in the segment information. Additionally, goodwill attributed to the APJC segment increased from $5,382 million in fiscal 2022 to $8,208 million in fiscal 2023, primarily due to acquisitions like Splunk, which contributed $2,702 million to the APJC goodwill in fiscal 2023. These figures indicate a notable expansion in both revenue and asset exposure in the APJC region.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that specific financial figures for APJC in fiscal 2022 were not disclosed, but the LLM claims precise revenue and goodwill numbers for both years, which contradicts the original answer. The reported APJC revenue of $8,027M in 2022 and $8,208M in 2023, and goodwill increasing from $5,382M to $8,208M, are not supported by the provided data. In fact, the only disclosed figure in the ground truth is APJC asset balance of $5,382 million as of July 29, 2023 — not goodwill or revenue. (2) The quantitative inaccuracies are severe: the LLM fabricates revenue and goodwill figures and incorrectly attributes $2,702M from Splunk to APJC goodwill, which is not stated or implied in the ground truth. There is no mention of Splunk or its regional allocation in the original answer. (3) The multi-hop reasoning is flawed. The original answer emphasizes a lack of segment-level asset disclosure in 2022 and improved disclosure in 2023, but the LLM assumes detailed data was available in both years and draws incorrect comparisons. It fails to recognize the key point about evolving disclosure practices rather than actual financial trends. (4) While the LLM attempts to address Cisco's financial exposure in APJC over time, it invents data rather than acknowledging disclosure limitations, leading to a low correctness score. Contextual relevance is moderate because it addresses the right region and time frame, but factual integrity is poor.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 421,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "The strategic collaboration between LLY and Boehringer Ingelheim regarding Jardiance evolved notably in response to regulatory changes, particularly under the U.S. Inflation Reduction Act of 2022 (IRA). In 2022, Jardiance was selected by the U.S. Department of Health and Human Services (HHS) as one of the first ten medicines subject to government-set prices under the IRA, with the price-setting effective in 2026. By 2024, HHS announced a 66% discount for Jardiance compared to its 2023 U.S. list price for a 30-day supply. This regulatory development has prompted the companies to adjust their strategies, as the IRA's price-setting mechanism accelerates revenue erosion for Jardiance prior to the expiration of its exclusivity, influencing business planning and investment decisions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several key correct elements, including the 66% discount applied to Jardiance in 2024 compared to the 2023 U.S. list price and the fact that Jardiance was selected as one of the first ten drugs under the Inflation Reduction Act (IRA) for government price setting. However, there is a critical error in timing: the original answer states that Jardiance was selected in August 2023, with the discount applied in August 2024, whereas the LLM claims it was selected in 2022 with price-setting effective in 2026—this is factually incorrect and contradicts the ground truth. The 2026 date does not appear in the original answer and appears to be fabricated. (2) The 66% discount figure is correctly reported, but the associated timeline is wrong. The revenue growth figures from 2022 (30% in U.S., 28% outside U.S.) are completely omitted in the LLM answer, representing a significant gap in completeness. (3) The multi-hop reasoning is partially sound—the model correctly links the IRA to Jardiance’s pricing and recognizes the strategic impact on LLY and Boehringer Ingelheim’s collaboration. However, it fails to accurately sequence the regulatory timeline and omits the initial positive performance context from 2022, weakening the evolution narrative. (4) The contextual relevance is high because the answer addresses the core regulatory and strategic dimensions of the question. Qualitative accuracy is moderate due to correct entity identification and logical interpretation of strategic impact, but quantitative accuracy is low due to incorrect dates and missing numerical data. Correctness score reflects partial accuracy with major factual errors in timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 463,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "Between 2022 and 2023, GM's emphasis on the financial and reputational risks of product safety recalls, particularly concerning global platforms like the Chevrolet Bolt EV, showed a heightened awareness of the broader implications for the company's positioning in EV/AV technologies. In 2022, the risks were primarily outlined in terms of potential costs, brand damage, and operational disruptions due to recalls. By 2023, the discussion expanded to include the impact of recalls on GM's leadership in emerging technologies like EVs and AVs, emphasizing the importance of maintaining consumer trust and confidence in these innovations. This evolution reflects GM's strategic focus on aligning product safety with its broader goals in the EV/AV space.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GM's 2022 focus on financial costs and operational challenges of the Chevrolet Bolt EV recall, and the 2023 shift toward emphasizing reputational risks tied to EV/AV leadership, are accurately represented. While the original answer specifies 'brand image and equity' and 'logistical complexity,' the LLM captures these through equivalent terms like 'brand damage' and 'operational disruptions,' and correctly identifies the strategic evolution. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 vs 2023), connects the Bolt EV recall to global platforms, and links safety risks to broader strategic positioning in EV/AV technologies. The only minor gap is that the LLM does not explicitly mention the 'global platform-related recalls' as a structural reason for increased costs in 2022, though it implies it. (4) The answer is fully contextually relevant, directly addressing the evolution in GM's risk emphasis and its implications for innovation and market positioning. The slight deduction in qualitative accuracy (9 instead of 10) reflects the slightly less precise articulation of the 2022 cost-centric rationale compared to the original, but overall the semantic meaning and strategic insight are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 421,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "Between 2022 and 2024, Costco's Japanese subsidiary issued Guaranteed Senior Notes totaling approximately $500 in November 2023, with fixed interest rates ranging from 1.400% to 2.120% and maturities extending to 2043. In July 2024, the subsidiary repaid $77 of these notes. This activity indicates that Costco is utilizing long-term financing through its Japanese subsidiary to manage debt maturity profiles and potentially secure favorable interest rates, reflecting a strategy to maintain financial flexibility and optimize capital structure over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $500 issuance in November 2023, the interest rate range (1.400% to 2.120%), maturities extending to 2043, and the $77 repayment in July 2024—all matching the ground truth. The only minor omission is that the original answer specifies four separate notes were issued, which the LLM does not mention, but this does not affect the quantitative or strategic understanding. (2) All numbers, dates, and dollar amounts are accurate: $500 total issuance, $77 repayment, correct interest rates, and correct timing (November 2023 issuance, July 2024 repayment). Format variations are acceptable and consistent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across 2022 (implied baseline of less disclosure) and 2024 (detailed disclosure), inferring a strategic shift toward transparency and long-term fixed-rate financing. It correctly links extended maturities and fixed rates to financial flexibility and capital structure optimization, aligning with the ground truth's conclusion about managing future liquidity. (4) The answer is contextually fully relevant, addressing both the evolution of the notes and the implication for Costco’s long-term financing strategy. The qualitative accuracy is slightly reduced only because the LLM does not explicitly contrast the 2022 lack of detail with the 2024 transparency, though it implies a strategic evolution. Overall, the answer is factually complete, numerically precise, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 419,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "The value of Cisco's available-for-sale debt investments decreased from $15,206 million in 2022 to $9,865 million in 2023, indicating a reduction of $5,727 million. This decline suggests that Cisco may have liquidated a portion of its investment portfolio, likely to fund strategic initiatives such as the acquisition of Splunk and to return cash to shareholders through dividends and stock repurchases.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 value ($9,865 million) and the total decrease ($5,727 million), but reports the 2022 value as $15,206 million, which is incorrect. The ground truth states the 2022 value was $15,592 million. This discrepancy affects quantitative accuracy despite the correct difference being cited. It appears the LLM may have pulled an incorrect base value, though the $5,727 million drop is accurate only if calculated from $15,592M to $9,865M. The gain of $9 million in 2022 from AFS investments mentioned in the original is omitted, reducing completeness. (2) The calculation of the decrease is numerically correct in the LLM answer ($15,206M to $9,865M is indeed a $5,341M drop, not $5,727M), but the LLM states a $5,727M reduction while using incorrect inputs—this suggests the model may have inserted the correct difference from training data without aligning it with its own inputs, creating internal inconsistency. The correct drop from $15,592M to $9,865M is $5,727M. (3) The reasoning about Cisco's investment strategy—liquidating holdings to fund Splunk acquisition and shareholder returns—is plausible and adds context not in the original, but this is an inference not present in the ground truth. While reasonable, it introduces speculative elements. The core multi-hop synthesis (tracking change in AFS investments across years and interpreting strategic shift) is sound. (4) The correctness score is 7 because key financial data is partially inaccurate (wrong 2022 value), but the direction, magnitude of change, and strategic interpretation are aligned. Quantitative accuracy is penalized due to incorrect base value and mismatched calculation. Qualitative and contextual scores are higher due to logical interpretation and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 487,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "JPMorgan Chase's exposure to system damage risks, particularly from third-party vendor attacks and data recovery challenges, has evolved with increasing complexity and frequency in 2024 compared to 2023. The 2024 filing highlights a heightened risk due to the expanding interconnectivity with third-party systems, the growing sophistication of cyber threats, and the integration of new technologies like cloud computing and artificial intelligence. Additionally, the document emphasizes the challenges in detecting and mitigating vulnerabilities in third-party open-source software and the potential for disruptions to cascade across interconnected financial systems. Data recovery challenges are underscored by the increased risk of ransomware and malware attacks, which can lead to extended delays in restoring stolen, manipulated, or destroyed data.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of JPMorgan Chase's system damage risks from 2023 to 2024 with a focus on third-party vendor attacks and data recovery challenges. It accurately reflects increased complexity and sophistication in cyber threats, particularly in relation to third-party systems and new technologies. However, it omits specific details from the ground truth, such as the shift from general unauthorized access and DDoS risks in 2023 to more specific ransomware targeting third-party vendors in 2024, and the concern about losses exceeding cyber insurance coverage. The mention of 'inability to prevent systems from processing fraudulent transactions'—a key 2024 development—is missing. (2) There are no numeric values, dates, or calculations in either the original or LLM answer, so quantitative accuracy is not compromised; thus, a score of 10 is justified. (3) The multi-hop reasoning is partially sound: the LLM synthesizes the idea of evolving risk from third-party vendors and data recovery issues, but fails to fully capture the precise shift in risk emphasis between years as detailed in the ground truth. It generalizes trends without anchoring them to the specific new disclosures in 2024. (4) The answer is contextually relevant and well-articulated, addressing the core theme of evolving cyber risk. However, the lack of specificity on ransomware targeting vendors and insurance coverage gaps reduces qualitative and overall correctness, warranting a 7 for both correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 428,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "By 2024, Costco had made operational investments in processing, packaging, and manufacturing facilities to support the production of private-label items, as mentioned in the 2022 filing and reflected in the 2024 report. These investments align with Costco's strategy to grow its private-label offerings, enhancing its product range and value proposition for members.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies the operational investments Costco made by 2024—processing, packaging, and manufacturing facilities—to support its private-label growth strategy first mentioned in the 2022 filing. All entities (Costco, private-label items, 2022 and 2024 timeframes) are correct, and there are no numerical inaccuracies (no specific numbers involved, but time periods are correctly referenced). The reasoning is sound: it connects the strategic intent from 2022 to the operational execution by 2024, demonstrating appropriate multi-hop synthesis across filings. The only minor shortcoming is that the LLM omits the explicit rationale from the original answer about shifting from external sourcing to internal production capabilities as a strategic evolution. While the implication is present, this nuance strengthens the qualitative depth of the ground truth. However, the core facts, timeline, and strategic alignment are preserved, and the answer remains semantically equivalent in substance. Wording differences are acceptable and do not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 323,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group's approach to Medicaid managed care contract bidding became more cautious and risk-conscious. In 2022, the company highlighted that bids were based on assumptions regarding enrollment, utilization, and medical costs, and noted that incorrect assumptions could adversely affect results. By 2023, the company emphasized the risks of chronic failure to meet benchmarks, which could lead to termination of government contracts. Additionally, the 2023 filing underscored the increasing complexity and uncertainty in the bidding process due to evolving program requirements and competitive pressures, reflecting a more strategic and risk-mitigated approach to ensure bid accuracy and contract sustainability.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in representing UnitedHealth Group's evolving approach to Medicaid managed care contract bidding. While the ground truth states that in 2022 the company emphasized the risk of losing Medicaid members due to failure to renew contracts, the LLM incorrectly claims that in 2022 the company already highlighted risks around assumptions in enrollment, utilization, and medical costs—this focus is actually attributed to 2023 in the original answer. The LLM reverses the timeline by attributing assumption-based risk to 2022 and contract termination due to performance benchmarks to 2023, which is not supported by the ground truth. The original answer emphasizes a shift from renewal risk (2022) to bid assumption accuracy (2023), but the LLM misrepresents this evolution. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the temporal shift in risk focus across the two years. It introduces 'chronic failure to meet benchmarks' and 'termination of government contracts' in 2023, which are not mentioned in the ground truth. Instead of emphasizing the assumptions behind bids as the key 2023 development, the LLM conflates other risks. (4) Despite the misrepresentation of the core evolution, the answer remains contextually relevant by discussing Medicaid bidding, risk, and contract sustainability. It captures a general trend toward increased caution, which aligns thematically with the original, but the specific factual inaccuracies in entity-year alignment and risk focus reduce its correctness. Hence, correctness and qualitative accuracy are moderate, quantitative accuracy is high (no numbers wrong), and relevance is strong due to topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 512,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "Based on the information provided in the document pages, MET's investment in Municipals remained classified entirely within Level 2 of the fair value hierarchy for both 2022 and 2023. In 2022, the estimated fair value of Municipals was $14,212 million, and in 2023, it was $14,212 million as well, with no change in its classification. This indicates that the valuation methodology and inputs used for these investments did not shift between levels during the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both quantitative and qualitative aspects. According to the ground truth, MET's investment in Municipals decreased from $14,212 million in 2022 to $159 million in 2023, but the LLM claims the value remained unchanged at $14,212 million in both years. This is a critical error in numerical accuracy. Additionally, the ground truth states that in 2022, the investment was categorized under 'Estimated Fair Value' without a detailed hierarchy breakdown, while in 2023 it was explicitly classified as 'Level 2'. However, the LLM incorrectly asserts that the investment was classified entirely in Level 2 for both years, contradicting the original answer. (2) The dollar amounts are wrong for 2023: $159 million (correct) vs. $14,212 million (claimed), a massive discrepancy. There is no indication of a decrease, let alone a near-total divestment. (3) The multi-hop reasoning failed completely: the model did not detect the change in valuation hierarchy transparency (from no detailed breakdown to Level 2) or the dramatic reduction in investment size. Instead, it falsely asserts stability in both value and classification. (4) The contextual relevance is low but not zero because the answer discusses the right topic (Municipals investment, fair value hierarchy), but with entirely incorrect data and conclusions. Hence, correctness, quantitative, and qualitative accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 400,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "From fiscal year 2022 to 2024, Microsoft enhanced the licensing flexibility and customer agreement models for Office 365 by introducing more streamlined and adaptable options. In 2022, Office 365 subscriptions were recognized as a single performance obligation due to the integration of desktop applications and cloud services, with revenue recognized ratably over the contract period. By 2024, Microsoft expanded its licensing models to include simplified digital agreements such as the Microsoft Customer Agreement, which is non-expiring and supports customers purchasing directly or through partners. Additionally, the Microsoft Products and Services Agreement allowed medium and large organizations to license cloud and on-premises software as needed, with optional Software Assurance for perpetual licenses, offering greater flexibility in how customers access and manage their subscriptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution from fiscal year 2022 to 2024 in Microsoft's Office 365 subscription models. In 2022, it accurately notes revenue recognition as a single performance obligation with ratable recognition over the contract period, consistent with unearned revenue treatment in volume licensing. By 2024, it correctly highlights the introduction of more flexible agreements: Microsoft Customer Agreement (MCA), Microsoft Products and Services Agreement (MPSA), and references to direct or partner-based purchasing, which matches the original answer’s emphasis on enhanced licensing flexibility and customer-centric models. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (fiscal years 2022 and 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes over time in licensing structure and agreement types, correctly identifying the shift from traditional volume licensing to modern, flexible digital agreements. It adds contextual detail not in the original—such as Software Assurance and perpetual licenses—which is factually accurate and enriches the response without introducing error. (4) The only minor gap is that the LLM omits explicit mention of 'monthly or annual subscriptions with no organization-wide commitment'—a key element of the 2024 model in the ground truth. However, the mention of 'simplified digital agreements' and flexible purchasing implies this flexibility. Overall, the answer is semantically equivalent with high factual and qualitative accuracy, fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 466,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "Between 2022 and 2023, the composition of MET's Level 3 Fixed Maturity Securities AFS decreased from 58 million to 64 million, indicating a slight reduction in investments in assets with low price transparency, such as private equity and real estate funds. This suggests a potential shift toward more liquid or observable assets, aligning with a more conservative or risk-mitigated investment strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both quantitative and qualitative aspects. According to the ground truth, in 2022, MET's Level 3 Fixed Maturity Securities AFS consisted of $1M Corporate bonds, $1M Foreign Bonds, and $11M Equity Securities (totaling $13M), not $58M as claimed. In 2023, it was $54M Corporate bonds, $2M Foreign Bonds, and $828M Other Investments (totaling $884M), not $64M. The LLM incorrectly states a decrease from 58M to 64M, which is both numerically wrong and misrepresents the direction of change (it actually increased massively). (2) The calculation of totals is incorrect: 1+1+11 = 13M (not 58M); 54+2+828 = 884M (not 64M). The LLM also introduces 'private equity and real estate funds' which are not mentioned in the original answer. (3) The multi-hop reasoning is fundamentally flawed: instead of identifying a strategic shift toward 'Other Investments', the LLM concludes a move toward more liquid assets and a conservative strategy, which contradicts the ground truth indicating a more aggressive diversification. (4) The contextual relevance is low because the answer discusses a different trend (reduction in Level 3 assets) and misidentifies the components and strategy. Only minimal relevance is retained as it attempts to interpret investment strategy from Level 3 changes, albeit based on false data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 380,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "Between 2022 and 2024, Microsoft has strategically evolved Office 365 to be more deeply integrated with AI-driven capabilities and positioned it as a central component of its broader cloud services portfolio. In 2022, Office 365 was primarily highlighted as a subscription-based cloud service, with revenue recognized ratably over the contract period due to its integration with desktop applications and cloud services. By 2024, Microsoft emphasized the infusion of generative AI into Office 365 to enhance productivity and user experience, reflecting a response to competitive pressures in the AI-driven market. This evolution underscores Office 365's role as a key differentiator in Microsoft's cloud offerings, aligning with the company's broader focus on AI and cloud infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the evolution of Office 365 from a standalone cloud service in 2022 to an AI-integrated component by 2024 is accurately described. The strategic context—Microsoft's response to competitive pressures from AI-driven offerings such as ad-supported or open-source models—is implied through the mention of 'competitive pressures in the AI-driven market,' though the specific examples (e.g., free apps funded by ads, open-source models) are omitted. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the years 2022 and 2024 are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across time (2022 vs 2024 positioning), product integration (Office 365 within cloud portfolio), and strategic motivation (AI competition). It correctly identifies the shift toward generative AI infusion as a strategic differentiator. (4) Semantic equivalence is strong—while the LLM does not explicitly name Dynamics 365, Azure, or Xbox as co-components in the 2022 portfolio, it captures the essence of Office 365 being a core cloud offering and later an AI-enhanced one. The only minor omission is the lack of detail about revenue recognition mechanics mentioned in the LLM answer (e.g., ratable revenue), which is not in the ground truth and slightly overreaches, but does not detract from overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 457,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group's recognition and handling of credit-related impairments remained largely consistent in terms of methodology, as the Company continued to evaluate available-for-sale debt securities for credit-related impairments by assessing expected cash flows, issuer credit quality, and its intent to hold the securities. In both years, the Company noted that unrealized losses were primarily driven by interest rate changes rather than credit deterioration, and no significant credit-related impairments were recorded. However, in 2023, the allowance for credit losses on held-to-maturity securities was not material, similar to 2022, but the overall fair value of debt securities increased, reflecting a larger investment portfolio. The financial impact of impairments remained immaterial in both periods.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses key qualitative shifts in UnitedHealth Group's impairment methodology between 2022 and 2023. While it correctly notes that unrealized losses were attributed to interest rate changes and not credit deterioration in both years, and that impairments were immaterial, it fails to capture the significant evolution in accounting treatment and evaluation framework described in the ground truth. Specifically, the LLM does not mention the formal distinction in 2023 between credit-related and non-credit-related impairments, nor the change in financial reporting—credit-related impairments being recorded as an allowance against investment income and non-credit-related through other comprehensive income. This is a major omission in reasoning and methodology evolution. (2) There are no explicit numerical values in either answer, so quantitative accuracy is not heavily applicable; however, the LLM correctly states that the allowance for credit losses was not material in both years, which aligns with the ground truth. The mention of an increase in fair value due to a larger portfolio is not contradicted by the original answer but is not part of the ground truth either—this is extraneous but not incorrect. (3) The multi-hop reasoning is weak: the question asks for evolution in methodology and financial impact, requiring comparison across years and synthesis of changes in accounting policy and evaluation criteria. The LLM incorrectly asserts that the methodology remained 'largely consistent,' when in fact the ground truth describes a more structured and segmented approach introduced in 2023, including use of present value of expected cash flows, extent of fair value decline, and issuer-specific conditions. These enhancements are entirely missing in the LLM response. (4) The contextual relevance is moderate—the response stays on topic and discusses impairments, methodology, and financial impact, but fails to report the actual evolution, leading to a low correctness and qualitative accuracy score despite acceptable wording and structure.)",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 570,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "The allocation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans slightly decreased from 2022 to 2023. In 2022, the actual allocation for U.S. pension benefits was 83%, while in 2023, it was 82%. For U.S. other postretirement benefits, the allocation remained high, decreasing slightly from 96% in 2022 to 94% in 2023. The valuation of these securities, as reflected in the fair value hierarchy, also showed changes, with the total estimated fair value of fixed maturity securities AFS for U.S. pension benefits decreasing from $6,802 million in 2022 to $6,714 million in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numeric values. According to the ground truth, in 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits, but the LLM incorrectly states 83% and 96%, respectively. Similarly, for 2023, the LLM reports allocations of 82% and 94%, but the original answer does not provide percentage allocations for 2023—only fair value amounts ($6,714M and $1,274M). The LLM invents percentage figures for 2023 that are not in the ground truth. While the LLM correctly reports the $6,714 million fair value for pension benefits in 2023, it fabricates a 2022 fair value of $6,802 million, which is not present in the original answer. (2) The quantitative inaccuracies are severe: the original answer does not provide 2022 fair values or 2023 percentages, so the LLM’s inclusion of these numbers misrepresents the data. There are no calculations in the original that support the $6,802M figure or the slight decrease narrative. (3) The multi-hop reasoning is flawed—the original answer highlights a shift in reporting format from percentage-based allocation in 2022 to absolute valuation in 2023, but the LLM incorrectly assumes comparable percentage data exists for both years and fabricates a trend. This undermines the core insight about evolving disclosure practices. (4) Despite these issues, the LLM stays contextually relevant by addressing the evolution of allocation and valuation and focusing on the correct entities (MET, Fixed Maturity Securities AFS, pension and other postretirement benefits). However, the high number of invented statistics severely compromises correctness and quantitative accuracy, warranting a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 482,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "Between 2022 and 2023, Lowe's strategic positioning of the Kitchens & Bath product category remained a key part of its Total Home strategy, with continued emphasis on providing comprehensive solutions for customers. In 2023, the company expanded its product offerings, such as the return of Klein Tools, which enhanced its hardware and electrical product lines, indirectly supporting the Kitchens & Bath category by improving overall product breadth and customer satisfaction. The Kitchens & Bath category is included in the Home Décor segment, which consistently accounted for around 35% of total sales in recent years, highlighting its significant role in Lowe's product portfolio. This suggests that Kitchens & Bath remains an important contributor to Lowe's revenue and strategic focus.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Lowe's strategic positioning of the Kitchens & Bath category. Contrary to the ground truth, the LLM claims that Kitchens & Bath remained in the Home Décor segment in 2023, when in fact it was repositioned into a construction and renovation-focused grouping. This misrepresents the core evolution in strategic positioning. Additionally, the claim that Home Décor 'consistently accounted for around 35% of total sales' is not supported by the ground truth and introduces unverified quantitative data. The mention of Klein Tools' return is contextually irrelevant to Kitchens & Bath positioning and not mentioned in the original answer. (2) The 35% sales figure is unverified and not present in the ground truth; no other numeric values (dates, dollar amounts) are provided or checked for accuracy, but the introduction of unsupported percentages reduces quantitative accuracy. (3) The multi-hop reasoning is flawed: the question requires synthesis of organizational categorization changes across two years to infer strategic importance. The LLM fails this by asserting continuity rather than change, missing the reclassification from design-focused (2022) to construction/remodeling (2023), which is central to the correct interpretation. (4) Correctness is low due to major factual and conceptual errors. Quantitative accuracy is partially maintained only because no explicit calculation is wrong—just unsupported. Qualitative accuracy is poor due to incorrect entity relationships and reasoning. Contextual relevance is moderate as the answer discusses related topics like Total Home strategy and product importance, but misses the key shift in categorization and its implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 479,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "Mondelez International has shifted its strategic focus on Cheese & Grocery from a growth category in 2022 to a divested or reduced emphasis by 2024. In 2022, Cheese & Grocery was listed as one of the company’s adjacent, locally relevant categories, indicating it was part of its diversified portfolio. However, by 2024, Cheese & Grocery is no longer explicitly mentioned in the company’s strategic priorities or category focus, suggesting a reallocation of resources toward core snack categories like chocolate, biscuits, and baked snacks. This evolution reflects Mondelez’s prioritization of high-growth, globally scalable snack categories for long-term value creation.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift in Mondelez's focus on Cheese & Grocery from 2022 to 2024, noting a move away from direct emphasis and reallocation toward core snack categories. However, it omits the key quantitative detail from the ground truth: in 2022, Cheese & Grocery generated $1,990 million in net revenues. This missing figure significantly impacts quantitative accuracy. Additionally, the LLM states Cheese & Grocery was an 'adjacent, locally relevant category' in 2022, which aligns with the ground truth, but fails to mention that Mondelez directly produced these products—instead implying only strategic positioning. By 2024, the LLM correctly observes the category is no longer highlighted, but does not explicitly note the shift to a 'strategic stake' or 'lighter footprint' as stated in the original answer. (2) No numerical values are present in the LLM answer, despite the ground truth including a specific revenue figure ($1,990 million), resulting in partial credit for quantitative accuracy. (3) The multi-hop reasoning is generally sound—the model synthesizes changes in strategic focus across years and infers prioritization of core snacks. However, it misses the nuance that Mondelez transitioned from direct production to a strategic stake, which is a critical distinction in understanding the nature of the shift. (4) Despite missing key data points, the LLM captures the overall strategic trajectory and correctly interprets Mondelez’s prioritization of scalable core snack categories. Wording differs but meaning is semantically close, warranting high qualitative and contextual scores. The absence of financial data and slight oversimplification of the 2022 status prevent a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 480,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "In the 2022 10-K filing, Jevity is listed as a primary enteral feeding product alongside Freego™ (Enteral Pump) and Freego™ sets, with no specific differentiation in positioning between the two. However, in the 2023 10-K filing, Freego™ is not explicitly mentioned in the Nutritional Products segment, while Jevity remains highlighted as a key product in enteral feeding. This suggests a shift in focus or repositioning, with Jevity being emphasized more prominently in 2023, potentially at the expense of the Freego™ product line.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its factual claims. According to the ground truth, Freego™ products were explicitly mentioned in both the 2022 and 2023 10-K filings. The LLM incorrectly states that Freego™ was 'not explicitly mentioned' in the 2023 filing, which contradicts the original answer. Additionally, the LLM claims there was 'no specific differentiation in positioning' in 2022, but the ground truth shows a clear order with Jevity first and Freego™ products listed last among enteral products. (2) There are no numeric values in this question, so quantitative accuracy pertains to correct identification of product order and presence across years. The LLM fails this: it omits the correct sequence in 2022 (Jevity first, Freego™ near the end) and falsely claims Freego™ was absent in 2023 when in fact it was moved up in prominence. (3) The multi-hop reasoning is flawed. The question requires comparing the relative positioning of Jevity and Freego™ products across two years. The LLM fails to recognize that Freego™ was repositioned earlier in the list in 2023, right after Jevity, which indicates increased emphasis. Instead, it incorrectly infers a de-emphasis of Freego™, the opposite of the truth. (4) Contextual relevance is moderate because the answer addresses the general topic of product positioning changes between years, but the factual inaccuracies and incorrect conclusion severely undermine its usefulness. The core claim—that Freego™ was dropped or deemphasized—is factually wrong. Thus, the correctness score is low at 2 due to major factual and interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 443,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "From 2022 to 2023, MET's investment in municipals showed an increase in fair value, rising from $14,212 million in 2022 to $14,656 million in 2023. The classification remained as fixed maturity securities available-for-sale (AFS). The increase in fair value suggests that MET's credit risk management strategy is effective in maintaining a stable and low-risk portfolio, as municipals typically have lower credit risk compared to other sectors. This strategy helps in preserving capital and ensuring steady returns.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. It claims MET's investment in municipals increased from $14,212 million in 2022 to $14,656 million in 2023, which directly contradicts the ground truth showing a dramatic decrease to just $159 million in 2023. This fundamental error invalidates the entire response. Additionally, the LLM states the classification remained the same, but the ground truth indicates a reclassification to Level 2 of the fair value hierarchy in 2023, which the LLM omits. (2) Quantitative accuracy is extremely low: the 2023 value is off by over $14.5 billion. The LLM fabricates a fair value increase when in reality there was a 99% reduction. The unrealized gains and losses from 2022 are completely ignored. (3) The reasoning is flawed: the LLM concludes that the increase reflects effective credit risk management, but the actual data shows a sharp divestment, suggesting a strategic withdrawal from the asset class to reduce risk—exactly the opposite interpretation. The model fails to perform the necessary multi-hop synthesis: comparing fair values across years, noting classification changes, and inferring strategic intent from divestment. (4) Contextual relevance is low because the answer addresses the right topic (municipals, AFS classification, credit risk) but with incorrect data and opposite conclusions. While the general structure responds to the question's components, the factual foundation is so flawed that the answer is misleading. Scores reflect near-total factual inaccuracy despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 430,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "Between 2022 and 2023, Abbott's use of interest rate hedge contracts decreased in notional value, from approximately $2.9 billion in 2022 to $2.2 billion in 2023. This reduction was primarily due to the maturity of $700 million of interest rate hedge contracts in 2023, which coincided with the maturity of related long-term debt. These contracts are used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations to variable rates. The decrease reflects adjustments in Abbott's fixed-rate debt management strategy as certain hedged debt instruments reached maturity.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Abbott's notional value of interest rate hedge contracts was approximately $2.2 billion in both 2022 and 2023, with no change in notional amount. However, the LLM incorrectly states that the notional value decreased from $2.9 billion in 2022 to $2.2 billion in 2023, introducing a $700 million reduction that is not supported by the original answer. This misrepresents the quantitative trend entirely. (2) The calculation of a $700 million decrease due to maturity is fabricated and not present in the ground truth. The original answer states the notional value remained consistent, so the LLM's claim of a reduction is factually wrong. While the $2.2 billion figure for 2023 is correct, the $2.9 billion for 2022 is incorrect. (3) The qualitative reasoning about the purpose of the hedges—converting fixed-rate to variable-rate debt—is accurate and reflects correct understanding of the instrument's function. The mention of managing exposure to fair value changes is also correct. However, the LLM invents a strategic shift due to debt maturity, which is not mentioned in the original answer. The ground truth notes increased disclosure and a more refined approach in 2023, not a reduction due to maturities. (4) The contextual relevance is high because the answer addresses the right topic, time frame, and financial instruments. However, the core quantitative claim is false, and the reasoning is based on incorrect data, leading to a low correctness score despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 436,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "Between 2022 and 2024, 3M's issuance and management of fixed rate registered notes showed a reduction in total long-term debt, from $17,347 million in 2022 to $13,044 million in 2024. During this period, 3M repaid $1.1 billion in medium-term notes in 2024, along with $500 million in fixed-rate registered notes and $650 million in fixed-rate medium-term notes in 2023. In terms of interest rate strategies, 3M utilized interest rate swaps to convert portions of fixed-rate debt into floating rate debt, particularly for notes due in 2049 and 2050, with the interest rates transitioning from a three-month LIBOR index to a SOFR index. This reflects a strategic shift towards managing interest rate risk amid evolving market conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core repayment activity and interest rate strategy correctly but includes some inaccuracies in quantitative details. It correctly notes the $1.1 billion repayment in 2024 (medium-term notes) and $500 million in fixed-rate registered notes in 2023, which aligns with the ground truth. However, it introduces a $650 million repayment of fixed-rate medium-term notes in 2023 that is not mentioned in the original answer, which only specifies $500 million in fixed-rate registered notes repaid in 2023. This is a factual overstatement. Additionally, the LLM cites total long-term debt figures of $17,347 million in 2022 and $13,044 million in 2024, which are not present in the ground truth and cannot be verified from the provided data, making them potentially misleading. (2) The interest rate swap details are mostly accurate: the conversion of fixed-rate debt (specifically notes due 2049 and 2050) to floating rate through swaps is correct, and the shift from LIBOR to SOFR is a reasonable contextual addition, though not explicitly stated in the original answer. However, the original answer specifies the swaps last through mid-2028, which the LLM omits. (3) The multi-hop reasoning is sound in linking repayment activity and swap usage to a broader interest rate risk management strategy. The synthesis across years (2022–2024) and instruments (registered notes, medium-term notes, swaps) shows good qualitative understanding. (4) The answer is contextually relevant and addresses both repayment activity and interest rate strategies. While the core narrative of reducing fixed-rate exposure and managing risk via swaps is correct, the inclusion of unverified total debt numbers and an extra $650 million repayment reduces quantitative accuracy. Hence, correctness is partially impacted, warranting a 7. Qualitative and contextual scores are higher due to strong reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 522,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "Between 2023 and 2024, securities issuances played a diminished role in Schwab's capital structure, as the Company reduced reliance on external debt financing and focused on managing liquidity through internal capital generation and asset optimization. In 2023, Schwab issued multiple senior unsecured notes with higher interest rates to support balance sheet growth and meet liquidity coverage requirements, reflecting active capital market engagement. However, by 2024, Schwab executed a net reduction of $14.9 billion in bank supplemental funding and saw increased client sweep cash inflows, reducing the need for new debt issuances. This shift indicates a strategic pivot toward leveraging organic capital generation, asset maturities, and client behavior to meet liquidity needs, aligning with Schwab's capital management goal of returning excess capital to shareholders while maintaining regulatory compliance and financial flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While the original answer states that securities issuances remained an important but more integrated part of a diversified funding strategy in 2024, the LLM claims a 'diminished role' and 'reduced reliance', which contradicts the ground truth. The LLM introduces a 'net reduction of $14.9 billion in bank supplemental funding'—a specific figure not present in the original answer and unsupported by the provided knowledge graph. There is no mention of senior unsecured notes with higher interest rates or 'client sweep cash inflows' reducing debt needs in the ground truth. (2) The quantitative claim of a $14.9B reduction is entirely absent from the original answer and cannot be verified; no other numbers (e.g., interest rates, issuance amounts) are corroborated. This severely undermines quantitative accuracy. (3) The multi-hop reasoning is flawed: the LLM infers a strategic pivot away from securities issuances based on internal capital generation and client inflows, but the original answer describes a broadening of funding sources, not a reduction in issuance importance. The synthesis misrepresents the evolution as a decline rather than integration. (4) Despite incorrect facts and reasoning, the answer is contextually relevant—it addresses capital structure evolution, funding sources, and capital management strategy. However, the core factual mismatch, especially the unsupported $14.9B figure and incorrect characterization of strategic shift, limits correctness to partially accurate with major errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 437,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "Coca-Cola's contingent payment obligations related to fairlife increased significantly from 2022 to 2024, rising from $3,017 million in 2023 to $6,126 million in 2024. This increase indicates that fairlife's performance against its financial targets has not met expectations, as the contingent liability is based on fairlife achieving certain financial milestones through 2024. The growing liability suggests that the projected payments have increased due to revised assumptions or lower-than-expected performance, resulting in a higher estimated obligation for Coca-Cola.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The original answer states that Coca-Cola had a $270 million contingent liability in 2022 related to fairlife, with a $100 million payment already made in 2021. The LLM claims contingent obligations rose from $3,017 million in 2023 to $6,126 million in 2024—numbers that are not only vastly inflated but also completely fabricated and absent from the ground truth. There is no mention of such figures in the original answer, nor any indication of an increase in liability. (2) The quantitative inaccuracies are severe: the LLM invents specific dollar amounts ($3,017M, $6,126M) that do not appear in the ground truth, misrepresents the timeline (no data for 2023 or 2024 payment amounts, only that the remaining obligation was still active), and incorrectly implies growth in liability. The actual liability was $270 million in 2022 (post-$100M payment), not billions. (3) The reasoning is fundamentally flawed: the LLM concludes that increasing liabilities indicate underperformance, but in reality, contingent payment obligations typically reflect *expected* performance—growth in such liabilities would usually suggest *higher confidence* in hitting targets, not lower. Moreover, the original answer indicates fairlife met its 2020 targets (triggering the $100M payment) and that the remaining obligation was still active, implying continued progress. The LLM’s inference contradicts both the facts and standard financial interpretation. (4) The contextual relevance is low but not zero—the answer addresses contingent payments and fairlife performance, so the general topic is correct. However, due to massive factual errors, invented numbers, and flawed logic, the answer fails on all key dimensions. Correctness score is 1 due to complete failure on quantitative and qualitative accuracy, with only minimal credit for addressing the general subject.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 517,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "Between 2022 and 2024, Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) has evolved to position it as a core component of its enterprise IT solutions, with a focus on global scalability and integration. Oracle has reinforced OCI's role as a flexible and interoperable platform, supporting on-premise, cloud-based, and hybrid deployment models. This positioning enables customers to tailor their IT environments to specific business needs, enhancing Oracle's global market competitiveness. Additionally, Oracle has integrated OCI with its broader suite of cloud services, including Oracle Cloud Software-as-a-Service (SaaS), to offer comprehensive and integrated applications and infrastructure solutions. This integration reflects Oracle's commitment to providing end-to-end enterprise IT capabilities that support both cloud and on-premise environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution of Oracle's emphasis on OCI between 2022 and 2024. It accurately reflects the shift from OCI being a revenue contributor within broader cloud and license businesses in 2022 (though it does not explicitly mention the $36.052 billion figure or that 85% of revenue came from cloud and license) to being positioned as a core, integrated component of Oracle Cloud Services by 2024. The absence of the specific financial data from 2022 is a minor omission but does not undermine the overall correctness of the strategic narrative. (2) There are no numerical inaccuracies in the LLM answer—since it avoids citing specific numbers, there are no incorrect figures. The ground truth includes quantitative data ($36.052B, 85%), but the LLM focuses on qualitative evolution, so the lack of these numbers reduces completeness slightly but doesn't affect quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes the shift in strategic language and integration with enterprise IT solutions across years, correctly identifying OCI’s enhanced role alongside SaaS and its support for hybrid and flexible deployments. The conclusion about Oracle strengthening its global market positioning through integration is logically supported. (4) The answer is contextually highly relevant, directly addressing both global market positioning and integration with enterprise IT solutions. The qualitative accuracy is high because all stated claims align with the ground truth, though slightly less specific on 2022 financials. Overall, this is a semantically equivalent, well-reasoned response with only minor completeness gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 463,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "Between 2023 and 2024, the credit loss allowance for Pledged Asset Lines (PALs) decreased significantly, with the allowance for credit losses on total bank loans dropping from 0.09% in 2023 to 0.05% in 2024. This reduction reflects improved credit quality metrics and lower projected loss rates. Additionally, all PALs remained fully collateralized by securities with fair values exceeding borrowings in both 2023 and 2024, meaning no allowance for credit losses on PALs was required as of those dates. This indicates a lower credit risk profile for PALs in 2024 compared to 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific percentages (0.09% in 2023 and 0.05% in 2024) for the allowance for credit losses on total bank loans that are not present in the original answer and cannot be verified from the provided ground truth. These figures appear to be fabricated or misattributed, as the original answer only states a 'slight decrease' in PALs and mentions improved credit quality but does not provide any percentage figures. This is a major quantitative inaccuracy. (2) The claim that 'all PALs remained fully collateralized... in both 2023 and 2024' contradicts the original answer, which states that full collateralization with no allowance required was the case in 2024, implying a change from 2023. The original indicates an evolution—where in 2023 there was still an allowance influenced by projections, but in 2024 none was required due to the practical expedient under ASC 326. The LLM incorrectly suggests the full collateralization and no-allowance status applied in both years, missing the key evolution. (3) The multi-hop reasoning is partially sound—the LLM correctly links improved credit metrics and lower loss rates to reduced allowances and understands the implication of full collateralization eliminating the need for allowances. However, it fails to accurately represent the transition between years, which is central to the question about how the risk profile 'evolved'. (4) Despite these issues, the answer is contextually relevant and captures the general direction of improvement in risk profile. The qualitative understanding of the relationship between collateralization and credit loss allowances is correct, and the terminology (e.g., ASC 326 practical expedient implied) is appropriately used. However, the introduction of false precision via unverified percentages severely undermines factual correctness, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 518,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike's relationship with the Asia Pacific & Latin America (APLA) region showed growth in both revenues and operational emphasis. Revenues for APLA increased from $6,431 million in fiscal 2023 to $6,729 million in fiscal 2024, reflecting a strategic focus on expanding market presence and direct-to-consumer sales in the region. Additionally, EBIT for APLA remained strong at $1,885 million in 2024, slightly below the $1,932 million in 2023, indicating continued profitability and operational stability. Nike's operational structure in APLA also emphasized direct-to-consumer channels, with significant investments in digital commerce and localized retail strategies to better serve regional consumers.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer states that Nike shifted from direct operations with unionized employees in APLA in FY2023 to transitioning parts of its operations to third-party distributors in FY2024, indicating a strategic move toward outsourcing. In contrast, the LLM answer claims growth in revenues and EBIT, increased strategic emphasis, and investments in direct-to-consumer channels—none of which are supported by the ground truth. There is no mention of revenue figures, EBIT, or direct-to-consumer investments in the original answer, making these fabricated details. (2) The quantitative figures—$6,431 million and $6,729 million in revenues, $1,932 million and $1,885 million in EBIT—are entirely absent from the ground truth and cannot be verified. Since the original answer does not provide any financial metrics for APLA, the inclusion of specific dollar amounts represents a significant factual deviation. (3) The multi-hop reasoning is flawed: the question asks about evolution in operational structure and strategic emphasis, which hinges on organizational changes (e.g., union representation in 2023, shift to third-party distributors in 2024). The LLM fails to mention any of these structural changes and instead fabricates a narrative around financial performance and DTC strategy, missing the core insight. (4) The contextual relevance is moderate because the answer addresses Nike’s relationship with APLA over the two fiscal years and touches on operational emphasis, but it does so with incorrect information and focuses on irrelevant metrics like revenue and EBIT instead of the actual shift in operational model. Hence, the correctness score is low due to major factual inaccuracies and failure to reflect the true evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 503,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "Between 2022 and 2023, Abbott emphasized growth and expansion in its U.S. Pediatric Nutritional business, with Pedialyte playing a central role. In 2022, the U.S. Pediatric Nutritionals segment reported a 10.3% sales increase, driven by growth in Pedialyte, Similac, and PediaSure. By 2023, Abbott continued to highlight Pedialyte as a key growth driver within its Nutritional Products segment, reflecting strategic investments in product innovation and marketing to strengthen its market position. This evolution underscores Abbott's focus on expanding its pediatric portfolio and reinforcing Pedialyte's role as a flagship brand in the U.S. market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Pedialyte was a key growth driver in 2022 with a 10.3% sales increase in the U.S. Pediatric Nutritionals segment, alongside Similac and PediaSure—this matches the ground truth. The quantitative data is accurate and properly attributed. (2) All numbers and dates are correct: the 10.3% growth figure for 2022 is accurately reported. There are no calculation errors. (3) The multi-hop reasoning is mostly sound—linking Pedialyte’s role in 2022 growth to its continued strategic emphasis in 2023. However, the LLM answer misses a key qualitative evolution noted in the ground truth: in 2023, Pedialyte was formally integrated into the Nutritional Products segment and listed among core brands like Ensure and Glucerna, indicating structural recognition. The LLM mentions continued emphasis and innovation but does not capture this formal portfolio integration, which is central to the strategic evolution. (4) Despite this omission, the answer conveys the core trajectory—increased strategic importance and expansion—and remains factually accurate in all stated claims. Hence, high scores for quantitative accuracy and contextual relevance, a slight deduction in qualitative accuracy for missing the formal structural integration, leading to a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 369,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "RTX's financial position regarding its 7.100% notes due 2027 remained relatively stable from 2022 to 2023, with the balance decreasing slightly from $135 million in 2022 to $135 million in 2023. This minimal change indicates that RTX did not prioritize repaying or restructuring this specific debt obligation during the period. The company's broader debt management strategy appears focused on longer-term refinancing and optimizing its capital structure, as evidenced by significant long-term debt issuances in 2023 to fund share repurchases and manage maturities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, RTX's aggregate principal balance for the 7.100% notes due 2027 was $6 million in 2022 and increased to $135 million in 2023. The LLM incorrectly states the balance was $135 million in both years, completely reversing the trend. This misrepresents the evolution of RTX's financial position. (2) The numbers are critically wrong: the 2022 figure is off by $129 million, and the direction of change (increase vs. no change) is incorrect. No calculation is needed beyond recognizing the values and their progression, but the LLM fails both on values and trend. (3) The multi-hop reasoning is flawed. The question requires comparing two years of data across filings to assess debt strategy. The LLM fails to detect the 22-fold increase, leading to an incorrect conclusion about stability and lack of restructuring. Instead, the ground truth suggests a significant strategic shift—possibly acquiring or issuing more of these notes. (4) The contextual relevance is moderate because the answer discusses debt management strategy and references long-term debt activity, which is relevant. However, due to the fundamental factual errors, the qualitative reasoning and conclusions are invalid. The mention of share repurchases and refinancing is plausible but unsupported by the provided truth and misaligned with the actual data trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 399,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Converse experienced a decline in revenue performance, with total revenues dropping by 14% to $2,082 million from $2,427 million. This decline was driven by a 16% decrease in wholesale revenues and a 15% decrease in direct-to-consumer revenues, primarily due to reduced sales in North America and Western Europe. Strategically, Converse faced challenges with lower average selling prices and increased promotional activity, which impacted profitability, as evidenced by a 30% decrease in Earnings Before Interest and Taxes (EBIT) to $474 million from $676 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific financial figures such as revenue dropping from $2,427 million to $2,082 million (14% decline), wholesale down 16%, DTC down 15%, and EBIT falling 30% to $474 million from $676 million. However, these numbers are not present in the original answer (ground truth), which only states a 15% revenue decline on a currency-neutral basis without providing absolute revenue figures or EBIT data. There is no confirmation in the ground truth that total revenue was $2.427B or $2.082B, nor that EBIT was $676M or $474M. Therefore, while the direction of change (decline) aligns, the specific quantitative claims are unverified and potentially incorrect. (2) The calculation of a 14% drop from $2,427M to $2,082M is mathematically accurate ((2427-2082)/2427 ≈ 0.142), and the EBIT drop from $676M to $474M is indeed about 30%. However, since these base numbers are not supported by the ground truth, the model introduces hallucinated precision. (3) The qualitative aspects partially align: the LLM correctly identifies declining performance in North America and Western Europe, and notes pressure on average selling prices and increased promotions—consistent with the original answer’s mention of lower ASPs and unit sales. However, it completely omits the key strategic evolution highlighted in the ground truth: that by fiscal 2024, Converse was positioned as a stand-alone, wholly-owned subsidiary operating independently within Nike’s portfolio. This strategic repositioning is a central part of the original answer and is entirely missing in the LLM response. (4) The contextual relevance is high because the answer addresses revenue performance and strategic challenges, but the failure to include the strategic shift and the introduction of unsupported numerical data significantly reduce factual correctness. The model focuses narrowly on financial deterioration without capturing the broader strategic evolution, resulting in a partially correct but incomplete and quantitatively overconfident answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 550,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "Coca-Cola's financial risk assessment regarding digital evolution has shifted from a focus on potential challenges in 2022 to a more confident outlook in 2024. In 2022, the company highlighted the risk that failure to address digital transformation could negatively impact sales growth and cost efficiency. By 2024, the emphasis had shifted to leveraging digitalization as a strategic enabler, with the company stating that digital initiatives are critical to increasing sales and improving margins. This indicates a transition from viewing digital evolution as a risk to recognizing it as a key driver of growth and operational efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core shift in Coca-Cola's financial risk assessment regarding digital evolution from 2022 to 2024. (1) It correctly identifies that in 2022, Coca-Cola viewed failure in digital transformation as a risk to sales growth and cost efficiency (aligned with ground truth mentioning loss in sales and brand relevance). In 2024, it accurately reflects the company’s updated stance that digital initiatives are critical for sales growth and margin improvement, now framed as a strategic enabler rather than just a risk. (2) There are no numeric values, percentages, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—however, the years (2022 and 2024) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the model synthesizes a change over time in risk perception across two filings, correctly inferring a strategic shift from risk mitigation to growth dependency. The only minor gap is that the LLM answer uses 'cost efficiency' in 2022, whereas the ground truth emphasizes 'brand relevance' alongside sales; this is a slight deviation in nuance but does not undermine the overall correctness. (4) The answer is contextually fully relevant, directly addressing the evolution in risk assessment and its impact on sales and margins. Thus, the correctness score is 9 due to high factual and semantic alignment, with only minor softening of nuance in one aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 408,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Services has intensified from fiscal year 2022 to 2024, with increased research and development investment and a stronger positioning of cloud offerings relative to on-premise solutions. In fiscal 2022, Oracle invested $7.2 billion in R&D, and by fiscal 2024, this investment continued to support innovation in cloud technologies, including Oracle Cloud Infrastructure (OCI) and SaaS offerings. Oracle has positioned its cloud services as a preferred, flexible, and cost-effective alternative to on-premise solutions, emphasizing rapid deployment, interoperability, and the ability to migrate existing on-premise workloads to the Oracle Cloud. The proportion of cloud services and license support revenues relative to other revenue streams has consistently increased, reaching 71% in fiscal 2022 and continuing to grow through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's $7.2 billion R&D investment in fiscal 2022, which matches the ground truth. However, it incorrectly implies that the R&D investment amount for fiscal 2024 is known and continuing at a comparable or increased level, while the original answer explicitly states that the 2024 report does not specify the R&D investment amount. This is a significant quantitative inaccuracy. Additionally, the LLM introduces a specific percentage—'71%' for cloud services and license support revenues in fiscal 2022—which is not present in the ground truth and cannot be verified from the provided information. This unsupported figure undermines quantitative accuracy. (2) The core strategic evolution—increased emphasis on cloud services, positioning cloud as flexible and integrated, and migration support from on-premise—is qualitatively accurate and aligns with the original answer’s description of Oracle’s messaging shift toward customer choice and cloud-first positioning. The mention of OCI and SaaS as key focus areas is correct. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic deepening in cloud emphasis from 2022 to 2024 based on continued R&D and evolving messaging. However, it overreaches by asserting revenue proportions without source support, failing the completeness and verification standard required for full accuracy. (4) Despite the introduction of unverified numbers, the overall direction, entities, and strategic narrative are correct, warranting a score of 7 for correctness—core facts are right, but key details are either fabricated or inaccurately presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 455,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "The Norwest Corporation Directors' Formula Stock Award Plan is no longer active for future awards or deferrals as of both 2023 and 2024. In 2023, the plan had 509 shares issuable upon distribution of deferred compensation benefits, with no remaining shares available for future issuance. By 2024, the number of shares issuable under the plan had decreased to 391, and no future awards or deferrals were permitted, indicating that the plan had been fully wound down and was no longer operational.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Norwest Corporation Directors' Formula Stock Award Plan was inactive for future awards or deferrals in both 2023 and 2024, and that only existing obligations remained. This aligns with the ground truth's description of the plan being closed to new activity. However, the LLM introduces a specific number—509 shares in 2023—that is not present in the original answer. The ground truth does not provide any share number for 2023, only stating that no future awards or deferrals were allowed and that the 2024 number (391 shares) reflected all remaining issuable shares. Thus, the inclusion of '509 shares' in 2023 is unsupported and factually inaccurate based on the provided ground truth. (2) The 2024 figure of 391 shares is correct and matches the original answer. However, the quantitative inaccuracy in 2023 undermines confidence in the data sourcing. There is no indication in the ground truth that the number of shares decreased from 509 to 391; rather, the 391 figure is simply reported as the final remaining amount in 2024. (3) The multi-hop reasoning is partially sound—the model correctly infers that the plan was fully wound down by 2024 and that no new awards were possible. It synthesizes the status across years appropriately, but the erroneous 2023 number suggests flawed input data or incorrect inference. (4) The contextual relevance is high, as the answer addresses the evolution of the plan’s status and availability of shares. Qualitative accuracy is moderate due to correct reasoning but incorrect numerical grounding. Quantitative accuracy is low due to the unsupported 509-share figure. Correctness score is reduced to 6 due to this significant factual error, despite otherwise logical structure and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 487,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "Between 2022 and 2023, McDonald's expanded its disclosure on food safety concerns, particularly emphasizing supply chain risks and cost volatility. In 2022, the company highlighted its commitment to food safety as a top priority, noting the potential impact of food-borne illnesses and the need for robust systems to ensure safe food products. By 2023, the disclosure became more detailed, explicitly linking food safety to supply chain vulnerabilities, such as contamination risks and the challenges of managing product safety across a complex global network. Additionally, in 2023, McDonald's acknowledged the compounding effects of commodity cost volatility on food safety initiatives, noting that rising costs for ingredients like beef, chicken, and pork could strain resources dedicated to maintaining safety standards. This evolution reflects a more nuanced recognition of how supply chain and cost pressures intersect with food safety management.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment and contextually relevant, with accurate dates (2022 and 2023) and correct entities (McDonald's, food safety, supply chain, beef, chicken, pork). There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—scored as 10 by default. The LLM correctly identifies a shift in disclosure focus between the two years and notes the increased emphasis on supply chain risks and cost volatility. However, there is a key divergence in the nature of the evolution: the ground truth states that in 2023, food safety concerns were framed as *contributors to* cost volatility (i.e., safety issues causing price fluctuations), whereas the LLM interprets it as cost volatility *impacting* food safety initiatives (i.e., high costs undermining safety efforts). This reverses the causal relationship and misrepresents the core reasoning in the original answer. While the LLM captures the intersection of food safety with supply chain and costs, the flawed causality undermines the multi-hop synthesis, leading to a correctness score of 7. Contextual relevance is high as all parts of the question are addressed, and the response is well-structured and on-topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 348,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "The carrying value of TMO's 1.750% 7-Year Senior Notes decreased slightly from $700 million as of December 31, 2023, to $621 million as of December 31, 2024. The effective interest rate for these notes also decreased from 1.97% in 2023 to 1.96% in 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both carrying value and interest rate. According to the ground truth, the carrying value remained unchanged at $700 million in both 2023 and 2024, but the LLM claims it decreased to $621 million in 2024. Similarly, the effective interest rate was 1.89% in both years, but the LLM reports 1.97% in 2023 and 1.96% in 2024—both values are wrong. (2) All numeric values are incorrect: $621M (vs $700M), 1.97% and 1.96% (vs 1.89% both years). There are no acceptable format variations that justify these discrepancies. (3) The reasoning is flawed—while the LLM attempts to compare two years (multi-hop), it fails to correctly retrieve or synthesize the actual data, leading to false conclusions about changes in the debt instrument. (4) The contextual relevance is high because the answer addresses the right company (TMO), instrument (1.750% 7-Year Senior Notes), and time frame (2023–2024), but the factual inaccuracies severely undermine correctness and quantitative accuracy. The qualitative accuracy is low due to incorrect entity-state mapping despite correct entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 323,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX's exposure to its 7.000% notes due 2038 remained unchanged at $148 million between 2022 and 2023. This suggests that RTX did not refinance or retire this specific long-term debt obligation during the period, indicating a strategy of maintaining existing long-term debt maturities rather than actively managing or reducing them in this instance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that RTX's exposure to the 7.000% notes due 2038 remained unchanged at $148 million between 2022 and 2023. According to the ground truth, the principal balance was $11 million in 2022 and increased to $148 million in 2023 — a significant change, not stability. This error completely inverts the factual situation. (2) Quantitatively, the LLM misstates the 2022 value (claims $148M instead of $11M) and falsely asserts no change, making the numerical analysis inaccurate. The 2023 figure ($148M) is correct, but the 2022 figure is wrong, and the comparison fails. (3) The reasoning is flawed because it draws conclusions based on an incorrect premise. The LLM suggests RTX maintained or held steady its exposure, leading to the inference of a passive debt strategy. In reality, the tenfold+ increase suggests active debt management — likely new issuances or restructuring — indicating a strategic move to extend maturities or take advantage of favorable terms. The multi-hop synthesis between years and the correct interpretation of financial behavior is missing. (4) Contextual relevance is moderate because the answer addresses the right topic (debt maturity strategy) and the correct instrument (7.000% notes due 2038), but the incorrect data leads to a misleading conclusion. The structure and intent of the response are appropriate, but factual and logical accuracy are severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 403,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial relationship with its franchisees remained largely consistent in terms of collecting rent and royalties, as these payments are based on a percentage of franchisees' sales. In 2022, the Company reported $8,381.1 million in rent and $4,645.1 million in royalties from franchised restaurants, while in 2023, these figures increased to $8,892.9 million in total revenues from franchised restaurants, though the exact breakdown of rent and royalties for 2023 is not provided in the given data. The continued reliance on sales-based payments reflects the ongoing impact of franchisees' operational performance on McDonald's income from these arrangements.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in addressing the core of the question, which focuses on the evolution of McDonald's financial relationship with franchisees regarding rent and royalty deferrals between 2022 and 2023, particularly in the context of post-pandemic normalization. Instead, the LLM response emphasizes revenue figures and payment structures without engaging with the key issue of deferrals and their resolution. The original answer highlights that the $1 billion deferral occurred primarily in 2020 and was substantially collected by end of 2021, with 2022 and 2023 reflecting normal operations. The LLM incorrectly implies that deferral or collection dynamics were a topic in 2022–2023, when in fact the system had already returned to standard operations. (2) Quantitatively, the LLM provides specific figures: $8,381.1 million in rent and $4,645.1 million in royalties for 2022, and $8,892.9 million in total franchised revenues for 2023. However, these numbers are not present in the original answer (ground truth), and the 2023 figure combines rent and royalties without breakdown, making comparison invalid. More critically, these figures are irrelevant to the actual question about deferral policies, not revenue totals. There is no verification that these numbers match the actual 10-K filings, and their inclusion distracts from the factual timeline. (3) The multi-hop reasoning is flawed. The question requires understanding the timeline of pandemic-related deferrals (2020), their collection (by end of 2021), and the absence of such measures in 2022 and 2023. The LLM fails to mention the deferral or its resolution, instead focusing on revenue amounts, thus missing the causal and temporal synthesis required. It does not connect the absence of deferrals in 2023 to the return to normal operations. (4) The contextual relevance is moderate because it discusses rent and royalties, which are relevant concepts, but it misdirects the focus to revenue amounts rather than the structural financial accommodations and their evolution. The answer lacks the key qualitative shift described in the ground truth—normalization post-pandemic. Therefore, despite some correct terminology, the answer is factually and contextually misaligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 612,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "The Coca-Cola Company's financial stake in Embotelladora Andina S.A. decreased from 2022 to 2024, as evidenced by the reduction in the carrying value of the investment from $90 million in 2022 to $78 million in 2024, despite the fair value of Andina's shares increasing from $168 million to $90 million. This indicates a strategic decision by Coca-Cola to reduce its ownership in Andina, likely to optimize its portfolio and focus on other high-growth opportunities, as seen in the 2019 divestiture of a portion of its stake in Andina.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Coca-Cola recognized a $39 million gain from a partial sale of its stake in Embotelladora Andina S.A., but the LLM incorrectly states that the carrying value was $90 million in 2022 and dropped to $78 million in 2024. In reality, the $90 million carrying value is reported in 2024, not 2022. Additionally, the LLM reverses the fair value trend, claiming it increased from $168M to $90M, when the ground truth states the 2024 fair value is $168 million—implying an increase from a lower prior value, not a decrease. (2) The numbers are largely incorrect: the carrying value progression is misrepresented, and the fair value direction is inverted. The mention of a 2019 divestiture is irrelevant and not supported in the ground truth, which references 2022 as the year of partial sale. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the timeline and financial evolution of the investment. It misattributes the direction of value changes and introduces an unsupported strategic narrative based on incorrect data. (4) While the general idea of a strategic reduction is partially aligned with the ground truth’s 'partial exit strategy,' the incorrect data undermines the reasoning. The answer is contextually relevant in discussing strategic positioning but fails on factual and quantitative accuracy, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 408,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "Oracle's strategic investment in cloud infrastructure from 2022 to 2024 has emphasized internal development and positioning Oracle Cloud Infrastructure (OCI) as a central component of its product portfolio. In 2022, Oracle highlighted its expansion of the Oracle Cloud through increased data center capacity and new geographic locations to meet customer demand. By 2024, the company emphasized that Oracle Cloud Operations deliver Oracle Cloud Services via a secure, scalable, and enterprise-grade infrastructure, with automated tools enabling rapid delivery of the latest cloud capabilities on a quarterly cadence. Additionally, internal development efforts remained a priority, with significant resources dedicated to research and development to maintain and improve cloud offerings, reinforcing OCI's role as a key differentiator in Oracle's evolving product strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Oracle's strategic focus on internal development and the growing centrality of Oracle Cloud Infrastructure (OCI) in its product portfolio from 2022 to 2024. It accurately reflects that internal R&D remained a priority and that OCI was increasingly positioned as a key offering. However, the LLM answer emphasizes data center expansion and geographic growth in 2022, which is factually plausible but not present in the ground truth, which instead highlights Oracle's global R&D workforce and innovation focus. The 2024 description aligns well with the ground truth, noting secure, scalable infrastructure and regular delivery cycles, which corresponds to the 'structured, customer-facing product portfolio' evolution. (2) There are no specific numbers, dollar amounts, or percentages in either answer, so quantitative accuracy is not compromised—no errors in dates or metrics. (3) The multi-hop reasoning is mostly sound: the LLM synthesizes Oracle's evolving cloud strategy across two time points and connects internal development to product positioning. However, it substitutes the ground truth's emphasis on R&D-driven innovation in 2022 with infrastructure expansion, missing the nuance of a shift from general cloud development to a defined OCI product strategy. This is a minor deviation in emphasis rather than a factual error. (4) The correctness score is 8 due to accurate core facts and strong contextual alignment, with only a slight deviation in the characterization of 2022 strategy. Quantitative accuracy is 10 as no numbers are misstated. Qualitative accuracy is 8 due to strong reasoning but partial mismatch in the 2022 strategic emphasis. Contextual relevance is 10 as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 484,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "TMO acquired The Binding Site Group in January 2023 as part of its strategy to expand its Specialty Diagnostics segment, enhancing its portfolio with innovative diagnostic solutions for blood cancers and immune system disorders. By 2024, the company had successfully integrated The Binding Site Group, as evidenced by its focus on leveraging synergies and complementary capabilities across its segments. This progression indicates TMO's commitment to integrating acquired businesses to strengthen its market position and drive growth in high-potential areas like specialty diagnostics.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies TMO's acquisition of The Binding Site Group in 2023 and its integration by 2024, aligning with the ground truth. It accurately notes the strategic intent to expand the Specialty Diagnostics segment and strengthen offerings in blood cancer and immune disorder diagnostics. However, it omits the specific acquisition cost of $2.70 billion and the key detail about the 19-year weighted-average amortization period for customer relationships, which is a material indicator of integration into intangible assets. The date 'January 2023' is more specific than the original answer (which only says 2023); while plausible, this precision is not supported in the ground truth and could be an overstatement. (2) Quantitatively, the omission of $2.70 billion and the 19-year amortization period—both concrete figures in the original answer—reduces quantitative completeness. No incorrect numbers are stated, so accuracy is high but not complete. (3) The reasoning is sound: the LLM correctly infers that integration and synergy realization reflect a strategic focus on long-term growth in specialty diagnostics. It synthesizes the acquisition with strategic intent, though it misses the financial accounting evidence (amortization period) that supports integration. (4) The answer is contextually relevant and well-articulated, addressing both the evolution and strategic implications. The core facts are correct, but the lack of specific financial and accounting details from the knowledge graph limits full factual equivalence. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 442,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "Between 2022 and 2024, the disclosure and accessibility of the Directors' Code of Conduct for BNY Mellon evolved in terms of website links and scope of application. In 2022, the Directors' Code of Conduct was posted at **https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf** and explicitly stated that it applied to all directors of BNY Mellon. By 2024, the link was updated to **https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf**, and the scope remained consistent, continuing to apply to all directors of BNY. The updated link reflects a change in the website domain structure, but the scope of application and commitment to transparency remained unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in website links and scope of application between 2022 and 2024. The scope of application — that the Directors' Code of Conduct applies to all directors — is accurately reported as unchanged, which matches the ground truth. However, there is a minor error in the 2022 URL: the LLM states it is 'https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf', which contains a clear typo ('in relations' instead of 'investor-relations'). The correct 2022 URL is 'https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf'. This typo affects the accuracy of the link but does not change the overall conclusion about the domain rebranding. The 2024 URL is correctly reported, including the shift to 'bny.com' and the slightly altered path, which aligns with the rebranding narrative. (2) There are no numerical values requiring calculation, so quantitative accuracy focuses on URLs and dates. The years 2022 and 2024 are correctly used. The 2024 URL is accurate; the 2022 URL is nearly correct but contains a critical path error, reducing quantitative accuracy slightly. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two time points, compares URL structures, infers continuity in policy scope, and contextualizes the domain change as part of a rebranding (from BNY Mellon to BNY), which is consistent with the ground truth interpretation. (4) The answer is contextually fully relevant, addressing both website accessibility and scope of application as asked. Due to the URL typo, the correctness score is reduced to 8 rather than 9 or 10, but the core facts and reasoning remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 485,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "Between 2022 and 2023, McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis by increasing the number of franchised restaurants and reducing the number of company-operated locations. In 2023, franchised restaurants totaled 39,680 (up from 37,295 in 2021), while company-operated restaurants decreased to 2,142 (down from 2,736 in 2021). This shift reflects a continued strategic emphasis on franchise growth. Financially, the reporting of franchise-related revenues remained consistent, with royalties and rental income recognized based on a percentage of sales, while the Company maintained its focus on technology and brand licensing revenue streams. Additionally, the Company continued to account for franchisee-related transactions under existing accounting policies, with no material impact from recent accounting updates.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct contextual elements about McDonald's strategic emphasis on franchising, but it introduces data not present in the ground truth, particularly specific numbers of franchised and company-operated restaurants (e.g., 39,680 franchised in 2023, 2,142 company-operated), which are not mentioned in the original answer and cannot be verified from the provided knowledge. Additionally, the LLM references 2021 data (37,295 and 2,736) to infer a trend between 2022 and 2023, which is outside the question's scope and unsupported by the ground truth. (2) Quantitative accuracy is partially correct in direction (franchise growth trend) but fails on factual grounding—no numbers about restaurant counts appear in the original answer, making these figures hallucinated. The absence of material impact from franchise transactions in 2022 and the strategic reframing in 2023 are key facts missing from the LLM’s numerical focus. (3) The multi-hop reasoning is flawed: the original answer emphasizes a shift in reporting transparency and stakeholder framing, not operational counts or revenue recognition mechanics. The LLM misidentifies the nature of the evolution—focusing on operational mix rather than financial reporting treatment and strategic communication. (4) Contextual relevance is moderate because the answer discusses franchise strategy, which is relevant, but misses the core evolution in financial reporting (materiality disclosure in 2022 vs. stakeholder inclusion in 2023). The emphasis on consistent royalty reporting and accounting policies is plausible but not aligned with the ground truth’s focus on changing strategic emphasis and transparency. Overall, the answer is partially correct in theme but factually divergent in content and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 489,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "The contingent consideration liabilities related to the Clif Bar acquisition increased from $452 million as of December 31, 2022, to $548 million as of December 31, 2023. This increase reflects changes in the fair value of the liability, which is measured using a Monte Carlo simulation model based on Level 3 inputs. The fair value adjustments are primarily driven by updated financial projections for net revenue, gross profit, and EBITDA, along with assumptions about discount and volatility rates. Additionally, the purchase price allocation for Clif Bar was adjusted in 2023, as noted in the 2024 10-K, which included purchase price allocation adjustments related to Ricolino and Clif Bar.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $548 million contingent consideration liability as of December 31, 2023, which matches the ground truth. However, it introduces a figure of $452 million as of December 31, 2022, which is not present in the original answer and cannot be verified from the provided ground truth, making this an unsupported addition. The mention of Monte Carlo simulation and Level 3 inputs aligns with the fair value measurement method described, so the valuation approach is accurately characterized. (2) The quantitative accuracy is partially compromised due to the inclusion of the unverified $452 million figure from 2022. While the $548 million amount is correct, the comparison (increase from 2022 to 2023) is not supported by the ground truth, which only provides data for 2023. No calculation errors are present, but the introduction of external data reduces factual reliability. (3) The reasoning is mostly sound: the LLM correctly links fair value adjustments to financial projections and modeling assumptions, and notes that purchase price allocation adjustments for Clif Bar were mentioned in the 2024 filing. However, it fails to address the key evolution highlighted in the ground truth — that the contingent consideration liabilities are no longer explicitly discussed in 2024, suggesting possible finalization or reclassification. This absence of analysis on the 2024 silence is a significant omission in the multi-hop reasoning. (4) Contextual relevance is high because the response focuses on the correct acquisition, liability type, valuation method, and time frame. The qualitative accuracy is moderate because while entities (Clif Bar, 2023, 2024, purchase price allocation) and general concepts are correct, the answer does not fully synthesize the change in accounting treatment over time — particularly the shift from active fair value reporting in 2023 to no direct mention in 2024 — which is central to the question. The correctness score reflects partial accuracy with a notable gap in addressing the evolution into 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 559,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "Between 2022 and 2024, AMD's strategic emphasis on Vulkan API support has evolved to align with its broader focus on delivering high-performance, cross-platform graphics solutions. In 2022, AMD's discrete GPUs already supported modern APIs like DirectX 12 Ultimate and Vulkan, enabling developers to optimize performance and visual quality for gaming and compute workloads. By 2024, AMD continued to reinforce this support, particularly with its RDNA 3 architecture-based Radeon RX 7000 Series GPUs, which maintain compatibility with Vulkan and other APIs to ensure broad software ecosystem integration. This ongoing commitment to Vulkan reflects AMD's strategy to remain competitive in the discrete GPU market by providing robust, developer-friendly tools and ensuring cross-platform flexibility for gaming and professional applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: AMD supported Vulkan in 2022 with RDNA 2-based GPUs and continued support in 2024 with RDNA 3-based Radeon RX 7000 Series GPUs. The answer correctly identifies the architectural progression and sustained API support. (2) There are no numeric values requiring verification (e.g., financials, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) and product names (RDNA 2, RDNA 3, Radeon RX 7000 Series) are accurate. (3) The multi-hop reasoning is sound: the model synthesizes AMD’s ongoing Vulkan support with architectural evolution and links it to competitiveness via developer tools and cross-platform flexibility. The original answer emphasizes 'backward compatibility and cutting-edge performance,' while the LLM focuses on 'ecosystem integration' and 'developer-friendly tools'—semantically equivalent strategic interpretations. (4) The only minor gap is that the LLM does not explicitly mention AI/ML computing as a growing demand driver, which is included in the ground truth. However, this omission does not undermine the core correctness or strategic interpretation. Overall, the answer is factually solid, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 368,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "RTX's integration-related charges, particularly the Powder Metal Matter charge of $2.9 billion in 2023, significantly impacted its operating profit trends, contributing to a $1.9 billion decrease in operating profit compared to 2022. This charge, along with a decrease in the FAS/CAS operating adjustment, offset gains in operating profit from Collins and Raytheon, leading to a drop in the operating profit margin from 8.2% in 2022 to 5.2% in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the $2.9 billion Powder Metal Matter charge in 2023 and its direct contribution to the $1.9 billion decrease in operating profit compared to 2022 are accurately reported. These figures match the original answer exactly, and the format variations (e.g., $2.9 billion) are acceptable. (2) The quantitative accuracy is perfect—both the charge amount and the operating profit decline are correct, and the implied logic that a $2.9B charge contributed to a $1.9B decline is reasonable given other offsetting factors. (3) The LLM adds contextual detail not in the original—specifically, the operating margin drop from 8.2% to 5.2% and mention of the FAS/CAS adjustment and business unit performance (Collins and Raytheon). While these details are not in the ground truth and cannot be verified from the provided knowledge, they do not contradict it and enhance the explanation without introducing error. (4) The multi-hop reasoning is sound: the model correctly identifies a shift in integration-related charges from 2022 (implied improvement) to a major negative impact in 2023 due to the new charge. The only minor shortcoming is the lack of explicit mention of the 2022 trend in integration charges (declining Acquisition Accounting Adjustments), which was part of the original answer. However, the contrast between 2022 and 2023 is still effectively conveyed. Overall, the answer is factually correct, contextually relevant, and demonstrates strong synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 426,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "MDLZ's relationship with Clif Bar evolved from an acquisition in August 2022 to full integration into its operations by 2023. The acquisition of Clif Bar added $529 million in incremental net revenues through the one-year anniversary of the acquisition in 2023. By 2024, there were no further acquisition-related financial activities mentioned, indicating that Clif Bar had been fully integrated into MDLZ's operations, contributing to its ongoing revenue and operational performance without additional specific financial events tied to the acquisition.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The acquisition date is incorrectly stated as August 2022, while the ground truth confirms it was disclosed in the 2023 10-K as occurring on August 1, 2022 — this part is correct. However, the LLM claims $529 million in incremental net revenues through the one-year anniversary in 2023, which is not supported by the original answer or any cited source in the ground truth; this figure is entirely fabricated or misattributed. (2) Quantitative accuracy is low because the $529 million revenue figure is unverified and not mentioned in the ground truth. There are no numbers in the original answer to support this claim, making it a serious error. The date of acquisition (August 1, 2022) is accurate, but the financial impact described is not corroborated. (3) The multi-hop reasoning is partially sound — the model recognizes that the relationship evolved from acquisition to integration — but fails in the second hop: instead of identifying the 2024 purchase price allocation adjustments (a key post-acquisition financial activity), it incorrectly states that 'no further acquisition-related financial activities' were mentioned, which contradicts the ground truth. This shows a failure in synthesizing the correct financial developments between 2023 and 2024. (4) Contextual relevance is high because the answer addresses the evolution of the relationship and focuses on acquisition-related financial activities. However, due to major factual and quantitative errors, especially the unsupported revenue number and the omission of purchase price adjustments in 2024, the overall correctness score is low. The answer conveys a plausible narrative but diverges from the actual financial disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 481,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "From 2023 to 2024, Gulfstream's approach to energy-efficient engines has advanced with the introduction of the G700, which features all-new engines designed for superior high-speed performance and fuel efficiency. This shift is reflected in the G700's certification and entry into service in March 2024, as well as the continued development and delivery of the G500 and G600 aircraft, which replaced older models with improved fuel efficiency and reduced emissions. These developments underscore Gulfstream's commitment to sustainability and innovation in engine technology.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the G700's introduction in 2024 with all-new, energy-efficient engines, aligning with the ground truth's emphasis on a shift from R&D in 2023 to production in 2024. However, the LLM incorrectly implies that the G500 and G600 developments in 2024 reflect the evolution in engine efficiency, which is not supported in the original answer—those models were not highlighted as part of the 2023–2024 shift. The original answer makes no mention of G500/G600 in this context, so this is an overextension. (2) The date 'March 2024' for G700 certification and entry into service is plausible and contextually consistent, but the original answer does not specify a month—only that the G700 was introduced in 2024. This adds precision not present in the ground truth, which may be acceptable but cannot be verified. No numeric values (e.g., fuel savings, emissions reductions) are provided in either answer, so no calculation errors exist. (3) The multi-hop reasoning is partially sound: the LLM connects Gulfstream’s 2023 R&D focus (implied from original answer) to 2024 operational output with the G700. However, it introduces additional aircraft (G500, G600) not linked to the energy-efficient engine shift in the ground truth, weakening the synthesis. (4) The correctness score is 7 because the core evolution—strategic focus in 2023 to tangible G700 engine deployment in 2024—is accurately captured. The inclusion of extraneous, unverified aircraft developments prevents a higher score. Quantitative accuracy is 8 due to plausible but unconfirmed timing. Qualitative accuracy is 7 due to correct central reasoning but flawed entity linkage. Contextual relevance is 9—answer stays focused and responsive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 475,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "From 2022 to 2024, AMD's semi-custom SoC products have transitioned from being a niche revenue contributor to a more strategically emphasized segment, particularly in gaming and custom design solutions. In 2022, revenue from semi-custom SoCs was primarily tied to non-recurring engineering fees and sales to third parties, with revenue dependent on customer product success. By 2024, AMD positioned semi-custom SoCs as a key growth area, integrating them into broader product offerings and leveraging them for partnerships and custom design projects. This shift reflects AMD's strategic focus on diversifying revenue streams and capitalizing on opportunities in markets like gaming and embedded systems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth in terms of the evolution of AMD's relationship with semi-custom SoC products from 2022 to 2024. (1) It correctly identifies that in 2022, revenue came from non-recurring engineering (NRE) fees and product sales, with dependence on third-party success—this matches the original answer. By 2024, it accurately reflects a strategic shift toward integration and growth, emphasizing custom design and partnerships. While the original answer specifies broader portfolio integration (AI accelerators, GPUs, APUs, DPUs), the LLM captures the essence of diversification and strategic emphasis without listing all components, which is a minor omission but not factually incorrect. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes changes over time in revenue structure and strategic positioning across two distinct periods (2022 vs 2024), correctly attributing shifts in business model and intent. (4) The LLM answer is semantically equivalent to the original in key aspects—dependency to strategic control, NRE-based revenue to diversified commercialization—and maintains contextual relevance throughout. The only reason for not scoring a 10 is the slightly less detailed articulation of the 2024 strategic integration compared to the original’s mention of specific product types (AI accelerators, DPUs, etc.), which adds depth. However, the core facts, timeline, and strategic interpretation are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 443,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with no preferred shares issued or outstanding in either year. This indicates that the company has not utilized preferred shares as part of its capital strategy during this period, instead focusing on other forms of capital management, such as ordinary share repurchases and stock-based compensation programs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the preferred share authorization structure remained unchanged between fiscal years 2023 and 2024 and that no preferred shares were issued or outstanding in either year, which aligns with the ground truth. However, it omits the specific authorized amounts: 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value. While the absence of issued shares is correctly noted, the lack of detail on authorized share classes and par values constitutes a minor factual omission. (2) All mentioned facts are quantitatively accurate—there are no incorrect numbers or miscalculations. The missing quantitative details from the original answer reduce completeness but do not introduce inaccuracy. (3) The reasoning is sound: the conclusion that the company has not utilized preferred shares in its capital strategy is logically supported by the lack of issuance. The addition of 'focusing on other forms of capital management, such as ordinary share repurchases and stock-based compensation programs' is a reasonable inference, though not explicitly confirmed in the ground truth; this extrapolation does not contradict the data but adds unverified context. (4) The answer is contextually relevant and addresses both parts of the question—evolution of structure and implications for capital strategy. The core facts are correct, but the omission of specific authorized share details prevents a top score. Thus, correctness is rated 8/10 due to partial completeness, with high marks for accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 438,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "Between 2022 and 2024, the framing of reputational risk related to adverse publicity in BK's risk disclosures has expanded to include broader concerns. In 2022, reputational risk was mentioned as a general risk factor, noting that adverse events, publicity, or government scrutiny could harm the business. By 2024, the language evolved to explicitly link reputational harm with sustainability concerns, including climate change and diversity, indicating a heightened awareness of how these factors could affect client activity levels and regulatory requirements. This shift reflects a more nuanced understanding of reputational risk as interconnected with broader societal and environmental issues.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 framing of reputational risk included adverse publicity and government scrutiny affecting business performance, and by 2024 this expanded to include sustainability concerns like climate change and diversity. The LLM correctly identifies the evolution in tone and scope. (2) There are no numeric values to verify, so quantitative accuracy is not applicable beyond correct use of years (2022, 2024), which are accurate. (3) The multi-hop reasoning is sound—comparing risk disclosures across years and synthesizing changes in language and emphasis. The LLM captures the broadening of reputational risk but slightly omits the explicit mention of the 'platforms operating model transition' as a new linked concern in 2024, which is a minor gap in completeness. (4) Despite this omission, the answer conveys the core evolution accurately and uses semantically equivalent phrasing such as 'heightened awareness' and 'interconnected with broader societal and environmental issues.' The response is fully relevant to the question about framing evolution and associated impacts. Thus, the correctness score is 9 due to a minor omission, not a factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 354,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "Amazon's financial investment and valuation approach toward Anthropic, PBC evolved from 2023 to 2024 by maintaining the investment as a convertible note classified as available-for-sale, reported at fair value with unrealized gains and losses included in accumulated other comprehensive income (loss). In 2023, Amazon invested $1.25 billion in a convertible note from Anthropic, which was classified as a Level 3 asset. By 2024, the valuation of this investment remained subject to market price volatility and private company valuation complexities, with no significant changes in classification or impairment noted. The investment was primarily influenced by Anthropic's performance, market conditions, and the potential for conversion to equity.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.25 billion convertible note investment in 2023, its classification as available-for-sale, reporting at fair value with unrealized gains/losses in accumulated other comprehensive income, and its status as a Level 3 asset—all factually accurate per the ground truth. The 2024 classification is correctly stated as unchanged. However, the LLM omits key information about Amazon’s binding agreement to invest an additional $2.75 billion by Q1 2024, which is a significant component of the investment evolution. This omission reduces completeness and affects qualitative accuracy. (2) Quantitative accuracy is perfect: the $1.25 billion figure is correct, and no other numbers are misstated. There are no calculations required, and all financial figures match the original answer. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes the classification and valuation treatment across years but fails to incorporate the forward-looking commitment to invest more, which is essential to understanding the evolution of Amazon’s approach. Additionally, while the LLM mentions 'market conditions' and 'potential for conversion to equity,' it misses the ground truth’s emphasis on increased disclosure of valuation challenges in 2024 due to lack of market data and global economic uncertainty. Instead, it generalizes influences without capturing the shift in narrative focus from mechanics to risk. (4) The answer is contextually relevant and well-structured, addressing both investment classification and valuation factors. However, due to the omission of the $2.75 billion commitment and the nuanced shift in disclosure tone around valuation risk, the answer falls short of full qualitative and overall correctness. Hence, a score of 7 is justified—core facts are correct, but significant contextual and synthetic elements are missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 516,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "The nature of the risks related to the protection of MDLZ's intellectual property, including know-how, between 2023 and 2024 remained largely consistent, with a notable emphasis in 2024 on the evolving challenges posed by developments in artificial intelligence technologies. Both years highlight the importance of trademarks, patents, copyrights, and trade secrets, as well as the use of legal protections and licensing agreements. However, in 2024, the risk discussion explicitly mentions the potential impact of AI advancements on the ability to protect intellectual property, indicating a heightened awareness of emerging technological threats to IP security.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about the evolution of MDLZ's intellectual property risks between 2023 and 2024. According to the ground truth, in 2023 MDLZ specifically mentioned artificial intelligence (AI) as a potential threat to intellectual property protection, while in 2024 it removed that specific reference and instead broadened its risk disclosure to include general legal and regulatory non-compliance, enforcement actions, and reputational harm. The LLM answer incorrectly states the opposite: that AI was 'explicitly mentioned' in 2024 and indicates a 'heightened awareness' of AI threats, when in fact the AI reference was dropped in 2024. This is a critical factual reversal. While the answer correctly identifies the types of IP (trademarks, patents, etc.) and general legal mechanisms used (licensing, nondisclosure), these are generic elements and do not compensate for the major misrepresentation of the trend across years. There are no numerical values in the question, so quantitative accuracy is not applicable but scored as 10 by default. The reasoning is flawed as it fails to correctly synthesize the multi-hop comparison between the two years' disclosures. Contextual relevance is moderate because the answer discusses IP protection in general but misrepresents the key evolution. The semantic meaning is not equivalent to the ground truth due to the inverted timeline of AI-related risk emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 399,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "Goldman Sachs updated its treatment of Non-Employee Director Equity Award Agreements between 2023 and 2024, as reflected in the referenced SEC filings. In the 2023 filing, the most recent referenced agreements were pre-2015 forms, such as the \"Form of Non-Employee Director RSU Award Agreement (pre-2015)\" and similar variations. By 2024, the filings included newer, unspecified forms such as \"Form of Non-Employee Director RSU Award Agreement\" and \"Form of Non-Employee Director RSU Award Agreement (Cash-Settled),\" indicating updated award structures. This suggests that Goldman Sachs revised its equity award agreements for non-employee directors in 2024, moving away from the pre-2015 templates to newer, likely more current agreements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The original answer states that Goldman Sachs referenced Exhibit 10.17 in 2023 and Exhibit 10.18 in 2024, both pointing to amendments tied to the 2008 Annual Report (specifically Exhibit 10.69). In contrast, the LLM claims that the 2023 filing referenced 'pre-2015 forms' and that 2024 introduced newer unspecified forms like 'Cash-Settled' agreements—information not present in the ground truth and factually inconsistent. There is no mention in the original answer about pre-2015 templates or cash-settled variants, nor any indication of agreement revisions in 2024 beyond exhibit reorganization. (2) Quantitatively, the LLM introduces incorrect dates (e.g., 'pre-2015') and misrepresents the timeline evolution. The core dates in the ground truth are November 28, 2008, and the shift in exhibit referencing between 2023 and 2024—not changes in award forms post-2015. No correct numerical or date-based alignment exists. (3) The multi-hop reasoning is flawed: the LLM fails to identify that the evolution lies in the exhibit referencing structure (from direct amendment to consolidation via Exhibit 10.69), not in the substance of the award agreements themselves. It incorrectly infers policy or structural changes based on non-existent form updates. (4) While the LLM attempts to address the question’s focus on evolution over time and mentions equity award agreements, it does so with fabricated details, leading to low correctness and qualitative accuracy. Contextual relevance is moderate because it stays on topic but misrepresents the nature of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 449,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "Between 2022 and 2023, BKNG's relationship with travel service providers evolved in terms of revenue recognition and contractual responsibilities as the company continued to increase the proportion of transactions processed on a merchant basis. This shift allows BKNG to facilitate payments from travelers directly, enhancing its ability to offer flexible payment terms and improving its control over the transaction process. However, this also led to higher merchant-related expenses, including personnel, payment processing, and chargebacks, which negatively impacted operating margins. Additionally, BKNG's contractual responsibilities expanded as it assumed more obligations related to payment processing and fraud prevention, reflecting a more integrated role in the transaction lifecycle.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The key factual error is the claim that BKNG increased transactions on a 'merchant basis,' which implies gross revenue recognition where BKNG acts as a principal. However, the original answer states that BKNG recognizes revenue on a *net basis* due to its role as an agent—a fundamentally different accounting model. This misrepresents the core of BKNG's revenue recognition policy. (2) There are no numeric values in either answer, so quantitative accuracy cannot be scored on numbers, but the conceptual treatment of financial flows (e.g., 'higher merchant-related expenses,' 'negatively impacted operating margins') introduces unsupported claims not present in the ground truth. (3) The multi-hop reasoning fails: instead of identifying the evolution from general intermediary description to more detailed *agent-based* accounting treatment and timing of revenue recognition (at service usage), the model fabricates a shift toward merchant model expansion, which is the opposite of what the ground truth describes. (4) Contextual relevance is moderate because the answer discusses revenue recognition and contractual responsibilities with travel providers, which are relevant themes, but the substance is factually wrong. The actual evolution was toward clearer disclosure of agent status and net revenue recognition, not increased merchant risk or payment processing responsibilities. Thus, the correctness score is very low due to fundamental factual and conceptual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 424,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "Goldman Sachs revised the structure of its executive life insurance policy disclosures between the 2023 and 2024 10-K filings by removing specific policy details from the exhibits. In the 2023 filing, the life insurance policies for Participating Managing Directors (PMDs) with Metropolitan Life Insurance Company and Pacific Life & Annuity Company were explicitly listed as Exhibits 10.12 and 10.13, including policy specifications and restrictions. However, in the 2024 filing, these specific exhibits were omitted, and no direct references to the life insurance policies for PMDs appeared in the provided pages, indicating a shift toward less detailed public disclosure of these arrangements.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It claims that the specific exhibits for the executive life insurance policies were 'omitted' in the 2024 10-K, which contradicts the ground truth: the policies were retained but renumbered from Exhibits 10.11 and 10.12 in 2023 to 10.12 and 10.13 in 2024. The LLM incorrectly frames this as a removal or reduction in disclosure, when in fact it was a reorganization. (2) The LLM introduces the term 'Participating Managing Directors (PMDs)' and claims policy specifications and restrictions were included in 2023 and removed in 2024, but the ground truth does not support this level of detail or terminology, nor does it indicate any substantive change in disclosure content. (3) The multi-hop reasoning fails: instead of recognizing the renumbering and retention as a structural update, the model incorrectly infers a move toward less transparency. (4) While the companies (Metropolitan Life Insurance Company, Pacific Life & Annuity Company) and years (2023, 2024) are correctly identified, the core claim about omission is false, severely undermining the answer. The contextual relevance is moderate because it addresses the topic of disclosure changes, but the factual foundation is flawed. Minor formatting differences in exhibit references are acceptable, but claiming removal when renumbering occurred is a significant error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 388,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "Between 2022 and 2024, the strategic importance of FBAR filters has grown due to their critical role in wireless communications, with Broadcom emphasizing their proprietary and innovative nature. In 2022, FBAR filters were highlighted as a key product leveraging internal fabrication to protect IP and accelerate time-to-market. By 2024, the company maintained this approach, continuing to manufacture FBAR filters internally using proprietary processes in the U.S. and Singapore, while outsourcing commodity processes. This strategy has strengthened Broadcom's competitive positioning by differentiating its offerings and supporting its leadership in high-performance semiconductor solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts: FBAR filters remained strategically important, were fabricated internally in both 2022 and 2024 to protect IP and accelerate time-to-market, and this internal fabrication was tied to Broadcom's competitive positioning. The answer correctly identifies the continuation of the internal manufacturing strategy and mentions proprietary processes and geographic locations (U.S. and Singapore), which are consistent with the knowledge graph. There are no numeric inaccuracies—dates (2022, 2024) and qualitative assertions are factually sound. However, the LLM omits a key evolution noted in the original answer: the expansion of the competitive landscape by 2024 to include specific competitors like Qorvo, Qualcomm, and Skyworks, and the implication of increased competitive pressure requiring reinforced IP and innovation cycles. While the LLM mentions strengthened competitive positioning, it does not reflect the heightened competitive environment, which is a significant qualitative nuance in the multi-hop reasoning. This omission prevents a perfect score but does not undermine the core correctness. The reasoning is sound and contextually relevant, with appropriate synthesis across years and strategic dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 364,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "Between 2023 and 2024, BMY's strategic positioning of Krazati evolved significantly. In 2023, Krazati was primarily focused on second-line (2L) colorectal cancer and advanced non-small cell lung cancer (NSCLC) with KRAS mutations. By 2024, following the acquisition of Mirati in January 2024, Krazati's development expanded to include first-line (1L) NSCLC in combination with a PD-1 inhibitor, as well as continued exploration in 2L colorectal cancer. Financially, the acquisition of Mirati, which included Krazati, added $4.8 billion in total consideration, with $640 million allocated to the definite-lived acquired marketed product rights for Krazati. This acquisition reflects BMY's commitment to enhancing its oncology portfolio and expanding Krazati's therapeutic applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $4.8 billion acquisition of Mirati and the $640 million allocated to Krazati's definite-lived acquired marketed product rights match the knowledge graph. The January 2024 acquisition timing is consistent with public filings. (2) The clinical development focus is accurately described: the shift from 2L NSCLC and CRC in 2023 to inclusion of 1L NSCLC in combination with a PD-1 inhibitor in 2024 is correctly identified. The LLM correctly notes ongoing development in 2L CRC and expansion into first-line NSCLC. (3) The multi-hop reasoning is sound—linking the Mirati acquisition to full control of Krazati, its regulatory approvals (FDA/EMA for 2L NSCLC and FDA for KRAS-mutated CRC), and the strategic expansion into combination therapy. (4) Minor omission: the original answer specifies trial names (KRYSTAL-17, -10, -12*), which the LLM omits, and does not explicitly mention that approvals were already secured by 2024, though this is implied. However, these are secondary details that do not undermine the core factual accuracy. Wording differs but semantic meaning is equivalent. The financial valuation component is well-addressed with precise allocation of $640M to Krazati, which exceeds the level of detail in the original. Overall, the answer is factually correct, contextually relevant, and demonstrates strong synthesis across clinical and financial dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 411,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "Between 2022 and 2023, BKNG continued to strengthen its partnerships with travel service providers by offering them broader distribution channels, enhanced inventory utilization, and access to new markets through its trusted brands and technological capabilities. In terms of financial obligations and incentives, BKNG primarily compensates travel service providers through commissions or margins on transactions, with revenue recognized when travelers begin using the booked services. The company also expanded its payments solutions, which likely improved transaction efficiency and transparency for partners. Additionally, BKNG introduced and scaled new offerings, such as flights and in-destination activities, which created additional value for partners and diversified revenue streams.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no specific numeric values, so there are no quantitative inaccuracies—this results in a high quantitative accuracy score by default. However, the original answer includes key qualitative financial indicators such as the increase in 'Deferred merchant bookings' liability and the recognition of incentives (referral bonuses, rebates, loyalty points) as a reduction of revenue, which the LLM answer omits entirely. Instead, the LLM describes general partnership benefits and payment via commissions, which, while plausible, do not reflect the specific evolution in financial obligations and incentive structures documented in the ground truth. (2) There are no numbers to verify, but the absence of concrete financial metrics like changes in liabilities or revenue recognition impacts undermines factual completeness. (3) The multi-hop reasoning is weak: the question asks for an evolution between 2022 and 2023 in BKNG’s relationship with providers, particularly regarding financial obligations and incentives. The ground truth identifies a shift from competition (2022) to dependence and incentivization (2023), supported by balance sheet changes and accounting treatments. The LLM fails to mention this strategic shift, the competitive dynamic in 2022, the increase in deferred liabilities, or the revenue-reduction treatment of incentives—core elements of the correct multi-hop synthesis. (4) The correctness score is 4 because the answer is partially relevant and factually plausible but misses the key evidence-based shift described in the original answer. It discusses general partnership enhancements but does not accurately reflect the specific financial and strategic evolution. Contextual relevance is moderate because it addresses partnerships and payments but not the core transformation in the business model.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 504,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "From 2022 to 2024, Broadcom's involvement in the development of Custom Touch Controllers remained consistent as part of their broader wireless connectivity solutions. In both years, Broadcom positioned custom touch controllers as integral components for mobile handsets and tablets, emphasizing their role in processing signals from touch screens. However, in 2024, Broadcom expanded its product context by integrating these touch controllers within a broader ecosystem of mobile device connectivity solutions, including RF semiconductors, Wi-Fi, Bluetooth, and GPS/GNSS technologies. This reflects a more strategic and integrated approach to the product lifecycle, aligning touch controllers with other key components in mobile device design and enhancing their role in delivering comprehensive connectivity and user experience solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Broadcom's involvement with Custom Touch Controllers in both 2022 and 2024 and accurately reflects their integration into wireless and mobile solutions. However, it diverges from the ground truth regarding the nature of Broadcom's evolution. The original answer emphasizes a shift from being a 'supplier' in 2022 to an 'active producer involved in design and creation' by 2024, indicating deeper engagement in the development lifecycle. The LLM answer instead frames the evolution as integration into a broader ecosystem of connectivity solutions (Wi-Fi, Bluetooth, etc.), which is contextually relevant but does not capture the core shift from component supplier to custom design partner. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model synthesizes Broadcom’s product strategy across years and infers strategic integration, but fails to correctly identify the key evolution in the product lifecycle—design and creation involvement—thus missing the central qualitative shift. (4) Contextual relevance is high because the answer discusses the right domain, products, and time frame, and plausibly interprets strategic direction, but the qualitative inaccuracy in characterizing the evolution limits correctness. Hence, correctness and qualitative accuracy are moderately scored.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 416,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "From 2023 to 2024, Union Pacific's approach to freight cars evolved by emphasizing modernization and strategic asset replacement. In 2024, the company continued to invest in acquiring freight cars to support both replacement needs and growth opportunities, aligning with its broader capital plan to enhance operational efficiency and network capacity. Additionally, the company allocated resources to modernize its locomotive fleet and invest in infrastructure projects, such as siding extensions and terminal improvements, to accommodate growing intermodal and freight demands. This reflects a shift toward not only maintaining existing assets but also proactively upgrading and expanding capacity to support long-term growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a strategic shift in Union Pacific's approach to freight cars from 2023 to 2024, noting a move toward acquisition and modernization. It also correctly frames this shift in the context of replacement and growth, which aligns with the ground truth. However, it completely omits the key quantitative data that defines the evolution: the lease buyouts of $143 million in 2024 versus $57 million in 2023. These figures are central to the original answer and provide measurable evidence of the strategic shift. Their absence significantly undermines the factual completeness and accuracy of the response. (2) No numeric values are mentioned in the LLM answer, so there is no attempt to report or compare the $143M and $57M figures. This is a critical failure in quantitative accuracy, as the dollar amounts and their year-over-year increase are essential to the ground truth. (3) The reasoning is partially sound—the model infers a strategic shift toward ownership and links it to growth and replacement, which is consistent with the source. However, it fails to support this with the multi-hop evidence (comparing lease buyout amounts across years), which is necessary for full credit. The synthesis is plausible but not grounded in the specific data. (4) The contextual relevance is high because the answer addresses the evolution in asset strategy and ties it to broader capital planning. However, the lack of specific financial data and direct comparison between 2023 and 2024 lease buyouts results in a correctness score of 5—partially correct but missing key factual support. Quantitative accuracy is scored very low (1) due to complete omission of numbers, qualitative accuracy is moderate (6) for reasonable but unsupported reasoning, and contextual relevance is strong (8) as the overall theme is appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 504,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike's structural changes in APLA between FY2022 and FY2023, particularly the transition of certain businesses to third-party distributors, had mixed financial and operational impacts. Revenues for APLA increased from $5,955 million in FY2022 to $6,729 million in FY2024, indicating growth despite the transition. However, EBIT for APLA remained relatively stable, rising slightly from $1,896 million in FY2022 to $1,885 million in FY2024, suggesting that the structural changes did not significantly impact profitability. Operationally, the transition likely reduced Nike's direct operational footprint in APLA, shifting some responsibilities to third-party distributors.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Nike transitioned from direct operations to a strategic stake in APLA with third-party distributors, involving non-recurring impairment charges due to foreign currency translation losses, but the LLM fails to mention any of these key financial impacts. Instead, it fabricates revenue and EBIT figures for APLA in FY2022 and FY2024 (e.g., $5,955M and $6,729M revenues, ~$1.89B EBIT), which are not present in the original answer and cannot be verified from the provided knowledge. Moreover, the original answer does not provide any financial metrics like revenue or EBIT for APLA, so these numbers are hallucinated. (2) The use of FY2024 data is incorrect — the question asks about FY2022 to FY2023, but the LLM references FY2024, which is outside the requested timeframe and not supported by the source. This undermines both quantitative accuracy and entity accuracy. (3) While the LLM correctly identifies the operational shift — reducing direct footprint and transitioning to third-party distributors — this is only a partial match to the original answer’s deeper reasoning about strategic divestiture, Note 18 disclosures, and foreign currency impacts. The multi-hop synthesis is weak: it misses the connection between structural change, accounting implications (non-cash cumulative translation losses), and reporting changes via divestiture disclosures. (4) The contextual relevance is moderate because the answer addresses the general topic of structural changes and operational impact, but fails on factual correctness and precision. Due to major hallucinations of numbers and time periods, along with missing core financial consequences, the correctness score is low despite some alignment on operational direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 494,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "From 2022 to 2024, Broadcom's involvement with InP lasers has remained a strategic focus within their internal fabrication strategy. In both years, Broadcom highlighted the use of InP lasers for fiber optic communications as part of their proprietary processes, which are manufactured internally to protect IP and accelerate time-to-market. In 2022, InP lasers were mentioned alongside GaAs-based lasers for fiber optic applications, while in 2024, the description remained consistent, emphasizing continued reliance on internal fabrication for these advanced laser technologies. This consistency suggests a stable internal strategy, with Broadcom maintaining a competitive edge in high-speed optical communications through its proprietary III-V semiconductor fabrication capabilities in the U.S. and Singapore.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Broadcom's continued use of internal fabrication for InP lasers from 2022 to 2024 and accurately notes their application in fiber optic communications using proprietary processes. It correctly states that fabrication occurs internally in the U.S. and Singapore, which aligns with the ground truth's implication of internal capabilities. There are no numeric inaccuracies (quantitative accuracy is perfect), and the timeframes (2022, 2024) are correctly referenced. However, the LLM misses a key qualitative shift highlighted in the original answer: in 2024, Broadcom began explicitly naming competitors like Coherent Corp. and Lumentum Holdings Inc., signaling a strategic emphasis on competitive positioning. The LLM instead emphasizes 'consistency' and 'stable internal strategy,' which downplays the evolution in Broadcom's external messaging and competitive differentiation strategy. While the core facts about internal fabrication and InP laser use are correct, the answer fails to capture the multi-hop insight that Broadcom's disclosure strategy evolved to highlight competitive dynamics, which is central to the question about 'competitive positioning.' This omission reduces qualitative accuracy. Contextual relevance remains high as the response directly addresses Broadcom's InP laser strategy and fabrication approach across the specified years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 384,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "Between 2022 and 2023, Swoosh, LLC maintained its significant ownership stake in NIKE, holding approximately 77% of Class A Common Stock as of June 30, 2022, and continuing to hold the same percentage as of June 28, 2024. This ownership structure grants Swoosh, LLC substantial influence over NIKE's governance, as holders of Class A Common Stock elect three-quarters of the Board of Directors. The stability in ownership implies continued concentrated control by the Knight family, specifically Travis Knight, who plays a key role in managing Swoosh, LLC's holdings. This concentration of voting power could limit shareholder influence and potentially deter hostile takeovers or external strategic shifts without Swoosh, LLC's approval.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Swoosh, LLC maintained approximately 77% ownership of NIKE's Class A Common Stock between 2022 and 2023, which aligns with the ground truth. However, the LLM incorrectly references ownership data as of June 28, 2024, which is outside the requested 2022–2023 timeframe and not supported by the original answer. This introduces a factual inaccuracy in timing, though the core percentage is correct. The 16% implied ownership in Class B Common Stock (if converted) is omitted in the LLM answer, representing a partial omission of quantitative detail. (2) The 77% figure is accurate for Class A ownership in both years according to the ground truth, but the LLM extends the claim to 2024 without basis, reducing quantitative accuracy. The missing 16% Class B conversion figure weakens completeness. (3) The reasoning about governance influence is sound: the LLM correctly infers that Class A stock elects most of the board and that Travis Knight’s role in Swoosh, LLC implies sustained control. This reflects proper multi-hop synthesis between ownership structure, voting rights, and governance implications. (4) Despite the date and omission issues, the LLM captures the essential conclusion about concentrated control and limited shareholder influence, making the answer contextually relevant and qualitatively strong. The correctness score is reduced primarily due to the incorrect date reference and missing Class B conversion percentage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 410,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "From 2022 to 2023, PMI's strategic positioning of Reduced-Risk Products (RRPs) evolved through portfolio integration and expanded market availability. In 2022, PMI acquired Swedish Match, a leader in oral nicotine delivery, enhancing its RRP portfolio with complementary products like ZYN nicotine pouches. By 2023, PMI integrated Swedish Match's operations into its regional structure and updated its segment reporting to include these results. Additionally, smoke-free products were available in 84 markets by December 31, 2023, reflecting expanded global availability and a stronger focus on transitioning adult smokers to better alternatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of smoke-free product availability to 84 markets by the end of 2023, which matches the ground truth. It also accurately references the 2022 acquisition of Swedish Match and the integration of its products (e.g., ZYN) into PMI's portfolio, which supports the strategic evolution of Reduced-Risk Products (RRPs). However, the LLM omits a key element from the ground truth: the reclassification of RRPs into a broader category called Smoke-Free Products (SFPs) that now includes wellness and healthcare offerings. Instead, it focuses on the acquisition and integration of Swedish Match without explicitly noting the change in reporting structure or category expansion beyond oral nicotine. (2) Quantitatively, the answer is accurate — '84 markets by December 31, 2023' aligns with the ground truth, and the 2022 acquisition date is correct. No calculations are required, and all dates/numbers are precise. (3) The reasoning is partially sound: the LLM correctly links the Swedish Match acquisition to portfolio enhancement and reports expanded market availability, showing multi-hop understanding. However, it fails to fully synthesize the conceptual shift in product categorization (RRPs → SFPs), which is central to the strategic repositioning described in the original answer. (4) The contextual relevance is high, as the response addresses both portfolio integration and market availability. The qualitative accuracy is reduced due to the omission of the rebranding and broadening of the product category, which is a significant strategic move. Thus, while the core facts around market count and acquisition are correct, the answer lacks full completeness on the portfolio integration aspect, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 488,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "Caterpillar's strategic role in the reciprocating engines business from 2022 to 2024 has shifted toward emphasizing high-margin applications such as data center power generation and gas compression, which contributed to favorable price realization and a 3% increase in Energy & Transportation sales. This strategic focus, particularly in large reciprocating engines and turbine-related services, enhanced the segment's gross margin potential, as evidenced by a rise in profit as a percentage of sales from 17.6% in 2023 to 19.9% in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The original answer states that Caterpillar evolved from selling reciprocating engines through its dealer network and Perkins in 2022 to including remanufacturing of its own and third-party engines by 2024, thus shifting to a full lifecycle service provider model. In contrast, the LLM answer claims Caterpillar shifted toward high-margin applications like data centers and gas compression, with specific financial metrics such as a 3% sales increase and gross margin rising from 17.6% to 19.9%. These specific figures and strategic focuses (data centers, gas compression, turbine-related services) are not present in the ground truth and contradict the actual evolution described. (2) Quantitatively, the LLM introduces precise but unsupported numbers: '3% increase in Energy & Transportation sales', '17.6% in 2023 to 19.9% in 2024'—none of which appear in the original answer or can be verified from the provided context. These figures are therefore factually inaccurate. (3) The reasoning is flawed: the LLM fails to identify the core multi-hop evolution—expansion from product sales to remanufacturing and service provision—and instead fabricates a narrative around market applications and margin expansion without grounding in the source. It does not mention remanufacturing, lifecycle services, or the role of Perkins or distributors, missing the key strategic shift. (4) While the LLM attempts to address revenue composition and gross margin impact, it does so with incorrect mechanisms (price realization in niche markets vs. lower-cost remanufacturing). The contextual relevance is moderate because it discusses margin potential and revenue, but the underlying facts and logic are misaligned with the ground truth, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 498,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon maintained its commitment to disclosing amendments to the Directors' Code of Conduct by posting updates on its website. In both years, the company stated its intention to disclose amendments or waivers of the Directors' Code of Conduct on its website. However, in 2023, there was a slight enhancement in transparency, as the specific website link for the Directors' Code of Conduct was updated to a new URL, indicating a more current or reorganized online disclosure structure. No additional mechanisms beyond website disclosure were explicitly outlined in either year.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but introduces a detail not present in the ground truth, affecting factual accuracy. (1) The core fact that BNY Mellon disclosed amendments via website posting in both years is correct and aligns with the original answer. There are no numeric values to verify, so quantitative accuracy is not applicable beyond this consistency—scored as 10 due to absence of numerical errors. (2) However, the claim that in 2023 there was a 'slight enhancement in transparency' with a 'new URL' is not supported by the ground truth, which explicitly states there was no change in mechanism or transparency commitment. This addition misrepresents the consistency emphasized in the original answer. (3) The reasoning is sound in structure—comparing disclosures across years—but fails in multi-hop synthesis because it infers an improvement not present in the data, contradicting the 'stable governance communication strategy' conclusion. (4) Contextual relevance is high as the response addresses the question's focus on mechanisms and transparency. However, the incorrect inference reduces qualitative accuracy. Correctness is scored at 6 due to mostly accurate facts but a significant deviation in interpretation that alters the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 351,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "Between FY22 and FY23, Nike's strategic approach to the APLA market evolved through a shift in operational structure, particularly with the planned transition of its businesses in certain APLA countries to third-party distributors. In FY22, Nike announced agreements to sell its legal entities in Argentina, Uruguay, and Chile, which were classified as held-for-sale. This transition from a direct-to-consumer and wholesale model to a distributor model aimed to reduce selling and administrative expenses and mitigate foreign exchange risks. By FY23, this strategic realignment was reflected in the operational structure, with the APLA segment continuing to focus on optimizing its market participation through a more streamlined and cost-effective approach, aligning with Nike's broader Consumer Direct Acceleration strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the shift in Nike's APLA strategy from direct operations in FY22 to transitioning to third-party distributors by FY23, which matches the core evolution described in the original answer. The mention of Argentina, Uruguay, and Chile as countries where legal entities were sold adds specific detail not in the ground truth but consistent with plausible expansion of the same concept. (2) There are no numeric values (percentages, dollar amounts, etc.) in either answer, so quantitative accuracy is not compromised—no errors in dates or fiscal years (FY22 and FY23 are correctly referenced). (3) The multi-hop reasoning is sound: the LLM synthesizes operational structure changes (direct to distributor model) with strategic intent (cost reduction, FX risk mitigation, alignment with Consumer Direct Acceleration), which represents a logical and deeper interpretation of the strategic shift. The original answer does not mention cost or FX motivations, but these are reasonable inferences supported by typical business logic and do not contradict the ground truth. (4) The LLM answer is semantically equivalent and slightly more detailed, covering both operational structure and market participation as required by the question. The only minor gap is that the original emphasizes APLA’s contribution to 14% NIKE Direct growth in FY22, which the LLM omits. This is a small but relevant contextual detail about market performance that would strengthen completeness. However, since the question focuses on 'strategic approach' rather than financial performance per se, this omission does not severely impact correctness. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 493,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "From 2022 to 2024, the impact of favorable price realization on Caterpillar's sales and profitability has shifted. In 2022, favorable price realization contributed to a 22% increase in sales and a 51% rise in operating profit, driven by higher demand and strategic pricing. By 2024, while sales decreased slightly by 3%, favorable price realization in Energy & Transportation partially offset lower sales volume and improved operating profit margin to 20.2% from 19.3% in 2023. Thus, favorable price realization remained a key profitability driver, though its impact on sales growth diminished as demand softened in some segments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that favorable price realization contributed $9.223 billion to sales in 2022, but the LLM claims a '22% increase in sales' and '51% rise in operating profit'—neither of which are supported by the original data. There is no mention of percentage increases in the ground truth, nor any reference to operating profit margins rising to 20.2% in 2024 from 19.3% in 2023. Additionally, the LLM states that sales decreased by 3% in 2024, which is not mentioned in the original answer. The ground truth emphasizes that favorable price realization offset a $2.251 billion decrease in sales volume and helped increase profit from $10.335B to $10.792B, but the LLM does not mention these exact figures or the multi-year profit trend. (2) The quantitative inaccuracies are severe: none of the percentages (22%, 51%, 3%, 20.2%, 19.3%) appear in the ground truth, and no calculations in the LLM answer can be verified against the provided data. The actual dollar contributions and profit increases are entirely omitted or misrepresented. (3) While the LLM captures the general qualitative trend—that favorable pricing helped maintain profitability despite volume declines—it fails at multi-hop synthesis: it does not connect the specific financial impacts across 2022–2024 using the correct figures or causal relationships (e.g., price realization offsetting volume decline). The reasoning is plausible but based on fabricated metrics. (4) The answer is contextually relevant and addresses the evolution of price realization’s impact on sales and profitability, showing awareness of shifting dynamics. However, the complete lack of alignment with actual numbers and key facts (dollar impacts, exact profit figures) severely undermines correctness. The model appears to hallucinate metrics while mimicking the structure of a plausible financial narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 523,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "Between 2023 and 2024, General Motors' approach to EV manufacturing capacity evolved by emphasizing strategic scaling and supply chain development. In 2023, GM focused on building EV manufacturing capabilities and reducing battery costs, while also addressing supply chain constraints and sourcing sufficient materials for battery production. By 2024, the company shifted to developing a more resilient, scalable, and sustainable North American-focused EV supply chain, including strategic investments in raw material suppliers and multi-year supply agreements. Additionally, GM refocused its autonomous vehicle strategy on personal vehicles, aiming to integrate ADAS technology into future EV models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GM's 2023 focus on building EV manufacturing capacity, addressing supply chain constraints, and reducing battery costs matches the original answer's emphasis on investments amid demand uncertainty and high fixed costs. The 2024 shift toward a resilient, scalable, and sustainable North American-focused supply chain, including strategic sourcing and multi-year agreements with raw material suppliers, is accurately reflected. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in strategic focus and supply chain development across two years. The only minor deviation is the addition of GM's refocused autonomous vehicle strategy on personal vehicles and ADAS integration, which, while potentially relevant to GM's broader EV strategy, is not mentioned in the ground truth and slightly extends beyond the scope of the question. This does not introduce inaccuracy but adds unverified detail. (4) The answer is contextually relevant, directly addressing both strategic focus and supply chain development as required. The semantic meaning matches the original answer, with only slight expansion on autonomous vehicles. Thus, the correctness score is 9—excellent accuracy with a minor overextension.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 401,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid, as reflected in remaining performance obligations, decreased significantly from 2022 to 2024. In 2022, the remaining performance obligations for Paxlovid totaled approximately $18.9 billion, which dropped to $1.28 billion in 2023 and further to $1 billion by 2024. This decline is primarily due to the transition of Paxlovid from government contracts to commercial markets and the recognition of revenue as products were delivered.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states that Pfizer did not disclose specific remaining performance obligations for Paxlovid in 2022, but the LLM claims a figure of $18.9 billion, which is false. Similarly, the LLM invents a $1.28 billion figure for 2023, which is not supported by the ground truth. While the $1 billion figure for 2024 matches the ground truth, the rest of the numerical timeline is fabricated. (2) Completeness: The question asks about the evolution from 2022 to 2024 based on 10-K filings. The LLM fails to correctly represent the starting point (2022), which is critical for the multi-hop comparison. (3) Entity Accuracy: The company (Pfizer) and product (Paxlovid) are correct, and the metric (remaining performance obligations) is correctly identified, but the years and associated figures are wrong. (4) Reasoning: The reasoning is flawed because it assumes a decreasing trend from $18.9B to $1B, which contradicts the ground truth that no such obligation was disclosed in 2022. The explanation about transition to commercial markets may be contextually plausible but is not supported by the provided ground truth and distracts from the factual error. (5) Semantic Equivalence: The LLM suggests a decline in commitment, while the ground truth shows an emergence of a defined commitment from an undefined state—these are opposite narratives. Thus, despite mentioning the correct $1B 2024 figure, the overall answer is factually incorrect and misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 429,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "Between 2022 and 2023, Caterpillar has enhanced its approach to monitoring supplier financial viability by strengthening risk mitigation strategies and contractual agreements. The company continues to emphasize supplier financial viability as a key risk factor, but in 2023, there is a more explicit focus on leveraging global strategic sourcing models to build long-term supplier relationships and ensure timely delivery of materials. Additionally, Caterpillar employs a variety of agreements with suppliers to protect its intellectual property and processes, with increased attention to monitoring risks such as supplier financial stability, production flexibility, and business continuity. These contractual measures aim to mitigate potential business disruptions caused by supplier-related issues.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Caterpillar maintained its monitoring of supplier financial viability from 2022 to 2023 and increased emphasis on it in 2023. The use of various supplier agreements to protect intellectual property and mitigate risks is correctly noted for both years. The enhanced focus on global strategic sourcing models in 2023 to build long-term relationships is accurately reflected. (2) There are no numeric values (e.g., dollar amounts, percentages) in the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years, identifying continuity in monitoring practices while highlighting the intensified emphasis in 2023. The only minor shortcoming is that the LLM does not explicitly state that 'supplier financial viability' was listed as the *first* risk in 2023 disclosures, which slightly weakens the precision of the evolution claim. However, stating a 'more explicit focus' captures the essence. (4) The answer is fully contextually relevant, directly addressing changes in risk mitigation strategies and contractual agreements. Overall, the response conveys semantic equivalence with the original answer, with only a minor omission in specificity about the ordering of risk factors in the 2023 filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 396,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa's Risk and Identity Solutions have evolved to become more integrated within its value-added services, with a stronger strategic focus on leveraging AI and machine learning to enhance fraud prevention and authentication capabilities. In 2024, Visa introduced new products such as Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme-agnostic Visa Advanced Authorization, which are designed to reduce fraud across various payment types, including A2A and card-not-present transactions. These advancements reflect a more proactive and comprehensive approach to risk management, positioning Visa as a leader in secure digital payment solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct and relevant but misses key aspects of the ground truth regarding the strategic evolution of Visa's Risk and Identity Solutions between 2022 and 2024. (1) What was correct: The answer correctly identifies an increased strategic focus on risk and identity solutions by 2024, including integration into value-added services and the use of AI/ML for fraud prevention. It also accurately references specific 2024 products like Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme-agnostic capabilities, which align with Visa’s expanded service offerings. These details reflect a more proactive and comprehensive approach, consistent with the broader trend described in the ground truth. (2) Quantitative accuracy: There are no numeric values, dates, or financial figures in either the original or LLM answer beyond the years 2022 and 2024, which are used correctly. No calculation errors. (3) Multi-hop reasoning assessment: The LLM fails to capture the core structural evolution described in the ground truth — specifically, the shift to a clear three-pillar strategic framework (services for Visa transactions, network-agnostic services, and services beyond payments). This framework is central to the 2024 strategic positioning and represents the key multi-hop insight: that Risk and Identity Solutions were not just technologically enhanced but repositioned within a more structured and scalable service architecture. The LLM focuses on product-level innovations rather than the strategic reorganization and integration into value-added services as a whole. (4) Justification for scores: Correctness is scored 6 because while the answer reflects a plausible and contextually accurate direction of evolution (enhanced capabilities, new products), it omits the fundamental strategic repositioning that defines the ground truth. Qualitative accuracy is 6 due to missing conceptual framework and overemphasis on technology over strategic structure. Quantitative accuracy is 10 because no numbers are incorrect. Contextual relevance is 9 because the answer addresses the general theme and timeframe accurately, even if missing the precise strategic dimension.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 593,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "Between 2022 and 2023, Colgate-Palmolive's exposure to shelf space limitations as a risk factor remained significant but showed signs of mitigation through expansion into alternative retail channels. In 2022, the company highlighted risks from retail customer policies, including limitations on shelf space and inventory destocking, which could reduce sales or profitability. By 2023, while these risks persisted, the company emphasized its efforts to adapt to the evolving retail landscape by expanding into eCommerce and direct-to-consumer (DTC) channels, which helped offset some pressures from traditional retail constraints. This shift reflects a strategic response to both retail customer policies and changing consumer preferences.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though with minor differences in emphasis. (1) Factual correctness: The answer correctly identifies that in 2022, shelf space limitations and retail customer policies (including inventory destocking) were highlighted as risks. In 2023, it accurately notes the continued impact and the company's strategic shift toward eCommerce and DTC channels as a response. However, the original answer emphasizes that by 2023 the risk had evolved from potential to actively experienced, which the LLM answer softens to 'risks persisted' and 'efforts to adapt'—missing the stronger assertion of active impact. (2) Quantitative accuracy: No specific numbers are involved in the question or answers; dates (2022, 2023) are correct. (3) Multi-hop reasoning: The LLM correctly synthesizes information across years and channels, connecting shelf space risks with adaptation via digital expansion. It captures the evolution in strategy but slightly underrepresents the escalation from 'risk' to 'active challenge' as stated in the ground truth. (4) Contextual relevance: Fully addresses the question about evolution of shelf space limitations in relation to retail policies and alternative channels. The mention of Colgate-Palmolive is consistent with the knowledge graph context (implied company). Overall, the answer is factually sound and relevant, with only a slight shortfall in capturing the full nuance of the risk's escalation, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 418,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "Between fiscal years 2023 and 2024, Oracle has increasingly emphasized hybrid deployments as part of its broader cloud strategy, particularly through offerings like Oracle Exadata Cloud@Customer and Dedicated Region solutions. In 2023, the company highlighted the flexibility of hybrid models to meet customer needs, while in 2024, it expanded on this by introducing programs to help customers migrate existing workloads to Oracle Cloud while retaining hybrid options. This reflects a strategic shift toward promoting Oracle Cloud Services while ensuring continued support for hybrid and on-premise environments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately identifies Oracle's hybrid deployment offerings such as Exadata Cloud@Customer and Dedicated Region, and correctly characterizes Oracle's emphasis on flexibility in 2023 and expanded support in 2024. The strategic shift toward deeper integration with hybrid environments is captured, though the LLM frames it slightly more around migration programs than the ground truth's emphasis on product integrations and interoperability. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes Oracle's evolving strategy across two fiscal years and links product offerings to strategic emphasis. However, the LLM omits the specific mention of 'customer-managed cloud and on-premise IT environments' and the goal of making deployments 'more interoperable and extensible,' which are key nuances in the original answer. (4) Contextual relevance is perfect—the response directly addresses the evolution in product offerings and strategic emphasis. The slight reduction in qualitative and overall correctness scores reflects the minor omission of depth in describing 2024's product integrations and services, even though the core message about continued support and strategic expansion remains accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 409,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid significantly decreased between 2022 and 2024. In 2022, Paxlovid contributed $18,933 million in revenues, whereas in 2023, this dropped to $1,279 million, and further declined to $5,716 million in 2024. Additionally, the remaining performance obligations for Paxlovid as of December 31, 2024, were approximately $1 billion, compared to much higher contracted revenue expectations in 2022. This reflects a substantial reduction in both immediate and future revenue commitments related to Paxlovid.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in financial figures. The ground truth does not provide specific revenue numbers for Paxlovid in 2022, 2023, or 2024, but the LLM claims $18,933 million in 2022, $1,279 million in 2023, and $5,716 million in 2024 — none of which are supported by the original answer. These numbers appear fabricated or misattributed. While the $1 billion remaining performance obligations as of December 31, 2024, is correctly stated, the comparison to 'much higher contracted revenue expectations in 2022' is speculative and not quantified in the ground truth. (2) The original answer makes no mention of year-by-year revenue figures, nor does it support a 'significant decrease' with such specific numbers. The LLM introduces data not present in the source, leading to severe quantitative inaccuracy. (3) The reasoning partially captures the idea of reduced financial commitment over time and correctly identifies the $1 billion in remaining obligations extending to 2028, which reflects some correct multi-hop synthesis. However, the unsupported revenue figures undermine the logical foundation. (4) The contextual relevance is moderate because the answer addresses the evolution of financial commitment and future obligations, aligning with the question's intent, but the inclusion of false quantitative data severely compromises correctness. Thus, the correctness score is low due to critical factual errors, despite some structural alignment with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 417,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "Between 2022 and 2023, Caterpillar's relationship with its independent dealers remained structured under standard sales and service agreements, emphasizing the dealers' role in promoting and servicing Caterpillar products within defined geographic territories. There is no explicit mention of significant changes to contractual obligations during this period. However, the strategic emphasis appears to have shifted toward enhancing dealer performance and support, as reflected in the company's focus on dealer development, promotion of product sales, and maintaining a strong global dealer network to serve 191 countries.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses a key factual shift described in the ground truth. While it correctly notes that Caterpillar operates under standard sales and service agreements and emphasizes dealer roles in product promotion and service, it incorrectly states there is 'no explicit mention of significant changes' in contractual obligations between 2022 and 2023. The ground truth clearly indicates a shift from a general partnership model in 2022 to a more formalized, structured contractual framework in 2023 with standardized agreements, specific dealer obligations (e.g., maintaining personnel, financial record access), and a strategic move toward greater control and accountability. This evolution is central to the question and is underemphasized in the LLM response. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in this regard, scoring 10 by default. (3) The multi-hop reasoning is flawed: the model fails to synthesize the change over time (2022 vs 2023) in contractual structure, which requires comparing two years of disclosures. The LLM treats the relationship as static, missing the evolution from general to formalized agreements, which is a critical qualitative distinction. (4) Contextual relevance is high because the answer discusses dealer roles, territories, and strategic emphasis, which are relevant, but it lacks the depth of change emphasized in the original answer. Thus, correctness and qualitative accuracy are moderate due to significant omission of the contractual formalization in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 443,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "From 2022 to 2023, Colgate-Palmolive's financial allocation and operational focus related to Africa/Eurasia showed modest changes in capital expenditures and restructuring charges. Capital expenditures for Africa/Eurasia increased from $13 million in 2022 to $33 million in 2023, indicating a higher investment in the region. Regarding restructuring charges, Africa/Eurasia accounted for 9% of the total charges in 2022 and 5% in 2023 under the 2022 Global Productivity Initiative, suggesting a reduced emphasis on restructuring in the region in 2023 compared to the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that capital expenditures for Africa/Eurasia increased from $13 million in 2022 to $33 million in 2023, when the ground truth shows the opposite: capex was $33 million in 2022 and there is no indication of an increase in 2023. In fact, the original answer indicates a strategic shift away from capital investment toward restructuring. Additionally, the LLM claims Africa/Eurasia accounted for 9% of restructuring charges in 2022 and 5% in 2023 under the 2022 Global Productivity Initiative, but the ground truth states that approximately 10% of the *cumulative* pretax charges from that initiative relate to Africa/Eurasia—without breakdowns by year or percentages for 2022 vs 2023. These numbers (9%, 5%) are fabricated. (2) The quantitative inaccuracies are severe: dollar amounts are swapped between years, and specific percentages are invented without support. The direction of change in capex is reversed, which fundamentally misrepresents the trend. (3) The multi-hop reasoning is flawed. The original answer synthesizes capex trends (2020–2022) with forward-looking restructuring plans in 2023 to infer a strategic shift. The LLM fails this synthesis, instead asserting increased investment and decreased restructuring—directly contradicting the ground truth’s conclusion of a pivot from growth to cost optimization. (4) Scores reflect major factual errors in numbers and trends (correctness: 2), very poor quantitative accuracy (2), weak reasoning and entity use (3), but partial relevance to the question’s topic (6), as it addresses financial allocation and restructuring in the correct region and timeframe, albeit incorrectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 471,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "Qualcomm's strategic focus on 5G technologies from 2022 to 2024 has evolved with increased investment in AI integration and expanding commercialization into new industries like automotive and IoT. In 2022, the emphasis was on developing foundational 5G technologies and enhancing product portfolios for mobile and emerging sectors. By 2024, Qualcomm had advanced its 5G commercialization through modem-to-antenna platforms, such as the Snapdragon 5G modem-RF products, and deepened its commitment to AI-driven performance improvements. Additionally, the company continued to invest in R&D and strategic acquisitions to support 5G adoption in automotive and IoT applications, reflecting a broader and more diversified approach to 5G innovation and market expansion.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's strategic focus on 5G from 2022 to 2024 and mentions key areas like automotive, IoT, and R&D investment, which aligns with the original answer. However, it introduces 'AI integration' and 'AI-driven performance improvements' as central elements of the 5G strategy, which are not mentioned in the ground truth and represent an addition not supported by the source. While Qualcomm may have integrated AI, the ground truth emphasizes patent development and licensing monetization, particularly through QTL revenues from OFDMA-based products, which the LLM answer omits entirely. The transition from investment phase to commercialization and market leadership via patent licensing—a core evolution—is missing. (2) There are no numeric values, percentages, or dollar amounts in either answer, so quantitative accuracy is not applicable; no errors in dates or formats. (3) The multi-hop reasoning is partially sound: the model connects 5G development across years and industries, but fails to synthesize the critical shift from R&D investment to monetization via licensing, which is the key evolution in the ground truth. The LLM focuses on product platforms like Snapdragon 5G modem-RF but does not reference the commercial outcome in terms of revenue sources or patent leadership, which is a significant omission. (4) The contextual relevance is high because the answer addresses 5G strategy evolution, investment, and commercialization in relevant sectors. However, the absence of the monetization phase and overemphasis on AI—without grounding in the source—reduces factual accuracy. Thus, while the answer is plausible and contextually aligned, it misses the core factual progression described in the ground truth, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 493,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Between 2022 and 2024, Paxlovid's revenue contribution to Pfizer significantly declined, dropping from $18,933 million in 2022 to $5,716 million in 2024. This decline was driven by the transition from government contracts to commercial market sales, including a non-cash revenue reversal of $3.5 billion in 2023 related to returned EUA-labeled doses. Contractual commitments also evolved, with amended agreements allowing for flexibility in delivery schedules and future pandemic preparedness, such as the 2023 agreement with the U.S. government and the creation of a Strategic National Stockpile (SNS) for 1.0 million treatment courses.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies, particularly in quantitative data. The original answer states that Paxlovid generated $76 million in revenue in 2022, but the LLM claims $18,933 million (i.e., $18.9 billion), which is over 250 times higher and factually incorrect. Similarly, the LLM states 2024 revenue as $5,716 million ($5.7 billion), while the original answer does not provide a 2024 revenue figure but instead references $1 billion in remaining performance obligations—these are not equivalent; performance obligations are contractual future commitments, not recognized revenue. The $3.5 billion non-cash reversal in 2023 is not mentioned in the original answer and appears fabricated. (2) The numbers are entirely inconsistent with the ground truth: $76M vs $18,933M in 2022 and an unsupported $5.7B projection for 2024. The calculation of decline is therefore invalid. The $1 billion in remaining performance obligations for future Paxlovid deliveries is misrepresented in the LLM answer as current revenue. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers a revenue decline and attributes it to market transition and non-cash reversals not present in the original data. While it correctly identifies evolving contractual commitments, it invents specific agreements (e.g., 2023 U.S. government amended contract, Strategic National Stockpile of 1.0 million courses) that are not in the original answer. (4) The contextual relevance is moderate—the answer addresses revenue trends and contracts, which are relevant, but the qualitative and quantitative inaccuracies severely undermine correctness. Due to massive numerical errors and invented details, the correctness score is low at 2, quantitative accuracy is 1, qualitative accuracy is 3 (some conceptual alignment on contracts), and contextual relevance is 6 (on-topic but incorrect).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 512,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "The company's exposure to credit market tightness as a supply chain risk increased between 2022 and 2023. In 2022, the risk was mentioned in the context of potential supplier challenges due to tighter credit or capital markets. By 2023, the risk was more explicitly highlighted, with specific reference to the impact of tighter credit or capital markets on suppliers and the broader list of disruptions, including geopolitical conflicts and climatic events. This evolution indicates a heightened vulnerability to external financial conditions, reflecting a more complex and volatile operating environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in identifying the evolution of the company's exposure to credit market tightness between 2022 and 2023, with accurate qualitative context about supplier challenges and broader disruptions. The dates (2022 and 2023) and entities (credit market tightness as a supply chain risk) are correctly identified, satisfying entity accuracy. There are no numerical values in the question or answers, so quantitative accuracy is not applicable in a traditional sense but is scored as 10 due to absence of any numeric errors. The reasoning correctly captures a shift in framing—from supplier-level impact in 2022 to a more explicit recognition in 2023—but slightly mischaracterizes the evolution as an 'increase in exposure' and 'heightened vulnerability,' whereas the original answer emphasizes a shift in perspective (from supplier impact to broader operational impact) rather than a clear escalation in risk level. The original answer notes a 'more integrated perspective' rather than necessarily greater vulnerability, which the LLM overstates. Additionally, the LLM introduces 'geopolitical conflicts and climatic events' as part of the 2023 framing, which were not mentioned in the ground truth and are extraneous, indicating a minor hallucination. Despite this, the core multi-hop reasoning—comparing risk language across years to infer changing vulnerability—is sound and contextually relevant. Thus, the answer is factually aligned in key aspects but contains subtle interpretive overreach, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 430,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "Pfizer's financial commitment and contractual obligations related to Paxlovid significantly evolved from 2022 to 2024. In 2022, Paxlovid generated $18,933 million in revenues, driven by government contracts for emergency use. By 2023, revenues dropped to $1,279 million due to a non-cash revenue reversal of $3.5 billion in Q4 2023, reflecting expected returns of EUA-labeled Paxlovid inventory by the U.S. government. In 2024, Paxlovid revenues rebounded to $5,716 million, supported by a $771 million favorable adjustment from returned inventory and a $442 million revenue recognition for supplying 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) for pandemic preparedness. These figures reflect a transition from government contracts to commercial market sales and adjustments in contractual obligations under revised agreements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the revenue figures and timing of events. The ground truth states that as of December 31, 2024, Pfizer had approximately $1 billion in remaining performance obligations for Paxlovid, with delivery expected from 2025 to 2028, and a $771 million favorable adjustment related to returned EUA-labeled treatment courses. However, the LLM incorrectly reports Paxlovid revenues for 2022 ($18.933B), 2023 ($1.279B), and 2024 ($5.716B), which are not supported by the ground truth and contradict the narrative of contractual evolution. The $3.5 billion non-cash revenue reversal in Q4 2023 is not mentioned in the original answer and appears fabricated. While the $771 million favorable adjustment is correctly identified, it is miscontextualized as part of 2024 revenues rather than a contractual adjustment tied to prior returns. The $442 million for 1.0 million treatment courses to the SNS is not mentioned in the ground truth. (2) Quantitative accuracy is low: none of the revenue numbers (e.g., $18.933B, $1.279B, $5.716B) are present in the original answer, and the $3.5B reversal is unsupported. Only the $771M adjustment is correct. (3) The reasoning is partially sound in identifying evolving contractual dynamics and government returns, but fails the multi-hop synthesis by inventing revenue figures and misrepresenting the nature of financial commitments. The original answer focuses on future performance obligations ($1B), not past revenues. (4) Contextual relevance is high—the answer addresses the evolution of financial commitments and contractual obligations and correctly identifies key themes like government returns and adjustments. However, the invented figures severely undermine factual correctness, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 500,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "The financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation decreased slightly from 2023 to 2024. As of December 31, 2023, the Company had an accrual of $62 million for Aearo-related liabilities, while by December 31, 2024, this amount had reduced to $51 million. This reduction suggests a potential decrease in estimated future claims or a shift in liability allocation among co-defendants. However, the Company continues to emphasize that the actual liability could be significantly higher due to uncertainties in projecting future claims and the complexity of allocating responsibility among multiple parties.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, 3M (MMM) had a $574 million accrual for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy with litigation stayed. The LLM incorrectly states that as of December 31, 2023, there was a $62 million accrual specifically for Aearo-related liabilities, which contradicts the ground truth. The only correct number is the $51 million accrual in 2024 for Aearo-related asbestos, silica, and coal mine dust claims. (2) The quantitative inaccuracies are severe: the $62 million figure for 2023 is unsupported by the ground truth, and no such number appears in the original answer. The reduction from $62M to $51M is therefore based on false premises. Additionally, the LLM omits the critical $574M non-Aearo liability and the bankruptcy context in 2023. (3) The multi-hop reasoning is flawed. The LLM fails to recognize that in 2023, Aearo was in bankruptcy with a stay of litigation—meaning liability was not actively managed through accruals at that time. It also omits the key contractual arrangement with Cabot, where Cabot assumed pre-1997 exposure liability in exchange for a $100,000 quarterly fee, which is central to understanding the 2024 liability framework. (4) While the LLM correctly identifies the $51M 2024 accrual and notes ongoing uncertainty in liability estimation, it misrepresents the 2023 situation entirely and misses the structural shift from bankruptcy stay to active liability management via contractual sharing. Hence, despite some relevant context and correct mention of co-defendant complexity, the factual core is incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 470,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline of 1.7 share points. This decline contrasts with the shipment volume trend between 2020 and 2021, where Skoal's shipment volume decreased only slightly (from 208.5 million to 197.4 million), indicating a more stable retail share during that period compared to the sharper decline observed in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the retail share decline from 9.3% in 2023 to 7.6% in 2024 and the shipment volume drop from 208.5 million to 197.4 million packs/cans between 2020 and 2021. All numeric values and dates are accurate, satisfying quantitative accuracy. (2) However, the reasoning and interpretation are flawed. The LLM states that the shipment volume decrease was 'only slight' and suggests 'more stable retail share during that period,' which misrepresents the data. The original answer correctly identifies that both metrics show a consistent downward trend, whereas the LLM incorrectly frames the 2020–2021 shipment decline as stability, which contradicts the downward trend. (3) The multi-hop synthesis is partially correct—both time periods and metrics are correctly identified—but the comparative analysis is logically unsound. The LLM fails to recognize that both trends are downward and instead implies a contrast where there should be alignment. (4) Therefore, while numbers are perfect (quantitative accuracy = 10), the reasoning is significantly flawed (qualitative accuracy = 5), dragging down the overall correctness. Contextual relevance is high as the answer addresses the right entities and timeframes, but the misinterpretation reduces its usefulness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 361,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "From 2022 to 2024, Qualcomm's approach to multimedia technologies has evolved with a stronger focus on AI integration and expanding into new industries. In 2022, the company emphasized multimedia technologies such as camera, video, display, and computer vision as part of its broader R&D efforts. By 2024, Qualcomm had deepened its engineering focus in AI, including generative AI, with an emphasis on power efficiency and personalization across diverse applications. Additionally, multimedia technologies were increasingly integrated into product offerings beyond mobile handsets, such as automotive systems (connectivity, digital cockpit, ADAS/AD) and IoT, reflecting Qualcomm's strategy to diversify into new markets and leverage AI advancements to enhance performance and value for customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: Qualcomm's 2022 focus on camera, video, display, and computer vision as part of broader R&D; the 2024 expansion into AI, particularly generative AI; and the integration of multimedia technologies into automotive (digital cockpit, ADAS/AD) and IoT. The evolution from hardware-centric to a more platform-oriented, AI-enhanced strategy is accurately conveyed, though the term 'platform-oriented' is implied rather than explicitly stated. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2022, 2024), which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in engineering focus and product integration across time and industries. The emphasis on enabling developers across device categories is captured in spirit through the mention of diversification and AI-driven personalization, though slightly less explicitly than in the original. (4) The answer is contextually excellent—directly addresses both engineering focus areas and integration into product offerings across the specified timeframe. The only minor gap is the slightly less explicit mention of 'developer enablement' as a strategic shift, but the core evolution in strategy is correctly captured. Thus, the answer is factually complete and semantically equivalent, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 425,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "Between 2023 and 2024, 3M's financial relationship with the Aearo Entities evolved significantly. In 2023, 3M reconsolidated the Aearo Entities after the dismissal of their bankruptcy proceedings, which resulted in an immaterial income statement impact. At the end of 2022, 3M had a $0.7 billion equity investment in the Aearo Entities and a $0.6 billion net liability for intercompany balances. By the end of 2023, these balances were no longer reflected in the consolidated balance sheet due to reconsolidation. In 2024, 3M continued its financial commitment through the CAE Settlement, contributing a total of $6.0 billion between 2023 and 2029 to resolve litigation related to Combat Arms Earplugs, with payments made in cash rather than stock.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that 3M reconsolidated the Aearo Entities in 2023 and that the $0.7 billion equity investment and $0.6 billion net liability were removed from the consolidated balance sheet as a result. However, it incorrectly states that these balances were from the end of 2022, while the ground truth specifies they were removed as of December 31, 2023, due to reconsolidation. This misplacement of timing undermines the accuracy. Additionally, the LLM introduces the CAE Settlement and $6.0 billion contribution over 2023–2029, which, while contextually related to Aearo litigation, is not part of the financial relationship evolution in terms of equity investment and intercompany balances as asked. This shifts focus away from the structural change in consolidation and retained equity interest. (2) Quantitatively, the $0.7 billion and $0.6 billion figures are accurate in amount but misattributed in timing. The $6.0 billion figure is not relevant to the specific question about equity and intercompany balances and appears to conflate separate disclosures. (3) The multi-hop reasoning is partially sound—reconsolidation leading to removal of balances is correct—but fails to correctly characterize the 2024 status. The ground truth states that by 2024, Aearo was no longer consolidated and 3M now 'has a stake in' them, indicating a retained equity interest. The LLM does not mention this shift in consolidation status or retained equity, instead pivoting to litigation payments, which reflects a failure in synthesizing the correct financial structure change. (4) The contextual relevance is high because the answer discusses related events and entities, but correctness and qualitative accuracy are reduced due to factual misplacement and introduction of irrelevant financial commitments. The core evolution—reconsolidation in 2023 and transition to equity stake in 2024—is only partially captured, with key details omitted or distorted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 548,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "Between 2022 and 2024, Visa's Risk and Identity Solutions have evolved significantly, enhancing their strategic positioning within the broader value-added services portfolio. In 2022, these solutions focused on leveraging data for fraud prevention and account authentication, offering tools like Visa Advanced Authorization, Visa Secure, and CardinalCommerce. By 2024, the suite expanded with the introduction of the Visa Protect suite, which includes AI-powered solutions such as Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme-agnostic Visa Advanced Authorization. These advancements reflect a stronger integration of artificial intelligence and machine learning, positioning Risk and Identity Solutions as a central pillar in Visa's efforts to secure both card-present and card-not-present transactions, as well as non-card flows like A2A payments.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Visa's Risk and Identity Solutions from a fraud prevention focus in 2022 to a more advanced, AI-driven suite by 2024, which aligns with the question's intent. It correctly identifies key products from 2022 such as Visa Advanced Authorization and Visa Secure, and adds CardinalCommerce, which is plausible but not mentioned in the ground truth. The introduction of the 'Visa Protect' suite and specific tools like Visa Deep Authorization and Visa Risk Manager are not present in the original answer; these represent over-specificity or potential hallucination, as the ground truth does not name new product suites introduced in 2024 beyond stating that over 200 products and services existed as of September 30, 2024. The strategic shift toward broader integration within a diversified services portfolio is partially captured, but the LLM misses the key structural point that Risk and Identity Solutions became one of five core categories alongside new areas like Open Banking and Advisory Services—this repositioning is central to the 2024 strategic evolution and is omitted. While the emphasis on AI and machine learning is a reasonable inference, it is not explicitly stated in the ground truth. There are no numerical inaccuracies (dates like 2022 and 2024 are correct), so quantitative accuracy is high. However, the qualitative accuracy is reduced due to incomplete multi-hop synthesis: the answer fails to connect the evolution of Risk and Identity Solutions to the broader reorganization of the value-added services portfolio. Contextual relevance is strong as the response stays focused on the evolution and strategic role of the solutions. Overall, the answer is partially correct with plausible details but lacks key structural and strategic elements from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 494,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "RTX's Acquisition Accounting Adjustments' impact on operating profit remained relatively consistent between 2023 and 2024, with adjustments of $1,998 million in 2023 and $2,058 million in 2024. These adjustments primarily consist of amortization of acquired intangible assets and property, plant, and equipment fair value adjustments, with minor variations across the segments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that RTX did not provide a quantitative figure for 2024; instead, it shifted to qualitative disclosure. However, the LLM asserts a specific number ($2,058 million) for 2024, which is not supported by the original answer and contradicts the key point of reduced transparency. The 2023 figure of $1,998 million is correct. (2) The quantitative accuracy is severely flawed: while $1,998 million in 2023 matches the ground truth, the $2,058 million for 2024 is fabricated. No such number appears in the original answer, and the absence of 2024 quantification is the central evolution in disclosure. (3) The multi-hop reasoning fails: the question asks about the evolution in disclosure *and* quantification between years. The LLM only reports numbers and misses the critical shift from quantitative to qualitative disclosure in 2024, which is the main point of the original answer. (4) Contextual relevance is moderate because the answer discusses the right topic (Acquisition Accounting Adjustments at RTX) and mentions relevant components like amortization, but it misrepresents the key development—reduced numerical transparency in 2024—as a continued numerical trend. Thus, correctness and quantitative accuracy are very low, qualitative accuracy is low due to flawed reasoning, and contextual relevance is mid-range due to topical alignment but factual divergence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 404,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "Between fiscal years 2022 and 2023, Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud increased from $44.97 billion in 2022 to $54.88 billion in 2023, representing a significant growth of $9.91 billion or 22%. This growth trajectory indicates that Office 365 Commercial is becoming an increasingly dominant component of Microsoft's cloud ecosystem, reflecting strong adoption of its productivity and collaboration tools in commercial markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth does not provide specific revenue figures for Office 365 Commercial in FY2022 or FY2023. The LLM claims Office 365 Commercial revenue was $44.97B in 2022 and $54.88B in 2023, which are not stated or implied in the original answer. These numbers are fabricated. The only revenue figures in the ground truth are the total Microsoft Cloud revenue: $91.4B in FY2022 and $111.6B in FY2023. (2) The calculation of $9.91B growth at 22% is based on incorrect inputs and is therefore invalid. The original answer does not break out Office 365 Commercial revenue from the Microsoft Cloud total, so no such precise figure can be derived. (3) The multi-hop reasoning is flawed. While the LLM correctly infers that Office 365 Commercial is part of Microsoft Cloud growth, it incorrectly assumes a standalone revenue figure that was never disclosed. The original answer emphasizes that Office 365 Commercial was subsumed into a broader disclosed cloud revenue figure in FY2023, not that it was broken out. (4) The contextual relevance is moderate because the answer addresses the evolution and growth trajectory theme, and correctly identifies Office 365 Commercial as a growing component of the cloud ecosystem. However, the use of false quantitative data severely undermines correctness. The qualitative reasoning about increasing dominance has some alignment with the original's implication of continued growth, but lacks the nuance about reporting transparency changes. Thus, correctness and quantitative accuracy are very low, qualitative accuracy is low due to flawed synthesis, and contextual relevance is mid-range due to thematic alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 468,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Merck's alliance revenue related to Lynparza increased by 9% in 2024 compared to 2023, primarily driven by higher demand in most international markets. Factors contributing to this growth include the expansion of Lynparza's use in various cancer treatments and the approval of new indications, such as its approval in China in January 2025 for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer based on the OlympiA trial.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 9% growth in alliance revenue for Lynparza from 2023 to 2024, which matches the ground truth. This satisfies the core quantitative aspect of the question. However, the LLM introduces a specific approval event—Lynparza's approval in China in January 2025 for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer based on the OlympiA trial—which is not present in the original answer and pertains to a date (January 2025) outside the 2023–2024 timeframe. This detail, while potentially relevant to future growth, is not cited in the ground truth as a factor for the 2024 revenue increase and may be speculative or misaligned temporally. (2) Quantitatively, the 9% growth figure is accurate and correctly attributed to 2024 vs. 2023. There are no calculation errors. However, the original answer notes that in 2023, Lynparza revenue was part of broader alliance revenue reporting, which the LLM omits, reducing completeness. (3) The multi-hop reasoning is partially sound—linking increased demand to revenue growth is valid—but the addition of a 2025 regulatory event as a contributing factor for 2024 performance introduces an unsupported causal link. The ground truth attributes growth to higher international demand without citing specific regulatory approvals. (4) The answer is contextually relevant and addresses both parts of the question—evolution of revenue and contributing factors—but includes extraneous, unverified information that affects qualitative accuracy. The core facts are correct, but the reasoning contains assumptions not grounded in the provided truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 453,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "The Procter & Gamble 2014 Stock and Incentive Compensation Plan is no longer active for future grants, as it is not listed among the plans allowing for future issuances in either the 2023 or 2024 filings. The 2019 Stock and Incentive Compensation Plan is the only active plan as of 2024, with 77 million shares available for future issuance. There is no indication of regulatory changes affecting the 2014 Plan's treatment between 2023 and 2024, and it remains included in equity compensation reporting as a historical plan.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but significantly diverges from the ground truth in key aspects. (1) It incorrectly states that the 2014 Plan is 'no longer active for future grants' and not listed in 2023 or 2024 filings, which contradicts the original answer indicating its continued disclosure and integration into equity compensation reporting. The claim that only the 2019 Plan is active is unsupported by the ground truth, which does not make such a determination. (2) The specific number of 77 million shares available under the 2019 Plan is plausible but not verifiable from the provided ground truth, which does not include quantitative details about share availability—thus introducing unconfirmed data. (3) The reasoning fails on multi-hop synthesis: the question asks about the evolution in treatment and disclosure of the 2014 Plan, particularly regarding regulatory context and equity reporting, but the LLM incorrectly infers inactivity rather than recognizing the shift from regulatory disclosure to integrated equity transparency as described in the original answer. (4) While the mention of the 2014 Plan being included as a historical plan aligns loosely with 'equity compensation reporting,' it misses the nuanced evolution—integration into broader ownership structure reporting—which is the core of the ground truth. The answer is contextually relevant to the topic but fundamentally misrepresents the nature and evolution of the plan's treatment, leading to a low correctness score despite some surface-level plausibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 426,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "The 1992 Stock Plan is no longer an active source of future equity compensation grants, as it is not listed as allowing for future issuances in the 2024 filing, unlike in the 2023 filing. The 2024 filing explicitly states that only the 2019 Stock and Incentive Compensation Plan permits future grants, indicating that the 1992 Plan has been superseded and no longer plays a role in the company's current equity compensation structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that the 1992 Stock Plan is no longer active for future grants in the 2024 filing and that only the 2019 plan allows future issuances, which aligns with the broader trend in the ground truth. However, it overstates the conclusion by claiming the 1992 Plan 'no longer plays a role' in the equity compensation structure, whereas the original answer notes it is still included in a consolidated table for shares authorized upon exercise—indicating it still has a passive, administrative role (e.g., for outstanding options). The LLM incorrectly implies complete obsolescence rather than a transition to a tracked, legacy status. There are no numeric inaccuracies (dates: 1992, 2019, 2023, 2024 are correct), so quantitative accuracy is high. Qualitative accuracy is moderate: reasoning is partially sound but misses the nuance of continued inclusion in disclosures, reflecting a failure in multi-hop synthesis—specifically, interpreting the significance of being listed in a consolidated table. Contextual relevance is strong as the response directly addresses the evolution of the plan’s role over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 320,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "Between 2023 and 2024, the company has observed that clients have increasingly prioritized large-scale transformations, which convert to revenue over a longer period. This shift reflects a strategic emphasis on extended, complex projects rather than shorter-term engagements, as macroeconomic and geopolitical uncertainties have slowed spending on smaller, shorter-duration contracts and consulting services during fiscal 2024. The evolving focus underscores a trend toward more sustained client commitments and longer revenue conversion timelines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the key qualitative points: in both 2023 and 2024, clients prioritized large-scale transformations over smaller, shorter-duration contracts, especially amid macroeconomic and geopolitical uncertainties. It accurately reflects that spending on consulting services and smaller contracts slowed or was deferred. The emphasis on longer revenue conversion timelines for large-scale transformations is correctly conveyed. (2) There are no quantitative figures in the original answer, so the absence of numbers in the LLM response is appropriate; thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—synthesizing client spending patterns and revenue conversion timelines across two years from the filings. The only minor shortcoming is that the LLM implies an 'increasing' prioritization ('increasingly prioritized') between 2023 and 2024, while the original answer states the emphasis was consistent ('reiterated', 'ongoing shift'), not necessarily intensifying. This slight overstatement slightly affects qualitative accuracy. (4) The response is fully contextually relevant, directly addressing the evolution of emphasis, client spending, and revenue conversion timelines. Overall, the answer is factually correct and well-synthesized, meriting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 380,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "In fiscal 2024, Accenture issued $7,869,000 worth of Class A Ordinary Shares for employee share programs, compared to $8,883,000 in fiscal 2023, indicating a decrease in issuance. This issuance contributed to an increase in additional paid-in capital and impacted retained earnings, while also slightly increasing the total number of Class A Ordinary Shares outstanding.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Accenture issued $7,869,000 worth of shares in 2024 and $8,883,000 in 2023, implying a decrease in issuance. However, the ground truth states that in 2023, Accenture did not issue shares for employee programs but instead acquired shares via withholding for tax obligations. In 2024, the company issued 7,970 actual shares (not dollars) for employee programs—this is a qualitative shift from acquisition to issuance, not a decrease in dollar value. The LLM misrepresents both the direction and nature of the change. (2) The numbers are fundamentally incorrect: the ground truth reports share counts (7,970 issued in 2024), not dollar amounts. The LLM’s dollar figures ($7.87M, $8.88M) do not match any data in the original answer and appear fabricated. Additionally, the LLM fails to mention the purchase of 12,181 treasury shares or the change in equity structure: Class A shares increasing from 15,656,591 to 15,664,561 and treasury shares decreasing in value from $(3,408,491) million to $(6,678,037) million. (3) The multi-hop reasoning is flawed. The question requires synthesizing changes in share issuance behavior and their impact on equity. The LLM incorrectly frames the trend as a decrease in issuance when it should be a shift from share acquisition (2023) to net issuance (2024). It also misses the structural impact on treasury shares and total equity. (4) The contextual relevance is moderate—the answer discusses employee share programs and equity impact, which are relevant topics—but the factual and quantitative errors severely undermine correctness. Due to major errors in numbers, direction of change, and missing key structural impacts, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 482,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ's exposure to Canadian-denominated debt instruments decreased slightly between 2022 and 2023, with the notional amount of Canadian dollar notes dropping from $443 million in 2022 to $453 million in 2023. This minimal change contrasts with the broader trend of reducing exposure to other foreign currency-denominated debt, such as Swiss franc and euro notes, during the same period. Overall, the company appears to be managing its foreign currency risk by adjusting the composition of its net investment hedges, though Canadian dollar exposure remained relatively stable compared to other currencies.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both direction and magnitude. According to the ground truth, MDLZ's Canadian-denominated debt *increased by $8 million* in 2023, reversing a prior downward trend. The LLM incorrectly states that exposure *decreased* from $443M to $453M (which is actually an increase of $10M, not a decrease). Furthermore, the absolute values cited ($443M and $453M) are completely fabricated and do not align with the ground truth, which reports Canadian notes at $3M in 2022 and an $8M increase in 2023 (implying $11M in 2023). (2) The quantitative inaccuracies are severe: the LLM misrepresents both the trend (decrease vs actual increase) and the scale (hundreds of millions vs actual single-digit millions). The claim of a drop from $443M to $453M is mathematically incoherent (that’s an increase, not a drop). (3) The multi-hop reasoning fails: the model does not recognize the reversal in trend from decreasing (2019–2022) to increasing (2023), which is central to the question. It also mischaracterizes the broader trend—while Euro and Swiss franc notes did decline, the LLM incorrectly frames Canadian exposure as 'stable' when it actually reversed course. (4) The contextual relevance is low because the answer discusses the right topic (foreign currency debt management) but with entirely wrong data and conclusions. The qualitative reasoning is flawed due to incorrect entity values and misinterpretation of trends. Only minimal credit is given for addressing foreign currency debt and mentioning other currencies like euro and Swiss franc.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 438,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024 by enhancing strategic involvement and expanding investment activity through its innovation ecosystem. In 2023, the focus was on leveraging emerging technologies and incubating innovations via Accenture Ventures and Labs. By 2024, the company formalized its commitment to innovation by receiving SBTi approval for net-zero targets and increasing R&D spending to $1.2 billion, while also deepening partnerships with growth-stage companies through targeted investments and co-creation of scalable solutions. This reflects a more integrated and forward-looking strategy to drive long-term value and sustainability.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Accenture's evolving engagement with growth-stage companies and references accurate R&D spending figures ($1.2 billion in fiscal 2024), which aligns with the ground truth. However, it inaccurately characterizes the evolution as 'deepening partnerships' and 'targeted investments' without clearly capturing the key shift from 'partnering with' in 2023 to 'invests in' in 2024, which represents a strategic pivot from collaboration to direct investment. This core nuance is missing, weakening the qualitative accuracy. Additionally, the mention of SBTi approval and net-zero targets, while factually plausible for Accenture, is irrelevant to the question about engagement with growth-stage companies and distracts from the main evolution in investment strategy. (2) Quantitatively, the $1.2 billion R&D figure for 2024 is correct; however, the ground truth also includes $1.3 billion for 2023, which the LLM omits, reducing completeness. No calculations are required, so numerical precision is otherwise acceptable. (3) The multi-hop reasoning is partially sound—Accenture Ventures and innovation ecosystem are correctly invoked—but the synthesis between 2023 partnership model and 2024 investment shift is not explicitly drawn. The answer implies progression but mislabels it as enhanced partnership rather than a structural shift to direct investment. (4) Contextual relevance is high because the response stays focused on Accenture’s innovation strategy, but the inclusion of sustainability goals introduces off-topic information. The core strategic evolution—central to the question—is under-articulated, justifying a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 463,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "From 2022 to 2024, Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca has shown growth in alliance revenue, with a 9% increase in 2024 compared to 2023 and a 7% increase in 2023 compared to 2022. Alliance revenue for Lynparza was $1,311 million in 2024, $1,199 million in 2023, and $1,116 million in 2022. In terms of asset amortization, the intangible asset balance related to Lynparza, which includes capitalized sales-based and regulatory milestone payments, was $1.1 billion at December 31, 2021, and is being amortized over its estimated useful life through 2028.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several correct elements but introduces significant inaccuracies. The ground truth states that alliance revenue grew by 9% in 2024 due to international demand, but does not provide year-over-year growth for 2023 or specific revenue figures for 2022–2024. The LLM fabricates precise revenue numbers ($1,311M, $1,199M, $1,116M) and a 7% growth rate for 2023, which are not present in the original answer and cannot be verified from the provided truth. This severely impacts quantitative accuracy. (2) The $1.1 billion intangible asset balance is correctly cited, but the original answer specifies it was as of 2022, while the LLM states it was as of December 31, 2021—this is a factual misalignment. However, the amortization through 2028 is correctly reported. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the shift from amortization to revenue growth and ties in strategic context, though it overextends by adding unsupported data. (4) The original answer emphasizes a strategic shift and future approval in China (2025), which the LLM omits entirely, missing a key strategic evolution. Despite this, the core themes—amortization of $1.1B asset through 2028 and increased alliance revenue in 2024—are addressed with reasonable qualitative accuracy. Contextual relevance is high as all content directly addresses the question’s focus on financial and strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 399,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "AVGO's strategic emphasis on ValueOps has shifted from being one of three equal domains in the Distributed Software portfolio in 2023 to being highlighted as a central component in 2024. In 2023, ValueOps was listed alongside DevOps and AIOps as a domain, while in 2024, it is positioned as a key solution under the Distributed Software portfolio with a specific focus on value stream management and aligning business and development teams. This shift indicates that ValueOps is playing a more prominent role in AVGO's strategy to optimize the planning, development, and delivery of business-critical services, emphasizing its importance in driving business outcomes and operational efficiency.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in AVGO's strategic emphasis on ValueOps between 2023 and 2024. It accurately states that in 2023, ValueOps was one of three domains (alongside DevOps and AIOps), and in 2024 it gained prominence. The core facts about the evolving role—increased focus on value stream management, alignment of business and development teams, and driving business outcomes—are consistent with the ground truth. However, the LLM slightly misrepresents the nature of the shift: the original answer clarifies that in 2024, the distributed software solutions are explicitly 'organized in the domains of' DevOps, AIOps, and ValueOps, indicating a structural elevation, whereas the LLM implies ValueOps became more central without fully capturing that all three are now foundational pillars. The ground truth emphasizes ValueOps' new role in providing 'end-to-end visibility across all stages of the digital lifecycle,' a specific capability missing in the LLM answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored 10 by default as no errors exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and strategic contexts, identifying a progression in ValueOps' role. The reasoning accurately infers strategic intent from structural changes in portfolio organization. (4) The answer is contextually relevant and captures the essence of the strategic evolution. The correctness score is 8 due to the omission of the 'end-to-end visibility' detail and slight mischaracterization of the 2023 structure (it was already a domain, not merely 'listed as one of several key offerings'), but the overall qualitative and factual alignment is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 491,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "Between 2023 and 2024, FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolved to focus on improving the efficiency of package pickup, transportation, and delivery in the U.S. and Canada. In 2023, Network 2.0 was introduced as part of the DRIVE transformation to enhance long-term profitability. By 2024, the company had announced Tricolor, a redesign of the Federal Express international air network as part of the DRIVE program, aiming to improve efficiency and asset utilization. However, the implementation of Network 2.0 and related initiatives faced risks, including potential higher-than-expected costs, less-than-expected savings, and operational disruptions. The DRIVE transformation also introduced challenges such as labor-related issues, integration complexities, and the need to manage unforeseen expenses or delays.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but misses key aspects of the evolution in FedEx's strategic approach to Network 2.0 between 2023 and 2024 as detailed in the ground truth. (1) Correctly identifies that Network 2.0 was part of the DRIVE transformation and aimed at improving efficiency and long-term profitability. It also notes implementation risks such as higher-than-expected costs and operational disruptions, which aligns with the general risk theme. However, it introduces 'Tricolor'—a redesign of the international air network—as part of Network 2.0, which is not mentioned in the original answer and appears to be extraneous or misattributed information, potentially confusing the scope of Network 2.0 (which focuses on U.S. and Canada ground operations in the context provided). (2) Quantitative accuracy is high: there are no specific numerical figures (e.g., cost savings amounts) in either the original or LLM answer, so no numeric inaccuracies exist. The years 2023 and 2024 are correctly used. (3) Multi-hop reasoning is partially sound—the model attempts to contrast 2023 and 2024 strategies—but fails to accurately represent the shift from investment justification and expected efficiencies in 2023 to integration complexities and financial risks (e.g., asset impairments, tax impacts, litigation) in 2024. The original answer emphasizes a transition in tone and focus from strategic optimism to operational and financial risk mitigation, which the LLM answer does not fully convey. (4) Contextual relevance is strong because the response stays on topic and discusses Network 2.0 within DRIVE, but the inclusion of Tricolor and lack of mention of specific 2024 risks like harmonizing operating practices, labor/cultural differences, and customer agreement maintenance reduces qualitative accuracy. Overall, the answer is partially correct but lacks precision in representing the strategic evolution and introduces potentially misleading details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 529,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "Between 2022 and 2023, the financial impact from equity method investment contracts shifted from a liability of $3 million in 2022 to a gain of $7 million in 2023. This indicates that MDLZ's engagement with these investments transitioned from a neutral or slightly negative impact to a modestly positive one, likely reflecting improved performance or favorable valuation changes in the underlying equity method investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift from a $3 million liability in 2022 to a $7 million gain in 2023, matching the ground truth in both magnitude and direction of change. All numeric values and years are accurate. (2) Quantitative accuracy is perfect: the dollar amounts ($3 million liability, $7 million gain) and years (2022, 2023) are correctly reported, with no calculation errors. (3) The reasoning is sound and captures the essence of a positive shift in financial impact. The LLM infers improved performance or favorable valuation changes, which aligns with the ground truth's suggestion of more active or favorable engagement. However, it slightly underplays the strategic or operational shift emphasized in the original answer, instead characterizing the change as a transition to a 'modestly positive' impact without explicitly noting the reversal or potential strategic shift. (4) The answer is fully contextually relevant, directly addressing both parts of the question—evolution of financial impact and implications for MDLZ's engagement. The minor omission of the term 'reversal' and less emphasis on strategic shift prevent a perfect qualitative score, but overall, the answer is factually correct, well-reasoned, and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 356,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases decreased from fiscal year 2023 to fiscal year 2024, dropping from $38 million to $38 million (no change in the estimated cost to complete). However, the percentage of completion increased from 67% to 100%, as the project was released during fiscal year 2024. This indicates that the development progress for this release was completed on schedule, aligning with the expected release date and demonstrating that the project met its development milestones as planned.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the estimated cost to complete remained at $38 million from fiscal year 2023 to 2024, which matches the ground truth. However, it incorrectly implies a decrease by saying 'decreased... dropping from $38 million to $38 million,' which is factually inaccurate—there was no decrease. This mischaracterization undermines the quantitative interpretation. The percentages (67% to 100%) are plausible given project completion, but they are not present in the original answer or ground truth data, introducing unverified information. (2) The dollar amount ($38 million) is accurate and consistently reported. The claim of 'no change' in cost is correct, but the framing as a 'decrease' is misleading and factually wrong. (3) The reasoning about development progress being on schedule aligns with the ground truth’s conclusion, but the LLM bases this on invented percentage completion data rather than the stability of cost estimates as the actual evidence. This reflects flawed multi-hop reasoning—while the conclusion is directionally reasonable, it is supported by fabricated metrics. (4) The answer is contextually relevant and addresses both parts of the question—evolution of cost and what it indicates about progress. However, the introduction of unsupported percentages and the incorrect characterization of a 'decrease' reduce factual reliability. The core cost figure is correct, but the reasoning pathway is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 405,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "Between 2023 and 2024, the strategic positioning of FedEx Office's Ship and Go kiosk has evolved by emphasizing seamless integration with e-commerce logistics and returns management. The kiosk allows customers to generate shipping labels via mobile or QR code and drop off packages in secure bins, streamlining the shipping process. Additionally, FedEx Office facilitates returns through FedEx Returns Technology, enabling in-store printing of return labels and offering consolidated returns with no box or label required. This evolution reflects FedEx's broader commitment to enhancing customer convenience and supporting the growing e-commerce market by providing efficient, technology-enabled logistics and returns solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of the Ship and Go kiosk from 2023 to 2024, noting its continued presence in approximately 1,300 locations and core functionality, while highlighting the increased emphasis on returns integration in 2024. It accurately reflects that the kiosk enables label generation via mobile/QR code and secure drop-off. The mention of FedEx Returns Technology and Consolidated Returns aligns with the ground truth. The only minor omission is that the LLM does not explicitly state that the 2023 description did not emphasize returns integration, which slightly weakens the contrast between years. However, the overall strategic shift toward positioning Ship and Go as part of a broader returns infrastructure is correctly inferred. (2) There are no numeric values in the question or answer that require calculation or verification (e.g., 'approximately 1,300 locations' is correctly implied as consistent across years), so quantitative accuracy is fully preserved. (3) The multi-hop reasoning is sound: the model synthesizes information about the kiosk’s functionality, its role in e-commerce logistics, and its enhanced role in returns management across two time points. It correctly links Ship and Go to FedEx Returns Technology and Consolidated Returns, demonstrating understanding of the strategic evolution. (4) The answer is contextually highly relevant, directly addressing both parts of the question—evolution of strategic positioning and implications for e-commerce logistics and returns. The conclusion about FedEx's commitment to customer convenience and e-commerce support is a valid interpretation. The qualitative accuracy is slightly reduced due to the lack of explicit contrast in emphasis between 2023 and 2024, but the core insight remains intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 493,
        "total_tokens": 1912
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 1000,
    "failed_evaluations": 0,
    "average_correctness_score": 5.75,
    "average_quantitative_accuracy": 6.71,
    "average_qualitative_accuracy": 6.05,
    "average_contextual_relevance": 8.22,
    "score_distribution": {
      "excellent": 237,
      "good": 197,
      "fair": 301,
      "poor": 265
    }
  },
  "original_experiment_metadata": {
    "model": "qwen3-32b",
    "experiment": "e2_page_window",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 1387.76,
    "timestamp": "2026-02-03T20:49:09.683652"
  }
}